SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a)

of the Securities Exchange Act of 1934

 

Filed by the Registrant     x

Filed by a Party other than the Registrant     ¨

 

Check the appropriate box:

 

¨Preliminary Proxy Statement
¨Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2))
xDefinitive Proxy Statement
¨Definitive Additional Materials
¨Solicitation Material Pursuant to Rule 14a-11(c) or rule 14a-12

 

PHOTOMEDEX, INC.FC GLOBAL REALTY INCOPORATED

(Name of Registrant as Specified in its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

xNo fee required.
¨Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

1)Title of each class of securities to which transaction applies:
2)Aggregate number of securities to which transaction applies:
3)Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11:
4)Proposed maximum aggregate value of transaction
5)Total fee paid:

 

¨Fee paid previously with preliminary materials.

 

¨Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

(1)Amount Previously Paid:
(2)Form, Schedule or Registration Statement No.:
(3)Filing Party:
(4)Date Filed:

 

 

 

 

PHOTOMEDEX, INC.FC GLOBAL REALTY INCORPORATED 

2300 Computer Drive, Building G

Willow Grove, Pennsylvania 19090

 

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

 

To be held on September 14, 2017November 29, 2018

 

To the Stockholders of PhotoMedex, Inc.:FC Global Realty Incorporated:

 

Notice is hereby given that an annual meeting of the stockholders of PhotoMedex, Inc.FC Global Realty Incorporated (the “Company”) will be held on September 14, 2017November 29, 2018 at 9:30 a.m. local time at The Cornell Club - New York, 6 East 44th Street, New York, NY 10017.2300 Computer Drive, Building G, Willow Grove, Pennsylvania 19090. At the annual meeting you will be asked to consider and vote upon the following proposals:

 

1.To approve an amendment and restatement of the Amended and Restated Articles of Incorporation of the Company to, among other things, change the name of the Company to “FC Global Realty Incorporated,” increase the number of authorized shares of common stock, $.01 par value per share, of the Company from fifty million (50,000,00) shares to five hundred million (500,000,000) shares, and increase the number of authorized shares of preferred stock, $.01 par value per share, of the Company from five million (5,000,000) shares to fifty million (50,000,000) shares.

2.To approve the issuance of securities oftransactions contemplated by that certain remediation agreement, dated September 24, 2018, among the Company, pursuant to that certain Interest Contribution Agreement, dated March 31, 2017, by and among First Capital Real Estate Operating Partnership, L.P., a Delaware limited partnership (the “Contributor”), First Capital Real Estate Trust Incorporated, a Maryland corporation (the “Contributor Parent”), FC Global Realty Operating Partnership,Opportunity Fund I-SS, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company (the “Acquiror”), and the Company (the “Contribution Agreement”), under which the Contributor has agreed to contribute certain real estate assets to the Acquiror, and in exchange, the Company has agreed to issue to the Contributor or its designees shares of the Company’s common stock and Series A Convertible Preferred Stock and, if certain additional real estate assets are contributed to the Acquiror, a warrant for the purchase of shares of common stock (the “Contribution Transaction”). Also under the Contribution Agreement, all outstanding compensation liabilities owed by the Company to Dr. Dolev Rafaeli, Dennis M. McGrath and Yoav Ben-Dror will be converted into secured convertible promissory notes. TheCompany’s common stock is listed on the NASDAQ Capital Market and, as a result, the Company is subject to NASDAQ’s Listing Rules. The potential consummation of the Contribution Transaction implicates certain of NASDAQ’s Listing Rules requiring prior stockholder approval in order to maintain the Company’s listing on the NASDAQ Capital Market,(the “Remediation Agreement), including (i)NASDAQ Listing Rule 5635(a), which requiresstockholder approval prior to the issuance of securities in connection with the acquisition of the stock or assets of another company if the common stock has or will have upon issuance voting power equal to or in excess of 20% of the voting power outstanding before the issuance of stock or securities convertible into or exercisable for common stock, or if the number of shares of common stock to be issued is or will be equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the stock or securities,and (ii)NASDAQ Listing Rule 5635(b), which requires stockholder approval when any issuance or potential issuance will result in a “change of control” of the issuer. In order to comply with these NASDAQ Listing Rules, the Company would need to obtain the approval of its stockholders prior to the issuance of all securities as contemplated by the Contribution Transaction, including thesecured convertible promissory notes. Accordingly, prior to stockholder approval at the annual meeting, theContributor has received a number of shares of common stock equal to up to 19.9% of the issued and outstanding common stock of the Company immediately prior to the initial closing of the Contribution Transaction and the balance of the shares shall be paid in the Company’s Series A Convertible Preferred Stock. At the annual meeting, stockholders will be asked to approve the issuance of shares of the Company’s common stock upon conversion of the Series A Convertible Preferred Stock, the issuance of the warrant, the issuanceconversion of shares of commonpreferred stock upon exercise of the warrant, the issuance of the secured convertible promissory notes, and the issuance of shares of common stock upon conversion of the secured convertible promissory notes, all as more particularly described in the accompanying proxy statement.that have been issued thereunder.

 

3.2.To approve aauthorize the Company’s Board of Directors, in its discretion, to implement one or more reverse stock splitsplits of the shares of the Company’s common stock at an exchange ratio of not less than 1-for-2 and not more than 1-for-7 and to authorize the Company’s Board of Directors, in its discretion, to implement such reverse stock split at an exchange ratio within this range and to do so1-for-15 at any time prior to the Company’s 20182019 annual meeting of stockholders by filing an amendment to the Company’s Amended and Restated Articles of Incorporation.

 

3.To adopt the FC Global Realty Incorporated 2018 Equity Incentive Plan (the “Plan”) to provide for long-term incentives in the form of grants of stock, stock options and other forms of incentive compensation to officers, employees, directors and consultants.

4.To elect seven (7)five (5) director nominees to the Company’s Board of Directors to serve until the next annual meeting of the Company’s stockholders or until their successors are elected and qualify, subject to their prior death, resignation or removal.

 

5.To ratify the appointment of Fahn Kanne & Co. Grant Thornton Israel to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2017.2018.

 

6.To approve the adjournment of the annual meeting for any purpose, including to solicit additional proxies if there are insufficient votes at the time of the annual meeting to approve the proposals described above.

 

The Board unanimously recommends a vote “FOR” the amendment and restatementapproval of the Company’s Amended and Restated Articles of Incorporation, “FOR” the issuance of securities under the ContributionRemediation Agreement, “FOR” approval of the reverse stock split,split(s), “FOR” adoption of the Plan , “FOR” each of the director nominees, “FOR” the ratification of the Company’s independent registered public accounting firm, and “FOR” the proposal to approve the adjournment of the annual meeting for any purpose, including to solicit additional proxies if there are insufficient votes at the time of the meeting to approve the proposals mentioned above.

 

Stockholders of record of the Company’s common stock at the close of business on July 21, 2017October 25, 2018 will be entitled to notice of, and are cordially invited to attend, the annual meeting and to attend any adjournment or postponement thereof.However, to assure your representation at the meeting, please vote your proxy via the internet, by telephone, or by completing, dating, signing and returning the enclosed proxy. Even if you have previously submitted your proxy, you may choose to vote in person at the meeting. Whether or not you expect to attend the annual meeting, please read the proxy statement and then promptly vote your proxy in order to ensure your representation at the annual meeting.

 

You may cast your vote by visitinghttp://www.proxyvote.com. You may also have access to the materials for the annual meeting by visiting the website:www.photomedex.comwww.fcglobalrealty.com.

 

Each share of common stock entitles the holder thereof to one vote.

 

You are urged to review carefully the information contained in the enclosed proxy statement prior to deciding how to vote your shares.

 

This notice and the attached proxy statement are first being disseminated to stockholders on or about August 14, 2017.October 31, 2018.

 

 BY ORDER OF THE BOARD OF DIRECTORS,
  
 /s/ Michele Pupach
 Michele Pupach
 Secretary

 

IF YOU RETURN YOUR PROXY CARD WITHOUT AN INDICATION OF HOW YOU WISH TO VOTE, YOUR SHARES WILL BE VOTED IN FAVOR OF EACH PROPOSAL.

 

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting to be Held on September 14, 2017November 29, 2018: This Proxy Statement is available at:http://www.photomedex.com/www.fcglobalrealty.com.

 

 

 

 

TABLE OF CONTENTS

 

INTRODUCTION1
QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING AND THE PROPOSALS3
When and where will the Meeting take place?3
What proposals are the stockholders being asked to consider?3
What are the recommendations of the Board?3
What is the Record Date for the Meeting?3
Who can vote at the Meeting?3
What is the proxy card?3
What is the difference between holding shares as a stockholder of record and as a beneficial owner?3
What is the quorum required for the Meeting?4
Assuming that a quorum is present, what vote is required to approve the proposals to be voted upon at the Meeting?4
How do I vote?4
What are the effects of not voting or abstaining? What are the effects of broker non-votes?5
What does it mean if I received more than one proxy card?5
What happens if I don’t indicate how to vote my proxy?5
What happens if I sell my shares after the record date but before the Meeting?5
What if I change my mind after I return my proxy?5
Who can help answer my other questions?6
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT7
DIRECTORS AND EXECUTIVE OFFICERS8
Directors and Executive Officers8
Family Relationships11
10
Involvement in Certain Legal Proceedings11
10
CORPORATE GOVERNANCE12
11
Overview12
11
Governance Structure12
11
The Board’s Role in Risk Oversight12
11
Independent Directors12
11
Audit Committee12
11
Compensation Committee13
12
Nominations and Corporate Governance Committee14
12
Stockholder Communications with the Board of Directors15
13
Code of Ethics15
13
REPORT OF THE AUDIT COMMITTEE16
14
EXECUTIVE COMPENSATION17
15
Summary Compensation Table - Fiscal Years Ended December 31, 20162017 and 2015201617
15
Outstanding Equity Awards Value at Fiscal Year-EndYear End Table17
Director Compensation18
17
TRANSACTIONS WITH RELATED PERSONS19

 

 

 

 

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE19
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS20
Overview20
Contribution Transaction20
Our Prior Business Operations21
Going Concern22
Results of Operations22
Liquidity and Capital Resources24
Off-Balance Sheet Arrangements26
Impact of Inflation26
Critical Accounting Policies26
Recent Accounting Pronouncements29
PROPOSAL NO. 1 – FIRST CHARTERREMEDIATION PROPOSAL20
31
GeneralOverview20
31
Reasons for the Amendments to our Current CharterStockholder Approval20
34
Possible EffectsInterests of the Amendments to our Current CharterCertain Persons22
34
No Dissenters’ Rights22
34
Vote Required23
34
PROPOSAL NO. 2 – CONTRIBUTION SECURITIES ISSUANCEREVERSE STOCK SPLIT PROPOSAL24
Explanatory Note24
Summary of Terms of the Contribution Transaction24
Contact Information and Business Conducted26
Background of the Contribution Transaction26
Reasons for the Contribution Transaction27
Activities of the Company Following the Contribution Transaction28
U.S. Federal Income Tax Consequences of the Contribution Transaction28
Accounting Treatment of the Contribution Transaction31
Requirements for Stockholder Approval36
Interests of Certain Persons in the Contribution Securities Issuance Proposal37
No Dissenters’ Rights37
Vote Required37
PROPOSAL NO. 3 – SECOND CHARTER PROPOSAL38
35
General38
35
Purposes of the Proposed Reverse Stock Split39
35
Factors Influencing the Board of Directors’ Discretion in Implementing the Reverse Stock Split39
36
Potential Effects of the Proposed Reverse Stock Split40
36
Effects on Ownership by Individual Stockholders40
37
Vote Required4037
PROPOSAL NO. 4 – PLAN PROPOSAL38
Overview38
Significant Features of the Plan38
New Plan Benefits42
No Dissenters’ Rights43
Vote Required43
PROPOSAL NO. 4 – DIRECTOR PROPOSAL41
44
Director Nominees41
44
Vote Required41
44
PROPOSAL NO. 5 – AUDITOR PROPOSAL42
45
General42
45
Principal Accountant Fees and Services42
45
Vote Required43
46
PROPOSAL NO. 6 – ADJOURNMENT PROPOSAL44
47
STOCKHOLDER PROPOSALS AND NOMINATIONS4548

TRANSACTION OF OTHER BUSINESS45
48
HOUSEHOLDING OF PROXY STATEMENT45
48
WHERE YOU CAN FIND MORE INFORMATION4548

 

ANNEX A – FORM OF AMENDED AND RESTATED ARTICLES OF INCORPORATIONFINANCIAL STATEMENTS

ANNEX B – CONTRIBUTIONREMEDIATION AGREEMENT

ANNEX C – FIRSTFORM OF CERTIFICATE OF AMENDMENT TO THE CONTRIBUTION AGREEMENT

ANNEX D – FORM OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATIONFC GLOBAL REALTY INCORPORATED 2018 EQUITY INCENTIVE PLAN

 

 

 

 

PHOTOMEDEX, INC.FC GLOBAL REALTY INCORPORATED

2300 Computer Drive, Building G

Willow Grove, Pennsylvania 19090

 

 PROXY STATEMENT

FOR

ANNUAL MEETING OF STOCKHOLDERS

 

 To be held on September 14, 2017November 29, 2018

 

INTRODUCTION

 

 This proxy statement is furnished in connection with the solicitation of proxies by the Board of Directors (the “Board”) of PhotoMedex, Inc.FC Global Realty Incorporated (“we,” “us,” “our” “PhotoMedex” or the “Company”) for use at the annual meeting of stockholders of the Company and at all adjournments and postponements thereof (the “Meeting”). The Meeting will be held on September 14, 2017November 29, 2018 at 9:30 a.m. local time at The Cornell Club - New York, 6 East 44th Street, New York, NY 10017,2300 Computer Drive, Building G, Willow Grove, Pennsylvania 19090, for the following purposes:

 

1.To approve an amendment and restatement of our Amended and Restated Articles of Incorporation to,the transactions contemplated by that certain remediation agreement, dated September 24, 2018, among other things, change the name of the Company, to “FC Global Realty Incorporated,” increaseOpportunity Fund I-SS, LLC, Dr. Dolev Rafaeli, Dennis M. McGrath and Yoav Ben-Dror (the “Remediation Agreement), including the numberissuance of authorized shares of our common stock $.01 par value per share, from fifty million (50,000,00) shares to five hundred million (500,000,000) shares, and increaseupon the numberconversion of authorized shares of our preferred stock $.01 par value per share, from five million (5,000,000) shares to fifty million (50,000,000) sharesthat have been issued thereunder (the “First CharterRemediation Proposal”).

 

2.To approveauthorize the issuanceCompany’s Board of securities pursuantDirectors, in its discretion, to that certain Interest Contribution Agreement, dated March 31, 2017, by and among First Capital Real Estate Operating Partnership, L.P., a Delaware limited partnership (the “Contributor”), First Capital Real Estate Trust Incorporated, a Maryland corporation (the “Contributor Parent” and together with the Contributor, the “Contributor Parties”), FC Global Realty Operating Partnership, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company (the “Acquiror”), and the Company (the “Contribution Agreement”), under which the Contributor has agreed to contribute certain real estate assets to the Acquiror, and in exchange, we agreed to issue to the Contributorimplement one or its designees shares of our common stock and Series A Convertible Preferred Stock and, if certain additional real estate assets are contributed to the Acquiror, a warrant for the purchase of shares of common stock (the “Contribution Transaction”). Also under the Contribution Agreement, all outstanding compensation liabilities owed by us to Dr. Dolev Rafaeli, Dennis M. McGrath and Yoav Ben-Dror will be converted into secured convertible promissory notes. Ourcommon stock is listed on the NASDAQ Capital Market and, as a result, we are subject to NASDAQ’s Listing Rules. The potential consummation of the Contribution Transaction implicates certain of NASDAQ’s Listing Rules requiring prior stockholder approval in order to maintain our listing on the NASDAQ Capital Market, including (i)NASDAQ Listing Rule 5635(a), which requiresstockholder approval prior to the issuance of securities in connection with the acquisition of the stock or assets of another company if the common stock has or will have upon issuance voting power equal to or in excess of 20% of the voting power outstanding before the issuance of stock or securities convertible into or exercisable for common stock, or if the number of shares of common stock to be issued is or will be equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the stock or securities,and (ii)NASDAQ Listing Rule 5635(b), which requires stockholder approval when any issuance or potential issuance will result in a “change of control” of the issuer. In order to comply with these NASDAQ Listing Rules, we would need to obtain the approval of our stockholders prior to the issuance of all securities as contemplated by the Contribution Transaction, including thesecured convertible promissory notes. Accordingly, prior to stockholder approval at the Meeting, theContributor has received a number of shares of common stock equal to up to 19.9% of our issued and outstanding common stock immediately prior to the initial closing of the Contribution Transaction and the balance of the shares shall be paid in our Series A Convertible Preferred Stock. At the Meeting, stockholders will be asked to approve the issuance of shares of common stock upon conversion of the Series A Convertible Preferred Stock, the issuance of the warrant, the issuance of shares of common stock upon exercise of the warrant, the issuance of the secured convertible promissory notes, and the issuance of shares of common stock upon conversion of the secured convertible promissory notes, all as more particularly described in this proxy statement (the “Contribution Securities Issuance Proposal”).

1

3.To approve a reverse stock splitsplits of the shares of ourthe Company’s common stock at an exchange ratio of not less than 1-for-2 and not more than 1-for-7 and to authorize the Board, in its discretion, to implement such reverse stock split at an exchange ratio within this range and to do so1-for-15 at any time prior to our 2018the Company’s 2019 annual meeting of stockholders by filing an amendment to ourthe Company’s Amended and Restated Articles of Incorporation (the “Second CharterReverse Stock Split Proposal”).

3.To adopt the FC Global Realty Incorporated 2018 Equity Incentive Plan (the “Plan”) to provide for long-term incentives in the form of grants of stock, stock options and other forms of incentive compensation to officers, employees, directors and consultants (the “Plan Proposal”).

 

4.To elect seven (7)five (5) director nominees to the Board to serve until the next annual meeting of our stockholders or until their successors are elected and qualify, subject to their prior death, resignation or removal (the “Director Proposal”).

 

5.To ratify the appointment of Fahn Kanne & Co. Grant Thornton Israel to serve as the Company’s independent registered public accounting firm for the year ending December 31, 20172018 (the “Auditor Proposal”).

 

6.To approve the adjournment of the annual meeting for any purpose, including to solicit additional proxies if there are insufficient votes at the time of the annual meeting to approve the proposals described above (the “Adjournment Proposal”).

 

The Board unanimously recommends a vote “FOR” the First CharterRemediation Proposal, the Contribution Securities IssuanceReverse Stock Split Proposal, the Second CharterPlan Proposal, each of the director nominees, the Auditor Proposal, and the Adjournment Proposal.

 

Stockholders of record of our common stock at the close of business on July 21, 2017October 25, 2018 (the “Record Date”) will be entitled to notice of, and are cordially invited to attend, the Meeting and to attend any adjournment or postponement thereof.However, to assure your representation at the Meeting, please vote your proxy via the internet, by telephone, or by completing, dating, signing and returning the enclosed proxy.Even if you have previously submitted your proxy, you may choose to vote in person at the Meeting. Whether or not you expect to attend the Meeting, please read the proxy statement and then promptly vote your proxy in order to ensure your representation at the Meeting.

 

This proxy solicitation is being made and paid for by the Company on behalf of its Board. In addition, we may retain a third party proxy solicitor for which we may incur fees. Our directors, officers and employees may also solicit proxies by personal interview, mail, e-mail, telephone, facsimile or other means of communication. These persons will not be paid any additional compensation for their efforts. We will also request brokers and other fiduciaries to forward proxy solicitation material to the beneficial owners of shares of our common stock that the brokers and fiduciaries hold of record. Upon request, we will reimburse them for their reasonable out-of-pocket expenses. In addition, we will indemnify our proxy solicitor, if any, against any losses arising out of that firm’s proxy soliciting services on our behalf.

 


None of the proposals included in this proxy statement has been approved or disapproved by the Securities and Exchange Commission (the “SEC”), and the SEC has not passed upon the fairness or merits of any proposals nor upon the accuracy or adequacy of the information contained in this proxy statement. Any representation to the contrary is unlawful.

 

2

 

 

QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING AND THE PROPOSALS

 

 The following are some questions that you, as a stockholder of the Company, may have regarding the Meeting and the proposals and brief answers to such questions. We urge you to carefully read this entire proxy statement, the annexes to this proxy statement and the documents referred to or incorporated by reference in this proxy statement because the information in this section does not provide all the information that may be important to you as a stockholder of the Company with respect to the proposals. See “Where You Can Find More Information.”

 

When and where will the Meeting take place?

 

The Meeting will be held on September 14, 2017November 29, 2018 at 9:30 a.m. local time at The Cornell Club - New York, 6 East 44th Street, New York, NY 10017.2300 Computer Drive, Building G, Willow Grove, Pennsylvania 19090.

 

What proposals are the stockholders being asked to consider?

 

 At the Meeting, you will be asked to vote upon the First CharterRemediation Proposal, the Contribution Securities IssuanceReverse Stock Split Proposal, the Second CharterPlan Proposal, each of the Director Proposal,director nominees, the Auditor Proposal, and the Adjournment Proposal.

 

What are the recommendations of the Board?

 

 The Board has approved the six proposals and unanimously recommends that the stockholders vote “FOR” each proposal, including “FOR” each director nominee.

 

What is the Record Date for the Meeting?

 

 Holders of our common stock as of the close of business on July 21, 2017,October 25, 2018, the Record Date for the Meeting, are entitled to notice of, and to vote at, the Meeting and any postponements or adjournments of the Meeting.

 

Who can vote at the Meeting?

 

 Stockholders who owned shares of our common stock on the Record Date may attend and vote at the Meeting. There were 5,297,5005,568,500 shares of common stock, and 123,668 shares of the Company’s newly designated non-voting Series A Convertible Preferred Stock, 7,485,627 shares of the Company’s non-voting Series C Preferred Stock, and 6,371,336 shares of the Company’s non-voting Series D Preferred Stock outstanding on the Record Date. All shares of common stock have one vote per share and vote together as a single class; noclass. No shares of the Series A Convertible Preferred Stock, Series C Preferred Stock or Series D Preferred Stock may vote upon any proposal. Information about the stockholdings of our directors and executive officers is contained in the section of this proxy statement entitled “Security Ownership of Certain Beneficial Owners and Management.”

 

What is the proxy card?

 

The proxy card enables you to appoint Michele Pupach, our Corporate Counsel and Secretary, as your representative at the Meeting. By completing and returning the proxy card as described herein, you are authorizing this person to vote your shares at the Meeting in accordance with your instructions on the proxy card. This way, your shares will be voted whether or not you attend the Meeting. Even if you plan to attend the Meeting, we think that it is a good idea to complete and return your proxy card before the Meeting date just in case your plans change. If a proposal comes up for vote at the Meeting that is not on the proxy card, the proxies will vote your shares, under your proxy, according to Ms. Pupach’s best judgment.

 

What is the difference between holding shares as a stockholder of record and as a beneficial owner?

 

Most of our stockholders hold their shares in an account at a brokerage firm, bank or other nominee holder, rather than holding share certificates in their own name. As summarized below, there are some distinctions between shares held of record and those owned beneficially.

Stockholder of Record

 

If, on the Record Date, your shares were registered directly in your name with our transfer agent, Broadridge Corporate Issuer Solutions, you are a “stockholder of record” who may vote at the Meeting, and we are sending these proxy materials directly to you. As the stockholder of record, you have the right to direct the voting of your shares by returning the enclosed proxy card to us, by voting online or to vote in person at the Meeting. Whether or not you plan to attend the Meeting, please complete, date and sign the enclosed proxy card or vote online to ensure that your vote is counted.

3

Beneficial Owner

 

If, on the Record Date, your shares were held in an account at a brokerage firm or at a bank or other nominee holder, you are considered the beneficial owner of shares held “in street name,” and these proxy materials are being forwarded to you by your broker or nominee who is considered the stockholder of record for purposes of voting at the Meeting. As the beneficial owner, you have the right to direct your broker on how to vote your shares and to attend the Meeting. However, since you are not the stockholder of record, you may not vote these shares in person at the Meeting unless you receive a valid proxy from your brokerage firm, bank or other nominee holder. To obtain a valid proxy, you must make a special request of your brokerage firm, bank or other nominee holder. If you do not make this request, you can still vote by using the voting instruction card enclosed with this proxy statement; however, you will not be able to vote in person at the Meeting.

 

What is the quorum required for the Meeting?

 

The representation in person or by proxy of holders of at least a majority of the issued and outstanding shares of our common stock entitled to vote at the Meeting is necessary to constitute a quorum for the transaction of business at the Meeting.

 

Assuming that a quorum is present, what vote is required to approve the proposals to be voted upon at the Meeting?

 

The approval of the First Charter Proposal requires the affirmative vote of the holders of a majority of the issued and outstanding shares of common stock of the Company not beneficially owned by “interested stockholders” (as defined in Section 78.423 of the Nevada Revised Statutes) or their affiliates and associates.

The approval of the Contribution Securities IssuanceRemediation Proposal requires the affirmative vote of a majority of the shares present in person or represented by proxy at the Meeting.

 

The approval of the Second CharterReverse Stock Split Proposal requires the affirmative vote of the holders of a majority of the issued and outstanding shares of common stock of the Company.

The approval of the Plan Proposal requires the affirmative vote of a majority of the shares present in person or represented by proxy at the Meeting.

 

The election of each director nominee requires the affirmative vote of a plurality of votes of the shares cast at the election.

 

The approval of the Auditor Proposal requires the affirmative vote of a majority of the shares present in person or represented by proxy at the Meeting.

 

The Meeting may be adjourned by the affirmative vote of a majority of the shares present in person or represented by proxy at the Meeting.

 

How do I vote?

 

Stockholders have four voting options. You may vote using one of the following methods:

 

·Internet. You can vote over the Internet by accessing the website at www.proxyvote.com, and following the instructions on the website. Internet voting is available 24 hours a day. If you vote over the Internet, do not return your proxy card.

 

·Telephone. If you hold shares directly in your own name and are the holder of record, you can vote by telephone by calling the toll-free number 1-800-690-6903 in the United States, Canada or Puerto Rico on a touch-tone phone. You will then be prompted to enter the control number printed on your proxy card and to follow the subsequent instructions. Telephone voting is available 24 hours a day. If, however, you hold the shares through a broker and not in your own name, then follow the specific instructions included in your proxy materials, including the specific phone number to use to vote your shares by phone.

 

4

·Mail. You can vote by mail by simply completing, signing, dating and mailing your proxy card in the postage-paid envelope included with this proxy statement.

 

·In Person. You may come to the Meeting and cast your vote there. The Board recommends that you vote by proxy even if you plan to attend the Meeting. If your shares of common stock are held in a stock brokerage account or through a bank, broker or other nominee, or, in other words, in “street name”, and you wish to vote in person at the Meeting, you must bring a letter from your bank, broker or nominee identifying you as the beneficial owner of the shares and authorizing you to vote such shares at the Meeting.

 

What are the effects of not voting or abstaining? What are the effects of broker non-votes?

 

 If you do not vote by virtue of not being present in person or by proxy at the Meeting, your shares will not be counted for purposes of determining the existence of a quorum.

 

 Abstentions will be counted for the purpose of determining the existence of a quorum, however, they will not be considered in determining the number of votes cast. Accordingly, an abstention will have no effect on the Contribution Securities IssuanceRemediation Proposal, the Plan Proposal, the Director Proposal, the Auditor Proposal, or the Adjournment Proposal, but will be treated in the same manner as a vote against the First Charter Proposal and the Second CharterReverse Stock Split Proposal.

 

 Broker non-votes occur on a matter when a broker is not permitted to vote on that matter without instructions from the beneficial owner and instructions are not given. These matters are referred to as “non-routine” matters. Broker non-votes will be counted for the purpose of determining the existence of a quorum, however the First CharterRemediation Proposal, the Contribution Securities IssuancePlan Proposal, the Second CharterReverse Stock Split Proposal, and the Director Proposal are “non-routine” matters. Thus, in tabulating the voting result for these proposals, shares that constitute broker non-votes are not considered votes cast on those proposals.

 

What does it mean if I received more than one proxy card?

 

If your shares are registered differently or in more than one account, you will receive more than one proxy card. Sign and return all proxy cards to ensure that all of your shares are voted.

 

What happens if I don’t indicate how to vote my proxy?

 

If you just sign your proxy card without providing further instructions, your shares will be counted as a vote “for” each of the proposals.

 

What happens if I sell my shares after the record date but before the Meeting?

 

The Record Date for the Meeting is earlier than the date of the Meeting. If you transfer your shares after the Record Date but before the date of the Meeting, you will retain your right to vote at the Meeting (provided that such shares remain outstanding on the date of the Meeting).

 

What if I change my mind after I return my proxy?

 

You may revoke your proxy and change your vote at any time before the polls close at the Meeting. You may do this by:

 

·sending a written notice to our corporate Secretary, stating that you would like to revoke your proxy of a particular date;

 

·signing another proxy card with a later date and returning it before the polls close at the Meeting;

 

·voting again at a later time, but prior to the date of the Meeting, via the Internet or telephone;

 

·attending the Meeting and voting in person.

  

5


 

Please note, however, that if your shares are held of record by a brokerage firm, bank or other nominee, you must instruct your broker, bank or other nominee that you wish to change your vote by following the procedures on the voting form provided to you by the broker, bank or other nominee. If your shares are held in street name, and you wish to attend and vote at the Meeting, you must bring to the Meeting a legal proxy from the broker, bank or other nominee holding your shares, confirming your beneficial ownership of the shares and giving you the right to vote your shares.Simply attending the Meeting will not constitute a revocation of your proxy.

 

Who can help answer my other questions?

 

If you have more questions about the proposals or how to submit your proxy, or if you need additional copies of this proxy statement or the enclosed proxy card or voting instructions, please contact PhotoMedex, Inc.,FC Global Realty Incorporated, Attn: Corporate Secretary, 2300 Computer Drive, Building G, Willow Grove, Pennsylvania 19090, telephone number 215-619-3600.

215-830-1430.

6

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The following table sets forth information regarding beneficial ownership of our common stock as of July 21, 2017the Record Date (i) by each person who is known by us to beneficially own more than 5% of our common stock; (ii) by each of our officers and directors; and (iii) by all of our officers and directors as a group. Unless otherwise specified, the address of each of the persons set forth below is in care of the Company, 2300 Computer Drive, Building G, Willow Grove, PA 19090.

 

Name and Address of Beneficial Owner Title of Class Amount and
Nature of
Beneficial
Ownership(1)
  Percent of
Class(2)
 
Suneet Singal, Chief Executive Officer(3) Common Stock  879,234   16.60%
Stephen M. Johnson, Chief Financial Officer Common Stock  0   * 
Richard J. Leider, Director Common Stock  0   * 
Bob Froehlich, Chairman and Director Common Stock  0   * 
Dolev Rafaeli, Director(4) Common Stock  185,375   3.50%
Dennis M. McGrath, Director(5) Common Stock  88,768   1.68%
Michael R. Stewart, Director Common Stock  0   * 
Darrel C. Menthe, Director Common Stock  0   * 
All directors and officers as a group (8 persons named above) Common Stock  1,153,377   21.77%
Katsumi Oneda (6) Common Stock  265,033   5.00%
Shlomo Ben-Haim (7) Common Stock  361,253   6.82%
Renaissance Technologies LLC (8) Common Stock  247,880   4.68%

* Less than 1%

Name and Address of Beneficial OwnerTitle of ClassAmount and
Nature of
Beneficial
Ownership(1)
Percent
of Class(2)
Michael R. Stewart, CEO, CFO and DirectorCommon Stock0*
Richard J. Leider, DirectorCommon Stock0*
Dennis M. McGrath, Director(3)Common Stock70,0651.25%
Kristen E. Pigman(4)Common Stock879,23415.79%
Dolev Rafaeli, Director(5)Common Stock221,0243.94%
All directors and officers as a group (5 persons named above)Common Stock1,190,42620.73%
Shlomo Ben-Haim(6)Common Stock361,2536.49%
Lewis C. Pell(7)Common Stock354,0646.36%
Yoav Ben-DrorCommon Stock299,1845.37%

 

(1)Beneficial Ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. EachExcept as described below, each of the beneficial owners listed above has direct ownership of and sole voting power and investment power with respect to the shares of our common stock.

 

(2)A total of 5,297,5005,568,500 shares of our common stock are considered to be outstanding pursuant to SEC Rule 13d-3(d)(1) as of June 1, 2017.the Record Date. For each beneficial owner above, any options exercisable within 60 days have been included in the denominator.

 

(3)Represents 879,234Includes 31,175 shares of common stock held by the Contributor. Mr. Singal is the Chief Executive Officerand vested options to purchase 38,890 shares of the Contributor Parent, which is the general partner of the Contributor.common stock.

 

(4)Includes 116,025Represents shares held by Opportunity Fund I-SS, LLC. Kristen Pigman is the Director of common stock, 33,750 additional sharesOP Fund I Manager, LLC, which is the member and manager of common stock subject to restriction agreements with usOpportunity Fund I-SS, LLC, and vested options to purchase 35,600 shareshas voting and dispositive power over the securities held by it. Mr. Pigman disclaims beneficial ownership of common stock. Does not include unvested options to purchase up to 1,900 shares of common stock, which may vest more than 60 days after June 1, 2017.such securities.

 

(5)Includes 26,528183,524 shares of common stock 24,750 additional shares of common stock subject to restriction agreements with us, and vested options to purchase 37,49037,500 shares of common stock. Does not include options to purchase up to 1,400 shares of common stock, which may vest more than 60 days after June 1, 2017.

 

(6)Includes 201,033230,772 shares held by Eastnet Investment Limited.

(7)Includes 234,064 shares of common stock, and 64,000120,000 shares held by trusts with respect to which Mr. OnedaPell may be deemed to have beneficial ownership.

 

(7)Shlomo Ben-Haim is, or may be deemed to be, the beneficial owner of 361,253 shares of common stock. Of the 361,253 shares, 230,772 shares are owned by Eastnet Investment Limited and the remaining shares are owned by Mr. Ben-Haim. Mr. Ben -Haim has voting and/or dispositive power over shares held by Eastnet Investment Limited. Mr. Ben-Haim's address is 8 Kensington Palace Gardens, London W84QP, United Kingdom. Eastnet Investment Limited's address is Nerine Chambers, PO Box 905, Road Town, Tortola, British Virgin Islands.

(8)Includes 229,928 sole dispositive power shares and 17,952 shared dispositive power shares. Renaissance Technologies LLC’s address is 800 Third Avenue, New York, NY 10022.

Except as contemplated by the ContributionRemediation Agreement, we do not currently have any arrangements which if consummated may result in a change of control of ourthe Company.

 

7

 

 

DIRECTORS AND EXECUTIVE OFFICERS

 

Directors and Executive Officers

 

Following is information about our directors and executive officers as of the date of this proxy statement.

 

NAME AGE POSITION
Suneet SingalMichael R. Stewart 3861 Chairman, Chief Executive Officer
Stephen M. Johnson46 and Chief Financial Officer
Richard J. Leider 57 Director
Dr. Bob FroehlichDennis M. McGrath 6461 Chairman and Director
Kristen E. Pigman63Director
Dr. Dolev Rafaeli 53 Director
Dennis M. McGrath60Director

Michael R. Stewart60DirectorDarrel C. Menthe45Director

Under the Contribution Agreement, the Board of Directors must consist of seven (7) persons of whom three (3) shall be designated by the Company, three (3) shall be designated by Contributor Parent, and one (1) (the “Nonaffiliated Director”) shall be selected by the other six (6) directors; provided, however, that at least four (4) of the members of the Board as so designated shall be independent directors as provided by the rules of NASDAQ (each an “Independent Director”). Of the Board designees of the parties, one (1) of the Company’s designees shall be an Independent Director, two (2) of the Contributor Parent’s designees shall be Independent Directors and the Nonaffiliated Director shall be an Independent Director. The Audit Committee, Compensation Committee and Nominations and Corporate Governance Committee of the Company shall each consist of the Company’s designee who is an Independent Director, one of Contributor Parent’s designees who is an Independent Director and the Nonaffiliated Director. In accordance with the foregoing, Dolev Rafaeli, Dennis M. McGrath and Michael R. Stewart were designated by the Company, Suneet Singal, Richard J. Leider and Dr. Bob Froehlich were designed by Contributor Parent, and Darrel Menthe has been designed by the other directors.

Suneet Singal has served as our Chief Executive Officer and Chief Financial Officer since the initial closingJune 2018 and as a member of the Contribution Transaction onour Board of Directors since May 17, 20172017. Mr. Stewart is a seasoned executive with over 25 years of experience in C-level positions and 36 total years’ experience in executive management, operations and finance. He brings a wealth of expertise with particular strength in operations, financial management, strategy, M&A, capital raise, FDA matters, medical reimbursement as well as sales, marketing, product development and product launch. He has extensive U.S. and International market expertise and has significant experience with public company board and SEC matters. Currently, Mr. Stewart operates as a private consultant to multiple companies which he started in late 2016. He is working with companies from private start-up to mid-size public companies assisting them with major negotiations, new product and company launches, merger and acquisitions and capital raises. From 2014 through 2016, Mr. Stewart served as Chairman and Chief Executive Officer of the Contributor Parent since March 2017.  Mr. Singal has served as the Chief Executive Officer of First Capital Real Estate Investments LLC (“FCREI”) since 2003, the Chief Executive Officer, Secretary and Chairman of First Capital Real Estate Trust, Inc. (“FCRETI”) since 2015, and asPresident, Chief Executive Officer and SecretaryDirector of FCRETI’s externalpublicly traded STRATA Skin Sciences, Inc. From 1990 to 2014, Mr. Stewart held the positions of CEO, COO and CFO at two publicly traded companies. In addition to his executive career and his non-independent board positions, Mr. Stewart has served as an independent public company director and as an advisor since 2015. He began his real estate finance career in 2001 and formed FCREI in 2003. In 2006, Mr. Singal merged a subsidiary of FCREI with a real estate lending platform. From 2007 to 2011, Mr. Singal obtained entitlements for over a dozen projects in California encompassing industrial, retail, multifamily, senior assisted living, hospitality and mixed-use asset types. Between May 2015 and December 2015, Mr. Singal owned and served on the board of directors of Castle Mortgage Corp., an agency approved mortgage bank thatseveral private companies. Mr. Singal acquired, repositioned and sold. Mr. Singal received a BAStewart obtained both his MBA in Finance with a concentrationand his BS in InvestmentsAccounting from California StateLaSalle University at Sacramento and is a licensed California Mortgage Broker.in Philadelphia. Mr. SingalStewart was selected to serve on our Board because of his background36 years’ experience in the commercial real estate industryexecutive management, operations and particular knowledge of the properties to be contributed in the Contribution Transaction.finance.

Stephen M. Johnson has served our Chief Financial Officer since the initial closing of the Contribution Transaction on May 17, 2017 and has served as Chief Financial Officer of the Contributor Parent since April 2017.  Mr. Johnson served as Head of Equity Volatility Trading Asia for DRW Holdings LLC, a multi-strategy proprietary trading firm, from April 2015 until October 2016. Prior to that, Mr. Johnson served as a Senior Portfolio Manager at Ronin Trading LLC, a proprietary derivative trading firm, from February 2014 until March 2015 and at Marquette Partners L.P., a proprietary derivative trading firm, between January 2012 and February 2014. He previously served as the Chief Financial Officer and Managing Partner at Hun Management LLC, a proprietary derivative trading firm, from April 2007 to January 2013. Mr. Johnson received a B.A. in Accounting from Michigan State University and an M.B.A. in Finance from the University of Chicago. He holds FINRA Series 24, 7, and 63 Licenses and is a CFA Level II Candidate.

8

Richard J. Leider was appointed tohas served as a member of our Board upon the initial closing of the Contribution Transaction onDirectors since May 17, 2017. Mr. Leider has more than 25 years of experience in the commercial real estate industry with active involvement in its sub-specialties of office, hospitality, investment, development, construction and strategic management. A hospitality veteran, Mr. Leider directed the repositioning, renovation and execution of the successful conversion of the Resort at Squaw Creek into a condominium hotel facility. Since March 2003, he has served as president of Paramount Hotels Inc. a California hotel management company. A principal and cofounder of Anvil Builders Inc., Mr. Leider has directed business development for that company since July 2010. From June 2005 to December 2008, he led the global real estate platform at Tano Capital, LLC and formerly directed the investment platform in Northern California on behalf of Buchanan Street. He was a managing director of global operations at Citadon, Inc., of San Francisco, a provider of Internet solutions for the real estate and construction industries, from June 2000 to December 2001. From 1996 to 2000, he was an executive director at DTZ Staubach Tie Leung in Hong Kong. While in Asia, Mr. Leider’s responsibilities included all aspects of the real estate life cycle, from advisory services to opportunistic institutional direct investment. Prior to his tenure with DTZ Staubach Tie Leung, Mr. Leider was a senior vice president at CBRE in San Francisco. Mr. Leider graduated from the University of California at Berkeley in 1981, earning a B.A. in Political Economies of Industrial Societies, and later studied at Worchester College at Oxford University. Mr. Leider serves on the Boards of Mercy Housing, American Cancer Society, Union Square Business Improvement District and its Public Policy Committee. He is a member of the Urban Land Institute, and CCIM Institute (Certified Commercial Investment Manager). Mr. Leider also serves as an independent board member of the Contributor Parent.First Capital Real Estate Trust Incorporated. Mr. Leider was selected to serve on our Board because of his twenty-five years’ background in the commercial real estate industry.

Dr. Bob FroehlichDennis M. McGrath was appointedhas served as a member of our Board of Directors since July 2009. He currently serves as the Executive Vice President and Chief Financial Officer of PAVmed, Inc. (Nasdaq: PAVM, PAVMW) since March 2017. Previously, from 2000 to 2017, Mr. McGrath served in several senior level positions of the Company, including from 2011 to 2017 as director, President, and Chief Financial Officer. Prior to our Board uponreverse merger with Radiancy, Inc. in December 2011, he also served as Chief Executive Officer from 2009 to 2011 and served as Vice President of Finance and Chief Financial Officer from 2000 to 2009. He received honors as a P.A.C.T. (Philadelphia Alliance for Capital and Technology) finalist for the initial closing2011 Investment Deal of the Contribution Transaction on May 17, 2017Year, award winner for the SmartCEO Magazine 2012 CEO of the Year for Turnaround Company, and serves as Chairmanfinalist for the Ernst & Young 2013 Entrepreneur of our Board. Dr. Froehlichthe Year. He has amassed over 40 years ofextensive experience in mergers and around Wall Street. Heacquisitions, both domestically and internationally, and particularly involving public company acquisitions, including Surgical Laser Technologies, Inc., (formerly, Nasdaq: SLTI), ProCyte Corporation (formerly, Nasdaq: PRCY), LCA Vision, Inc. (formerly, Nasdaq: LCAV) and Think New Ideas, Inc. (formerly, Nasdaq: THNK). Prior to joining the Company, he served in several senior level positions of AnswerThink Consulting Group, Inc. (then, Nasdaq: ANSR, now, The Hackett Group, Nasdaq: HCKT), a business consulting and technology integration company, including from 1999 to 2000 as Chief Operating Officer of the Internet Practice, the largest division of AnswerThink Consulting Group, Inc., while concurrently during the merger of the companies, serving as the acting Chief Financial Officer of Think New Ideas, Inc. (then, Nasdaq: THNK, now, Nasdaq: HCKT), an interactive marketing services and business solutions company. Mr. McGrath also served from 1996 until 1999 as Chief Financial Officer, Executive Vice President and director of TriSpan, Inc., an internet commerce solutions and technology consulting company, which was acquired by AnswerThink Consulting Group, Inc. in 1999. During his tenure at Arthur Andersen & Co., where he began his career, he became a Certified Public Accountant in the public sector1981, holds inactive licenses in Pennsylvania and New Jersey, and has a B.S., maxima cum laude, in accounting from 1975 until 1985, workingLaSalle University. In addition to continuing as a Budget Analyst fordirector of PhotoMedex, he serves as the Cityaudit chair and a director of Dayton, Ohio, the Chief Financial Officer for Montgomery County, Ohio's Water & Sewer Districtseveral medical device companies, including DarioHealth Corp. (Nasdaq: DRIO), Noninvasive Medical Technologies, Inc. and the first City Manager for the City of Beavercreek, Ohio. In 1985, he transitionedCagent Vascular, LLC, and as an advisor to the private sector where he was a senior executive with Ernst & Whinneyboard of an orphan drug company, Palvella Therapeutics, LLC. Formerly from 19852007 to 1989. From 1989 to 1997, Dr. Froehlich held several senior executive roles at Van Kampen Merritt which after its merger with American Capital became Van Kampen American Capital. In 2001, he was appointed Vice Chairman of Scudder Investments when Scudder Funds merged with Kemper Funds. In 2002, when Deutsche Bank acquired Scudder Investments, Dr. Froehlich was named Vice Chairman of Deutsche Asset Management, a role he held until he retired in 2009. He came out of retirement in 2009, to help rebrand Hartford Financial after it's near financial collapse servingMr. McGrath served as a Senior Executive with The Hartford Mutual Funds. In 2012, he retired for the second time. Since his second retirement from Wall Street, Dr. Froehlich has begun a new chapter in his professional career by building a portfoliodirector of boards spanning private, public, not-for-profit and mutual fund companies. From a private company perspective, on June 4, 2014, Dr. Froehlich became the Chairman of the Board, CEO, President & Owner of the Kane County Cougars Baseball Club, the Class "A" minor league affiliate of the Arizona Diamondbacks and a member of the Midwest League.Embrella Cardiovascular, Inc. (sold to Edwards Lifesciences Corporation, NYSE: EW). He was a Co-Owner and Director since January 7, 2013. On August 2, 2016, Dr. Froehlich was appointed an Independent Director for Galen Robotics, Inc., a spin-off from John Hopkins University, focusing on the surgical robotic microsurgery market. From a public company perspective, on October 3, 2014, Dr. Froehlich was appointed an Independent Director for AXAR Acquisition Corp. (formerly AR Capital Acquisition Corp.) (NASDAQ: AXAR), a special purpose acquisition corporation formed for the purpose of effecting a merger, capital stock exchange or similar business combinations. He serves as Chairman of the Compensation Committee and a member of the Audit Committee. In July 2014, Dr. Froehlich was appointed an Independent Director and Audit Committee, Conflicts Committee and Nominating & Governance Committee member for NexPoint Capital, Inc., a publicly registered non-traded business development company. In March 2017, Dr. Froehlich was appointed an Independent Director, Nominating & Corporate Governance Committee member and Audit Committee Chairman for First Capital Investment Corporation, a publicly registered non-traded business development company with an objective of investing primarily in small and middle market companies in the United States. From a not-for-profit company perspective, Dr. Froehlichalso serves on the Board of Directors of The Midwest League of Professional Baseball Clubs, Inc., onTrustees for Manor College and the Board of Visitors for Taylor University. Mr. McGrath was selected to serve on our Board because of his 30 years’ experience in the development and implementation of innovative business and marketing practices.


Kristen E. Pigman has served as a member of our Board of Directors since June 2018. As President of The Pigman Companies, LLC (“TPC”), Mr. Pigman coordinates acquisition, planning, financing, development, construction, and disposition of commercial real estate projects for TPC, its partners, and institutional and corporate clients. Before the creation of TPC in 1994, Mr. Pigman was a titled officer and partner of The Koll Company of Newport Beach, CA. Prior to joining Koll in 1989, Mr. Pigman was President of The Sandpiper Companies, a real estate development firm headquartered in Scottsdale, Arizona; and an executive with Coldwell Banker Commercial Real Estate Group. He served as ChairmanPresident for five years of the Sacramento Valley Chapter of National Association of Industrial and Office Properties (“NAIOP”) and was a member of the National Board for Kane County Cougars Foundation, Inc.,of Directors of NAIOP and as an Independent Trustee and Distribution Committee Chairman and Audit Committee, and Litigation Committee member for Highland Capital Mutual Funds, a major mutual fund company. Previously from 2013 to 2016, Dr. Froehlich was an Independent Director and Audit CommitteeVice Chairman for ARC Healthcare Trust, Inc.,the NAIOP National Office Development Forum. He also was Vice President of Development and a publicly registered non-traded real estate investment program and an Independent Director and Lead Independent Director, Audit Committee Chairman and Conflicts Committee Chairman for ARC Realty Finance Trust, Inc., a publicly registered non-traded real estate investment program. From 2012 to 2016, Dr. Froehlich was an Independent Director and Lead Independent Director, Audit Committee Chairman and Conflicts Committee Chairman for American Realty Capital Daily NAV Trust, Inc., a publicly registered nontraded real estate investment program. From 2013 to 2016, Dr. Froehlich was Lead Independent Trustee and Audit Committee Chairman for Realty Capital Income Funds. From 2014 to 2016, Dr. Froehlich was on the Advisorymember of Board of Directors for Internet Connectivity Group, Inc.,the Sacramento Area Commerce and Trade Organization, Chairman of the Building Industry Association Commercial Developer’s Council, and a full service digital media firm focusingmember of numerous other trade organizations and Chambers of Commerce. Mr. Pigman has been and continues to be involved in a number of charitable organizations, including The Comstock Club, Easter Seals, the American Lung Association, the Police Athletic League, the Leukemia Society, The Heart Foundation, the Principal for a Day Program, and the Boy Scouts of America, having attained the rank of Eagle Scout in that organization. Mr. Pigman graduated with honors from The Mercersburg Academy in Mercersburg, PA, accepted an English Speaking Union “Jr. Rhodes” Scholarship and took his ‘A’ levels at The Truro School, Truro, Cornwall, UK, attended Rollins College in Winter Park, FL on point of sale strategies. Dr. Froehlich received his Ph.D.a baseball scholarship, and earned a B.S. in Economics cum laude from California Coast University in 1979, a M.A. from Central Michigan University in 1978, a M.P.A. from theThe University of Dayton in 1976 and a B.A. from the University of Dayton in 1975. In 2008, he was awarded an Honorary Doctorate of Commercial Sciences from the Board of Trustees of Central Michigan University. Dr. FroehlichMaryland. Mr. Pigman was selected to serve on our Board because of his extensive finance experience and his experience serving as an independent director for public companies, including as audit committee chair.real estate development experience.

9

Dr. Dolev Rafaeli was appointedhas served as a member of our Board inof Directors since December 2011. He previously served as our Chief Executive Officer from December 2011 until the initial closing of the Contribution Transaction on May 17, 2017. Dr. Rafaeli joined our subsidiary Radiancy Inc. (“Radiancy”) in February 2006 as president and CEO. He has over 29 years of experience managing international operations. Prior to joining Radiancy, Dr. Rafaeli served from 2004 to 2006 as president and CEO of the USR Group, a consumer electronics products manufacturer, managing operations in Israel, China, Hong Kong and the U.S. Between 2000 and 2004, Dr. Rafaeli founded and served as general manager of Orbotech Ltd. (ORBK-NASDAQ), an automated optical inspection capital equipment manufacturer for the electronics industry in China and Hong Kong, where he was instrumental in building these operations into a $100 million a year business. Between 1997 and 2000, Dr. Rafaeli served as CEO of USR Ltd., a global electronics contract manufacturing company providing design, supply chain and manufacturing services to dozens of clients in the communications, consumer and medical device fields. USR Ltd. employed approximately 1,000 individuals. Dr. Rafaeli previously served as director of operations and manager of the Arad manufacturing facility for Motorola in its Land Mobile Product Solutions division, manufacturing and distributing communications, consumer and other infrastructure electronics products in excess of $400 million annually. Dr. Rafaeli graduated with a B.Sc. in industrial engineering and management cum laude and a M.Sc. in operations management from the Technion-Israel Institute of Technology, and holds a Ph.D. in business management from Century University and an MBA (with distinction) from Cornell University. Dr. Rafaeli was selected to serve on our Board because of his over twenty five -years’years of senior executive and board of directorsdirectors’ experience with private and public multi-national companies and his vast mergers and acquisitions successful track record.

Dennis M. McGrath, was appointed to our Board in July 2009. He previously served as our President and Chief Financial Officer from July 2009 until the initial closing of the Contribution Transaction on May 17, 2017. Mr. McGrath had previously served as CFO and Vice President, finance and administration from January 2000 through June 2009 and as Chief Executive Officer from July 2009 until the merger date with Radiancy. He has held several senior-level positions in prior endeavors, including, from February 1999 to January 2000, serving as the COO of Internet Practice, the largest division for AnswerThink Consulting Group, Inc., a company specializing in business consulting and technology integration. Concurrently, from August 1999 until January 2000, Mr. McGrath served as CFO of Think New Ideas, Inc., a company specializing in interactive marketing services and business solutions. In addition to the financial reporting responsibilities, he was responsible for the merger integration of Think New Ideas, Inc. and AnswerThink Consulting Group, Inc. Prior to that, from September 1996 to February 1999, Mr. McGrath was CFO and executive vice-president, operations of TriSpan, Inc., an internet commerce solutions and technology consulting company that was acquired by AnswerThink Consulting Group, Inc. in 1999. Mr. McGrath is currently a director of Noninvasive Medical Technologies, Inc., LabStyle, Inc. and Cagent Vascular, Inc. In addition, Mr. McGrath serves on the Board of Trustees for Manor College and the Board of Visitors for Taylor University. Mr. McGrath graduated with a B.S. in accounting from LaSalle University in 1979 and became a Certified Public Accountant in 1981 and holds inactive licenses in Pennsylvania and New Jersey. Mr. McGrath was selected to serve on our Board because of his thirty years’ experience in the development and implementation of innovative business and marketing practices.

Michael R. Stewart is a seasoned executive with over 25 years of experience in C-level positions and 36 total years’ experience in executive management, operations and finance. He brings a wealth of expertise with particular strength in operations, financial management, strategy, M&A, capital raise, FDA matters, medical reimbursement as well as sales, marketing, product development and product launch. He has extensive U.S. and International market expertise, and has significant experience with public company board and SEC matters. Currently, Mr. Stewart operates as a private consultant to multiple companies which he started in late 2016. He is working with companies from private start-up to mid-size public companies assisting them with major negotiations, new product and company launches, merger and acquisitions and capital raises. From 2014 through 2016, Mr. Stewart served as President, Chief Executive Officer and Director of publicly traded STRATA Skin Sciences, Inc. From 1990 to 2014, Mr. Stewart held the positions of CEO, COO and CFO at two publicly traded companies. In addition to his executive career and his non-independent board positions, Mr. Stewart has served as an independent public company director and as an advisor to the board of several private companies. Mr. Stewart obtained both his MBA in Finance and his BS in Accounting from LaSalle University in Philadelphia. Mr. Stewart was selected to serve on our Board because of his 36 years’ experience in executive management, operations and finance.

10

Darrel C. Mentheis an attorney with more than 20 years’ experience in business law and corporate disputes. A partner of Sage Law Partners and the founder of its California office, Mr. Menthe is active in areas of unfair competition, fraud disputes, and corporate governance issues. Mr. Menthe was previously a founding partner of Miller Miller Menthe LLP, a law office based in Newport Beach and Culver City, California. Darrel Menthe has tried jury trials, bench trials, and arbitrations, and has successfully obtained verdicts, appellate decisions, and dismissals on behalf of multiple clients. Mr. Menthe also practiced law in the antitrust department of the Los Angeles office McGuireWoods LLP, a national law firm based in Richmond, Virginia. From 1996-1998, Mr. Menthe practiced in the Los Angeles office of Fried, Frank, Harris, Shriver and Jacobson, a New-York based law firm. Menthe is the author of a frequently reviewed how-to guide on the pleading requirements of civil racketeering cases. Mr. Menthe has published extensively on the First Amendment aspects of the regulation of outdoor advertising in numerous nationally recognized law journals, including the Hastings Constitutional Law Quarterly and the Boston University Law Review. Darrel Menthe graduated from the University of California, San Diego, with a B.A. magna cum laude in Comparative Literature and Political Science. He obtained an M.A. in political science from UCLA. Mr. Menthe obtained his law degree from Stanford Law School in 1996, where he also worked as Senior Submissions Editor for the Stanford Journal of International Law. Mr. Menthe reads German, Russian, and Spanish. Mr. Menthe currently serves as President of the Culver City Downtown Business Association, the governing Board of the Downtown Culver City Business Improvement District established by the City of Culver City. He has been a member of that Board since 2013. Mr. Menthe is presently the Vice President and Treasurer of the Culver City Centennial Celebration Committee, Inc., a non-profit corporation created in 2014 to plan and execute the 2017 civic celebrations. Mr. Menthe spent six years on the Board of Directors of the Parish Church of St. Augustine by-the-Sea in Santa Monica and currently serves as Treasurer of the parish. Mr. Menthe serves on the Board of Directors for the Culver City Rotary Club.

Our directors currently have terms which will end at our next annual meeting of the stockholders or until their successors are elected and qualify, subject to their prior death, resignation or removal. Officers serve at the discretion of the Board of Directors. Members of our Board of Directors are encouraged to attend meetings of the Board of Directors and the Annual Meeting of Stockholders. The Board of Directors held nineten meetings and executed fiveten unanimous written consents in lieu of a meeting in 2016.2017.

 

Family Relationships

 

There are no family relationships among any of our officers or directors.

 

Involvement in Certain Legal Proceedings

 

To the best of our knowledge, none of our directors or executive officers has, during the past ten years:

 

·been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offences);

 

·had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;

 

·been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;

 

·been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;

 

·been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

 

·been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

11

CORPORATE GOVERNANCE

 

Overview

 

Our Board of Directors maintains charters for select committees. In addition, our Board of Directors has adopted a written set of corporate governance guidelines and a code of business conduct and ethics and a code of conduct for our chief executive and senior financial officers that generally formalize practices that we already had in place. We have adopted a Code of Ethics on Interactions with Health Care Professionals, an Anti-Fraud Program and a policy for compliance with the Foreign Corrupt Practices Act. To view the charters of our Audit, Compensation and Nominations and Corporate Governance Committees, Codecode of Ethics,ethics, corporate governance guidelines, codes of conduct and whistle blower policy,other documents, please visit our website at www.photomedex.com,www.fcglobalrealty.com under the Corporate Governance section of the Investor Relations page (this website address is not intended to function as a hyperlink and the information contained on our website is not intended to be a part of this Report). In compliance with NASDAQ rules, the majority of our Board of Directors is comprised of independent directors.page.

 

Governance Structure

 

Following the initial closing of the Contribution Transaction, we chose to appoint a separate Chairman of our Board of Directors who is notCurrently, our Chief Executive Officer.Officer is also our Chairman. Our Board of Directors has madebelieves that, at this decision based on their belief that an independent Chairman of the Board can act astime, having a balance to thecombined Chief Executive Officer who also servesand Chairman is the appropriate leadership structure for the Company. In making this determination, the board considered, among other matters, Mr. Stewart executive management experience and believed that Mr. Stewart is highly qualified to act as both Chairman and Chief Executive Officer due to his experience, knowledge, and personality. Among the benefits of a non-independent director.combined Chief Executive Officer/Chairman considered by the Board is that such structure promotes clearer leadership and direction for the Company and allows for a single, focused chain of command to execute our strategic initiatives and business plans.

 

The Board’s Role in Risk Oversight

 

Our Board of Directors administers its risk oversight function as a whole by making risk oversight a matter of collective consideration. While management is responsible for identifying risks, our Board of Directors has charged the Audit Committee of the Board of Directors with evaluating financial and accounting risk and the Compensation Committee of the Board of Directors with evaluating risks associated with employees and compensation. Investor-related risks are usually addressed by the Board as a whole. We believe an independent Chairman of the Board adds an additional layer of insight to our Board of Directors’Board’s risk oversight process.

 

Independent Directors

 

In considering and making decisions as to the independence of each of the directors of the Company, the Board considered transactions and relationships between the Company (and its subsidiaries) and each director (and each member of such director’s immediate family and any entity with which the director or family member has an affiliation such that the director or family member may have a material indirect interest in a transaction or relationship with such entity). TheOur Board has determined that the following directors and director nominees are independent as defined in the applicable SEC and NASDAQ rules and regulations, and that each constitutes an “Independent Director” as defined in NASDAQ Marketplace Rule 5605, and that such members constitute a majority of the entire Board:Nasdaq Stock Market: Richard J. Leider Dr. Bob Froehlich, Michael R. Stewart and Darrel Menthe.Kristen E. Pigman.

 

Audit Committee

 

Our Board of Directors has established an Audit Committee to assist it in fulfilling its responsibilities for general oversight of the integrity of our consolidated financial statements, compliance with legal and regulatory requirements, the independent auditors’ qualifications and independence, the performance of our independent auditors and an internal audit function and risk assessment and risk management. The duties of our Audit Committee include: reviewing and approving the scope of the annual audit, the audit fee and the financial statements; appointing, evaluating and determining the compensation of our independent auditors; reviewing disclosure controls and procedures, internal control over financial reporting, any internal audit function and corporate policies with respect to financial information; reviewing other risks that may have a significant impact on our financial statements; preparing the Audit Committee report for inclusion in the annual proxy statement; establishing procedures for the receipt, retention and treatment of complaints regarding accounting and auditing matters; approving all related party transactions, as defined by applicable Nasdaq Rules, to which the Company is a party; and evaluating the Audit Committee charter annually.

·appointing, evaluating and determining the compensation of our independent auditors;

·reviewing and approving the scope of the annual audit, the audit fee and the financial statements;

·reviewing disclosure controls and procedures, internal control over financial reporting, any internal audit function and corporate policies with respect to financial information;

·reviewing other risks that may have a significant impact on our financial statements;

12

·preparing the Audit Committee report for inclusion in the annual proxy statement;

·establishing procedures for the receipt, retention and treatment of complaints regarding accounting and auditing matters;

·approving all related party transactions, as defined by applicable Nasdaq Rules, to which the Company is a party; and

·evaluating annually the Audit Committee charter.

 

The Audit Committee works closely with management as well as our independent auditors. The Audit Committee has the authority to obtain advice and assistance from, and receive appropriate funding from us for, outside legal, accounting or other advisors as the Audit Committee deems necessary to carry out its duties.

 

Our Board of Directors has adopted a written charter for the Audit Committee that meets the applicable standards of the SEC and NASDAQ.Committee. The proposed members of the Audit Committee Dr. Bob Froehlich, Michael R. Stewartare Richard J. Leider and Darrel Menthe. Michael R. Stewart will serve as the Chair of the Audit Committee.Kristen E. Pigman. The Audit Committee meets regularly and held seven meetings during 2016 and executed one unanimous written consent as part of a meeting.in 2017.

 


The Board of Directors determined that each member of the Audit Committee satisfies the independence and other composition requirements of the SEC and NASDAQ. OurSEC. Due to recent changes to our Board has determined that Dr. Bob Froehlich and Michael R. Stewart both qualify ascomposition, we temporarily at this time do not have an independent director who also meets the qualifications for “audit committee financial expert” as defined under Item 407(d)(5) of Regulation S-K and haveS-K. We anticipate that we will appoint a new independent director who meets these qualifications within in the requisite accounting or related financial expertise required by applicable NASDAQ rules.next six months. 

 

Compensation Committee

 

Our Compensation Committee discharges the Board of Directors’Board’s responsibilities relating to compensation of our Chief Executive Officer and other executive officers, produces an annual report on executive compensation for inclusion in our annual proxy statement and this Report and provides general oversight of compensation structure. Other specific duties and responsibilities of the Compensation Committee include: reviewing and approving objectives relevant to executive officer compensation; evaluating performance and recommending to the Board the compensation, including any incentive compensation, of our Chief Executive Officer and other executive officers in accordance with such objectives; reviewing employment agreements for executive officers; recommending to the Board the compensation for our directors; administering our equity compensation plans and other employee benefit plans; evaluating human resources and compensation strategies, as needed; and evaluating the Compensation Committee charter periodically.

·reviewing and approving objectives relevant to executive officer compensation;

·evaluating performance and recommending to the Board of Directors the compensation, including any incentive compensation, of our Chief Executive Officer and other executive officers in accordance with such objectives;

·reviewing employment agreements for executive officers;

·recommending to the Board of Directors the compensation for our directors;

·administering our equity compensation plans (except the Non-Employee Director Plan) and other employee benefit plans;

·evaluating human resources and compensation strategies, as needed; and

·evaluating periodically the Compensation Committee charter.

 

Our Board of Directors has adopted a written charter for the Compensation Committee. The proposed members of the Compensation Committee are Richard J. Leider Michael R. Stewart and Darrel Menthe. Mr. Leider will serve as the Chair of the Compensation Committee. Our Board of Directors determined that each member of the Compensation Committee satisfies the independence requirements of NASDAQ.Kristen E. Pigman. The Compensation Committee held three formal meetings during 2016.one meeting and executed no unanimous written consents in lieu of a meeting in 2017.

 

The Compensation Committee reviews executive compensation from time to time and reports to the Board, of Directors, which makes all final decisions with respect to executive compensation. The Compensation Committee adheres to several guidelines in carrying out its responsibilities, including performance by the employees, our performance, enhancement of stockholder value, growth of new businesses and new markets and competitive levels of fixed and variable compensation.

13

 

Nominations and Corporate Governance Committee

 

Our Board of Directors has established a Nominations and Corporate Governance Committee for the purpose of reviewing all Board of Director-recommendedBoard-recommended and stockholder-recommended nominees, determining each nominee’s qualifications and making a recommendation to the full Board of Directors as to which persons should be our Board of Directors’Board’s nominees. The duties and responsibilities of the Nominations and Corporate Governance Committee include: identifying and recommending to our Board individuals qualified to become members of our Board; recommending to our Board the director nominees for the next annual meeting of stockholders; recommending to our Board director committee assignments; reviewing and evaluating succession planning for our Chief Executive Officer and other executive officers; monitoring the independence of our directors; developing and overseeing the corporate governance principles applicable to members of our Board, officers and employees; monitoring the continuing education for our directors; and evaluating the Nominations and Corporate Governance Committee charter annually.

·identifying and recommending to our Board of Directors individuals qualified to become members of our Board of Directors;

·recommending to our Board of Directors the director nominees for the next annual meeting of stockholders;

·recommending to our Board of Directors director committee assignments;

·reviewing and evaluating succession planning for our Chief Executive Officer and other executive officers;

·monitoring the independence of our directors;

·developing and overseeing the corporate governance principles applicable to members of our Board of Directors, officers and employees;

·monitoring the continuing education for our directors; and

·evaluating annually the Nominations and Corporate Governance Committee charter.

 

Our Board of Directors has adopted a written charter for the Nominations and Corporate Governance Committee. The proposed members of the Nominations and Corporate Governance Committee are Richard J. Leider Michael R. Stewart and Darrel C. Menthe. Dr. Froehlich will serve as the Chair of the Nominations and Corporate Governance Committee.Kristen E. Pigman. The Nominations and Corporate Governance Committee held one meeting during 2016 in conjunction with a meeting of the full Board of Directors.2017.

 

Our Nominations and Corporate Governance Committee utilizes a variety of methods for identifying and evaluating nominees for our directors. Our Nominations and Corporate Governance Committee will regularly assess the appropriate size of our Board of Directors and whether any vacancies on the Board of Directors are expected due to retirement or other circumstances. When considering potential director nominees, the Nominations and Corporate Governance Committee also considers the candidate’s character, judgment, diversity, age, skills, including financial literacy and experience in the context of the needs of the Company and of our existing directors. The Nominations and Corporate Governance Committee also seeks director nominees who are from diverse backgrounds and who possess a range of experiences as well as a reputation for integrity. The Nominations and Corporate Governance Committee considers all of these factors to ensure that our Board of Directors as a whole possesses a broad range of skills, knowledge and experience useful to the effective oversight and leadership of the Company.

 

Our Nominations and Corporate Governance Committee does not have a specific policy with regard to the consideration of candidates recommended by stockholders, however any nominees proposed by our stockholders will be considered on the same basis as nominees proposed by the Board. If you or another stockholder want to submit a candidate for consideration to the Board, you may submit your proposal to our Corporate Counsel in accordance with the stockholder communication procedures set forth below.

 


All director nominees included in this proxy statement were approved by the Nominations and Corporate Governance Committee.

 

14

Stockholder Communications with the Board of Directors

 

Our Board of Directors has established a process for stockholders to communicate with the Board of Directors or with individual directors. Stockholders who wish to communicate with our Board of Directors or with individual directors should direct written correspondence to Michele Pupach, Corporate Counsel atmpupach@photomedex.com mpupach@fcglobalrealty.com or to the following address (our principal executive offices): Board of Directors, c/o Corporate Secretary, 2300 Computer Drive, Building G, Willow Grove, Pennsylvania 19090. Any such communication must contain:

 

·a representation that the stockholder is a holder of record of our capital stock;

 

·the name and address, as they appear on our books, of the stockholder sending such communication; and

 

·the class and number of shares of our capital stock that are beneficially owned by such stockholder.

 

Ms. Pupach or the Corporate Secretary, as the case may be, will forward such communications to our Board of Directors or the specified individual director to whom the communication is directed unless such communication is unduly hostile, threatening, illegal or similarly inappropriate, in which case Ms. Pupach or the Corporate Secretary, as the case may be, has the authority to discard the communication or to take appropriate legal action regarding such communication.

 

Code of Ethics

 

We have adopted a Code of Ethics that applies to all of our employees, officers and directors.  The Code of Ethics is available on our web site atwww.photomedex.com www.fcglobalrealty.comunder the Corporate Governance section of the Investor Relations page.We intend to provide disclosure of any amendments or waivers of our Code of Ethics on our website within four business days following the date of the amendment or waiver.

 

15

13 

 

 

REPORT OF THE AUDIT COMMITTEE

FOR THE FISCAL YEAR ENDED DECEMBER 31, 20162017

 

The Audit Committee of the Board is comprised of threetwo non-employee directors, eachboth of whom has been determined by the Board to be “independent” meeting the independence requirements of the listing rules of NASDAQ and the SEC. The Board has determined that Dr. Robert Froehlich and Mr. Michael R. Stewart qualify as “audit committee financial experts” under Item 407(d)(5) of Regulation S-K and have the requisite accounting or related financial expertise required by applicable NASDAQ rules. The Audit Committee assists the Board’s oversight of the integrity of the Company’sour financial reports, compliance with legal and regulatory requirements, the qualifications and independence of the Company’sour independent registered public accounting firm, the audit process, and internal controls. The Audit Committee operates pursuant to a written charter adopted by the Board. The Audit Committee is responsible for appointing, evaluating and determining the compensation of our independent auditors; reviewing and approving the scope of the annual audit, the audit fee and the financial statements; reviewing disclosure controls and procedures, internal control over financial reporting, any internal audit function and corporate policies with respect to financial information; reviewing other risks that may have a significant impact on our financial statements; establishing procedures for the receipt, retention and treatment of complaints regarding accounting and auditing matters; and approving all related party transactions, as defined by applicable NASDAQ rules, to which the Company is a party. The Audit Committee also reviews and recommends to the Board that the audited financial statements be included in the Company’sour Annual Report on Form 10-K.

 

Following the end of the fiscal year ended December 31, 2016,2017, the Audit Committee as constituted at such time (1) reviewed and discussed the audited financial statements for the fiscal year ended December 31, 20162017 with Company management; (2) discussed with the independent auditors the matters required to be discussed by Statement on Auditing Standards No. 61, as amended (AICPA, Professional Standards, Vol. 1. AU section 380), as adopted by the PCAOB in Rule 3200T; and (3) received the written disclosures and the letters from the independent accountants required by applicable requirements of the PCAOB regarding the independent accountants’ communications with the Audit Committee concerning independence, and has discussed with the independent accountants their independence.

 

Based on the review and discussions referred to above, the Audit Committee had recommended to the Board that the audited financial statements be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 20162017 for filing with the SEC.

 

/s/ The Audit Committee 
Michael R. Stewart (Chair)Richard J. Leider 
Dr. Bob Froehlich
Darrel C. MentheKristen E. Pigman 

 

16

14 

 

 

EXECUTIVE COMPENSATION

 

Summary Compensation Table - Fiscal Years Ended December 31, 20162017 and 20152016

 

The following table sets forth information concerning all cash and non-cash compensation awarded to, earned by or paid to the named persons for services rendered in all capacities during the noted periods.  No other executive officers received total annual salary and bonus compensation in excess of $100,000.

 

Name and Principal Position Year  Salary
($)
  Non-Equity
Incentive Plan
Compensation
($) (1)
  Stock
Awards
($) (2)
  All Other
Compensation
($) (3)
  Total
($)
 
Dolev Rafaeli, Chief Executive Officer 2016   495,000   1,200,000   71,719   46,347   1,813,066 
  2015   495,000   1,273,269   0   20,213   1,788,482 
Dennis M. McGrath, President and 2016   395,000   316,000   52,594   45,156   808,750 
Chief Financial Officer 2015   395,000   316,000   0   21,933   723,933 
Name and Principal PositionYear

Salary

($)

Stock Awards

($) (1)

Non-Equity Incentive Plan Compensation
($) (2)
All Other Compensation
($) (3)

Total

($)

Suneet Singal,

Former Chief Executive Officer(4)

201767,5000910,0000977,500
201600000

Stephen Johnson,

Former Chief Financial Officer(5)

2017182,308000182,308
201600000

Dolev Rafaeli,

Former Chief Executive Officer(6)

20173,260,30700111,7583,372,065
2016495,00071,7191,200,00046,3471,813,066

Dennis M. McGrath,

Former Chief Financial Officer(7)

2017970,2840058,6981,028,983
2016395,00052,594316,00045,156808,750

 

(1)“Non-Equity Incentive Plan Compensation”The amounts shown for restricted stock awards relate to shares granted under our Amended and Restated 2005 Equity Compensation Plan. These amounts are equal to the aggregate grant-date fair value with respect to the awards made in 2016, computed in accordance with the foregoing table isFinancial Accounting Standards Board (“FASB”) ASC Topic 718 (formerly SFAS 123R), before amortization and without giving effect to estimated forfeitures.

(2)The amounts shown for Dr. Rafaeli and Mr. McGrath relate to the bonus earned in 2016, and 2015, even though such bonus may have been paid in a subsequent period. Dr. Rafaeli’s bonus of $1,200,000 and Mr. McGrath’s bonus of $316,000 remainremained accrued but unpaid for both 2016 and 2015.

(2)2016. The amountsamount shown for Suneet Singal represents the grant of restricted stock awards relatepursuant to shares granted under our 2005 Equity Plan. These amounts area separation agreement, dated December 22, 2017, between the Company and Mr. Singal. This amount is equal to the aggregate grant-date fair value with respect to the awardsaward made in 2016 and 2015,2017, computed in accordance with FASB ASC Topic 718 (formerly SFAS 123R), before amortization and without giving effect to estimated forfeitures..

 

(3)“All Other Compensation” includesIncludes car allowance ($1,000 per month),allowances, premiums for supplementary life and/or disability insurance, of $7,910 and matching 401(k) plan contributions, of $2,962 forinterest payments on payout notes issued to Dr. Rafeali and Mr. McGrath. ForMcGrath, and director fees paid or earned to Dr. Rafaeli it includes matching 401(k) plan contributionsand Mr. McGrath after such persons resigned as executive officers of $13,250 and premiums for supplementary life and/or disability insurance of $6,549.the Company.

 

(4)Mr. Singal served as our Chief Executive Officer from May 17, 2017 until January 2, 2018. Under Mr. Singal’s employment agreement, he was entitled to an annual base salary of $250,000, as well as bonuses and other equity compensation as determined by our Compensation Committee. On October 11, 2017, we entered into an amended a restated employment agreement with Mr. Singal. Under this agreement, Mr. Singal was entitled to a base salary of $250,000 per annum, payable in accordance with our normal payroll practices, provided however, that the base salary would accrue, and not be paid, until (i) the 20% Unsecured Convertible Promissory Note issued to the First Capital Real Estate Operating Partnership, L.P. by the Company on July 25, 2017 had been repaid in full and (ii) Mr. Singal began working for the Company on a full-time basis. In connection with Mr. Singal’s resignation, on December 22, 2017, we entered into a separation agreement with Mr. Singal, pursuant to which Mr. Singal agreed to resign and we agreed to issue to Mr. Singal 1,000,000 shares of our common stock, 333,333 shares of which vested immediately, 333,333 shares of which will vest upon the first anniversary of the separation agreement, and 333,334 shares of which will vest upon the second anniversary of the separation agreement. The parties agreed that the issuance of such shares is in lieu of any other payment that Mr. Singal may already be entitled to receive under his employment agreement. By unanimous consent of the board of directors these shares were subsequently cancelled.

(5)Mr. Johnson served as our Chief Financial Officer from May 17, 2017 until January 2, 2018. Under Mr. Johnson’s employment agreement, he was entitled to an annual base salary of $300,000, as well as bonuses and other equity compensation as determined by our Compensation Committee. In connection with Mr. Johnson resignation, on December 22, 2017, we entered into a separation agreement with Mr. Johnson, pursuant to which Mr. Johnson agreed to resign and we agreed to pay to Mr. Johnson $405,432.70 in twelve (12) installments. We also agreed to pay for the health (medical, dental and/or vision) insurance policies for Mr. Johnson and his family for a period of twelve (12) months. We made the initial payment for Mr. Johnson’s separation and health benefits on January 8, 2017. On February 12, 2018, we entered into an amended and restated separation agreement with Mr. Johnson, pursuant to which we agreed to pay Mr. Johnson $122,500.64 in eleven installments as follows: the first six installments of $10,000, the following four installments of $12,500, and a final installment of $12,500.64. The first payment was made on February 15, 2018 and subsequent payments are to be made on or before the 15th day of each succeeding month, with the final installment to be paid on or before December 15, 2018. We also agreed to provide a health (medical, dental and/or vision) insurance reimbursement payment for Mr. Johnson and his family, for a period of eleven (11) months, in the agreed upon amount of $3,025 per month. In addition, we agreed to issue to Mr. Johnson 271,000 shares of common stock, which will be issued six months after the date of the amended and restated separation agreement. The foregoing amounts are in lieu of any other payment that Mr. Johnson may already be entitled to receive under his employment agreement.


(6)Dr. Rafaeli resigned as our Chief Executive Officer on Mary 17, 2017. Under Dr. Rafaeli’s employment agreement, he was entitled to an annual base salary of $495,000, certain bonuses based on success in sales, as well other equity compensation as determined by our Compensation Committee. In connection with Dr. Rafaeli’s resignation, we and Dr. Rafaeli agreed to convert all compensation due under his employment agreement into a secured convertible payout note to be issued following stockholder approval. On October 12, 2017, we issued the payout note in the principal amount of $3,133,934 to Dr. Rafaeli. The payout note was due on October 12, 2018, carried a ten percent (10%) interest rate, payable monthly in arrears commencing on December 1, 2017, and was secured by a security interest in all of our assets. On December 22, 2017, we entered into a stock grant agreement with Dr. Rafaeli and certain other note holders to (i) cause the early conversion of the payout note into 3,134,876 shares of our common stock, (ii) effectuate the release of all security interests associated with the payout note, (iii) provide for the issuance of 1,034,509 additional shares of common stock as consideration for the various agreements of Dr. Rafaeli contained in the stock grant agreement, (iv) provide for twelve (12) monthly payments of $21,328.16 on the first of each month commencing on January 1, 2018, which amounts are equal to the interest payments that would have been made absent the conversion of the payout note, (v) obtain the agreement of the Dr. Rafaeli to provide certain support services to the Company, and (vi) obtain the conditional resignation of Dr. Rafaeli from our Board. Accordingly, all of our obligations under the payout note were satisfied upon entering into the stock grant agreement and the simultaneous conversion of the payout note. The stock grant agreement was subsequently terminated pursuant to the Remediation Agreement. See “Remediation Proposal” below for more information.

(7)Mr. McGrath resigned as our Chief Financial Officer on Mary 17, 2017. Under Mr. McGrath’s employment agreement, he was entitled to an annual base salary of $395,000, an annual bonus in an amount not less than $316,000, as well other equity compensation as determined by our Compensation Committee. In connection with Mr. McGrath’s resignation, we and Mr. McGrath agreed to convert all compensation due under his employment agreement into a secured convertible payout note to be issued following stockholder approval. On October 12, 2017, we issued the payout note in the principal amount of $977,666 to Mr. McGrath. The payout note was due on October 12, 2018, carried a ten percent (10%) interest rate, payable monthly in arrears commencing on December 1, 2017, and was secured by a security interest in all of our assets. On December 22, 2017, we entered into a stock grant agreement with Mr. McGrath and certain other note holders to (i) cause the early conversion of the payout note into 977,960 shares of our common stock, (ii) effectuate the release of all security interests associated with the payout note, (iii) provide for the issuance of 322,727 additional shares of common stock as consideration for the various agreements of Mr. McGrath contained in the stock grant agreement, (iv) provide for twelve (12) monthly payments of $6,653.56 on the first of each month commencing on January 1, 2018, which amounts are equal to the interest payments that would have been made absent the conversion of the payout note, (v) obtain the agreement of the Mr. McGrath to provide certain support services to the Company, and (vi) obtain the conditional resignation of Mr. McGrath from our Board. Accordingly, all of our obligations under the payout note were satisfied upon entering into the stock grant agreement and the simultaneous conversion of the payout note. The stock grant agreement was subsequently terminated pursuant to the Remediation Agreement. See “Remediation Proposal” below for more information.


Outstanding Equity Awards Value at Fiscal Year-EndYear End Table

 

The following table includes certain information with respect to the value of all unexercised options and unvested shares of restricted stock previously awarded to the executive officers named above at the fiscal year end,ended December 31, 2016.2017.

 

  Option Awards  Stock Awards 
Name Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
(2)
  Number of
Securities
Underlying
Unexercised
Options (#) Un-
exercisable

(2)
  Equity
Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options (#)
  Option
Exercise
Price ($)
  Option
Expiration
Date
  

Number
of Shares
or Units
of Stock
That
Have Not

Vested
(#)

  Market
Value of
Shares or
Units of
Stock That
Have Not
Vested
($)(1)
  Equity
Incentive
Plan Awards:
Number of
Unearned
Shares, Units
or Other
Rights That
Have Not
Vested (#)
  Equity
Incentive Plan
Awards:
Market or
Payout Value
of Unearned
Shares, Units
or Other
Rights That
Have Not
Vested ($)(1)
 
Dolev  16,800   11,200   0   100.00   3/18/2022   0   0   N/A   N/A 
Rafaeli  3,800   5,700   0   100.00   2/28/2023   0   0   N/A   N/A 
   0   N/A   0   N/A   N/A   0   0   33,750   75,938 
Dennis  1,750   0   0   31.20   6/15/19   0   0   N/A   N/A 
McGrath  2,120   0   0   100.00   12/13/21   0   0   N/A   N/A 
   10,020   0   0   78.00   12/13/21   0   0   N/A   N/A 
   10,800   7,200   0   100.00   3/18/22   0   0   N/A   N/A 
   2,800   4,200   0   100.00   2/28/23   0   0   N/A   N/A 
   0   N/A   0   N/A   N/A   0   0   24,750   55,688 

17

 Option Awards(1)Stock Awards(2)
NameNumber of
Securities
Underlying Unexercised
Options (#) Exercisable
Number of
Securities
Underlying Unexercised
Options (#) Un-
exercisable
Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying Unexercised
Unearned
Options (#)
Option Exercise Price ($)Option
Expiration
Date
Number of
shares or
units of stock
that have not
vested

(#)
Market
value of
shares of
units of
stock that
have not
vested

($)
Equity
incentive
plan
awards:
Number of
unearned
shares,
units or
other rights
that have
not vested

(#)
Equity
incentive
plan awards:
Market or
payout value
of unearned
shares, units
or other
rights that
have not
vested

($)
Suneet Singal000N/AN/A666,667576,6670N/A
Stephen Johnson000N/AN/A0N/A0N/A
Dolev Rafaeli28,00000100.003/18/20220N/A0N/A
9,50000100.002/28/20230N/A0N/A
Dennis M. McGrath1,7500031.206/15/190N/A0N/A
2,12000100.0012/13/210N/A0N/A
10,0200078.0012/13/210N/A0N/A
18,00000100.003/18/220N/A0N/A
7,000000100.002/28/230N/A0N/A

 

(1)The market value of unvested shares of restricted stock is based on $2.20 per share, which wasAll options grants were under the closing price of our stock on December 31, 2016.Amended and Restated 2005 Equity Compensation Plan.

 

(2)All options grants were underThe amount shown represents the 2005 Equity Plan.grant of restricted stock. This table has been updatedamount is equal to reflect the one for five reverse stock split effected September 23, 2016.aggregate grant-date fair value with respect to the award made, computed in accordance with FASB ASC Topic 718 (formerly SFAS 123R).

Mr. Rafaeli and Mr. McGrath vest in the 45,000 and 33,000 shares of restricted stock, respectively, granted on November 7, 2014 equally on each of the first four anniversaries of the issuance date. The outstanding stock options vest ratably on each of the five anniversaries of the grant date. All unvested shares and options vest upon a change of control as defined in each of their employment agreements. Upon the sale of the consumer products division to ICTV Brands Inc. on January 23, 2017, a change of control event was triggered.

 

Director Compensation

 

Directors who are also our employeesexecutive officers receive no separate compensation for serving as directors or as members ofcommitteesof our BoardBoard. Each other director receives an annual cash retainer of Directors.$40,000, payable quarterly and the chairman of each committee receives an additional annual fee of $10,000 for audit, $5,000 for each of compensation and nominations. The table below sets forth our non-employeenon-executive officer directors’ compensation throughfor the year ended December 31, 2016.2017.  

 

Name Fees Earned or
Paid in Cash
($)
  All Other
Compensation
($) (1)
  Total
($)
 
Lewis Pell  40,000   0   40,000 
Yoav Ben-Dror  45,000   360,000   405,000 
Stephen P. Connelly  40,000   0   40,000 
Dan Amiram  50,000   0   50,000 

 

Name

Fees earned
or paid in
cash ($)

All other
compensation

($)

Total ($)

Robert Froehlich(1)28,125028,125
Richard J. Leider(1)28,125028,125
Darrell C. Menthe(1)25,000025,000
Michael R. Stewart(1)31,250031,250
Lewis Pell(2)17,100017,100
Yoav Ben-Dror(2)(3)15,200960,134975,334
Stephen P. Connelly(2)17,100017,100
Dennis McGrath(4)25,0001,003,9831,028,983
Dolev Rafaeli(4)25,0003,347,0653,372,065

 

(1)Dr.New Directors compensated for the period of May 17, 2017 through December 31, 2017.

(2)Lewis C. Pell, Yoav Ben-Dror received a monthly payment of $30,000 for his services asand Stephen P. Connelly resigned from the executive director for Radiancy Ltd. and Photo Therapeutics, Ltd.Board effective May 17, 2017.

 


18(3)We and Dr. Ben-Dror agreed to convert all compensation due under his previous agreements into a secured convertible payout note to be issued following stockholder approval. On October 12, 2017, we issued the payout note in the principal amount of $1,515,000 to Dr. Ben-Dror. The payout note was due on October 12, 2018, carried a ten percent (10%) interest rate, payable monthly in arrears commencing on December 1, 2017, and was secured by a security interest in all of our assets. On December 22, 2017, we entered into a stock grant agreement with Dr. Ben-Dror and certain other note holders to (i) cause the early conversion of the payout note into 1,515,455 shares of our common stock, (ii) effectuate the release of all security interests associated with the payout note, (iii) provide for the issuance of 500,100 additional shares of common stock as consideration for the various agreements of Dr. Ben-Dror contained in the stock grant Agreement, (iv) provide for twelve (12) monthly payments of $10,310.42 on the first of each month commencing on January 1, 2018, which amounts are equal to the interest payments that would have been made absent the conversion of the payout note, and (v) obtain the agreement of the Dr. Ben-Dror to provide certain support services to the Company.Accordingly, all of our obligations under the payout note were satisfied upon entering into the stock grant agreement and the simultaneous conversion of the payout note. The stock grant agreement was subsequently terminated pursuant to the Remediation Agreement. See “Remediation Proposal” below for more information.

(4)See Summary Compensation Table – Fiscal Years Ended December 31, 2017 and 2016.

18 

 

 

TRANSACTIONS WITH RELATED PERSONS

 

None of our directors, director nominees, executive officers, 5% stockholders, or immediate family member of such persons has been involved in any transactions with us which are required to be disclosed pursuant to Item 404 of Regulation S-K.

 

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

 

Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), requires our directors and executive officers and beneficial holders of more than 10% of our common stock to file with the SEC initial reports of ownership and reports of changes in ownership of our equity securities. We believe, based solely on a review of the copies of such reports furnished to us and representations of these persons that all reports needed to be filed have been filed for the year ended December 31, 2016.2017.

 

19

19 

 

 

PROPOSAL NO. 1 – FIRST CHARTER PROPOSALMANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following management’s discussion and analysis should be read in conjunction with our financial statements and the notes thereto and the other financial information appearing elsewhere in this proxy statement.

 

GeneralOverview

The Company, founded in 1980, is transitioning from its former business as a skin health company to a company focused on real estate development and asset management, concentrating primarily on investments in and the management and development of income producing real estate assets. Our objective is to generate current income and long-term net asset value growth using institutional best practices in evaluating our investments.

Until the recent sale of our consumer products division, we were a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. Starting in 2014, we began to sell off certain business units and product lines and on January 23, 2017, we sold the last remaining major product line. Following this transaction, we had only minimal operations and assets remaining, of immaterial value to our company. We are in the process of liquidating the remaining legacy inventory and assets of this business line, after which time we will no longer operate within the skin health business.

Following the Contribution Transaction described below, our focus is to build the Company into a leading real estate, asset management and development company concentrating primarily on investments in high yield income producing assets and other opportunistic commercial properties via direct property ownership and asset management. Our objective is to generate long-term net asset value growth while adhering to institutional best practices and a deep research process for all investments.

For income producing properties, we intend to acquire assets that provide recurring income with the potential for income growth over the long-term. We believe there can be an attractive risk/reward profile to such properties based on the location and the underlying creditworthiness of the tenants. We intend to use such income generation to fund additional acquisitions and development opportunities and for general corporate purposes. In addition, we intend to invest in land assets that can be developed into income generating properties or properties for sale. We believe that our size and scale provide an opportunity to take advantage of smaller-tier assets that most traditional investors do not focus on due to size limitations, thus creating unique investment opportunities. In particular, we intend to target assets in secondary and tertiary markets that require minimal capital expenditures but generate initial unlevered cash flow yields that are higher than those in primary markets.

A second component of our investment strategy will revolve around sourcing asset management opportunities for which we would operate as an asset manager of real estate properties. We are not structured as a Real Estate Investment Trust, thus we have the ability to retain earnings and to operate in real estate asset management, development and peripheral real estate activities, items that may be limited by Real Estate Investment Trust requirements. We will look to utilize our existing infrastructure to provide economies of scale to owners of real estate assets as we grow our portfolio over time.

Contribution Transaction

 

On May 17,March 31, 2017, our Board approvedwe entered into an amendment and restatement of our current Amended and Restated Articles of IncorporationInterest Contribution Agreement with First Capital Real Estate Operating Partnership, L.P. (the “Current CharterContributor”) to, among other things, change the name of the Company to “FC, First Capital Real Estate Trust Incorporated (the “Contributor Parent”), and FC Global Realty Incorporated”Operating Partnership, LLC, our wholly-owned subsidiary (the “Acquiror”). The parties entered into amendments to the Interest Contribution Agreement on August 3, 2017, October 11, 2017 and increaseDecember 22, 2017. Pursuant to the number of authorizedInterest Contribution Agreement, as amended (which we collectively refer to as the “Contribution Agreement”), the Contributor contributed certain real estate assets to the Acquiror. In exchange, the Contributor received shares of our common stock and preferred stock. The full text of the proposed Amended and Restated Articles of Incorporation (the “Restated Charter”) is attached hereto asAnnex A.

Our Current Charter authorizes the Company to issue fifty million (50,000,000) shares of common stock, $.01 par value per share, and five million (5,000,000) shares of preferred stock, $.01 par value per share. As of the Record Date, there were 5,297,500 shares of common stock and 123,668 shares of ournewly designated Series A Convertible Preferred Stock outstanding. We also have reserved 147,088 shares of common stock for issuance under our 2005 Equity Compensation Plan, 240,018 shares of common stock for issuance under our 2000 Non-Employee Director Stock Option Plan and 64,500 shares of common stock for issuance under outstanding warrants. The proposed Restated Charter will increaseas described below. This transaction, which we refer to as the number of authorized shares of common stock to five hundred million (500,000,000) shares and increase the number of authorized shares of preferred stock to fifty million (50,000,000) shares.Contribution Transaction, closed on May 17, 2017.

 

The proposed Restated Charter will also includeOn the following amendmentsclosing date, the Contributor transferred assets totaling $10 million to our Current Charter:the Acquiror, consisting of the following:

 

·the addition of a provision regarding our election not to be governed by certain provisions of the Nevada Revised Statutes regulating business combinations with interested stockholders;

·the addition of a provision regarding our election not to be governed by certain provisions of the Nevada Revised Statutes regulating control share acquisitions;

·the removal of a provision regarding the number of directors of the Company, which is included in our Amended and Restated Bylaws;

·the removal of a provision regarding vacancies in our Board, which is included in our Amended and Restated Bylaws; and

·the removal of a provision regarding the location of stockholder meetings and the location of our books and records, which is included in our Amended and Restated Bylaws.

The Restated Charter will become effective upon filing with the Nevada Secretary of State’s Office and we anticipate that such filing will occur promptly following stockholder approval at the Meeting.

Reasons for the Amendments to our Current Charter

Name Change

Our Board determined that the change of the name of our company to FC Global Realty Incorporated will more accurately reflect our new business following the Contribution Transaction. See “Proposal No. 2 - Contribution Securities Issuance Proposal—Activities of the Company Following the Contribution Transaction” for more information regarding our new business following the Contribution Transaction. Following the name change, the new symbol for the trading of our common stock on the NASDAQ Capital Market will be “FCRE”.

Increase in Authorized Stock

The primary purpose of the amendment to increase our authorize stock is to facilitate the issuance of shares under the Contribution Agreement, as described more fully under Proposal 2 below. This amendment will also provide us with increased flexibility in meeting future corporate needs and requirements by providing additional authorized shares of common stock and preferred stock, which will be available for issuance from time to time as determined by the Board for any proper corporate purpose including additional equity financings without the expense and delay associated with a special stockholders’ meeting, except where required by applicable rules, regulations and laws.

20

No Restrictions on Business Combinations with Interest Stockholders

The proposed Restated Charter also amends our Current Charter to state that the Company elects not to be governed by the terms and provisions of Sections 78.411 through 78.444, inclusive, of the Nevada Revised Statutes (referred to herein as the “Business Combination Statue”), regulating business combinations with interested stockholders.

The Business Combination Statute prohibits a Nevada corporation with at least 200 stockholders of record from engaging in various “combination” transactions with any interested stockholder for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the transaction is approved by the Board of Directors prior to the date the interested stockholder obtained such status; or after the expiration of the three-year period, unless:

·the transaction is approved by the Board of Directors or a majority of the voting power held by disinterested stockholders, or

·if the consideration to be paid by the interested stockholder is at least equal to the highest of: (a) the highest price per share paid by the interested stockholder within the three years immediately preceding the date of the announcement of the combination or in the transaction in which it became an interested stockholder, whichever is higher, (b) the market value per share of common stock on the date of announcement of the combination and the date the interested stockholder acquired the shares, whichever is higher, or (c) for holders of preferred stock, the highest liquidation value of the preferred stock, if it is higher.

A “combination” is defined to include mergers or consolidations or any sale, lease exchange, mortgage, pledge, transfer or other disposition, in one transaction or a series of transactions, with an “interested stockholder” having: (a) an aggregate market value equal to 5% or more of the aggregate market value of the assets of the corporation, (b) an aggregate market value equal to 5% or more of the aggregate market value of all outstanding shares of the corporation, or (c) 10% or more of the earning power or net income of the corporation. In general, an “interested stockholder” is a person who, together with affiliates and associates, owns (or within three years, did own) 10% or more of a corporation's voting stock.

The Business Combination Statute could prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire our Company even though such a transaction may offer our stockholders the opportunity to sell their stock at a price above the prevailing market price. Therefore, the application of the Business Combination Statute would limit the ability of our stockholders to approve a transaction that they may deem to be in their interests. Our Board of Directors determined that the Business Combination Statute places unnecessary burdens on the Company in connection with the completion of beneficial business transactions with interested stockholders, and has thus decided to amend our Current Charter to specifically forego the provisions of the Business Combination Statue.

Since we are already subject to the Business Combination Statute, the amendment to our Current Charter to state that we elect not to be governed by it requires the affirmative vote of the holders of a majority of the issued and outstanding shares of common stock of the Company not beneficially owned by “interested stockholders” (as defined in Section 78.423 of the Nevada Revised Statutes) or their affiliates and associates. An “interested stockholder” means any person, other than the Company or any subsidiary of the Company, who is: (i) the beneficial owner, directly or indirectly, of 10 percent or more of the voting power of the outstanding voting shares of the Company; or (ii) an affiliate or associate of the Company who at any time within the past 2 years was the beneficial owner, directly or indirectly, of 10 percent or more of the voting power of the then outstanding shares of the Company. Accordingly, shares held by these persons will not be counted in considering the Charter Proposal.

In addition, the amendment to elect not to be governed by the Business Combination Statute is not effective until 18 months after the vote of stockholders and does not apply to any combination of the Company with a person who first became an interested stockholder on or before the effective date of the amendment.

No Restrictions on Control Share Acquisitions

The proposed Restated Charter also amends our Current Charter to state that the Company elects not to be governed by the terms and provisions of Sections 78.378 through 78.3793, inclusive, of the Nevada Revised Statutes (referred to herein as the “Control Share Statue”), restricting certain acquisitions of a controlling interest in a corporation. The Control Share Statute applies only to Nevada corporations with at least 200 stockholders of record, including at least 100 stockholders of record who are Nevada residents, and which conduct business directly or indirectly in Nevada.

21

The Control Share Statute prohibits an acquiror, under certain circumstances, from voting its shares of a target corporation’s stock after crossing certain ownership threshold percentages, unless the acquiror obtains approval of the target corporation’s disinterested stockholders. The Control Share Statute specifies three thresholds: one-fifth or more but less than one-third, one-third but less than a majority, and a majority or more, of the outstanding voting power. Once an acquiror crosses one of the above thresholds, those shares in an offer or acquisition, and acquired within 90 days thereof, become “control shares” and such control shares are deprived of the right to vote until disinterested stockholders restore the right. The Control Share Statute also provides that if control shares are accorded full voting rights and the acquiring person has acquired a majority or more of all voting power, all other stockholders who do not vote in favor of authorizing voting rights to the control shares are entitled to demand payment for the fair value of their shares in accordance with statutory procedures established for dissenters’ rights.

As of the date of this proxy statement, we do not have 100 or more stockholders of record who are Nevada residents, and are therefore not subject to the Control Share Statute, although there can be no assurance that in the future this statute will not apply to us. Our Board of Directors has determined that, should we become subject to the Control Share Statute, it would place unnecessary burdens on the Company in connection with the completion of third party financings, and has thus decided to amend our Current Charter to specifically forego the provisions of the Control Share Statue.

Removal of Duplicative Provisions

The proposed Restated Charter also amends our Current Charter to remove certain provisions regarding the size of our Board, the method for filling vacancies in our Board, and the locations of stockholder meetings and of our corporate records. These provisions are not required to be included in our articles of incorporation under Nevada law and are also included in our Amended and Restated Bylaws, so our Board determined to remove these provisions from our Current Charter.

Possible Effects of the Amendments to our Current Charter

Release No. 34-15230 of the staff of the SEC requires disclosure and discussion of the effects of any stockholder proposal that may be used as an anti-takeover device. Please see “Reasons for the Amendments to our Current Charter—No Restrictions on Business Combinations with Interested Stockholders” and “Reasons for the Amendments to our Current Charter—No Restrictions on Control Share Acquisitions” above for certain anti-takeover effects of our election not to be governed by the Business Combination Statute and Control Share Statute.

The proposed increase in the authorized number of shares of our common stock and preferred stock could have an anti-takeover effect, in that additional shares could be issued (within the limits imposed by applicable law) in one or more transactions that could make a change in control or takeover of us more difficult. For example, additional shares could be issued by us so as to dilute the stock ownership or voting rights of persons seeking to obtain control of us, even if the persons seeking to obtain control offers an above-market premium that is favored by a majority of the independent stockholders. Similarly, the issuance of additional shares to certain persons allied with our management could have the effect of making it more difficult to remove our current management by diluting the stock ownership or voting rights of persons seeking to cause such removal. We have no plans or proposals to adopt other provisions or enter into other arrangements that may have material anti-takeover consequences. This proposal is not being presented with the intent that it be utilized as a type of anti- takeover device.

Our stockholders should recognize that, as a result of this proposal, they will own a fewer percentage of shares with respect to our total authorized shares than they presently own and will be diluted as a result of any issuance of shares by us in the future.

Other than in connection with the Contribution Agreement, there are currently no specific plans, arrangements, commitments or understandings for the issuance of the additional shares of stock which are proposed to be authorized (except with respect to potential issuances of shares upon exercise of currently outstanding options and warrants).

No Dissenters’ Rights

Under Nevada law, holders of our common stock are not entitled to dissenter’s rights of appraisal with respect to the approval of the proposed Restated Charter.

22

Vote Required

 The approval of the First Charter Proposal requires the affirmative vote of the holders of a majority of the issued and outstanding shares of our common stock not beneficially owned by “interested stockholders” (as defined in Section 78.423 of the Nevada Revised Statutes) or their affiliates and associates. An Abstention will be treated in the same manner as a vote against the First Charter Proposal. Since the First Charter Proposal is considered to be a “non-routine” matter, shares that constitute broker non-votes are not considered votes cast on the First Charter Proposal.

Our Board of Directors unanimously recommends a vote “FOR” approval of the First Charter Proposal.

23

 PROPOSAL NO. 2 – CONTRIBUTION SECURITIES ISSUANCE PROPOSAL

Explanatory Note

The Contribution Transaction does not require the vote of our stockholders and although we are seeking to make amendments to our Current Charter through the First Charter Proposal, the increase in authorized capital stock contemplated by such amendments is not required in order to consummate the Contribution Transaction. In fact, the Contribution Transaction’s initial closing has occurred prior to the Meeting. Accordingly, your vote in connection with the Contribution Transaction relates only to our issuance of securities upon conversion of the securities issued or to be issued in connection with the Contribution Transaction as described in more detail below. Nevertheless, we are providing you with detailed information regarding the Contribution Transaction that is similar to the information that you would receive if you were required to vote on the Contribution Transaction. We are not providing financial statements, and we will not be providing financial statements, with respect to the contributed properties delivered at the Initial Closing, however, because our acquisition of those contributed properties constitutes the acquisition of assets and does not constitute the acquisition of a business under U.S. generally accepted accounting practices or Regulation S-X promulgated by the SEC.

A copy of the Contribution Agreement is attached hereto asAnnex B.

A copy of the First Amendment to the Contribution Agreement is attached hereto asAnnex C.

Summary of Terms of the Contribution Transaction

This summary of the terms of the Contribution Transaction highlights information included elsewhere in this proxy statement. This summary does not contain all of the information you should consider before voting on the Contribution Securities Issuance Proposal. You should read the entire proxy statement carefully, including the annexes attached hereto. For your convenience, we have included cross references to direct you to a more complete description of the topics described in this summary.

·Contribution Agreement; Parties. On March 31, 2017, the Company and the Acquiror entered into the Contribution Agreement with the Contributor and the Contributor Parent.

·Contribution Transaction. Pursuant to the Contribution Agreement, the Contributor will be required to contribute certain real estate assets to the Acquiror and in other instances may, at its option, contribute certain real estate assets to the Acquiror, in a series of three installments no later than December 31, 2017. In exchange, the Contributor will receive shares of our common stock and newly designated Series A Convertible Preferred Stock. See “The Contribution Transaction” below.

·First Contribution. In the first contribution installment, which closed on May 17, 2017, the Contributor transferred or agreed to transfer $10 million of assets to the Acquiror, consisting of the following: three vacant land sites slatedintended for development as gas stations located in northern California,


·a 75% interest in a limited liability company that owns a vacant land site slatedintended for development as a gas station, located in Northernnorthern California; and an

·a 100% interest in a limited liability company which owns a 17.9133% interest in a limited liability company called Avalon Jubilee LLC that owns property located in Los Lunas, New Mexico being developed as a single family residential development. As described below, Contributor Parent has agreed to transfer a 17.9133% interest in this limited liability company within 30 days following the Initial Closing. In return, we issued to the Contributor 879,234 shares of our common stock and 123,668 shares of Series A Convertible Preferred Stock, which are in turn convertible to 3,091,700 shares of common stock upon stockholder approval at the Meeting. At the closing of the first contribution, we assumed the liabilities associated with these initial contributed properties. See “The Contribution Transaction—First Contribution” below.

·Changes to Board and Officers. At the closing of the first contribution, the following directors of the Company resigned: Lewis C. Pell, Yoav Ben-Dror and Stephen P. Connelly. Messrs. Rafaeli and McGrath, our Chief Executive Officer and Chief Financial Officer, respectively, resigned from such offices. Dr. Ben-Dror resigned as managing director of the Company’s foreign subsidiaries. Suneet Singal was appointed as Chief Executive Officer of the Company, and Stephen Johnson was appointed the Company’s Chief Financial Officer. At the Initial Closing, our Board was restructured to consist of seven (7) persons of whom three (3), Dolev Rafaeli, Dennis M. McGrath and Michael R. Stewart, were designated by us and three (3), Suneet Singal, Richard J. Leider and Dr. Bob Froehlich, were designated by the Contributor Parent. The seventh director, Darrel C. Menthe was selected by the other six (6) directors at a special meeting of the Board on May 25, 2017. See “The Contribution Transaction—First Contribution” below.

24

·Second Contribution. The Contributor Parent is also required to contribute two additional property interests valued at $20 million if certain conditions are satisfied by December 31, 2017. This second installment is mandatory. These properties consist of Contributor Parent’s ownership interest in (i) a private hotel that is currently undergoing renovations to convert to a Wyndham Garden Hotel (or $5.89 million in cash following the sale of the hotel) and (ii) Dutchman’s Bay and Serenity Bay, two planned full service resort hotel developments located in Antigua and Barbuda. In exchange for these properties, we will issue to the Contributor shares of our common stock if this Contribution Securities Issuance Proposal has been approved by our stockholders or shares of our Series A Convertible Preferred Stock if this Contribution Securities Issuance Proposal has not yet been approved by our stockholders. “The Contribution Transaction—Second Contribution” below.

·Third Optional Contribution. The Contributor Parent has the option to contribute either or both of two additional property interests valued at $66.5 million if certain conditions are satisfied by December 31, 2017. This third installment is optional in the Contributor Parent’s sole discretion. The Contributor Parent may contribute to us its interest in a resort development project on an island just south of Hilton Head, South Carolina. The Contributor Parent also may contribute to us a golf and surf club development project on the Baja Peninsula in Mexico. In exchange for these properties, we will issue to the Contributor shares of our common stock if this Contribution Securities Issuance Proposal has been approved by our stockholders or shares of our Series A Convertible Preferred Stock if this Contribution Securities Issuance Proposal has not yet been approved by our stockholders. In addition, we will issue to the Contributor a five (5) year warrant to purchase up to 25,000,000 shares of our common stock at an exercise price of $3.00 per share that vests with respect to the number of underlying shares upon the achievement of specified milestones. “The Contribution Transaction—Optional Contribution” below.

·Payout Notes. Amounts due to Messrs. Rafaeli and McGrath under their employment agreements, as well as amounts due to Dr. Yoav Ben-Dror for his services as a board member and officer of our foreign subsidiaries, will be converted to convertible secured notes if and when our stockholders approve this Contribution Securities Issuance Proposal. These convertible secured notes will be due one year after stockholder approval, carry a ten percent (10%) interest rate and will be convertible into shares of our common stock. These convertible secured notes will be secured by a security interest in all of our assets and the holders of the notes will receive certain registration rights. “The Contribution Transaction—Payout Notes” below.

·Reasons for the Contribution Transaction.  Our Board considered a number of factors before deciding to enter into the Contribution Agreement, including, among other things, the price to be paid (i.e., the number of shares to be issued) by us for the assets being contributed, the strategic and financial benefits of acquiring the contributed assets, the new business plan and strategy that will be undertaken by our Company following the closing of the transactions contemplated by the Contribution Agreement, and the expected future business prospects of our Company after we acquire the contributed assets. Our Board also considered our current financial condition. See “Reasons for the Contribution Transaction” below.

·Recommendation of our Board of Directors. Our Board has determined by an unanimous vote that the Contribution Securities Issuance Proposal is desirable and has directed that it be submitted to our stockholders for their approval. Our Board unanimously recommends that you vote “FOR” the Contribution Securities Issuance Proposal. You should read “Reasons for the Contribution Transaction” for a discussion of factors that our Board considered in deciding to recommend the approval of the Contribution Securities Issuance Proposal.

·Required Vote  Approval of the Contribution Securities Issuance Proposal requires the affirmative vote of a majority of the shares present in person or represented by proxy at the Meeting. See “Vote Required” below.

·Nature of Our Business Following the Contribution Transaction  Following the Contribution Transaction, our business will be primarily focused on the development and operation of the contributed properties. In addition, we will continue to operate the LHE® medical device business of Radiancy will continue to defend and prosecute the existing litigation involving our company and will consider other strategic investments or alternatives for our Company. See “Activities of the Company Following the Contribution Transaction” below.

 

In exchange for these assets, we issued to the Contributor 879,234 shares of our common stock, which represented approximately 19.9% of our issued and outstanding common stock immediately prior to the closing date, at a per share value of $2.5183, or $2,214,175 in the aggregate. We issued the remaining $7,785,825 of the approximately $10 million agreed upon consideration to the Contributor in the form of 123,668 shares of our newly designated non-voting Series A Convertible Preferred Stock. Each share of the Series A Convertible Preferred Stock is convertible into 25 shares of our common stock, subject to the satisfaction of certain conditions, including stockholder approval of such conversion, which was obtained on October 12, 2017.

·Conditions to Contribution Transaction   The first contribution was and each of the second contribution and third optional contribution are subject to customary closing conditions and certain other specific conditions that are described in more detail below. “The Contribution Transaction—Conditions to the Contribution Transaction” below.

 

25

 The Contribution Agreement contemplated that additional contributions would be made prior to December 31, 2017; however, the Contributor failed to satisfy the conditions precedent to those additional contributions before the December 31, 2017 deadline such that only the closing described above was completed.

 

We elected to early adopt ASU 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business. Accordingly, the determination of whether the transaction represents a business combination was evaluated by applying ASU 2017-01 guidance. We have determined that the group of assets assumed do not include (and also, none of them on a stand-alone basis) include, an input and a substantive process that together significantly contribute to the ability to create output and thus it was determined that the contribution represents an acquisition of assets rather than a business combination. Accordingly, the total sum of the fair value of consideration given (i.e. the fair value of the equity interests issued) together with the transaction costs, was allocated to the individual assets acquired and liabilities assumed based on their relative fair values at the date of acquisition. Such allocation did not give rise to goodwill.

·U.S. Federal Income Tax Consequences.Our U.S. stockholders will not realize any gain or loss for U.S. federal income tax purposes as a result of the Contribution Transaction. See “U.S. Federal Income Tax Consequences of the Contribution Transaction” below.

 

Contact Information andOur Prior Business Conducted

PhotoMedex, Inc.

2300 Computer Drive, Building G

Willow Grove, Pennsylvania 19090

(215) 619-3600Operations

 

PhotoMedex,Until the recent sale of the last significant business unit (its consumer products division which was sold to ICTV Brands, Inc. was originally incorporated in Delaware in 1980 and then re-incorporated in Nevada on December 30, 2010. Until January 23, 2017, when we sold substantially all of our assets to2017), the Company was a third party, we were a global health products and servicesGlobal Skin Health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. WeThe Company provided proprietary products and services that addressaddressed skin diseases and conditions including psoriasis, acne, actinic keratosis (a precursor to certain types of skin cancer), photo damage and UV damageunwanted hair.

Before the Company commenced its current real estate business, it organized the business into three operating segments based upon the management structure, products and services offered, markets served and types of customers, as follows: The Consumer segment (sold to ICTV Brands, Inc. on January 23, 2017) derived its revenues from the sun. Our experience indesign, development, manufacturing and selling of long-term hair reduction and acne consumer products. The Physician Recurring segment derived its revenues from the physician market provided us with a platformXTRAC (sold to expand our skin health solutionsMELA Sciences on June 22, 2015) procedures performed by dermatologists, the sales of skincare products (sold to spa markets,Pharma Cosmetics on September 15, 2016), the sales of surgical disposables and accessories to hospitals and surgery centers (sold to Dalian JiKang Medical Systems September 1, 2015) and on the repair, maintenance and replacement parts on various products. The Professional segment generated revenues from the sale of equipment, such as well as traditional retail, onlinelasers, medical and infomercial outlets for home-useesthetic light and heat based products and LED products. Through our subsidiary Radiancy, which merged into PhotoMedex in 2011, we added a range of home-use devices under the no!no!® brand, for various indications including hair removal, acne treatment, skin rejuvenation and lower back pain. In addition, our professional product line increased its offerings for acne treatment, skin tightening, psoriasis care and hair removal sold to physician clinics and spas. On January 23, 2017, we sold substantially all of our remaining assets save for our LHE® product line. From and after January 23, 2017, we continue to own the rights to, and operate, our LHE® product line.

 

OurThe proprietary LHE® brand technology combines the benefits of direct heat and a full-spectrum light source for a variety of clinical applications, including psoriasis care, acne treatment, skin tightening, skin rejuvenation, wrinkle reduction, collagen renewal, vascular and pigmented lesion treatments and hair removal. This technology was originally used primarily in our professional products, including capital equipment sold to physicians and skin care specialists worldwide. The technology was then adapted to our hand-held consumer line of products like no!no! Skin, a medical device for acne. Except for the liquidation of remaining inventory, the carrying amount of which is insignificant as of June 30, 2018, this business segment effectively ceased operations with the sale to NEOVA on September 23, 2016.


Going Concern

 

Additional information about ourThe accompanying condensed consolidated financial statements have been prepared assuming the Company can be found on our website at http://www.photomedex.com. The information provided on our website is notwill continue as a partgoing concern, which contemplates the realization of this proxy statementassets and is not incorporated herein by reference.satisfaction of liabilities in the normal course of business.

 

BackgroundAs of June 30, 2018, we had an accumulated deficit of approximately $137 million and stockholders’ deficit of approximately $2.9 million. Cash and cash equivalents as of June 30, 2018 were approximately $892. To date, and subsequent to the recent sale of our last significant business unit, we have dedicated most of our financial resources to general and administrative expenses.

On March 31, 2017, we entered into the Contribution Transaction

Our Board and senior management have from timeAgreement, under which certain real estate investment properties were contributed to time evaluated and considered a variety of strategic alternatives as part of a long-term strategy to increase stockholder value. In connection with such evaluation and,the Company in particular, followingexchange for the sale of substantially allissuance of our assets in January 2017, we sought to identify and acquire a substantial business in an area that provided opportunities for significant growth.

During January 2017, we commenced discussions with the Contributor Parties with respect to the potential acquisition of certain of the Contributor Parties’ assets. Over the next few months, the parties, together with their respective advisors, continued to discuss the potential transaction and conducted due diligence. After the parties came to a mutual understanding as to the proposed material terms of the Contribution Transaction, including a formula for determining the consideration (payable in equity of the Company) to be paid for the contributed properties and the mutually agreed upon value of the contributed properties, the Contributor Parties’ legal counsel was authorized to prepare a draftcapital stock. Closing of the Contribution Agreement occurred on May 17, 2017. However, the assets assumed in such contribution do not represent a business and are not producing cash flows and/or revenues at present.

On December 22, 2017, we entered into a securities purchase agreement with Opportunity Fund I-SS, LLC, a Delaware limited liability company (“OFI”), under which OFI could invest up to $15 million in the Company in a series of closings, in exchange for which OFI would receive shares of our Series B Preferred Stock at a purchase price of $1.00 per share. On December 22, 2017, we completed the first closing, pursuant to which OFI provided $1.5 million to us in exchange for 1,500,000 shares of Series B Preferred Stock. On January 24, 2018, we completed a second closing, pursuant to which OFI provided approximately $2.2 million to us in exchange for 2,225,000 shares of Series B Preferred Stock. On August 24, 2018, 2018, we completed a third closing, pursuant to which OFI provided $100,000 to us in exchange for 100,000 shares of Series B Preferred Stock. Under the purchase agreement, OFI could, but was deliverednot obligated to, make additional investments in one or more subsequent closings until an aggregate amount of $15 million was invested or the purchase agreement was terminated in accordance with its terms. OFI had no obligation to continue to invest in the Company, and its counselthere are restrictions placed by OFI on February 24, 2017. During the period from February 24, 2017 through March 31, 2017, the parties negotiated the termsuse of the Contribution Agreement. In addition, ancillary agreements, including an Assignment and Assumption Agreement, Certificate of Designation of the Series A Convertible Preferred Stock, Lock Up Agreement, Registration Rights Agreement, Amended and Restated Articles of Incorporation of the Company, Amended and Restated Bylaws of the Company, Voting Agreement, Form of Payout Notes, Payout Notes Security Agreement, Employment Agreement with Suneet Singal and Warrant, were prepared and negotiated during this time. Our Boardthese funds. The securities purchase agreement was updated informally by management on a regular basis regarding the status of the proposed Contribution Transaction during the time that discussions and negotiations took place, including, without limitation, at the meetings of the Board held on February 8, 2017 and March 29, 2017.

26

At a meeting of our Board held on March 29, 2017, our legal counsel discussed and answered questions from the members of the Board regarding the Contribution Agreement, the proposed final version of which, and a summary of the material terms and conditions of which, were deliveredsubsequently terminated pursuant to the Board prior to the meeting. Our legal counsel also discussed and answered questions from the members of the Board regarding the ancillary agreements contemplated to be entered into at the closing of the transaction. In addition, conflicts of interest with respect to the proposed transaction were disclosed, including that Messers. Rafaeli, McGrath and Ben-Dror would receive the convertible secured notes as part of the Contribution Transaction. In addition, at the meeting, our financial advisor gave a detailed presentation to the Board regarding their analysis of the relative value of the properties being contributed and answered questions from members of the Board regarding their valuation methodology, the nature of the assets being contributed, liens and other encumbrances relating to the assets and the fairness of the consideration being paid for the contributed assets. After discussion and consideration, our Board unanimously determined that the Contribution Transaction is in the best interests of the Company and its stockholders and approved and adopted resolutions approving the Contribution Agreement, the transactions contemplated thereby, including, without limitation, the issuance of shares of our common stock and/or Series A Convertible Preferred Stock at closing and the Contribution Transaction, and the ancillary agreements to be entered into by the Company in connection therewith.Remediation Agreement.  

 

The Contribution Agreement was entered into on March 31, 2017 and publicly announced at the closeThese conditions as of business on such date.

Reasons for the Contribution Transaction

 The decision by the Board to approve the entry into the Contribution Agreement with the Contributor Parties was based on a careful evaluation of our strategic alternatives following the sale of substantially all of our remaining assets in January 2017. To enhance value and grow the Company, management met with several other strategic partners, but could not arrive at satisfactory terms relating to any one of those strategic transactions. After engaging in these discussions and similar discussions with the Contributor Parties, management and the Board felt that the opportunity presented by the Contributor Parties would result in the greatest potential for value for the Company’s stockholders. Due to our financial condition and the uncertainty ofJune 30, 2018 raised substantial doubt about our ability to continue as a going concern, we didconcern. The accompanying consolidated financial statements do not engage financialinclude any adjustments to reflect the possible future effects on recoverability and legal advisors to prepare a fairness opinion regardingclassification of liabilities that may result from the Contribution Transaction, as such an opinion would be expensive and would strain our remaining financial resources. After considering our strategic alternatives, and the opportunities for our remaining LHE business if no strategic transaction was pursued, the Board determined that the Contribution Transaction pursuant to the termsoutcome of the Contribution Agreement was desirable and in the best interests of the Company.

 Our Board considered a number of factors before deciding to enter into the Contribution Agreement, including, among other things, the type and nature of the assets to be contributed to us by the Contributor Parties, the strategic and financial benefits that the Contribution Transaction will provide to the Company, the new management team that would lead the Company following the consummation of the Contribution Transaction, the Company’s discussions with other possible strategic partners, the potential future growth of the LHE business line, the future business prospects of the Company following the successful consummation of the Contribution Transaction, and the terms and conditions of the Contribution Agreement.

 Ultimately, our Board concluded that the terms of the Contribution Agreement are fair to the Company and will provide the Company with the ability to achieve the following considerations and objectives:

·Remain listed on the NASDAQ Capital Market instead of potentially being delisted in which case our common stock would trade on the over-the-counter markets;

·Achieve growth through the development of a portfolio of real estate assets leveraging the expertise of a new management team that will be engaged upon the consummation of the Contribution Transaction;

·Allow the Company to resume growth and provide some return to its stockholders;

·Provide additional cash to the Company by which to continue operations;

27

·Allow the Company space to begin marketing its remaining LHE business line; and

·Arrange for certain employment and board-related payments to management and board members, who had agreed to forebear to allow the Company to continue to operate with limited financial resources, although those payments were not a material concern to the Board during its review as the Board was seeking the best option it could find for the Company.

Activities of the Company Following the Contribution Transaction

Following the first contribution we have a new management team led by Suneet Singal, who is the Chief Executive Officer of the Contributor Parent. Our main business is now the development of the real property contributed to the Acquiror by the Contributor Parties in the Contribution Transaction. We will also continue to operate the LHE medical device business of Radiancy. We will also continue to defend and prosecute the existing litigation involving the Company, and will consider other strategic investments or alternatives for the Company.this uncertainty.

 

U.S. Federal Income Tax ConsequencesResults of the Contribution TransactionOperations

U.S. Federal Income Tax ConsiderationsComparison of Six Months Ended June 30, 2018 and 2017

 

The following is atable sets forth key components of our results of operations during the six months ended June 30, 2018 and 2017.

(All dollar amounts in thousands)

  Six Months Ended June 30, 
  2018  2017 
Rental income $11  $ 
Depreciation expense  (1)   
Operating expenses:        
General and administrative  2,144   1,848 
Operating loss $(2,134) $(1,364)
Revaluation of option to purchase redeemable convertible preferred stock  2,295    
Revaluation of asset contribution related financial instruments     2,622 
Interest and other financing expense, net  (72)  (46)
Income tax provision  (209)   
Income (loss) from continuing operations  (120)  728 
Income (loss) from discontinued operations  219   (1,438)
Net income (loss) including portion attributable to non-controlling interest  99   (710)
Loss attributable to non-controlling interest  2    
Net Income (loss)  101   (710)
Dividend on redeemable convertible preferred stock  (141)   
Accretion of redeemable convertible preferred stock to redemption value  (1,968)   
Net loss attributable to common stockholders $(2,008) $(710)

22 

General and administrative expenses. For the six months ended June 30, 2018, general discussionand administrative expenses were approximately $2.14 million and are mainly comprised of certain material U.S. federal income tax consequencespayroll and related expenses, professional service, rent and other operating expenses. For the six months ended June 30, 2017, general and administrative expenses were approximately $1.85 million.

Revaluation of option to purchase redeemable convertible preferred stock.For the six months ended June 30, 2018, the revaluation of the contributionsoption to purchase redeemable convertible preferred stock decreased by approximately $2.30 million due to the decrease in the conversion rate of certainthe underlying redeemable convertible preferred stock, which caused the fair value of the instrument to decrease. The carrying amount of this instrument included in the accompanying condensed consolidated balance sheet decreased by $677 thousand during the six months ended June 30, 2018 due to the partial exercise of the written call option.

Interest and other financing expense, net. Net interest and other financing expense related to our notes payable for the six months ended June 30, 2018 was approximately $72 thousand.

Net loss. The factors discussed above resulted in a net loss, including discontinued operations, of approximately $2 million during the six months ended June 30, 2018, as compared to net loss of approximately $710 thousand, of which approximately $1.4 million was attributable to discontinued operations during the six months ended June 30, 2017, with the Company primarily becoming a real estate assets to the Company by the Contributor in exchange for the issuanceasset management and development company.

Comparison of Years Ended December 31, 2017 and 2016

The following table sets forth key components of our sharesresults of operations during the years ended December 31, 2017 and 2016.

(All dollar amounts in thousands)

  Year Ended December 31, 
  

2017

(As Restated)

  2016 
Revenues $  $ 
Cost of revenues      
Gross profit      
Operating expenses:        
General and administrative expenses  10,817    
Impairment of investment in other company  1,439     
Loss from continuing operations before interest and other financing expense, net  (12,256)   
Revaluation of asset contribution related financial instruments, net  (1,392)   
Revaluation of Option to purchase redeemable convertible B preferred stock  (3,018)   
Interest and other financing expense, net  (267)   
Loss from continuing operations  (16,933)   
Discontinued operations:        
Loss from discontinued operations, net of taxes  (2,459)  (13,264)
Net loss $(19,392) $(13,264)

General and administrative Expenses. For the year ended December 31, 2017, general and administrative expenses were approximately $10.82 million. For the year ended December 31, 2016 general and administrative expenses were included in the loss from discontinued operations, (see Note 2 Discontinued Operations, to our consolidated financial statements).


Impairment of investment in other company. We evaluate investments in other company for impairment whenever events or changes in circumstances indicate that the Contributor,carrying amount of an investment may not be recoverable in accordance with ASC 320 “Investments - Debt and Equity Securities”. The judgments regarding declines in value are based on operating performance, market conditions and our ability and intent to hold as well as its ability to influence significant decisions of the ownershipventure. During the year ended December 31, 2017, based on managements’ most recent analyses, impairment losses have been identified related to our investment in other company amounting to $1,439 thousand (As Restated).

Revaluation of asset contribution. For the year ended December 31, 2017, the revaluation of asset contribution increased to approximately $1.39 million due to the re-measurement of the asset contribution that resulted in a loss due to the reduced fair value of the asset.

Revaluation of option to purchase redeemable convertible B preferred stock.For the year ended December 31, 2017, the revaluation of the option to purchase redeemable convertible B preferred stock increased to approximately $3.0 million due to excess of the initial value of the option liability over the proceeds received, net with the changes in the fair value of the Option at December 31, 2017.

Interest and dispositionother financing expense, net. Net interest and other financing expense for the year ended December 31, 2017 was approximately $0.26 million. The functional currency of all U.S. members of the group, as well as Radiancy Ltd. (Israel), is the U.S. Dollar. The other foreign subsidiaries’ functional currency is each subsidiaries’ respective local currency. 

Net Loss. The factors discussed above resulted in a net loss, including discontinued operations, of approximately $19.4 million (As Restated) during the year ended December 31, 2017, as compared to net loss of approximately $13.26 million during the year ended December 31, 2016.

Liquidity and Capital Resources

As of June 30, 2018, we had an accumulated deficit of approximately $137 million and stockholders’ deficit of approximately $2.9 million. Cash and cash equivalents as of June 30, 2018 were approximately $892. To date, and subsequent to the recent sale of our shares owned by U.S. holderslast significant business unit, we have dedicated most of our financial resources to general and non-U.S. holders of the Company.administrative expenses.

 

This discussion is based on provisionsWe have historically financed our activities with cash from operations, the private placement of the Internal Revenue Code; Treasury regulations promulgatedequity and debt securities, borrowings under the Code (final, temporary and proposed); administrative rulingslines of the Internal Revenue Service; and judicial decisions, as applicablecredit and, in effect on the datemost recent periods with sale of this proxy statement, which are subject to different interpretationscertain assets and which may be subject to change with retroactive effects. Any change in governing provisions or their interpretation may affect the accuracy of the statements and conclusions in this proxy statement. Therefore, the following discussion is meant for general informational purposes only and does not purport to be a complete analysis or list of all potential U.S. federal income tax considerations that may apply to the Company and its stockholders as a result of the Contribution Transaction. This discussion does not address all aspects of U.S. federal income taxation that may be relevant to certain classes of stockholders, nor does it account for the individual facts and circumstances of any particular holder or class of holder, which may change the effects of U.S. federal income taxes upon such holder or holders. Therefore, nothing in this section should be, nor is it intended to be, construed as legal or tax advice.business units.

 

Additionally, this discussion is only concerned with the effects of U.S. Federal Income Tax laws upon the Contribution Transaction, the Company, and the Company’s stockholders, and therefore does not address other forms of taxation and their potential effects upon the transaction, the Company, and the Company’s stockholders. This discussion does not consider the effects of, among other tax matters, any withholding tax requirements, whether under the laws of the United States or foreign entities; the application of the U.S. federal Medicare taxes imposed on certain net investment income; any other aspects of U.S. federal taxation other than those pertaining specifically to the U.S. federal income tax; tax consequences which may result from any United States-based state or local laws; or any non-United States tax laws, whether income or otherwise. Persons and entities which hold the Company’s shares must consult their own tax advisors regarding tax consequences of the Contribution Transaction in light of their specific financial and tax circumstances. The Company will not request an IRS tax ruling regarding the U.S. federal income tax consequences of the Contribution Transaction or any other related matters; thus, there can be no assurance that the IRS will not challenge the U.S. federal income tax treatment described below or that, if challenged, such treatmentWe will be sustained by a court.

This discussion is limited solelyrequired to U.S. federal income tax considerations relevant to U.S. holders and non-U.S. holders that will hold the Company’s shares before or after the closing of the Contribution Transaction. It does not address each and every aspect of U.S. federal income taxation that may be important to certain stockholders considering their own particular financial and tax circumstances, including stockholders who may be subject to special treatment under the U.S. tax laws, such as:

·banks or other financial institutions, underwriters, or insurance companies;

28

·traders in securities who elect to apply a mark-to-market method of accounting;

·real estate investment trusts and regulated investment companies;

·tax-exempt organizations, qualified retirement plans, individual retirement accounts, or other tax-deferred accounts;

·expatriates or former long-term residents of the United States;

·partnerships or other pass-through entities (or arrangements treated as such) or investors therein;

·dealers or traders in securities, commodities or currencies;

·grantor trusts;

·persons subject to the alternative minimum tax;

·U.S. persons whose "functional currency" is not the U.S. dollar;

·persons who received our shares as a result of the exercise of incentive stock options or through the issuance of restricted stock under an equity incentive plan or otherwise as compensation;

·persons who own (directly or through attribution) 5% or more (by vote or value) of our outstanding stock either before, or after, the transaction; or

·holders holding our shares, as a position in a “straddle,” as part of a “synthetic security” or “hedge,” as part of a “conversion transaction,” or other integrated investment or risk reduction transaction.

For the purposes of this discussion, the term “U.S. holder” means a beneficial owner of our shares, either before or after any stage of the Contribution Transaction, or, for U.S. federal income tax purposes:

·an individual who is a citizen or resident of the United States;

·a corporation (or other entity that is classified as a corporation for U.S. federal income tax purposes) that is created or organized in or under the laws of the United States, any State thereof or the District of Columbia;

·an estate the income of which is subject to U.S. federal income tax regardless of its source; or

·a trust (i) if a court within the United States is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (ii) that has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person for U.S. federal income tax purposes.

For purposes of this discussion, a “non-U.S. holder” means a beneficial owner of our shares, either before or after any stage of the Contribution Transaction, that is neither a U.S. holder nor a partnership (or an entity or arrangement treated as a partnership) for U.S. federal income tax purposes.

If a partnership, including for this purpose any entity or arrangement that is treated as a partnership for U.S. federal income tax purposes, holds our shares, the U.S. federal income tax treatment of a partner in such partnership generally will depend on the status of the partner and the activities of the partnership. A holder that is a partnership and the partners in such partnership should consult their tax advisors with regard to the U.S. federal income tax consequences of the Contribution Transaction and the subsequent ownership and disposition of shares received in Contribution Transaction.

THIS SUMMARY DOES NOT PURPORT TO BE A COMPREHENSIVE ANALYSIS OR DESCRIPTION OF ALL POTENTIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE CONTRIBUTION TRANSACTION AND STOCKHOLDERS SHOULD CONSULT WITH THEIR OWN TAX ADVISORS REGARDING THE PARTICULAR TAX CONSEQUENCES TO THEM OF THE CONTRIBUTION TRANSACTION, INCLUDING THE APPLICABILITY AND EFFECTS OF U.S. FEDERAL, STATE, LOCAL AND OTHER TAX LAWS.

29

U.S. Federal Income Tax Consequences of the Contribution Transaction to the Company

Following a change of control, as defined in Section 382 of the Internal Revenue Code and its related regulations, the tax attributes of the company undergoing the change can be limited, particularly the ability by the company to utilize certain U.S. tax attributes, such as net operating losses and tax creditsobtain additional liquidity resources in order to offset U.S. taxable income resulting from certain defined typessupport our operations. At this time, there is no guarantee that we will be able to obtain an adequate level of transactions. The amount of any net operating loss under the United States Internal Revenue Code that may be utilizable by a company would be an amount equal to (a) the value of that company, multiplied by (b) the long-term tax-exempt rate. If the Section 382 limitation for any year after the change of control exceeds the taxable income of a company for that year, offset by losses attributable to activity in the periods before the change of control, then the Section 382 limitationfinancial resources required for the next year wouldshort and long-term support of our operations or that we will be increased byable to obtain additional financing as needed, or meet the amountconditions of such excess unused Section 382 limitation. In addition, any carryforwardsfinancing, or that the costs of net operating losses are disallowed by the Internal Revenue Code Section 382 if a company, post-transaction, doessuch financing may not meet the continuity of business requirements of that Section; meaning, that if a company, post-transaction, does not continue the business enterprise of the company pre-transaction at all times during the two-year period beginning on the date of the change of control. In the event that a company does not meet the continuity of business regulations, then the section 382 limitation for any post-change year would be zero.prohibitive.

 

Based on the termsSummary of the Contribution Agreement, the rules for determining share ownership under Section 382 and the Treasury regulations promulgated thereunder, and certain factual assumptions, the Company currently expects it will undergo a change of control following the closing of the Second Contribution under the Contribution Agreement. That closing is expected to occur no later than December 31, 2017. In that event, the limitations and other rules described above are expected to apply to the Company and its U.S. affiliates as of the date of that closing, which is currently unknown. In particular, given that (i) the Company is already under Section 382 limitations as a result of several mergers in the past ten years; (ii) the Company has historically been a loss corporation in the preceding five (5) years; and (iii) the Company will be entering into a new business line as a result of the Contribution Transaction, the ability of the Company and its U.S. affiliates to utilize certain U.S. tax attributes against income or gain recognized pursuant to certain transactions, may be limited. In such case, the Company and its U.S. affiliates could be subject to substantial additional U.S. federal income tax liability. In addition, the ability of the Company to restructure or access cash earned by its non-U.S. subsidiaries without significant U.S. tax liability may be limited.

Cash Flows

U.S. Federal Income Tax Consequences of the Contribution Transaction to the Company’s Stockholders

U.S. Holders

Except as described herein, no gain or loss is expected to be recognized by a U.S. person or entity which holds our shares prior to or after the closing of any stage of the Contribution Transaction as a result of the contribution of the real estate assets to the Company. A U.S. holder’s aggregate tax basis in the Company’s shares at each stage of the Contribution Transaction should continue to equal the holder’s aggregate tax basis in such shares immediately prior to and after that stage, and such U.S. holder’s holding period for the shares will continue to run, uninterrupted, and will include the holding period for the shares prior to the closing of each stage of the Contribution Transaction. In the case of a U.S. holder that acquired different blocks of our shares at different times and at different prices, Treasury regulations promulgated under the Code provide detailed rules for tracking and/or allocating the tax basis and holding period of those shares. U.S. holders that acquired different blocks of our shares at different times and at different prices should consult their tax advisors regarding the tracking and/or allocation of the tax basis and holding period of such shares for their particular tax circumstances.

Whether or not a holder of our stock will recognize gain, or loss, upon the disposition of that stock at any point in the Contribution Transaction, and whether such gain, or loss, will be subject to income taxation in the United States or to any form of withholding, will be determined purely by the individual holder’s facts and circumstances, and each holder should again consult their tax advisor to determine the consequences, if any, of the disposition of our stock.

Non-U.S. Holders

Similarly, as described above, non-U.S. holders generally will not be subject to U.S. federal income or withholding tax as a result of the Contribution Transaction. However, non-U.S. holders should consult their tax advisors regarding any applicable tax treaties that may provide for different rules.

Likewise, whether or not a holder of our stock will recognize gain, or loss, upon the disposition of that stock at any point in the Contribution Transaction, and whether such gain, or loss, will be subject to income taxation in the United States or to any form of withholding, will be determined purely by the individual holder’s facts and circumstances, and each holder should again consult their tax advisor to determine the consequences, if any, of the disposition of our stock.

30

Accounting Treatment of the Contribution Transaction

 

The Company will accountfollowing table provides detailed information about our net cash flow for the acquisition pursuantperiods indicated:

Cash Flow

(In thousands)

  Six Months Ended June 30,  Year Ended December 31, 
  2018  2017  2017  2016 
Net cash provided by (used in) operating activities $(1,679) $(5,359) $(9,298) $358 
Net cash provided by (used in) investing activities  (326)  4,824   6,797   2,148 
Net cash provided by (used in) financing activities  1,932      906   (684)
Effect of exchange rate changes on cash  17   279   208   (2,789)
Net decrease in cash and cash equivalents  (56)  (256)  (1,387)  (967)
Cash and cash equivalents at beginning of period  948   2,335   2,335   3,302 
Cash and cash equivalent at end of period $892  $2,079  $948  $2,335 


Net cash used in operating activities was approximately $1.7 million for the six months ended June 30, 2018, compared to approximately $5.4 million net cash used in operating activities for the Contribution Agreement usingsix months ended June 30, 2017. The primary reason for the change is the continual wind-down of the former business operations ahead of the acquisition method of accounting in accordance with FASB Accounting Standards Codification Topic 805 (ASC 805), “Business Combinations.”income-producing real estate properties.

 

The Company has concluded that FASB Accounting Standards Codification Topic 805 (ASC 805) “Business Combinations” applies as the acquisition includes a 17.9133% interestNet cash and used in an LLC that operates a single family residential development. The Company will account for this interest an investment under the equity method of accounting in accordance with FASB Accounting Standards Codification Topic 323 (ASC 323) “Investments – Equity Method and Joint Ventures.” Under the equity method, the Company will record the investment initially at fair value and adjust the carrying amountoperating activities was approximately $9.3 million for the Company’s share of income oryear ended December 31, 2017 compared to approximately $0.36 million net cash provided by operating activities for the year ended December 31, 2016. The primary reason for the change was loss of the LLC and reduce the carrying amount for any cash distributions received.

ASC 805 requires that one company, either the Company or the Contributor, be designated as the acquirer for accounting purposes based on the evidence available. For the reasons below, the Company will, at least until there is an additional closing, be treated as the acquiring entity for accounting purposes. In identifying the Company as the acquiring entity, the following pertinent facts and circumstances support the conclusion that the Company will be the acquirer for financial accounting purposes:

·After the completion of the first contribution, even assuming that the Series A Convertible Preferred Stock is converted to common stock, the Contributor Parent’s shareholders are expected to own approximately 47.33% of the issued and outstanding shares of the combined company, but the Company’s stockholders will still hold the remaining 52.67% of those shares, and will therefore still hold a majority voting interest in the Company. Prior to any conversion of the Series A Preferred stock, the Contributor Parent’s shareholders only own 16.6% of the outstanding common stock. Assuming that the Contributor Parent’s ownership reaches 47.33% there will still be other, original Company stockholders with significant holdings.

·As of the closing date of the first contribution, Mr. Suneet Singal, the Contributor Parent’s Chief Executive Officer, was appointed as Chief Executive Officer and President of the Company. Mr. Stephen Johnson was appointed as Chief Financial Officer of the Company. Mr. Singal and Mr. Johnson succeeded Dennis McGrath and Dr. Dolev Rafaeli, who resigned from employment by the Company. Other Company management personnel remain with the Company.

·Also as of the closing date of the first contribution, three members of the Board resigned. However, Dr. Rafaeli and Mr. McGrath remain on the Board, and the Company has appointed a third member. The Contributor Parent selected its own three representatives to the Board, including Mr. Singal, Mr. Richard Leider, an independent member of the Contributor Parent’s Board, and Dr. Bob Froehlich, an independent member of the board of directors of an affiliate of the Contributor Parent. Jointly, the six directors then selected an independent seventh member. As a result, neither company has a majority position on the Board.

·Furthermore, analyzing the relative comparative sizes of the contributing company and the Company, after taking into consideration only the contribution of the assets under the first contribution to the Company, a significant majority of the assets after the first contribution will be those held by the Company prior to the transaction.

·The additional potential contribution transactions are subject to significant contingencies.

As the Company is identified as the acquiring entity, the historical financial statements of the Company will remain the historical financial statements of the Company post-transaction. The Company will then measure the contributed assets acquired and liabilities assumed at their fair values, including net tangible and identifiable intangible assets acquired and liabilities assumed, as of the May 17 closing date. Any excess of the purchase price over those fair values will be recorded as goodwill.

The allocation of purchase price reflected in the unaudited pro forma combined financial statements is based on preliminary estimates using appraisals prepared by independent third parties of the respective assets, which the management of both the Company pre-transactionasset sale to ICTV Brands, Inc. and the Contributor Parent believe are reasonable based on the currently available information. The final purchase pricesignificant reductions in accounts payable and fair value assessment of assets andaccrued liabilities will be based in part on a detailed valuation that has not yet been completed.

31

Upon the contribution of any of the four properties contemplated in the Second and Third Contributions, the Company expects that the Contributor Parent will obtain control of the Company and the acquisition will be accounted for as a reverse acquisition of the Company by an implied entity consisting of a “carve out” of certain operations of the Contributor Parent, or the FC Carve-Out. At that point, the Company’s previous financial statements will be recast as the financial statements of the FC Carve-Out which will be the continuing accounting entity with the Company’s capital structure. Those financial statements will depict FC’s 47.33% interest in the Company for the period between the First and Second Contributions as an equity method investee under ASC 323. The assets and liabilities of the original Company will be recorded as though they were contributed to the continuing accounting entity at fair value on the date of the Second Contribution. The assets contributed in the Initial Closing will revert to the balance sheet of the continuing entity at the original carrying value on the balance sheet of the FC Carve-Out unless impaired.

The Contribution Transaction

On March 31, 2017, the Company and the Acquiror entered into the Contribution Agreement with the Contributor and the Contributor Parent, under which the Contributor may contribute certain real estate assets to the Acquiror in a series of three installments no later than December 31, 2017. A First Amendment to the Contribution Agreement was signed on August 3, 2017. In exchange, the Contributor will receive shares of our common stock and newly designated Series A Convertible Preferred Stock as described below.

First Contribution

In the first contribution installment, which had an initial closing on May 17, 2017 (the “Initial Closing”), the Contributor transferred or agreed to transfer $10 million of assets (the “Contributed Assets”) to the Acquiror, consisting of the following:

·three vacant land sites slated for development as gas stations located in northern California,

·a 75% interest in a limited liability company that owns a vacant land site slated for development as a gas station, located in Northern California; and

·an interest in a limited liability company which owns property located in Los Lunas, New Mexico being developed as a single family residential development (the “Avalon Property”). As described below, Contributor Parent has agreed to transfer its 17.9133% interest in this limited liability company (the “Avalon Interest”) within 30 days following the Initial Closing.

Pursuant to the terms and conditions of an Agreement to Waive Closing Deliverables by and among the Parties dated as of May 17, 2017, the Contributing Parties agreed to deliver the Avalon Interest to the Acquiror, in up to two installments (the “Installments”), on or before the thirtieth (30th) calendar day following the Initial Closing (the “Delivery Deadline”), with the first of the Installments, a 6% interest in the Avalon Property being delivered to the Acquiror as soon as practicable following the Initial Closing but in any event prior to the Delivery Deadline. Notwithstanding that the Contributor did not complete the transfer of the Avalon Interest to the Acquiror at the Initial Closing, the Parties agreed that the Acquiror would be entitled to all economic benefits of ownership of the Avalon Interest (as if the Acquiror were the Contributor) from and after the date of the Initial Closing.

The proposed gas station sites are located in Atwater and Merced, California and have an appraised value of $2.6 million. The residential development in New Mexico consists of 251, non-contiguous, single family residential lots and a 10,000 square foot club house. 37 lots have been finished, and the remaining 214 are platted and engineered lots. The appraised value of this property is approximately $7.4 million.

In exchange for the Contributed Assets, the Company issued to the Contributor 879,234 duly authorized, fully paid and non-assessable shares of the Company’s common stock, which represented approximately 19.9% of the Company’s issued and outstanding common stock immediately prior to the Initial Closing, at a Per Share Value (defined below) of $2.5183, or $2,214,175 in the aggregate. These shares of common stock are restricted and unregistered.

The Company issued the remaining $7,785,828 of the approximately $10 million consideration to the Contributor in the form of 123,668 shares of the Company’s newly designated non-voting Series A Convertible Preferred Stock, par value $0.01 per share. Each share of the Series A Convertible Preferred Stock is convertible into 25 shares of the Company’s common stock, subject to the satisfaction of certain conditions, including stockholder approval in accordance with the rules of The Nasdaq Stock Market (“Nasdaq”). The shares of Series A Convertible Preferred Stock are restricted and unregistered.

32

The number of shares of common stock issued to the Contributor and to be issued upon conversion of the Series A Convertible Preferred Stock was determined by dividing the $10 million value of the Contributed Assets by $2.5183, a specified price per share value which represents a 7.5% premium above the volume-weighted average price (“VWAP”) of all on-exchange transactions in the Company’s common stock executed on Nasdaqsettled during the forty-three (43) trading days prior to the trading day immediately prior to the public announcement of the transaction by the Company and the Contributor Parent, as reported by Bloomberg L.P. (the “Per Share Value”). The shares of common stock both issued to the Contributor and issuable upon the conversion of the Series A Convertible Preferred Stock carry registration rights as specified in a Registration Rights Agreement, dated May 17,year ended December 31, 2017.

 

The Company also assumedNet cash used in investing activities was $326 thousand for the obligations ofsix months ended June 30, 2018, compared to approximately $4.8 million provided by for the Contributor and its affiliates under certain agreements covering the delivered Contributed Assets, including an Operating Agreement of Central Valley Gas Station Development, LLC, a Delaware limited liability company, dated January 28, 2013, and all amendments thereto; the Operating Agreement of Avalon Jubilee, LLC, a New Mexico limited liability company dated as of May 16, 2012, and all amendments thereto; a Development Services Agreement dated September 15, 2015 by and between UR-FC Contributed Assets, LLC, a Delaware limited liability company, as owner, and Land Strategies, LLC, a Nevada limited liability company, as Developer, with respect to real property owned by Avalon Jubilee, LLC; and a Construction Contract dated November 19, 2014 between Central Valley Gas Stations Development, LLC, as owner, and First Capital Builders, LLC, as Contractor, with respect to the project known commonly as Green Sands and Buhach Rd., Atwater, CA. The Acquiror expects to enter into amended operating agreements with respect to some or all of these entities.six months ended June 30, 2017. 

 

Additionally, the Company assumed those ancillary agreements, commitments and obligations with respect to the delivered Contributed Assets specified in that certain Assignment and Assumption AgreementNet cash provided by and between the Acquiror Parties and the Contributor Parties dated as of May 17, 2017.

As a condition to the Initial Closing, certain existing stockholders of the Company and certain entities who may become stockholders as a result of the transactions contemplated by the Contribution Agreement entered into a Lock-Up and Resale Restriction Agreement effective as of May 17, 2017, pursuant to which these stockholders agreed to certain restrictions on transfer of their shares.

Under the Contribution Agreement, at the Initial Closing our Board must consist of seven (7) persons of whom three (3) shall be designated by the Company, three (3) shall be designated by Contributor Parent, and one (1) Nonaffiliated Director shall be selected by the other six (6) directors; provided, however, that at least four (4) of the members of the Board as so designated shall be Independent Directors. Of the Board designees of the parties, one (1) of the Company’s designees shall be an Independent Director, two (2) of the Contributor Parent’s designees shall be Independent Directors and the Nonaffiliated Director shall be an Independent Director. The Audit Committee, Compensation Committee and Nominations and Corporate Governance Committee of the Company shall each consist of the Company’s designee who is an Independent Director, one of Contributor Parent’s designees who is an Independent Director and the Nonaffiliated Director.

In accordance with the foregoing, at the Initial Closing, Lewis C. Pell, Yoav Ben-Dror and Stephen P. Connelly resigned from our Board, Dolev Rafaeli, Dennis M. McGrath and Michael R. Stewart were designated by the Company, and Suneet Singal, Richard J. Leider and Dr. Bob Froehlich were designed by Contributor Parent to serve as members of the Board. The seventh director, Darrel C. Menthe,investing activities was designed and appointed to the Board by the other directors at a special meeting of the Board held on Thursday, May 25, 2017. At that special meeting of the Board, Dr. Bob Froehlich, Michael R. Stewart and Darrel C. Menthe were appointed to our Audit Committee, with Mr. Stewart serving as the Chair of the Audit Committee. Richard J. Leider, Michael R. Stewart and Darrel C. Menthe were appointed to our Compensation Committee, with Mr. Leider serving as the Chair of the Compensation Committee. Richard J. Leider, Michael R. Stewart and Darrel C. Menthe were appointed to our Nominations and Corporate Governance Committee, with Dr. Froehlich serving as the Chair of the Nominations and Corporate Governance Committee.

Additionally, the following officer changes became effective as of the Initial Closing:

33

Dr. Dolev Rafaeli, Dennis McGrath, and Dr. Yoav Ben-Dror resigned from their positions as officers of the Company and its subsidiaries. Dr. Rafaeli resigned as Chief Executive Officer, and Mr. McGrath resigned as President and Chief Operating Officer, of the Company. The Company acknowledged and agreed that the resignations of Messrs. Rafaeli, McGrath and Ben-Dror constitute valid terminations of their respective employment agreements for “Good Reason” (as that term is defined in their respective employment agreements) and the Board consented to the waiver of the notice requirements and cure periods as described in their respective resignation letters and confirmed that each of Messrs. Rafaeli and McGrath are entitled to all of the compensation described in Section 7(c) of their respective employment agreementsapproximately $6.8 million for the remainder of the term of such employment agreements. 

Suneet Singal was appointed as Chief Executive Officer of the Company and Stephen Johnson was appointed the Chief Financial Officer of the Company.

Dr. Ben-Dror resigned as managing director of the Company’s foreign subsidiaries, including Radiancy (Israel) Limited and Photo Therapeutics Limited in the United Kingdom. He will not continue his affiliation with those companies. Mr. Ben-Dror resigned from his positions and agreed to engage in a non-compete agreement with the Company and support of transition of his respective Board duties in lieu of his agreement for lock-up of his shares, and he will be entitled to all his compensation through a term that matches the term of Messrs. Rafaeli and McGrath.

Mr. George Hopmeier and Ms. Lana Green have also resigned as managing directors of Photo Therapeutics. They will not continue their affiliation with that company.

Mr. Singal will replace Dr. Ben-Dror as director of the Company’s foreign subsidiaries.

Second Contribution

The Contributor Parent is also required to contribute two additional property interests valued at $20 million if certain conditions as set forth in the Contribution Agreement are satisfied byyear ended December 31, 2017. This second installment is mandatory.

2017 compared to approximately $2.15 million for the year ended December 31, 2015. The Contributor Parent must contribute toprimary reason for the Acquiror either its 100% ownership interest in a private hotel that is currently undergoing renovations to convert to a Wyndham Garden Hotel, orchange was the cash proceedsreceived from the sale of the property. This 265 room full service hotel is located in Amarillo, Texas and has an appraised value of approximately $16 million, with an outstanding loan of $10.6 million. Before contributingconsumer division to ICTV Brands, Inc. for the property to the Acquiror, the Contributor Parent must resolve a lawsuit concerning ownership of the property. Only when the Contributor Parent has confirmed that it is the full and undisputed owner of the property may it contribute that interest to the Acquiror. However, the Contributor has received an offer to purchase the property from an unrelated third party, and the Acquiror has agreed to accept a minimum of $5.89 million in cash from that sale in place of the property, the difference between the appraised value and outstanding loan, so long as the sale is consummated not later than Augustyear ended December 31, 2017.

 

Additionally,Net cash provided by financing activities was approximately $1.9 million for the Company hassix months ended June 30, 2018, compared to $0 net cash provided by financing activities for the six months ended June 30, 2017. 

Net cash provided by (used in) financing activities was approximately $0.9 million for the year ended December 31, 2017 compared to approximately $0.68 million net cash used in financing activities for the year ended December 31, 2016. The increase was due to the funding received from OFI in December 2017.

Private Placement

On December 22, 2017, we entered into a Promissory Notesecurities purchase agreement with the ContributorOFI, under which it has loaned a principal amount ofOFI could invest up to $145,000 and an origination fee of $7,500, with interest thereon of 20% per annum, to the Contributor to make certain payments due to vendors of the Amarillo hotel to ensure their continued provision of services to the Amarillo hotel during the pendency of the sale of this property. The loan is due September 1, 2017. Suneet Singal, Chief Executive Officer of$15 million in the Company has agreed to freeze his salary from the Company and pledge it as repayment should the loan, origination fee and/or accrued interest be unpaid on that date. The Company has also reserved the right to claw backin a portionseries of the shares issued to the Contributor Partiesclosings, in the First Closing, in an amount equal to the disbursed but unpaid principal amount, the origination fee, and any accrued but unpaid interest.

In exchange for each of these properties, we will issue to the Contributor 7,941,866 shares of our common stock or 317,675which OFI would receive shares of our Series A ConvertibleB Preferred Stock at a purchase price of $1.00 per share. See Note 5 to our condensed consolidated financial statements for the terms of the Series B Preferred Stock.

On December 22, 2017, we completed the first closing, pursuant to which will be convertible into 7,941,866 shares of our common stock, which number of shares was determined by dividing the $20OFI provided $1.5 million value of that contribution by the Per Share Value. The shares shall be comprised entirely of shares of common stock if the issuance has been approved by our stockholders prior to the issuance thereof and shall be comprised entirely ofus in exchange for 1,500,000 shares of Series A ConvertibleB Preferred Stock if such approval hasStock. On January 24, 2018, we completed a second closing, pursuant to which OFI provided $2.2 million to us in exchange for 2,225,000 shares of Series B Preferred Stock. OFI could, but was not yet been obtained.

34

Optional Contributionobligated to, make additional investments in one or more subsequent closings until an aggregate amount of $15 million was invested or the securities purchase agreement was terminated in accordance with its terms.

 

The Contributor Parent hassecurities purchase agreement was terminated pursuant to the option to contribute either or both of two additional property interests valued at $66.5 million if certain conditions as set forth in the Contribution Agreement are satisfied by December 31, 2017. This third installment is optional in the Contributor Parent’s sole discretion.Remediation Agreement. See “Remediation Proposal” for more information.

 

The Contributor Parent may contribute to the Acquiror its interest in a resort development project on an island just south of Hilton Head, South Carolina. The Contributor Parent currently has the property under a Letter of IntentPayout Notes and expects to close on the property by December 31, 2017. This property is valued by the Contributor Parent at $22.5 million, based upon a senior lending position that the Contributor Parent holds under the Letter of Intent on this property.Stock Grant Agreement

 

The Contributor Parent also may contribute to the Acquiror a golf and surf club development project on the Baja Peninsula in Mexico. The Contributor Parent also has this property under a Letter of Intent and expects to close by December 31, 2017. This property is valued by the Contributor Parent at $44 million based on the Contributor Parent’s commitment of $5 million upon closing on this property, plus a commitment for an additional $5 million and a second commitment of $34 million for construction of the project.

In exchange for each of these properties, we will issue to the Contributor 34,328,714 shares of our common stock or 1,373,149 shares of our Series A Convertible Preferred Stock, which will be convertible into 34,328,714 shares of our common stock, which number of shares was determined by dividing $86,450,000 (130% of the value of that contribution) by the Per Share Value. The shares shall be comprised entirely of shares of common stock if the issuance has been approved by our stockholders prior to the issuance thereof and shall be comprised entirely of shares of Series A Convertible Preferred Stock if such approval has not yet been obtained. In addition, we will issue to the Contributor a five (5) year warrant (the “Warrant”) to purchase up to 25,000,000 shares of our common stock at an exercise price of $3.00 per share that shall vest with respect to the number of underlying shares upon the achievement of the milestones specified Contribution Agreement. The number of warrant shares and the exercise price will be equitably adjusted in the event of a stock split, stock combination, recapitalization or similar transaction.

Payout Notes

Under the Contribution Agreement, amounts due to Dr. Dolev Rafaeli and Dennis M. McGrath under their employment agreements, as well as amounts due to Dr. Yoav Ben-Dror for his services as a board member and officer of our foreign subsidiaries, will bewere converted to convertible secured notes (the “Payout Notes”) afterin the principal amounts of $3,133,934, $977,666 and $1,515,000, respectively, following approval from our stockholders. The Payout Notes will bestockholders on October 12, 2017. These notes were due one year after the stockholder approval and carryon October 12, 2018, carried a ten percent (10%) interest rate, payable monthly in arrears commencing on December 1, 2017, and were secured by a security interest in all of our assets pursuant to a security agreement that we entered into with the holders on October 12, 2017. These notes were convertible into shares of our common stock and we agreed to register the shares underlying the these notes within thirty (30) days of issuance with best efforts to cause the registration statement covering such shares to become effective within one-hundred twenty (120) days of issuance.  

On December 22, 2017, we entered into a stock grant agreement with Dr. Dolev Rafaeli, Dennis M. McGrath and Dr. Yoav Ben-Dror to (i) cause the early conversion of the notes into an aggregate of 5,628,291 shares of our common stock, (ii) effectuate the release of all security interests associated with the notes, (iii) provide for the issuance of an aggregate of 1,857,336 additional shares of common stock, (iv) provide for certain cash payments in amounts equal to the interest payments that would have been made to the holders absent the conversion of the notes, (v) obtain the agreement of the note holders to provide certain support services to the Company, and (vi) obtain the conditional resignation of certain of the note holders from our Board. Accordingly, the notes were paid in full.


 Pursuant to the stock grant agreement, we agreed to make twelve (12) monthly payments on the first of each month commencing on January 1, 2018 in the amounts of $21,328.16, $6,653.56 and $10,310.42 to Messrs. Rafaeli, McGrath, and Ben-Dror, respectively. These cash payments are consideration for certain consulting services provided by the note holders specified in the stock grant agreement.

The stock grant agreement was terminated pursuant to the Remediation Agreement. See “Remediation Proposal” for more information.

Note Payable

In connection with the initial closing under the Contribution Agreement on May 17, 2017, we assumed an installment note, dated April 7, 2015, made by the Contributor in favor of George Zambelli in the original principal amount of $470 thousand and a Long Form Deed of Trust and Assignment of Rents, dated April 7, 2015, between First Capital Real Estate Investments, LLC, as trustor, Fidelity National Title Company, as trustee, and George Zambelli, as beneficiary, which secures the note. The note carries a per annum interest rate of 8% which is payable on a monthly basis from the initial closing date. As of June 30, 2018, the note amounted to $457 thousand ($452 thousand out of which is classified as non-current note payable) and has a maturity date of April 10, 2020.

Off-Balance Sheet Arrangements

At June 30, 2018, we had no off-balance sheet arrangements.

Impact of Inflation

We have not operated in a highly inflationary period, and do not believe that inflation has had a material effect on revenues or expenses. 

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations in this proxy statement are based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses and disclosures at the date of approvalthe financial statements. On an on-going basis, we evaluate our estimates. We use authoritative pronouncements, historical experience and other assumptions as the basis for issuancemaking estimates. Actual results could differ from those estimates. Management believes that the following critical accounting policies affect our more significant judgments and estimates in the preparation of our consolidated financial statements. These critical accounting policies and the significant estimates made in accordance with these policies have been discussed with our Audit Committee.

Acquisition of Investment Properties.The Company allocates the purchase price of real estate to identifiable tangible assets such Payout Notes by stockholdersas land, building, land improvements and tenant improvements acquired based on their fair value. In estimating the fair value of each component management considers appraisals, replacement cost, its own analysis of recently acquired and existing comparable properties, market rental data and other related information. The Company’s investment properties as of December 31, 2017 were acquired on May 17, 2017, and included four vacant land sites set for development into gas stations. The Company determined that the fair value of these investment properties on the acquisition date was $2,055 (As Restated).

Impairment of Investment Properties. Our long-lived assets include mainly these investment properties. The Company periodically evaluates its long-lived assets, including investment properties, for indicators of impairment in accordance with ASC 360, “Property, Plant, and Equipment”, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The judgments regarding the existence of indicators of impairment are based on the operating performance, market conditions, as well as the Company’s ability to hold and its intent with regard to each property. The judgments regarding whether the carrying amounts of these assets may not be recoverable are based on estimates of future undiscounted cash flows from properties which include estimates of future operating performance and market conditions.


Impairment of Investment in Other Company.The Company evaluates investments in other company for impairment whenever events or changes in circumstances indicate that the carrying amount of an investment may not be recoverable in accordance with ASC 320 “Investments - Debt and Equity Securities”. The judgments regarding declines in value are based on operating performance, market conditions and the Company’s ability and intent to hold as well as its ability to influence significant decisions of the venture.

Option to Purchase Redeemable Convertible B Preferred Stock. The fair value of the option to purchase redeemable convertible B preferred stock that was issued to an investor in connection with a securities purchase agreement in December 2017 (the “Initial Date”) was estimated using the Black-Scholes-Merton option-pricing model. We accounted for the aforesaid option according to the provisions of ASC 480, “Distinguishing Liabilities from Equity” since the option is considered freestanding, as the Company believes it is legally detachable and separately exercisable. In addition, the option is exercisable for Convertible B Preferred Stock which are subject to possible redemption at the Meeting (each such payment, a “Monthly Interest Paymentoption of the holder. We classified the option as non-current liability, remeasured at fair value each reporting period until the option will be exercised or expired, with changes in the fair values being recognized in our statement of comprehensive loss as financial income or expense. The fair value of the option was estimated at the Initial Date and eachDecember 31, 2017 by using hybrid method that includes scenario of conversion and scenario liquidation and the Black-Scholes option pricing model. In the first scenario, the Series B Preferred Stock price applied in the model was assumed based on the as-converted price on the date of estimation. Expected volatility was estimated by using a group of peers in the real estate development, homebuilding and income-producing properties sectors, and applying a 75% percentile ranking based on the total capitalization of the Company. In the second scenario, the option was estimated based on the value of the option in a proposed liquidation scenario. A probability weighting was applied to determine the expected value of the option.

Revenue Recognition. We recognized revenues from the product sales when the following four criteria were met: (i) the product had been shipped and we had no significant remaining obligations; (ii) persuasive evidence of an arrangement existed; (iii) the price to the buyer was fixed or determinable; and (iv) collection was probable. Revenues from product sales were recorded net of provisions for estimated chargebacks, rebates, expected returns and cash discounts. We shipped most of our products FOB shipping point, although from time to time certain customers, for example governmental customers, will insist upon FOB destination. Among the factors we took into account when determining the proper time at which to recognize revenue was when title to the goods transferred and when the risk of loss transferred. Shipments to distributors or physicians that did not fully satisfy the collection criterion were recognized when invoiced amounts were fully paid or fully assured. With respect to sales arrangements under which the buyer had a right to return the related product, revenue was recognized only if all the following were met: the price was fixed or determinable at the date of sale; the buyer had paid, or was obligated to pay and the obligation was not contingent on resale of the product; the buyer’s obligation would not be changed in the event of theft or physical destruction or damage of the product; the buyer had economic substance; we did not have significant obligations for future performance to directly bring about resale of the product by the buyer; and the amount of future returns could be reasonably estimated.  We provided a provision for product returns based on the experience with historical sales returns, in accordance with ASC Topic 605-15 with respect to sales of product when right of return exists.

Inventories. We carried inventories at the lower of cost or market. Cost was determined to be purchased cost for raw materials and the production cost (materials, labor and indirect manufacturing cost) for work-in-process and finished goods. For our consumer and LHE products, cost was determined on the weighted-average method. For the Physician market products, cost was determined on the first-in, first-out method. Reserves for slow-moving, excess and obsolete inventories reduce the historical carrying value of our inventories and were provided based on historical experience and product demand. Management evaluated the adequacy of these reserves periodically based on forecasted sales and market trends. There is no value to the remaining inventory as of December 31, 2017. The inventories as of December 31, 2016 were classified as assets held for sale.

Allowance for Doubtful Accounts. Accounts receivable were reduced by an allowance for amounts that may become uncollectible in the future. From time to time, our customers disputed the amounts due to us, and, in other cases, our customers experienced financial difficulties and could not pay on a timely basis. In certain instances, these factors ultimately result in uncollectible accounts. The determination of the appropriate reserve needed for uncollectible accounts involves significant judgment. Such factors include changes in the financial condition of our customers as a result of industry, economic or customer-specific factors. A change in the factors used to evaluate collectability could result in a significant change in the allowance needed.


Goodwill and Intangibles Assets. As part of the purchase price allocation for the 2011 reverse acquisition, we recorded goodwill in the amount of $24,005 and definite-lived intangibles in the amount of $12,000. Goodwill reflected the value or premium of the acquisition price in excess of the fair values assigned to specific tangible and intangible assets. Goodwill had an indefinite useful life and therefore was not amortized as an expense but was reviewed annually for impairment of its fair value to the Company. During the third quarter of 2016, we recorded goodwill and other intangible asset impairment charges of approximately $3.52 million, as we determined that a portion of the value of our goodwill and other intangible assets was impaired in connection with the then pending transaction with ICTV Brands, Inc. We recorded an impairment of the entire remaining balance of Consumer segment goodwill in the amount of approximately $2.26 million and recorded the impairment of the Consumer segment of the intangibles for its licensed technology in the amount of approximately $1.26 million (see Note 2 Discontinued Operations, to our consolidated financial statements). We derecognized an amount of approximately $1.04 million of goodwill related to the Physician Recurring segment in connection with the asset sale of the Neova product line.

Stock-based compensation. We account for stock based compensation to employees in accordance with the “Share-Based Payment” accounting standard. The standard requires estimating the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in our consolidated statement of operations. The fair value of employee stock options is estimated using a Black-Scholes valuation model. The fair value of restricted shares is based on the quoted market price of our common stock on the date of issuance. Compensation costs for share-based payment awards are recorded using the graded vesting attribution method over the vesting period, net of estimated forfeitures.

Income taxes.As part of the process of preparing our consolidated financial statements, we are required to estimate our income taxes in each of the jurisdictions in which we operate. This process requires us to estimate our actual current tax exposure and make an assessment of temporary differences resulting from differing treatment of items, for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheet. We must then assess the likelihood that our deferred tax assets will be recovered from future taxable income and, to the extent we believe that recovery is more likely than not, we establish a valuation allowance. At year end December 31, 2016, material amounts of valuation allowances were recorded representing: 100% of the net deferred tax assets in the US and in the UK. Our assessment for the year ended December 31, 2017, is that a 100% valuation allowance is still required. To the extent we establish a valuation allowance or increase this allowance in a period, we must include an expense within the tax provision in the consolidated statement of operations. Significant management judgment is required in determining our deferred tax assets and liabilities and any valuation allowance recorded against our net deferred tax assets. In the event that we generate taxable income in the jurisdictions in which we operate and in which we have net operating loss carry-forwards that we can utilize to offset all or part of this taxable income, we may be required to adjust our valuation allowance.

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act. The Tax Cuts and Jobs Act makes broad and complex changes to the U.S. tax code, including, but not limited to, reducing the U.S. federal corporate tax rate from 35 percent to 21 percent; eliminating the corporate alternative minimum tax and changing how existing alternative minimum tax credits can be realized; creating a new limitation on deductible interest expense; changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017; limitations on the deductibility of certain executive compensation.

In December 2017, the SEC issued Staff Accounting Bulletin No. 118, or SAB 118, which addresses situations where the accounting is incomplete for the income tax effects of the Act. SAB 118 directs taxpayers to consider the impact of the Act as “provisional” when a company does not have the necessary information available, prepared or analyzed (including computations) to finalize the accounting for the change in tax law. Companies are provided a measurement period of up to one year to obtain, prepare, and analyze information necessary to finalize the accounting for provisional amounts or amounts that cannot be estimated as of December 31, 2017.

With regards to the Tax Cuts and Jobs Act impact on the tax provision as it relates to the Company for period year-ending December 31, 2017, we have recognized the provisional impact of tax reform related to the revaluation of deferred tax assets and liabilities from 35% to 21% of $17.2 million tax expense, which is offset by a reduction in the valuation allowance.

In the years ended December 31, 2017 and 2016, we reported financial results for both operations and discontinued operations. ASC 740-20-45 sets down the general rule for allocating income tax expense or benefit between operations and discontinued operations. The general rule requires the computation of tax expense or benefit by entity taking into consideration all items of income, expense, and tax credits. Next, a computation is made taking into consideration only those items related to continuing operations. Any difference is allocated to items other than continuing operations e.g. discontinued operations. Under these general rules, no tax expense or benefit would be allocated to discontinued operations.


 An exception to these rules apply under ASC 740-20-45-7 where an entity has 1) a loss from continuing operations and income related to other items such as discontinued operations and 2) the entity would not otherwise recognize a benefit for the loss from continuing operations under the approach described in ASC 740-20-45. This fact pattern applies for the years ended December 31, 2016 for entities in the US and the UK. Application of this rule exception results in the allocation of tax expense to discontinued operations with an offsetting amount of tax benefit reported by the US and UK companies.

 We follow ASC Topic 740-10, “Income Taxes” which clarifies the accounting for uncertainty in tax positions. ASC Topic 740-10 requires that we recognize in our financial statements the impact of a tax position, if that position will more likely than not be sustained upon examination, based on the technical merits of the position, without regard the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is greater than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded.

Recent Accounting Pronouncements

In May 2014, FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (ASU 2014-09), which amends the existing accounting standards for revenue recognition. In August 2015, FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delays the effective date of ASU 2014-09 by one year. FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. The new standard also permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective method). In April 2016, FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. ASU 2016-10 covers two specific topics: performance obligations and licensing. This amendment includes guidance on immaterial promised goods or services, shipping or handling activities, separately identifiable performance obligations, functional or symbolic intellectual property licenses, sales-based and usage-based royalties, license restrictions (time, use, geographical) and licensing renewals. In addition, in May 2016, FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, which is intended to not change the core principle of the guidance in Topic 606, but rather affect only the narrow aspects of Topic 606 by reducing the potential for diversity in practice at initial application and by reducing the cost and complexity of applying Topic 606 both at transition and on an ongoing basis. The Company has adopted this standard effective January 1, 2018. This new standard did not have a material impact on the Company’s consolidated financial statements.

In February 2016, FASB issued ASU 2016-02, “Leases”. This guidance will require that lease arrangements longer than 12 months result in an entity recognizing an asset and liability equal to the present value of the lease payments in the statement of financial position. This guidance is effective for annual periods beginning after December 15, 2018, and interim periods therein. This standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of ASU 2016-02 will have on its financial statements and related disclosures.

In November 2016, FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): “Restricted Cash” (ASU 2016-18), which requires companies to include amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The Company adopted this guidance effective January 1, 2018. This new guidance did not have a material impact on the Company’s consolidated financial statements.

In May 2017, FASB issued ASU 2017-09 “Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting”, which includes guidance on changes to terms and conditions of share-based payment awards. The amendment provides guidance about which changes to terms or conditions of a share-based payment award require an entity to apply modification accounting. The guidance became effective for the fiscal year beginning on January 1, 2018, including interim periods within that year. The Company adopted this guidance effective January 1, 2018. This new guidance did not have a material impact on the Company’s consolidated financial statements.  


In June 2018, FASB issued ASU 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The changes take effect for public companies for fiscal years starting after Dec. 15, 2018, including interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity’s adoption date of Topic 606. The Company is currently evaluating the impact of adopting this standard on its financial statements and related disclosures, but does not expect it to have a material impact.


 PROPOSAL NO. 1 – REMEDIATION PROPOSAL

Overview

Background Information

On October 12, 2017, we issued to Dr. Dolev Rafaeli, Dennis M. McGrath and Yoav Ben-Dror (the Interest Payment DateNote Holders”) Secured Convertible Promissory Notes in the principal amounts of $3,133,934, $977,666 and $1,515,000, respectively (the “Notes”). ThePursuant to the terms of the Notes, the principal willwas to convert to shares of our common stock at maturity at the lower of (i) the Per Share Value$2.5183 or (ii) the VWAPvolume-weighted average price with respect to on-exchange transactions in ourthe Company’s common stock executed on NASDAQThe Nasdaq Stock Market (“Nasdaq”) (or such other market ason which our stock may then trade on)trade) during the thirty (30) trading days prior to the maturity date, as reported by Bloomberg L.P.; provided, however, that the valuethere was a conversion floor of our common stock shall in no event be less than $1.75 per share. In addition, each holdershare (the “Floor Price”).

On December 22, 2017, we and the Note Holders entered into a stock grant agreement (the “Stock Grant Agreement”) to, among other things, cause the early conversion of a Payout Note may elect to have a Monthly Interest Payment paid inthe Notes into an aggregate of 5,628,291 shares of our common stock at(the “Payout Shares”), resulting in a conversion price of $0.9997, which is less than the VWAP with respectFloor Price. In addition, pursuant to on-exchange transactions in ourthe Stock Grant Agreement, we agreed to (i) issue an additional 1,857,336 shares of common stock executed on NASDAQ (or such other market as our stock may then trade on) during the thirty (30) trading days ending five (5) NASDAQ trading days prior to the applicable Interest Payment Date,Note Holders as reported by Bloomberg L.P.

The Payout Notes will be secured by aconsideration for the various agreements of the Note Holders contained in the Stock Grant Agreement, including the Note Holders’ agreement to give up their first priority security interest and convert the Notes to equity and (ii) provide the Note Holders with certain cash payments in all of our assets;consideration for services to be provided however, that such security interest will be subordinated to any (i) claims or liensby the Note Holders, in an amount equal to the holdersamount of any debt (including mortgage debt) being assumedinterest foregone by usthe Note Holders as a result of the transaction contemplatedconversion of the Notes.

On December 22, 2017, we and OFI entered into a securities purchase agreement (the “Purchase Agreement”), pursuant to which OFI could invest up to $11,000,000 in the Company in a series of closings, in exchange for which OFI will receive shares of our Series B Preferred Stock at a purchase price of $1.00 per share. To date, the Company and OFI completed the three closing under the Purchase Agreement, pursuant to which OFI provided, in the aggregate, $3,825,000 to us in exchange for an aggregate of 3,825,000 shares of Series B Preferred Stock.

On April 20, 2018, we and OFI entered into a cancellation and exchange agreement (the “Exchange Agreement”), pursuant to which OFI agreed to provide an additional $2,000,000 to us in exchange for 2,000,000 shares of Series B Preferred Stock, subject to certain conditions set forth in the Exchange Agreement, including, among other things, the cancellation of 95,770 shares of our Series A Preferred Stock held by OFI in exchange for 5,382,274 shares of our common stock. Under the ContributionExchange Agreement, closing of this additional investment was to occur following stockholder approval, which was not obtained.

Pursuant to the terms of the Certificate of Designation for the Series B Preferred Stock, the Series B Preferred Stock, which votes on an as-converted basis, was issued to OFI with a conversion price that constitutes a discount to the market price of the common stock at the date of issuance of the Series B Preferred Stock, resulting in the Series B Preferred Stock having a greater voting rights than the existing shares of common stock, which violates the Nasdaq’s voting rights rule. On April 20, 2018, the Company and OFI entered into a supplemental agreement (the “Supplemental Agreement”), pursuant to which (i) OFI agreed to limit the voting power of the Series B Preferred Stock to address this violation and (ii) all post-closing indebtedness incurred by us orthe parties thereto corrected a violation of Nasdaq’s Listing Rules that require approval from our subsidiaries. The holdersstockholders prior to the issuance of common stock upon conversion of the Series B Preferred Stock issued under the Purchase Agreement that are in excess of 19.99% of our issued and outstanding common stock on the date of initial issuance of the Series B Preferred Stock to OFI, which resulted from a provision in the Purchase Agreement that incorrectly stated that such percentage is to be calculated as of the applicable conversion date of the Series B Preferred Stock instead of the date of initial issuance thereof.

We were also notified by letter from Nasdaq on April 10, 2018 that the Company is not in compliance with Nasdaq’s Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2.5 million in stockholders’ equity.

Remediation Agreement

In order to comply with Listing Rule 5550(b)(1) and address the concerns of the staff of Nasdaq regarding the stockholder approval violations described above, on September 24, 2018, we entered into a remediation agreement with OFI and the Note Holders (the “Remediation Agreement”). A copy of the Remediation Agreement is attached hereto as Annex B.


Pursuant to the Remediation Agreement, the Stock Grant Agreement was terminated, the Payout NotesShares were cancelled, and we issued to the Note Holders an aggregate of 7,485,627 shares of newly-designated Series C Preferred Stock. In addition, the resignations of Dr. Rafaeli and Mr. McGrath from our Board, which were previously effective upon certain events set forth in the Stock Grant Agreement, will have demand registration rights which requirenow become effective upon the filinglast to occur of a re-sale registration statement on appropriate form that registers for re-sale(i) receipt of all of the shares of common stock underlying the Payout Notes within thirty (30) daysSeries C Preferred Stock and (ii) the date that the shares of issuancecommon stock underlying the Series C Preferred Stock are registered for re-sale in accordance with best efforts to cause the same to become effective within one-hundred twenty (120) days of issuance.Registration Rights Agreement (as defined below).

ConditionsIn addition, the Purchase Agreement (subject to the Contribution Transactionsurvival of certain provisions identified in the Remediation Agreement), the Supplemental Agreement and the Exchange Agreement were terminated, the Series B Preferred Stock issued to OFI was cancelled and we issued to OFI 6,217,490 shares of newly-designated Series D Preferred Stock. In addition, OFI agreed to purchase $100,000 of shares of Series D Preferred Stock for a purchase price of $0.65 per share on the last day of each month, commencing on September 30, 2018, until it has purchased an aggregate of $500,000 of shares of Series D Preferred Stock; provided that, upon closing of any material business combination involving the Company that is approved by OFI, OFI agreed to purchase an additional $1,500,000 of shares of Series D Preferred Stock at a price of $0.65 per share. Notwithstanding the foregoing, from and after the date that stockholder approval of the Remediation Agreement has been obtained, instead of purchasing shares of Series D Preferred Stock, OFI agreed to purchase shares of common stock at a price of $0.65 per share.

 

Each ofThe Remediation Agreement also terminated two voting agreements, dated December 22, 2017, among OFI, the first contribution, second contribution and optional contribution are subject to customary closing conditionsNote Holders and certain other specific conditions, includingsecurity holders, the following:registration rights agreement, dated December 22, 2017, between the Company and OFI, and the registration rights agreement, dated December 22, 2017, between the Company and the Note Holders.

On September 24, 2018, in connection with the Remediation Agreement, we entered into a registration rights agreement (the “Registration Rights Agreement”) with OFI and the Note Holders, pursuant to which we agreed to register all shares of common stock that may be issued upon conversion of the Series C Preferred Stock and Series D Preferred Stock, as well as all other shares of our capital stock held by OFI (the “Registrable Securities”), under the Securities Act. We agreed to file a registration statement covering the resale of such Registrable Securities within 30 days of the date of the Registration Rights Agreement and cause such registration statement to be declared effective under the Securities Act as soon as possible but, in any event, no later than 120 days following the filing date if such registration statement is filed on Form S-3 or 150 days if such registration statement is filed on Form S-1. If such registration statement is not filed or declared effective by the SEC on or prior to such dates, or if after such registration statement is declared effective, without regard for the reason thereunder or efforts therefor, such registration statement ceases for any reason to be effective for more than an aggregate of 30 trading days during any 12-month period, which need not be consecutive, then in addition to any other rights the holders of Registrable Securities may have under the Registration Rights Agreement or under applicable law, we shall pay to each holder an amount in cash, as partial liquidated damages and not as a penalty, equal to 1.0% of the product obtained by multiplying (x) $1.00 by (y) the number of shares of Registrable Securities held by the holder (the “Investment Amount”); provided that, in no event will we be liable for liquidated damages in excess of 1.0% of the Investment Amount in any single month and that the maximum aggregate liquidated damages payable to the holders under the Registration Rights Agreement shall be ten percent (10%) of the Investment Amount. Notwithstanding the foregoing, the filing and effective date deadlines above shall be tolled (i.e., extended), during such time as the Company is actively pursuing a business combination involving the Company that is approved by each of OFI and the Note Holders.

Series C Preferred Stock

The terms of the Series C Preferred Stock are governed by a certificate of designation (the “Series C Certificate of Designation”) filed by us with the Nevada Secretary of State on September 24, 2018. Pursuant to the Series C Certificate of Designation, we designated 7,485,627 shares of our preferred stock as Series C Preferred Stock. Following is a summary of the material terms of the Series C Preferred Stock:

 

·The first contribution was subjectDividends. Except for stock dividends or distributions for which adjustments are to be made pursuant to the following conditions:Series C Certificate of Designation, holders of Series C Preferred Stock shall be entitled to receive, and the Company shall pay, dividends on shares of Series C Preferred Stock equal (on an as-if-converted-to-common-stock basis) to and in the same form as dividends actually paid on shares of common stock when, as and if such dividends are paid on shares of common stock. No other dividends shall be paid on shares of Series C Preferred Stock.

 

35

o·The entry into a registration rights agreement requiring us to register for resale the shares being issued in connection with the Contribution Transaction;

oThe entry into a lock up agreement that restricts the transfer of our shares that are held by certain of our affiliates and certain affiliatesLiquidation. Upon any liquidation, dissolution or winding-up of the Contributor Parent;

oThe restructuringCompany, whether voluntary or involuntary (a “Liquidation”), holders of our Board as described above;

oThe resignation of certain of our officers as described above;

oThe entry into an employment agreement with Mr. Suneet Singal, who became our new Chief Executive Officer at the closingSeries C Preferred Stock shall be entitled to receive out of the first contribution.assets, whether capital or surplus, of the Company the same amount that a holder of common stock would receive if the Series C Preferred Stock were fully converted to common stock immediately prior to such Liquidation, which amount shall be paid to the holders of Series C Preferred Stockpari passu with all holders of Series D Preferred Stock and in preference to the holders of common stock.

 

·The second contribution is subject toVoting Rights. Except as provided by law or by the following conditions:

oIf the property in Antigua is contributed, the Citizenship by Investment Unit must have approved the project for purposesother provisions of the Citizen By Investment Program;

oThe memorandumSeries C Certificate of agreement, dated July 28, 2015, among Brown McLennon, First Capital Real Estate Investment andDesignation, the Governmentholders of Antigua and Barbuda shallSeries C Preferred Stock have been amended to reflect that Brown McLennon’s expected 24 units in the LLC (as defined in the memorandum of agreement) have been transferred to First Capital Real Estate Investment and certain of the conditions specified in the memorandum of agreement shall have been satisfied or irrevocably waived by the Government of Antigua and Barbuda and no new material conditions shall have been substituted therefor; and

oIf the property in Amarillo is contributed, the dispute between the Contributor and Silverlake Park, LLC shall have been finally adjudicated or settled in favor of the Contributor.voting rights.

 

·Conversion.On thedate on which stockholder approval with respect to the Remediation Agreement and the transactions contemplated thereby has been obtained (the “Conversion Date”), each share of Series C Preferred Stock shall be automatically converted into such number of fully paid and non-assessable shares of common stock as is determined by dividing $1.00 by the conversion price in effect on the Conversion Date. The third contributionconversion price is optionalinitially equal to $1.00, subject to adjustment as described in the discretionSeries C Certificate of the Contributor, butDesignation.

·Redemption. The Series C Preferred Stock is also subject to the condition that if the property in Mexico is contributed, then there must be in place a design and marketing agreement with a design firm owned by Tiger Woods or another celebrity golfer of equivalent stature under which all contractual obligations of the parties have been fully performed through such date and the design and marketing agreement must require the design firm to design the golf course at the property and permit it to utilize the name and likeness of the celebrity golfer to promote the golf course for a period of at least ten (10) years.not redeemable.

 

In each case, our Board will determine whether or notSeries D Preferred Stock

The terms of the pre-contribution conditions have been satisfied before acceptingSeries D Preferred Stock are governed by a certificate of designation (the “Series D Certificate of Designation”) filed by us with the property interests and issuingNevada Secretary of State on September 24, 2018. Pursuant to the Series D Certificate of Designation, we designated 9,294,414 shares of our preferred stock toas Series D Preferred Stock. Following is a summary of the Contributor.material terms of the Series D Preferred Stock:

·Dividends. Holders of shares of Series D Preferred Stock shall receive cumulative dividends, pro rata among such holders, prior to and in preference to any dividend on our outstanding common stock at the per annum rate of 8% of the Stated Value (as defined below). Dividends on each share of Series D Preferred Stock will accrue daily and be cumulative from and including the date of issuance thereof and shall be payable upon the occurrence of a Liquidation or a conversion. The “Stated Value” shall mean $1.00 per share, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series D Preferred Stock. Holders shall also be entitled to receive dividends on shares of Series D Preferred Stock equal (on an as-if-converted-to-common-stock then convertible) to and in the same form as dividends actually paid on shares of our common stock when, as and if such dividends are paid on shares of the common stock.

·Liquidation. Upon a Liquidation, holders of Series D Preferred Stock shall be entitled to receive out of the assets, whether capital or surplus, of the Company the same amount that a holder of common stock would receive if the Series D Preferred Stock were fully converted to common stock immediately prior to such Liquidation, which amount shall be paid to the holders of Series D Preferred Stockpari passu with all holders of Series C Preferred Stock and in preference to the holders of common stock.

·Voting Rights. Except as provided by law or by the other provisions of the Series D Certificate of Designation, the holders of Series D Preferred Stock have no voting rights. However, as long as any shares of Series D Preferred Stock are outstanding, the holders of Series D Preferred Stock shall have the right to prohibit or veto the Company from entering intoany agreement or taking any action with respect to (i) a Change in Control Transaction (as defined below) or (ii) the issuance any equity securities or equity-linked securities at a price per share below $0.6505, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the common stock. The Company must notify the holders of Series D Preferred Stock at least twenty (20) days in advance of the events described above and the holder shall exercise its veto right by notifying the Company in writing within fifteen (15) days after the receipt of such notice that it is exercising its veto right to prohibit such agreement from being entered into or action from being taken. A “Change in Control Transactionmeans the acquisition by any person of beneficial ownership of more than 50% (on a fully diluted basis) of either (i) the then outstanding shares of common stock, taking into account as outstanding for this purpose such common stock issuable upon the exercise of options or warrants, the conversion of convertible stock or debt, and the exercise of any similar right to acquire such common stock or (ii) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors.


·Conversion.On theConversion Date, each share of Series D Preferred Stock, plus accrued, but unpaid, dividends thereon (the “Aggregate Preference Amount”), shall be automatically converted into such number of fully paid and non-assessable shares of common stock as is determined by a formula (computed on the Conversion Date) (i) the numerator of which is equal tothe Aggregate Preference Amount and (ii) the denominator of which is equal to the conversion price. The conversion price is initially equal to $1.00, subject to adjustment as described in the Series D Certificate of Designation.

·Redemption. The Series D Preferred Stock is not redeemable.

Reasons for Stockholder Approval

 

The Contribution Agreement is subject toAt the usual pre- and post-closing representations, warranties and covenants, and restricts our conduct totime that in the ordinary course of business between the signing and December 31, 2017.

First Amendment to the Interest Contribution Agreement

On August 3, 2017, the Companywe entered into a First Amendment (the “First Amendment”) to the Interest Contribution Agreement, dated March 31, 2017, by and among the Contributor Parties and the Acquiror Parties, as modified by the Agreement to Waive First Closing Deliverables, dated May 17, 2017, and the Agreement to Waive Second Closing Deliverables, dated July 3, 2017 (collectively, the “Contribution Agreement”). Under the First Amendment, the Contributor Parties irrevocably waived any conditions to the closings set under the Contribution Agreement, including those conditions contained in Section 7 of the Contribution Agreement that require the Company to maintain its listing and active trading of its securities on any of the NASDAQ markets. The Contributor Parties also reaffirmed their obligation to use their best efforts to satisfy the Mandatory Contribution Conditions and contribute the Mandatory Entity Interests, both as defined in the Contribution Agreement, on or before December 31, 2017. Additionally, the Acquiror Parties confirmed the Contributor Parties’ understanding that the failure of the Contributor Parties to satisfy the Mandatory Contribution Conditions after using commercially reasonable efforts to do so does not give rise to a unilateral right of the Acquiror Parties to terminate the Contribution Agreement pursuant to Article 10 of the Contribution Agreement.

Finally, the First Amendment clarified that references in the ContributionStock Grant Agreement and its Exhibits to NASDAQ shall, to the extent necessary, be deemed to be references to NASDAQ or such other trading market as the Company’s securities may be trading on, including, without limitation, the OTCQB. For purposes of calculating the number of the Company’s shares into which the principal of the Payout Notes under the ContributionPurchase Agreement, will be converted, if the Company’s shares are not traded on NASDAQ on the approval date of those Payout Notes, VWAP shall be calculated with respect to the transaction in the Company’s shares executed on the OTCQB or such other market as the Company’s shares may then be traded on instead of NASDAQ.

Requirements for Stockholder Approval

Although trading of our common stock on NASDAQ was suspended effective July 7, 2017 and our stock is currently quotedtraded on the OTCQB,Nasdaq Capital Market, so we have an appeal pending with NASDAQ and our common stock has not officially been delisted from the NASDAQ Capital Market. As a result, we arewere subject to NASDAQ’sNasdaq’s Listing Rules. The potential consummationissuance of securities under the Contribution Transaction implicatesStock Grant Agreement and the Purchase Agreement implicated certain of NASDAQ’sNasdaq’s Listing Rules requiring prior stockholder approval in order to maintain our listing on the NASDAQNasdaq Capital Market, including:including:

 

·NASDAQ NasdaqListing Rule 5635(a)5635(d), which requiresstockholder approval prior to the issuance of securities in connection with a transaction other than a public offering involving: (1) the acquisitionsale, issuance or potential issuance of common stock (or securities convertible into or exercisable for common stock) at a price less than the greater of book or market value which together with sales by officers, directors or substantial shareholders of the company equals 20% or more of common stock or assets20% or more of another company ifthe voting power outstanding before the issuance; or (2) the sale, issuance or potential issuance of common stock (or securities convertible into or exercisable common stock) equal to 20% or more of the common stock has or will have upon issuance voting power equal to20% or in excess of 20%more of the voting power outstanding before the issuance for less than the greater of stockbook or securities convertible into or exercisable for common stock, or if the number of shares of common stock to be issued is or will be equal to or in excess of 20%market value of the number of shares of common stock outstanding before the issuance of the stock or securities;stock; and

 

·NASDAQNasdaq Listing Rule 5635(b), which requires stockholder approval when any issuance or potential issuance will result in a “change of control” of the issuer.

 

36

In orderAs noted above, we entered into the Remediation Agreement to comply withaddress concerns of the staff of Nasdaq regarding our violation of these NASDAQ Listing Rules,rules. Pursuant to the Remediation Agreement, we would needagreed to obtain theseek stockholder approval of our stockholders prior to the issuance of all securities as contemplated by the Contribution Transaction, including the Payout Notes.At the Meeting, stockholders will be asked to approve the issuance of shares of common stock upon conversion of the Series A Convertible Preferred Stock, the issuance of the Warrant, the issuance of shares of common stock upon exercise of the Warrant, the issuance of the Payout Notes,Remediation Agreement and the issuance of shares of common stock upon conversion of the Payout Notes.shares of Series C Preferred Stock and Series D Preferred Stock issued thereunder.

 

We are not asking you to approve the Contribution Transaction or the Contribution Agreement. We are solely asking you to approve the issuance of securities as set forth above in accordance with the Contribution Agreement.

Interests of Certain Persons in the Contribution Securities Issuance Proposal

 

As noted above, amounts due toCertain of the Note Holders, Dr. Dolev Rafaeli and Dennis M. McGrath, under their employment agreements, as well as amounts due to Dr. Yoav Ben-Dror for his services asare members of our Board of Directors. In addition, Kristen E. Pigman, a boardmember of our Board, is also the Director of OP Fund I Manager, LLC, which is the member and officermanager of OFI. Accordingly, the Remediation Agreement was considered an interested party transaction and was approved by a majority of our foreign subsidiaries, will be converted into the Payout Notes. The Payout Notes will be issued upon stockholder approval at the Meeting. The aggregate amounts due to Messrs. Rafaeli, McGrath and Ben-Dror for accrued compensation for services, reimbursement obligations or other matters through December 31, 2016 are $6,381,219, $2,019,692, and $525,000, respectively and as of June 30, 2017, these amounts had decreased to approximately $4,767,500, $1,224,500 and $1,515,000, respectively.non-interested directors.

 

No Dissenters’ Rights

 

Under Nevada law, holders of our common stock are not entitled to dissenter’s rights of appraisal with respect to the approval of the Contribution Securities IssuanceRemediation Proposal.

 

Vote Required

 

 The approval of the Contribution Securities IssuanceRemediation Proposal requires the affirmative vote of a majority of the shares present in person or represented by proxy at the Meeting. An abstention will have no effect on the Contribution Securities IssuanceRemediation Proposal. Since the Contribution Securities IssuanceRemediation Proposal is considered to be a “non-routine” matter, shares that constitute broker non-votes are not considered votes cast on the Contribution Securities IssuanceRemediation Proposal.

 

Our Board of Directors unanimously recommends a vote “FOR” approval of the Contribution Securities IssuanceRemediation Proposal.

 

37


PROPOSAL NO. 32SECOND CHARTERREVERSE STOCK SPLIT PROPOSAL

 

General

 

On June 26, 2017,October 22, 2018, our Board approved an amendment to theour Amended and Restated Charter,Articles of Incorporation, subject to approval by our stockholders, to effect aone or more reverse stock splitsplits of the shares of our common stock at an exchange ratio of not less than 1-for-2 and not more than 1-for-7,1-for-15, to be selected at the discretion of our Board. Stockholder approval of this Second CharterReverse Stock Split Proposal will authorize our Board, in its discretion, to effect theone or more reverse stock split,splits, at a specific exchange ratio within the approved range as they deem appropriate, at any time prior to our 20182019 annual meeting of stockholders. Our Board believes that approval of this Second CharterReverse Stock Split Proposal to effect aone or more reverse stock splitsplits and to determine the exchange ratio as opposed to approval of an immediate single reverse stock split at a specific ratio, and to effect such reverse stock splitsplits at any time prior to our 20182019 annual meeting of stockholders, will provide our Board with maximum flexibility to react to current market conditions and therefore to achieve the purposes of thea reverse stock split,splits, if implemented, and to act in the best interests of our stockholders.

 

To effect thea reverse stock split, we would file an amendment to theour Amended and Restated CharterArticles of Incorporation with the Secretary of State of the State of Nevada. The form of amendment to effect thea proposed reverse stock split is attached to this proxy statement as Annex D.C. If our Board elects to implement aone or more reverse stock splitsplits as approved by our stockholders, then the number of shares of our common stock will be reduced in accordance with the selected exchange ratio for the reverse stock split. Any fractional share resulting from the selected exchange ratio for thea single reverse stock split will be rounded up to the nearest whole share. The par value of our common stock would remain unchanged at $0.01 per share. TheAny reverse stock split would become effective upon the filing of thean amendment with the Secretary of State of the State of Nevada. Our Board may elect not to implement a reverse stock split, in its discretion, even if the proposal to grant our Board the discretion to effect a reverse stock split is approved by our stockholders.

 

38

On January 26, 2009, we effected a reverse stock split of our authorized and our issued and outstanding common stock at an exchange ratio of 1-for-7 after receiving stockholder approval for such reverse stock split. On February 3, 2010, we effected a reverse stock split of our authorized and our issued and outstanding common stock at an exchange ratio of 1-for-6 after receiving stockholder approval for such reverse stock split. On September 23, 2016, we effected a reverse stock split of our issued and outstanding common stock at an exchange ratio of 1-for-5 after receiving stockholder approval for such reverse stock split.

Purposes of the Proposed Reverse Stock Split

 

Our Board believes that we should provide for the right to implement aone or more reverse stock splitsplits for the following reasons:

 

·to enhance the acceptability and marketability of our common stock; and

 

·to enable us to use thea reverse stock split as may be required to maintain, and our Board believes it is in our and our stockholders’ best interests to maintain,regain the listing of our common stock on the Nasdaq Capital Market.Market or another national securities exchange.

 

Our Board believes that theone or more reverse stock splitsplits will enhance the acceptability and marketability of our common stock to the financial community and the investing public and may mitigate any reluctance on the part of certain brokers and investors to trade in our common stock. Many institutional investors have policies prohibiting them from holding stocks in their own portfolios which trade at prices below certain levels. These policies reduce the number of potential investors in our common stock at its current market price. In addition, analysts at many leading brokerage firms are reluctant to recommend stocks to their clients, or monitor the activity of stocks, that trade at a price per share below certain levels. A variety of brokerage house policies and practices also tend to discourage individual brokers within those firms from dealing in stocks that trade at a price per share below certain levels. Some of those policies and practices pertain to the payment of brokers’ commissions and to time-consuming procedures that function to make the handling of such stocks unattractive to brokers from an economic standpoint. Additionally, because brokers’ commissions on such stocks generally represent a higher percentage of the stock price than commissions on higher-priced stocks, the current share price of our common stock can result in an individual stockholder paying transaction costs that represent a higher percentage of total share value than would be the case if our share price were higher. This factor may also limit the willingness of institutions to purchase our stock.

 

Our Board also believes that, after effecting thea reverse stock split, the enhanced acceptability and marketability of our common stock will facilitate our ability to regain the abilitylisting of our common stock to trade on the Nasdaq Capital Market.Market or another national securities exchange. Our common stock is currently listed on that market. However, with regard to the first contribution made on May 17, 2017 under the Contribution Agreement, Nasdaq has taken the position that a change of control has taken place, requiring the Company to complete an Initial Listing Application to continue its trading on the Nasdaq Capital MarketOTC Pink Sheets.

 

Our Board believes that listing on a national securities exchange, either the Nasdaq Capital Market or the NYSE American, is the preferred listing market for our common stock. As of the date of the filing of this proxy statement, we believe that we will meet all qualitative and quantitative standards for initial listing of our common stock on this market,these national securities exchanges, except for the minimum bid requirement of Four Dollars ($4.00) per share.share and certain of the corporate governance requirements that we expect to resolve within the next six months. Thus, if the reverse stock split is approved by our stockholders and implemented by our Board, we expect to satisfy the $4.00 per share minimum bid price requirement for listing on this market. Our Board believes that the implementation of the reverse stock split is in the best interests of the Company and our stockholders.

 


Factors Influencing the Board of Directors’ Discretion in Implementing the Reverse Stock Split

 

Our Board intends to implement a reverse stock split if it believes that such an action is in the best interests of the Company and our stockholders. Such determination, as well as the determination of the specific ratio to be utilized, will be based on factors such as existing and expected marketability and liquidity of our common stock, prevailing market conditions and the likely effect on the market price of our common stock. Our Board will also consider factors such as the historical and projected performance of our common stock, our projected performance, prevailing market and industry conditions and general economic trends, and will place emphasis on the expected closing price of our common stock over the short and longer period following the effectiveness of the reverse stock split.

 

39

No further action on the part of our stockholders would be required to either effect or abandon the reverse stock split. Notwithstanding approval of the reverse stock split proposal by the stockholders, our Board may, in its discretion, determine to delay the effectiveness of the reverse stock split up until our 20182019 annual meeting of stockholders or choose not to implement the reverse stock split at all.

 

Potential Effects of the Proposed Reverse Stock Split

 

The immediate effect of a reverse stock split would be to reduce the number of shares of our common stock and to increase the trading price of our common stock. However, we cannot predict the specific effect of any reverse stock split upon the market price of our common stock. Based on the data we have reviewed leading up to this Second CharterReverse Stock Split Proposal, it appears that in some cases a reverse stock split improves stock performance while in other cases it does not, and in some cases a reverse stock split improves overall market capitalization while in other cases it does not. There is no assurance that the trading price of our common stock after the reverse stock split will rise in proportion to the reduction in the number of shares of our common stock outstanding as a result of the reverse stock split. Also, there is no assurance that a reverse stock split will lead to a sustained increase in the trading price of our common stock. The trading price of our common stock may change due to a variety of factors, such as our operating results and other factors related to our business and general market conditions.

 

As a summary and for illustrative purposes only, the following table reflects the approximate number of shares of our common stock that would be outstanding as a result of the potential reverse stock split ratios within the range of this Second CharterReverse Stock Split Proposal based on 5,297,5005,568,500 shares of our common stock outstanding as of the Record Date, without accounting for fractional shares, which will be rounded up to the nearest whole share:

 

Proposed Reverse Stock Split Percentage Reduction  Shares to Be Outstanding 
1-for-2  50%  2,648,750 
1-for-3  67%  1,765,834 
1-for-4  75%  1,324,375 
1-for-5  80%  1,059,500 
1-for-6  83%  882,917 
1-for-7  86%  756,786 

Proposed Reverse Stock Split Percentage Reduction  Shares to Be Outstanding 
1-for-2  50.0%  2,784,250 
1-for-3  67.7%  1,856,167 
1-for-4  75.0%  1,392,125 
1-for-5  80.0%  1,113,700 
1-for-6  83.3%  928,084 
1-for-7  85.7%  795,500 
1-for-8  87.5%  696,063 
1-for-9  88.9%  618,723 
1-for-10  90.0%  556,850 
1-for-11  90.9%  506,228 
1-for-12  91.7%  464,042 
1-for-13  92.3%  428,347 
1-for-14  92.9%  397,750 
1-for-15  93.3%  371,234 

 

The resulting decrease in the number of shares of our common stock outstanding could potentially impact the liquidity of our common stock, on the Nasdaq Common Market, especially in the case of larger block trades.

 


Effects on Ownership by Individual Stockholders

 

Our stockholders should recognize that if a reverse stock split is effected, they will own a smaller number of shares than they currently own (approximately equal to the number of shares owned immediately prior to the reverse stock split divided by the selected block factor (i.e. two, three, four, five, six or seven)etc.) and after giving effect to the rounding up of fractional shares to the nearest whole share, as described below). The reverse stock split would not affect any stockholder’s percentage ownership interests in the Company or such stockholder’s proportionate voting power, except to the extent that interests in fractional shares would be rounded up to the nearest whole share.

 

Vote Required

 

The approval of the Second CharterReverse Stock Split Proposal requires the affirmative vote of the holders of a majority of the issued and outstanding shares of our common stock. An Abstention will be treated in the same manner as a vote against the Second CharterReverse Stock Split Proposal. Since the Second CharterReverse Stock Split Proposal is considered to be a “non-routine” matter, shares that constitute broker non-votes are not considered votes cast on the Second CharterReverse Stock Split Proposal.

 

Our Board of Directors unanimously recommends a vote “FOR” approval of the Second CharterReverse Stock Split Proposal.

 

40

 PROPOSAL NO. 4 – PLAN PROPOSAL

 

Overview

On April 18, 2018, our Board adopted the FC Global Realty Incorporated 2018 Equity Incentive Plan (the “Plan”). Long-term incentives have been a critical component of our compensation programs and are intended to reward our employees for long-term sustained performance that is aligned with stockholder interests. Our Board approved the Plan for grants of restricted stock, stock options and other forms of incentive compensation to our officers, employees, directors and consultants.

Adoption of the Plan was needed to replenish the pool of shares available for the grant of stock-based compensation. As of the Record Date, no shares remained available for grant under our Amended and Restated 2005 Equity Compensation Plan and only 71,865 shares remained available for grant under our Amended and Restated 2000 Non-Employee Director Stock Option Plan.

The Plan incorporates key corporate governance practices, including the following:

·limits the number of shares available to 5,000,000, which represents approximately 22% of our issued and outstanding common stock on a fully-diluted basis (assuming conversion of all outstanding preferred stock and all other securities that are exercisable or exchangeable for, or convertible into, our common stock) as of the Record Date;

·all shares granted in connection with awards other than options and stock appreciation rights count as two (2) shares against the share limit;

·the price of any option may not be altered or repriced without stockholder approval;

·discounted stock options and stock appreciation rights are prohibited;

·reload options are not permitted;

·performance goals may be imposed on grants;

·no ability of participants to receive dividend payments with respect to restricted stock until the shares are vested;

·liberal share counting is not permitted; and

·payment of the exercise price or applicable taxes made by delivery of shares, or withholding of shares, in satisfaction of a participant’s obligation, will not result in additional shares becoming available for subsequent awards under the Plan.

The Plan was submitted to stockholders for approval in order to qualify certain awards made to certain officers as deductible for federal income tax purposes under the federal income tax rules applicable to incentive stock options.

Our Board believes equity compensation is an important component of our compensation programs. Our ability to attract, retain and motivate top quality employees is material to our success, and we believe we can better achieve these objectives with grants made under the Plan. In addition, our Board believes that the interests of both our and our stockholders are advanced by affording our employees, officers and directors the opportunity to acquire or increase their proprietary interests in the Company.

Significant Features of the Plan

The following is a summary of certain significant features of the Plan. The information which follows is subject to, and qualified in its entirety by reference to, the Plan document, which is attached to this proxy statement as Annex D. We urge you to read the Plan in its entirety.


Awards that may be granted include: (a) Incentive Stock Options, (b) Non-qualified Stock Options, (c) Stock Appreciation Rights, (d) Restricted Awards, (e) Performance Share Awards, and (f) Performance Compensation Awards. These awards offer our officers, employees, consultants and directors the possibility of future value, depending on the long-term price appreciation of our common stock and the award holder’s continuing service with the Company.

Stock options give the option holder the right to acquire from us a designated number of shares of common stock at a purchase price that is fixed upon the grant of the option. The exercise price will not be less than the market price of the common stock on the date of grant. Stock options granted may be either tax-qualified stock options (so-called “incentive stock options”) or non-qualified stock options.

Stock appreciation rights (“SARs”), which may be granted alone or in tandem with options, have an economic value similar to that of options. When a SAR for a particular number of shares is exercised, the holder receives a payment equal to the difference between the market price of the shares on the date of exercise and the exercise price of the shares under the SAR. Again, the exercise price for SARs normally is the market price of the shares on the date the SAR is granted. Under the Plan, holders of SARs may receive this payment – the appreciation value – either in cash or shares of common stock valued at the fair market value on the date of exercise. The form of payment will be determined by us.

Restricted shares are shares of common stock awarded to participants at no cost. Restricted shares can take the form of awards of restricted stock, which represent issued and outstanding shares of our common stock subject to vesting criteria, or restricted stock units, which represent the right to receive shares of our common stock subject to satisfaction of the vesting criteria. Restricted shares are forfeitable and non-transferable until the shares vest. The vesting date or dates and other conditions for vesting are established when the shares are awarded.

The Plan also provides for performance compensation awards, representing the right to receive a payment, which may be in the form of cash, shares of common stock, or a combination, based on the attainment of pre-established goals.

All of the permissible types of awards under the Plan are described in more detail as follows:

Purposes of Plan: The purposes of the Plan are to: attract and retain officers, employees and directors for the Company and its subsidiaries; motivate them by means of appropriate incentives to achieve long-range goals; provide incentive compensation opportunities; and further align their interests with those of our stockholders through compensation that is based on our common stock.

Administration of the Plan: Administration of the Plan is entrusted to the Compensation Committee of the Board of Directors (the “Committee”). Among other things, the Committee has the authority to select persons who will receive awards, determine the types of awards and the number of shares to be covered by awards, and to establish the terms, conditions, performance criteria, restrictions and other provisions of awards. The Committee has authority to establish, amend and rescind rules and regulations relating to the Plan.

Eligible Recipients: Persons eligible to receive awards under the Plan will be those officers, employees, consultants, and directors of the Company and its subsidiaries who are selected by the Committee administering the Plan.

Shares Available Under the Plan: The maximum number of shares of our common stock that may be delivered to participants under the Plan is 5,000,000, subject to adjustment for certain corporate changes affecting the shares, such as stock splits. Shares subject to an award under the Plan for which the award is canceled, forfeited or expires again become available for grants under the Plan. Shares subject to an award that is settled in cash will not again be made available for grants under the Plan.

Stock Options:

General. Subject to the provisions of the Plan, the Committee has the authority to determine all grants of stock options. That determination will include: (i) the number of shares subject to any option; (ii) the exercise price per share; (iii) the expiration date of the option; (iv) the manner, time and date of permitted exercise; (v) other restrictions, if any, on the option or the shares underlying the option; and (vi) any other terms and conditions as the Committee may determine.

Option Price. The exercise price for stock options will be determined at the time of grant. Normally, the exercise price will not be less than the fair market value on the date of grant. As a matter of tax law, the exercise price for any incentive stock option awarded may not be less than the fair market value of the shares on the date of grant. However, incentive stock option grants to any person owning more than 10% of our voting stock must have an exercise price of not less than 110% of the fair market value on the grant date.


Exercise of Options. An option may be exercised only in accordance with the terms and conditions for the option agreement as established by the Committee at the time of the grant. The option must be exercised by notice to us, accompanied by payment of the exercise price. Payments may be made in cash or, at the option of the Committee, by actual or constructive delivery of shares of common stock to the holder of the option based upon the fair market value of the shares on the date of exercise.

Expiration or Termination. Options, if not previously exercised, will expire on the expiration date established by the Committee at the time of grant. In the case of incentive stock options, such term cannot exceed ten years provided that in the case of holders of more than 10% of our voting stock, such term cannot exceed five years. Options will terminate before their expiration date if the holder’s service with the Company or a subsidiary terminates before the expiration date. The option may remain exercisable for specified periods after certain terminations of employment, including terminations as a result of death, disability or retirement, with the precise period during which the option may be exercised to be established by the Committee and reflected in the grant evidencing the award.

Incentive and Non-Qualified Options. As described elsewhere in this summary, an incentive stock option is an option that is intended to qualify under certain provisions of the Internal Revenue Code of 1986, as amended (the “Code”), for more favorable tax treatment than applies to non-qualified stock options. Any option that does not qualify as an incentive stock option will be a non-qualified stock option. Under the Code, certain restrictions apply to incentive stock options. For example, the exercise price for incentive stock options may not be less than the fair market value of the shares on the grant date and the term of the option may not exceed ten years. In addition, an incentive stock option may not be transferred, other than by will or the laws of descent and distribution, and is exercisable during the holder’s lifetime only by the holder. In addition, no incentive stock options may be granted to a holder that is first exercisable in a single year if that option, together with all incentive stock options previously granted to the holder that also first become exercisable in that year, relate to shares having an aggregate market value in excess of $100,000, measured at the grant date.

Stock Appreciation Rights: Awards of SARs may be granted alone or in tandem with stock options. SARs provide the holder with the right, upon exercise, to receive a payment, in cash or shares of stock, having a value equal to the excess of the fair market value on the exercise date of the shares covered by the award over the exercise price of those shares. Essentially, a holder of a SAR benefits when the market price of the common stock increases, to the same extent that the holder of an option does, but, unlike an option holder, the SAR holder need not pay an exercise price upon exercise of the award.

Stock Awards: Stock awards can also be granted under the Plan. A stock award is a grant of shares of common stock or of a right to receive shares in the future. These awards will be subject to such conditions, restrictions and contingencies as the Committee shall determine at the date of grant. Those may include requirements for continuous service and/or the achievement of specified performance goals.

Cash Awards: A cash award is an award that may be in the form of cash or shares of common stock or a combination, based on the attainment of pre-established performance goals and other conditions, restrictions and contingencies identified by the Committee.

Section 162(m) of the Code: Section 162(m) of the Code limits publicly-held companies to an annual deduction for U.S. federal income tax purposes of $1.0 million for compensation paid to each of their chief executive officer and their three highest compensated executive officers (other than the chief executive officer) determined at the end of each year, referred to as covered employees.

Performance Criteria: Under the Plan, one or more of the following performance criteria will be used by the Committee in establishing performance goals:

·net earnings or net income (before or after taxes);

·basic or diluted earnings per share (before or after taxes);

·net revenue or net revenue growth;

·gross revenue;

·gross profit or gross profit growth;


·net operating profit (before or after taxes);

·return on assets, capital, invested capital, equity, or sales;

·cash flow (including, but not limited to, operating cash flow, free cash flow, and cash flow return on capital);

·earnings before or after taxes, interest, depreciation and/or amortization;

·gross or operating margins;

·improvements in capital structure;

·budget and expense management;

·productivity ratios;

·economic value added or other value added measurements;

·share price (including, but not limited to, growth measures and total shareholder return);

·expense targets;

·margins;

·operating efficiency;

·working capital targets;

·enterprise value;

·safety record;

·completion of acquisitions or business expansion;

·achieving research and development goals and milestones;

·achieving product commercialization goals; and

·other criteria as may be set by the Committee from time to time.

Any one or more of the performance criteria may be used on an absolute or relative basis to measure the performance of the Company, as the Committee may deem appropriate, or as compared to the performance of a group of comparable companies, or published or special index that the Committee deems appropriate.

In determining the actual size of an individual performance compensation award, the Committee may reduce or eliminate the amount of the award through the use of negative discretion if, in its sole judgment, such reduction or elimination is appropriate. The Committee shall not have the discretion to (i) grant or provide payment in respect of performance compensation awards if the performance goals have not been attained or (ii) increase a performance compensation award above the maximum amount payable under the Plan.

Other Material Provisions: Awards will be evidenced by a written agreement, in such form as may be approved by the Committee. In the event of various changes to the capitalization of the Company, such as stock splits, stock dividends and similar re-capitalizations, an appropriate adjustment will be made by the Committee to the number of shares covered by outstanding awards or to the exercise price of such awards. The Committee is also permitted to include in the written agreement provisions that provide for certain changes in the award in the event of a change of control of the Company, including acceleration of vesting. Except as otherwise determined by the Committee at the date of grant, awards will not be transferable, other than by will or the laws of descent and distribution. Prior to any award distribution, we are permitted to deduct or withhold amounts sufficient to satisfy any employee withholding tax requirements. Our Board also has the authority, at any time, to discontinue the granting of awards. The Board also has the authority to alter or amend the Plan or any outstanding award or may terminate the Plan as to further grants, provided that no amendment will, without the approval of our stockholders, to the extent that such approval is required by law or the rules of an applicable exchange, increase the number of shares available under the Plan, change the persons eligible for awards under the Plan, extend the time within which awards may be made, or amend the provisions of the Plan related to amendments. No amendment that would adversely affect any outstanding award made under the Plan can be made without the consent of the holder of such award.

Federal Income Tax Consequences of Awards: The following is based on current laws, regulations and interpretations, all of which are subject to change. It does not purport to be complete and does not describe the state, local or foreign tax considerations or the consequences for any particular individual.

Stock Options. In general, the grant of a stock option will not be a taxable event to the recipient and will not result in a tax deduction to us. The tax consequences resulting from an exercise of a stock option and the subsequent disposition of the shares acquired upon the exercise depends, in part, on whether the option is an incentive stock option or a non-qualified stock option. Upon the exercise of a non-qualified stock option, the holder will recognize ordinary compensation income in an amount equal to the excess of the fair market value of the shares received upon exercise over the exercise price (the “spread”). We will be able to claim a tax deduction for this spread, provided we satisfy compensation reporting requirements under the Code and are not otherwise precluded from taking a deduction because of Section 162(m) deduction limitations described below. Any gain or loss upon the subsequent sale or exchange of the shares by the holder will be capital gain or loss, long term or short term, depending upon the holding period for the shares. Upon the exercise of an incentive stock option, a holder will generally not recognize taxable income and no tax deduction will be available to us, provided the option is exercised when the holder is an employee or, in certain circumstances, within a limited time thereafter. The difference between the exercise price and the fair market value of the shares on the date of exercise is treated by the holder as an item of adjustment for purposes of the alternative minimum tax. If the shares acquired upon an exercise of an incentive stock option are subsequently sold by the holder and such sale takes place after the statutory “holding period” (which is the later of two years from the date of grant or one year after the date of exercise), the gain or loss realized will be the difference between the sales price and the exercise price and will be treated as a long term capital gain or loss. If the sale takes place prior to expiration of the holding period, the holder of the shares will recognize ordinary income at the time of sale equal to the spread and we will be entitled to a tax deduction in equal amount. The remaining gain to the holder, if any, will be capital gain, either long term or short term.


Stock Appreciation Rights. No taxable income will be realized by a recipient in connection with the grant of a SAR. Generally, when the holder of a SAR exercises the SAR, the amount of cash or the fair market value of the shares received upon exercise will be ordinary compensation income to the holder and we will be entitled to a corresponding tax deduction, subject to Section 162(m).

Restricted Shares. An award of restricted shares, like the grant of an option, is not taxable to the recipient. The holder of restricted shares generally will recognize ordinary compensation income at the time the restrictions on the shares lapse, which is the vesting date thereof, based on the fair market value of our shares on that date. Subject to the Section 162(m) limitations, this amount is deductible for federal income tax purposes by us. Dividends paid with respect to restricted shares prior to vesting will be taxable as ordinary compensation income to the holder (not as “qualifying dividends”) and will be deductible by us. A holder of restricted shares may elect under Section 83(b) of the Code, in lieu of the treatment described above, to take immediate recognition of income at the time the shares are received. In that event, the holder will recognize ordinary compensation income equal to the fair market value of the shares at the date of grant, which amount will be deductible by us, and dividends subsequently paid to the holder with respect to the shares will be taxable to the holder as “qualifying dividends” and will not be deductible by us.

Other Awards. Cash awards are generally taxable as ordinary compensation income in the year of receipt and will be deductible as such by us. Restricted stock units, deferred cash awards and other types of deferred awards are subject to Section 409A of the Code regarding non-qualified deferred compensation plans. We intend to use reasonable efforts to design any such awards in a manner that avoids Section 409A of the Code or that complies with Section 409A of the Code.

Potential Limitation on Company Deductions. We will generally be entitled to a tax deduction in connection with awards in an amount equal to the ordinary income recognized by a recipient at the time the recipient realizes such income, subject to Section 162(m) limitations of the Code, as discussed elsewhere in this proxy statement.

Recognition of Compensation Expense. In accordance with Statement of Financial Accounting Standards No.123R, “Share-Based Payment,” we are required to recognize compensation expense in our income statement for the grant-date fair value of stock options and other equity-based compensation issued to our employees and directors, the amount of which can only be determined at the time of grant.

New Plan Benefits

On June 20, 2018, we entered into an employment agreement with Michael R. Stewart, our new Chief Executive Officer, pursuant to which we agreed to grant to Mr. Stewart 400,000 shares of our common stock upon approval of the Plan by our stockholders. The following table sets forth the benefits or amounts that will be received by Mr. Stewart under the Plan.

FC Global Realty Incorporated 2018 Equity Incentive Plan
Name and PositionDollar Value ($)(1)Number of Shares
Michael R. Stewart, Chief Executive OfficerN/A400,000

(1)The value of the stock will be equal to the fair market value of the shares on the date of grant.


Additional future awards, if any, that will be made to eligible persons under the Plan are subject to the discretion of the Committee and, therefore, we cannot currently determine the benefits or number of shares subject to awards that may be granted in the future to our employees, consultants and non-employee directors under the Plan.

No Dissenters’ Rights

Under Nevada law, holders of our common stock are not entitled to dissenter’s rights of appraisal with respect to the approval of the Plan.

Vote Required

 The approval of the Plan Proposal requires the affirmative vote of a majority of the shares present in person or represented by proxy at the Meeting. An abstention will have no effect on the Plan Proposal. Since the Plan Proposal is considered to be a “non-routine” matter, shares that constitute broker non-votes are not considered votes cast on the Plan Proposal.

Our Board of Directors unanimously recommends a vote “FOR” approval of the Plan Proposal.


 PROPOSAL NO. 4 – DIRECTOR PROPOSAL

 

Director Nominees

 

Our Nominations and Corporate Governance Committee has recommended the election of the seven (7)five (5) director nominees listed below.

 

Suneet Singal

Richard J. Leider

Dr. Bob Froehlich

Dolev Rafaeli

Dennis M. McGrath

Kristen E. Pigman

Dr. Dolev Rafaeli

Michael R. Stewart

Darrel C. Menthe

 

For biographical information regarding these nominees, see “Directors and Executive Officers” above. If elected at the Meeting, these nominees will hold office until the next annual meeting or until their successors are qualified, subject to their prior death, resignation or removal.

 

The slate of nominees to the Board is favored by the Board. The present Board believes that the slate reflects a broad range of experience with regard to financial, investment and regulatory matters and to the various product lines and interests of the Company. Finally, the present Board believes that the slate of directors contains individuals who will be able to assist in the further development of the Company and its product offerings.Company.

 

Vote Required

 

The affirmative vote of a plurality of votes of the shares of our common stock present in person or represented by proxy at the Meeting and entitled to vote is required to elect the directors nominated above. That means the seven (7)five (5) nominees will be elected if they receive more affirmative votes than any other nominees. In the absence of instructions to the contrary, shares of common stock represented by properly executed proxies will be voted for the seven (7)five (5) nominees listed herein below, all of whom are recommended by our Board and who have consented to be named and to serve if elected.

 

In the event that any nominee recommended by the Nominations and Corporate Governance Committee is unable or declines to serve as a director at the time of the Meeting, the proxies will be voted for any nominee who is designated by the present Board to fill the vacancy. It is not expected that any nominee will be unable or will decline to serve as a director. Our Board knows of no reason why any of the nominees will be unavailable or decline to serve as a director.

 

TheOur Board of Directors unanimously recommends a vote FOR“FOR” each director nominee.

41


PROPOSAL NO. 5 – AUDITOR PROPOSAL

 

General

 

We first engaged Fahn Kanne & Co. Grant Thornton Israel (“Grant Thornton Israel”) to serve as our independent registered public accounting firm for the year ended December 31, 2011. The Audit Committee of our Board has selected Grant Thornton Israel to serve as our independent registered public accounting firm for the year to be ended December 31, 20172018 and has set its compensation for that year. As such, Grant Thornton Israel will, among other things, audit our financial statements and opine on our system of internal controls for the fiscal year ending December 31, 2017.2018. Representatives of Grant Thornton Israel are expected to be present at the Meeting and will have an opportunity to make a statement if they desire to do so, and are expected to be available to respond to appropriate questions.

 

Stockholder ratification of the selection of Grant Thornton Israel as our independent registered public accounting firm, and ratification of the authority of the Audit Committee to set the auditors’ compensation, is not required by our Bylaws or otherwise. However, our Board is submitting the selection of Grant Thornton Israel to the stockholders for ratification as a matter of corporate practice. If the stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee in its discretion may direct the appointment of a different independent accounting firm at any time during the year if the Audit Committee determines that such a change would be in the best interests of us and our stockholders.

 

We present the following information concerning our relationship with Grant Thornton Israel as background to this proposal.

 

Principal Accountant Fees and Services

 

The following table shows the fees paid or accrued by us for the audit and other services provided by Grant Thornton Israel for 20162017 and 2015:2016:

 

  2016  2015 
Audit Fees (1) $200,000  $394,000 
Audit-Related Fees (2)  -   18,000 
Tax Fees (3)  433,000   321,000 
All Other Fees  -   - 
Total $633,000  $733,000 

(in thousands)

  2017  2016 
Audit Fees (1) $200  $200 
Audit-Related Fees (2)      
Tax Fees (3)  105   433 
All Other Fees      
Total $305  $633 

 

(1)Consists of fees billed for the audit of our annual financial statements, review of financial statements included in our Quarterly Reports on Form 10-Q and services that are normally provided by the auditors in connection with statutory and regulatory filings or engagements.

 

(2)Consists of assurance and related services that are reasonably related to the performance of the audit and reviews of our financial statements and are not included in “audit fees” in this table, principally related to the limited scope audit of the 401(K) plan and due diligence services.

 

(3)Consists of all tax related services.

Engagement of the Independent Auditor. The Audit Committee is responsible for approving every engagement of Grant Thornton Israel to perform audit or non-audit services for us before Grant Thornton Israel is engaged to provide those services. Under applicable SEC rules, the Audit Committee is required to pre-approve the audit and non-audit services performed by the independent auditors in order to ensure that they do not impair the auditors’ independence. The SEC’s rules specify the types of non-audit services that an independent auditor may not provide to its audit client and establish the Audit Committee’s responsibility for administration of the engagement of the independent auditors.

 

Consistent with the SEC’s rules, our Audit Committee Charter requires that the Audit Committee review and pre-approve all audit services and permitted non-audit services provided by the independent auditors to us or any of our subsidiaries. The Audit Committee may delegate pre-approval authority to a member of the Audit Committee and if it does, the decisions of that member must be presented to the full Audit Committee at its next scheduled meeting.

 

42

The Audit Committee’s pre-approval policy provides as follows:

 

·First, once a year when the base audit engagement is reviewed and approved, management will identify all other services (including fee ranges) for which management knows it will engage Grant Thornton Israel for the next 12 months. Those services typically include quarterly reviews, specified tax matters, certifications to the lenders as required by financing documents, consultation on new accounting and disclosure standards and, in future years, reporting on management’s internal controls assessment.

 

·Second, if any new “unlisted” proposed engagement arises during the year, the engagement will require approval of the Audit Committee.

 

All fees to our independent accounting firms were approved by the Audit Committee.

 

Auditor Selection for Fiscal 20172018. The Audit Committee selected Grant Thornton Israel to serve as our independent auditors for the year ending December 31, 2017.2018. The Audit Committee’s selection is now being submitted to our stockholders for ratification at the Meeting.

 

Vote Required

 

The affirmative vote of a majority of the outstanding shares of our common stock present in person or represented by proxy at the Meeting and entitled to vote is required to ratify the selection of Grant Thornton Israel.

 

Our Board of Directors unanimously recommends a vote “FOR” approval of the Auditor Proposal.

 

43

46 

 

PROPOSAL NO. 6 – ADJOURNMENT PROPOSAL

 

 The Board has determined that the adjournment of the Meeting for any purpose, including to solicit additional proxies if there are insufficient votes at the time of the Meeting to approve the proposals described herein, is advisable and in the best interests of the Company and its stockholders and has approved the adjournment of the Meeting for any purpose, including to solicit additional proxies if there are insufficient votes at the time of the Meeting to approve the proposals described herein.

 

 The Meeting may be adjourned by the affirmative vote of a majority of the shares present in person or represented by proxy at the Meeting.

 

Our Board of Directors unanimously recommends a vote “FOR” approval of the Adjournment Proposal.

44


STOCKHOLDER PROPOSALS AND NOMINATIONS

 

Proposals of our stockholders that are intended to be presented by such stockholders at our next annual meeting of stockholders must be received by us no later than 120 days before September 14, 2018November 29, 2019 in order to be considered for inclusion in the proxy statement relating to that meeting. In the event, however, that we change the meeting date for the next annual stockholders meeting by more than 30 days from September 14, 2018November 29, 2019 we will notify stockholders and allow a reasonable time for stockholder proposals to be included in the notice of annual meeting. A stockholder proposal will need to comply with the SEC regulations under Rule 14a-8 of the Exchange Act, regarding the inclusion of stockholder proposals in company-sponsored proxy materials. Although our Board will consider stockholder proposals, we reserve the right to omit from our proxy statement, or to vote against, stockholder proposals that we are not required to include under the Exchange Act, including Rule 14a-8.

 

 Proposals of our stockholders submitted outside the processes of Rule 14a-8 must have been received by us no later than July 14, 2018.September 29, 2019. If a stockholder gives notice of such a proposal after this deadline, our proxy agents will be allowed to use their discretionary voting authority to vote against the stockholder proposal when and if the proposal is raised at our 20182019 annual meeting.

 

 You may write to Michele Pupach, Corporate Counsel, at our principal executive office, 2300 Computer Drive, Building G, Willow Grove, Pennsylvania 19090, to deliver the materials and notices discussed above regarding the requirements for making stockholder proposals.

 

 TRANSACTION OF OTHER BUSINESS

 

 At the date of this proxy statement, the only business which the Board intends to present at the Meeting is as set forth above. If any other matter or matters are properly brought before the Meeting, or an adjournment or postponement thereof, it is the intention of the persons named in the accompanying form of proxy to vote the proxy on such matters in accordance with their best judgment.

 

HOUSEHOLDING OF PROXY STATEMENT

 

The rules promulgated by the SEC permit companies, brokers, banks or other intermediaries to deliver a single copy of our proxy materials to households at which two or more stockholders reside (“Householding”). Stockholders sharing an address who have been previously notified by their broker, bank or other intermediary and have consented to Householding, either affirmatively or implicitly by not objecting to Householding, received only one copy of our proxy materials. A stockholder who wishes to participate in Householding in the future must contact his or her broker, bank or other intermediary directly to make such request. Alternatively, a stockholder who wishes to revoke his or her consent to Householding and receive separate proxy materials for each stockholder sharing the same address must contact his or her broker, bank or other intermediary to revoke such consent. Stockholders may also obtain a separate proxy statement or may receive a printed or an e-mail copy of this proxy statement without charge by sending a written request to PhotoMedex,FC Global Realty Incorporated, Inc., Attn: Corporate Secretary, 2300 Computer Drive, Building G, Willow Grove, Pennsylvania 19090, or by calling us at 215-619-3600.215-830-1430. We will promptly deliver a copy of this proxy statement upon request. Householding does not apply to stockholders with shares registered directly in their name.

 

WHERE YOU CAN FIND MORE INFORMATION

 

We file annual, quarterly and current reports, proxy statements and other information with the SEC under the Exchange Act. You may read and copy this information at, or obtain copies of this information by mail from, the SEC'sSEC’s Public Reference Room, 450 Fifth Street, N.W., Washington, D.C. 20549, at prescribed rates. Please call the SEC at (800) SEC-0330 for further information about the public reference room. Our filings with the SEC are also available to the public from commercial document retrieval services and at the web site maintained by the SEC athttp://www.sec.gov.

 The SEC allows us to “incorporate by reference” into this proxy statement documents that we file with the SEC. This means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be a part of this proxy statement, and later information that we file with the SEC will update and supersede that information. We incorporate by reference the documents listed below and any documents filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this proxy statement and before the date of the Meeting:

45

·Annual Report on Form 10-K for the fiscal year ended December 31, 2016;

·Quarterly Report on Form 10-Q for the quarter ended March 31, 2017; and

·Current Reports on Form 8-K filed on April 3, 2017; May 19, 2017; May 26, 2017; June 28, 2017; July 6, 2017; July 10, 2017; July 18, 2017; July 26, 2017; July 31, 2017; and August 3, 2017.

Notwithstanding the foregoing, information furnished under Items 2.02, 7.01 and 8.01 of any Current Report on Form 8-K, including the related exhibits, is not incorporated by reference in this proxy statement. In addition, statements contained in this proxy statement, or in any document incorporated in this proxy statement by reference, regarding the contents of any contract or other document, are only summaries of the material terms and as such we encourage you to carefully read in its entirety that contract or other document filed as an exhibit with the SEC.

 

 Any person, including any beneficial owner, to whom this proxy statement is delivered may request copies of proxy statements and any of the documents incorporated by reference in this document or other information concerning us, without charge, by written request directed to PhotoMedex, Inc.,FC Global Realty Incorporated, Attn: Corporate Secretary, 2300 Computer Drive, Building G, Willow Grove, Pennsylvania 19090, or by calling us at 215-619-3600. Documents incorporated by reference are available without charge, excluding any exhibits to those documents unless the exhibit is specifically incorporated by reference into those documents.215-830-1430.

 


 THIS PROXY STATEMENT DOES NOT CONSTITUTE THE SOLICITATION OF A PROXY IN ANY JURISDICTION TO OR FROM ANY PERSON TO WHOM OR FROM WHOM IT IS UNLAWFUL TO MAKE SUCH PROXY SOLICITATION IN THAT JURISDICTION. YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED OR INCORPORATED BY REFERENCE IN THIS PROXY STATEMENT TO VOTE YOUR SHARES AT THE MEETING. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT FROM WHAT IS CONTAINED IN THIS PROXY STATEMENT. THIS PROXY STATEMENT IS DATED AUGUST 8, 2017.OCTOBER 25, 2018. YOU SHOULD NOT ASSUME THAT THE INFORMATION CONTAINED IN THIS PROXY STATEMENT IS ACCURATE AS OF ANY DATE OTHER THAN THAT DATE, AND THE MAILING OF THIS PROXY STATEMENT TO STOCKHOLDERS DOES NOT CREATE ANY IMPLICATION TO THE CONTRARY.

46


ANNEX A

 

FINANCIAL STATEMENTS

Page No.
Condensed Consolidated Financial Statements for the Three and Six Months Ended June 30, 2018 and 2017A-2
Condensed Consolidated Balance Sheets as of June 30, 2018 (unaudited) and December 31, 2017A-3
Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended June 30, 2018 and 2017 (unaudited)A-4
Condensed Consolidated Statements of Comprehensive Loss for the Six Months Ended June 30, 2018 and 2017 (unaudited)A-5
Condensed Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Stockholders’ Deficit for the Six Months Ended June 30, 2018 (unaudited)A-6
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2018 and 2017 (unaudited)A-7
Notes to Condensed Consolidated Financial Statements (unaudited)A-8
Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016A-29
Report of Independent Registered Public Accounting FirmA-30
Consolidated Balance Sheets, December 31, 2017 (Restated) and 2016A-31
Consolidated Statements of Comprehensive Loss, Years ended December 31, 2017 (Restated) and 2016A-32
Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders’ Deficit, Years ended December 31, 2017 (Restated) and 2016A-33
Consolidated Statements of Cash Flows, Years ended December 31, 2017 (Restated) and 2016A-34
Notes to Restated Consolidated Financial StatementsA-35

A-1 

FC GLOBAL REALTY INCORPORATED

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 AND 2017


FC GLOBAL REALTY INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 (In thousands, except share and per share amounts)

  June 30 2018  December 31, 2017 
  (unaudited)    
ASSETS      
Current assets:        
Cash and cash equivalents $892  $948 
Prepaid expenses and other current assets  507   646 
Total current assets  1,399   1,594 
Non-current assets:        
Investment properties  2,380   2,055 
Investment in other company, net  1,806   1,806 
Property and equipment, net  4   5 
Other assets, net  302   334 
Total non-current assets  4,492   4,200 
Total assets $5,891  $5,794 
         
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT        
Current liabilities:        
Notes payable $516  $778 
Accounts payable  705   612 
Accrued compensation and related expenses  389   467 
Other accrued liabilities  2,745   2,450 
Total current liabilities  4,355   4,307 
Non-current liabilities:        
Option to purchase Redeemable Convertible Preferred Stock (Note 5)  1,418   4,390 
Note payable, net of current portion  452   454 
Total non-current liabilities  1,870   4,844 
Total liabilities  6,225   9,151 
Commitments and contingencies (Note 4)        
  Redeemable Convertible Preferred Stock Series B, $.01 par value; 15,000,000 shares authorized at June 30, 2018 (unaudited) and December 31, 2017; 1,855,337 and 1,500,000 issued and outstanding at June 30, 2018 (unaudited) and December 31, 2017, respectively, net of amount allocated to option to purchase additional shares; Aggregate liquidation preference $1,948 and $1,503 at June 30, 2018 (unaudited) and December 31, 2017, respectively (Note 5)  2,545   87 
Stockholders’ deficit (Note 5):        
  Common Stock, $.01 par value, 500,000,000 shares authorized at June 30, 2018 (unaudited) and December 31, 2017; 14,833,920 shares issued and outstanding at June 30, 2018 (unaudited) and 11,868,619 shares issued and outstanding at December 31, 2017  149   119 
  Preferred A Stock $.01 par value, 3,000,000 shares authorized at June 30, 2018 (unaudited) and December 31, 2017; 123,668 issued and outstanding at June 30, 2018 (unaudited) and December 31, 2017;  1   1 
Additional paid-in capital  134,974   132,446 
Accumulated deficit  (137,030)  (135,022)
Accumulated other comprehensive loss  (1,145)  (1,162)
       Total stockholders’ deficit attributable to FC Global Realty Incorporated  (3,051)  (3,618)
Noncontrolling interest  172   174 
Total stockholders’ deficit  (2,879)  (3,444)
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit $5,891  $5,794 

The accompanying notes are an integral part of these consolidated financial statements. 


FC GLOBAL REALTY INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

  (In thousands, except share and per share amounts)

(unaudited)

  For the Three Months Ended June 30, 
  2018  2017 
       
Rental income $11  $ 
Rental expense  1    
Gross income  10    
         
General and administrative  934   1,848 
Operating loss  (924)  (1,848)
Revaluation of option to purchase redeemable convertible preferred stock (Note 5)  2,568    
Revaluation of asset contribution related financial instruments     2,622 
Interest and other financing expense, net  (38)  (46)
Income from continuing operations, before taxes on income  1,606   728 
Taxes on income (income tax provision)  3    
Income from continuing operations  1,609   728 
         
Discontinued operations:        
Gain from discontinued operations (Note 2)  140   411 
         
Net income including portion attributable to non-controlling interest  1,749   1,139 
Loss attributable to non-controlling interest  1    
Net income  1,750   1,139 
Dividend on redeemable convertible preferred stock  (62)   
Net income attributable to common stockholders and participating securities $1,688  $1,139 
         
Basic net income per share (Note 3):        
Continuing operations $0.08  $0.12 
Discontinued operations  0.01   0.07 
  $0.09  $0.19 
         
Diluted net income (loss) per share (Note 3):        
Continuing operations $0.08  $(0.04)
Discontinued operations  0.01   0.07 
  $0.09  $0.03 
         
Shares used in computing basic net loss per share  12,846,190   4,786,218 
Shares used in computing diluted net loss per share  19,716,419   36,185,555 
         
Other comprehensive income:        
Foreign currency translation adjustments  (4)  176 
Comprehensive income $1,746  $1,315 

The accompanying notes are an integral part of these consolidated financial statements.


FC GLOBAL REALTY INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

  (In thousands, except share and per share amounts)

(unaudited)

  For the Six Months Ended June 30, 
  2018  2017 
Rental income $11  $ 
Rental expense  1    
Gross income  10    
         
General and administrative  2,144   1,848 
Operating loss  (2,134)  (1,848)
Revaluation of option to purchase redeemable convertible preferred stock (Note 5)  2,295    
Revaluation of asset contribution related financial instruments     2,622 
Interest and other financing expense, net  (72)  (46)
Income from continuing operations, before taxes on income  89   728 
Taxes on income (Note 6)  (209)   
Income (loss) from continuing operations  (120)  728 
Discontinued operations:        
Income (loss) from discontinued operations (Note 2)  219   (1,438)
Net income (loss) including portion attributable to non-controlling interest  99   (710)
Loss attributable to non-controlling interest  2    
Net income (loss)  101   (710)
Dividend on redeemable convertible preferred stock  (141)   
Accretion of redeemable convertible preferred stock to redemption value  (1,968)   
Net loss attributable to common stockholders and participating securities $(2,008) $(710)
         
Basic net income (loss) per share (Note 3):        
         
Continuing operations $(0.15) $0.14 
Discontinued operations  0.01   (0.07)
  $(0.14) $(0.07)
         
Diluted net income (loss) per share (Note 3):        
Continuing operations $(0.15) $(0.29)
Discontinued operations  0.01   (0.06)
  $(0.14) $(0.35)
         
Shares used in computing basic net loss per share  12,360,105   4,574,830 
Shares used in computing diluted net loss per share  12,360,105   20,361,237 
         
Other comprehensive income (loss):        
Reclassification of cumulative translation adjustment to statement of operations $  $3,021 
Foreign currency translation adjustments  17   278 
Total other comprehensive income  17   3,299 
Comprehensive income (loss) $118  $2,589 

The accompanying notes are an integral part of these consolidated financial statements. 


FC GLOBAL REATLY INCORPORATED AND SUBSIDIARIES

  CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE

PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT

FOR THE SIX MONTHS ENDED JUNE 30, 2018

  (In thousands, except share and per share amounts)

(unaudited)

    Stockholders’ deficit 
  

 Redeemable

Convertible Preferred

Stock

Series B

 Common Stock 

Series A Preferred

Stock

 

Additional Paid-In

Capital

 

Accumulated

Deficit

 

 Accumulated Other Comprehensive

Loss

 

Noncontrolling

Interest

    
  Shares Amount Shares Amount Shares Amount          Total 
BALANCE, JANUARY 1, 2018  1,500,000 $87  11,868,619 $119  123,668 $1 $132,446 $(135,022)$(1,162)$174 $(3,444)
Stock based compensation            —    5        5 
Issuance of Series B redeemable convertible preferred stock and embedded option  2,225,000  2,225                   
Partial exercise of series B redeemable convertible preferred stock written call option (Note 5)    677                   
Dividend on Series B redeemable convertible preferred stock (Note 5)    141            (141)     (141)
Accretion of Series B redeemable convertible preferred stock to redemption value (Note 5)    1,968            (1,968)     (1,968)
Conversion of series B redeemable convertible preferred stock into common stock  (1,869,663) (2,553) 2,965,301  30      2,523        2,553 
Foreign currency translation adjustment                  17    17 
Net Income (Loss)                101    (2)  99 
BALANCE, JUNE 30  1,855,337 $2,545  14,833,920 $149  123,668 $1 $134,974 $(137,030)$(1,145)$172 $(2,879)

The accompanying notes are an integral part of these consolidated financial statements.


FC GLOBAL REALTY INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 (In thousands)

(Unaudited)

  For the Six Months Ended June 30, 
  2018  2017 
Cash Flows From Operating Activities:        
Net Income $(120) $728 
Adjustments to reconcile loss to net cash used in operating activities related to continuing operations:        
Stock-based compensation  5   124 
Revaluation of asset contribution related financial instruments, net     (2,622)
Revaluation of option to purchase redeemable convertible preferred stock (Note 5)  (2,295)   
Depreciation and amortization  2   296 
Changes in operating assets and liabilities:        
Prepaid expenses and other current assets  171   1,388 
Accounts payable  93   (1,396)
Accrued compensation and related expenses  (78)  (1,452)
Other accrued liabilities  324   (4,113)
Adjustments related to continuing operations  (1,898)  (7,047)
Adjustments related to discontinued operations  219   1,688 
Net cash used in operating activities  (1,679)  (5,359)
Cash Flows From Investing Activities:        
Direct expenses related to asset acquisition     (283)
Purchases of  investment properties  (326)   
Net cash used in investing activities - continuing operation  (326)  (283)
Net cash provided by investing activities - discontinued operations     5,107 
Net cash (used in) provided by investing activities  (326)  4,824 
Cash Flows From Financing Activities:        
Proceeds from issuance of redeemable convertible preferred stock and embedded option (Note 5)  2,225    
Payment of notes payable  (293)   
Net cash provided by financing activities -continuing operation  1,932    
Net cash provided by financing activities  1,932    
Effect of exchange rate changes on cash and cash equivalents  17   279 
Change in cash and cash equivalents  (56)  (256)
Cash and cash equivalents at the beginning of period  948   2,335 
Cash and cash equivalents at the end of period $892  $2,079 
Supplemental disclosure of non-cash activities:        
Cash paid for income taxes $  $73 
Cash paid for interest $72  $ 
Receivable from acquirer of group of assets $  $2,000 
Partial exercise of written call option on redeemable convertible preferred stock (Note 5) $677  $ 
Dividend on redeemable convertible preferred stock (Note 5) $141  $ 
Accretion of redeemable convertible preferred stock to redemption value (Note 5) $1,968  $ 
Conversion of Series B redeemable convertible preferred stock into common stock $2,553  $ 
Contribution of investment property and investment in other company against stock issue, financial assets related to future mandatory asset contribution and financial liabilities for optional asset acquisition $  $4,836 

The accompanying notes are an integral part of these consolidated financial statements.


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 1

Background:

FC Global Realty Incorporated (and its subsidiaries) (the “Company”), re-incorporated in Nevada on December 30, 2010, originally formed in Delaware in 1980, is, since earlier in 2017, a real estate development and asset management company concentrated primarily on investments in high quality income producing assets, hotel and resort developments, residential developments and other opportunistic commercial properties.

Until the recent sale of the Company’s last significant business unit (its consumer products division which was sold to ICTV Brands, Inc. on January 23, 2017), the Company was a Global Skin Health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. The Company provided proprietary products and services that addressed skin diseases and conditions including psoriasis, acne, actinic keratosis (a precursor to certain types of skin cancer), photo damage and unwanted hair.

On March 31, 2017, the Company entered into an Interest Contribution Agreement with First Capital Real Estate Operating Partnership, L.P. (the “Contributor”), First Capital Real Estate Trust Incorporated (the “Contributor Parent”), and FC Global Realty Operating Partnership, LLC, the Company’s wholly-owned subsidiary (the “Acquiror”). The parties entered into amendments to the Interest Contribution Agreement on August 3, 2017, October 11, 2017 and December 22, 2017. Pursuant to the Interest Contribution Agreement, as amended (collectively, the “Contribution Agreement”), the Contributor contributed certain real estate assets to the Acquiror. In exchange, the Contributor received shares of the Company’s common stock and newly designated Series A Convertible Preferred Stock. This transaction closed on May 17, 2017. As a result of the Contribution Agreement, the Company has primarily become a real estate asset management and development company for the purpose of investing in a diversified portfolio of quality commercial and residential real estate properties and other real estate investments located in the United States.

Stock Delisting from Nasdaq and Transfer to OTC

On February 23, 2018 and March 13, 2018, the Company had received two delisting notices from Nasdaq this year, the first concerning the Company’s failure to comply with the $1.00 minimum bid price under Nasdaq Marketplace Rule 5550(a)(2), and the second with regard to the Company’s stockholder equity, which had fallen below the minimum $2.5 million required to be maintained under Nasdaq Marketplace Rule 5550(b)(1).

On June 18, 2018, the Company received a delisting determination letter from The Nasdaq Stock Market’s Listing Qualifications Department (“Nasdaq”) relating to the Company’s Common Stock. In that letter, Nasdaq stated that the Company is not in compliance with Nasdaq’s Listing Rules 5635(b), 5635(c), 5635(d)(1) and 5635(d)(2) with regard to shareholder approval of certain transactions involving the sale of shares of Series B Preferred Stock to Opportunity Fund I-SS, LLC (“OFI”), the conversion of certain promissory notes held by affiliates of the Company and related transactions entered into with such affiliates, the acquisition of common stock and Series A Preferred Stock by OFI from First Capital Real Estate Operating Partnership, L.P. and the timing of these transactions and contingencies between them.

As a result of the violations of the shareholder equity and shareholder approval rules, Nasdaq has determined to delist the Company’s securities. While the Company has a right of appeal with regard to this most recent notice, the Company’s Board of Directors, after evaluating the matter, has determined that it is in the Company’s best interests to remove its securities from trading on Nasdaq while it addresses these issues, and has therefore waived its right of appeal.

The Company’s common stock ceased to trade on the Nasdaq Capital Market prior to the opening of business on June 20, 2018, and moved on that date to trading and quotation on the Pink Current Information tier operated by the OTC Markets Group Inc. The Company’s trading symbol remains FCRE. Trading and quotation information is available at www.otcmarkets.com. The Company intends to apply for its common stock to be quoted and traded on the OTCQB Market.

The Company plans to continue to maintain an independent Board of Directors with an independent Audit Committee and provide annual financial statements audited by a registered Public Company Accounting Oversight Board auditor and unaudited interim financial reports, prepared in accordance with US GAAP. In addition, the Company’s Board of Directors will continue to evaluate options to maximize the value of the Company’s assets, including opportunities to invest in or acquire one or more operating businesses that provide opportunities for appreciation in value.


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 1 (Cont.)

Liquidity and Going Concern

As of June 30, 2018, the Company had an accumulated deficit of $137 million and the Company incurred an operating loss for the six months ended June 30, 2018 of approximately $2 million. Subsequent to the sale of the Company’s last significant business unit, the consumer products division as described above, and to date, the Company has dedicated most of its financial resources to general and administrative expenses associated with its ongoing business of real estate development and asset management.

As of June 30, 2018, the Company’s cash and cash equivalents amounted to $892. While the Company is a party to a Securities Purchase Agreement (the “OFI Purchase Agreement”) with OFI, and has raised certain funds under that agreement in both 2017 and in 2018 through the date of the financial statements (see also Note 5), OFI has no obligation to continue to invest in the Company, and there are restrictions placed by OFI on the use of these funds. The Company has historically financed its activities with cash from operations, the private placement of equity and debt securities, borrowings under lines of credit and, in the most recent periods with sales of certain assets and business units. The Company will be required to obtain additional liquidity resources in order to support its ongoing operations.

At this time, there is no guarantee that the Company will be able to obtain an adequate level of financial resources required for the short and long-term support of its operations or that the Company will be able to obtain additional financing as needed, or meet the conditions of such financing, or that the costs of such financing may not be prohibitive. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on recoverability of assets and classification of liabilities that may result from the outcome of this uncertainty. 

Resignation of Officers and Director

Effective June 16, 2018, Vineet P. Bedi resigned his position as Chief Executive Officer and President of the Company, as well as President of the Company’s subsidiaries.

Also effective June 16, 2018, Matthew Stolzar resigned his position as Chief Financial Officer and Chief Investment Officer of the Company and of the Company’s subsidiaries.

Effective June 18, 2018, Robert Froehlich resigned as Chairman and a member of the Company’s Board of Directors as well as from his membership in the Board’s Audit, Compensation and Nominations and Corporate Governance Committees.

Appointment of Officers

On June 20, 2018, the Company’s Board of Directors appointed Michael R. Stewart to fill the positions of both Chief Executive Officer and Chief Financial Officer of the Company.

Appointment of Directors

Effective June 18, 2018, Kristen E. Pigman was appointed by the Board. Effective June 20, 2018, Michael E. Singer was appointed by the Board. Effective August 15, 2018, Michael Singer resigned from his position (see also Note 7).


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 2

Discontinued Operations:

On January 23, 2017, the Company sold its last significant business unit (its consumer products division) to ICTV Brands, Inc. This business was a substantial business unit of the Company and the sale brought a strategic shift in focus of management. The Company accordingly classified this former business as held for sale and discontinued operations in accordance with ASC 360 “Impairment or disposal of long-lived assets” during the fourth quarter of the year ended December 31, 2016.

The accompanying consolidated financial statements as of and for the three and six months ended June 30, 2017 have been retrospectively adjusted to reflect the operating results of the consumer business as discontinued operations separately from continuing operations. The Company recognized a net loss from discontinued operations of $1,438, including the loss on the sale of the discontinued operations in the six months ended June 30, 2017, which represents the difference between the adjusted net purchase price and the carrying value of the disposal group.

The Company recognized a gain of $219 related to the discontinued operations during the six months ended June 30, 2018, as a result of the sale of residual inventory to third parties.

The following is a summary of income (loss) from discontinued operations for the three and six months ended June 30, 2018 and 2017:

  For the Three Months Ended June 30,  For the Six Months Ended June 30, 
  2018  2017  2018  2017 
             
Revenues: $  $  $  $3,539 
Cost of revenues           100 
Gross profit           3,439 
Operating expenses:                
Engineering and product development           143 
Selling and marketing           620 
General and administrative           2,342 
Other income, net     (2,650)      (2,650)
Loss on disposal of assets     2,166      4,251 
Income (loss) from discontinued operations before interest and other financing expense, net     484      (1,267)
Interest and other financing expense, net           (77)
Income (loss) from discontinued operations before income taxes     484      (1,344)
Income tax expenses allocated to discontinued operations     (73)     (94)
Income (loss) from discontinued operations     411      (1,438)
Gain from disposal of discontinued operations, net of taxes  140      219    
Net gain (loss) from discontinued operations $140  $411  $219  $(1,438)


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 3

Summary of Significant Accounting Policies:

Accounting Principles

The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with our consolidated financial statements and related notes contained in Amendment No. 1 to our Annual Report on Form 10-K/A for the fiscal year ended December 31, 2017. The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) related to interim financial statements. As permitted under those rules, certain information and footnote disclosures normally required or included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The financial information contained herein is unaudited; however, management believes all adjustments have been made that are considered necessary to present fairly the results of the Company’s financial position and operating results for the interim periods. All such adjustments are of a normal recurring nature. The accompanying condensed consolidated balance sheet as of December 31, 2017 has been derived from the consolidated financial statements contained in Amendment No. 1 to our Annual Report on Form 10-K/A.

The results for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018 or for any other interim period in the future.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and the wholly and majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Entities in which the Company directly or indirectly owns more than 50% of the outstanding voting securities, and for which other interest holders do not possess the right to affect significant management decisions, are generally accounted for under the voting interest consolidation method of accounting. Participation of other interest holders in the net assets and in the earnings or losses of a consolidated subsidiary is reflected in the line items “Non-controlling Interest” in the Company’s consolidated balance sheets and “net income (loss) attributable to the non-controlling interest” in the Company consolidated statements of comprehensive loss. Non-controlling interest adjusts the Company’s consolidated results of operations to reflect only the Company’s share of the earnings or losses of the consolidated subsidiary.

Any changes in the Company’s ownership interest in a consolidated subsidiary, through additional equity issuances by the consolidated subsidiary or from the Company acquiring the shares from existing shareholders, in which the Company maintains control is recognized as an equity transaction, with appropriate adjustments to both the Company’s additional paid-in capital and the corresponding non-controlling interest.

Use of Estimates

The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect amounts reported of assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates and be based on events different from those assumptions. As part of these financial statements, the more significant estimates include (1) identification of and measurement of instruments in equity and mezzanine transactions; (2) impairment of investment properties and investment in other company; (3) evaluation of going concern; and (4) contingencies.

Revenue recognition

On April 26, 2018, the Company’s subsidiary, RETPROP I, LLC, completed the acquisition of a 7,738 square-foot medical office building in Dayton, Ohio for a $326 purchase price, paid in cash consideration. The building’s former owner, and current tenant, a medical practice, has entered into a lease with the Company to continue its occupancy through April 2022, with the option to renew that lease for two additional five-year terms. The Company is accounting for the arrangement as an operating lease under ASC 840, Leases.

The Company records rental revenues on a straight-line basis under which contractual rent increases are recognized evenly over the lease term. Certain properties have leases that provide for tenant occupancy during periods where no rent is due or where minimum rent payments change during the term of the lease. Accordingly, receivables from tenants that we expect to collect over the remaining lease term are recorded on the balance sheet as straight-line rent receivables.

Note 3 (Cont.)

A-11 

FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Summary of Significant Accounting Policies:

Income (Loss) per Share

The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per share”. Basic income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period, net of the weighted average number of treasury shares (if any). Securities that may participate in dividends with the common stock (such as the convertible Series A Preferred Stock and Series B Preferred Stock) are considered in the computation of basic income (loss) per share using the two-class method. However, in periods of net loss, participating securities are included only if the holders of such securities have a contractual obligation to share the losses of the Company. Accordingly, the outstanding Series A preferred shares were included in the computation, while the Series B preferred shares were not.

Diluted income (loss) per common share is computed similar to basic income per share, except that the denominator is decreased (increased) to include the number of additional potential common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Potential common shares are excluded from the computation for a period in which a net income (loss) is reported or if their effect is anti-dilutive. The Company’s potential common shares consist of stock options, stock warrants and restricted stock awards issued under the Company’s stock incentive plans and their potential dilutive effect is considered using the treasury method, and of convertible Series A Preferred Stock and Series B Preferred Stock which their potential dilutive effect is considered using the “if-converted method”.

The net income (loss) from continuing operations and the weighted average number of shares used in computing basic net income (loss) per share from continuing operations for the three and six months ended June 30, 2018 and 2017, is as follows: 

  Three Months Ended June 30,  Six Months Ended June 30, 
  2018  2017  2018  2017 
             
Numerator:                
Net income (loss) $ 1,750  $1,139  $101   (710)
Net loss (gain) from discontinued operations attributable to common stockholders  (140)  (411)  (219)  1,438 
Accretion of Series B Preferred Stock to redemption value (*)        (1,968)   
Preferred dividend on Series B Preferred Stock (**)  (62)     (141)   
Participation of stockholders of Series A Preferred Stock in the net loss from continuing operations        384    
Participation of stockholders of Series A and B Preferred Stock in the net income from continuing operations  (512)  (131)     (66)
Net basic income (loss) from continuing operations attributable to common stockholders $(1,036) $597  $(1,843) $662 
                 
Denominator:                
Shares of common stock used in computing basic net income (loss) per share  12,846,190   4,786,218   12,360,105   4,574,830 
                 
Net income (loss) per share of common stock from continuing operations, basic $0.08  $0.12  $(0.15) $0.14 

FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 3 (Cont.)

Summary of Significant Accounting Policies:

Loss per Share (Cont.)

(*)Based on the rights and privileges of Series B Preferred Stock, since the Company did not obtain shareholder approval at March 31, 2018, the then outstanding Series B Preferred Stock became redeemable at the option of OFI. Consequently, in each reporting period commencing March 31, 2018, the outstanding Series B Preferred Stock is recorded at its maximum redemption value until the occurrance of redemption or a conversion as prior.

(**)The net loss used for the computation of basic and diluted net loss per share for three and six months ended June 30, 2018, includes the preferred dividend requirement of 8% per share per annum for the Series B Preferred Stock, compounded annually which shall be distributed to stockholders in case of distributable assets determined in the Company’s certificate of designation under the liquidation preference right (see also Note 5).

The net income (loss) from continuing operations and the weighted average number of shares used in computing diluted net income (loss) per share from continuing operations for the three and six months ended June 30, 2018 and 2017, is as follows:

             
  Three Months Ended June 30,  Six Months Ended June 30, 
  2018  2017  2018  2017 
             
Numerator:            
Net basic income (loss) from continuing operations attributable to common stockholders $1,036  $597  $(1,843) $662 
Participation of stockholders of Series A and B Preferred Stock in net income from continuing operations  512             
Adjustment related to revaluation of asset contribution related financial instruments, net securities     (2,622)     (2,622)
Participation of stockholders of Series A Preferred Stock in the adjustment related to revaluation of asset contribution related financial instruments, net securities     470      470 
Net basic income (loss) from continuing operations attributable to common stockholders $1,548  $(1,555) $(1,843) $(1,490)
                 
Denominator:                
Shares of common stock used in computing basic net income (loss) per share  12,846,190   4,786,218   12,360,105   4,574,830 
Incremental shares related to assumed conversion of Series A and B Preferred Stock into Common Stock  6,870,229             
Incremental shares related to assumed exercise of asset contribution financial instruments     31,399,337      15,786,407 
Diluted number of common and common stock equivalent shares outstanding  19,716,419   36,185,555   12,360,105   20,361,237 
                 
Net income (loss) per share of common stock from continuing operations, diluted $0.08  $(0.04) $(0.15) $(0.07)


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

For the three months ended June 30, 2018, diluted income per share excludes stock options and common stock to be issued upon written call option, as the effect of their inclusion would be anti-dilutive. For the six months ended June 30, 2018, diluted loss per share excludes stock options, Series A and B Preferred Stock and common stock to be issued upon written call option, as the effect of their inclusion would be anti-dilutive. For the three and six months ended June 30, 2017, diluted loss per share excludes stock options and Series A Preferred Stock, as the effect of their inclusion would be anti-dilutive due to the net loss attributable to common stockholders for the period.


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)


Note 4

Commitments and Contingencies:

Litigation

JFURTI

The Company is a party to JFURTI, LLC, et al v. Suneet Singal, et al, filed in the United States District Court for the Southern District of New York. The suit names as defendants Suneet Singal, an officer of various First Capital companies as well as the Company’s former Chief Executive Officer and former member of the Company’s Board of Directors, Frank Grant and Richard Leider, board members of First Capital Real Estate Investments, LLC, First Capital Real Estate Advisors, LP, Presidential Realty Corporation, Presidential Realty Operating Partnership, Downey Brand LLP and now the Company (under its previous name, PhotoMedex Inc.), as well as nominal derivative defendants First Capital Real Estate Trust Incorporated and First Capital Real Estate Operating Partnership, L.P. Mr. Leider is also on the Board of Directors of the Company.

A Motion to Dismiss this action was filed with the court on behalf of all defendants. On April 12, 2018, plaintiffs filed an Amended Complaint in this matter. Plaintiffs also filed a response to the defendants’ Motion. Defendants filed a Memorandum in support of their Motion to Dismiss as well as a response to the plaintiffs’ response to the Motion, addressing both the original and the Amended Complaint in those filings. The Motion is now pending before the Court and there is no time frame known in which the Court may rule on the Motion.

The Company intends to defend itself vigorously against this suit. At this time, the amount of any loss, or range of loss, cannot be reasonably estimated as the case has only been initiated and no discovery has been conducted to determine the validity of any claim or claims made by plaintiffs. Therefore, the Company has not recorded any reserve or contingent liability related to these particular legal matters. However, in the future, as the cases progress, the Company may be required to record a contingent liability or reserve for these matters. More information is available from the Company’s prior filings in its Annual Reports on Form 10-K/A for the year ended December 31, 2018; and in its Quarterly Report for the quarter ended March 31, 2018 on Form 10-Q.

Avalon

On January 12, 2018, the Company received a copy of a complaint, dated November 17, 2017, that was filed by Alpha Alpha, LLC in the Thirteenth Judicial District Court in the County of Valencia in the State of New Mexico against Avalon Jubilee, LLC, the holding company that owns the property in Los Lunas, New Mexico, HiTex, LLC, MCBB, LLC, Land Strategies, LLC, Ronald R. Cobb and John Does 1-5. The suit asked the court to, among other things, determine whether there have been unauthorized transfers of interest in Avalon Jubilee LLC; and declare who are the holders of interests in Avalon Jubilee LLC. Although the complaint did not name the Company or any of its subsidiaries or specifically question the Company’s interest in Avalon Jubilee LLC, it raised questions about whether the transfers of interest leading to the Company’s acquisition of its interest in Avalon Jubilee LLC were properly made in accordance with the Avalon Jubilee operating agreement.

On April 27, 2018, the Company, and certain of its subsidiaries, entered into an agreement with Alpha Alpha LLC and Presidential Realty Corporation and certain of its subsidiaries, under which the Company’s subsidiary, First Capital Avalon Jubilee LLC, was recognized as a 17.9133% member in Avalon Jubilee, LLC, and the operating agreement and other documents were so amended to reflect that acknowledgement. In 2017, the Company recognized an impairment expense of $1,439 to account for our estimate of the impact that the described litigation may have on the operations and fair value of the underlying asset.  The settlement and recognition of the Company’s ownership interest was viewed as a favorable outcome.

Employee Misappropriation of Funds

In January 2018, as a result of new control procedures instituted by the management team, the Company discovered that a former employee had charged personal expenses to a company credit card, making unauthorized payments to herself in the form of bonuses and car allowances and theft of Company inventory over several years as mentioned below. Upon discovery, the Company took immediate steps to remove such employee’s access to Company assets, placed her on paid leave, and launched an internal investigation. Based on the results of the preliminary internal investigation, the employee was terminated on January 26, 2018.


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 4 (Cont.)

Commitments and Contingencies:

The Company engaged an accounting firm to conduct a forensic accounting investigation, which concluded that the employee misappropriated corporate funds for her personal benefit by charging personal items to a company credit card, making unauthorized payments to herself in the form of bonuses and car allowances and theft of Company inventory between May 2011 through January 2018, resulting in an aggregate misappropriation of Company funds in the amount of approximately $484.

After considering the qualitative and quantitative aspects in accordance with Staff Accounting Bulletin No. 99, the Company has concluded that this misappropriation of Company funds did not lead to a material misstatement on any of the previous financial statements covering the aforementioned period of time that would require restatement of those financial statements. Such determination was based, among others, on the following: (i) the magnitude of the theft, as a percentage, was low relative to revenue, pretax income and asset balance, (ii) the theft would not create any changes to the financial reporting line items, and (iii) most of the journal entries created by the employee, if revised today, would cause zero change to net income or assets and liabilities as those entries related to the Company’s former business operations which were sold to a third parties.

The Company is currently evaluating its options on how best to proceed with recovering these assets.

Other litigation

The Company and certain subsidiaries are, and have been, involved in other miscellaneous litigation and legal actions, including product liability, consumer, commercial, tax and governmental matters, which can arise from time to time in the ordinary course of our business. The Company believes that these other litigations and claims will likely be resolved without a material effect on our consolidated financial position, results of operations or liquidity. However, litigation and legal actions are inherently unpredictable, and excessive verdicts can result in such situations. Although the Company believes it has or will have substantial defenses in these matters, it may, in the future, incur judgments or enter into settlements of claims that could have a material adverse effect on results of operations in a particular period.

Registration Rights Agreement with OFI

As a condition to the first closing under the OFI Purchase Agreement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with OFI, pursuant to which the Company agreed to register all shares of common stock that may be issued upon conversion of the Series B Preferred Stock (the “Registrable Securities”) under the Securities Act of 1933, as amended (the “Securities Act”). The Company agreed to file a registration statement covering the resale of such Registrable Securities within 30 days of the first closing and cause such registration statement to be declared effective under the Securities Act as soon as possible but, in any event, no later than 120 days following the filing date if such registration statement is filed on Form S-3 or 150 days if such registration statement is filed on Form S-1. If such registration statement is not filed or declared effective by the SEC on or prior to such dates, or if after such registration statement is declared effective, without regard for the reason thereunder or efforts therefor, such registration statement ceases for any reason to be effective for more than an aggregate of 30 trading days during any 12-month period, which need not be consecutive, then in addition to any other rights the holders of Series B Preferred Stock may have under the Registration Rights Agreement or under applicable law, the Company shall pay to each holder an amount in cash, as partial liquidated damages and not as a penalty, equal to 1% of the product obtained by multiplying (x) $1.00 by (y) the number of shares of Registrable Securities held by the holder (such product being the “OFI Investment Amount”); provided that, in no event will the Company be liable for liquidated damages in excess of 1% of the OFI Investment Amount in any single month and that the maximum aggregate liquidated damages payable to the holders under the Registration Rights Agreement shall be 10% of the OFI Investment Amount.

On January 23, 2018, the Company had filed a registration statement on Form S-3 to register the shares issued to OFI in the first closing. OFI waived its right to liquidated damages in connection with the late filing of such registration statement until May 31, 2018.  However, as that registration statement did not become effective by the required deadline, the Company may be required to make liquidated damages payments to the holder of Series B Preferred Stock as of May 31, 2018. As of June 30, 2018, the Company has not completed the registration process and therefore recorded a provision of $59 as part of other accrued liabilities based on management’s best estimate of the liability that the Company has incurred under the Registration Rights Agreement.


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 4 (Cont.)

Registration Rights Agreements with Payout Note Holders

On October 12, 2017, the Company issued secured convertible promissory notes (the “Payout Notes”) to Dr. Dolev Rafaeli, the Company’s former Chief Executive Officer, Dennis M. McGrath, the Company’s former President and Chief Financial Officer, and Dr. Yoav Ben-Dror, the former director of the Company’s foreign subsidiaries (collectively, the “Note Holders”) in the principal amounts of $3,134, $978 and $1,515, respectively. The Payout Notes were due on October 12, 2018, carried a 10% interest rate, payable monthly in arrears commencing on December 1, 2017, and were convertible into shares of the Company’s Common Stock at maturity. The Company had agreed to register the shares underlying the Payout Notes within 30 days of issuance with best efforts to cause the registration statement covering such shares to become effective within 120 days of issuance. On November 14, 2017, the Company filed a registration statement on Form S-3 (the “First Registration Statement”) to register all shares that may be issued upon conversion of the Payout Notes. On December 22, 2017, the Company and the Note Holders entered into a stock grant agreement (the “Stock Grant Agreement”) to, among other things, cause the early conversion of the Payout Notes into an aggregate of 5,628,291 shares of the Company’s Common Stock (the “Payout Shares”) and provide for the issuance of an aggregate of 1,857,336 additional shares of Common Stock to the Note Holders as consideration for the various agreements of the Note Holders contained in the Stock Grant Agreement (the “Additional Shares”), subject to stockholder approval. On January 23, 2018, the First Registration Statement was amended to include the Payout Shares issued under the Stock Grant Agreement.

In connection with the Stock Grant Agreement, the Company entered into a registration rights agreement (the “Payout Registration Rights Agreement”) with the Note Holders, pursuant to which the Company agreed to register the shares of common stock under the Additional Shares under the Securities Act. The Company agreed to file a registration statement covering the resale of the Additional Shares within 30 days of the Stock Grant Agreement and cause such registration statement to be declared effective under the Securities Act as soon as possible but, in any event, no later than 120 days following the filing date if such registration statement is filed on Form S-3 or 150 days if such registration statement is filed on Form S-1. If such registration statement is not filed or declared effective by the SEC on or prior to such dates, or if after such registration statement is declared effective, without regard for the reason thereunder or efforts therefor, such registration statement ceases for any reason to be effective for more than an aggregate of 30 trading days during any 12-month period, which need not be consecutive, then in addition to any other rights the Note Holders may have under the Payout Registration Rights Agreement or under applicable law, the Company shall pay to each Note Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to 1% of the product obtained by multiplying (x) $1.00 by (y) the number of shares of common stock held by the Note Holder included in the registration statement (such product being the “Payout Investment Amount”); provided that, in no event will the Company be liable for liquidated damages in excess of 1% of the Payout Investment Amount in any single month and that the maximum aggregate liquidated damages payable to the Note Holders under the Payout Registration Rights Agreement shall be 10% of the Payout Investment Amount. The registration rights provision contained in the Payout Notes was incorporated by reference into the Payout Registration Rights Agreement, except that the Note Holders waived the breach by the Company for failure to timely file the First Registration Statement and agreed that they are not entitled to liquidated damages as a result of such failure. Under the Payout Registration Rights Agreement, the Note Holders are entitled to liquidated damages if the First Registration Statement is not declared effective within 120 days following the date of the Payout Notes.

On January 23, 2018, the Company filed a registration statement on Form S-3 for the Additional Shares. The Note Holders waived their rights to liquidated damages in connection with the late filing of such registration statement and in connection with the effectiveness deadline for such registration statement until May 31, 2018. However, as that registration statement did not become effective by the required deadline, the Company may be required to make liquidated damages payments to the holders of the Payout Notes since May 31, 2018. As of June 30, 2018, the Company has not completed the registration process and therefore recorded a provision of $56 as part of other accrued liabilities based on management’s best estimate of the liability that the Company has incurred under the Registration Rights Agreement.


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 4 (Cont.)

Amended and Restated ArticlesSeparation Agreement

On February 12, 2018, the Company entered into an Amended and Restated Separation Agreement with Mr. Stephen Johnson, its former Chief Financial officer, pursuant to which the Company has agreed to pay Mr. Johnson an amount of Incorporation$123 in 11 installments as follows: the first six installments of $10 each, and the following five installments of $12.5 each. The first payment was made on February 15, 2018, and subsequent payments are to be made on or before the 15th day of each succeeding month, with the final installment to be paid on or before December 15, 2018.

 

The Company will also provide a health (medical, dental and/or vision) insurance reimbursement payment for Mr. Johnson and his family, for a period of 11 months, in the agreed upon amount of $3 per month.

In addition, the Company has agreed to issue to Mr. Johnson 271,000 shares of the Company’s common stock, subject to appropriate adjustment for any stock splits, stock or business combinations, recapitalizations or similar events occurring after the date of the agreement. Those shares will be issued on any business day during the period commencing on the date that is six months after the date of the agreement and ending on the date that is three business days after such six-month anniversary. As of June 30, 2018, the aforesaid shares were not issued to Mr. Johnson. As of June 30, 2018, the balance payable to Mr. Johnson, included in accrued compensation and related expenses, is $343 (including the amount related to the shares component).

Resignation of Officers and Director

As discussed in Note 1, the former CEO and CFO of the Company resigned on June 16, 2018 asserting resignations for “good reason” as that term is used in their employment agreements, to which the Company disagrees. To the Company’s knowledge, no complaints against the Company have been filed to date. The Company and its legal counsel believes that a potential claim, if any, would be without merit and intends to vigorously defend against such a claim should one arise. At this stage, the amount of any loss, or range of loss, is highly uncertain and cannot be reasonably estimated. Therefore, the Company has not recorded any contingent liability or reserve related to this particular potential legal matter. If, in the future, the likelihood that the Company could have a loss becomes probable and estimable, the Company may be required to record a contingent liability or reserve for this matter.

A-18 

 

 

FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

AMENDED AND RESTATED ARTICLES OF INCORPORATIONNote 5

Redeemable Convertible Preferred Stock and Stockholders’ Deficit:

 

OFCommon Stock

The Company’s common stock confers upon their holders the following rights:

The right to participate and vote in the Company’s stockholder meetings, whether annual or special. Each share will entitle its holder, when attending and participating in the voting in person or via agent or letter, to one vote;

The right to a share in the distribution of dividends, whether in cash or in the form of bonus shares, the distribution of assets or any other distribution pro rata to the par value of the shares held by them; and

The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the shares held by them.

Convertible Series A Preferred Stock

The terms of the Convertible Series A Preferred Stock are governed by a certificate of designation (the “Series A Certificate of Designation”) filed by the Company with the Nevada Secretary of State on May 15, 2017. Pursuant to the Series A Certificate of Designation, the Company designated 3,000,000 shares of the Company’s preferred stock as “Series A Convertible Preferred Stock.” The Company issued 123,668 shares of Convertible Series A Preferred Stock in connection with the Contribution Agreement. Following is a summary of the material terms of the Series A Convertible Preferred Stock:

Dividends. Except for stock dividends or distributions for which adjustments are to be made, holders shall be entitled to receive, and the Company shall pay, dividends on shares of Convertible Series A Preferred Stock equal (on an as-if-converted-to-common-stock basis) to and in the same form as dividends actually paid on shares of the common stock when, as and if such dividends are paid on shares of the common stock. No other dividends shall be paid on shares of Convertible Series A Preferred Stock.

Liquidation. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company, after the Redeemable Convertible Series B Preferred Stockholder’s liquidation preference, the same amount that a holder of common stock would receive if the Convertible Series A Preferred Stock were fully converted (disregarding for such purposes any conversion limitations) to common stock which amounts shall be paid pari passu with all holders of common stock.

Voting. Except as otherwise provided in the Series A Certificate of Designation or as otherwise required by law, the Convertible Series A Preferred Stock shall have no voting rights. However, as long as any shares of Convertible Series A Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Convertible Series A Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Convertible Series A Preferred Stock or alter or amend the Series A Certificate of Designation, (b) amend the Company’s articles of incorporation or other charter documents in any manner that adversely affects any rights of the holders, (c) increase the number of authorized shares of Convertible Series A Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

Conversion. Each share of Convertible Series A Preferred Stock shall be convertible, at any time and from time to time from at the option of the holder thereof, into that number of shares of common stock determined by dividing $62.9575 by the Conversion Price. The Conversion Price for the Series A Convertible Preferred Stock is equal to $2.5183, subject to adjustment as described in the Series A Certificate of Designation.

FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 5 (Cont.)

Stockholders’ Equity (Cont.):

 

PHOTOMEDEX, INC.Redeemable Convertible Series B Preferred Stock

The terms of the Redeemable Convertible Series B Preferred Stock are governed by a certificate of designation (the “Series B Certificate of Designation”) filed by the Company with the Nevada Secretary of State on December 22, 2018, as supplemented by that certain supplemental agreement, dated April 20, 2018, between the Company and OFI (the “Supplemental Agreement”), which clarified certain voting and conversion limitations with respect to the Series B Preferred Stock in response to comments from the staff of NASDAQ. Pursuant to the Series B Certificate of Designation, the Company designated 15,000,000 shares of the Company’s preferred stock as “Series B Preferred Stock”. As more fully described below, the Company has issued a total of 3,725,000 shares of Redeemable Convertible Series B Preferred Stock in connection with the OFI Purchase Agreement during 2017 and 2018. Following is a summary of the material terms of the Redeemable Convertible Series B Preferred Stock: 

 

Pursuant to NRS Chapter 78

Dividends. Holders of shares of Redeemable Convertible Series B Preferred Stock shall receive cumulative dividends, pro rata among such holders, prior to and in preference to any dividend on our outstanding common stock at the per annum rate of 8% of the Series B Original Issue Price (as defined below). Dividends on each share of Series B Preferred Stock will accrue daily and be cumulative from December 22, 2017 (the “Series B Original Issue Date”) and shall be payable upon the occurrence of any voluntary or involuntary liquidation, dissolution or winding up of the Company (a “Liquidation Event”), a conversion or a redemption. The “Series B Original Issue Price” shall mean $1.00 per share, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Redeemable Convertible Series B Preferred Stock. Holders shall also be entitled to receive dividends on shares of Redeemable Convertible Series B Preferred Stock equal (on an as-if-converted-to-common-stock basis regardless of whether the Redeemable Convertible Series B Preferred Stock is then convertible or otherwise subject to conversion limitations) to and in the same form as dividends actually paid on shares of our common stock when, as and if such dividends are paid on shares of the common stock.

 

Liquidation. In the event of (i) a Liquidation Event or (ii) a merger or consolidation (other than one in which our stockholders own a majority by voting power of the outstanding shares of the surviving or acquiring corporation) or a sale, lease, transfer, exclusive license or other disposition of all or substantially all of our assets (a “Deemed Liquidation Event”), the holders of shares of Redeemable Convertible Series B Preferred Stock then outstanding shall be entitled to be paid out of our assets available for distribution to stockholders before any payment shall be made to the holders of our common stock, Series A Convertible Preferred Stock or any other class of securities authorized that is specifically designated as junior to the Redeemable Convertible Series B Preferred Stock (the “Junior Securities”) by reason of their ownership thereof, but  -pari passu-  with the holders of shares of any class of securities authorized that is specifically designated as  pari passu  with the Redeemable Convertible Series B Preferred Stock (the “Parity Securities”) on a pro rata basis, an amount per share equal to the Series B Original Issue Price, plus any accrued dividends thereon. If upon any such Liquidation Event or Deemed Liquidation Event, our assets available for distribution to stockholders shall be insufficient to pay the holders of shares of Redeemable Convertible Series B Preferred Stock the full amount to which they shall be entitled and the holders of Parity Securities the full amount to which they shall be entitled, the holders of shares of Redeemable Convertible Series B Preferred Stock and the holders of shares of Parity Securities shall share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full. Upon a Liquidation Event or a Deemed Liquidation Event, in the event that following the payment of such liquidation preference the Company shall have additional cash and other assets of available for distribution to stockholders, then the holders of shares of Redeemable Convertible Series B Preferred Stock shall participate  pari passu  with the holders of shares of Parity Securities and Junior Securities based on the then current conversion rate (disregarding for such purposes any conversion limitations) with respect to all remaining distributions, dividends or other payments of cash, shares or other assets and property of our company, if any. As of June 30, 2018, the aggregate liquidation preference amounted to $1,948 (unaudited). The foregoing dollar amount does not include dividends, as the Company’s Board of Directors has not declared any dividends since inception.

1.          The name of the corporation (the “Corporation”) is PhotoMedex, Inc.

2.          The address of the registered office of the Corporation in the State of Nevada shall be at [Jolley Urga Wirth Woodbury & Standish, 3800 Howard Hughes Parkway, Sixteenth Floor, Las Vegas, Nevada 89169. The name and address of the Corporation’s registered agent in the State of Nevada is Jolley Urga Wirth Woodbury & Standish.]

3.            (a)              The total number of shares of capital stock which the Corporation shall have authority to issue is five hundred fifty million (550,000,000) shares, of which (i) fifty million (50,000,000) shares are designated as preferred stock, with a par value of $0.01 per share (“Preferred Stock”) and (ii) five hundred million (500,000,000) shares are designated as common stock, with a par value of $0.01 per share (“Common Stock”).

(b)           The Preferred Stock of the Corporation may be issued by the Board of Directors of the Corporation in one or more series and each such series shall have such voting powers, full or limited, or no voting powers, and such designations, preferences, limitations or restrictions as the Board of Directors of the Corporation may determine, from time to time, including but not limited to:

(i)          the designation of such class or series;

(ii)         the dividend rate, if any, of such class or series, the conditions and dates upon which such dividends shall be payable, the preference or relation which such dividends shall bear to the dividends payable on any other class or classes or of any other series of capital stock, whether such dividends shall be cumulative or non-cumulative, and whether such dividends may be paid in shares of any class or series of capital stock or other securities of the Corporation;

(iii)        whether the shares of such class or series shall be subject to redemption by the Corporation, and, if made subject to such redemption, the times, prices and other terms and conditions of such redemption;

(iv)        the terms and amount of any sinking fund provided for the purchase or redemption of the shares of such class or series;

(v)         whether or not the shares of such class or series shall be convertible into or exchangeable for shares of any other class or classes or series of capital stock or other securities of the Corporation, and, if provision be made for conversion or exchange, the times, prices, rates, adjustment and other terms and conditions of such conversion or exchange; 

A-20 

 

 

(vi)        the extent, if any, to which the holders of the shares of such class or series shall be entitled to vote, as a class or otherwise, with respect to the election of the directors or otherwise,FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and the number of votes to which the holder of eachper share of such class or series shall be entitled;amounts)

(unaudited)

 

(vii)       the restrictions, if any, on the issue or reissue of any additional shares or any class or series of Preferred Stock; andNote 5 (Cont.)

Stockholders’ Equity (Cont.):

 

(viii)      the rights
Voting Rights. On any matter presented to our stockholders for their action or consideration, each holder of Redeemable Convertible Series B Preferred Stock shall be entitled to cast the number of votes equal to the quotient of the aggregate investment amount invested to purchase Series B Preferred Stock divided by $1.12, the market value of the Company’s common stock on December 21, 2017, or approximately 0.893 votes per share (subject to certain conversion limitations described below). Except as provided by law or by the other provisions of the Series B Certificate of Designation, the holders shall vote together with the holders of shares of common stock as a single class. However, as long as any shares of Redeemable Convertible Series B Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the holders of the shares of such class or series upon the dissolution of, or upon the distribution of assets of, the Corporation.

(c)          Holders of shares of Common Stock shall be entitled to cast one vote for each share held at all stockholders’ meetings for all purposes, including the election of directors. The Common Stock does not have cumulative voting rights.

(d)          Subject to such rights as may be granted to the holders of any series of Preferred Stock, no holder of shares of stock of any class shall be entitled as a matter of right to subscribe for or purchase or receive any part of any new or additional issue of shares of stock of any class, or of securities convertible into shares of stock of any class, whether now hereafter authorized or whether issued for money, for consideration other than money, or by way of dividend.

4.          The purpose of the Corporation shall be to engage in any lawful act or activity for which corporations may be organized in Nevada.

5.          Except as otherwise provided by law, a director or officer is not individually liable to the Corporation or its stockholders or creditors for any damages as a result of any act or failure to act in his or her capacity as a director or officer unless it is proven that (a) the director’s or officer’s act or failure to act constituted a breach of his or her fiduciary duties as a director or officer; and (b) the breach of those duties involved intentional misconduct, fraud or a knowing violation of law. Any repeal or modification of this paragraph 5 by the stockholders of the Corporation shall be prospective only, and shall not adversely affect any limitation of the personal liability of a director of officer of the Corporation for acts or omissions prior to such repeal or modification.

6.          The Corporation shall provide indemnification to its directors and officers to the maximum extent permitted by law. The Corporation shall pay advancements of expenses in advance of the final disposition of the action, suit, or proceedings upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately determined that he or she is not entitled to be indemnified by the corporation.

7.          The provisions of NRS Sections 78.378 to 78.3793, inclusive, shall be inapplicable to the Corporation.

8.          The provisions of NRS Sections 78.411 to 78.444, inclusive, shall be inapplicable to the Corporation.

9.          These Restated Articles of Incorporation were approved by the Board of Directors and the holders of a majority of the outstanding shares of Redeemable Convertible Series B Preferred Stock (the “Requisite Holders”), (i) issue any class of equity securities that is senior in rights to the Redeemable Convertible Series B Preferred Stock, (ii) issue any Parity Securities, (iii) alter or change adversely the powers, preferences or rights given to the Redeemable Convertible Series B Preferred Stock or alter or amend the Series B Certificate of Designation, (iv) amend our articles of incorporation or other charter documents in any manner that adversely affects any rights of the holders of Redeemable Convertible Series B Preferred Stock, (v) except pursuant to the redemption provisions of Parity Securities, redeem any shares of our preferred stock or common stock (other than pursuant to employee or consultant agreements giving us the right to repurchase shares at the original cost thereof upon the termination of services and provided that such repurchase is approved by our Board of Directors), or (vi) enter into any agreement with respect to any of the foregoing.

Conversion. Each share of Redeemable Convertible Series B Preferred Stock plus accrued, but unpaid, dividends thereon (the “Aggregate Preference Amount”), shall be convertible, at any time and from time to time at the option of the holder thereof, into that number of shares of common stock determined by a formula (computed on the date of conversion), (i) the numerator of which is equal to the Aggregate Preference Amount and (ii) the denominator of which is equal to the quotient of the Conversion Price divided by $1.33. The “Conversion Price” for the Redeemable Convertible Series B Preferred Stock was adjusted to $0.8684 starting in February 2018, subject to adjustment as described in the Series B Certificate of Designation. In addition, upon the earlier to occur of: (i) a Deemed Liquidation Event or (ii) if there has not been a breach or default by us under the OFI Purchase Agreement that has occurred and is continuing, May 31, 2018, each share of Redeemable Convertible Series B Preferred Stock plus accrued, but unpaid, dividends thereon shall be automatically converted into that number of shares of common stock determined by dividing $1.33 by the Conversion Price. Notwithstanding the forgoing, if the Company has not obtained stockholder approval with respect to the issuance of shares upon conversion in excess of 19.99% of the issued and outstanding common stock on the applicable conversion date (the “Stockholder Approval”), then the Company may not issue, upon conversion of the Redeemable Convertible Series B Preferred Stock, a number of shares of common stock which, when aggregated with any shares of common stock issued on or after the Series B Original Issue Date and prior to such conversion date, would exceed 19.99% of the issued and outstanding shares of common stock (subject to adjustment for forward and reverse stock splits, recapitalizations and the like) (the “Issuable Maximum”). Each holder shall be entitled to a portion of the Issuable Maximum equal to the quotient obtained by dividing (i) the Series B Original Issue Price of such holder’s Redeemable Convertible Series B Preferred Stock by (ii) the aggregate Series B Original Issue Price of all Redeemable Convertible Series B Preferred Stock issued to all holders. In the light of the above, on May 31, 2018, 1,869,663 shares of the Series B Preferred Stock along with pro-rata accrued dividends were automatically converted into 2,965,301 shares of common stock. As a result of this conversion, an amount of $2,553 was transferred from Redeemable Convertible Preferred Stock Series B account into equity.

FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 5 (Cont.)

Stockholders’ Equity (Cont.):

Redemption. If (i) there is a breach by us of any of our representations and warranties contained in Sections 3.1(a) (Subsidiaries), 3.1(b) (Organization and Qualification), 3.1(c) (Authorization; Enforcement), 3.1(d) (No Conflicts), 3.1(f) (Issuance of the Shares), 3.1(g) (Capitalization), or 3.1(n) (Taxes) of the OFI Purchase Agreement that has not been cured within 30 days after the date of such breach or (ii) Stockholder Approval has not been obtained by March 31, 2018 (each, a “Redemption Event”), then each holder of Redeemable Convertible Series B Preferred Stock may, at its option, require us to redeem any or all of the shares of Redeemable Convertible Series B Preferred Stock held by such holder at a price per share equal to $1.33, plus accrued, but unpaid, dividends through and including the date of such redemption. The Company must provide a notice (as “Event Notice”) to each holder of the occurrence of a Redemption Event of the kind described in (i) above (a “Breach Event”) as soon as practicable after becoming aware of such Breach Event, but in any event, not later than 15 days after such Breach Event and such notice shall provide a reasonable description of such Breach Event. A holder must send written notice of redemption (a “Redemption Notice”) to the Company within 90 days after (i) the Company provides such holder an Event Notice with respect to a Breach Event or (ii) the occurrence of a Redemption Event of the kind described in (ii) above. For the avoidance of doubt, if the Company does not timely provide an Event Notice, the holder shall nevertheless have the right to deliver a Redemption Notice in connection with any Redemption Event. If a holder fails to send a Redemption Notice on prior to the 90th day after the occurrence of any Redemption Event, then such holder will lose such holder’s right to redemption with respect to the particular Redemption Event, but not any other Redemption Event. As of March 31, 2018, the Company did not obtain shareholder approval and therefore, the then outstanding Series B Preferred Stock became redeemable at the option of OFI. Consequently, in each reporting period commencing March 31, 2018, the outstanding Series B Preferred stock is recorded on its maximum redemption value until the earlier of an redemption or conversion occurrence.

Securities Purchase Agreement

On December 22, 2017, the Company entered into the OFI Purchase Agreement with OFI, under which OFI may, but is not obligated to, invest up to $15,000 in the Company in a series of closings over a period prior to December 31, 2018, in exchange for which OFI will receive shares of the Company’s Redeemable Convertible Series B Preferred Stock (“Series B Shares”) at a purchase price of $1.00 per share (the “Option”).

On December 22, 2017 (the “Initial Date”), the Company and OFI completed the first closing under the OFI Purchase Agreement, pursuant to which OFI exercised a portion of the Option and provided $1,500 to the Company in exchange for 1,500,000 Series B Shares. On January 24, 2018 (the “Second Date”), the Company and OFI completed a second closing under the OFI Purchase Agreement, pursuant to which OFI provided $2,225 to us in exchange for 2,225,000 Series B Shares.

Under the OFI Purchase Agreement, the proceeds from the first closing were to be used for working capital and general corporate purposes, the proceeds from the second closing were to be used to perform due diligence and invest in Income Generating Properties (as defined in the OFI Purchase Agreement) that have been approved by our Board of Directors, and proceeds from subsequent closings were be used to invest in Income Generating Properties (as defined in the OFI Purchase Agreement) that have been approved by our Board of Directors or as otherwise agreed to between us and OFI in writing prior to such subsequent closings. On March 16, 2018, the Company and OFI entered into a letter agreement, pursuant to which OFI agreed that the Company may use all proceeds for the purposes and uses described in a budget agreed to between us and OFI at the time the letter agreement was signed. In connection with such letter agreement, the Company agreed to provide OFI, on a quarterly basis, on or prior to 15 days after the end of each quarter, a report that describes, in reasonable detail, the actual expenses incurred and payments made during such period compared to the expenses and payments specified in the budget for such period, certified by our Chief Financial Officer.


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 5 (Cont.)

Stockholders’ Equity:

Under ASC 480, “Distinguishing Liabilities from Equity”, Since the Series B Shares have conditional redemption provisions which are outside of the control of the Company and also contain a deemed liquidation preference, the Series B Shares were classified as mezzanine financing at the Initial Date at the residual amount, which was the difference between the total proceeds received and the fair value of the Option. Subsequently, accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument using an appropriate methodology, usually the interest method. Changes in the redemption value are considered to be changes in accounting estimates. As described above, as of June 30, 2018, the Series B Shares are presented at their full redemption amount.

Under ASC 480, the aforementioned written call Option is considered freestanding, as the Company believes it is legally detachable and separately exercisable. As the option is exercisable for shares subject to possible redemption at the option of the holder, as of the Initial Date, the Option was measured at fair value and recorded as a non-current financial liability on the consolidated balance sheet. Excess of the initial value of the option liability over the proceeds received was charged immediately into the consolidated statement of comprehensive loss as financing expenses in the fourth quarter of 2017. The Option is marked to market in each reporting period until it is exercised or expired, as earlier, when changes in the fair value of the Option are charged into statement of comprehensive income or loss. For the three and six month periods ended June 30, 2018, the Company recorded income in the total amount of $2,568 and $2,295, respectively due to revaluation of Option to purchase redeemable convertible B preferred stock.

In addition, at the Initial Date, the Company incurred de minimis direct and incremental issuance costs which were charged immediately into the consolidated statement of comprehensive loss as finance expenses, as the written call Option was presented at fair value.

At the Initial Date, each Series B Share was convertible into 1.24789 shares of common stock valued at $1.00 per share. As a result, Beneficial Conversion Feature (the “BCF”) amounting to approximately $372 was measured assuming full conversion. However, the conversion of the Preferred Stock is subject to certain contingencies, which impact the timing and amount of the BCF. At the Initial Date which is also the commitment date, the Company should record a BCF for the Preferred Stock for any shares convertible at that time without requiring stockholder approval through the planned proxy statement. However, as no residual proceeds were allocable to the Series B Shares at the Initial Date, no BCF was recognized with respect to the first closing.

In conjunction with the Second Date, OFI partially exercised the written call option present in the OFI Purchase Agreement and therefore upon exercise, the pro-rata share of this liability amounting to $677 was reclassified in the condensed consolidated balance sheet from Option to purchase redeemable convertible preferred stock into redeemable convertible preferred stock Series B, during the three month period ended March 31, 2018.

On the Second Date, each Series B Share (exclusive of dividends) was convertible into 1.24789 shares of common stock valued at $1.00 per share. As a result of the reclassification of the exercised written call option, there was no additional BCF measured.

The fair value of the Option was based on management estimates and values derived from a calculation to provide an approximate indication of value. The fair value of Option is estimated at each reporting and exercise date, including, December 31, 2017, January 24, 2018 and June 30, 2018 by using hybrid method that includes scenario of conversion and scenario liquidation and the Black-Scholes option pricing model. In the first scenario, the Series B Preferred Stock price applied in the model was assumed based on the as-converted price on the date of estimation. Expected volatility was estimated by using a group of peers in the real estate development, homebuilding and income-producing properties sectors, and applying a 75% percentile ranking based on the total capitalization of the Company. In the second scenario, the Option was estimated based on the value of the Option in a proposed liquidation scenario. A probability weighting was applied to determine the expected value of the Option. The Company measured the fair value of the Option on a recurring basis in accordance with ASC 820, “Fair Value Measurement and Disclosures” (primary inputs classified at level 3).


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 5 (Cont.)

Stockholders’ Equity:

The following are the key underlying assumptions that were used:

  December 31, 
2017
  January 24, 
2018
  June 30, 
2018
 
Dividend yield (%)  0   0   0 
Expected volatility (%)  36.9   37.9   42.4 
Risk free interest rate (%)  1.74   1.75   2.11 
Strike price  1.00   1.00   1.00 
Series B Preferred Stock price  1.13   1.10   0.83 
Probability of if-converted scenario (%)  90   90   90 
Probability assumed liquidation scenario (%)  10   10   10 
Expected term of Option (years)  1.0   0.9   0.5 
Option’s fair value per share $0.33  $0.30  $0.13 

The following tabular presentation reflects the activity in the Option to purchase Redeemable Convertible B Preferred Stock during the six months ended June 30, 2018 -

  Fair value of Option to 
purchase Redeemable 
Convertible B Preferred 
Stock
 
  (Unaudited) 
    
Opening balance, January 1, 2018 $4,390 
Partial exercise of series B redeemable convertible preferred stock written call option  (677)
Revaluation of option to purchase redeemable convertible B preferred stock  (2,295)
     
Closing balance, June 30, 2018 $1,418 

In the absence of voluntary conversion and assuming no breaches as described above under “Redemption,” the Series B Shares would have automatically converted on May 31, 2018. As such, accretion adjustments to the carrying amount of the Series B Shares to the automatic conversion date of May 31, 2018 are recorded as deemed dividends. However, at March 31, 2018, the Company did not obtain shareholder approval and therefore, the then outstanding Series B Preferred Stock became redeemable at the option of OFI. As such, as of June 30, 2018, the Company has adjusted the carrying value of the Convertible Series B Preferred Stock to the maximum redemption amount. Activity in the account redeemable convertible preferred stock Series B for the six months ended June 30, 2018, is outlined in the below table -

  June 30, 2018 
  Unaudited 
    
Opening balance, January 1, 2018 $87 
Proceeds from issuance of Series B Shares  2,225 
Accretion of Series B Preferred Stock to redemption value  1,968 
Partial exercise of Series B Preferred Stock written call option on the second date  677 
Conversion of Series B Preferred Stock into Common Stock  (2,553) 
Dividend on Series B Preferred Stock  141 
     
Closing balance, June 30, 2018 $2,545 

FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 5 (Cont.)

Stockholders’ Equity:

Under the Agreement, the Series B Preferred Stock, up to the stated limits, would automatically convert to the Company’s common stock on May 31, 2018. Consequently, 1,869,663 shares of Series B Preferred Stock held by OFI have been converted into 2,965,301 shares, or 19.99% of the 11,868,619 outstanding shares of common stock as of May 31, 2018, which is the applicable conversion date under the OFI Purchase Agreement. The remaining 1,855,337 unconverted shares of the Series B Preferred Stock will remain as mezzanine and will accrued a preferred dividend until such time a conversion is approved by the Company’s shareholders.

In addition, pursuant to NRS 78.390 the OFI Purchase Agreement, the Company agreed that so long as the Series B Shares purchased by OFI are outstanding, the Company’s debt (as determined in accordance with U.S. generally accepted accounting principles) should not exceed 45% of its fixed assets, without the prior written consent of the Requisite Holders. As of June 30, 2018, the Company has met this covenant.

Cancellationand NRS 78.320,Exchange Agreement

On April 20, 2018, the Company and this instrument correctly setsOFI entered into a Cancellation and Exchange Agreement (the “Exchange Agreement”), pursuant to which OFI agreed to provide an additional $2,000 to the Company in exchange for 2,000,000 shares of the Company’s Series B Preferred Stock, subject to certain conditions set forth in full the articlesExchange Agreement, including, among other things, the cancellation of incorporation,95,770 shares of the Company’s Series A Preferred Stock held by OFI in exchange for 5,382,274 shares of the Company’s common stock (the “OFI Shares”). Under the Exchange Agreement, closing of this additional investment shall occur promptly following the filing of the Information Statement (as defined below) with the SEC and mailing of the Information Statement to the stockholders of the Company, and in any event within 3 days thereafter.

In accordance with the Exchange Agreement, the Company has obtained the irrevocable written consent of at least a majority of the stockholders of the Company (excluding OFI) that is final and binding (the “Stockholder Consent”) approving the issuance of the OFI Shares and the issuance of Common Stock upon conversion of all of the Series B Preferred Stock held by OFI or issuable under the OFI Purchase Agreement. The Stockholder Consent shall become effective on the 20th day following the filing and mailing of a definitive information statement on Schedule 14C (the “Information Statement”), at which time stockholder approval of such issuances shall become effective (“Stockholder Approval”). Pursuant to the Exchange Agreement, the Company agreed to issue the OFI Shares as amendedsoon as practicable after obtaining Stockholder Approval and restated.in any event within 3 business days of obtaining Stockholder Approval.

Pursuant to the Exchange Agreement, the Company agreed that the OFI Shares shall constitute “Registrable Securities” under the registration rights agreement between the Company and OFI, dated December 22, 2017, and the Company shall use commercially reasonable efforts to promptly amend the registration statement filed by the Company on January 23, 2018 to include the OFI Shares and any other shares of common stock of the Company that are issuable to OFI upon conversion of Series B Preferred Convertible Stock held by OFI that are not already included in such registration statement.


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 5 (Cont.)

Stockholders’ Equity:

Common Stock Options

The Company’s Amended and Restated 2000 Non-Employee Director Stock Option Plan authorized 1,250,000 shares. As of June 30, 2018, the number of shares available for future issuance pursuant to this plan is 240,018; all other shares had either been issued or reserved for issuance upon exercise of stock options.

The Company’s Amended and Restated 2005 Equity Compensation Plan authorized 3,500,000 shares. As of June 30, 2018, there are no further shares available for future issuance pursuant to this plan; all other shares had either been issued or reserved for issuance upon exercise of stock options.

A summary of stock option transactions under these plans during the six months ended June 30, 2018 are as follows:

   Number of Stock 
Options
  Weighted 
Average 
Exercise Price
  Weighted 
Average 
Remaining 
Term 
(in years)
  Aggregate  
Intrinsic 
Value (*)
 
Outstanding at January 1, 2018   79,890  $94.51   4.1  $ 
Granted/vested   147,088  $0.98   9.8  $ 
Exercised             
Expired/cancelled   (147,088)         
Outstanding at June 30, 2018   79,890  $33.90   7.8  $ 
Exercisable at June 30, 2018   79,890  $33.90   7.8  $ 

(*)The aggregate intrinsic value represents the total intrinsic value (the difference between the deemed fair value of the Company’s Ordinary Shares on the last day of the second quarter of 2018 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on June 30, 2018. This amount is impacted by the changes in the fair value of the Company’s shares.

The total equity-based compensation expense related to the Company’s equity-based awards, recognized during the six months ended June 30, 2018 and 2017, total the amounts of $5 (unaudited) and $935 (unaudited) ($811 out of which related to the three months ended June 30, 2017 is included in discontinued operations), respectively.

As of June 30, 2018, there was $11 (unaudited) of total unrecognized compensation cost related to non-vested stock awards that based on their original vesting terms was expected to be recognized.


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 6

Income Taxes:

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 (the “Tax Act”). The Tax Act makes broad and complex changes to the U.S. tax code, including, but not limited to, reducing the U.S. federal corporate tax rate from 35 percent to 21 percent; eliminating the corporate Alternative Minimum Tax (“AMT”) and changing how existing AMT credits can be realized; creating a new limitation on deductible interest expense; changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017; and changing limitations on the deductibility of certain executive compensation.

In December 2017, the SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”), which addresses situations where the accounting is incomplete for the income tax effects of the Act. SAB 118 directs taxpayers to consider the impact of the act as “provisional” when the Company does not have the necessary information available, prepared or analyzed (including computations) to finalize the accounting for the change in tax law. Companies are provided a measurement period of up to one year to obtain, prepare, and analyze information necessary to finalize the accounting for provisional amounts or amounts that cannot be estimated.

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which the related temporary difference becomes deductible. The benefit of tax positions taken or expected to be taken in the Company’s income tax returns are recognized in the consolidated financial statements if such positions are more likely than not of being sustained. As of June 30, 2018, an amount of $1.6 million related to corporate international unrecognized tax benefits is included in other accrued liabilities.

Taxes, which may apply in the event of a disposal of investments in subsidiaries, have not been included in computing the deferred taxes, as the Company anticipates it would liquidate those subsidiaries that can be closed on a tax free basis.

The Company files corporate income tax returns in the United States, both in the Federal jurisdiction and in various State jurisdictions. The Company is subject to Federal income tax examination for calendar years 2014 through 2017 and is also generally subject to various State income tax examinations for calendar years 2014 through 2017. Photo Therapeutics Limited files in the United Kingdom. Radiancy (Israel) Limited files in Israel. The Israeli subsidiary is subject to tax examination for calendar years 2013 through 2017.

During the six months ended June 30, 2018, the Company recognized an income tax provision of $209 relating to adjustments of accruals and prepaid tax assets.


FC GLOBAL REALTY INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts)

(unaudited)

Note 7

Subsequent Events:

Resignation of Director

Effective August 15, 2018, Michael Singer resigned as Chairman and a member of the Company’s Board of Directors as well as from his membership in the Board’s Audit, Compensation and Nominations and Corporate Governance Committees; he had served as Chairman of the Audit Committee.


FC GLOBAL REALTY INCORPORATED

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2017 AND 2016


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Fahn Kanne & Co.

Head Office

32 Hamasger Street

Tel-Aviv 6721118, ISRAEL

PO Box 36172, 6136101

T +972 3 7106666

F +972 3 7106660

www.gtfk.co.il

Board of Directors and Stockholders

FC Global Realty Incorporated (Formerly: PhotoMedex Inc.)

Opinion on the financial statements

We have audited the accompanying consolidated balance sheets of FC Global Realty Incorporated (Formerly: PhotoMedex Inc.) (a Nevada corporation) and subsidiaries (the “Company”) as of December 31, 2017 and 2016, the related consolidated statements of comprehensive loss, changes in redeemable convertible preferred stock and stockholders’ deficit, and cash flows for each of the two years in the period ended December 31, 2017, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2017 and 2016, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2017, in conformity with accounting principles generally accepted in the United States of America.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has incurred net losses for each of the years ended December 31, 2017 and 2016 and has not yet generated any revenues from real estate activities. As of December 31, 2017, there is an accumulated deficit of $135,022.  These conditions, along with other matters as set forth in Note 1, raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Restatement of previously issued financial statements

As discussed in Note 1 to the consolidated financial statements, the 2017 consolidated financial statements have been restated to correct an error.

Basis for opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ FAHN KANNE & CO. GRANT THORNTON ISRAEL

We have served as the Company’s auditor since 2011.

Tel Aviv, Israel

April 2, 2018 (except for Note 1, as to which the date is May 21, 2018)


FC GLOBAL REALTY INCORPORATED (FORMERLY: PHOTOMEDEX, INC.) AND SUBSIDIARIES

 CONSOLIDATED BALANCE SHEETS

 (In thousands, except share and per share amounts)

  December 31, 
  2017  2016 
  (As Restated)    
ASSETS      
Current assets:        
Cash and cash equivalents $948  $2,335 
Prepaid expenses and other current assets  646   601 
Assets held for sale (Note 2 and 4)     15,565 
Total current assets  1,594   18,501 
Non-current assets:        
Investment properties (Note 5)  2,055    
Investment in other company (Note 5)  1,806    
Property and equipment, net (Note 7)  5    
Other assets, net  334    
Total non-current assets  4,200    
Total assets $5,794  $18,501 
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT        
Current liabilities:        
Notes payable $778  $ 
Accounts payable  612   6,648 
Accrued compensation and related expenses (Note 10)  467   4,029 
Other accrued liabilities  2,450   6,023 
Liabilities related to assets held for sale     3,209 
Total current liabilities  4,307   19,909 
Non-current liabilities:        
Option to purchase Redeemable Convertible B Preferred Stock (Note 14)  4,390    
Note payable, net of current portion (Note 12)  454    
Total non-current liabilities  4,844    
Total liabilities  9,151   19,909 
Commitment and contingencies (Note 13)        
Redeemable Convertible Preferred Stock Series B, $.01 par value; 15,000,000 shares authorized at December 31, 2017; 1,500,000 issued and outstanding at December 31, 2017, net of amount allocated to option to purchase additional shares; Aggregate liquidation preference $1,503,000 at December 31, 2017 (Note 14)  87    
Stockholders’ deficit (Note 14):        
Common Stock, $.01 par value, 500,000,000 and 50,000,000 shares authorized at December 31, 2017 and 2016 respectively; 11,868,619 and 4,361,094 shares issued and outstanding at December 31, 2017 and 2016, respectively  119   44 
Preferred stock, $.01 par value, 32,000,000 shares authorized at December 31, 2017; 0 shares issued and outstanding at December 31, 2017      
Preferred A Stock $.01 par value, 3,000,000 shares authorized at December 31 ,2017; 123,668 issued and outstanding at December 31, 2017;  1    
Additional paid-in capital  132,446   118,762 
Accumulated deficit  (135,022)  (115,635)
Accumulated other comprehensive loss  (1,162)  (4,579)
Total stockholders’ deficit attributable to FC Global Realty Incorporate  (3,618)  (1,408)
Noncontrolling interest (Note 5)  174    
Total stockholders’ deficit  (3,444)  (1,408)
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit $5,794  $18,501 

The accompanying notes are an integral part of these consolidated financial statements.

 

A-31 


FC GLOABAL REALTY INCORPORATED (FORMERLY: PHOTOMEDEX, INC.) AND SUBSIDIARIES

 CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (AS RESTATED)

  (In thousands, except share and per share amounts)

  For the Year Ended
December 31,
 
  2017  2016 
  (As Restated)    
       
Revenues: $  $ 
Cost of revenues      
Gross profit      
         
Operating expenses:        
General and administrative  10,817    
Impairment of investment in other company (Note 5)  1,439    
   12,256    
         
Operating loss  (12,256)   
         
Revaluation of asset contribution related financial instruments, net (Note 5)  (1,392)   
Revaluation of Option to purchase redeemable convertible B preferred stock (Note 14)  (3,018)   
Interest and other financing expense, net  (267)   
Loss from continuing operations  (16,933)   
         
Discontinued operations:        
Loss from discontinued operations, net of taxes  (2,459)  (13,264)
         
Net loss including portion attributable to noncontrolling interest  (19,392)  (13,264)
         
Loss attributable to noncontrolling interest  8    
         
Net loss attributable to FC Global Realty Incorporated $(19,384) $(13,264)
         
Basic and diluted net loss per share:        
Continuing operations $ (3.07) $ 
Discontinued operations  (0.45)  (3.18)
  $(3.52) $(3.18)
         
Shares used in computing basic and diluted net loss per share  5,073,751   4,171,549 
         
Other comprehensive loss:        
Reclassification of cumulative translation adjustment $3,228  $ 
Foreign currency translation adjustments  189   (2,810)
Total other comprehensive income (loss)  3,417   (2,810)
Comprehensive loss $ (15,967) $(16,074)

The accompanying notes are an integral part of these consolidated financial statements

A-32 

 

FC GLOBAL REATLY INCORPORATED (FORMERLY: PHOTOMEDEX, INC.) AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN WITNESS WHEREOF,EQUITY (DEFICIT) (AS RESTATED)

(In thousands, except share and per share amounts)

  

Redeemable Convertible Preferred Stock

Series B

  Stockholders’ deficit 
    Common Stock  Series A Preferred Stock  Additional Paid-In  Accumulated  Accumulated Other Comprehensive  Noncontrolling    
  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Deficit  Loss  Interest  Total 
                                             
BALANCE, DECEMBER 31, 2015        4,398,344  $44        $116,793  $(102,371) (1,769)    $12,697 
Stock-based compensation related to stock options and restricted stock                    1,969            1,969 
Restricted stock canceled        (37,250)                        
Foreign currency translation adjustment                          (2,810)     (2,810)
                                             
Loss                       (13,264)        (13,264)
BALANCE, DECEMBER 31, 2016        4,361,094  $44        $118,762  $(115,635) (4,579)    (1,408)
                                             
Stock-based compensation related to stock options and restricted stock                    1,466            1,466 
                                             
Common shares issued for asset contribution (Note 5)        879,234   9         1,266            1,275 
                                             
Preferred A stock issued for asset contribution (Note 5 )              123,668   1   4,482            4,483 
Common shares issued for Note Payout (Note 14)          5,628,291   56          5,570              5,626 
Common shares issued for severance (Note 14)        1,000,000   10         900            910 
Issuance of series B redeemable convertible preferred stock and embedded option, net of stock issuance costs of $42  1,500,000                               
Amortization of discount related to written call option (Note14)    $84                            
Accretion of dividend (Note 14)    $3                  (3         (3)
Noncontrolling interest from asset acquisition (As Restated)                             182   182 
Reclassification of cumulative translation adjustment                          3,228      3,228 
Foreign currency translation adjustment                                 189      189 
Net Loss (As Restated)                       (19,384)     (8)  (19,392)
BALANCE, DECEMBER 31, 2017 (As Restated)  1,500,000  $87   11,868,619  $119   123,668  $1  $132,446  $(135,022) $(1,162) $174  $(3,444)

The accompanying notes are an integral part of these consolidated financial statements.

A-33 

FC GLOBAL REALTY INCORPORATED (FORMERLY: PHOTOMEDEX, INC.) AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

  For the Year Ended
December 31,
 
  2017  2016 
  (As Restated)    
Cash Flows From Operating Activities:        
Net loss $(17,543) $ 
Adjustments to reconcile loss to net cash provided by (used in) operating activities related to continuing operations:        
Depreciation and amortization  297    
Impairment of investment in other company  1,439    
Deferred income taxes  66    
Stock-based compensation  655    
Capital loss from sale of assets  2,567    
Revaluation of asset contribution related financial instruments, net (Note 5)  1,392    
Revaluation of option to purchase redeemable convertible B preferred stock (Note 14)  2,890    
Issuance costs allocated to Option to purchase redeemable convertible B preferred stock (Note 14)  42    
Changes in operating assets and liabilities:        
Accounts receivable  1,518    
Prepaid expenses and other assets  2,072    
Accounts payable  (2,134)   
Accrued compensation and related expenses  2,936    
Other accrued liabilities  (2,906)   
Amortization of discount on mezzanine  84     
Adjustments related to continuing operations  10,918    
Adjustments related to discontinued operation  (2,673)  358 
Net cash provided by (used in) operating activities  (9,298)  358 
Cash Flows From Investing Activities:        
Direct expenses related to asset acquisition (Note 5)  (283)   
Purchases of property and equipment  (22)   
Stock based compensation  10     
Payment of note receivable  (159)   
Net cash provided by investing activities – continuing operation  (454)   
Net cash provided by investing activities – discontinued operations  7,251   2,148 
Net cash provided by investing activities  6,797   2,148 
Cash Flows From Financing Activities:        
Proceeds from issuance of redeemable  preferred B stock and embedded option, net of issuance cost of $42 (Note 14)  1,458    
Proceeds from note payable  111    
Net cash provided by financing activities –continuing operation  1,569    
Net cash provided by (used in) financing activities – discontinued operations  (663)  (684)
Net cash provided by (used in) financing activities  906   (684)
Effect of exchange rate changes on cash  208   (2,789)
Change in cash and cash equivalents  (1,387)  (967)
Cash and cash equivalents at the beginning of year  2,335   3,302 
Cash and cash equivalents at the end of year $948  $2,335 
Supplemental disclosure of non-cash activities:        
Cash paid for income taxes $36  $203 
Cash paid for interest $126  $281 
Contribution of investment property and investment in other company against stock issue, financial assets related to future mandatory asset contribution and financial liabilities for optional asset acquisition (Note 5) $4,836  $ 
Conversion of Payout Notes into shares of common stock $5,626  $ 

A-34 

The accompanying notes are an integral part of these consolidated financial statements. 

 FC GLOBAL REALTY INCORPORATED (FORMERLY: PHOTOMEDEX, INC.)

NOTES TO RESTATED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts.)

Note 1

Background:

FC Global Realty Incorporated (formerly PhotoMedex Inc.) (and its subsidiaries) (the “Company” or “FCRE”), re-incorporated in Nevada on December 30, 2010, originally formed in Delaware in 1980, is, since earlier in 2017, a real estate development and asset management company concentrated primarily on investments in high quality income producing assets, hotel and resort developments, residential developments and other opportunistic commercial properties.

Under its previous name, PhotoMedex, Inc., the undersigned officerCompany was, until the recent sale of the Company’s last significant business unit (its consumer products division which was sold to ICTV Brands, Inc. on January 23, 2017), as described below and in other sections of this report, a Global Skin Health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. The Company provided proprietary products and services that addressed skin diseases and conditions including psoriasis, acne, actinic keratosis (a precursor to certain types of skin cancer), photo damage and unwanted hair.

Starting in August 2014, the Company began to restructure its operations and redirect its efforts in a manner that management expected would result in improved results of operations and address certain defaults in its commercial bank loan covenants. As part of such redirected efforts, management continued its comprehensive efforts to minimize the Company’s operational costs and capital expenditures. During this time the Company has signed these restated articlesalso sold off certain business units and product lines to support this restructuring, and on January 23, 2017, sold the last remaining major product line, its consumer products division.

As a result of incorporation this ___ daythe Contribution Agreement (see also Note 5), the Company has primarily become a real estate asset management and development company for the purpose of _______,investing in a diversified portfolio of quality commercial and residential real estate properties and other real estate investments located both throughout the United States.

Resignation and Appointment of Officers and Directors:

Pursuant to the Contribution Agreement and Purchase Agreement (see also Notes 5 and 14, respectively), there were changes to the Company’s named executive officers and its Board of Directors that were made on May 17, 2017 and December 22, 2017.

 

_________________, Chief Executive OfficerExpansion of Company’s Board of Directors quorum:

At the Initial Date of the First Contribution under the Contribution Agreement (see also Note 5), the Company’s Board of Directors was expanded, so that the Board of Directors consists of seven persons, of whom (i) three were designated by the Company’s departing board, (ii) three were designated by Contributor Parent; and (iii) one (the “Nonaffiliated Director”) was selected by the other six directors.

In March 2018, two members of the Company’s Board of Directors resigned from their position as directors and Opportunity Fund I-SS, LLC has notified the Company that it exercised its right under the Purchase Agreement (see also Note 14) to appoint two replacement directors to the Company’s Board of Directors (see also Note 17).

Special Meeting of Stockholders

Following the Initial Closing of the First Contribution under the Contribution Agreement (see also Note 5), the Company was required to file a proxy statement and hold a special meeting of its stockholders to authorize and approve the following matters:

an increase in the number of authorized shares of common stock, $.01 par value per share, of the Company from 50,000,000 shares to 500,000,000 shares and increase the number of authorized shares of preferred stock, $.01 par value per share, of the Company from 5,000,000 shares to 50,000,000 shares;

the issuance to the Contributor or its designee or designees of the Company’s common and/or preferred shares in exchange for the contributed assets, and the issuance of the Warrant and, upon exercise of the Warrant, the underlying shares of the Company’s Common Stock in exchange for the contribution of the optional property interests, if any are made;

A-35 

the amendment and restatement of the Articles of Incorporation of the Company;

the approval of the issuance of the Payout Notes and the issuance of the Company’s Common Stock upon conversion thereof; and

the election of a new Board of Directors as set forth above in Resignation and Appointment of Officers and Directors in this report.

The Annual Meeting of Shareholders was convened on September 14, 2017, then adjourned and reconvened on October 12, 2017, at which meeting all of the proposals specified in the Company’s Definitive Proxy and further described in that Proxy and in this filing were approved by the stockholders.

Liquidity and Going Concern:

As of December 31, 2017, the Company had an accumulated deficit of $135,022 (As Restated) and the Company incurred a net loss attributable to FC Global Realty Incorporated, for the year ended December 31, 2017 of $19,387 (As Restated). Subsequent to the sale of the Company’s last significant business unit, the consumer products division as described above, and to date, the Company has dedicated most of its financial resources to general and administrative expenses.

As of December 31, 2017, the Company’s cash and cash equivalents amounted to $948. While the Company is a party to a Securities Purchase Agreement with Opportunity Fund I-SS, LLC, and has raised certain funds under that agreement in both 2017 and in 2018 through the date of the financial statements, Opportunity Fund has no obligation to continue to invest in the Company, and there are restrictions placed by Opportunity Fund on the use of these funds. The Company has historically financed its activities with cash from operations, the private placement of equity and debt securities, borrowings under lines of credit and, in the most recent periods with sales of certain assets and business units. The Company will be required to obtain additional liquidity resources in order to support its operations.

At this time, there is no guarantee that the Company will be able to obtain an adequate level of financial resources required for the short and long-term support of its operations or that the Company will be able to obtain additional financing as needed, or meet the conditions of such financing, or that the costs of such financing may not be prohibitive.

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on recoverability of assets and classification of liabilities that may result from the outcome of this uncertainty.

As discussed in Note 4, on January 23, 2017, the Company sold its consumer products division to ICTV Brands, Inc., for a total selling price of $9.5 million. The Company collected $5 million of that purchase price; the remaining amount of up to $4.5 million was to be payable through a contingent royalty on the sale of consumer products by ICTV Brands. As discussed in further detail below, that royalty arrangement was settled in July 2017 for a payment of $2 million to the Company.

On July 12, 2017 the Company, along with its subsidiaries Radiancy, Inc. (“Radiancy”), Photo Therapeutics Ltd. (“PHMD UK”), and Radiancy (Israel) Limited (“Radiancy Israel” and together with the Company, Radiancy and PHMD UK the “Sellers” and each individually a “Seller”) entered into a Termination and Release Agreement (the “Release”) between the Sellers and ICTV Brands Inc. (“ICTV”) and its subsidiary ICTV Holdings, Inc. (“ICTV Holdings”). The Sellers, ICTV and ICTV Holdings are referred to herein individually as a “Party” and collectively as the “Parties.”

Under the terms of the Release, the Asset Purchase Agreement among the Parties, dated October 4, 2016, as amended by the First Amendment to the Asset Purchase Agreement, dated January 23, 2017 (as so amended, the “Purchase Agreement”), is terminated and of no further force and effect, except for certain surviving rights, obligations and covenants described in the Release. Pursuant to the Release, each of the Sellers, on one hand, and ICTV and ICTV Holdings, on the other hand, fully release, forever discharge and covenant not to sue any other Party, from and with respect to any and all past and present claims arising out of, based upon or relating to the Purchase Agreement (other than the surviving covenants described in the Purchase Agreement) or the transactions contemplated thereby.

 

A-36 

 

ANNEX B

Pursuant to the terms of the Release, ICTV was required to pay to the Company, within 3 business days of the date of the Release, $2,000 in cash and in immediately available funds (the “Payment”). Subject to this Payment, neither ICTV nor ICTV Holdings shall have any further royalty or other payment obligations under the Purchase Agreement. The Company received $2,000 on July 13, 2017.

 

As partial consideration for the releases provided by ICTV Holdings to the Sellers pursuant to the Release and in accordance with the terms therein, on July 12, 2017, the Sellers and ICTV Holdings entered into a Bill of Sale and Assignment (“Bill of Sale”), which provides that each Seller sell, assign, transfer, convey and deliver to ICTV Holdings, and ICTV Holdings purchase and accept from each Seller, all of the right, title and interest, legal or equitable, of each such Seller in and to a deposit in the amount of $210 held by a consumer division vendor, Sigmatron International, Inc. (“Sigmatron”), pursuant to an arrangement between one or more of the Sellers and Sigmatron.

As the total selling price has been adjusted to an amount that was less than the aggregate carrying amount of the assets held for sale, the Company recorded a loss from sale of asset in an amount of $4,652 (net of a gain of $3,228 with respect to accumulative translation adjustment that was reclassified from accumulated other comprehensive income to earnings). This loss is included in discontinued operations for each period.

As discussed in Note 5, on March 31, 2017, the Company entered into a Contribution Agreement with First Capital Real Estate Operating Partnership, L.P., and its parent, First Capital Real Estate Trust Incorporated, under which certain real estate investment properties were to be contributed to the Company in three stages in exchange for the issuance of Company stock. The closing of the First Contribution under this transaction occurred on May 17, 2017, and consideration transferred consisted of shares of common and preferred stock. As of December 31, 2017, neither the Secondary nor the Optional Contribution were made and the Contribution Agreement was terminated at that date.

As discussed in Note 14, on December 22, 2017, the Company entered into a Purchase Agreement with Opportunity Fund I-SS, LLC, a Delaware limited liability company (the “Investor”), pursuant to which the Investor may invest up to $15 million ($1.5 million out of which, net of expenses was received on December 22, 2017) in the Company in a series of closings, in exchange for which the Investor will receive shares of the Company’s newly designated Series B Preferred Stock (“Convertible Redeemable Series B Preferred Stock” or “Series B Shares”) at a purchase price of $1.00 per share.

As discussed in Note 17, on January 24, 2018, the Company and the Investor completed a second closing under the Purchase Agreement, pursuant to which the Investor provided approximately $2,225 to the Company, net of expenses, in exchange for 2,225,000 shares of the Company’s Convertible Redeemable Series B Preferred Stock. While the Company is a party to a Securities Purchase Agreement with Opportunity Fund I-SS, LLC, and has raised certain funds under that Agreement, Opportunity Fund has no obligation to continue to invest in the Company, and there are restrictions placed by Opportunity Fund on the use of these funds.

Restatement of Previously Issued Consolidated Financial Statements

In connection with the preparation of its financial statements for the quarter ended March 31, 2018, the Company determined that the appraisal relied upon, in part, to provide the basis for the agreed upon value of one of the assets acquired, among other assets, on May 17, 2017 pursuant to the Contribution Agreement entered into on March 31, 2017 with First Capital Real Estate Operating Partnership, L.P., and the other parties (see also Note 5) thereto included an error. The estimated value in the appraisal informed, in part, the basis for the agreed upon value in the Contribution Agreement and the consideration applied to account for the acquisition of assets. After learning of the error with the appraisal, the Company ordered a new appraisal, which was obtained on May 7, 2018. The Company determined that the retrospective accounting required to allocate the fair value consideration in the initial contribution agreement would have led to an additional impairment charge of $577 in the fourth quarter of 2017. Due to this error, the Company has restated its audited consolidated financial statements for the years ended December 31, 2017.

The combined impacts of all adjustments to the applicable line items in our audited consolidated financial statements are provided in the tables below.

Consolidated Balance Sheet as of December 31, 2017
  (As
Previously
Reported)
  Adjustments  (Restated) 
Investment properties $2,600  $(545) $2,055 
Total non-current assets  4,745   (545)  4,200 
Total assets  6,339   (545)  5,794 
Accumulated deficit  (134,445)  (577)  (135,022)
Total stockholders’ deficit attributable to FC Global Realty Incorporated  (3,041)  (577)  (3,618)
Noncontrolling interest  142   32   174 
Total stockholders’ deficit  (2,899)  (545)  (3,444)
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit  6,339   (545)  5,794 

A-37 

Consolidated Statement of Comprehensive Loss for the Year Ended  December 31, 2017
  (As
Previously
Reported)
  Adjustments  (Restated) 
Impairment of investment in other company $862  $577  $1,439 
Operating loss  (11,679)  (577)  (12,256)
Loss from continuing operations  (16,356)  (577)  (16,933)
Net loss including portion attributable to noncontrolling interest  (18,815)  (577)  (19,392)
Net loss attributable to FC Global Realty Incorporated  (18,807)  (577)  (19,384)
             
Basic EPS: Continuing operations   $(2.96) $(0.11) $(3.07)
Basic and diluted net loss per share $(3.41) $(0.11) $(3.52)
Comprehensive loss $(15,390)  (577) $(15,967)

Consolidated Statement of Cash Flows for the ended  December 31, 2017
  (As
Previously
Reported)
  Adjustments  (Restated) 
Net loss $(16,966) $(577) $(17,543)
Adjustments to reconcile loss to net cash provided by (used in) operating activities related to continuing operations:            
Impairment of investment in other company  862   577   1,439 
Adjustments related to continuing operations  10,341   577   10,918 

Note 2

Discontinued Operations:

As this business was a substantial business unit of the Company, and as such the sale brings a strategic shift in focus of management. The Company accordingly classified this former business as held for sale and discontinued operations in accordance with ASC Topic 360.

The accompanying consolidated financial statements as of and for the year ended December 31, 2016 have been retrospectively adjusted to reflect the operating results and balance sheet items of the Consumer business as discontinued operations separately from continuing operations. Also, as of December 31, 2016, balance sheet items related to the Consumer business were presented as assets held for sale. The Company recognized a loss of $13,264, on the sale of the discontinued operations in the year ended December 31, 2016, which represents the difference between the adjusted net purchase price and the carrying value of the disposal group.

 

A-38 

The following is a summary of assets and liabilities held for sale in the consolidated balance sheet as of December 31, 2016, which has been retrospectively adjusted to reflect the assets and liabilities of the skin health business as discontinued operations: 

  December 31,
2016
 
ASSETS    
Current assets:    
Cash and cash equivalents $ 
Restricted cash deposits  342 
Accounts receivable, net of allowance for doubtful accounts of $1,192  4,125 
Prepaid expenses and other current assets  2,652 
   Assets held for sale (Note 4)  8,362 
Total current assets  15,481 
     
Non-current assets:    
   Property and equipment, net (Note 7)  77 
   Other assets, net  7 
Total non-current assets  84 
Total assets $15,565 
     
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)    
Current liabilities:    
Other accrued liabilities  2,068 
Deferred revenues  1,141 
Total current liabilities $3,209 
     
Total net assets of discontinued operation $12,356 

The following is a summary of loss from discontinued operations for the year ended December 31, 2017 and 2016:

  For the Year Ended December 31, 
  2017  2016 
       
Revenues: $3,880  $38,397 
         
Cost of revenues  100   8,086 
         
Gross profit  3,780   30,311 
         
Operating expenses:        
Engineering and product development  143   1,249 
Selling and marketing  620   21,729 
         
General and administrative  2,342   13,233 
Impairment loss     3,518 
Other income, net  (1,504)   
Loss on sale of assets  4,652   2,574 
   6,253   42,303 
Loss before interest and other financing expense, net  (2,473)  (11,992)
         
Interest and other financing expense, net     (385)
Loss before income taxes  (2,473)  (12,377)
         
Income tax expense (benefit)  (14)  762 
         
Loss from discontinuing operations  (2,459)  (13,139)
         
    Loss from discontinued operations, net of taxes     (125)
         
Loss $(2,459) $(13,264)

 

EXECUTION COPYNote 3

Summary of Significant Accounting Policies:

 

INTEREST CONTRIBUTION AGREEMENTAccounting Principles

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Certain reclassifications from the prior year presentation have been made to conform to the current year presentation. These reclassifications did not have material impact on the Company’s equity, net assets, results of operations or cash flows.

A-39 

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and the wholly and majority-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Entities in which the Company directly or indirectly owns more than 50% of the outstanding voting securities, and for which other interest holders do not possess the right to affect significant management decisions, are generally accounted for under the voting interest consolidation method of accounting. Participation of other interest holders in the net assets and in the earnings or losses of a consolidated subsidiary is reflected in the line items “Noncontrolling Interest” in the Company’s consolidated balance sheets and “net income (loss) attributable to the noncontrolling interest” in the Company consolidated statements of comprehensive loss. Noncontrolling interest adjusts the Company’s consolidated results of operations to reflect only the Company’s share of the earnings or losses of the consolidated subsidiary.

Any changes in the Company’s ownership interest in a consolidated subsidiary, through additional equity issuances by the consolidated subsidiary or from the Company acquiring the shares from existing shareholders, in which the Company maintains control is recognized as an equity transaction, with appropriate adjustments to both the Company’s additional paid-in capital and the corresponding noncontrolling interest.

Held for Sale Classification and Discontinued Operations

Under ASC 205 “Presentation of Financial Statement - Discontinued Operations”, a disposal group is reported as held for sale when management has approved or received approval to sell and is committed to a formal plan, the disposal group is available for immediate sale, the business is being actively marketed, the sale is anticipated to occur during the next 12 months and certain other specified criteria are met. A disposal group classified as held for sale is recorded at the lower of its carrying amount or estimated fair value less cost to sell. If the carrying value of the business exceeds its estimated fair value less cost to sell, a loss is recognized. However, when a disposal group meets the held for sale criteria, the Company first evaluates whether the carrying amounts of the assets not covered by ASC 360-10 included in the disposal group (such as goodwill) are required to be adjusted in accordance with other applicable GAAP before measuring the disposal group at fair value less cost to sell.

Assets and liabilities related to a disposal group classified as held for sale are segregated in the consolidated balance sheet in the period in which the disposal group is classified as held for sale (see also Note 2 and 4).

Only disposal of a component of an entity or a group of components of an entity that represents a strategic shift that has or will have a major effect on an entity’s operations and financial results shall be reported as discontinued operations.

The results of discontinued operations are reported in discontinued operations in the consolidated statement of comprehensive loss for current and prior periods commencing in the period in which the business meets the criteria of a discontinued operation, and include any gain or loss recognized on closing or adjustment of the carrying amount to fair value less cost to sell. Depreciation is not recorded on assets of a business while it is classified as held for sale (see also Note 2, Discontinued Operations).

 

Use of Estimates

The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect amounts reported of assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates and be based on events different from those assumptions. As part of these financial statements, the more significant estimates include (1) stock-based compensation; (2) identification of and measurement of instruments in equity transactions; (3) impairment of investment properties and investment in other company; (4) evaluation of going concern; and (5) contingencies.

Functional Currency

The currency of the primary economic environment in which the operations of the Company are conducted is the US dollar (“$” or “Dollars”). Thus, the functional currency of the Company and such subsidiaries (other than the foreign UK subsidiary as mentioned below) is the dollar (which is also the reporting currency of the Group). The operations of the UK subsidiary is conducted in the local currency of this subsidiary, which is Great Britain Pounds (GBP).

A-40 

In accordance with ASC 830, “Foreign Currency Matters”, balances denominated in, or linked to, foreign currencies are stated on the basis of the exchange rates prevailing at the balance sheet date. For foreign currency transactions included in the statement of comprehensive loss, the exchange rates applicable to the relevant transaction dates are used. Transaction gains or losses arising from changes in the exchange rates used in the translation of such balances are carried to financing income or expenses.

Assets and liabilities of foreign subsidiaries, whose functional currency is the local currency, are translated from its respective functional currency to U.S. dollars at the balance sheet date exchange rates. Income and expense items are translated at the average rates of exchange prevailing during the year. Translation adjustments are reflected in the consolidated balance sheets as a component of accumulated other comprehensive income or loss.

Fair Value Measurements

The Company measures and discloses fair value in accordance with ASC 820 “Fair Value”, which defines fair value, establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions there exists a three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Level 1 - unadjusted quoted prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date.

Level 2 - pricing inputs are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through corroboration with observable market data.

Level 3 - pricing inputs are unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or estimation. Fair value is determined using comparable market transactions and other valuation methodologies, adjusted as appropriate for liquidity, credit, market and/or other risk factors.

This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.

The fair value of cash and cash equivalents are based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other monetary assets and liabilities is estimated to be equal to their fair value due to the short-term nature of these instruments.

As of December 31, 2017, an option to purchase redeemable convertible preferred stock as embedded in the Purchase Agreement (see also Note 14) was measured at fair value on a recurring basis using level 3 inputs.

INTEREST CONTRIBUTION AGREEMENTCash and Cash Equivalents

The Company invested its excess cash in highly liquid short-term investments. The Company considered short-term investments that were purchased with an original maturity of three months or less to be cash equivalents.

Short-term Deposits

Short-term deposits are deposits with original maturities of more than three months but less than one year. Short-term deposits are presented at their costs including accrued interest.

Accounts Receivable and Allowance for Doubtful Accounts

The majority of the Company’s accounts receivable were due from consumers, distributors (domestic and international), physicians and other entities in the medical field, divisions which are no longer operated by the Company. Accounts receivable were most often due within 30 to 90 days and are stated at amounts due from customers net of an allowance for doubtful accounts. Accounts outstanding longer than the contractual payment terms were considered past due. Allowance for doubtful accounts was determined by considering a number of factors, including the length of time trade accounts receivable are past due, the Company’s previous loss history, the customer’s current ability to pay its obligation to the Company and available information about their credit risk, and the condition of the general economy and the industry as a whole. The Company wrote off accounts receivable when they were considered uncollectible, and payments subsequently received on such receivables were credited to the allowance for doubtful accounts. The Company did not recognize interest accruing on accounts receivable past due. As of December 31, 2016, the account receivable is included in the discontinued operation. As of December 31, 2017, there are no outstanding accounts receivable.

A-41 

Inventories

Inventories were stated at the lower of cost or market. Cost is determined to be purchased cost for raw materials and the production cost (materials, labor and indirect manufacturing cost, including sub-contracted work components) for work-in-process and finished goods. For the Company’s consumer and LHE products, cost was determined on the weighted-average method. For the pre-merged PhotoMedex products, cost was determined on the first-in, first-out method.

Reserves for slow moving and obsolete inventories were provided based on historical experience and product demand. Management evaluates the adequacy of these reserves periodically based on forecasted sales and market trend.

As of December 31, 2016, the inventory is included in the discontinued operation. As of December 31, 2017, there are no inventories.

Investment in Other Company

The investment in the other company is stated at cost, since the Company does not have the ability to exercise significant influence over operating and financial policies of those investees. The Company’s investments in the other company is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an investment may not be recoverable, in accordance with ASC 320 “Investments – Debt and Equity Securities”. As of December 31, 2017, based on managements’ most recent analyses, impairment losses have been identified in the amount of $862 (see also Notes 5 and 13).

Property, Equipment and Depreciation

Property and equipment are recorded at cost, net of accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, primarily three to seven years for computer hardware and software, furniture and fixtures, and machinery and equipment. Leasehold improvements are amortized over the lesser of the useful lives or lease terms. Expenditures for major renewals and betterments to property and equipment are capitalized, while expenditures for maintenance and repairs are charged as an expense as incurred. Upon retirement or disposition, the applicable property amounts are deducted from the accounts and any gain or loss is recorded in the consolidated statements of comprehensive loss. Useful lives are determined based upon an estimate of either physical or economic obsolescence or both.

Realizability of property and equipment was based on estimates of undiscounted future cash flows over the remaining useful life of the asset. If the amount of such estimated undiscounted future cash flows was less than the net book value of the asset, the asset was written down to fair value (see also Impairment of Long-Lived Assets and Intangibles).

Patent Costs and Licensed Technologies (this

Costs incurred to obtain or defend patents and licensed technologies were capitalized and amortized over the shorter of the remaining estimated useful lives or eight to 12 years. Core and product technology was also recorded in connection with the reverse acquisition on December 13, 2011 and was being amortized on a straight-line basis over ten years for core technology and five years for product technology (see also Note 8).

Management evaluated the recoverability of intangible assets based on estimates of undiscounted future cash flows over the remaining useful life of the asset. If the amount of such estimated undiscounted future cash flows is less than the net book value of the asset, the asset is written down to fair value. During the year ended December 31, 2016, the Company recorded an impairment of patents and licensed technologies in the amount of $1,261 which is included in discontinued operation (see also Impairment of Long-Lived Assets and Intangibles).

Other Intangible Assets

Other intangible assets were recorded in connection with the reverse acquisition on December 13, 2011. The assets which were determined to have definite useful lives were amortized on a straight-line basis over ten years. Such assets primarily included customer relationships and trademarks. (See Note 9).

A-42 

Accounting for the Impairment of Goodwill

The Company evaluates the carrying value of goodwill annually at the end of the calendar year and also between annual evaluations if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit to which goodwill was allocated to below its carrying amount. Such circumstances could include but are not limited to: (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. Goodwill impairment evaluation is performed subsequent to Impairment evaluation of long-lived assets and intangibles (see also Notes 6 and 7). Goodwill impairment testing involves a two-step process. Step 1 compares the fair value of the Group’s reporting units to which goodwill was allocated to their carrying values. If the fair value of the reporting unit exceeds its carrying value, no further analysis is necessary. The reporting unit fair value is based upon consideration of various valuation methodologies, including guideline transaction multiples, multiples of current earnings, and projected future cash flows discounted at rates commensurate with the risk involved. If the carrying amount of the reporting unit exceeds its fair value, Step 2 must be completed to quantify the amount of impairment. Step 2 calculates the implied fair value of goodwill by deducting the fair value of all tangible and intangible assets, excluding goodwill, of the reporting unit, from the fair value of the reporting unit as determined in Step 1. The implied fair value of goodwill determined in this step is compared to the carrying value of goodwill. If the implied fair value of goodwill is less than the carrying value of goodwill, an impairment loss, equal to the difference, is recognized. As part of the purchase price allocation for the 2011 reverse acquisition, the Company recorded goodwill in the amount of $24,005 and definite-lived intangibles in the amount of $12,000. Goodwill reflected the value or premium of the acquisition price in excess of the fair values assigned to specific tangible and intangible assets. Goodwill had an indefinite useful life and therefore was not amortized as an expense but was reviewed annually for impairment of its fair value to the Company. The fair value of Goodwill associated with the operating and reporting units was estimated using a combination of Income and Market Approach methodologies to valuation. The Income method of valuation explicitly recognizes the current value of future economic benefits developed by discounting future net cash flows to their present value at a rate that reflects both the current return requirements of the market and the risks inherent in the market. The Market approach measures the value of an asset through the analysis of recent sales or offerings of comparable property. Our business was organized into three operating and reporting units which were defined as Consumer, Physician Recurring, and Professional Equipment. Upon completion of our goodwill impairment analysis in connection with the transaction with ICTV Brands.

As of December 31, 2016, the Company recorded an impairment of the entire remaining balance of goodwill (allocated to consumer segment) in the amount of $2,257 which is included in discontinued operation. Such determination was based on the market approach.

Accrued Warranty Costs

The Company offered a standard warranty on product sales of its previous skin care business generally for a one to two-year period. The Company provided for the expected cost of estimated future warranty claims on the date the product is sold. Total accrued warranty was included in other accrued liabilities on the balance sheet. The activity in the warranty accrual during the years ended December 31, 2017 and 2016 is summarized as follows:

  December 31, 
  2017  2016 
Accrual at beginning of year $241  $330 
Additions charged to warranty expense     56 
Expiring warranties     (145)
Sale of consumer segment (*)  (241)    
Total (**)     241 
Less: current portion     (241)
Long term accrued warranty $  $ 

(*) The buyer of the remaining consumer products business assumed the warranty obligations.

(**) Included in liabilities related to assets held for sale.

For extended warranty on the consumer products, see also Revenue Recognition below.

Revenue Recognition

The Company recognized revenues from the product sales when the following four criteria have been met: (i) the product has been delivered and the Company has no significant remaining obligations; (ii) persuasive evidence of an arrangement exists; (iii) the price to the buyer is fixed or determinable; and (iv) collection is reasonably assured. Revenues from product sales are recorded net of provisions for estimated chargebacks, rebates, expected returns and cash discounts.

The Company shipped most of its products FOB shipping point, although from time to time certain customers, for example governmental customers, will be granted FOB destination terms. Among the factors the Company takes into account when determining the proper time at which to recognize revenue are (i) when title to the goods transfers and (ii) when the risk of loss transfers. Shipments to distributors or physicians that do not fully satisfy the collection criteria are recognized when invoiced amounts are fully paid or fully assured and included in deferred revenues until that time.

A-43 

For revenue arrangements with multiple deliverables within a single, contractually binding arrangements (usually sales of products with separately priced extended warranty), each element of the contract is accounted for as a separate unit of accounting when it provides the customer value on a stand-alone basis and there is objective evidence of the fair value of the related unit.

With respect to sales arrangements under which the buyer had a right to return the related product, revenue was recognized only if all the following conditions are met: the price was fixed or determinable at the date of sale; the buyer has paid, or was obligated to pay and the obligation was not contingent on resale of the product; the buyer’s obligation would not be changed in the event of theft or physical destruction or damage of the product; the buyer had economic substance; the Company did not have significant obligations for future performance to directly bring about resale of the product by the buyer; and the amount of future returns could be reasonably estimated.

The Company provided a provision for product returns based on the experience with historical sales returns, in accordance with ASC 605-15 with respect to sales of product when a right of return existed. Reported revenues are shown net of the returns provision. Such allowance for sales returns were included in Other Accrued Liabilities (see also Note 11).

Deferred revenue included amounts received with respect to extended warranty maintenance, repairs and other billable services and amounts not yet recognized as revenues. Revenues with respect to such activities were deferred and recognized on a straight-line basis over the duration of the warranty period, the service period or when service was provided, as applicable to each service. All such deferred revenues were derecognized.

Shipping and Handling Costs

Shipping and handling fees billed to customers were reflected as revenues while the related shipping and handling costs were included in selling and marketing expense. Shipping and handling costs have not been material.

Advertising Costs

Advertising costs were charged to expenses as incurred. Advertising costs were included in the loss on discontinued operations (see Note 2 Discontinued Operation).

Concentrations of credit risk

Financial instruments which subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The carrying amounts of these instruments approximate fair value due to their short-term nature. The Company deposits cash and cash equivalents and short-term deposits in major financial institutions in the US, UK, and in Israel. The Company performs periodic evaluations of the relative credit standing of these institutions. The Company is of the opinion that the credit risk in respect of these balances is immaterial. In addition, the Company performed with respect to its previous skin business an ongoing credit evaluation and established an allowance for doubtful accounts based upon factors surrounding the credit risk of customers (see also Accounts Receivable above).

Concentrations of credit risk

Most of the Company’s sales were generated in North America and Asia Pacific, to a large number of customers. Management periodically evaluated the collectability of the trade receivables to determine the amounts that were doubtful of collection and determine a proper allowance for doubtful accounts. Accordingly, the Company’s trade receivables did not represent a substantial concentration of credit risk.

Income Taxes

The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting and tax basis of assets and liabilities and are measured using enacted tax rates and laws that are expected to be in effect when the differences reverse. Any resulting net deferred tax assets are evaluated for recoverability and, accordingly, a valuation allowance is provided when it is more likely than not that all or some portion of the deferred tax asset will not be realized.

A-44 

The Company or its subsidiaries may incur additional tax liabilities in the event of an intercompany dividend distribution or a deemed dividend distribution under the U.S. income tax law and regulations. Prior to 2014, it was the Company’s policy not to cause a distribution of dividends which would generate an additional tax liability to the Company. During the years ended December 31, 2014 and 2015, the Company’s affiliates borrowed funds from the subsidiary in Israel. These borrowings resulted in a large deemed distribution taxable in the U.S. Furthermore, management can no longer represent that the earnings of its non U.S. subsidiaries will remain permanently invested outside the U.S. Therefore, beginning in 2014, the Company has provided deferred taxes on the undistributed earnings of its non U.S. subsidiaries. Taxes, which may apply in the event of a disposal of investments in subsidiaries, have not been included in computing the deferred taxes, as the Company anticipates it would liquidate those subsidiaries that can be closed on a tax-free basis.

The Company accounts for uncertain tax positions in accordance with an amendment to ASC 740-10,AgreementIncome Taxes” which clarified the accounting for uncertainty in tax positions. This amendment provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded.

During the years ended December 31, 2017 and 2016, the Company determined that the liability for unrecognized tax benefits could suitably be extinguished by application of net operating loss carryforwards and carrybacks, with any residual impact arising as a liability in 2017 and 2016 that has been duly provided for.

Contingencies

The Company and its subsidiaries are involved in certain legal proceedings that arise from time to time in the ordinary course of business. We account for business contingent liabilities in accordance with ASC 450 “Contingencies”. Except for income tax contingencies, the Company records accruals for contingencies to the extent that the management concludes that the occurrence is probable and that the related amounts of the loss can be reasonably estimated. A provision is recorded when it is both probable and when a liability has been incurred and the related amounts of the loss can be reasonably estimated. Legal expenses associated costs incurred in connection with the contingencies are expensed as incurred.

With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. Other than the matters discussed in Note 13, as of December 31, 2017, the Company is not a party to any other litigation that it believes would have a material adverse effect on the Company’s business, financial position, results of operations or cash flows.

Impairment of Long-Lived Assets and Intangibles

Long-lived assets, such as property and equipment, and definite-lived intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset (or group of assets) may not be recoverable. Impairment test is applied at the lowest level where there are identifiable independent cash flows, which may involve a group of assets.

Recoverability of assets to be held and used (or group of assets) is measured by a comparison of the carrying amount of an asset to the undiscounted cash flows expected to be generated by the asset. If an asset is determined to be impaired, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell and are no longer depreciated. The assets and liabilities of a disposed group classified as discontinued operations are presented separately in the appropriate asset and liability sections of the balance sheet.

Indefinite-life intangible assets are tested for impairment, on an annual basis or more often, when triggering events indicate that it is more likely than not that the asset is impaired, by comparing the fair value of the asset with its carrying amount. If the carrying amount of the intangible asset exceeds its fair value, an impairment loss is recognized in the amount of that excess. Subsequent reversal of a previously recognized impairment loss is prohibited.

Pursuant to ASC 360 the Company tested the long-lived assets and determined that changes in circumstances indicated that its carrying value may not be recoverable. The carrying amount of the assets is considered recoverable if it exceeds the sum of undiscounted cash flows expected from the use or eventual disposition of the asset. Upon completion of our goodwill impairment analysis in connection with the pending transaction with ICTV Brands, as of December 31, 2016, the Company recorded an impairment of the entire remaining balance of Consumer segment goodwill in the amount of $2,257. The Company recorded an impairment of the Consumer segment intangibles for its entire remaining Licensed Technology balance in the amount of $1,261. These impairment charges are included in discontinued operations.

A-45 

Loss per Share (As Restated)

The Company computes net loss per share in accordance with ASC 260, “Earnings per share”. Basic loss per share are computed by dividing net loss by the weighted-average number of common shares outstanding during the period, net of the weighted average number of treasury shares (if any). Securities that may participate in dividends with the Common Stock (such as the convertible Preferred Stock Series A and Series B) are considered in the computation of basic income per share using the two-class method. However, in periods of net loss, participating securities are included only if the holders of such securities have a contractual obligation to share the losses of the Company. Accordingly, the outstanding Series A preferred shares were included in the computation, while the Series B preferred shares were not.

Diluted loss per common share is computed similar to basic earnings per share, except that the denominator is increased to include the number of additional potential common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Potential common shares are excluded from the computation for a period in which a net loss is reported or if their effect is anti-dilutive. The Company’s potential common shares consist of stock options, stock warrants and restricted stock awards issued under the Company’s stock incentive plans and their potential dilutive effect is considered using the treasury method and of convertible Preferred Stock Series A and Series B which their potential dilutive effect is considered using the “if-converted method”.

The net loss from continuing operations and the weighted average number of shares used in computing basic and diluted net loss per share from continuing operations for the years ended December 31, 2017 and 2016, is as follows: (in thousands except share and per share amounts)

  Year ended December 31, 
  2017  2016 
  (As Restated)    
       
Numerator:        
Net loss attributable to common stockholders $19,384  $13,264 
Net loss from discontinued operations attributable to common stockholders  (2,459)  (13,264)
Accretion of dividend for the period (*)  3    
Participation of stockholders of series A preferred stock in the net loss from continuing operations  (1,365)   
         
Net loss from continuing operations attributable to common stockholders $       15,563  $ 
         
Denominator:        
Shares of common stock used in computing basic and diluted net loss per share  5,073,751   4,171,549 
         
Net loss per share of Ordinary Share from continuing operations, basic and diluted $3.07  $ 

(*)The net loss used for the computation of basic and diluted net loss per share for the year ended December 31, 2017, includes the dividend requirement of 8% per share per annum for the Series B preferred stock, compounded annually which shall be distributed to stockholders in case of distributable assets determined in the Company’s certificate of designation (the “Certificate of Designation”) under the liquidation preference right (see also Note 14).

For the year ended December 31, 2017, diluted loss per share excludes the impact of stock options, stock warrants, series Preferred A Stock, series Preferred B Stock, common stock to be issued upon exercise of asset contribution financial instruments and common stock to be issued upon written call option totaling 43,053,913 shares, as the effect of their inclusion would be anti-dilutive. For the year ended December 31, 2016, diluted loss per share excludes the impact of stock options totaling 1,000 shares.

Convertible Redeemable Series B Preferred Stock

The Company classifies its Convertible Redeemable Series B Preferred Stock outside of Stockholders’ deficit because certain features of the Company’s Certificate of Designation could require redemption of some or all classes of Convertible Redeemable Series B Preferred Stock upon events not solely within the control of the Company (see also Note 14).

A-46 

Option to purchase Convertible Redeemable Series B Preferred Stock:

The Company has classified the option to purchase additional shares of its Convertible Redeemable Series B Preferred Stock as a liability in accordance with ASC 480, “Distinguishing Liabilities from Equity as the underlying Series B Preferred Shares are subject to redemption feature. The Company measures the option at fair value by using the Black Scholes Pricing Model in each reporting period until they are exercised or expired, with changes in the fair values being recognized in the Company’s statement of comprehensive loss (see also Note 14).

Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation Stock Compensation. Under”, (“ASC 718”), which requires companies to estimate the fair value recognition provision, of this statement, share-equity based compensation cost is datedmeasured at payment awards on the date of grant date based on the fair using an option pricing model. The value of the portion of the award that is ultimately expected to vest and is recognized as operating an expense over the applicable vesting period of requisite service periods in the stock award using Company’s consolidated statement of comprehensive loss.

The Company recognizes compensation expense for the value of its awards granted based on the graded vesting method over the requisite or derived service period of each of the awards, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model which requires a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon historical daily stock price observations of its common stock. The expected option term represents the period that the Company’s stock options are expected to be outstanding and is determined based on the simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends. 

Recently Issued Accounting Standards

Recent Accounting Pronouncements adopted

On March 30, 2016, the FASB issued ASU 2016-09, “Compensation-Stock Compensation”, which effects all entities that issue share-based payment awards to their employees. The amendments in this update cover such areas as the recognition of excess tax benefits and deficiencies, the classification of those excess tax benefits on the statement of cash flows, an accounting policy election for forfeitures, the amount an employer can withhold to cover income taxes and still qualify for equity classification and the classification of those taxes paid on the statement of cash flows. This update is effective for annual and interim periods beginning after December 15, 2016. This guidance can be applied either prospectively, retrospectively or using a modified retrospective transition method. The Company adopted the new guidance prospectively effective January 1, 2017. This new guidance did not have a material impact on the Company’s consolidated financial statements.

Recent Accounting Pronouncements not adopted yet

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (ASU 2014-09), which amends the existing accounting standards for revenue recognition. In August 2015, FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delays the effective date of ASU 2014-09 by one year. FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. The new revenue recognition standard will be effective in the first quarter of 2018, with the option to adopt it in the first quarter of 2017. The Company currently anticipates adopting the new standard effective January 1, 2018. The new standard also permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective method). In April 2016, FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. ASU 2016-10 covers two specific topics: performance obligations and licensing. This amendment includes guidance on immaterial promised goods or services, shipping or handling activities, separately identifiable performance obligations, functional or symbolic intellectual property licenses, sales-based and usage-based royalties, license restrictions (time, use, geographical) and licensing renewals. In addition, in May 2016, FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, which is intended to not change the core principle of the guidance in Topic 606, but rather affect only the narrow aspects of Topic 606 by reducing the potential for diversity in practice at initial application and by reducing the cost and complexity of applying Topic 606 both at transition and on an ongoing basis. The Company is not expecting that the adoption of this standard will have a material impact on its financial statements and related disclosures. 

A-47 

In February 2016, the FASB issued ASU 2016-02, “Leases”. This guidance will require that lease arrangements longer than 12 months result in an entity recognizing an asset and liability equal to the present value of the lease payments in the statement of financial position. This guidance is effective for annual periods beginning after December 15, 2018, and interim periods therein. This standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of ASU 2016-02 will have on its financial statements and related disclosures.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): “Restricted Cash” (ASU 2016-18), which requires companies to include amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period, however, the Company has not elected to early adopt ASU 2016-18. This new guidance is not expected to have a material impact on the Company’s consolidated financial statements. 

In January 2017, the FASB issued ASU 2017-01 Business Combinations (Topic 805): “Clarifying the Definition of a Business”. ASU 2017-01 provides amendments to clarify the definition of a business and affect all companies and other reporting organizations that must determine whether they have acquired or sold a business. The amendments are intended to help companies and other organizations evaluate whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The guidance is effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years and should be applied prospectively as of the beginning of the period of adoption. Early adoption is permitted under certain circumstances. The Company is currently evaluating the potential effect of the guidance on its consolidated financial statements.

In May 2017, the FASB issued ASU 2017-09 “Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting”, which includes guidance on changes to terms and conditions of share-based payment awards. The amendment provides guidance about which changes to terms or conditions of a share-based payment award require an entity to apply modification accounting. The guidance will be effective for the fiscal year beginning on January 1, 2018, including interim periods within that year (early adoption is permitted). The Company is currently evaluating the potential effect of the guidance on its consolidated financial statements.

Note 4

Discontinued Operations Assets Held for Sale:

A disposal group is reported as held for sale when management has approved or received approval to sell and is committed to a formal plan, the disposal group is available for immediate sale, the business is being actively marketed, the sale is anticipated to occur during the next 12 months and certain other specified criteria are met. A disposal group classified as held for sale is recorded at the lower of its carrying amount or estimated fair value less cost to sell. If the carrying value of the business exceeds its estimated fair value less cost to sell, a loss is recognized. However, when disposal group meets the held for sale criteria, the Company first evaluates whether the carrying amounts of the assets not covered by ASC 360-10 included in the disposal group (such as goodwill) are required to be adjusted in accordance with other applicable GAAP before measuring the disposal group at fair value less cost to sell.

Assets and liabilities related to a disposal group classified as held for sale are segregated in the consolidated balance sheet in the period in which the disposal group is classified as held for sale.

Only disposal of a component of an entity or a group of components of an entity that represents a strategic shift that has or will have a major effect on an entity’s operations and financial results shall be reported as discontinued operations. The revised guidance did not change the criteria required to qualify for held for sale presentation.

A-48 

In connection with the sale of the Consumer Division to ICTV Brands, Inc., announced on October 4, 2016 and subsequently completed on January 23, 2017, the assets related to this transaction were included as of December 31, 2016 as part of Assets Held for Sale, as follows:

Inventory $7,336 
Property and equipment  911 
Other assets  115 
Assets held for sale as of December 31, 2016 $8,362 

A-49 

Note 5

Acquisitions:

On March 31, 2017, the Company and its newly-formed subsidiary FC Global Realty Operating Partnership, LLC, a Delaware limited liability company (“Acquiror”) entered into an Interest Contribution Agreement (the Execution Date“Contribution Agreement”), by and among with First Capital Real Estate Operating Partnership, L.P., a Delaware limited partnership (“ContributorContributor”), and First Capital Real Estate Trust Incorporated, a Maryland corporation, (the Contributor Parent“Contributor Parent” and, together with Contributor, the Contributor Parties“Contributor Parties”), FC Global Realty Operating Partnership, LLC,under which the Contributor will contribute mostly certain real estate assets (the “Contributed Properties”) to the Company’s subsidiary. In exchange, the Contributor will receive shares of the Company’s Common Stock and/or newly designated Series A Convertible Preferred Stock.

The first installment of contributed assets (the “First Contribution”) closed on May 17, 2017 (the “Initial Closing”).

First Contribution

In the Initial Closing, the Contributor transferred certain assets comprising the Contributed Properties to the Company. On the Initial Closing date, the Contributor transferred to the Acquiror four vacant land sites set for development into gas stations, which are located in Atwater and Merced, Northern California, and which had an agreed upon value of approximately $2.6 million.  One of these vacant land sites was contributed through the transfer of a Delaware75% membership interest in a limited liability company (“Acquiror”),that owns the vacant land site located in Northern California, in which profits and PhotoMedex, Inc.,losses are allocated 75% to the Company and 25% to the noncontrolling member subject to a Nevada corporation (“Acquiror Parentpreferred equity split in which the noncontrolling member earns the first 10% of net profits and together with Acquiror, the Acquiror Parties”). Eachbalance of the Contributor Parties and each of the Acquiror Parties90% is referred to herein individually as a “Party” and collectively as the “Parties”).

RECITALS:

WHEREAS, the Contributor owns the Contributed Entities (as defined below) and owns interests in certain real estate properties that are not owned by the Contributed Entities (the “Contributed Real Properties” and collectively with the Contributed Entities, the “Contributed Interests”), as more fully described herein;

WHEREAS, Contributor desires to contribute the Contributed Interests to Acquiror, and Acquiror desires to acquire the Contributed Interests from Contributor, subject to the terms and conditions set forth in this Agreement (the “Contribution”);

NOW, THEREFORE, in consideration of the premises and of the respective promises, representations, warranties, covenants, conditions, and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

ARTICLE 1

CONTRIBUTION

1.1           Contribution. Subject to the terms and conditions contained in this Agreement, Contributor agrees to, and Contributor Parent agrees to cause Contributor to, contribute the Contributed Interests to Acquiror, and Acquiror agrees to, and Acquiror Parent agrees to cause Acquiror to, acquire and accept the Contributed Interests, subject to the Assumed Liabilities (as herein defined), and Acquiror Parent agrees to issue to Contributor or its designee or designees in consideration therefor the Transaction Shares (as herein defined).

1.2           Certain Definitions. As used herein, the following terms have the meanings ascribed to them below and other capitalized terms have the meanings ascribed to them throughout this Agreement:

(a)          “Acquiror Group” means the Acquiror Parent and its consolidated Subsidiaries.

(b)          “Acquiror Material Adverse Effect” means any event, condition, change, development, circumstance or set of facts that, individually or in the aggregate with any other such events, conditions, changes, developments, circumstances or sets of facts, (i) has a material adverse effect on the business, financial condition or results of operations of the Acquiror Group, taken as a whole, or (ii) prevents or materially delays the performance of the Acquiror Parties’ obligations and covenants hereunder or the consummation by the Acquiror Parties of the Transactions contemplated hereby and by the other Transaction Agreements;provided,however, that the term “Acquiror Material Adverse Effect” shall not include any event, condition, change, development, circumstance or set of facts resulting from compliance by Acquiror Parties withbe paid along the terms of this Agreementthe 75% split to the Company and each other Transaction Agreement, or actions expressly permitted by this Agreement or expressly taken with25% to the written consentnoncontrolling member. The Contributor then completed the transfer to the Acquiror of Contributor Parent.its 17.9% passive interest in a limited liability company that is constructing a single family residential development located in Los Lunas, New Mexico (the “Avalon Property”) on June 26, 2017.

 

1

(c)          “Acquiror Parent Common Stock” meansThis residential development in New Mexico consisted of 251, non-contiguous, single family residential lots and a 10,000 square-foot club house. 37 of the common stocklots had been finished, and the remaining 214 were platted and engineered lots. The agreed upon value of Acquiror Parent, par value $0.01 per share.its share of this property was approximately $7.4 million. 

 

(d)          “Acquiror Parent Preferred Stock” meansIn return for the Series A Preferred StockContributed Properties, the Company issued to the Contributor 879,234 duly authorized, fully paid and non-assessable shares of Acquiror Parent,the Company’s common stock, par value $0.01 per share having(the “Common Stock”), which represented approximately 19.9% of the relative rights, designations, preferencesCompany’s issued and limitations specifiedoutstanding Common Stock immediately prior to the Initial Closing, at an agreed upon Per Share Value (defined below) of $2.5183, or $2,214 in the Certificateaggregate. These shares of Designation.

(e)          “Acquiror Parent Securities” means the Acquiror Parent Shares and the Warrant (as defined inSection 9.1(b)(ii) below) (including the Acquiror Parent Common Stock underlying the Warrant.)

(f)          “Acquiror Parent Shares” means shares of Acquiror Parent Common Stock or Acquiror Parent Preferred Stock, as applicable.

(g)          “Acquiror Required Consents” means the consents referred to inSection 5.5 hereof.

(h)          “Additional Contributed Entities” means the entities thatare restricted and unregistered. The Company issued the Additional Contributed Interests.

(i)     ��    “Additional Contributed Interests” means the Optional Entity Interests (as defined inSection 9.1(a)) and the Mandatory Entity Interests (as defined inSection 9.2(a)).

(j)          “Additional Contributed Properties” means any properties owned by an Additional Contributed Entity.

(k)          “Affiliate” means, with respect to any Person, a Person that directly or indirectly controls, is controlled by, or is under common control with, such Person.

(l)          “Approval Date” means the date the stockholdersremaining $7,786 of the Acquiror Parent approve each ofapproximately $10 million agreed upon consideration to the matters set forth inSection 6.6at the Special Meeting.

(m)          “Assignment and Assumption Agreement” means the Assignment and Assumption AgreementContributor in the form attached hereto asExhibitof 123,668 shares of the Company’s newly designated non-voting Series A Convertible Preferred Stock, par value $0.01 per share (the “Series A Stock” or “Convertible Series A Preferred Stock”).

(n)          “Assumed Liabilities” means Each share of the obligations (whether fixed or contingent)Series A Stock is convertible into 25 shares of Contributor or its Affiliates pursuantthe Company’s Common Stock, subject to the agreements and other documents set forth onSchedule 1.2(n) hereof, as they exist on the Closing Date with respect to each Closing hereunder.

(o)          “Business Day” means any day other than a Saturday, a Sunday, or a day on which banks are closed for businesssatisfaction of certain conditions, including stockholder approval in New York, New York, United States of America.

(p)          “Certificate of Designation” means the Certificate of Designation of the Acquiror Parent Preferred Stock in the form ofExhibit B to this Agreement.

(q)          “Code” means the United States Internal Revenue Code of 1986, as amended.

(r)          “Commission” means the U.S. Securities and Exchange Commission.

2

(s)          “Contracts” means all currently existing contracts, agreements, and instruments to which a Person is a party or by which any Person is bound or to which any of its assets is subject.

(t)          “Contributed Entities” means the entities described onSchedule 4.7(a) hereof, as they exist on the Closing Date with respect to each Closing hereunder.

(u)          “Contributed Interests” means the Interests of the Contributor or its Affiliates in the Contributed Real Properties and the Contributed Entities.

(v)         “Contributor Group” means the Contributor Parent and its consolidated Subsidiaries.

(w)          “Contributor Material Adverse Effect” means any event, condition, change, development, circumstance or set of facts that, individually or in the aggregate with any other such events, conditions, changes, developments, circumstances or sets of facts, (i) has a material adverse effect on the business, financial condition or results of operations of the Contributed Entities or the Contributed Properties, taken as a whole, or (ii) prevents or materially delays the performance of the Contributor Parties’ obligations and covenants hereunder or the consummation by the Contributor Parties of the Transactions contemplated hereby and by the other Transaction Agreements;provided, however, that the term “Contributor Material Adverse Effect” shall not include any event, condition, change, development, circumstance or set of facts resulting from compliance by Contributor Partiesaccordance with the termsrules of this Agreement and each other Transaction Agreement, or actions expressly permitted by this Agreement or expressly taken with the written consent of Acquiror Parent.

(x)          “Contributor Required Consents” means the consents referred to inSection 4.5 hereof.

(y)          “Control” and derivatives of such term mean having the ability, whether or not exercised, to direct the management or policies of a Person through ownership of a voting Interest, pursuant to a written agreement, or otherwise.

(z)          “Employee Benefit Plan” means any “employee benefit plan” (within the meaning of Section 3(3) of ERISA, regardless of whether such plan is subject to ERISA), and any other personnel policy (oral or written), equity option, restricted equity, equity purchase plan, other equity or equity-based compensation plan or arrangement, phantom equity or appreciation rights plan or arrangement, collective bargaining agreement, bonus plan or arrangement, incentive award plan or arrangement, vacation or holiday pay policy, retention or severance pay plan, policy or agreement, deferred compensation agreement or arrangement, change in control, hospitalization or other welfare, medical, dental, vision, accident, disability, life or other insurance, executive compensation or supplemental income arrangement, consulting agreement, employment, severance or retention agreement, and any other plan, agreement, arrangement, program, practice, or understanding providing any compensation or benefits.

(aa)         “Encumbrances” means liens, pledges, charges, encumbrances, claims, mortgages, deeds of trust, security interests, restrictions, rights of first refusal, defects in title, or other burdens, options or encumbrances of any kind.

3

(bb)         “Environmental Laws” means the Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C. § 9601et seq.; the Resource Conservation and Recovery Act, 42 U.S.C. § 6901et seq.; the Federal Water Pollution Control Act, 33 U.S.C. § 1251et seq.; the Clean Air Act, 42 U.S.C. § 7401et seq.; the Hazardous Materials Transportation Act, 49 U.S.C. § 5101et seq.; the Toxic Substances Control Act, 15 U.S.C. §§ 2601 through 2629; the Oil Pollution Act, 33 U.S.C. § 2701et seq.; the Emergency Planning and Community Right-to-Know Act, 42 U.S.C. § 11001et seq.; and the Safe Drinking Water Act, 42 U.S.C. §§ 300f through 300j; the Endangered Species Act, 16 U.S.C. § 1531 et seq., in each case as amended to the date hereof, and all similar Laws as of the date hereof of any Governmental Authority having jurisdiction over the property in question addressing pollution or protection of the environment, natural resources, or biological or cultural resources and all regulations implementing the foregoing.

(cc)         “Environmental Liabilities” means any and all environmental, corrective action and response costs (including costs of remediation), damages, natural resource damages, settlements, consulting fees, expenses, penalties, fines, orphan share, prejudgment and post-judgment interest, court costs, attorneys’ fees and other liabilities incurred or imposed (a) pursuant to any order, notice of responsibility, directive (including requirements embodied in Environmental Laws), injunction, judgment or similar act (including settlements) by any Governmental Authority or court of competent jurisdiction to the extent arising out of any violation of, or remedial obligation under, any Environmental Laws or (b) pursuant to any claim or cause of action by a Governmental Authority or other Person for personal injury, property damage, damage to natural resources, remediation or response costs to the extent arising out of any violation of, or any remediation obligation under, any Environmental Laws.

(dd)         “Environmental Permits” means any and all licenses, certificates, permits, directives, requirements, registrations, government approvals, agreements, authorizations, and consents that are required under or are issued pursuant to any Environmental Laws.

(ee)         “ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations thereunder.

(ff)         “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.

(gg)         “GAAP” means United States generally accepted accounting principles, consistently applied.

(hh)         “Governmental Authority” means any national government and/or government of any domestic or foreign state, territory or other political subdivision, and departments, courts, commissions, boards, bureaus, ministries, agencies, or other instrumentalities of any of them.

(ii)         “Hazardous Materials” means any pollutants, contaminants, toxic or hazardous substances, materials, wastes, constituents, compounds or chemicals that are regulated by, or may form the basis of liability under any Environmental Laws, including (a) petroleum hydrocarbons, petroleum products, petroleum substances, natural gas, crude oil, or any components, fractions, or derivatives thereof, and (b) asbestos-containing materials and polychlorinated biphenyls.

(jj)         “HSR Act” means the Hart Scott Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulation thereunder.

(kk)         “Income Tax” shall mean any income, capital gains, franchise and similar Tax.

4

(ll)         “Indebtedness” of any Person means, without duplication: (i) indebtedness of such Person for borrowed money; (ii) obligations of such Person to pay the deferred purchase or acquisition price for any assets or property of such Person; (iii) reimbursement obligations of such Person in respect of drawn letters of credit or similar instruments issued or accepted by banks and other financial institutions for the account of such Person; (iv) obligations of such Person under any lease to the extent such obligations are required to be classified and accounted for as a capital lease on a balance sheet of such Person under GAAP; (v) indebtedness of others as described inclauses (i) through(iv) above guaranteed by such Person; but Indebtedness does not include accounts payable to trade creditors or accrued expenses, in each case arising in the ordinary course of business consistent with past practice and that are not yet due and payable, or are being disputed in good faith, and the endorsement of negotiable instruments for collection in the ordinary course of business.

(mm)         “Initial Contributed Interests” shall mean the properties or entities set forth onSchedule 1.2(mm) hereto.

(nn)         “Interest” means, with respect to any Person: (i) capital stock, membership interest, partnership interest, other equity interest, rights to profits or revenue and any other similar interest of such Person; (ii) any security or other interest convertible into or exchangeable or exercisable for any of the foregoing; and (iii) any right (contingent or otherwise) to subscribe for, purchase or otherwise acquire any of the foregoing.

(oo)         “Laws” means all laws, statutes, rules, regulations, ordinances, orders, decrees, requirements, judgments, and codes of Governmental Authorities, including, without limitation, Environmental Laws and the Code.

(pp)         “Lock Up Agreement” means the Lock Up Agreement to be signed by certain Affiliates of the Contributor Parties and the Acquiror Parties in the form ofExhibit C to this Agreement.

(qq)         “Maryland Statute” means the General Corporation Law of the State of Maryland, as amended from time to time.

(rr)         “Material Contract” means any Contract or document which is one or more of the following types:

(i)          Organizational Documents of any Party or any of its controlled Affiliates;

(ii)         Contracts with any Party or any of their controlled Affiliates other than contracts solely between or among a Party and its wholly-owned Subsidiaries or among such Subsidiaries;

(iii)        operating agreements, development agreements, or other similar agreements requiring any Party or any of its controlled Affiliates to make expenditures that would reasonably be expected to be in excess of $25,000 in the aggregate during the twelve (12)-month period following the Execution Date, other than customary joint operating agreements;

(iv)        non-competition agreements or any agreements that restrict, limit, or prohibit any Party or any of its controlled Affiliates from engaging in any line of business or the way such entity conducts business, including area of mutual interest agreements, during any period after the Initial Closing;

(v)         indentures, mortgages or deeds of trust, loans, credit or note purchase agreements, sale-lease back agreements, guaranties, bonds, letters of credit, or similar financial agreements or other agreements or instruments governing Indebtedness;

5

(vi)        Contributed Leases involving aggregate payments in excess of $10,000 in any calendar year;

(vii)       contracts for the construction and installation or rental of equipment, fixtures, or facilities with guaranteed production throughput requirements or demand charges or involving aggregate payments per contract in excess of $10,000 in any calendar year, which, in either case, cannot be terminated by a Party or its Affiliates without penalty on sixty (60) days or less notice; and

(viii)      agreements that could reasonably be expected to result in (A) aggregate payments by Party or its Affiliates of more than $5,000 or (B) revenues of more than $5,000 during the current or any subsequent calendar year.

(ss)         “NASDAQ” means The Nasdaq Stock Market Inc.(“Nasdaq”), which was obtained on October 12, 2017. The shares of Series A Stock do not have voting rights and are restricted and unregistered. The number of shares of Common Stock issued to the eachContributor and to be issued upon conversion of the Nasdaq Market tiers.

(tt)         “Nevada Statute” meansSeries A Stock was determined by dividing the Revised Statutes$10 million agreed upon value of the State of Nevada, as amended from time to time.

(uu)         “Organizational Documents” means (i) with respect toContributed Assets by $2.5183, a corporation, the charter, articles or certificate of incorporation, as applicable, and bylaws thereof, and any certificate of designations pursuant thereto, (ii) with respect to a limited liability company, the certificate of formation or organization, as applicable, and the operating agreement or limited liability company agreement thereof, (iii) with respect to a partnership, the certificate of formation and the partnership agreement thereof, and (iv) with respect to any other Person, the organizational, constituent and/or governing documents and/or instruments of such Person.

(vv)         “Per Share Value” meansspecified price per share value which represents a 7.5% premium above the volume-weighted average price (“VWAPVWAP”) of all on-exchange transactions in Acquiror Parent Sharesthe Company’s Common Stock executed on NASDAQNasdaq during the Forty-Three (43) NASDAQforty-three trading days (each a “Trading Day”) prior to the Trading Daytrading day immediately prior to the public announcement of the transaction by the Acquiror ParentCompany and the Contributor Parent, of the Transaction, as reported by Bloomberg L.P. (the “Per Share Value”). The shares of Common Stock both issued to the Contributor and issuable upon the conversion of the Series A Stock carry certain registration rights as specified in a Registration Rights Agreement dated May 17, 2017.

At the Initial Closing, the Company assumed the liabilities associated with the Contributed Properties, except that it did not assume any liabilities with respect to the Avalon Property until that property’s contribution was completed on June 26, 2017. The obligations that the Acquiror assumed at the Initial Closing include the following: Obligations of the Contributor and its affiliates under certain agreements covering the contributed properties, including an Operating Agreement of Central Valley Gas Station Development, LLC, a Delaware limited liability company, dated January 28, 2013, and all amendments thereto; and a Construction Contract dated November 19, 2014 between Central Valley Gas Stations Development, LLC, as owner and First Capital Builders, LLC, as Contractor, with respect to the project known commonly as Green Sands and Buhach Rd., Atwater, CA. Once the full interest in the Avalon Property was contributed to the Company, the Company also assumed the Operating Agreement of Avalon Jubilee, LLC, a New Mexico limited liability company dated as of May 16, 2012, and all amendments thereto; and a Development Services Agreement dated September 15, 2015 by and between UR-FC Contributed Assets, LLC, a Delaware limited liability company, as Owner, and Land Strategies, LLC, a Nevada limited liability company, as Developer, with respect to real property owned by Avalon Jubilee, LLC. As of the Initial Closing, the Company also assumed an installment note dated April 7, 2015 made by First Capital Real Estate Investments, LLC (“FCREI”) in favor of George Zambelli (“Zambelli”) in the original principal amount of $470 (the “Note”) and a Long Form Deed of Trust and Assignment of Rents dated April 7, 2015 between FCREI, as Trustor, Fidelity National Title Company, as Trustee (“Trustee”), and Zambelli, as Beneficiary (the “Deed of Trust”), which secures the Note (see also Note 12).

A-50 

Second Contribution

Contributor Parent was also required to contribute two additional property interests valued at the agreed upon value amount of $20 million if certain conditions as set forth in the Contribution Agreement are satisfied by December 31, 2017. This second installment was mandatory under the original terms of the Contribution Agreement. As discussed below, the contribution Agreement was terminated and this second contribution did not take place.

The agreement stated that Contributor Parent must contribute to the Acquirer its 100% ownership interest in a private hotel that was currently undergoing renovations to convert to a Wyndham Garden Hotel. This 265 room full service hotel was located in Amarillo, Texas and had an agreed upon value of approximately $16 million and outstanding loans of approximately $10.11 million. Before contributing the property to the Acquiror, Contributor Parent was required to resolve a lawsuit concerning ownership of the property. Only when Contributor Parent had confirmed that it was the full and undisputed owner of the property was it able to contribute that interest to the Acquiror. If the contribution was made, the Company would have been required to account for this transaction as a business combination under ASC 805, Business Combinations.

On July 3, 2017, the Company and the Acquiror entered into an Agreement to Waive Second Closing Deliverables (the “Second Waiver”) with the Contributor Parties, amending the Contribution Agreement. The Contributor Parties had received an offer to purchase the Amarillo Hotel from a non-related third party. Under the Second Waiver, the Company and the Acquiror agreed to waive the requirement for the Contributor Parties to contribute to the Acquiror their 100% ownership interest in the Amarillo Hotel, and to accept in its place a contribution in cash of not less than $5.89 million from the Contributor Parties from the sale proceeds of the Amarillo Hotel, after the satisfaction of the outstanding loan, provided that the sale is completed and closed upon not later than August 31, 2017. In exchange the Contributor Parties would receive shares of stock in the Company, such amount to be calculated as set forth in the Second Waiver and Contribution Agreement. The sale of the Amarillo Hotel was not completed and closed by August 31, 2017, therefore the waiver of the requirement for the contribution of the interest in the Amarillo Hotel lapsed.

On September 22, 2017, the Company and Acquiror entered into a Second Agreement to Waive Closing Deliverables (the “Second Agreement”) with the Contributor Parties, amending the Contribution Agreement. Pursuant to the terms of the Second Agreement, the Company and the Acquiror agreed to extend the date for the closing of the sale of the Amarillo Hotel until October 18, 2017, with the contribution of the funds from the sale to be made not later than October 23, 2017. In exchange the Contributor Parties would receive shares of stock in the Company, such amount to be calculated as set forth in the Contribution Agreement, as amended by the Second Waiver and the Second Agreement. If the sale of the Amarillo Hotel was not completed and closed by October 18, 2017, the waiver of the requirement for the contribution of the interest in the Amarillo Hotel would lapse. The sale was not completed.

In addition, the agreement stated that Contributor Parent must contribute to the Acquiror its interest in Dutchman’s Bay and Serenity Bay (referred to as the “Antigua Resort Developments”), two planned full-service resort hotel developments located in Antigua and Barbuda in which Contributor Parent would contribute a 75% interest in coordination with the Antigua government. Serenity Bay is a planned five-star resort comprised of five contiguous parcels (28.33 acres) zoned for hotel and residential use that are planned for 246 units and 80 one, two and three-bedroom condo units. Dutchman’s Bay is a planned four star condo hotel with 180 guestrooms, 102 two bedroom condos, and 14 three bedroom villas. For the property in Antigua, Contributor Parent was required to obtain an amendment to its agreement with the government to extend the time for development of these properties and confirm that all development conditions in the original agreement with the government had been either satisfied or waived.

In exchange for each of these properties, the agreement stated the Company would issue to Contributor a number of duly authorized, fully paid and non-assessable shares of the Company’s Common Stock or Series A Convertible Preferred Stock, determined by dividing the $20 million agreed upon value of that contribution by the Per Share Value. The agreement stated that shares would be comprised entirely of shares of Common Stock if the issuance had been approved by the Company’s stockholders prior to the issuance thereof and would be comprised entirely of shares of Series A Convertible Preferred Stock if such approval had not yet been obtained.

A-51 

The Company had determined in accordance with the updated guidance of ASU 2017-01, Business Combinations (Topic 805) Clarifying the Definition of a Business that the Amarillo property (an operating hotel) represented a business as it included an organized workforce with the necessary skills, knowledge and experience to perform the acquired process and an input that the workforce could develop or convert into output. However, it was determined that the Antigua property did not represent a business. Based on the above conclusion it was determined that the Amarillo property component was not required to be analyzed under the provisions of ASC 815-10 “Derivatives and Hedging” since such contract between an acquirer and a seller to enter into a business combination are scoped out from its provisions. As for the Antigua property it was determined that such future transaction did not constitute a derivative instrument in accordance with ASC 815-10 - Derivatives and Hedging as the net settlement criteria was not met. Further, the Company considered the provisions of Subtopic ASC 815-40 “Contracts in the Entity’s Own Equity” and determined that such contractual obligations cannot be considered as indexed to an entity’s own stock, as its settlement provisions are not based on a fixed monetary amount or a fixed amount of a debt instrument issued by the entity but rather on the fair value of the Antigua property which represents a real estate asset. Based on the terms of this component, (i.e. the fair value of the Antigua property and the fair value of the shares that the Company is obligated to issue for this asset), it was determined that such freestanding financial instrument represented a financial asset required to be measured upon initial recognition of at fair value. Subsequent to initial recognition the financial instrument (which might be a financial asset or a financial liability depending on the fair value of its settlement terms) is required to be re-measured at fair value, with changes in fair value reported in earnings (within the line item “Revaluation of asset contribution related financial instrument, net”).

Optional Contribution

Contributor Parent had the option to contribute either or both of two additional property interests valued at the agreed upon value of $66.5 million if certain conditions as set forth in the Contribution Agreement were satisfied by December 31, 2017. This third installment was optional in Contributor Parent’s sole discretion. As discussed below, the contribution Agreement was terminated and this optional contribution did not take place.

The agreement stated that the Contributor Parent may contribute to the Acquiror its interest in a resort development project on an island just south of Hilton Head, South Carolina (“Melrose”). Contributor Parent had the property under a Letter of Intent and expected to close on the property by December 31, 2017. Melrose was valued by Contributor Parent at an agreed upon value of $22.5 million, based upon a senior lending position that Contributor Parent held under the Letter of Intent on this property.

The agreement stated that the Contributor Parent also may contribute to the Acquiror a golf and surf club development project on the Baja Peninsula in Mexico (“Punta Brava”). Contributor Parent also had this property under a Letter of Intent and expected to close by December 31, 2017. Punta Brava was valued at the agreed upon value by Contributor Parent at $44 million based on Contributor Parent’s commitment of $5 million upon closing on this property, plus a commitment for an additional $5 million and a second commitment of $34 million for construction of the project.

In exchange for each of these properties, the Company would issue to Contributor a number of duly authorized, fully paid and non-assessable shares of the Company’s Common Stock or Series A Convertible Preferred Stock, determined by dividing an agreed upon value of $86,450 (130% of the value of the agreed upon value of $66,500) by the Per Share Value. The shares would be comprised entirely of shares of Common Stock if the issuance had been approved by the Company’s stockholders prior to the issuance thereof and would be comprised entirely of shares of Series A Convertible Preferred Stock if such approval had not yet been obtained. In addition, the Company would issue to Contributor a five year warrant (the “Warrant”) to purchase up to 25,000,000 shares of the Company’s Common Stock at an exercise price of $3.00 per share that would vest with respect to the number of underlying shares upon the achievement of the milestone specified in the Contribution Agreement. The number of warrant shares and the exercise price would be equitably adjusted in the event of a stock split, stock combination, recapitalization or similar transaction. These optional contributions represented a potential liability to the Company as the number of shares and warrants to be issued is fixed but the market value of the shares fluctuates. It is possible that the share price could have risen to a level that upon contribution of the properties causing the Company to give consideration that exceeded the fair value of the assets acquired. This would represent a potential liability to the Company and to quantify the liability the Company has used the Black Scholes formula. The warrants also represented a potential liability in that the Company may be required to issues shares at $3 when the share price was significantly higher.

A-52 

To estimate the fair value of the liability associated with optionality granted to the Contributor as well as the warrant liability, Management has used the Black Scholes option pricing formula. The key input in the calculation is the assumption of how volatile the Company stock was to be over the life of the option. The more volatile the Company is expected to be, the greater its potential liability.  Future volatility is unknown, as such Management had used a volatility proxy of 39.45% which equaled the average volatility of stocks in the Company’s forward looking peer group of Real Estate Development at that time.  After the calculation is performed, additional factors must be considered. It is possible that despite being economically rational to contribute the properties based on the Company stock price relative to the value of the optional properties, the Contributor may not have the ability to contribute. Therefore a 50% discount was applied to the option value produced by the Black Scholes formula to arrive at final liability value for the optionality component. The warrants received a further 50% discount as they contained a vesting schedule with milestones that must be achieved by the Contributor once the property was contributed. With the expiration of the agreement on December 31, 2017, the fair value of the liability was $0.

The Company has determined that the Company’s contractual obligations under the optional contributions does not constitute a derivative instrument in accordance with ASC 815-10 - Derivatives and Hedging as the net settlement criteria is not met. Further, the Company considered the provisions of Subtopic ASC 815-40 Contracts in the Entity’s Own Equity and determined that such contractual obligations cannot be considered as indexed to an entity’s own stock, as its settlement provisions are not based on a fixed monetary amount or a fixed amount of a debt instrument issued by the entity but rather on the fair value of certain real estate assets. Thus, such freestanding financial instrument were classified as financial liabilities and were measured upon initial recognition at fair value. Subsequent to initial recognition the financial liabilities are remeasured at fair value, with changes in fair value reported in earnings (within the line item “Revaluation of asset contribution related financial instruments, net”).

 

(ww)         “Person” means anyThe Company elected to early adopt ASU 2017-01 Business Combinations (Topic 805) Clarifying the Definition of a Business. Accordingly, the determination whether the asset contribution transaction represents a business combination was evaluated by applying the ASU 2017-01 guidance. The Company has determined that the group of assets assumed in the First Contribution does not (and also, none of them on a stand-alone basis) include, an input and a substantive process that together significantly contribute to the ability to create output and thus it was determined that the First Contribution represents an acquisition of assets rather than a business combination. Accordingly, the total sum of the fair value of consideration given (i.e. the fair value of the equity interests issued) together with the transaction costs and the fair value of financial assets was allocated to the individual corporation, partnership,assets acquired and liabilities assumed in the first contribution based on their relative fair values at the date of acquisition. Such allocation did not give rise to goodwill.

The consideration for the assets acquisition as of the Initial Date consists of the following:

Fair value 879,234 shares of FC Global common stock (*) $1,275 
Fair value 123,668 shares of FC Global Series A preferred stock (*)  4,483 
Fair value of financial liability related to Optional contribution (**)  857 
Fair value of Warrant (***)  1,925 
Fair value of asset related to future mandatory asset contribution (***)  (4,175)
Fair value of assumed note payable on acquired asset  470 
Transaction costs  283 
Total consideration $5,118 

(*)Fair value of Common shares based on quoted market price on date of transaction and Fair value of preferred shares based on the number of common shares to which they can be converted on the transaction date

(**)Related to Optional Contribution

(***)Related to Second Contribution

The fair value of the assets acquired, and liabilities assumed were based on management estimates and values, including estimates based on historical sales of similar parcels. Adjustments were applied to such historical sales and assumptions were applied to other attributes of the assets in order to estimate market value. The following table summarizes the allocation of the consideration to the assets acquired in the transaction.

A-53 

The allocation of aforesaid total consideration is as follows (As Restated):

Investment properties $2,055 
Investment in other company  3,245 
Less: Noncontrolling interest (***)  (182)
Total assets acquired at fair value $5,118 
Impairment of investment in other company (*)  (1,439)
Total asset value as of December 31, 2017 $3,679 

(*) Loss from impairment was recorded amounting to $1,439 (As Restated) as part of operating expenses in the Company’s consolidated statement of comprehensive loss during the year ended December 31, 2017 (see also Note 13).

(***) Attributable to the 25% noncontrolling membership interest in a limited liability company trust, estate, Governmental Authority,that owns a vacant land site located in Northern California

The fair value of options, warrants and asset related to future mandatory asset contribution granted was estimated at the Initial Date by using the Black-Scholes option pricing model. The following are the data and assumptions used:

Options Value:

May 17, 2017
Dividend yield (%)0
Expected volatility (%)39.45
Risk free interest rate (%)1.25
Strike price1.93
Stock price1.45
Probability (%)50
Expected term of options (years)0.62

Warrants Value:

May 17, 2017
Dividend yield (%)0
Expected volatility (%)39.45
Risk free interest rate (%)1.25
Strike price3
Stock price1.45
Probability (%)50
Expected term of options (years)5

Asset related to future mandatory asset contribution:

May 17, 2017
Dividend yield (%)0
Stock price1.45
Probability (%)70

As of December 31, 2017, neither the Secondary nor the Optional Contribution were made and the Contribution Agreement was terminated at that date. Consequently, as of December 31, 2017, the fair value of the asset contribution related to aforementioned financial instruments was reduced to $0. During the period from the closing of the Initial Date and until December 31, 2017, the Company has recognized a net loss as revaluation of the fair value of asset contribution related financial instruments in the total amount of $1,392.

A-54 

Note 6

Inventories, net:

  December 31, 
  2017  2016 
Raw materials and work-in-process $  $1,968 
Finished goods     5,368 
Total inventories $  $7,336 
Less assets held for sale (*)     (7,336)
Total inventory $  $ 

(*) Inventory was classified as part of the assets held for sale as of December 31, 2016. In January 2017, all of the consumer inventory was sold to ICTV (see also Note 2 and 4).

Note 7

Property and Equipment, net:

  December 31, 
  2017  2016 
Equipment, computer hardware and software $320  $5,005 
Furniture and fixtures  350   433 
Leasehold improvements  112   438 
   782   5,876 
Accumulated depreciation and amortization  (777)  (4,888)
Total property and equipment, net $5  $988 
Less Assets held for sale (*)     (911)
Total property and equipment, net $5  $77 

(*) In January 2017, the consumer division property and equipment was sold to ICTV (see also Note 2 and 4).

During the years ended December 31, 2017 and 2016, depreciation expenses were $178 and $292, respectively.

Note 8

Patents and Licensed Technologies, net:

  December 31, 
  2017  2016 
Gross Amount beginning of period $  $3,376 
Disposals     (177)
Translation differences     36 
Gross Amount end of period     3,235 
         
Accumulated amortization     (1,974)
Impairment of assets (see Note 9 below)     (1,261)
         
Total patents and licensed technology $  $ 

During the years ended December 31, 2017 and 2016, amortization expenses were $0 and $230, respectively.

Note 9

Goodwill and Other Intangible Assets:

As part of the purchase price allocation for a reverse acquisition transaction in 2011, the Company recorded goodwill in the amount of $24,005 and definite-lived intangibles in the amount of $12,000. Goodwill reflects the value or anypremium of the acquisition price in excess of the fair values assigned to specific tangible and intangible assets. Goodwill has an indefinite useful life and therefore is not amortized as an expense but is reviewed annually for impairment of its fair value to the Company. Activity in goodwill during the year ended December 31, 2016 was as follows:

Balance at January 1, 2016 $3,581 
Disposal on sale of assets  (1,039)
Impairment of goodwill  (2,257)
Translation differences  (285)
Balance at December 31, 2016 $ 

A-55 

The fair value of Goodwill associated with the operating and reporting units were estimated using a combination of Income and Market Approach methodologies to valuation. The Income method of valuation explicitly recognizes the current value of future economic benefits developed by discounting future net cash flows to their present value at a rate that reflects both the current return requirements of the market and the risks inherent in the market. The Market approach measures the value of an asset through the analysis of recent sales or offerings of comparable property.

The Company’s business was organized into three operating and reporting units which are defined as Consumer, Physician Recurring, and Professional Equipment.

During the third quarter of 2016, we recorded goodwill and other entity.intangible asset impairment charges of $3,518, as we determined that a portion of the value of the Company’s goodwill and other intangible assets was impaired in connection with the then pending transaction with ICTV Brands, Inc. (See also Note 1). The Company recorded an impairment of the entire remaining balance of Consumer segment goodwill in the amount of $2,257 and recorded the impairment of the Consumer segment of the intangibles for its licensed technology in the amount of $1,261. During the year ended December 31, 2016 the Company derecognized an amount of $1,039 of goodwill related to the Physician Recurring segment in connection with the asset sale of the Neova product line. All such impairment changes are included in discontinued operations.

Note 10

Accrued Compensation and related expenses:

  December 31, 
  2017  2016 
Accrued payroll and related taxes $453  $262 
Accrued vacation  14   66 
Accrued commissions and bonuses (*)     3,701 
Total accrued compensation and related expense $467  $4,029 

(*)The amount related to the obligation the Company had in connection with the Payout Notes Holders as of December 31, 2016. On December 22, 2017, the then outstanding payout notes were converted into shares of common stock of the Company (see also Note 14).

Note 11

Other Accrued Liabilities:

  December 31, 
  2017  2016 
Accrued taxes, including liability for unrecognized tax benefit, (see also Note 15) $1,549  $1,606 
Other accrued liabilities  901   4,417 
Total other accrued liabilities $2,450  $6,023 

Note 12

Note payable:

Following the Initial Closing of the Interest Contribution Agreement (see also Note 5), the Company assumed an installment note dated April 7, 2015 made by the Contributor in favor of George Zambelli (“Zambelli”) in the original principal amount of $470 (the “Note”) and a Long Form Deed of Trust and Assignment of Rents dated April 7, 2015 between FCREI, as Trustor, Fidelity National Title Company, as Trustee (“Trustee”), and Zambelli, as Beneficiary (the “Deed of Trust”), which secures the Note. The Note carries a per annum interest rate of 8% which is payable on a monthly basis from the Initial Closing. As of December 31, 2017, the Note amounted to $459 ($454 out of which is classified as non-current note payable) and has a maturity date of April 10, 2020.

A-56 

Note 13

Commitments and Contingencies:

 

(xx)        “Permitted Encumbrances” means anyLeases

The Company has entered into a non-cancelable operating lease agreement for real property which expires on December 31, 2018. Rent expense was $188 and $550 for the years ended December 31, 2017 and 2016 respectively. The future annual minimum payment under this lease, relating to the Company’s continuing operations are as follows:

Year Ending December 31,   
     
2018 $70 

As a result of the following:sale of the Consumer Products division to ICTV Brands, the Company no longer had a need for certain of its leased properties, including the facilitates located in the United Kingdom and in Israel. In connection with the Transition Services Agreement entered into between the Company and ICTV, the Company maintained certain of its leased properties for a specified period of time to allow ICTV to transition its operations to its own facilities. Leases that expired during that transition period were not renewed. As of December 31, 2017, the Company terminated the leases in Israel and entered into an early surrender agreement for the United Kingdom facility that was consummated on October 17, 2017.

Litigations

JFURTI

The Company is a party to JFURTI, LLC, et al v. Suneet Singal, et al, filed in the United States District Court for the Southern District of New York.  The suit names as defendants Suneet Singal, an officer of various First Capital companies as well as the Company’s former Chief Executive Officer and former member of the Company’s Board of Directors,, Frank Grant and Richard Leider, board members of  First Capital Real Estate Investments, LLC, First Capital Real Estate Advisors, LP, Presidential Realty Corporation, Presidential Realty Operating Partnership, Downey Brand LLP and now the Company (under its previous name, PhotoMedex Inc.), as well as nominal derivative defendants First Capital Real Estate Trust Incorporated and First Capital Real Estate Operating Partnership, L.P. Mr. Leider is also on the Board of Directors of the Company.

The suit is the ninth filed by Jacob Frydman and/or JFURTI, LLC in a dispute between the plaintiffs and the First Capital group of companies, which entered into a series of agreements with Mr. Frydman beginning in September 2015. Mr. Frydman had founded, sponsored, and taken public United Realty Trust Incorporated, a Real Estate Investment Trust (“REIT”). Mr. Frydman was the CEO and Chairman of the REIT as well as the owner of various other United Realty branded companies affiliated with the REIT business. In September 2015, Mr. Frydman and Mr. Singal negotiated and agreed to a transaction between various First Capital branded companies, on the one hand, and the United Realty branded companies affiliated with the REIT business, on the other hand, as a result of which the REIT was rebranded as the Contributor Parent.

After the September 2015 transaction was concluded, several disputes arose between the parties. This suit is the ninth action brought by Mr. Frydman in state and federal courts relating to these disputes, and the second attempt by Mr. Frydman and JFURTI to bring federal claims derivatively in this Court against First Capital entities and other parties. The first action, titled JFURTI, LLC and Jacob Frydman v. Forum Partners Investment Management LLC et al., No. 16 Civ. 8633 (the “Prior Action”), commenced on November 7, 2016 and asserted, inter alia, derivative RICO and securities fraud claims. The Court dismissed the action in a decision and order dated April 27, 2017.

Following dismissal of the Prior Action, Mr. Frydman sent letters to each member of the Contributor Parent’s Board of Directors (the “Demand Letter”) demanding that the Board investigate and remediate the dissipation of assets as alleged by plaintiffs. In particular, the Demand Letter questioned (i) Encumbrancesa letter of intent with Presidential Realty Corporation, or Presidential, announced in an 8K filed by First Capital REIT on or about July 18, 2016; (ii) First Capital REIT’s use of funds raised between September 15, 2015 and February 28, 2016; (iii) an interest contribution agreement with Presidential entered into on or about December 16, 2016; (iv) the Contributor Parent’s failure to file quarterly and annual reports; (iv) an interest contribution agreement entered into on March 31, 2017 with PhotoMedex; and (v) other purportedly fraudulent acts such as publishing an artificially inflated NAV, defaulting on certain mortgage loans, misrepresentations by Singal with respect to certain properties contributed to the REIT through the Master Agreement executed on September 15, 2015, and various loan agreements with Forum Partners Investment Management LLC, or Forum. The Demand Letter also demanded inspection of certain corporate documents pursuant to Md. Code § 2-512.

A-57 

The Contributor Parent commenced such an investigation, and offered such an inspection, but Mr. Frydman and JFURTI failed to wait for Taxesthe results of the investigation or governmental assessments, chargesmake any inspection, and instead brought suit in the same court as the Prior Action. The suit alleges, among other claims, violations of § 10(b) of the Exchange Act and Rule 10b-5 (1) against Mr. Singal and First Capital Real Estate Investments LLC for misrepresentations in connection with the Master Agreement entered into on September 15, 2015 and related agreements; (2) against Downey Brand for failure to file certain deeds; (3) against First Capital defendants (except Grant and Leider), Forum defendants, and Presidential defendants for a fraudulent scheme to sell Contributor Parent assets to Presidential; and (4) against First Capital defendants, the Forum defendants, and the Company for the transfer of First Capital REIT and First Capital OP assets to the Company in exchange for allegedly worthless shares. There are also claims under state law for common law fraud, conversion, fraudulent conveyance, waste and mismanagement, accounting, injunctive relief, and violation of Cal. Bus. & Prof. Code § 17-200. Many of the claims asserted in the Complaint, including the securities fraud claims, were never raised in the Demand Letter, as required by law. The suit seeks damages against all defendants for the failure of the REIT to respond to the Demand Letter, and an injunction against the sale of the assets to the Presidential defendants.

The parties submitted a motion for an order (i) staying all proceedings in this action for 60 days, or until the end of 2017, and (ii) extending the defendants time to respond to the complaint, or to make a motion with respect to the complaint, until 45 days after First Capital REIT’s response to the Demand Letter. The Court granted that motion on October 31, 2017. Upon completion of their investigation, the Contributor Parent provided a response to the Demand Letter, denying all claims made in the letter. A Motion to Dismiss this action has now been filed with the Court on behalf of all plaintiffs.

The Company intends to defend itself vigorously against this suit. At this time, the amount of any loss, or range of loss, cannot be reasonably estimated as the case has only been initiated and no discovery has been conducted to determine the validity of any claim or claims made by plaintiffs. Therefore, the Company has not recorded any reserve or contingent liability related to these particular legal matters. However, in the future, as the cases progress, the Company may be required to record a contingent liability or reserve for these matters. 

DSKX 

On February 19, 2016, the Company and its subsidiaries entered into Agreements and Plans of Merger and Reorganization with DS Healthcare Group, Inc. and its subsidiaries (“DSKX”), under which DSKX would acquire the Company’s subsidiaries Radiancy, Inc. and PhotoMedex Technology, Inc. in exchange for shares of stock in DSKX as well as cash payments and notes for future cash payments. Subsequent to the signing of those Agreements, on March 23, 2016, after discussion with its independent registered public accounting firm, DSKX concluded that the unaudited condensed consolidated financial statements of DSKX for the two fiscal quarters ended June 30, 2015 and September 30, 2015 should no longer be relied upon because of certain errors in such financial statements. Also, DSKX reported that its audit committee, consisting of all members of its board of directors other than Daniel Khesin (at the time DSKX’s President and Chairman of the Board and a member of its board of directors), had engaged independent counsel to conduct an investigation regarding certain transactions involving Mr. Khesin and other individuals; the committee’s investigation had begun earlier in February. The board also reported that it had terminated the employment of Mr. Khesin as DSKX’s president and as an employee of DSKX, and also terminated Mr. Khesin’s employment agreement, dated December 16, 2013, for cause. 

The Company was not advised of this investigation during its negotiations with DSKX or after signing the Merger Agreements until the evening of March 21, 2016. On April 12, 2016, the Company sent a Reservation of Rights letter to DSKX. The Notice states that, based upon the disclosures set forth in DSKX’s Current Report on Form 8-K filed on March 23, 2016 and subsequent press releases and filings by DSKX with the United States Securities and Exchange Commission (collectively, the “DSKX Public Disclosure”), DSKX is in material breach of various representations, warranties, covenants and agreements set forth in the Agreements; had failed to provide to the Company the information contained in the DSKX Public Disclosures during the discussions relating to the negotiation and execution of the Agreements; and continues to be in material breach under the Agreements. As a result, the conditions precedent to the closing of these transactions as set forth in the Agreements may not be able to occur. The Notice also declares that the Company reserves all its rights and remedies under the Agreements, including, without limitation, the right to terminate the Agreements and collect a termination fee from DSKX of $3 million. The Notice further asserts that the Company regards certain provisions of the Agreements to have been waived by DSKX and to no longer be in effect, including the non-solicitation and no-shop provisions, negative covenants, and termination events, as applicable solely to the PHMD Group, as well as the payment not yet due; (ii) Encumbrancesof any termination fee by PHMD to DSKX. Finally, the Notice provided that are carriers’, warehousemen’s, mechanics’, materialmen’s, repairmen’sthe Company has the right to terminate the Agreements to pursue, consider and enter into any acquisition proposal or other similar Encumbrances arisingtransaction without the payment of fees and expenses to DSKX. 

A-58 

On May 27, 2016, the Company and its subsidiaries Radiancy, Inc., an indirectly wholly-owned subsidiary of the Company (“Radiancy”), and PhotoMedex Technology, Inc., a wholly-owned subsidiary of the Company (“P-Tech”), terminated: (a) the Agreement and Plan of Merger and Reorganization, dated as of February 19, 2016 (the “Radiancy Merger Agreement”), among the Company, Radiancy, DS Healthcare Group, Inc. (“DSKX”) and PHMD Consumer Acquisition Corp., a wholly-owned subsidiary of DSKX (“Merger Sub A”), and (b) the Agreement and Plan of Merger and Reorganization, dated as of February 19, 2016 (the “P-Tech Merger Agreement” and together with the Radiancy Merger Agreement, the “Merger Agreements”), among the Company, P-Tech, DSKX, and PHMD Professional Acquisition Corp., a wholly-owned subsidiary of DSKX (“Merger Sub B”). Pursuant to the Merger Agreements, Radiancy was to merge with Merger Sub A, with Radiancy as the surviving corporation in such merger, P-Tech was to merge with Merger Sub B, with P-Tech as the surviving corporation in such merger, and DSKX was to become the holding company for Radiancy and P-Tech. 

Given the material breaches identified in the Company’s notice to DSKX, and other disclosures and communications by DSKX, in connection with the Company’s termination of the Merger Agreements and pursuant to their terms, the Company sought to recover a termination fee of $3.0 million, an expense reimbursement of up to $750, and its liabilities and damages suffered as a result of DSKX’s failures and breaches in connection with each of the Merger Agreements. On May 27, 2016, the Company, Radiancy and P-Tech filed a complaint in the U.S. District Court for the Southern District of New York alleging breaches of the Merger Agreements by DSKX and seeking the damages described in the foregoing sentence. On August 1, 2016, DSKX filed its answer to the complaint, denying the allegations stated in the complaint and alleging its own counterclaims including, among others, the Company’s alleged failure to disclose the Mouzon and Cantley cases filed against Radiancy.

On June 23, 2017, the Company and its subsidiaries, Radiancy, Inc. (“Radiancy”) and PhotoMedex Technology, Inc. (“P-Tech”), entered into a Confidential Settlement and Mutual Release Agreement (the “DS Settlement Agreement”) with DS Healthcare Group, Inc. (“DSKX”) and its subsidiaries, PHMD Consumer Acquisition Corp. and PHMD Professional Acquisition Corp.

The terms of the DS Settlement Agreement are confidential. According to the DS Settlement Agreement the parties dismissed the suit between them with prejudice on June 23, 2017. The amount under this settlement agreement was recorded under discontinued operation.

Linda Andrews

During 2016, Linda Andrews, an alleged user of the no!no! Hair device, filed a product liability claim against the Company, its subsidiary Radiancy, Inc., and Dr. Dolev Rafaeli, in the United States District Court for the Middle District of Florida, Orlando Division, alleging that use of the device had caused a relapse of and complication to a pre-existing medical condition resulting from her treatment for cancer. The complaint alleged, among other claims, that Radiancy failed to provide adequate warnings regarding the operation of the device. The Company and Dr. Rafaeli filed a motion to dismiss the claims against them; Radiancy filed an answer to the Complaint. Ms. Doe then sought leave to amend her complaint to clarify the claims; the Company, Radiancy and Dr. Rafaeli filed appropriate responses and renewed the motion to dismiss the claims against the Company and Dr. Rafaeli. 

On June 22, 2017, the United States District Court for the Middle District of Florida, Orlando Division, dismissed the Company and Dr. Dolev Rafaeli, its former Chief Executive Officer, from the case of Linda Andrew v. Radiancy, Inc.; the Company (under the name PhotoMedex, Inc.); and Dr. Rafaeli. Ms. Andrew had filed a product liability suit alleging damages from her use management or operation of a Contributed Propertyno!no! hair device. The claims against the Company and Dr. Rafaeli were dismissed without prejudice. The Company’s subsidiary, Radiancy, Inc., entered into a settlement with Ms. Andrews in 2017; the terms of the settlement are confidential.

Other litigation

The Company and certain subsidiaries are, and have been, involved in other miscellaneous litigation and legal actions, including product liability, consumer, commercial, tax and governmental matters, which can arise from time to time in the ordinary course of business; (iii)our business. The Company believes that these other litigations and claims will likely be resolved without a material effect on our consolidated financial position, results of operations or liquidity. However, litigation and legal actions are inherently unpredictable, and excessive verdicts can result in such situations. Although the Company believes it has or will have substantial defenses in these matters, it may, in the future, incur judgments or enter into settlements of claims that could have a material adverse effect on results of operations in a particular period. 

A-59 

Avalon (As Restated) 

On January 12, 2018, we received a copy of a complaint, dated November 17, 2017, that was filed by Alpha Alpha, LLC in the Thirteenth Judicial District Court in the County of Valencia in the State of New Mexico against Avalon Jubilee, LLC, the holding company that owns the property in Los Lunas, New Mexico, HiTex, LLC, MCBB, LLC, Land Strategies, LLC, Ronald R. Cobb and John Does 1–5. The suit asks the court to, among other things, determine whether there have been unauthorized transfers of interest in Avalon Jubilee LLC; and declare who are the holders of interests in Avalon Jubilee LLC. Although the complaint does not name the Company or any of its subsidiaries or specifically question the Company’s interest in Avalon Jubilee LLC, it raises questions about whether the transfers of interest leading to our acquisition of our interest in Avalon Jubilee LLC (under the Contribution Agreement described in Note 5) were properly made in accordance with respectthe Avalon Jubilee operating agreement. The Company has begun an internal investigation into this matter and will disclose the results of that investigation once it has been completed. Although neither our company nor any of its subsidiaries is a party to any Contributed Property, (iii) Encumbranceslitigation regarding this matter, we recognized an impairment expense of $1,439 (As Restated) to account for our estimate of the impact that are zoning regulations, entitlements or other land use or environmental regulations by any Governmental Authority, (iv) Encumbrances, restrictions, exceptionssuch litigation may have on the operations and other matters set forth on any Title Insurance Policy or preliminary reports issued by a reputable title company delivered or made available tofair value of the Acquiror Parties not later than the Execution Date, including, without limitation, any mortgages, deeds of trust, security agreements and UCC filings with respect to any Indebtedness set forth therein, and (v) Encumbrances that are disclosed onSchedule 1.2(xx).underlying asset.

  

(yy)         “Registration Rights Agreement” means the Registration Rights Agreement with Party to the Purchase Agreement

As discussed in Note 14, as a condition to the form attached hereto asExhibit Dfirst closing under the Purchase Agreement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Investor, pursuant to which the Company agreed to register all shares of Common Stock that may be executed and delivered by Acquiror Parent and Contributor Parent (and Contributor Parent’s affiliates receiving a portionissued upon conversion of the Acquiror Parent Shares) at or following the Initial Closing.

6

(zz)         “Required Consents” means the Acquiror Required Consents and the Contributor Required Consents.

(aaa)        “SEC Documents” means all reports, schedules, forms, statements, and other documents (including exhibits and other information incorporated therein) required to be filed or furnishedSeries B Preferred Stock (the “Registrable Securities”) under the Securities Act or the Exchange Act.

(bbb)        “Securities Act” means the Securities Act of 1933, as amended and(the “Securities Act”). The Company agreed to file a registration statement covering the rules and regulations thereunder.

(ccc)        “Subsidiary” means, with respect to a Person, any Person, whether incorporated or unincorporated,resale of which (i) at least fifty percent (50%)such Registrable Securities within 30 days of the Interests having by their terms ordinary voting power to elect a majority of the board of directors or other Persons performing similar functions, (ii) a general partner interest, (iii) a managing member interest, or (iv) the ability to exercise Control, is directly or indirectly owned, held or controlled by the subject Person or by one or more offirst closing and cause such Person’s Subsidiaries.

(ddd)        “Tax” or “Taxes” means (i) all taxes, assessments, fees, unclaimed property and escheat obligations, and other charges of any kind whatsoever imposed by any Governmental Authority, including any federal, state, local and/or foreign Income Tax, surtax, remittance tax, presumptive tax, net worth tax, special contribution tax, production tax, severance tax, value added tax, withholding tax, gross receipts tax, windfall profits tax, profits tax, ad valorem tax, personal property tax, real property tax, sales tax, goods and services tax, service tax, transfer tax, use tax, excise tax, premium tax, stamp tax, motor vehicle tax, entertainment tax, insurance tax, capital stock tax, franchise tax, occupation tax, payroll tax, employment tax, unemployment tax, disability tax, alternative or add-on minimum tax and estimated tax, (ii) any interest, fine, penalty or additions to tax imposed by a Governmental Authority in connection with any item described inclause (i), and(iii) any liability in respect of any item described inclauses (i) or(ii) above, that arises by reason of a contract, assumption, transferee or successor liability, operation of Law (including by reason of participation in a consolidated, combined or unitary Tax Return) or otherwise.

(eee)        “Tax Return” shall mean any report, return, informationregistration statement schedule, attachment, payee statement or other information required to be provided or provided to any Governmental Authority with respect to Taxes or any amendment thereof, including any return of an affiliated, combined or unitary group, and any and all work papers relating to any Tax Return.

(fff)        “Transaction Agreements” means this Agreement and each other agreement to be executed and delivered at any of the Closings pursuant hereto.

(ggg)        “Transaction Shares” means all the Acquiror Parent Shares issuable to the Contributor Parties pursuant hereto, including, without limitation, (i) the Acquiror Parent Common Stock underlying the Warrant and (ii) the Acquiror Parent Preferred Stock and the Acquiror Parent Common Stock into which the Acquiror Parent Preferred Stock is convertible.

(hhh)        “Transactions” means the transactions contemplated by this Agreement and the Transaction Agreements.

7

ARTICLE 2

PURCHASE PRICE

2.1           Purchase Price and Assumption of Liabilities.

(a)          The total consideration to be paid for the Initial Contributed Interests will consist of such number of the duly authorized, fully paid and nonassessable Acquiror Parent Shares as shall be determined by dividing the Initial Contributed Interests Value (as defined inSection 3.1) by the Per Share Value (the “Purchase Price”); provided, however, that the Transaction Shares shall consist of shares of Acquiror Common Stock and Acquiror Preferred Stock as follows (i) a number of shares of Acquiror Common Stock that constitutes 19.9% of the issued and outstanding Acquiror Common Stock immediately prior to the Initial Closing shall be issued to the Contributor, and (ii) a number of shares of Acquiror Preferred Stock that constitutes the balance of the Transaction Shares after the issuance of the Acquiror Common Stock as described inSection 2.1(a)(i) shall be issued to the Contributor.

(b)          At the Initial Closing, the Acquiror shall assume the Assumed Liabilities associated with the Initial Contributed Interests.

ARTICLE 3

DETERMINATION OF VALUE OF CONTRIBUTOR INTERESTS

3.1           Valuation of Initial Contributed Interests. The parties hereto agree that the Initial Contributed Interests have a value of Ten Million Dollars ($10,000,000.00) (“Initial Contributed Interests Value”). The number of Transaction Shares issuable to the Contributor Parties in consideration of the Initial Contributed Interests is determined in accordance withSection 2.1.

3.2           Valuation of Mandatory Entity Interests. The parties hereto agree that Antigua has a value of $14,109,000 and that Amarillo has a value of $5,891,000, as set forth inSection 9.2(b) hereof. The number of Transaction Shares issuable to the Contributor Parties in consideration for the Mandatory Entity Interests is determined in accordance withSection 9.2.

3.3           Valuation of Optional Entity Interests. The parties hereto agree that Punta Brava and Melrose have the values (excluding the amounts attributable to the Warrant), as set forth inSection 9.1(b)(i) hereof. The number of Transaction Shares issuable to the Contributor Parties in consideration for the Optional Entity Interests shall be determined in accordance withSection 9.1.

ARTICLE 4

REPRESENTATIONS AND WARRANTIES OF CONTRIBUTOR PARTIES

The Contributor Parties jointly and severally represent and warrant to the Acquiror Parties as follows:

4.1           Contributor. Each Contributor Party is corporation or limited partnership, as the case may be, that is duly incorporated or formed, validly existing and in good standing under the Laws of its jurisdiction of incorporation or formation.

4.2           Power. Each Contributor Party has the corporate or limited partnership, as the case may be, power and authority to enter into and perform its obligations under this Agreement and each other Transaction Agreement to which it is a party and to consummate the Transactions contemplated by this Agreement and such other Transaction Agreements.

8

4.3           Authorization and Enforceability. The execution, delivery and performance of this Agreement and each other Transaction Agreement to which such Contributor Party is a party, and the consummation of the Transactions contemplated hereby and thereby, have been duly and validly authorized by all necessary action on the part of each Contributor Party. This Agreement has been duly executed and delivered by each Contributor Party, and at each Closing each other Transaction Agreement to which a Contributor Party is a party will have been duly executed and delivered by such Contributor Party, and this Agreement constitutes the valid and binding obligation of each Contributor Party, and at each Closing each other Transaction Agreement to which a Contributor Party is a party will constitute the valid and binding obligation of such Contributor Party, in each case enforceable in accordance with its terms except as such enforceability may be limited by applicable bankruptcy or other similar Laws affecting the rights and remedies of creditors generally as well as to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law).

4.4           No Conflicts. Except as required under the HSR Act, filings required pursuant to the rules and regulations of NASDAQ and filings required pursuant to applicable federal and state securities Laws, and assuming the receipt of the Contributor Required Consents, the execution, delivery and performance of this Agreement by each Contributor Party, and the consummation of the Transactions contemplated by this Agreement and the other Transaction Agreements, do not and will not (a) violate any provision of the Organizational Documents of the Contributor Parties, (b) result in a breach of or default (with due notice or lapse of time or both) or the creation of any Encumbrance or give rise to any right of termination, cancellation, or acceleration under any note, bond, mortgage, indenture, or other financing instrument or any Contract or other contract or agreement to which any member of the Contributor Group is a party or by which any of them is bound or to which any of their assets or properties is subject, (c) violate any judgment, order, ruling, or decree applicable to any member of the Contributor Group or to which such member is a party in interest, or (d) violate any Law applicable to any member of the Contributor Group, except any matters described in clauses (b), (c), or (d) above which would not have a Contributor Material Adverse Effect.

4.5           Consents, Approvals or Waivers. Except as required under (i) the HSR Act, (ii) filings required pursuant to the rules and regulations of NASDAQ and filings required pursuant to applicable federal and state securities Laws, (iii) the Contributor Required Consents, as set forth onSchedule 4.5 hereto, the execution, delivery and performance of this Agreement and the other Transaction Agreements to be executed by the Contributor Parties will not be subject to any consent, approval or waiver from any Governmental Authority or other third Person, except for consents and approvals of Governmental Authorities that are customarily obtained after a Closing.

4.6           Bankruptcy. There are no bankruptcy, reorganization, or receivership proceedings pending, being contemplated by, or, to the knowledge of the Contributor Parties, threatened against any Contributor Party or any of the Contributed Entities (whether by a member of the Contributor Group or a third Person). The Contributor Parties are not entering into this Agreement with actual intent to hinder, delay, or defraud any creditor. Immediately prior to, and immediately subsequent to, any Closing hereunder, (a) neither Contributor Party will have incurred, nor does it intend to or believe that it will incur, debts (including contingent obligations) beyond its ability to pay such debts as such debts mature or come due (taking into account the timing and amounts of cash to be received from any source, and amounts to be payable on or in respect of debts), (b) the amount of cash available to each Contributor Party after taking into account all other anticipated uses of funds will be sufficient to pay all such amounts on or in respect of debts, when such amounts are required to be paid, and (c) each Contributor Party will have sufficient capital with which to conduct its business.

9

4.7           Identification of the Contributed Entities; Ownership of Contributed Entity Interests.

(a)          Set forth onSchedule 4.7(a) is a description of each of the Contributed Entities, including (i) the name thereof, (ii) the form of organization, (iii) the jurisdiction of organization, (iv) the date of organization, and (iv) the percentage Interest in the Contributed Entity owned by Contributor (or, if owned by an Affiliate of the Contributor, naming such Affiliate and the percentage Interest in the Contributed Entity owned by such Affiliate) on the date hereof. The Contributor Parties have, prior to the date hereof, delivered or made available to the Acquiror Parties, true, correct and complete copies of the Organization Documents of each of the Contributed Entities.

(b)          Except as set forth onSchedule 4.7(b), Contributor is the record and beneficial of, and has good and valid title to, the Contributed Entity Interests, free and clear of all Encumbrances, other than Permitted Encumbrances and restrictions on transfer that may be imposed by state or federal securities Laws or the Organizational Documents of the Contributed Entities. At each Closing hereunder, and except as set forth onSchedule 4.7(b), the delivery by Contributor to Acquiror of the Assignment and Assumption Agreement will vest Acquiror with good and valid title to all of the Contributed Equity Interests with respect to the assets or entities being contributed, free and clear of all Encumbrances other than Permitted Encumbrances and restrictions on transfer that may be imposed by state or federal securities Laws or the Organizational Documents of the Contributed Entities and Encumbrances arising exclusively by, through or under Acquiror or its Affiliates.

(c)          Each Contributed Entity has been duly organized or formed, validly existing and in good standing under the Laws of its jurisdiction of incorporation or organization, and is duly qualified to carry on its business in each jurisdiction where the nature of its business or the ownership or leasing of its properties makes such qualification necessary, except as set forth onSchedule 4.7(c) or where the failure to be so qualified has not had or would not be reasonably expected to have, individually or in the aggregate, a Contributor Material Adverse Effect.

(d)          Except as set forth onSchedule 4.7(d), (i) there are no outstanding options, warrants or other securities or subscription, preemptive or other rights convertible into or exchangeable or exercisable for any Interest of any of the Contributed Entities and there are no “phantom stock” rights, stock appreciation rights or other similar rights with respect to any Contributed Entity, (ii) there are no Contracts of any kind to which any Contributed Entity is a party or by which any Contributed Entity is bound, obligating such Contributed Entity to issue, deliver, grant or sell, or cause to be issued, delivered, granted or sold, additional Interests in, or options, warrants or other securities or subscription, preemptive or other rights convertible into, or exchangeable or exercisable for, Interests in, any Contributed Entity, or any “phantom stock” right, stock appreciation right or other similar right with respect to any Contributed Entity, or obligating any Contributed Entity to enter into any such Contract.

(e)          Except as set forth onSchedule 4.7(e), there are no securities or other instruments or obligations of any Contributed Entity, the value of which is in any way based upon or derived from any Interest of any Contributed Entity or having the right to vote (or convertible into, or exchangeable or exercisable for, securities having the right to vote) on any matters on which any Contributed Entity’s Interest owner may vote.

(f)          Except as set forth onSchedule 4.7(f), there are no Contracts, contingent or otherwise, obligating any Contributed Entity to repurchase, redeem or otherwise acquire any Interest of, the Contributed Entity. There are no voting trusts, registration rights agreements or stockholder agreements to which any Contributed Entity is a party with respect to the voting of the Interests of any such Contributed Entity or with respect to the granting of registration rights for any of the Interests of the Contributed Entity. There are no rights plans affecting any Contributed Entity.

10

(g)          Except as set forth onSchedule 4.7(g), the Contributed Entities have no liabilities other than (i) the Permitted Encumbrances, (ii) in connection with future performance obligations under any operating agreement disclosed to the Acquiror Parties, or (iii) those liabilities that will be satisfied at or prior to the applicable Closing with respect to the assets or entities being contributed at such Closing.

(h)          Except as set forth onSchedule 4.7(h), since the formation of the Contributed Entities, each of their sole business is and has been to own (directly or indirectly) one or more of the Contributed Properties and matters relating thereto.

4.8           Litigation. Except as set forth onSchedule 4.8:

(a)          there are no actions, suits, demands, investigations, administrative proceedings, or other proceedings pending before any Governmental Authority or arbitrator or, to the Contributor Parties’ knowledge, threatened orally or in writing, before any Governmental Authority or arbitrator involving the Contributed Interests or against any Contributed Entity, and

(b)          there are no actions, suits, demands, investigations, administrative proceedings, or other proceedings pending before any Governmental Authority or arbitrator or, to the Contributor Parties’ knowledge, threatened orally or in writing, against any member of the Contributor Group that would be reasonably expected to prevent, impair or delay materially the Contributor Parties’ ability to perform their respective obligations under this Agreement and the other Transaction Agreements.

4.9           Compliance with Laws. Except as disclosed onSchedule 4.9, (a) each of the Contributed Entities is, and during the past two years has been, in compliance in all material respects with all applicable Laws, (b) no Contributor Party or Contributed Entity has received written notice of any violation in respect of any applicable Law by any Contributed Entity or with respect to any Contributed Property, (c) no Contributor Party or Contributed Entity has received written or oral notice that any Contributed Entity is under investigation by any Governmental Authority for potential non-compliance in any material respect with any Law, (d) no Contributed Entity is subject to any material outstanding judgment, order, or decree of any Governmental Authority, and (e) no Contributor Party or Contributed Entity has received, nor to the Contributor Parties’ knowledge, has any third Person received, any written notice since January 1, 2016 of a violation of, or a default by, any Contributed Entity with respect to any Law or any decision, ruling, order or award of any Governmental Authority or arbitrator applicable to any Contributed Entity.

4.10         Contributed Entity Agreements. The Contributor Parent has, prior to the date hereof, furnished to Acquiror Parent true, correct and complete copies of the organizational documents of the Contributed Entities and each material Contract to which any member of the Contributor Group is a party with respect to the Contributed Entities.

4.11         Brokers and Other Advisors. Except for Maxim Group LLC, the fees and expenses of which will be paid by the Contributor Parent, no broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission, or the reimbursement of expenses relating thereto, in connection with the Transactions based upon arrangements made by or on behalf of the Contributor Parent or any of its Subsidiaries.

11

4.12         Contributed Properties.

(a)          Schedule 4.12(a)(1) sets forth a list of the address of (i) each real property owned or leased (as lessee or sublessee), including ground leased, by any Contributed Entity as of the date of this Agreement and (ii) each of the Contributed Real Properties (all such real property interests, together with all buildings, structures and other improvements and fixtures located on or under such real property are individually referred to herein as a “Contributed Property” and collectively referred to herein as the “Contributed Properties”).Schedule 4.12(a)(2) sets forth the name of the owner of each of the Contributed Properties which, as of the date of this Agreement, is under contract or signed letter of intent for purchase or sale or which is required under a binding contract to be leased or subleased after the date of this Agreement. Except as set forth inSchedule 4.12(a)(3), there are no real properties that any Contributed Entity is obligated to buy, lease or sublease at some future date.

(b)          Except as set forth inSchedule 4.12(b), a Contributor or a Subsidiary thereof, or a Contributed Entity (as the case maybe), owns fee simple title or leasehold title (as applicable) to each of the Contributed Properties, in each case, free and clear of all Encumbrances, except for Permitted Encumbrances. The Contributor Parties have delivered or made available to the Acquiror Parties true, correct and complete copies of all the mortgages, deeds of trust, security agreements and UCC filings (and any promissory notes or guaranties related thereto) with respect to any Indebtedness currently affecting a Contributed Property.

(c)          Except as set forth inSchedule 4.12(c), to the knowledge of the Contributor Parties, the Contributed Properties are supplied with utilities and other services reasonably required for their continued operation as they are now being operated (if at all).

(d)          Except as set forth inSchedule 4.12(d), to the knowledge of the Contributor Parties, no Contributor Party has received (i) written notice that any certificate, permit or license from any Governmental Authority having jurisdiction over any of the Contributed Properties or any agreement, easement or other right of an unlimited duration that is necessary to permit the lawful use and operation of the buildings and improvements on any of the Contributed Properties or that is necessary to permit the lawful use and operation of all utilities, parking areas, retention ponds, driveways, roads and other means of egress and ingress to and from any of the Contributed Properties is not in full force and effect as of the date of this Agreement, except for such failures to be in full force and effect that, individually or in the aggregate, would not reasonably be expected to have, a Contributor Material Adverse Effect, or of any pending written threat of modification or cancellation of any of same, that would reasonably be expected to have a Contributor Material Adverse Effect, or (ii) written notice of any uncured violation of any Laws affecting any of the Contributed Properties which, individually or in the aggregate, would reasonably be expected to have a Contributor Material Adverse Effect.

(e)          Except as set forth inSchedule 4.12(e), no condemnation, eminent domain or similar proceeding has occurred or is pending with respect to any owned Contributed Property or, to the knowledge of the Contributor Parties, any Contributed Property leased by any Contributor or any Contributed Entity, that would interfere in any material manner with the current use of the Contributed Properties (assuming its continued use in the manner it is currently used), or otherwise would impair in any material manner the current operations of such Contributed Properties (assuming its continued use in the manner it is currently operated), where such interference or impairment, individually or in the aggregate, would reasonably be expected to have a Contributor Material Adverse Effect, and to the knowledge of the Contributor Parties, no Contributor Party has received any written notice to the effect that (i) any condemnation or rezoning proceedings are threatened for any Contributed Property, that would interfere in any material manner with the current use of the Contributed Properties (assuming its continued use in the manner it is currently used), or otherwise would impair in any material manner the current operations of such Contributed Properties (assuming its continued use in the manner it is currently operated), where such interference or impairment, individually or in the aggregate, would reasonably be expected to have a Contributor Material Adverse Effect, or (ii) any zoning regulation or ordinance (including with respect to parking), building, fire, health or other Law has been violated (and remains in violation) for any Contributed Property, where such violation, individually or in the aggregate, would reasonably be expected to have a Contributor Material Adverse Effect.

12

(f)          True and complete copies of all leases (including ground leases) affecting the Contributed Properties (individually referred to herein as a “Contributed Lease” and collectively referred to herein as the “Contributed Leases”), in each case, as such Contributed Lease is in effect as of the date hereof, together with all amendments, modifications, supplements, renewals and extensions through the date hereof related thereto, have been delivered or made available to Acquiror Parties. A list of the Contributed Leases is set forth inSchedule 4.12(f). Except as set forth inSchedule 4.12(f), (i) to the knowledge of the Contributor Parties, no party is in breach or violation of, or default under, any Contributed Lease and (ii) each Contributed Lease is valid, binding and enforceable in accordance with its terms and is in full force and effect with respect to the applicable Contributor or Contributed Entity and, to the knowledge of the Contributor Parties, with respect to the other parties thereto, except as may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar Laws affecting creditors’ rights generally and by general principles of equity (regardless of whether enforceability is considered in a proceeding in equity or at Law). No Contributed Entity is party to any oral Contributed Entity Lease.

(g)          Except as set forth inSchedule 4.12(g), as of the date of this Agreement, (i) no purchase option has been exercised under any Contributed Lease and (ii) to the knowledge of the Contributor Parties, no holder of a purchase option under any Contributed Lease has provided written notice to any Contributor Party of its intention to exercise such option; in each case, for which the purchase has not closed prior to the date of this Agreement.

(h)          Except for Permitted Encumbrances or as set forth inSchedule 4.12(h), (i) there are no unexpired options to purchase, rights of first refusal or first offer or any other rights to purchase or otherwise acquire any Contributed Property or any portion thereof that have been granted by any Contributor or any Contributed Entity that would materially adversely affect the Contributor’s or any Contributed Entity’s ownership, ground lease or right to use a Contributed Property and, individually or in the aggregate, would reasonably be expected to have a Contributor Material Adverse Effect, and (ii) there are no other outstanding rights or agreements to enter into any contract for sale, ground lease or letter of intent to sell or ground lease any Contributed Property or any portion thereof that is owned by any Contributed Entity, which, in each case, is in favor of any party other than the Contributed Entity (a “Contributed Third Party”).

(i)          Except as set forth inSchedule 4.12(i), no Contributed Entity is a party to any agreement pursuant to which the Contributed Entity manages or manages the development of any real property for any Contributed Third Party.

(j)          True and complete copies of title insurance policies or valid marked-up title commitments evidencing title insurance with respect to the Contributed Properties (each, a “Contributed Title Insurance Policy” and, collectively, the “Contributed Title Insurance Policies”) have been delivered or made available to Acquiror Parties. To the knowledge of the Contributor Parties, no written claim has been made against any Contributed Title Insurance Policy, which, individually or in the aggregate, would reasonably be expected to have a Contributor Material Adverse Effect.

(k)          Schedule 4.12(k) lists each Contributed Property which is (i) under development as of the date hereof, and describes the status of such development as of the date hereof, and (ii) which is subject to a binding agreement for development or commencement of construction by a Contributor or the Contributed Entity.

13

(l)          Except as set forth inSchedule 4.12(l), (i) each Contributed Entity has good and valid title to, or a valid and enforceable leasehold interest in, or other right to use, all personal property owned, used or held for use by them as of the date of this Agreement (in each case other than property owned by tenants and used or held in connection with the applicable tenancy), and (ii) the Contributor has all necessary development rights; except (in each case) as, individually or in the aggregate, has not had and would not reasonably be expected to have, a Contributor Material Adverse Effect. No Contributor’s or Contributed Entity’s ownership of or leasehold interest in any such personal property is subject to any Encumbrances, except for Permitted Encumbrances.

(m)          Schedule 4.12(m) lists the parties currently providing third-party property management services to a Contributed Entity or with respect to a Contributed Property which provide for payment in any year in excess of $25,000 and the number of facilities currently managed by each such party.

(n)          Except as set forth onSchedule 4.12(n), no Contributor Party has any knowledge of (i) any structural defects relating to any Contributed Property, (ii) Contributed Properties whose building systems are not in working order, or (iii) physical damage to any Contributed Property for which there is not insurance in effect covering the cost of the restoration and the loss of revenue (subject to a reasonable deduction or retention limit) except, in each case, as would not result in a Contributor Material Adverse Effect.

(o)          Except as set forth inSchedule 4.12(o), (i) no Contributed Entity is an obligor under any Indebtedness and (ii) no Contributed Property is subject to any Indebtedness.

(p)          Schedule 4.12(p) lists all buildings, fixtures or items of personal property (having a value in excess of $25,000) owned by the Contributor Parties or a Subsidiary (other than the Contributed Entities) that are intended to be sold or transferred to the Acquiror pursuant hereto.

4.13         Taxes. Except as would not have a Contributor Material Adverse Effect or as disclosed onSchedule 4.13, (a) all Tax Returns and reports required to be filed with respect to each Contributed Entity and Contributed Property have been timely filed (after giving effect to any properly filed extensions) and all such Tax Returns and reports are accurate and complete in all material respects, and all Taxes required to be paid have been paid; and (b) no deficiencies for any Taxes have been proposed, asserted or assessed with respect thereto, and no requests for waivers of the time to assess any such Taxes are pending.

4.14         Insurance. Each Contributed Entity has in place the public liability, casualty, property and other insurance coverages with respect to its business and assets consistent with the types and coverages of insurance maintained by comparable entities in accordance with prudent business practices, and in all cases required under the terms of any Contract or other obligation to which the Contributed Entities are parties or to which they or their assets are subject. Each of such insurance policies is in full force and effect in all material respects and all premiums due and payable thereunder have been fully paid when due. None of the Contributed Entities has received from any insurance company any notice of cancellation or intent to cancel any such insurance policy or any coverage thereunder.

14

4.15         Hazardous Materials. Except as may be disclosed in writing in any written documentation or materials delivered or made available to the Acquiror Parties, and further except as disclosed onSchedule 4.15, to the knowledge of the Contributor Parties (i) no Contributor Party or Contributed Entity has received any written notice from the United States Environmental Protection Agency or other Governmental Authority or any other Person claiming any current violation of, or requiring current compliance with, any Environmental Laws or Environmental Permits or demanding payment or contribution for any release of Hazardous Materials in, on, under, or upon any of the Contributed Properties, where such violation, non-compliance or demand for payment or contribution would be reasonably expected to have, individually or in the aggregate, a Contributor Material Adverse Effect, and (ii) no litigation is pending, or has been threatened in writing in the last twelve (12) months, with respect to Hazardous Materials located in, on, under or upon any of the Contributed Properties, by any Governmental Authority or any other Person, that has had or would be reasonably expected to have, individually or in the aggregate, a Contributor Material Adverse Effect.

4.16         Affiliate Transactions. Since January 1, 2016, there have been no transactions, or series of related transactions, agreements, arrangements or understandings, nor are there any currently proposed transactions, or series of related transactions, that would be required to be disclosed under Item 404 of Regulation S-K promulgateddeclared effective under the Securities Act that haveas soon as possible but, in any event, no later than 120 days following the filing date if such registration statement is filed on Form S-3 or 150 days if such registration statement is filed on Form S-1. If such registration statement is not been otherwise disclosed in the documents filed or declared effective by the Contributor Parent under theSecurities and Exchange Act since such date.

4.17         Certain Business Practices. Since January 1, 2016, neither the Contributor Parent nor any of its Subsidiaries (nor, to the knowledge of the Contributor Parties, any of their respective officers, directors, employeesCommission on or agents) has made or agreed to make any contribution, payment, gift or entertainment to, or accepted or received any contributions, payments, gifts or entertainment from, any government official, employee, political party or agent or any candidate for any federal, state, local or foreign public office, where either the contribution, payment or gift or the purpose thereof was illegal under the Laws of any federal, state, local or foreign jurisdiction and was intended to benefit any Contributed Entity.

4.18         FIRPTA. Neither Contributor nor Contributor Parent is a “foreign person” within the meaning of Code Section 1445(f)(3), and shall certify to that effect and certify its taxpayer identification number at each Closing pursuant to Code Section 1445(b)(2).

4.19         Intellectual Property. No Contributed Entity: (a) owns any patents, registered trademarks, or registered copyrights, (b) has any pending applications or registrations for any trademarks, patents or copyrights or (c) is a party to any Contracts with respect to an exclusive license by such Contributed Entity of any trademarks or patents. Except as, individually or in the aggregate, would not reasonably be expected to have a Contributor Party Material Adverse Effect, (i) no Intellectual Property (as defined inSection 5.19(i)(i)) used by any Contributed Entity infringes or is alleged to infringe any Intellectual Property rights of any third party, (ii) to the Knowledge of Contributor Parties, no Person is misappropriating, infringing or otherwise violating any Intellectual Property of any Contributed Entity, and (iii) each Contributed Entity owns or is licensed to use, or otherwise possess valid rights to use, all Intellectual Property necessary to conduct the business of such Contributed Entity as it is currently conducted. Since December 31, 2015, no Contributor Party has received any written or, to the Knowledge of Contributor Party, verbal complaint, claim or notice alleging misappropriation, infringement or violation of any Intellectual Property rights of any third party.

4.20         Limitations.EXCEPT AS AND TO THE EXTENT EXPRESSLY REPRESENTED OTHERWISE HEREIN, THE CONTRIBUTOR PARTIES EXPRESSLY DISCLAIM ANY REPRESENTATION OR WARRANTY, EXPRESS, IMPLIED, OR STATUTORY, AS TO (I) TITLE TO ANY OF THE ASSETS, (II) ANY ESTIMATES OF THE VALUE OF THE ASSETS OR FUTURE REVENUES GENERATED BY THE ASSETS, (III) ANY OTHER MATERIALS OR INFORMATION THAT MAY HAVE BEEN MADE AVAILABLE OR COMMUNICATED TO ACQUIROR PARTIES OR THEIR AFFILIATES, OR ANY OF THEIR RESPECTIVE EMPLOYEES, AGENTS, CONSULTANTS, REPRESENTATIVES OR ADVISORS IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR ANY DISCUSSION OR PRESENTATION RELATING THERETO, AND FURTHER DISCLAIMS ANY REPRESENTATION OR WARRANTY, EXPRESS, IMPLIED, OR STATUTORY, OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, IT BEING EXPRESSLY UNDERSTOOD AND AGREED BY THE PARTIES THAT, EXCEPT AS PROVIDED TO THE CONTRARY IN THIS AGREEMENT, THE CONTRIBUTED ENTITY INTERESTS AND THE CONTRIBUTED PROPERTIES ARE BEING TRANSFERRED “AS IS, WHERE IS,” WITH ALL FAULTS AND DEFECTS.

15

4.21         Knowledge. As used in this Agreement, except as otherwise expressly stated, “to the knowledge of the Contributor Parties”, “to the Contributor Parties’ knowledge”, or phrases of similar import mean to the actual knowledge of Suneet Singal and any other executive officer of a Contributor Party (as such term is defined in Exchange Act Rule 3b-7).

ARTICLE 5

REPRESENTATIONS AND WARRANTIES OF ACQUIROR PARTIES

The Acquiror Parties jointly and severally represent and warrant to the Contributor Parties as follows:

5.1           Existence and Qualification.

(a)          Each Acquiror Party is a corporation or limited liability company, as the case may be, that is duly organized or formed, validly existing and in good standing under the Laws of its jurisdiction of incorporation or organization, and is duly qualified to carry on its business in each jurisdiction where the nature of its business or the ownership or leasing of its properties makes such qualification necessary, except where the failure to be so qualified has not had or would not be reasonably expected to have, individually or in the aggregate, an Acquiror Material Adverse Effect.

(b)          Schedule 5.1 hereof sets forth the name and jurisdiction of incorporation or organization of each Subsidiary of the Acquiror Parent, and the name of each jurisdiction where such Subsidiary is qualified or required to be qualified to do business. Each such Subsidiary has been duly organized or formed, validly existing and in good standing under the Laws of its jurisdiction of incorporation or organization, and is duly qualified to carry on its business in each jurisdiction where the nature of its business or the ownership or leasing of its properties makes such qualification necessary, except where the failure to be so qualified has not had or would not be reasonably expected to have, individually or in the aggregate, an Acquiror Material Adverse Effect. Except as set forth onSchedule 5.1 all of the securities or other Interests of each such Subsidiary are wholly owned, directly or indirectly, by the Acquiror Parent.

5.2           Power. Each Acquiror Party has the corporate or limited liability company, as the case may be, power and authority to enter into and perform its obligations under this Agreement and each other Transaction Agreement to which it is a party and to consummate the Transactions contemplated by this Agreement and such other Transaction Agreements.

16

5.3           Authorization and Enforceability. The execution, delivery and performance of this Agreement and each other Transaction Agreement to which such Acquiror Party is a party, and the consummation of the Transactions contemplated hereby and thereby, have been duly and validly authorized by all necessary action on the part of each Acquiror Party. This Agreement has been duly executed and delivered by each Acquiror Party, and at each Closing each other Transaction Agreement to which an Acquiror Party is a party with respect to the assets or entities being contributed or the consideration therefor, will have been duly executed and delivered by such Acquiror Party, and this Agreement constitutes the valid and binding obligation of each Acquiror Party, and at each Closing each other Transaction Agreement to which an Acquiror Party is a party with respect to the assets or entities being contributed or the consideration therefor, will constitute the valid and binding obligation of such Acquiror Party, enforceable in accordance with its terms except as such enforceability may be limited by applicable bankruptcy or other similar Laws affecting the rights and remedies of creditors generally as well as to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law).

5.4           No Conflicts. Except as required under the HSR Act, filings that will be made pursuant to the rules and regulations of NASDAQ and filings pursuant to applicable federal and state securities Laws and assuming the receipt of the Acquiror Required Consents, the execution, delivery and performance of this Agreement by each Acquiror Party, and the consummation of the Transactions contemplated by this Agreement and the other Transaction Agreements, do not and will not (a) violate any provision of the Organizational Documents of the Acquiror Parties, (b) result in a breach of or default (with due notice or lapse of time or both) or the creation of any Encumbrance or give rise to any right of termination, cancellation, or acceleration under any note, bond, mortgage, indenture, or other financing instrument or any Contract or other contract or agreement to which any member of the Acquiror Group is a party or by which any of them is bound or to which any of their assets or properties is subject, (c) violate any judgment, order, ruling, or decree applicable to any member of the Acquiror Group or to which such member is a party in interest, or (d) violate any Law applicable to any member of the Acquiror Group, except any matters described in clauses (b), (c), or (d) above which would not have an Acquiror Material Adverse Effect.

5.5           Consents, Approvals or Waivers. Except as required under (a) the HSR Act, (b) filings that will be made pursuant to the rules and regulations of NASDAQ and filings pursuant to applicable federal and state securities Laws, (c) the Acquiror Required Consents, as set forth onSchedule 5.5 hereto, the execution, delivery and performance of this Agreement and the other Transaction Agreements to be executed by the Acquiror Parties will not be subject to any consent, approval or waiver from any Governmental Authority or other third Person except for consents and approvals of Governmental Authorities that are customarily obtained after a Closing.

5.6           Litigation. Except as disclosed onSchedule 5.6:

(a)          there are no actions, suits, demands, investigations, administrative proceedings, or other proceedings pending before any Governmental Authority or arbitrator or, to the knowledge of the Acquiror Parties, threatened orally or in writing, before any Governmental Authority or arbitrator against either Acquiror Party or any Affiliate of an Acquiror Party that have had or would be reasonably expected to have, individually or in the aggregate, an Acquiror Material Adverse Effect; and

(b)          there are no actions, suits, demands, investigations, administrative proceedings, or other proceedings pending before any Governmental Authority or arbitrator or, to the knowledge of the Acquiror Parties, threatened orally or in writing, against any member of the Acquiror Group that would be reasonably expected to prevent, impair or delay materially the Acquiror Parties’ ability to perform their respective obligations under this Agreement and the other Transaction Agreements.

5.7           Investment Company. Neither Acquiror Party is now, and immediately after the issuance the Acquiror Parent Shares pursuant to the Transaction, will not be, required to register as an “investment company” or a company “controlled by” an entity required to register as an “investment company” within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations thereunder.

17

5.8           Independent Investigation. Acquiror and Acquiror Parent are (or its advisors are) experienced and knowledgeable in the real estate investment business and aware of the risks of that business. Acquiror and Acquiror Parent acknowledge and affirm that (a) each of them has completed such independent investigation, verification, analysis and evaluation of the Contributed Properties and has made all such reviews and inspections of the Contributed Properties as it has deemed necessary or appropriate to enter into this Agreement, and (b) if any Closing occurs, each of them will be deemed to have completed its independent investigation, verification, analysis, and evaluation of the Contributed Properties contributed at such Closing and made all such reviews and inspections of the Contributed Properties as it will have deemed necessary or appropriate to consummate the Transactions contemplated hereby.

5.9           Brokers and Other Advisors. Except for Sandler O’Neill & Partners, L.P., the fees and expenses of which will be paid by the Acquiror Parent, no broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission, or the reimbursement of expenses relating thereto, in connection with the Transactions based upon arrangements made by or on behalf of the Acquiror Parent or any of its Subsidiaries.

5.10         Bankruptcy. There are no bankruptcy, reorganization, or receivership proceedings pending, being contemplated by, or, to the knowledge of the Acquiror Parties, threatened, against either Acquiror Party or any other member of the Acquiror Group (whether by a member of the Acquiror Group or a third Person). The Acquiror Parties are not entering into this Agreement with actual intent to hinder, delay, or defraud any creditor. Immediately prior to and immediately subsequent to, any Closing, (a) neither Acquiror Party will have incurred, nor does it intend tosuch dates, or believe that it will incur, debts (including contingent obligations) beyond its ability to payif after such debts as such debts mature or come due (taking into account the timing and amounts of cash to be received from any source, and amounts to be payable on or in respect of debts), (b) the amount of cash available to each Acquiror Party after taking into account all other anticipated uses of fundsregistration statement is anticipated to be sufficient to pay all such amounts on or in respect of debts, when such amounts are required to be paid, and (c) each Acquiror Party will have sufficient capital with which to conduct its business.

5.11         Valid Issuance. At each Closing, the Transaction Shares to be issued thereat will be duly authorized, validly issued, fully paid and non-assessable and will be free of any Encumbrances, other than restrictions on transfer under federal and state securities Laws and will not be subject to preemptive rights. The Acquiror Parent Shares comprising the Purchase Price will be issued and granted in compliance in all material respects with (a) all applicable securities and other Laws and (b) all requirements set forth in applicable Contracts of Acquiror Parent.

5.12         Capitalization.

(a)          As of the date hereof, the authorized capital of Acquiror Parent consisted solely of (i) Fifty Million (50,000,000) shares of common stock, par value $0.01 per share, of which 4,418,266 shares were issued and outstanding, and (ii) Five Million (5,000,000) shares of preferred stock, par value $0.01 per share, of which no shares were issued and outstanding.

(b)          All of the issued and outstanding shares of Acquiror Parent Shares are duly authorized and validly issued in accordance with the Organizational Documents of Acquiror Parent, are fully paid and non-assessable, and were not issued in violation of any preemptive rights, rights of first refusal, or other similar rights of any Person.

18

(c)          Except as disclosed onSchedule 5.12(c), there are no preemptive rights or other outstanding rights, options, warrants, conversion rights, stock appreciation rights, redemption rights, repurchase rights, agreements, arrangements, calls, subscription agreements, commitments or rights of any kind that obligate Acquiror Parent to issue or sell any equity interests of Acquiror Parent or of any other member of the Acquiror Group or any securities or obligations convertible or exchangeable into or exercisable for, or giving any Person a right to subscribe for or acquire, any equity interests in Acquiror Parent or any other member of the Acquiror Group, and no securities or obligations evidencing such rights are authorized, issued or outstanding.

(d)           Acquiror Parent does not have any outstanding bonds, debentures, notes, or other obligations the holders of which have the right to vote (or convertible into or exercisable for securities having the right to vote) with the holders of equity interests in Acquiror Parent or any other member of the Acquiror Group on any matter pursuant to such outstanding bonds, debentures, notes or other obligations.

5.13         SEC Documents.

(a)          Acquiror Parent has timely filed with or furnished the Commission since January 1, 2016 with all SEC Documents required to be filed or furnished by it. The SEC Documents, including any audited or unaudited financial statements and any notes thereto or schedules included therein (the “Financial Statements”), at the time filed or furnished (except to the extent corrected by a subsequently filed or furnished SEC Document filed or furnished prior to the Execution Date) (i) did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein (in the light of the circumstances under which they were made) not misleading, (ii) complied in all material respects with the applicable requirements of the Exchange Act and the Securities Act, as applicable, (iii) complied as to form in all material respects with applicable accounting requirements and with the published rules and regulations of the Commission with respect thereto, (iv) in the case of the Financial Statements, were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto or the omission of notes to the extent permitted by Regulation S-K or, in the case of unaudited statements, as permitted by Form 10-Q of the Commission) and subject, in the case of interim financial statements, to normal year-end adjustments, and (v) in the case of the Financial Statements, fairly present in all material respects the consolidated financial condition, results of operations, and cash flows of Acquiror Parent as of the dates anddeclared effective, without regard for the periods indicated therein.

(b)          The Acquiror Parent has heretofore furnished to the Contributor Parent true, correct and complete copies of any and all submission, filings, amendmentsreason thereunder or modifications (including Commission comments and responses to Commission comments) which have either (i) not been filed with the Commission but which are expected to be filed in the same or in a similar form, or (ii) which are not currently publicly available on the Commission’s EDGAR system. In addition, the Acquiror Parent has heretofore furnished to the Contributor Parent in unredacted form true, correct and complete copies of each Exhibit filed with the Commission and reflected in the Acquiror Parent’s Annual Report on Form 10-K for the year ended December 31, 2016 or on Forms 10-Q or 8-K for any later date or period, which has been filed in redacted form pursuant to a confidential treatment request.

5.14         No Indebtedness or Liabilities.

(a)          There is no Indebtedness or other liabilities of or with respect to the Acquiror Group that would be required by GAAP to be reserved, reflected, or otherwise disclosed on a consolidated balance sheet of Acquiror Parent other than (i) liabilities reserved, reflected, or otherwise disclosed in the consolidated balance sheet of Acquiror Parent as of December 31, 2016 (including the notes thereto) included in the Financial Statements, (ii) liabilities incurred in the ordinary course of business consistent with past practice since December 31, 2016, (iii) fees and expenses incurred in connection with the Transactions contemplated by this Agreement and the other Transaction Agreements or (iv) liabilities that would not reasonably be expected to have an Acquiror Material Adverse Effect.

19

(b)          Except as disclosed onSchedule 5.14(b), the Acquiror Group has no Environmental Liabilities.

(c)          The aggregate Indebtedness of the Acquiror Group to Dr. Dolev Rafaeli, Dennis M. McGrath and Yoav Ben-Dror (collectively, the “Executives”) for accrued compensation for services, reimbursement obligations or other matters through September 30, 2016 (whether or not the same are due and payable) are $6,381,219, $2,019,692, and $525,000, respectively and as of June 30, 2017, the Acquiror Parent expects the amount of these accrued liabilities to be equal to approximately $4,767,500, $1,224,500 and $1,515,000, respectively.

5.15         Internal Controls; Listing Exchange.

(a)          Acquiror Parent has established and maintains disclosure controls and procedures (asefforts therefor, such term is defined in Rule 13a-15 under the Exchange Act) as required by Rule 13a-15 under the Exchange Act, such disclosure controls and procedures are reasonably designed to ensure that material information required to be disclosed by Acquiror Parent in the reports it files or submits to the Commission under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Commission, and that such material information is accumulated and communicated to Acquiror Parent’s management as appropriate to allow timely decisions regarding required disclosure.

(b)           Since January 1, 2016, (i) Acquiror Parent has not been advised by its independent auditors of any significant deficiency or material weakness in the design or operation of internal controls that could adversely affect Acquiror Parent’s internal controls, (ii) Acquiror Parent has no knowledge of any fraud, whether or not material, that involves management or other employees who have a significant role in Acquiror Parent’s internal controls, and (iii) there have been no changes in internal controls or, to the knowledge of the Acquiror Parties, in other factors that could reasonably be expected to materially affect internal controls, including any corrective actions with regard to any significant deficiency or material weakness.

(c)          Except as disclosed onSchedule 5.15(c), the Acquiror Parent Shares are listed on NASDAQ, and Acquiror Parent has not received any notice of delisting from NASDAQ. No judgment, order, ruling, decree, injunction, or award of any securities commission or similar securities regulatory authority or any other Governmental Authority, or of NASDAQ, preventing or suspending trading in any securities of Acquiror Parent has been issued, and no proceedings for such purpose are, to the knowledge of the Acquiror Parties, pending, contemplated or threatened. Acquiror Parent has taken no action that is designed to terminate, or would have the effect of terminating, the registration of the Acquiror Parent Shares under the Exchange Act or the delisting of the Acquiror Parent Shares from NASDAQ or any other securities exchange.

5.16         Compliance with Laws. Except as disclosed onSchedule 5.16, (a) each Acquiror Party is, and during the past two years has been, in compliance in all material respects with all applicable Laws, (b) no Acquiror Party has received written notice of any violation in any respect of any applicable Law, (c) no Acquiror Party has received written or oral notice that it is under investigation by any Governmental Authority for potential non-compliance in any material respect with any Law, (d) no Acquiror Party is subject to any material outstanding judgment, order or decree of any Governmental Authority, and (e) no member of the Acquiror Group has received nor, to the Acquiror Parties’ knowledge, has any third Person received, any written notice since January 1, 2016 of a violation of or a default by such Person with respect to any Law or any decision, ruling, order or award of any Governmental Authority or arbitrator applicable to any member of the Acquiror Group.

20

5.17         Affiliate Transactions. Since January 1, 2016, there have been no transactions, or series of related transactions, agreements, arrangements or understandings, nor are there any currently proposed transactions, or series of related transactions, that would be required to be disclosed under Item 404 of Regulation S-K promulgated under the Securities Act that have not been otherwise disclosed in the Acquiror Parent’s SEC Documents filed prior to the date hereof.

5.18         Certain Business Practices. Since January 1, 2016, neither the Acquiror Parent nor any of its Subsidiaries (nor, to the knowledge of the Acquiror Parties, any of their respective officers, directors, employees or agents) has made or agreed to make any contribution, payment, gift or entertainment to, or accepted or received any contributions, payments, gifts or entertainment from, any government official, employee, political party or agent or any candidate for any federal, state, local or foreign public office, where either the contribution, payment or gift or the purpose thereof was illegal under the Laws of any federal, state, local or foreign jurisdiction.

5.19         Intellectual Property.

(a)          The members of the Acquiror Group own solely and exclusively all Intellectual Property that the Acquiror Group owns or purports to own (“Acquiror Intellectual Property”) free and clear of all Encumbrances.

(b)          The members of the Acquiror Group have sufficient rights to use all Intellectual Property used in their respective businesses as presently conducted, all of which rights shall survive the consummation of the Transactions contemplated by this Agreement. The Acquiror Intellectual Property is subsisting, and the issued or granted Registered Intellectual Property included therein is valid and enforceable. No Acquiror Intellectual Property is subject to any outstanding order, judgment, decree or agreement adversely affecting the Acquiror’s or its Subsidiaries’ use of, or its rights to, such Intellectual Property.

(c)          Neither the Acquiror nor any of its Subsidiaries is infringing, misappropriating, or otherwise violating, or has infringed, misappropriated, or otherwise violated the valid and enforceable Intellectual Property rights of any Person during the six year period immediately preceding the date of this Agreement, and there are no pending, outstanding, or, to the knowledge of the Acquiror Parties, threatened oral or written notices (including invitations to take a license), actions, suits, claims, investigations or other legal proceedings asserting the same.

(d)          To the knowledge of the Acquiror Parties, no third party is infringing, misappropriating or otherwise violating any Acquiror Intellectual Property, except as would not, individually or in the aggregate, reasonably be expected to have an Acquiror Material Adverse Effect.

(e)          Except as would not result in a Acquiror Material Adverse Effect, the Acquiror Parent and each of its Subsidiaries have taken all reasonable measures to protect the confidentiality and value of all Trade Secrets that are owned by the Acquiror or any of its Subsidiaries, and to the knowledge of the Acquiror Parties, such Trade Secrets have not been used, disclosed to or discovered by any Person except pursuant to appropriate non-disclosure and/or license agreements or obligations.

21

(f)          To the knowledge of the Acquiror Parties, the Acquiror Parent and each of its Subsidiaries have obtained from all parties (including current or former employees, officers, directors, consultants and contractors) who have created or developed any portion of, or otherwise who would have any rights in or to, Acquiror Intellectual Property assignments of any work, invention, improvement or other rights in or to such Acquiror’s Intellectual Property to the Acquiror or its Subsidiaries except where the failure to do so would not result in an Acquiror Material Adverse Effect.

(g)          The IT Assets owned or used by the Acquiror or any of its Subsidiaries operate and perform in accordance with their documentation and functional specifications and otherwise as required by the Acquiror and its Subsidiaries in connection with their business. To the knowledge of the Acquiror Parties, no Person has gained unauthorized access to such IT Assets. The Acquiror and each of its Subsidiaries implements commercially reasonable measures designed to (A) protect the confidentiality, integrity and security of its IT Assets and the information stored or contained therein or transmitted thereby from any unauthorized use, access, interruption or modification by third parties, (B) prevent the introduction of “back door,” “time bomb,” “Trojan horse,” “virus,” “worm,” “spyware” and other malicious code into software used in the business of the Acquiror and its Subsidiaries in a manner consistent with industry practice and (C) the Acquiror and its Subsidiaries have implemented reasonable backup and disaster recovery technology consistent with industry practices.

(h)          Schedule 5.19(h) sets forth (i) all trademarks and service marks registered or applied for by any member of the Acquiror Group or which any member of the Acquiror Group has a license or other right to use, anywhere in the world, and (ii) all Uniform Resource Locators (“urls”) and websites maintained by or for any member of the Acquiror Group.

(i)          For purposes of this Agreement, the following terms have the following meanings:

(i)          “Intellectual Property” means, anywhere in the world, all (A) trademarks, service marks, brand names, certification marks, collective marks, d/b/a’s, Internet domain names, logos, symbols, trade dress, trade names, and other indicia of origin, all applications and registrations for the foregoing, and all goodwill associated therewith and symbolized thereby, including all renewals of same; (B) inventions and discoveries, whether patentable or not, and all patents, registrations, invention disclosures and applications therefor, including divisions, continuations, continuations-in-part and renewal applications, and including renewals, extensions and reissues; (C) confidential information, trade secrets and know-how, including processes, schematics, business methods, formulae, drawings, prototypes, models, designs, customer lists and supplier lists (collectively, “Trade Secrets”); (D) published and unpublished works of authorship, whether copyrightable or not (including databases and other compilations of information), copyrights therein and thereto, and registrations and applications therefor, and all renewals, extensions, restorations and reversions thereof; and (E) all other intellectual property or proprietary rights.

(ii)         “IT Assets” means computers, computer software, firmware, middleware, servers, workstations, routers, hubs, switches, data communications lines, and all other information technology equipment, and all associated documentation.

(iii)        “Registered” means issued by, registered with or the subject of a pending application before any Governmental Authority or Internet domain name registrar.

22

5.20         Taxes.

(a)          Except as would not have an Acquiror Material Adverse Effect or as disclosed onSchedule 5.20(a), (a) all Tax Returns and reports required to be filed with respect to each member of the Acquiror Group and real property owned by such members have been timely filed (after giving effect to any properly filed extensions) and all such Tax Returns and reports are accurate and complete in all material respects, and all Taxes required to be paid have been paid; and (b) no deficiencies for any Taxes have been proposed, asserted or assessed with respect thereto, and no requests for waivers of the time to assess any such Taxes are pending.

(b)          Except as set forth onSchedule 5.20(b), no audits, examination or investigations by any Governmental Authority relating to any Tax Returns of any member of the Acquiror Group are in progress or, to the knowledge of the Acquiror Parties, contemplated.

(c)          Neither Acquiror nor Acquiror Parent is a “foreign person” within the meaning of Code Section 1445(f)(3), and shall certify to that effect and certify its taxpayer identification number at each Closing pursuant to Code Section 1445(b)(2).

5.21         Insurance. Each member of the Acquiror Group has in place the public liability, casualty, property and other insurance coverages with respect to its business and assets consistent with the types and coverages of insurance maintained by comparable entities in accordance with prudent business practices, and in all cases required under the terms of any Contract or other obligation to which the members of the Acquiror Group are parties or to which they or their assets are subject. Each of such insurance policies is in full force and effect in all material respects and all premiums due and payable thereunder have been fully paid when due. No member of the Acquiror Group has received from any insurance company any notice of cancellation or intent to cancel any such insurance policy or any coverage thereunder.

5.22         Labor.

(a)          None of the employees of any member of the Acquiror Group are represented by any collective bargaining or similar agreement. The Acquiror Parent is not aware of any current or planned unionization effort with respect to employees of any member of the Acquiror Group.

(b)          Except as disclosed onSchedule 5.22(b) hereof, none of the members of the Acquiror Group is the sponsor of any defined benefit, defined contribution or similar pension or Employee Benefit Plan. In addition, no member of the Acquiror Group is a party to any multiemployer pension plan or similar plan.

(c)          All salaries, benefits and other compensation which are required to be paid to any employees of the members of the Acquiror Group have been so paid, except for amounts not yet due and payable.

(d)          There has not been, since January 1, 2016, any labor dispute, walkout, strike or similar unrest affecting employees of any member of the Acquiror Group.

5.23         Hazardous Materials. To the knowledge of the Acquiror Parties, no Hazardous Materials are stored or have been used on any of the properties which any member of the Acquiror Group owns or leases or on which the business activities of any member of the Acquiror Group have been conducted, except in conformance with all applicable Environmental Laws.

23

5.24         Certain Business Practices. Since January 1, 2016, neither the Acquiror Parent nor any of its Subsidiaries (nor, to the knowledge of the Acquiror Parties, any of their respective officers, directors, employees or agents) has made or agreed to make any contribution, payment, gift or entertainment to, or accepted or received any contributions, payments, gifts or entertainment from, any government official, employee, political party or agent or any candidate for any federal, state, local or foreign public office, where either the contribution, payment or gift or the purpose thereof was illegal under the Laws of any federal, state, local or foreign jurisdiction.

5.25         Absence of Certain Changes. Except as disclosed onSchedule 5.25, there has not occurred any event, occurrence, change, discovery or development of a state of circumstances or facts which would, individually or in the aggregate, reasonably be expected to result in an Acquiror Material Adverse Effect.

5.26         Limitations.EXCEPT AS AND TO THE EXTENT EXPRESSLY REPRESENTED OTHERWISE HEREIN, THE ACQUIROR PARTIES EXPRESSLY DISCLAIM ANY REPRESENTATION OR WARRANTY, EXPRESS, IMPLIED, OR STATUTORY, AS TO ANY MATERIALS OR INFORMATION THAT MAY HAVE BEEN MADE AVAILABLE OR COMMUNICATED TO THE CONTRIBUTOR PARTIES OR THEIR AFFILIATES, OR ANY OF THEIR RESPECTIVE EMPLOYEES, AGENTS, CONSULTANTS, REPRESENTATIVES OR ADVISORS IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR ANY DISCUSSION OR PRESENTATION RELATING THERETO, AND FURTHER DISCLAIMS ANY REPRESENTATION OR WARRANTY, EXPRESS, IMPLIED, OR STATUTORY, OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

5.27         Knowledge. As used in this Agreement, “to the knowledge of the Acquiror Parties”, “to Acquiror Parties’ knowledge”, or phrases of similar import means to the actual knowledge of Dr. Dolev Rafaeli and Dennis M. McGrath.

ARTICLE 6

COVENANTS OF THE PARTIES

6.1           Access to Acquiror Group. Subject to the limitations expressly set forth in this Agreement, the Acquiror Parties shall, and shall cause the members of the Acquiror Group to, provide Contributor Parent and its representatives access to the premises, properties, personnel, books, records (including Tax records), Contracts and documents of the Acquiror Parties and access to and the right to copy the books and records of the members of the Acquiror Group in possession or control of any of the members of the Acquiror Group for the purpose of conducting a confirmatory review of the Acquiror Parties and the members of the Acquiror Group but only to the extent the Acquiror Parties have authority to grant such access without breaching any obligation of confidentiality binding on the Acquiror Parties or any of their Affiliates. Such access by Contributor Parent shall be limited to normal business hours, and Acquiror Parties’ investigation shall be conducted in a manner that minimizes interference with the operation of the business of the Acquiror Group.

6.2           Access to Contributor Group. Subject to the limitations expressly set forth in this Agreement, the Contributor Parties shall, and shall cause the members of the Contributor Group to, provide Acquiror Parent and its representatives access to premises, properties, personnel, books, records (including Tax records), Contracts and documents of the Contributed Entities and relating to the Contributed Entity Interests or the Contributed Properties and access to and the right to copy the books and records of the members of the Contributor Group relating to the Contributed Entities, the Contributed Entity Interests or the Contributed Properties in possession or control of any of the members of the Contributor Group for the purpose of conducting a confirmatory review of the Contributed Entities, Contributed Entity Interests and Contributed Properties, but only to the extent the Contributor Parties have authority to grant such access without breaching any obligation of confidentiality binding on the Contributor Parties or any of their Affiliates. Such access by Acquiror shall be limited to normal business hours, and Acquiror’s investigation shall be conducted in a manner that minimizes interference with the operation of the business of Contributor Group.

24

6.3           Press Releases. Neither the Contributor Parties nor the Acquiror Parties, nor any Affiliate thereof, shall make any press release or public disclosure regarding the existence of this Agreement, the contents hereof, or the transactions contemplated hereby without the prior written consent of Acquiror Parent (in the case of announcements by Contributor or its Affiliates) or Contributor Parent (in the case of announcements by Acquiror Parties or their Affiliates), which consent, in each case, may be withheldstatement ceases for any reason or no reason;provided, however, the foregoing shallto be effective for more than an aggregate of 30 trading days during any 12-month period, which need not restrict disclosures by Acquiror Parties or Contributor Parties (a) to the extent that such disclosures are required by applicable securities or other Laws or the applicable rules of any stock exchange having jurisdiction over the disclosing Party or its Affiliates, (b) to Governmental Authorities and third Persons holding rights of consent or other rights that may be applicable to the Transactions contemplated by this Agreement, as reasonably necessary to provide notices, seek waivers, amendments or terminations of such rights, or seek such consents, (c) to such Party’s investors and members, including each Parties’ Affiliates’ investors and limited partners, and to prospective investors or other Persons as part of fundraising or marketing activities undertaken by such Parties’ Affiliates provided such disclosures are made to Persons subject to an obligation of confidentiality with respect to such information or (d) as may be necessary for, or permitted pursuant to, the exercise of the rights and fulfillment of the obligations of a Party under this Agreement. Contributor and Parties and Acquiror Parties shall each be liable for the compliance of its respective Affiliates with the terms of thisSection 6.3. The Parties agree that neither Acquiror Parties nor Contributor Parties will have an adequate remedy at law if any of the foregoing Persons violate (or threaten to violate) any of the terms of thisSection 6.3. In such event, Acquiror Parties or Contributor Parties, as applicable, shall have the right,consecutive, then in addition to any other itrights the holders of Series B Preferred Stock may have under the Registration Rights Agreement or under applicable law, the Company shall pay to obtain injunctive reliefeach holder an amount in cash, as partial liquidated damages and not as a penalty, equal to restrain any breach or threatened breach1% of the termsproduct obtained by multiplying (x) the Series B Original Issue Price by (y) the number of thisSection 6.3withoutshares of Registrable Securities held by the postingholder (such product being the “Investment Amount”); provided that, in no event will the Company be liable for liquidated damages in excess of 1% of the Investment Amount in any bond.single month and that the maximum aggregate liquidated damages payable to the holders under the Registration Rights Agreement shall be 10% of the Investment Amount. On January 23, 2018, the Company filed a registration statement on Form S-3 to register the shares issued to OFI in the first closing. OFI waived its right to liquidated damages in connection with the late filing of such registration statement. 

 

6.4           OperationRegistration Rights Agreements with Payout Note Holders

As discussed in Note 14, the Payout Notes were convertible into shares of Businesscommon stock and the Company agreed to register the shares underlying the Payout Notes within thirty (30) days of Acquiror Parties. Until December 31,issuance with best efforts to cause the registration statement covering such shares to become effective within one-hundred twenty (120) days of issuance. On November 14, 2017, (or,the Company filed a registration statement on Form S-3 (the “First Registration Statement”) to register all shares that may be issued upon conversion of the Payout Notes, which was subsequently amended to include the Payout Shares issued under the Stock Grant Agreement. In connection with the Stock Grant Agreement, the Company entered into a registration rights agreement (the “Payout Registration Rights Agreement”) with the Note Holders, pursuant to which the Company agreed to register the shares of common stock under the Additional Shares under the Securities Act. The Company agreed to file a registration statement covering the resale of the Additional Shares within 30 days of the Stock Grant Agreement and cause such registration statement to be declared effective under the Securities Act as soon as possible but, in any event, no later than 120 days following the filing date if all Closingssuch registration statement is filed on Form S-3 or 150 days if such registration statement is filed on Form S-1. If such registration statement is not filed or declared effective by the Securities and Exchange Commission on or prior to such dates, or if after such registration statement is declared effective, without regard for the reason thereunder or efforts therefor, such registration statement ceases for any reason to be effective for more than an aggregate of 30 trading days during any 12-month period, which need not be consecutive, then in addition to any other rights the Note Holders may have occurred prior thereto,under the Payout Registration Rights Agreement or under applicable law, the Company shall pay to each Note Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to 1% of the product obtained by multiplying (x) $1.00 by (y) the number of shares of Common Stock held by the Note Holder included in the registration statement (such product being the “Payout Investment Amount”); provided that, in no event will the Company be liable for liquidated damages in excess of 1% of the Payout Investment Amount in any single month and that the maximum aggregate liquidated damages payable to the Note Holders under the Payout Registration Rights Agreement shall be 10% of the Payout Investment Amount. The registration rights provision contained in the Payout Notes was incorporated by reference into the Payout Registration Rights Agreement, except that the Note Holders waived the breach by the Company for failure to timely file the First Registration Statement and agreed that they are not entitled to liquidated damages as a result of such failure. Under the Payout Registration Rights Agreement, the Note Holders are entitled to liquidated damages if the First Registration Statement is not declared effective within 120 days following the date of the final Closing pursuant hereto),Payout Notes, but the Acquiror Parties shall, and shall cause each other member ofNote Holders subsequently agreed to waive their rights to such liquidated damages until April 20, 2018. On January 23, 2018, the Acquiror Group to, operate its business in the ordinary course, and, without limiting the generality of the foregoing and, except as otherwise expressly contemplated by this Agreement or except as otherwise consented to in writing by the Contributor Parent (which consent shall not be unreasonably withheld, conditioned or delayed), the Acquiror Parties shall, and shall cause each other member of the Acquiror Group to:

(a)          not offer, issue, deliver, grant or sell, or authorize or propose to offer, issue, deliver, grant or sell, any securities or other Interests in any member of the Acquiror Group (including, without limitation, rights, options, warrants, conversion rights, stock appreciation rights, redemption rights, repurchase rights, agreements, arrangements, calls, subscription agreements, commitments or rights of any kind) or any securities or obligations convertible or exchangeable into or exercisable for, or giving any PersonCompany filed a right to subscribe for or acquire, any Interests in any member of the Acquiror Group, other than (i) issuances of Acquiror Parent Shares pursuant to options or warrants outstandingregistration statement on the date hereof and disclosed onSchedule 5.12(c) hereof in accordance with the terms thereof, and (ii) issuances of Interests by any wholly-owned Subsidiary of a member of the Acquiror Group to another wholly-owned Subsidiary of a member of the Acquiror Group;

25

(b)          not make any investment in or acquire Interests or other securities of, or make any capital contribution to, any Person other than a wholly-owned Subsidiary of a member of the Acquiror Group;

(c)          except as disclosed onSchedule 6.4(c), or as specifically contemplated hereby, not amend any of the Organizational Documents of any member of the Acquiror Group;

(d)          not declare or pay any dividend or make any distribution to its security holders;

(e)          not approve any expenditure that is outside of the ordinary course of business and that is anticipated to cost more than fifty thousand dollars ($50,000) per activity or series of related activities (excepting, in each case, emergency operations required under presently existing contractual obligations and operations necessary to avoid material monetary penalty or forfeiture or nonconsent penalty under any provision of any applicable Contract or order of any Governmental Authority, all of which will be deemed to be approved, provided Acquiror Parent promptly notifies Contributor Parent of any such emergency operation);

(f)          not transfer, sell, hypothecate, encumber, or otherwise dispose of any of their assets, except for (i) sales and dispositions made in the ordinary course of business and (ii) other sales and dispositions of assets individually or in the aggregate not exceeding fifty thousand dollars ($50,000);

(g)          not (i) take any action to terminate, materially amend, or extend any Material Contract or (ii) enter into any agreement that, if in existence at the Execution Date would be a Material Contract unless terminable without penalty on sixty (60) days or shorter notice;

(h)          maintain insurance coverage on the Acquiror Group and their assets in the amounts and of the types presently in force and not make any election to be excluded from any such coverage;

(i)          maintain in full force and effect all Contracts (exceptForm S-3 for the termination of such Contract by its own terms);

(j)          not incur any Indebtedness or take or failAdditional Shares. The Note Holders waived their rights to take any action that would cause a lien or encumbrance to arise or exist on their material assets or otherwise allow a lien to attach to or encumber the Assets;

(k)          maintain all material permits and approvals issued by Governmental Authorities affecting the Acquiror Group and its material assets;

(l)          use commercially reasonable efforts to maintain and preserve intact the current organization, business and franchises of the Acquiror Group and to preserve the rights, franchises, goodwill and relationships with their service providers, customers, lenders, suppliers, regulators and others having business relationships with the Acquiror Group;

(m)          not waive, release, assign, settle or compromise any claim, action or proceeding relating to a member of the Acquiror Group or any of their Assets except for claims involving a dollar amount of $50,000 or less and that do not impose any restrictions on the Company’s ability to engage in any line of business or would reasonably be expected to have an Acquiror Material Adverse Effect;

26

(n)          except as specified onSchedule 6.4(n), not file any amended Tax Return, revoke or change any Tax election, change a Tax accounting period, enter into any closing agreement with respect to Taxes, settle any Tax claim or assessment unless in connection with an ongoing audit, surrender any right to claim a refund of Taxes, or consent to any extension or waiver of the limitation period applicable to any Tax claim or assessment, in each case that would be reasonably likely to have the effect of materially increasing the Tax liability of the Acquiror Group for any period after the Initial Closing Date;

(o)          not, except as required by the terms of any Employee Benefit Plan of any member of the Acquiror Group as in effect on the date hereof or as described inSchedule 6.4(o), (i) grant, increase or accelerate the vesting or payment of, or announce or promise to grant, increase or accelerate the vesting or payment of, any wages, salaries, bonuses, incentives, severance pay, other compensation, pension or other benefits payable or potentially available (including amounts payable to the Executives whether before or after the June 30, 2017 date referred to inSection 5.14(c) that are consistent withSection 5.14(c) and existing employment agreements and other compensation arrangements) to any Employee of any member of the Acquiror Group; or (ii) establish, adopt or amend (or promise to take any such action(s)) any Employee Benefit Plan of any member of the Acquiror Group or any benefits potentially available thereunder applicable to any employee thereof;

(p)          not take any action to delist the Acquiror Parent Shares from NASDAQ or the Tel Aviv Stock Exchange or to list the Acquiror Parent Shares on any other securities exchange or securities trading or quotation system;

(q)          not adopt any plan or agreement of complete or partial liquidation, dissolution, restructuring, recapitalization, merger, consolidation or other reorganization or otherwise effect any transaction whereby by any Person or group acquires more than a majority of the outstanding equity interests of any member of the Acquiror Group;

(r)          not take any action that would or would reasonably be expected to prevent or materially delay any Closing or the consummation of the Transactions;

(s)          not merge with or into or consolidate with any other entity, acquire or dispose of any material amount of assets outside of the ordinary course of business or engage in any other transaction outside the ordinary course of business;

(t)          not take any action or fail to take any action that would reasonably be expected to cause Acquiror or any other member of the Acquiror Group that is not currently treated as a corporation for U.S. federal Income Tax purposes, to not be treated as a corporation;

(u)          not repurchase or otherwise acquire any shares of its capital stock for less than fair market value (other than (i) the repurchase, redemption or other acquisition or retirement for value of any such capital stock held by any current or former director or employee of any member of the Acquiror Group pursuant to any director or employee equity subscription agreement or plan, stock option agreement or similar agreement or plan or (ii)liquidated damages in connection with the exerciselate filing of stock options or stock appreciation rights by way of cashless exercise); or declare, set aside or pay any dividend or other distribution payablesuch registration statement and in cash, shares of its capital stock, property, rights or otherwiseconnection with respect to any shares of its capital stock;

(v)         not take (or omit to take) any action that would cause the Acquiror to become a Shell Company (as defined in Section 405 of the Securities Act); and

(w)          not agree or commit to do any of the foregoing.effectiveness deadline for such registration statement until April 20, 2018.

 

27

A-60 

 

6.5           Operation of Business of Contributor Parties. Until December 31, 2017 (or, if all Closings have occurred prior thereto, the date of the final Closing pursuant hereto), the Contributor Parties shall, and shall cause each other member of the Contributor Group to, operate the Contributed Entities, the Additional Contributed Entities and the Contributed Properties, prior to their transfer to the Acquiror, in the ordinary course, and, without limiting the generality of the foregoing and, except as otherwise expressly contemplated by this Agreement or except as otherwise consented to in writing by the Acquiror Parent (which consent shall not be unreasonably withheld, conditioned or delayed), the Contributor Parties shall, and shall cause each other member of the Contributor Group to:Note 14

Stockholders’ Equity:

 

(a)          not offer, issue, deliver, grant or sell, or authorize or propose to offer, issue, deliver, grant or sell, any Contributed Interests or Additional Contributed Interest (including, without limitation, rights, options, warrants, conversion rights,Common Stock

The Company’s common stock appreciation rights, redemption rights, repurchase rights, agreements, arrangements, calls, subscription agreements, commitments or rights of any kind) or any securities or obligations convertible or exchangeable into or exercisable for, or giving any Person a right to subscribe for or acquire, any Contributed Interests or Additional Contributed Interests;confer upon their holders the following rights: 

 

The right to participate and vote in the Company’s stockholder meetings, whether annual or special. Each share will entitle its holder, when attending and participating in the voting in person or via agent or letter, to one vote;

(b)          not amend

The right to a share in the distribution of dividends, whether in cash or in the form of bonus shares, the distribution of assets or any other distribution pro rata to the par value of the shares held by them;

The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the shares held by them.

Convertible Series A Preferred Stock

The terms of the Organizational DocumentsConvertible Series A Preferred Stock are governed by a certificate of any Contributed Entitydesignation, or Additional Contributed Entity;the Series A Certificate of Designation, filed by the Company with the Nevada Secretary of State on May 15, 2017. Pursuant to the Series A Certificate of Designation, the Company designated 3,000,000 shares of the Company’s preferred stock as Series A Convertible Preferred Stock. As more fully described in Note 5, the Company issued 123,668 shares of Convertible Series A Preferred Stock in connection with the Contribution Agreement. Following is a summary of the material terms of the Series A Convertible Preferred Stock: 

 

(c)          not permit any Contributed Entity or Additional Contributed Entity to declare or pay any dividend or make any distribution to its security holders;

Liquidation - Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, the holders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation, after the Redeemable Convertible Series B Preferred Stockholder’s liquidation preference, the same amount that a holder of Common Stock would receive if the Convertible Series A Preferred Stock were fully converted (disregarding for such purposes any conversion limitations hereunder) to Common Stock which amounts shall be paid pari passu with all holders of Common Stock.

 

(d)          not approve any expenditure by a Contributed Entity or Additional Contributed Entity that is outside of the ordinary course of the business of the Contributed Entity or Additional Contributed Entity;

Voting - Except as otherwise provided in the Series A Certificate of Designation or as otherwise required by law, the Convertible Series A Preferred Stock shall have no voting rights. However, as long as any shares of Convertible Series A Preferred Stock are outstanding, we shall not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Convertible Series A Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Convertible Series A Preferred Stock or alter or amend the Series A Certificate of Designation, (b) amend the Company’s articles of incorporation or other charter documents in any manner that adversely affects any rights of the holders, (c) increase the number of authorized shares of Convertible Series A Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

 

(e)          not transfer, sell, hypothecate, encumber, or otherwise dispose of any Contributed Properties or Additional Contributed Properties;

Conversion - Each share of Convertible Series A Preferred Stock shall be convertible, at any time and from time to time from at the option of the holder thereof, into that number of shares of common stock determined by dividing $62.9575 by the Conversion Price. The Conversion Price for the Series A Convertible Preferred Stock is equal to $2.5183, subject to adjustment as described in the Series A Certificate of Designation.

 

(f)          not (i) take any action to terminate, materially amend, or extend any Material Contract relating to a Contributed Entity or Additional Contributed Entity or (ii) enter into any agreement that, if in existence at the Execution Date would be a Material Contract of a Contributed Entity or Additional Contributed Entity unless terminable without penalty on sixty (60) days or shorter notice;A-61 

(g)          maintain insurance coverage on the Contributed Properties and the Additional Contributed Properties in the amounts and of the types presently in force and not make any election to be excluded from any such coverage;

(h)          maintain in full force and effect all Contracts (except for the termination of such Contract by its own terms) of the Contributed Entities and the Additional Contributed Entities;

(i)          not incur any Indebtedness or take or fail to take any action that would cause a lien or Encumbrance to arise or exist on the Contributed Properties or Additional Contributed Properties or otherwise allow an Encumbrance to attach to or encumber the Contributed Properties or Additional Contributed Properties;

(j)          maintain all material governmental permits and approvals affecting the Contributed Entities, the Additional Contributed Entities, the Contributed Properties and the Additional Contributed Properties;

28

 

(k)          use commercially reasonable efforts to maintain and preserve intact the current organization, business and franchises of the Contributed Entities and the Additional Contributed Entities and to preserve

Dividends - Except for stock dividends or distributions for which adjustments are to be made, holders shall be entitled to receive, and the Company shall pay, dividends on shares of Convertible Series A Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of Convertible Series A Preferred Stock.

A-62 

Redeemable Convertible Series B Preferred Stock

Convertible Series B preferred stock confer upon their holders all the rights franchises, goodwill and relationships with their service providers, customers, lenders, suppliers, regulators and others having business relationshipsof Common Stock. As more fully described below, the Company issued 1,500,000 shares of Redeemable Convertible series B Preferred Stock in connection with the Contributed EntitiesSecurities Purchase Agreement. In addition, based on the Company’s Certificate of Designation, the Series B Shares bear the following rights and privileges:

Liquidation Preference - Holders of the Series B Shares shall receive cumulative dividends, pro rata among such holders, prior to and in preference to any dividend on the Company’s outstanding Common Stock and Series A Convertible Preferred Stock, at the per annum rate of 8% of the Series B Original Issue Price ($1.00). Dividends on each Series B Share will accrue daily and be cumulative from the original issued date of December 22, 2017 and shall be payable upon the occurrence of any voluntary or involuntary liquidation, dissolution or winding up of the, a conversion or a redemption. The redemption price shall be $1.00 per share, subject to appropriate adjustment. Holders shall also be entitled to receive dividends on the Series B Shares (on an as-if-converted-to-Common-Stock basis) as dividends actually paid on shares of the Company’s Common Stock when, as and if such dividends are paid on shares of the Common Stock. As of December 31, 2017, the aggregate liquidation preference amounted to $1,503. The foregoing dollar amount does not include dividends, as the Company’s Board of Directors has not declared any dividends since inception.

Voting - Each holder of the Series B Shares shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series B Shares held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter subject to certain conversion limitations.

Conversion - Each Series B Share shall be convertible at the option of the holder thereof, at any time after the date of issuance of such share, into such number of fully paid and non-assessable Common Stock as is determined by dividing the original issue price plus accrued, but unpaid, dividends by the applicable conversion price at that time in effect for such Series B Share. The Series B Shares are automatically converted to Common Stock on May 31, 2018 should voluntary conversion or redemption not occur prior to that time.

Redemption – Under certain conditions beyond the Company’s control, the Series B shareholders may require redemption of the Series B Shares at a price per share equal to $1.33, plus accrued, but unpaid, dividends through and including the date of such redemption.

Reverse Split and Retroactive Adjustment of Shares and Per Share Information

On September 7, 2016, the Additional Contributed Entities;Company’s Board of Directors approved a reverse stock split in a ratio of 1-for-5 (the “2016 Reverse Split”). The amount of authorized Common Stock as well as the par value for the Common Stock were not effected. Any fractional shares resulting from the 2016 Reverse Split were rounded up to the nearest whole share. 

 

(l)          not waive, release, assign, settle or compromise any claim, action or proceeding relating to any Contributed Entity, Additional Contributed Entity, Contributed Property or Additional Contributed Property, other than asAll common stock, stock warrants, stock options and per share amounts set forth inherein are presented to give retroactive effect to the schedules provided pursuant toSection 4.12;2016 Reverse Split for all periods presented.

 

(m)          not file any amended Tax Return, revoke or change any Tax election, change a Tax accounting period, enter into any closing agreement with respectChange of Authorized Shares

On October 19, 2017, the Company filed Amended and Restated Articles of Incorporation to Taxes, settle any Tax claim or assessment unless in connection with an ongoing audit, surrender any right to claim a refund of Taxes, or consent to any extension or waiver ofamong the limitation period applicable to any Tax claim or assessment, in each case that would be reasonably likely to have the effect of materially increasing the Tax liability of any Contributed Entity or Additional Contributed Entity for any period after the Closing Date;

(n)          not adopt any plan or agreement of complete or partial liquidation, dissolution, restructuring, recapitalization, merger, consolidation or other reorganization or otherwise effect any transaction whereby by any Person or group acquires more than a majority of the outstanding equity interests of any Contributed Entity or Additional Contributed Entity;

(o)          not take any action that would or would reasonably be expected to prevent or materially delay the Closing and the consummation of the Transactions; and

(p)          not agree or commit to do any of the foregoing.

Notwithstanding anything to the contrary above, the Contributor Parties shall have no obligations with respect to the Contributed Properties or Contributed Interests pursuant to the above provisions (except as specifically contemplated hereby) following their contribution to the Acquiror hereunder, or with respect to any matters that would not reasonably affect the consummation of the Transactions contemplated hereby.

6.6           Stockholder Approval. The conversion of the Acquiror Parent Preferred Stock and the exercise of the Warrant (as defined inSection 9.1(b)(ii) below) require the vote of the stockholders of Acquiror Parent under applicable Law, the rules and regulations of NASDAQ, and/or the Organizational Documents of Acquiror Parent. As promptly as possible following the Execution Date, the Acquiror Parent shall prepare and as promptly as possible following the Initial Closing, file with the Commission a proxy statement (the “Proxy Statement”) and take all actions necessary under the Nevada Statute and the listing rules of NASDAQ to hold a special meeting of its stockholders (the “Special Meeting”) to authorize and approve the following matters:

(a)          anthings, increase in the number of authorized shares of common stock, $.01 par value per share, of Acquiror Parentthe Company from fifty million (50,000,00)50,000,000 shares to five hundred500,000,000 million (500,000,000) shares and to increase the number of authorized shares of preferred stock, $.01 par value per share, of Acquiror Parentthe Company from five million (5,000,000)5,000,000 shares to fifty million (50,000,000) shares;

(b)          the issuance to the Contributor or its designee or designees of the Transaction Shares in exchange for the Contributed Entity Interests and the Additional Contributed Entity Interests, as provided herein, and the issuance of the Warrant and, upon exercise of the Warrant, the issuance of the underlying shares of Acquiror Parent Common Stock, in exchange for the Optional Entity Interests;

29

(c)          the amendment and restatement of the Articles of Incorporation of the Acquiror Parent to provide as set forth inExhibit E hereof;50,000,000 shares.

 

(d)Contribution Agreement

As discussed in Note 5, upon the amendment and restatementInitial Closing of the Bylaws ofFirst Contribution, the Acquiror Parent to provide as set forth inExhibit F hereof;

(e)          the election of a new Board of Directors to consist of seven (7) persons to serve until the next annual meeting of the Acquiror Parent’s stockholders or until their successors are elected and qualify, subject to their prior death, resignation or removal, of whom (i) three (3) shall be designated by the Acquiror Parent, (ii) three (3) shall be designated by Contributor Parent; and (iii) one (1) (the “Nonaffiliated Director”) shall be selected by the other six (6) directors;provided, however,that at least four (4) of the members of the Board of Directors as so designated shall be independent directors as provided by the rules of NASDAQ (each an “Independent Director” and, collectively, the “Independent Directors���). Of the board designees of the parties, one (1) of the Acquiror Parent’s designees shall be an Independent Director, two (2) of the Contributor Parent’s designees shall be Independent Directors and the Nonaffiliated Director shall be an Independent Director. The compensation committee, nominations and corporate governance committee and audit committee of the Acquiror Parent shall each consist of the Acquiror Parent’s designee who is an Independent Director, one of the Contributor Parent’s designees who is an Independent Director and the Nonaffiliated Director; and

(f)          the approval of the Payout Notes (as defined inSection 6.17) and the issuance of the Acquiror Parent Common Stock upon conversion of the Payout Notes.

6.7           Registration Statements; Information in Proxy Statement and Registration Statement.

(a)          Promptly following the Execution Date, the Acquiror Parent shall prepare and file with the Commission two registration statements on Form S-3 (or such other form available for this purpose) (the “Registration Statements”) to register (a) the primary offering by the Company (i) to the Executives of the Acquiror Parent Common Stock underlying the Payout Notes, and (ii) to the unaffiliated shareholders of Contributor Parent of the Acquiror Parent Common Stock distributed to such unaffiliated shareholders as a dividend by Contributor Parent and (b) the secondary offering (i) by the Contributor Parties of all the Transaction Shares (including, without limitation, the shares of Acquiror Parent Common Stock underlying the Warrant) retained by the Contributor Parties, (ii) by Maxim Group LLC of the Transaction Shares received by it as compensation for services rendered to Contributor Parent, and (ii) by certain affiliates of the Contributor Parent who receive Transaction Shares from Contributor Parent. The Registration Statement will be prepared and filed in accordance with the Registration Rights Agreement.

(b)          Each of the Parties shall use its commercially reasonable efforts to provide promptly such information and financial statements and other documents as may reasonably be required for inclusion in the Proxy Statement and the Registration Statements, shall direct that its counsel cooperate with counsel to the other Parties in the preparation of the Proxy Statement and the Registration Statements and shall request the cooperation of their respective auditors in the preparation of the Proxy Statement and the Registration Statements. None of the information supplied or to be supplied by or on behalf of the any of the Parties for inclusion or incorporated by reference in the Proxy Statement and the Registration Statements will, at the time the Proxy Statement or the Registration Statements is filed with the Commission or at the time it becomes effective under the Securities Act, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they are made, not misleading. If any information provided any Party is discovered or any event occurs with respect to any of the Parties, or any change occurs with respect to the other information provided by the Parties included in the Proxy Statement or the Registration Statements which is required to be described in an amendment of, or a supplement to, the Proxy Statement or Registration Statements so that such document does not include any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, such Party shall notify the other Parties promptly of such event. No Party shall be required to file with the Commission or to distribute any Proxy Statement or the Registration Statements that it reasonably believes contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they are made, not misleading.

30

6.8           Voting Agreement. The Persons identified onSchedule 6.8 shall, on or prior to the Execution Date, have entered into a voting agreement in the form ofExhibit G, pursuant to which such Persons shall have agreed to vote all the shares of Acquiror Parent they beneficially own or own of record in favor of the matters set forth inSection 6.6 at the Special Meeting or any adjournment or postponement thereof and for the election of directors as described inSection 6.6(a)(v) and the provisions of the voting agreement relating to the election of directors shall remain effective until the number of Transaction Shares issued to the Contributor exceeds 50%879,234 duly authorized, fully paid and non-assessable shares of the issuedCompany’s common stock, par value $0.01 per share and outstanding Parent Common123,668 shares of the Company’s newly designated non-voting Series A Convertible Preferred Stock, on a post-issuance and fully-diluted basis.par value $0.01 per share for certain Contributed Properties.


Payout Notes

6.9           Election of Directors; Schedule 14f-1.

(a)          Prior toFollowing the Initial Closing Date (i) the Board of Directors of the Acquiror Parent shall fixFirst Contribution under the number of directors constitutingContribution Agreement (see also Note 5), amounts due to Dr. Dolev Rafaeli, the entire Board of Directors at seven (7)Company’s former Chief Executive Officer and (ii) eachDennis McGrath, the Company’s former Chief Financial Officer under their employment agreements, as well as amounts due to Dr. Yoav Ben-Dror for his services as a board member of the Board of Directors of Acquiror Parent shall tender his or her resignation asCompany’s foreign subsidiaries, were to be converted to convertible secured notes (the “Payout Notes”) after approval from the Company’s stockholders. The Payout Notes would be due one year after the stockholder approval and carry a Director, and the Board of Directors shall accept such resignations in seriatim or other appropriate manner such that the Board of Directors, on the Initial Closing Date shall consist of seven (7) persons10% interest rate. The principal would convert to serve until the next annual meetingshares of the Acquiror Parent’s stockholders or until their successors are elected and qualify, subject to their prior death, resignation or removal, of whom (i) three (3) shall be designated by the Acquiror Parent (at least one of whom shall be an Independent Director), (ii) three (3) shall be designated by Contributor Parent (at least two of whom shall be Independent Directors), and (iii) one (1) shall be the Nonaffiliated Director;provided, however, that at least four (4) of the members of the Board of Directors as so designated shall be Independent Directors. As required by the rules of NASDAQ, the compensation committee, nominations and corporate governance committee and audit committee of the Acquiror Parent shall each consist of the Acquiror Parent’s designee who is an Independent Director, one of the Contributor Parent’s designees who is an Independent Director and the Nonaffiliated Director. The names of the nominees, and all other information relevant to the Schedule 14f-1 referred to below, shall be furnished to the Acquiror Parent not less than fifteen (15) days prior to the Initial Closing Date.

(b)          Not later than ten (10) days prior to the Initial Closing Date, the Acquiror Parent shall prepare and file with the Commission an information statement on Schedule 14f-1 pursuant to Section 14(f) of the Exchange Act and Rule 14f-1 thereunder. The Acquiror Parent shall provide the Contributor Parent with a draft thereof for approval not less than three (3) Business Days prior to the filing thereof.

31

6.10         Governmental Reviews.

(a)          The Contributor Parties and the Acquiror Parties shall each in a timely manner (i) make (or cause their applicable Affiliates to make) all required filings, and prepare applications to, and conduct negotiations with, obtain consents, approvals or actions of, and give all notices to each Governmental Authority or any other Person as to which such filings, applications, negotiations, consents, approvals, actions or notices are necessary or appropriate in the consummation of the transactions contemplated hereby, and (ii) provide such information as the other may reasonably request in order to make such filings, prepare such applications, conduct such negotiations, obtain such consents approvals or actions, and give such notices. Each Party shall cooperate with and use all reasonable efforts to assist the other with respect to such filings, applications and negotiations. If a Party or any of its Affiliates intends to participate in any meeting or discussion with any Governmental Authority with respect to such filings, applications, or negotiations, or the transactions contemplated by this Agreement, it shall give the other Party reasonable prior notice of, and an opportunity to participate in, such meeting or discussion. Acquiror shall bear one-half and Contributor shall bear one-half of the cost of all filing or application fees payable to any Governmental Authority with respect to the transactions contemplated by this Agreement, regardless of whether Acquiror, Contributor, or any Affiliate of any of them is required to make the payment. Each Party shall provide prompt notice to the other Party when any such filings, application, negotiation, consent, approval, action or notice referred to above in thisSection 6.10(a) is obtained, taken, made or given, as applicable, and will advise such other Party of any communications (and, unless precluded by Law, provide copies of any such written communications) with any Governmental Authority or other Person relating therewith.

(b)          Without limiting the generality ofSection 6.10(a), as soon as practicable following the date of this Agreement and in any event within fifteen (15) Business Days after the date hereof, the Parties shall make such filings as may be required by the HSR Act with respect to the transactions contemplated by this Agreement, which filings shall include a request for early termination of any applicable waiting period. Thereafter, the Parties shall file as promptly as practicable all reports or other documents required or requested by the U.S. Federal Trade Commission or the U.S. Department of Justice pursuant to the HSR Act or otherwise, including requests for additional information concerning such transactions, so that the waiting period specified in the HSR Act will expire or be terminated as soon as reasonably possible after the date of this Agreement. Each Party shall cause its counsel to furnish each of the other Parties such necessary information and reasonable assistance as such other Parties may reasonably request in connection with the Parties’ preparation of necessary filings or submissions under the provisions of the HSR Act.

6.11         Audits and Filings.

(a)          From and after the date of this Agreement, the Acquiror Parties shall, and shall use their reasonable efforts to cause their Affiliates and their and their Affiliates’ respective officers, directors, managers, employees, agents and representatives to, cooperate with the Contributor Parties, their Affiliates and their respective agents and representatives and make available to the Contributor Parties, their Affiliates and their respective agents and representatives any and all books, records, information and documents that are attributable to the Acquiror Parties’ and their Affiliates’ business, Tax, financial, or other reporting requirements and audits, including (i) any filings with any Governmental Authority and (ii) any filings that may be required by the Commission under securities Laws applicable to the Acquiror Parties and their Affiliates, including the filing by the Acquiror Parties with the Commission of one or more registration statements to register the Acquiror Parent Securities under the Securities Act or of any report required to be filed by the Acquiror Parties under the Exchange Act with respect to the Transactions (together with the Securities Act and the rules and regulations promulgated under such acts, the “Securities Laws”) (any such filings described inclause (ii), the “Filings”).

(b)          From and after the date of this Agreement, the Contributor Parties shall, and shall use their reasonable efforts to cause their Affiliates and their and their Affiliates’ respective officers, directors, managers, employees, agents and representatives to, cooperate with the Acquiror Parties, their Affiliates and their respective agents and representatives and make available to the Acquiror Parties, their Affiliates and their respective agents and representatives any and all books, records, information and documents that are attributable to the Contributor Parties’ and their Affiliates’ business, Tax, financial, or other reporting requirements and audits, including any Filings.

32

(c)          From and after the date of this Agreement, each Party shall, and shall use its reasonable efforts to cause their Affiliates to, cooperate with the independent auditors chosen by the other Party in connection with any audit by the other Party of any financial statements of such Party that the other Party or any of their Affiliates require to comply with the requirements of the Securities Laws. Such cooperation will include (i) reasonable access to the other Party’s officers, managers, employees, agents and representatives who were responsible for preparing or maintaining the financial records and work papers and other supporting documents used in the preparation of such financial statements as may be required by such Party to perform an audit or conduct a review in accordance with generally accepted auditing standards or to otherwise verify such financial statements, (ii) delivery of one or more customary representation letters from a Party to the other Party’s auditor that are reasonably requested by the such Party to allow such auditors to complete an audit (or review of any financial statements) and to issue an opinion with respect to an audit of those financial statements required pursuant to thisSection 6.11(c), (iii) using reasonable efforts to obtain the consent of the independent auditor(s) of other Party that conducted any audit of such financial statements to be named as an expert in any Filing or offering memorandum for any equity or debt financing of the such Party, and (iv) using reasonable efforts to cause the independent auditor(s) of the other Party that conducted any audit of such financial statements to provide customary “comfort letters” to any underwriter or purchaser in connection with any equity or debt financing of the other Party. Notwithstanding the foregoing, nothing herein shall expand a Party’s representations, warranties, covenants, or agreements set forth in this Agreement or give a Party, their Affiliates, or any third Person any rights to which it is not entitled hereunder.

6.12         Listing of Acquiror Parent Shares. At each Closing, Acquiror and Acquiror Parent shall issue the Acquiror Parent Securities issuable at such Closing pursuant to this Agreement in accordance with this Agreement and all applicable Securities Laws and the rules and policies of NASDAQ and each other securities exchange on which the Acquiror Parent Shares are listed or trading. Without limiting the generality of the foregoing, Acquiror Parent shall complete all such filings with NASDAQ and such other exchange and otherwise take all such actions as may be reasonably necessary for the Acquiror ParentCompany’s Common Stock to be issued pursuant hereto (and underlying the Warrant) to be accepted by NASDAQ and such other exchange for issuance and approved for listing thereon from and after the time of Closing (or, with respect to Transaction Shares that are issued following the Closing, from and after the date of the issuance of such Transaction Shares), subject to official notice of issuance.

6.13         Further Assurances. After each Closing, the Contributor Parties and the Acquiror Parties each agree to take such further actions and to execute, acknowledge, and deliver all such further documents as are reasonably requested by the other for carrying out the purposes of this Agreement or of any document delivered pursuant to this Agreement or the other Transaction Agreements.

6.14         Required Consents. Each Party shall obtain all Required Consents necessary or, in the reasonable judgment of the other Party, desirable, to permit (a) the acquisition by Acquiror of the Contributed Entity Interests and the entry into the Assignment and Assumption Agreement and the performance of the obligations of the Acquiror Parties thereunder and (b) any other action required to consummate the transactions contemplated by this Agreement and the other Transaction Agreements. The Parties acknowledge that a breach or failure to perform the covenants set forth in this section shall, for the avoidance of doubt, be a material breach resulting in a failure of the conditions to Closing of the other Party, and the other Party shall be entitled to exercise their remedies set forth inSection 10.3 with respect thereto.

33

6.15         Amendment of Acquiror Parent Articles of Incorporation and Bylaws. Prior to the Initial Closing, Acquiror Parent shall amend and restate Bylaws in the form set forth onExhibit Fhereto and upon obtaining Shareholder Approval, the Acquiror Parent shall amend and restate the Articles of Incorporation as set forth onExhibit E hereto. Subject to the foregoing, Acquiror Parent shall not amend or otherwise modify its Organization Documents without the consent of Contributor Parent.

6.16         Change of Trading Symbol. Acquiror Parent shall use commercially reasonable efforts to cause the trading symbol for Acquiror Parent on NASDAQ and each other securities exchange on which Acquiror Parent Shares are traded or authorized for trading to be changed to a symbol designated by Contributor Parent and which is available as a trading symbol on such exchange or exchanges.

6.17         Arrangements with Acquiror Parent Executives. On the Approval Date, all outstanding compensation liabilities owed to the Executives as of such Approval Date will be converted into secured convertible promissory notes (the “Payout Notes”) in the form ofExhibit H hereto, with the following principal terms:

(a)          Maturity one year following the Approval Date (the “Maturity Date”);

(b)          Principal mandatorily convertible on the Maturity Date into unregistered Acquiror Parent Shares, with the value of the Acquiror Parent Shares to be determined on the basis ofat the lower of (i) the Per Share Value or (ii) the VWAP with respect to on-exchange transactions in Acquiror Parent Sharesthe Company’s Common Stock executed on the NASDAQ during the thirty (30) Trading Days30 trading days prior to the Maturity Datematurity date as reported by Bloomberg L.P. (the “Note Conversion Price”), with such Acquiror Parent Shares to be issued within 10 Business Days thereafter;; provided, however,, that the value of the Acquiror Parent Shares shallCompany’s Common Stock should in no event be less than $1.75 per share (the “Floor Price”). In the event that the Note Conversion Price on the Maturity Date is lower than the Floor Price, then the Acquiror Parent may, in its discretion, elect to either: (i) pay the principal amount of theshare. The Payout Notes in cash to the Executives or (ii) extend the Maturity Date for a period of sixty (60) days, at the conclusion of which the foregoing mechanism for determining the Note Conversion Price and repayment of the Payout Notes shallwould be determined with finality;provided, however, that at the conclusion of such sixty (60) day period, no Floor Price shall apply in the determining the Note Conversion Price.

(c)          10% interest payable monthly in arrears in cash or unregistered Acquiror Parent Shares, determined at the election of each of the Executives by notice delivered not less than three (3) NASDAQ Trading Days prior to the relevant interest payment date, with the value of the Acquiror Parent Shares to be determined on the basis of the VWAP with respect to on-exchange transactions in Acquiror Parent Shares executed on the NASDAQ during the thirty (30) NASDAQ Trading Days ending five (5) NASDAQ Trading Days prior to the relevant interest payment date.

(d)          Securedsecured by a security interest in all assets of the Acquiror Parent in the form of the Payout Notes Security Agreement set forth asExhibit I hereto;Company; provided, however,, that such security interest willwould be subordinated to any (i) claims or liens to the holders of any debt (including mortgage debt) being assumed by the Acquiror ParentCompany as a result of the Transactions,transaction contemplated by the Agreement, and (ii) all post-Closing Indebtednesspost-closing indebtedness incurred by the Acquiror ParentCompany or its Subsidiaries.

(e)          Not guaranteed as to payment by any third party.

(f)          Demandsubsidiaries. The holders of the Payout Notes would have registration rights requiringwhich would require the filing of a re-sale registration statement on appropriate form that registers for re-sale the shares of Common Stock underlying the Payout Notes within thirty (30) days of the Approval Dateissuance with best efforts to cause the same to become effective within one-hundred twenty (120)120 days followingof issuance. The form of those Payout Notes was agreed to at the Approval Datetime of signing of the Contribution Agreement and containing other customary provisions.

34

(g)          A covenant that provides, among other things, that, if permitted to do so by Law, the Acquiror Parent shall (at its expense) will facilitate public sales of any Acquiror Parent Shares received by the Executives inwas attached as an exhibit thereto. In connection with the Payout Notes, under Rule 144 promulgated under the Securities Actparties also agreed to a form of security agreement (the “Security Agreement”), which was also attached as an exhibit to the Contribution Agreement. 

On October 12, 2017, following approval by the first anniversaryCompany’s stockholders, the Company issued a secured convertible promissory notes (the “Payout Notes”) to Dr. Dolev Rafaeli, the Company’s former Chief Executive Officer, Dennis M. McGrath, the Company’s former President and Chief Financial Officer, and Dr. Yoav Ben-Dror, the former director of the Approval Date.

6.18         Continuing D&O Insurance. Acquiror Parent shall provide for continuing directorCompany’s foreign subsidiaries (collectively, the “Note Holders”) in the principal amounts of $3,134, $978 and officer insurance coverage for the directors$1,515, respectively. The Payout Notes were due on October 12, 2018, carried a 10% interest rate, payable monthly in arrears commencing on December 1, 2017 (each such payment, a “Monthly Interest Payment” and officerseach date of Acquiror Parent for a period of six years following the Initial Closing Date, on terms of coverage consistent in all material respects with the coverage provided on the Execution Date.

6.19         Execution of Closing Deliverables. At each Closing the Contributor Parent shall cause the Contributor, to executesuch payment, an “Interest Payment Date”), and deliver all items called for to be executed and delivered by such Persons pursuant to, and in accordance with,Section 8.2 of this Agreement.

6.20         Executive Releases. On the Approval Date the Executives shall deliver (i) an agreement (in form and substance reasonably acceptable to the Contributor Parent) that terminates, effective on the Approval Date, any and all employment or similar agreements between the Executives and any memberswere convertible into shares of the Acquiror Group and any and all rights of the Executives under Employee Benefit Plans (including, without limitation, stock option, restricted stock and other plans) providing for any form of compensation, consideration, reimbursement or benefits to the Executives except for benefits available under COBRA for a period of 18 months following the Approval Date, and (ii) a general release in the form attached to the existing employment agreements between the Executives and the Acquiror Parent, a copy of which has been made available to the Contributor Parties.

6.21         Distribution of Transaction Shares. Promptly following the date that a Registration Statement covering the resale of any Transaction Shares (or shares of Acquiror ParentCompany’s Common Stock issued to Contributor upon the exercise of the Warrant) has been declared effective by the Commission, the Contributor Parties shall cause the distribution of the Transaction Shares (or shares of Acquiror Parent Common Stock issued to Contributor upon the exercise of the Warrant) to the partners of the Contributor and the shareholders of Contributor Parent such that no more than 50% of the Transaction Shares (and shares of Acquiror Parent Common Stock issued to Contributor upon the exercise of the Warrant) shall thereafter be held by Affiliates of the Contributor Parent and the remaining Transaction Shares (or shares of Acquiror Parent Common Stock issued to Contributor upon the exercise of the Warrant) shall be held by at least 1,000 shareholders of the Contributor Parent who are not Affiliates of the Contributor Parent. Prior to such distribution, Acquiror Parent shall hold such Transaction Shares (and shares of Acquiror Parent Common Stock issued to Contributor upon the exercise of the Warrant) and shall not transfer or otherwise dispose of such Transaction Shares (and shares of Acquiror Parent Common Stock issued to Contributor upon the exercise of the Warrant) without the unanimous consent of the board of directors of Acquiror Parent.

ARTICLE 7

CONDITIONS TO CLOSING

7.1           Conditions of Contributor Parties to the Closings.maturity. The obligations of the Contributor Parties to consummate the transactions contemplated by this Agreement are subject, at the option of the Contributor Parties, to the satisfaction on or prior to each Closing of each of the following conditions (in each case, with respect to the assets or entities being contributed at such Closing, and the payment of the consideration therefor):

35

(a)          The Acquiror Parties’ representations and warranties shall be true and correct in all respects as of the date of this Agreement and as of such Closing Date as though made on and as of the Closing Date, except for inaccuracies which would not, individually or in the aggregate, cause or reasonably be expected to cause an Acquiror Material Adverse Effect;

(b)          The Acquiror Parties shall have performed and observed, in all material respects (and in all respects in the case of any covenants and agreements qualified by materiality or Acquiror Material Adverse Effect), all covenants and agreements to be performed or observed by Acquiror Parties under this Agreement and the other Transaction Agreements prior to or on such Closing Date;

(c)          On such Closing Date, no (i) injunction, order or award restraining, enjoining or otherwise prohibiting the consummation of the Transactions shall have been issued and remain in force, (ii) suit, action, or other proceeding (excluding any such matter initiatedPayout Notes were secured by a Contributor Party or any of its Affiliates) shall be pending before any Governmental Authority or body of competent jurisdiction (or threatened) seeking to enjoin or restrain or otherwise prohibit the consummation of the Transactions; and (iii) suit, action, or other proceeding (including arbitral proceedings) shall be pending or threatened against any member of the Acquiror Group which, if determined wholly adversely to such member, would or could have an Acquiror Material Adverse Effect;

(d)          The Contributor Parties shall have received all Contributor Required Consents, and the Acquiror Parties shall have received all Acquiror Required Consents, which the Contributor Parties deem necessary or desirable;

(e)          All material consents and approvals of any Governmental Authority (including any under the HSR Act) required for the transfer of the Contributed Entity Interests from Contributor to Acquiror as contemplated by this Agreement, except consents and approvals of assignments by Governmental Authorities that are customarily obtained after closing, shall have been granted, or the necessary waiting period (including any under the HSR Act) shall have expired, or early termination of the waiting period shall have been granted;

(f)          The Acquiror Parties shall have deliveredsecurity interest in all of the deliverablesproperties, assets and personal property of the Acquiror Parties areCompany (the “Security Agreement”). 

On December 22, 2017, the Company and the Note Holders entered into a stock grant agreement (the “Stock Grant Agreement”) to cause the early conversion of the Payout Notes into an aggregate of 5,628,291 shares of the Company’s Common Stock (the “Payout Shares”), valued at $5,626 based on the quoted share price in the market for our common stock on December 22, 2017, and to effectuate the release of all security interests associated with the Payout Notes.

Pursuant to the Stock Grant Agreement, the Company also agreed to provide for the issuance of an aggregate of 1,857,336 additional shares of Common Stock to the Note Holders as consideration for the various agreements of the Note Holders contained in the Stock Grant Agreement (the “Additional Shares”), subject to stockholder approval. In addition, as promptly as possible following entry into the Stock Grant Agreement, the Company is required to deliver pursuant hereto;

(g)          The Contributor Parties shall have received such novationsfile a proxy statement and general releases as they may reasonably require from each ownerhold a special meeting of Interests (other thanits stockholders to authorize and approve the Contributor Parties) in the Contributed Entities with respect to the assets and interests being contributed and from each creditorissuance of the Contributed Entities, in such form as shall be satisfactory to the Contributor Parties;

(h)          With respect to the Subsequent Closings, the Contributor Parent may, in its discretion, require that it receive an opinion fromAdditional Shares. As of December 31, 2017, a prominent investment banking firm or adviser to the effect that the transactions contemplated with respect to each Subsequent Closing are fair toproxy statement was not filed, and special meeting of the stockholders ofhas not been held. Therefore, during the Contributor Parent from a financial point of view;

(i)          The shares of Acquiror Parent Common Stock issuable at such Closing shall be approved for listing on NASDAQ and each other exchange on which such shares are listed, subject only to official notice of issuance thereof;

(j)          On or prior to the Initial Closing Date, Acquiror Parent shall have entered into the Registration Rights Agreement;

36

(k)          On or prior to the Initial Closing Date, Acquiror Parent shall have entered into the Lock Up Agreement;

(l)          On or prior to the Initial Closing Date, the Executives shall have resigned from their respective executive offices at the Company (it being understood, however, that their respective employment agreements will remain in full force and effect until the Approval Date) and each of the Executives shallyear ended December 31, 2017, no expenses have been appointed to such non-executive positions of the Acquiror or its subsidiaries as the Board of Directors of the Acquiror Parent shall determine and such non-executive positions shall be reasonably acceptable to the Executives and subject to the approval of the Contributor Parent; and

(m)          On or prior to the Initial Closing Date, the Acquiror Parent shall have entered into an employment agreement with Suneet Singal in the form ofExhibit J hereto.

7.2           Conditions of Acquiror Parties to the Closings. The obligations of Acquiror Parties to consummate the transactions contemplated by this Agreement are subject, at the option of Acquiror Parties, to the satisfaction on or prior to each Closing of each of the following conditions:

(a)          The Contributor Party representations and warranties relevant to the interests being contributed at such Closing shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date as though made on and as of the Closing Date, except for inaccuracies which would not, individually or in the aggregate, cause a Contributor Material Adverse Effect;

(b)           The Contributor Parties shall have performed and observed, in all material respects (and in all respects, in the case of any covenants and agreements qualified by materiality or Contributor Material Adverse Effect), all covenants and agreements to be performed or observed by Contributor Parties under this Agreement and the other Transaction Agreements with respect to the interests being contributed at such Closing prior to or on such Closing Date;

(c)          On such Closing Date, (i) no injunction, order or award restraining, enjoining, or otherwise prohibiting the consummation of the Transactions to be effected at such Closing shall have been issued and remain in force with respect to the interests being contributed on such Closing Date, (ii) no suit, action, or other proceeding (excluding any such matter initiated by any Acquiror Party or any of its Affiliates) shall be pending before any Governmental Authority or body of competent jurisdiction (or threatened) seeking to enjoin or restrain or otherwise prohibit the consummation of the Transactions to be effected at such Closing ; and (iii) no suit, action, or other proceeding (including arbitral proceedings) shall be pending or threatened against any member of the Contributor Group which, if determined wholly adversely to such member, would or could have a Contributor Material Adverse Effect;

(d)          The Acquiror Parties shall have received all Acquiror Required Consents with respect to the interests to be contributed on such Closing Date and the Contributor Parties shall have received all Contributor Required Consents with respect to the interests to be contributed on such Closing Date, which the Acquiror Parties deem necessary or desirable;

(e)          All material consents and approvals of any Governmental Authority (including any under the HSR Act) required for the transfer of the Contributed Entity Interests to Acquiror on such Closing Date, as contemplated under this Agreement, except consents and approvals of assignments by Governmental Authorities that are customarily obtained after closing, shall have been granted or the necessary waiting period (including any under the HSR Act) shall have expired, or early termination of the waiting period shall have been granted;

37

(f)          The Acquiror Parent Common Stock issuable at such Closing Date shall be approved for listing on NASDAQ and each other exchange on which such shares are listed, subject only to official notice of issuance thereof;

(g)          The Contributor Parties shall have delivered all of the deliverables the Contributor Parties are required to deliver pursuant hereto with respect to the interests to be contributed on such Closing Date; and

(h)          On or prior to the Initial Closing Date, the Contributor, certain Affiliates of Contributor Parent and Maxim Group LLC shall have entered into the Registration Rights Agreement with Acquiror Parent in the form ofExhibit D hereto.

ARTICLE 8

CLOSING

8.1           Time and Place of Closing.

(a)          The consummation of the contribution of the Initial Contributed Entity Interests contemplated by this Agreement (the “Initial Closing”) shall, unless otherwise agreed to in writing by Acquiror and Contributor, take place at the offices of Ellenoff Grossman & Schole LLP, located at 1345 Avenue of the Americas, New York, New York 10105, at 10:00 a.m., local time, on or about May 17, 2017 (subject toSection 10.1 hereof), or if all conditions inArticle 7 to be satisfied prior to the Initial Closing have not yet been satisfied or waived, as soon thereafter as such conditions have been satisfied or waived. The date on which the Initial Closing occurs is referred to herein as the “Initial Closing Date.” The Initial Closing may, by mutual agreement, be undertaken remotely by electronic distribution of Initial Closing documentation.

(b)          The consummation of the contribution of the Mandatory Entity Interests and the Optional Contributed Entity Interests contemplated by this Agreement (the “Subsequent Closings”) shall, unless otherwise agreed to in writing by Acquiror and Contributor, take place at the offices of Ellenoff Grossman & Schole LLP, located at 1345 Avenue of the Americas, New York, New York 10105, at 10:00 a.m., local time, such date or dates as the parties may agree following the satisfaction of the conditions precedent to such closings (subject toSection 10.1 hereof). The date on which each Subsequent Closing occurs is referred to herein as the “Subsequent Closing Date” with respect to the transactions to occur on such date. Any of the Subsequent Closings may, by mutual agreement, be undertaken remotely by electronic distribution of Subsequent Closing documentation. The term “Closing” shall apply to the Initial Closing and each Subsequent Closing and the term “Closing Date” shall apply to the Initial Closing Date and each Subsequent Closing Date.

8.2           Obligations of the Contributor Parties at Closings. At each Closing, upon the terms and subject to the conditions of this Agreement, and subject to the simultaneous performance by Acquiror Parties of their obligations pursuant toSection 8.3, the Contributor Parties shall deliver or cause to be delivered, among other things, the following:

(a)          to Acquiror Parties, counterparts of the Assignment and Assumption Agreement, with respect to the assets or entities being contributed, duly executed by Contributor;

(b)          to Acquiror Parties, a certificate of non-foreign status from each of Contributor and Contributor Parent meeting the requirements of Treasury Regulation Section 1.1445-2(b)(2);

38

(c)          to Acquiror Parties, a certificate duly executed by Suneet Singal, dated as of the Closing, certifying on behalf of Contributor that the conditions set forth inSections 7.2(a) and7.2(b) with respect to the assets or entities being contributed, have been fulfilled;

(d)          to Acquiror Parties, a certificate duly executed by the secretary or any assistant secretary of each of the Contributor Parties, dated as of such Closing Date, (i) attaching and certifying on behalf of each Contributor Party complete and correct copies of the resolutions or unanimous consent of the board of directors, managers, members, partners, or other equivalent governing body of such Contributor Party authorizing the execution, delivery, and performance by such Contributor Party of this Agreement and the transactions contemplated hereby with respect to the assets or entities being contributed, and (ii) certifying on behalf of such Contributor Party the incumbency of each officer of such Contributor Party executing this Agreement, any other Transaction Agreement or any document deliveredrecorded in connection with such Closing;the Additional Shares.

 

(e)          to Acquiror Parties, copies of all Contributor Required Consents received from Governmental Authorities or third Parties with respectPursuant to the assets or entities being contributed;Stock Grant Agreement, the Company also agreed to make 12 monthly payments on the first of each month commencing on January 1, 2018 in the amounts of $21, $7 and $10 to Messrs. Rafaeli, McGrath, and Ben-Dror, respectively (collectively, the “Cash Payments”). The Cash Payments equal to the interest payments that would have been made to the Note Holders absent the conversion of the Payout Notes and are consideration for certain consulting services provided by the Note Holders specified in the Stock Grant Agreement. 

 

(f)          to the Acquiror Parties, executed counterparts of the Lock Up Agreement in the form ofExhibit C; and

(g)          all other instruments, documents, and other items reasonably necessary to effectuate the terms of this Agreement, as may be reasonably requested by Acquiror Parties.

8.3           Obligations of Acquiror Parties at Closing. At each Closing, upon the terms and subject to the conditions of this Agreement, and subject to the simultaneous performance by the Contributor Parties of their obligations pursuant toSection 8.2, Acquiror Parties shall deliver or cause to be delivered, among other things, the following:

(a)          to Contributor (or Contributor’s designee or designees, as may be provided in writing to Acquiror prior to the Initial Closing Date), the number of duly authorized and issued and nonassessable Transaction Shares comprising the Purchase Price with respect to the assets or entities being contributed;

(b)          to Contributor, counterparts of the Assignment and Assumption Agreement with respect to the assets or entities being contributed, duly executed by Acquiror Parent on behalf of itself and the other members of the Acquiror Group;

(c)          to Contributor, a certificate byIn addition, Dr. Dolev Rafaeli and Dennis M. McGrath datedresigned from the Board of Directors of the Company effective upon the last to occur of (i) receipt of all of the Payout Shares and all of the Additional Shares, (ii) receipt of all of the Cash Payments (either in accordance with the schedule provided in the Stock Grant Agreement or, at the Company’s option, in one lump sum on an accelerated basis), and (ii) the date that the Payout Shares and the Additional Shares have been registered for re-sale in accordance with the Payout Registration Rights Agreement. 

In connection with the Stock Grant Agreement, the Security Agreement was automatically terminated. 

Shares to former Chief Executive Officer

On December 22, 2017, Mr. Suneet Singal resigned from his position as Chief Executive Officer of the Company, effective as of January 2, 2018. In connection with such Closing Date, certifyingresignation, on behalfDecember 22, 2017, the Company and Mr. Singal entered into a separation agreement (the “Agreement”), pursuant to which Mr. Singal agreed to resign and the Company agreed to issue to Mr. Singal 1,000,000 shares of such Acquiror Party that the conditions set forth inSections 7.1(a)Company’s Common Stock, 333,333 shares of which will vest immediately, 333,333 shares of which will vest upon the first anniversary of the Agreement, and7.1(b) 333,334 shares of which will vest upon the second anniversary of the Agreement. 


Since the aforesaid shares of common stock were agreed to have been fulfilledgranted to Mr. Singal as a result of his resignation from the Chief Executive Officer position and Mr. Singal has no obligation to render service in the future with respect to the assets or entities being contributed;

(d)          to Contributor, a certificate duly executed byadditional Shares, the secretary or any assistant secretaryCompany has recognized an amount of each Acquiror Party, dated$910 as part of the general and administrative expenses in the consolidated statement of comprehensive loss. The amount was determined based on the quoted share price in the market as of such Closing Date, (i) attaching and certifying on behalf of such Acquiror Party complete and correct copies of the resolutions of the Board of Directors or other equivalent governing body of such Acquiror Party authorizing the execution, delivery, and performance by such Acquiror Party of this Agreement and the transactions contemplated hereby with respect to the assets or entities being contributed, and (ii) certifying on behalf of such Acquiror Party the incumbency of each officer of such Acquiror Party executing this Agreement, any other Transaction Agreement, or any document delivered in connection with such Closing;

39

(e)          to Contributor, copies of all Acquiror Required Consents received from Governmental Authorities or third Parties with respect to the assets or entities being contributed;

(f)          to Contributor, an executed counterpart of the Registration Rights duly executed by Acquiror Parent with respect to the Acquiror Parent Common Stock being issued on such Closing Date;December 22, 2017.

 

(g)          to Contributor, executed counterparts of the Lock UpSecurities Purchase Agreement in the form ofExhibit C;

(h)          to Contributor Parent, the full and unconditional guarantee of obligations of the Contributed Entities to mortgage lenders and other parties to Contracts with the Contributed Entities with respect to the assets or entities being contributed, in such form as may be required by such parties and as is reasonably satisfactory to the Acquiror Parent pursuant to such Contracts or in order to obtain any required consents;

(i)          to Contributor Parties, a certificate of non-foreign status from each of Acquiror and Acquiror Parent meeting the requirements of Treasury Regulation Section 1.1445-2(b)(2); and

(j)          all other instruments, documents, and other items reasonably necessary to effectuate the terms of this Agreement, as may be reasonably requested by Contributor.

ARTICLE 9

ADDITIONAL CONTRIBUTIONS

9.1           Optional Contributions.

(a)          Optional Entity Interests. On or before December 31,22, 2017, the Contributor Parties shall have the right, but not the obligation, to contribute to the Acquiror all of their right, title and interest in and to either or both of the following two entitiesCompany entered into a Securities Purchase Agreement (the Optional Entity Interests”):

(i)          All of the Contributor Parties’ interests in the property known as “La Lobera,” located in Punta Banda, Delegation of Maneadero, Urbanization District “General Abelardo L. Rodriguez,” Ensenada, Baja California, being described in that certain Property Title No. 553, File No. 90570, issued on or about September 30, 1964, consisting of 100 hectares of land, or the entity which owns such property (“Punta Brava”); and

(ii)         All of the Contributor Parties’ interests in Melrose Plantation, Daufuskie Island, SC 29915 or the entity which owns such property (“Melrose”).

(b)          Consideration for Optional Entity Interests. In consideration of the contribution of the Optional Entity Interests, the Acquiror Parent shall issue to the Contributor the following securities on the date of the closing of the contribution of the Optional Entity Interests (the “Optional Entity Interest Closing”):

40

(i)          Transaction Shares with a value (the “Optional Transaction Share Value”) of $86,450,000 (which is 130% of $66,500,000 (the “Contributor Basis”), of which $44,000,000 of such Contributor Basis is attributable to Punta Brava and $22,500,000 of such Contributor Basis is attributable to Melrose), with the number of such additional Transaction Shares being determined by dividing the Optional Transaction Share Value by the Per Share Value; provided, however, that the Optional Transaction Share Value stated above assumes that (and it shall be a condition precedent to the Acquiror Parties obligations at the Optional Entity Interest Closing that) the Contributor Basis has been fully paid for in cash or cash equivalents (which term shall include, among other things, commercial paper, Treasury bills or notes, government securities, money market holdings, marketable securities, and operating partnership units) by the Contributor Parties and that the Contributor Parties have no requirement to (A) make any additional payments of any kind relating to the property represented by the Additional Entity Interests, (B) deliver any additional equity or other consideration of any kind to any Person in connection with the acquisition of the property represented by the Additional Entity Interests, or (C) repay any Indebtedness or make any debt service or similar payments relating to Indebtedness that Encumbers the property represented by the Additional Entity Interests. The Transaction Shares issuable under thisSection 9.1(b)(i) shall be comprised entirely of shares of Acquiror Parent Common Stock if the issuance of such Transaction Shares has been approved by the shareholders of the Acquiror Parent in accordance with NASDAQ rules prior to the issuance thereof and such additional Transaction Shares shall be comprised entirely of shares of Acquiror Parent Preferred Stock if such approval has not yet been obtained.

(ii)         A five (5) year warrant, in the form ofExhibit K hereto (the “Warrant”) to purchase 25,000,000 shares of Acquiror Parent Common Stock (with 16,666,667 of such shares being attributable to Punta Brava and 8,333,333 of such shares being attributable to Melrose) at an exercise price of $3.00 per share that shall vest with respect to the number of underlying shares specified in the table below upon the achievement of the milestone specified in the table below. The number of warrant shares and the exercise price will be equitably adjusted in the event of a stock split, stock combination, recapitalization or similar transaction.

Milestone to be AchievedNumber of Warrant Shares to Vest
First revenues of at least $500,000 from either asset sales or real estate income – Punta Brava8,333,334
Upon Ground-Breaking with respect to the golf course (Shovels in the ground) - Punta Brava8,333,333
First revenues of at least $500,000 from either asset sales or real estate income – Melrose4,666,667
Upon Ground-Breaking with respect to residential home lots (Shovels in the ground)- Melrose4,666,666
Total25,000,000

(c)          Closing Deliveries for Optional Entity Interests. If the Contributor Parties elect to contribute the Optional Entity Interests, then, as a condition to the Optional Entity Interest Closing, the Parties shall make the following deliveries to each other at or prior to the Optional Entity Interest Closing.

41

(i)          The Acquiror Parties shall deliver to the Contributor Parties: (A) the number of duly authorized and issued and nonassessable Transaction Shares as is required to be delivered pursuant toSection 9.1(b)(i), (B) the Warrant, (C) signed counterparts to an Assignment and Assumption Agreement relating to the Optional Entity Interests, (D) an officer’s certificate certifying to the Contributor Parties that the representations and warranties of the Acquiror Parties contained inArticle 5 of this Agreement are true and correct, except for (1) inaccuracies which would not, individually or in the aggregate, cause or reasonably be expected to cause an Acquiror Material Adverse Effect and (2) other reasonable exceptions to be specified on a schedule that result from events occurring between the Initial Closing and the Optional Entity Interest Closing; and (E) all other instruments, documents and other items reasonably necessary to effectuate the contribution of the Optional Entity Interests, or as may be reasonably requested by the Acquiror Parties.

(ii)         The Contributor Parties shall deliver to the Acquiror Parties: (A) signed counterparts to an Assignment and Assumption Agreement relating to the Optional Entity Interests; (B) an officer’s certificate certifying to the Acquiror Parties that the representations and warranties of the Contributor Parties contained inArticle 4 of this Agreement are true and correct as they relate to the Optional Entity Interests and the properties associated with the Optional Entity Interests, except for (1) inaccuracies which would not, individually or in the aggregate, cause or reasonably be expected to cause an Acquiror Material Adverse Effect and (2) other reasonable exceptions to be specified on a schedule that result from events occurring between the Closing and the Optional Entity Interest Closing; (C) if Punta Brava is contributed, then an officer’s certificate certifying to the Acquiror Parties that the following representations and warranties are true and correct in all respects: (I) Punta Brava is a party to a valid and binding unexpired agreement (the “Design and Marketing Agreement“Purchase Agreement”) with a design firm (the “Design Firm”) owned by Tiger Woods or another celebrity golfer of equivalent stature (the “Celebrity Golfer”) under which all contractual obligations of the parties to the Design and Marketing Agreement through the Optional Entity Interest Closing date have been fully performed by, including without limitation, any payment obligations under the Design and Marketing Agreement due on or prior to the date Optional Entity Interest Closing date and that the Design and Marketing Agreement requires the Design Firm to design the golf course at Punta Brava and permits Punta Brava to utilize the name and likeness of the Celebrity Golfer to promote the golf course at Punta Brava for a period of at least ten (10) years following the Optional Entity Interest Closing date and (II) the Design and Marketing Agreement contains customary terms and conditions as are standard for similar agreements in the industry; and (D) all other instruments, documents and other items reasonably necessary to effectuate the contribution of the Optional Entity Interests, or as may be reasonably requested by the Acquiror Parties.

(d)          Other Matters Relating to the Optional Entity Interest Contribution.

(i)          The Optional Entity Interest Closing shall occur on or before December 31, 2017 or not at all.

(ii)         If the Contributor Parties elect to contribute either Punta Brava or Melrose but not both Punta Brava and Melrose, the number of Transaction Shares and Warrants issuable to the Contributor at the Optional Entity Interest Closing shall be adjusted accordingly based upon the relative Optional Transactional Share Values described above. The conditions precedent for the contribution of Punta Brava and/or Melrose must be satisfied or waived as described above before the Contributor Parties make an election to contribute Punta Brava and/or Melrose.

(iii)        If the Contributor Parties seek a waiver of any condition precedent to the contribution of the Optional Entity Interests, such waiver must be approved unanimously by the board of directors of the Acquiror Parent.

42

9.2           Mandatory Contributions.

(a)          Mandatory Entity Interests. Upon the satisfaction or waiver of the conditions specified inSection 9.2(e) (the “Mandatory Contribution Conditions”) on or before December 31, 2017, the Contributor Parties shall contribute to the Acquiror all of their right, title and interest in and to the following two entities (the “Mandatory Entity Interests”):

(i)          All of the Contributor Parties’ interests in Goat Head Hill Resort Development Fee, Ltd., which is the owner of the Contributor Parties interests in Dutchman’s Bay, Block # 412296A, Parcel #68 and Goat Head Hill, Block #52148A, Parcel #317 (“Antigua”); and

(ii)         All of the Contributor Parties’ interests in Amarillo Ambassador 265, LLC (“Amarillo”).

(b)          Consideration for Mandatory Entity Interests. In consideration of the contribution of the Mandatory Entity Interests and subject to the satisfaction or waiver of the Mandatory Contribution Conditions prior to December 31, 2017, the Acquiror Parent shall issue to the Contributor on the date of the closing of the contribution of the Mandatory Entity Interests (the “Mandatory Entity Interest Closing”), Transaction Shares with a value (the “Mandatory Transaction Share Value”) of $20,000,000 (which Mandatory Transaction Share Value is allocated $14,109,000 to Antigua and $5,891,000 to Amarillo and will be reduced accordingly if one, but not the other, Mandatory Entity Interest is contributed as a result of the failure to satisfy applicable Mandatory Contribution Conditions or other conditions precedent or concurrent to their contribution), with the number of such additional Transaction Shares being determined by dividing the Mandatory Transaction Share Value by the Per Share Value. The Transaction Shares issuable under thisSection 9.2(b) shall be comprised entirely of shares of Acquiror Parent Common Stock if the issuance of such Transaction Shares has been approved by the shareholders of the Acquiror Parent in accordance with NASDAQ rules prior to the issuance thereof and such additional Transaction Shares shall be comprised entirely of shares of Acquiror Parent Preferred Stock if such approval has not yet been obtained.

(c)          Determinations Relating to Punta Brava and Melrose. Upon the determination by the Contributor that the conditions set forth herein have been satisfied with respect either of the Mandatory Interest Entities, the Contributor shall deliver written notice of such determination to the Acquiror Parent together with (i) an Officer’s Certificate that certifies that each of the conditions precedent to the contribution of the Mandatory Interest Entities has been satisfied, and (ii) the such materials as may be necessary to reasonably support the Contributor’s certificate that such conditions have been satisfied. The Acquiror Parent shall, within ten (10) days following the receipt of such notice, advise the Contributor Parent whether or not it agrees with such determination, and, if it does not so agree, specifying the reasons therefor in reasonable detail. The Acquiror Parent shall not unreasonably fail to agree with the determination of the Contributor. If the Acquiror Parent does not agree with the determination of the Contributor, then the Contributor may, in its discretion, elect either (i) to endeavor, together with the Acquiror Parent, in good faith, to resolve any disagreement on or before December 31, 2017, or (ii) to withdraw the relevant Mandatory Interest Entity from this Agreement. Under no circumstances shall either the failure to resolve any disagreement or the determination of Contributor to withdraw an asset from this Agreement result in or impose any liability whatsoever to any of the Parties hereto, or to any other Person or entity.

(d)          Closing Deliveries for Mandatory Entity Interests. In addition to the Mandatory Contribution Conditions, it shall be a condition to the Mandatory Entity Interest Closing that the Parties make the following deliveries to each other at or prior to the Mandatory Entity Interest Closing.

43

(i)          The Acquiror Parties shall deliver to the Contributor Parties: (A) the number of duly authorized and issued and nonassessable Transaction Shares as is required to be delivered pursuant toSection 9.2(b), (B) signed counterparts to an Assignment and Assumption Agreement relating to the Mandatory Entity Interests, (C) an officer’s certificate certifying to the Contributor Parties that the representations and warranties of the Acquiror Parties contained inArticle 5 of this Agreement are true and correct, except for (1) inaccuracies which would not, individually or in the aggregate, cause or reasonably be expected to cause an Acquiror Material Adverse Effect and (2) other reasonable exceptions to be specified on a schedule that result from events occurring between the Initial Closing and the Mandatory Entity Interest Closing; and (D) all other instruments, documents and other items reasonably necessary to effectuate the contribution of the Mandatory Entity Interests, or as may be reasonably requested by the Acquiror Parties.

(ii)         The Contributor Parties shall deliver to the Acquiror Parties: (A) signed counterparts to an Assignment and Assumption Agreement relating to the Mandatory Entity Interests; (B) an officer’s certificate certifying to the Acquiror Parties that the representations and warranties of the Contributor Parties contained inArticle 4 of this Agreement are true and correct as they relate to the Mandatory Entity Interests and the properties associated with the Mandatory Entity Interests, except for (1) inaccuracies which would not, individually or in the aggregate, cause or reasonably be expected to cause an Acquiror Material Adverse Effect and (2) other reasonable exceptions to be specified on a schedule that result from events occurring between the Initial Closing and the Mandatory Entity Interest Closing; (C) if Antigua is contributed, an officer’s certificate certifying to the Acquiror Parties that the Citizenship by Investment Unit has approved the Antigua Contributed Property as an approved project for purposes of the Citizen by Investment Program, and (D) all other instruments, documents and other items reasonably necessary to effectuate the contribution of the Mandatory Entity Interests, or as may be reasonably requested by the Acquiror Parties.

(e)          Mandatory Contribution Conditions.

(i)          The following conditions must be satisfied prior to the contribution of Antigua at the Mandatory Entity Interest Closing: (A) the memorandum of agreement, dated July 28, 2015 (the “MOA”) among BrownMcLennon, First Capital Real Estate Investment (“FCREI”) and the Government of Antigua and Barbuda (“GOAB”) shall have been amended to reflect that BrownMcLennon’s expected 24 units in the LLC (as defined in the MOA) have been transferred to FCREI in consideration for BrownMcLennon being engaged as an independent contractor, to act as broker for the Contributor Parties or their affiliates in connection with the sale of timeshare interests and/or other residential units for which BrownMcLennon would be entitled to a commission from FCREI and all performance dates shall have been extended by at least twelve (12) months; and (B) the conditions specified in Section 4A of the MOA (other than the conditions specified in Sections 4A(9) through, and including 4A(17)) shall have been satisfied or irrevocably waived in writing by GOAB and no new material conditions shall have been substituted therefor.

(ii)         The following condition must be satisfied prior to the contribution of Amarillo at the Mandatory Entity Interest Closing: The dispute between the Contributing Parties and Silverlake Park, LLC (the “Claimant”) pursuant to which the Claimant has attempted to transfer by quitclaim deed 75% of the Contributing Parties’ interest in Amarillo shall have been finally adjudicated or settled in favor of the Contributing Parties and such judgment or settlement shall indicate that the Contributing Parties have full ownership rights in Antigua that may be transferred to the Acquiror Parties free and clear of all Encumbrances (other than existing liens in favor of lenders arising prior to the Initial Closing) or other restrictions and no future payment or other obligation of the Acquiror Parties shall exist under such judgment or settlement.

44

(iii)        The following conditions must be satisfied by the Acquiror Parent prior to the first Mandatory Interest Closing: (1) the Articles of Incorporation of the Acquiror Parent shall have been amended and restated in the form ofExhibit E hereto, and (ii) all necessary corporate approvals shall have been obtained in order that the Transaction Shares issuable pursuant to Section 9.2(b) hereof shall be Acquiror Parent Common Stock.

(f)          Other Matters Relating to the Mandatory Entity Interest Contribution.

(i)          The Mandatory Entity Interest Closing shall occur on or before December 31, 2017 or not at all.

(ii)         If the Mandatory Contribution Conditions or other conditions precedent for one of Antigua or Amarillo are satisfied or waived, but not for both, then only the Mandatory Entity Interests of the entity whose Mandatory Contribution Conditions and conditions precedent have been satisfied or waived shall be contributed, but not those of the other entity and the number of Transaction Shares shall be adjusted accordingly based upon the relative Mandatory Transaction Share Values described above.

(iii)        If the Contributor Parties seek a waiver of any Mandatory Contribution Condition or other condition precedent to the contribution of the Mandatory Entity Interests, such waiver must be approved unanimously by the board of directors of the Acquiror Parent.

ARTICLE 10

TERMINATION

10.1         Termination. This Agreement may be terminated at any time prior to Closing: (a) by the mutual prior written consent of the Contributor Parties and the Acquiror Parties, (b) by either the Acquiror Parties or the Contributor Parties by giving written notice to the other on or before the twentieth (20th) day following the date hereof that indicates that the results of its due diligence investigation into the other Party is not satisfactory to it, or (c) by either the Contributor Parties or the Acquiror Parties if the Closing has not occurred on or before 5:00 pm local time in New York on May 17, 2017;provided,however, that the Contributor Parties shall be entitled to an automatic 45 day extension of such date if requested by the Contributor Parties in writing (May 17, 2017 or such extended date being the “End Date”);provided,further however, that, no Party shall be entitled to terminate this Agreement underSection 10.1(c) if the Closing has failed to occur as a result of such Party’s or its Affiliates’ breach of any representations or warranties set forth herein or such Party’s failure to perform or observe such Party’s or its Affiliates’ covenants and agreements hereunder (including the failure to perform the obligations of such Party with respect to Closing the transactions contemplated hereunder if and when required) in each case in a manner that causes the conditions of the other Party not to be satisfied (a “Material Breach”);provided, however, that none of the following shall constitute a Material Breach (i) the failure to satisfy a condition or complete an action that is outside of the control of a party, including, without limitation, the failure to obtain the vote or consent of a party’s shareholders, if required or deemed desirable, (ii) the failure to obtain the consent, approval or other action of any third party or Governmental Authority or any similar failure to satisfy a requirement, including, without limitation, the Commission, NASDAQ or the Tel Aviv Stock Exchange including, without limitation, the effectiveness of the Registration Statement (iii) the determination that the Registration Statement or any other required disclosure or similar document of the Acquiror Parties or the Contributor Parties will require the historical financial statements of the Contributor Parent if the matters set forth in clauses (i), (ii) or (iii) above shall prevent a Closing as set forth above, and notwithstanding anything to the contrary in this Agreement, the Closing shall be deferred until the matters set forth in such clauses have been satisfied, and either Party may terminate this Agreement, without penalty or damages, if a Closing has not occurred on or before August 15, 2017.

45

10.2         Effect of Termination. If this Agreement is terminated pursuant toSection 10.1, this Agreement shall become void and of no further force or effect (except for the provisions ofSection 10.3 andArticle 11 (and the definitions used in such Section and Article), all of which shall continue in full force and effect).

10.3         Damages for Failure to Complete the Closing.

(a)          In the event that (i) the Acquiror Parties have satisfied all obligations they are required to satisfy prior to any of the Closings contemplated hereby (other than those obligations that have been waived in writing by the Contributor Parties) and the Acquiror Parties stand ready, willing and able to satisfy each of their obligations required to be satisfied at the Closing) and (ii) the Contributor Parties are in Material Breach, then the Acquiror Parties shall be entitled to elect, in their sole discretion, to either (x) seek specific performance of this Agreement, or (y) terminate this Agreement and to receive an amount in cash equal to their direct out-of-pocket expenses incurred in connection with the negotiation and preparation for Closing, supported by reasonable documentation. Upon the occurrence of a termination by the Acquiror Parties pursuant to thisSection 10.3(a), the Contributor Parties shall, within twenty (20) days, pay to the Acquiror Parties in cash the aforesaid amount by wire transfer of immediately available funds to a bank account or accounts to be designated in writing by the Acquiror Parties.

(b)          In the event that (i) the Contributor Parties have satisfied all obligations they are required to satisfy prior to any of the Closings contemplated hereby (other than those obligations that have been waived in writing by the Acquiror Parties) and the Contributor Parties stand ready, willing and able to satisfy each of their obligations required to be satisfied at the Closing) and (ii) the Acquiror Parties are in Material Breach, then the Contributor Parties shall be entitled to elect, in their sole discretion, to either (x) seek specific performance of this Agreement, or (y) terminate this Agreement and to receive an amount in cash equal to their direct out-of-pocket expenses incurred in connection with the negotiation and preparation for Closing, supported by reasonable documentation. Upon the occurrence of a termination by the Contributor Parties pursuant to thisSection 10.3(b), the Acquiror Parties shall, within twenty (20) days, pay to the Contributor Parties in cash the aforesaid amount by wire transfer of immediately available funds to a bank account or accounts to be designated in writing by the Contributor Parties.

ARTICLE 11

MISCELLANEOUS

11.1         Limitation on Actions. Except as specifically set forth herein, the representations, warranties, covenants, and agreements set forth herein shall not survive, and shall be of no further force or effect after, the Closing Date.

11.2         Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original instrument, but all such counterparts together shall constitute but one agreement. Signatures to this Agreement transmitted by facsimile transmission, by electronic mail in “portable document format” (.pdf) form, or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing the original signature.

46

11.3         Notices. All notices that are required or may be given pursuant to this Agreement shall be sufficient in all respects if given in writing, in English and by personal delivery (if signed for receipt), by certified or registered United States mail (postage prepaid, return receipt requested), by a nationally recognized overnight delivery service for next day delivery, or transmitted via electronic mail (following appropriate confirmation of receipt by return email, including an automated confirmation of receipt) and shall be deemed to have been made and the receiving Party charged with notice, when received except that if received after 5:00 p.m. (in the recipient’s time zone) on a Business Day or if received on a day that is not a Business Day, such notice, request or communication will not be effective until the next succeeding Business Day. All notices shall be addressed as follows:

If to Acquiror Parties:

PhotoMedex, Inc.

2300 Computer Drive, Building G

Willow Grove, PA 19090

Attention: Dr. Dolev Rafaeli

Email: dolev@radiancy.com

With a copy (which shall not constitute notice) to:

BEVILACQUA PLLC
1629 K Street, NW, Suite 300

Washington, DC  20006

Attention: Louis A. Bevilacqua, Esq.

Email: lou@bevilacquapllc.com

If to Contributor Parties:

First Capital Real Estate Trust Incorporated

60 Broad Street, 34th Floor

New York NY 10004

Attention: Suneet Singal

Email: s@firstcapitalre.com

With a copy (which shall not constitute notice) to:

Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas, 11th Floor

New York, NY 10105

Attention: Barry I. Grossman, Esq.

Email: bigrossman@egsllp.com

Either Party may change its address for notice by notice to the other in the manner set forth above. All notices shall be deemed to have been duly given at the time of receipt by the Party to which such notice is addressed.

11.4         Expenses. Except as otherwise provided in this Agreement, all expenses incurred by the Contributor Parties in connection with or related to the authorization, preparation or execution of this Agreement, and the Exhibits and Schedules hereto and thereto, and all other matters related to the Closing, including all fees and expenses of counsel, accountants and financial advisers employed by the Contributor Parties, shall be borne solely and entirely by the Contributor Parties, and all such expenses incurred by Acquiror Parties shall be borne solely and entirely by Acquiror Parties.

47

11.5         Governing Law. This Agreement and the legal relations between the Parties shall be governed by and construed under and in accordance with the laws of the State of New York, without regard to conflicts of law principles that would result in the application of any law other than the laws of the State of New York

11.6         Dispute Resolution. Each Party hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive personal jurisdiction of the United States District Court for the Southern District of New York, or if such court does not have jurisdiction, any New York State court sitting in the County of New York, New York with respect to any dispute, claim or controversy arising out of or in relation to or in connection with this Agreement, and each of the Parties agrees that any action instituted by it against the other with respect to any such dispute, controversy or claim will be instituted exclusively in the New York State and United States District Court for the Southern District of New York. Each Party (a) irrevocably submits to the exclusive jurisdiction of such courts, (b) waives any objection to laying venue in any such action or proceeding in such courts, (c) waives any objection that such courts are an inconvenient forum or do not have jurisdiction over it, and (d) agrees that service of process upon it may be effected by mailing a copy thereof by registered mail (or any substantially similar form of mail), postage prepaid, to it at its address specified inSection 11.3. The foregoing consents to jurisdiction and service of process shall not constitute general consents to service of process in the State of New York for any purpose except as provided herein and shall not be deemed to confer any rights on any Person other than the Parties to this Agreement.THE PARTIES HEREBY WAIVE TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY ANY PARTY AGAINST ANOTHER IN ANY MATTER WHATSOEVER ARISING OUT OF OR IN RELATION TO OR IN CONNECTION WITH THIS AGREEMENT. FURTHER, NOTHING HEREIN SHALL DIVEST A COURT OF COMPETENT JURISDICTION OF THE RIGHT AND POWER TO GRANT A TEMPORARY RESTRAINING ORDER, TO GRANT TEMPORARY INJUNCTIVE RELIEF, OR TO COMPEL SPECIFIC PERFORMANCE OF ANY DECISION OF AN ARBITRAL TRIBUNAL MADE PURSUANT TO THIS PROVISION.

11.7         Captions. The captions in this Agreement are for convenience only and shall not be considered a part of or affect the construction or interpretation of any provision of this Agreement.

11.8         Waivers. Any failure by any Party to comply with any of its obligations, agreements or conditions herein contained may be waived by the Party to whom such compliance is owed by an instrument signed by the Party to whom compliance is owed and expressly identified as a waiver, but not in any other manner. No waiver of, or consent to a change in, any of the provisions of this Agreement shall be deemed or shall constitute a waiver of, or consent to a change in, other provisions hereof (whether or not similar), nor shall such waiver constitute a continuing waiver unless otherwise expressly provided.

11.9         Assignment. No Party shall assign or otherwise transfer all or any part of this Agreement to any third Person other than an Affiliate, nor shall any Party delegate any of its rights or duties hereunder (including by change of control, merger, consolidation, or stock purchase) to any third Person other than an Affiliate, without the prior written consent of the other Party and any transfer or delegation made without such consent shall be void. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and assigns. Notwithstanding the foregoing, Acquiror may, by providing written notice to Contributor, but without Contributor’s consent, assign its rights and delegate its duties hereunder in whole (but not in part) to an Affiliate of Acquiror;provided, however, such assignment shall not be permitted if it would reasonably be anticipated to increase the liability of any member of the Contributing Group with respect to Taxes.

48

11.10         Entire Agreement. This Agreement and the documents to be executed hereunder and the Exhibits and Schedules attached hereto constitute the entire agreement among the Parties pertaining to the subject matter hereof, and supersede all prior agreements, understandings, negotiations and discussions, whether oral or written, of the Parties pertaining to the subject matter hereof. In entering into this Agreement, none of the Parties has relied on any statement, representation, warranty, covenant, or agreement of any other Party or its representatives other than those expressly contained in this Agreement.

11.11         Amendment. This Agreement may be amended or modified only by an agreement in writing signed by the Contributor Parties and the Acquiror Parties and expressly identified as an amendment or modification.

11.12         No Third-Person Beneficiaries. Nothing in this Agreement shall entitle any Person other than the Acquiror Parties and the Contributor Parties to any claim, cause of action, remedy or right of any kind.

11.13         Severability. If any provision of this Agreement, or any application thereof, is held invalid, illegal or unenforceable in any respect under any Law, this Agreement shall be reformed to the extent necessary to conform, in each case consistent with the intention of the Parties, to such Law, and, to the extent such provision cannot be so reformed, then such provision (or the invalid, illegal or unenforceable application thereof) shall be deemed deleted from (or prohibited under) this Agreement, as the case may be, and the validity, legality and enforceability of the remaining provisions contained herein (and any other application of such provision) shall not in any way be affected or impaired thereby.

11.14         Business Day. If the date specified in this Agreement for giving any notice or taking any action is not a Business Day (or if the period during which any notice is required to be given or any action taken expires on a date which is not a Business Day), then the date for giving such notice or taking such action (and the expiration of such period during which notice is required to be given or action taken) shall be the next day which is a Business Day.

11.15         References. In this Agreement: (a) references to any gender includes a reference to all other genders; (b) references to the singular includes the plural, and vice versa; (c) reference to any Article or Section means an Article or Section of this Agreement; (d) reference to any Exhibit or Schedule means an Exhibit or Schedule to this Agreement, all of which are incorporated into and made a part of this Agreement; (e) unless expressly provided to the contrary, “hereunder”, “hereof”, “herein” and words of similar import are references to this Agreement as a whole and not any particular Section or other provision of this Agreement; (f) references to “$” or “dollars” means United States Dollars; and (g) “include” and “including” mean include or including without limiting the generality of the description preceding such term.

11.16         Construction. Acquiror and Contributor are capable of making such investigation, inspection, review and evaluation of the Contributed Entity Interest and the Acquiror Group, respectively, as a prudent purchaser would deem appropriate under the circumstances, including with respect to all matters relating to their value, operation and suitability. Contributor Parties and Acquiror Parties have had the opportunity to exercise business discretion in relation to the negotiation of the details of the transaction contemplated hereby. This Agreement is the result of arm’s-length negotiations from equal bargaining positions. It is expressly agreed that this Agreement shall not be construed against any Party, and no consideration shall be given or presumption made, on the basis of the Persons who drafted this Agreement or any particular provision thereof.

49

11.17         Limitation on Damages. Notwithstanding anything to the contrary contained herein, none of the Acquiror Parties, the Contributor Parties, or any of their respective Affiliates shall be entitled to consequential, special, or punitive damages in connection with this Agreement and the transactions contemplated hereby (other than consequential, special, or punitive damages suffered by third Persons for which responsibility is allocated between the Parties in this Agreement) and each of the Acquiror Parties and the Contributor Parties, for itself and on behalf of its Affiliates, hereby expressly waives any right to consequential, special, or punitive damages in connection with this Agreement and the transactions contemplated hereby (other than consequential, special, or punitive damages suffered by third Persons for which responsibility is allocated between the Parties in this Agreement).

11.18         Recourse Only Against Parties. All claims, obligations, liabilities, or causes of action (whether in contract or in tort, in law or in equity, or granted by statute) that may be based upon, in respect of, arise under, out or by reason of, be connected with, or relate in any manner to this Agreement, or the negotiation, execution, or performance of this Agreement (including any representation or warranty made in, in connection with, or as an inducement to, this Agreement), may be made only against (and are expressly limited to) the entities that are expressly identified as parties in the preamble to this Agreement or any successor or permitted assign of any such Parties (“Contracting Parties”). No Person who is not a Contracting Party, including without limitation any director, officer, employee, incorporator, member, partner, manager, stockholder, Affiliate, agent, attorney, or representative of, and any financial advisor or lender to, any Contracting Party, or any director, officer, employee, incorporator, member, partner, manager, stockholder, Affiliate, agent, attorney, or representative of, and any financial advisor or lender to, any of the foregoing (“Nonparty Affiliates”), shall have any liability (whether in contract or in tort, in law or in equity, or granted by statute) for any claims, causes of action, obligations, or liabilities arising under, out of, in connection with, or related in any manner to this Agreement or based on, in respect of, or by reason of this Agreement or its negotiation, execution, performance, or breach; and, to the maximum extent permitted by law, each Contracting Party hereby waives and releases all such liabilities, claims, causes of action, and obligations against any such Nonparty Affiliates. Without limiting the foregoing, to the maximum extent permitted by law, (a) each Contracting Party hereby waives and releases any and all rights, claims, demands, or causes of action that may otherwise be available at law or in equity, or granted by statute, to avoid or disregard the entity form of a Contracting Party or otherwise impose liability of a Contracting Party on any Nonparty Affiliate, whether granted by statute or based on theories of equity, agency, control, instrumentality, alter ego, domination, sham, single business enterprise, piercing the veil, unfairness, undercapitalization, or otherwise; and (b) each Contracting Party disclaims any reliance upon any Nonparty Affiliates with respect to the performance of this Agreement or any representation or warranty made in, in connection with, or as an inducement to this Agreement.

[Signature Page Follows]

50

IN WITNESS WHEREOF, this Agreement has been signed by each of the Parties as of the date first above written.

CONTRIBUTOR:
FIRST CAPITAL REAL ESTATE OPERATING
PARTNERSHIP, L.P.

By: First Capital Real Estate Trust Incorporated, its

general partner

By:/s/ Suneet Singal
Name:Suneet Singal
Title:Chief Executive Officer
CONTRIBUTOR PARENT:
FIRST CAPITAL REAL ESTATE TRUST
INCORPORATED
By:/s/ Suneet Singal
Name:Suneet Singal
Title:Chief Executive Officer
ACQUIROR:
FC GLOBAL REALTY OPERATING PARTNERSHIP, LLC
By:/s/ Dolev Rafaeli
Name:Dolev Rafaeli
Title:President
ACQUIROR PARENT:
PHOTOMEDEX, INC
By:/s/ Dolev Rafaeli
Name:Dolev Rafaeli
Title:Chief Executive Officer

Exhibits

Exhibit A – Assignment and Assumption Agreement

Exhibit B – Certificate of Designation

Exhibit C – Lock Up Agreement

Exhibit D – Registration Rights Agreement

Exhibit E – Amended and Restated Articles of Incorporation of Acquiror Parent

Exhibit F – Amended and Restated Bylaws of Acquiror Parent

Exhibit G – Voting Agreement

Exhibit H – Form of Payout Notes

Exhibit I – Payout Notes Security Agreement

Exhibit J – Employment Agreement with Suneet Singal

Exhibit K – Warrant

Exhibit A

Assignment and Assumption Agreement

ASSIGNMENT AND ASSUMPTION AGREEMENT

THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Agreement”) is entered into as of the __ day of ____, 2017, by and between First Capital Real Estate Operating Partnership, L.P., a Delaware limited partnership (“Assignor”), First Capital Real Estate Trust Incorporated (“Assignor Parent”), FC Global Realty Operating Partnership,Opportunity Fund I-SS, LLC, a Delaware limited liability company (the “Investor”), under which the Investor may, but is not obligated to, invest up to $15 million in the Company in a series of closings over a period prior to December 31, 2018, in exchange for which the Investor will receive shares of the Company’s newly designated Redeemable Convertible Series B Preferred Stock (“AssigneeSeries B Shares) at a purchase price of $1.00 per share (the “Option”). 

On December 22, 2017 (the “Initial Date”), the Company and the Investor completed the first closing under the Purchase Agreement, pursuant to which the Investor exercised a portion of the Option and provided $1,500 to the Company in exchange for 1,500,000 shares of Series B Shares.

Proceeds from any subsequent closings must be used to invest in Income Generating Properties (as that term is defined in the Purchase Agreement) that have been approved by the Company’s Board of Directors or as otherwise agreed to between the Company and the Investor in writing prior to such subsequent closings. 

Under ASC 480, “Distinguishing Liabilities from Equity” preferred stock that is not redeemable or is redeemable solely at the option of the issuer shall be included in stockholders’ equity. If the instrument meets any of the following criteria, mezzanine classification between liabilities and stockholders’ equity would be required: 

it is redeemable at a fixed or determinable price on a fixed or determinable date or dates
it is redeemable at the option of the holder; or
It has conditions for redemption which are not solely within the control of the issuer, such as stocks which must be redeemed out of future earnings

In addition, per ASC 480, deemed liquidation events that require (or permit at the holders options) the redemption of only one or more of a particular class of equity instrument for cash or other assets cause those instruments to be considered contingently redeemable and therefore, subject to mezzanine classification. 

Since the Series B Shares have conditional redemption provisions which are outside of the control of the Company and also contain a deemed liquidation preference, the Series B Shares were classified as mezzanine financing at their initial fair value at the Initial Date. Subsequent measurement is unnecessary if it is not probable that the instrument will become redeemable. If it is probable that the equity instrument will become redeemable the following measurement methods shall be applied in accordance with either of the following methods and shall be applied in a consistent manner:

Accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument using an appropriate methodology, usually the interest method. Changes in the redemption value are considered to be changes in accounting estimates.

Recognize changes in the redemption value (for example, fair value) immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the instrument.

Under ASC 480, the aforementioned written call Option is considered freestanding, as the Company believes it is legally detachable and separately exercisable. As the option is exercisable for shares subject to possible redemption at the option of the holder, as of the Initial Date, the Option was measured at fair value in total amount of $5,584 and recorded as a non-current financial liability on the consolidated balance sheet as of December 31, 2017. Excess of the initial value of the option liability over the proceeds received, amounting to $4,084, was charged immediately into the consolidated statement of comprehensive loss as financing expenses. As such, there were no residual proceeds to allocate to the Series B preferred shares at the Initial Date.


The Option is marked to market in each reporting period when changes in the fair value of the Option are charged into statement of comprehensive loss. Consequently, during the year ended December 31, 2017, the Company recorded finance income of $1,194 related to change in the fair value of the instrument during the period from the Initial Date through December 31, 2017.

In addition, the Company has incurred direct and incremental issuance costs amounting to $42 which were charged immediately into the consolidated statement of comprehensive loss as finance expenses, as the Option was presented at fair value at the Initial Date.

On December 22, 2017, each Series B Share was convertible into 1.24789 shares of common stock valued at $1.00 per share. As a result, Beneficial Conversion Feature (the “BCF”) amounting to approximately $372 was measured assuming full conversion. However, the conversion of the Preferred Stock is subject to certain contingencies, which impact the timing and amount of the BCF. As of December 31, 2017, the Company should record a BCF for the Preferred Stock for any shares convertible at that time without requiring stockholder approval through the planned proxy statement. However, as no residual proceeds were allocable to the Series B Shares, no BCF was recognized at December 31, 2017. 

The fair value of the Option was based on management estimates and values derived from a calculation to provide an approximate indication of value. The fair value of Option was estimated at the Initial Date and December 31, 2017 by using hybrid method that includes scenario of conversion and scenario liquidation and the Black-Scholes option pricing model. In the first scenario, the Series B Preferred Stock price applied in the model was assumed based on the as-converted price on the date of estimation. Expected volatility was estimated by using a group of peers in the real estate development, homebuilding and income-producing properties sectors, and applying a 75% percentile ranking based on the total capitalization of the Company. In the second scenario, the option was estimated based on the value of the option in a proposed liquidation scenario. A probability weighting was applied to determine the expected value of the option. 

The following are the key underlying assumptions that were used:

Option Value:

  December 22,
2017
  December 31,
2017
 
Dividend yield (%)  0   0 
Expected volatility (%)  36.9   36.9 
Risk free interest rate (%)  1.72   1.74 
Strike price  1.00   1.00 
Series B Preferred Stock price  1.24   1.13 
Probability of if-converted scenario (%)  90   90 
Probability assumed liquidation scenario (%)  10   10 
Expected term of Option (years)  1.0   1.0 

In the absence of voluntary conversion and assuming no breaches as described above under “Redemption”, the Series B Shares automatically convert on May 31, 2018. As such, accretion adjustments to the carrying amount of the Series B Shares to the automatic conversion date of May 31, 2018 are recorded as deemed dividends. 

The table below summarizes the change in the mezzanine financing during the year ended December 31, 2017: 

  

December 31, 

2017 

 
    
Opening balance $ 
Proceeds from issuance of Series B Shares  1,500 
Recognition of written call Option as a discount of Series B Shares  (1,500)
Amortization of discount  84 
Accretion of cumulative dividend  3 
     
Closing balance $87 

In addition, upon the Purchase Agreement, the Company agreed the following:

To nominate two directors to the Company’s Board of Directors upon request of the Investor (see also Note 17).

So long as the shares of Series B Shares purchased by the Investor are outstanding, the Company’s debt (as defined by U.S. generally accepted accounting principles) shall not exceed 45% of its fixed assets without the prior written consent of the Requisite Holders. As of December 31, 2017, the covenant has been met by the Company.

Subject to stockholder approval, to amend the Certificate of Designation for the Company’s Series A Shares to change the conversion price from $2.5183 to $1.12024 such that each share of Series A Share will be initially convertible into 56.2 shares of Common Stock instead of 25 shares of Common Stock.

The above inducement is considered as modification for which the fair value of the Series A Shares shall be measured pre-and post-modification subject to the stockholders’ approval. Should the fair value change by greater than 10% as a result of the modification, any original Series A Shares will be considered extinguished with the incremental value reflected in expense. Should the modification not result in a greater than 10% change, the modification of the conversion feature for the Series A Shares will be treated analogous to modification for stock compensation arrangements. Any incremental value, will be recorded as a deemed dividend to the Series A Shareholders.

As of December 31, 2017, the stockholders’ approval has not been taken place.

Common Stock Options

The Company has a Non-Employee Director Stock Option Plan. This plan has authorized 74,000 shares; of which 2,135 shares had been issued or were reserved for issuance as awards of shares of common stock, and 12,079 shares were reserved for outstanding stock options. As of December 31, 2017 the number of shares available for future issuance pursuant to this plan is 71,865.

In addition, the Company has a 2005 Equity Compensation Plan (“2005 Equity Plan”) which has authorized 1,200,000 shares, of which 467,328 shares had been issued or were reserved for issuance as awards of shares of common stock, and 143,815 shares were reserved for outstanding options. There are no further shares available for future issuance pursuant to this plan.

A summary of stock option transactions under the Non-Employee Director Stock Option Plan and the 2005 Equity Plan during the years ended December 31, 2017 and 2016 were as follows:

   Number of Stock Options  Weighted Average Exercise Price 
Outstanding at December 31, 2015   150,138   67.99 
Granted       
Exercised       
Expired/cancelled   (15,988)  82.26 
Outstanding at December 31, 2016   134,150  $85.22 
Granted       
Exercised       
Expired/cancelled   (133,150)  91.43 
Outstanding at December 31, 2017   1,000  $75.00 
Exercisable at December 31, 2017   800  $75.00 


A summary of non-vested restricted stock during the years ended December 31, 2017 and 2016, were as follows:

   Shares of restricted stock  Weighted Average Grant-Date Fair
Value
 
Non-vested at December 31, 2015   258,572   10.57 
Granted       
Vested/cancelled   (129,211)  10.04 
Non-vested at December 31, 2016   129,361   11.11 
Granted       
Vested/cancelled   (122,861)  14.69 
Non-vested at December 31, 2017   6,500   9.25 

The total equity-based compensation expense related to all of the Company’s equity-based awards, recognized during the years ended December 31, 2017 and 2016, as part of the discontinuing operation in total amount of $69 and $1,969, respectively. In addition, during the years ended December 31, 2017, an amount of $2,364 was recorded as general and administrative expenses as part of continuing operation.

At December 31, 2017, there was $35 of total unrecognized compensation cost related to non-vested stock awards that based on their original vesting terms was expected to be recognized over a weighted-average period of .17 years. Following the completion of the transaction described in Note 17, such compensation will be accelerated.

Note 15

Income Taxes:

On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 (the “Tax Act”). The Tax Act makes broad and complex changes to the U.S. tax code, including, but not limited to, reducing the U.S. federal corporate tax rate from 35 percent to 21 percent; eliminating the corporate alternative minimum tax (AMT) and changing how existing AMT credits can be realized; creating a new limitation on deductible interest expense; changing rules related to uses and limitations of net operating loss carryforwards created in tax years beginning after December 31, 2017; limitations on the deductibility of certain executive compensation.

In December 2017, the SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”), which addresses situations where the accounting is incomplete for the income tax effects of the Act. SAB 118 directs taxpayers to consider the impact of the Act as “provisional” when the Company does not have the necessary information available, prepared or analyzed (including computations) to finalize the accounting for the change in tax law. Companies are provided a measurement period of up to one year to obtain, prepare, and analyze information necessary to finalize the accounting for provisional amounts or amounts that cannot be estimated as of December 31, 2017.

With regards to the Tax Act impact on the tax provision as it relates to the Company for the year-ending December 31, 2017, we have recognized the provisional impact of tax reform related to the revaluation of deferred tax assets and liabilities from 35% to 21% of $17.3 million (As Restated) tax expense, which is offset by a reduction in the valuation allowance.

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date.

A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which the related temporary difference becomes deductible. The benefit of tax positions taken or expected to be taken in the Company’s income tax returns are recognized in the consolidated financial statements if such positions are more likely than not of being sustained.


For the years ended December 31, 2016, and 2015, the following table summarizes the components of income before income taxes from continuing operations and the provision for income taxes:

  Year Ended December 31, 
  2017  2016 
Loss from continuing operations before income tax:        
U.S. (As Restated) $(16,261) $ 
Israel  (453)   
UK  (219)   
Loss from continuing operations before income taxes (As Restated) $(16,933) $ 
         
Income tax expense (benefit):        
United States -  Federal tax:        
Current $  $ 
Deferred      
         
United States - State tax:        
Current      
Deferred:      
         
Israel:        
Current      
Deferred       
         
UK:        
Current      
Deferred      
         
Other foreign:        
Current      
Deferred:      
         
Income tax expense (benefit) $  $ 

For the years ended December 31, 2017 and 2016, the following table reconciles the federal statutory income tax rate to the effective income tax rate:

  Year Ended December 31, 
  2017  2016 
Federal Tax rate  34%  34%
         
Federal tax expense (benefit) at 34% (As Restated) $(5,758) $ 
State and local income tax, net of Federal benefit  (271)   
Foreign rate differential  519    
Increase in taxes from permanent differences in stock-based compensation  333    
Increase in taxes from permanent difference in Intangible asset impairment      
US taxation of foreign earnings – Subpart F      
Return to provision and other adjustments  289    
Impact of deferred tax adjustments      
Federal Tax reform (As Restated)  17,260    
Change in valuation allowance (As Restated)  (12,372)   
         
Income tax expense (benefit) $  $  

As of December 31, 2017, the Company had approximately $125 million of Federal net operating loss carryforwards in the United States. A 100% valuation allowance has been recorded against these tax attributes and the net deferred tax assets of the U.S. group of companies. Based on current operating conditions and the availability of projected future sources of taxable income, the Company determined that it was not more likely than not that the net deferred tax assets of the U.S. companies would be realized in the future. The Federal NOLs expire generally from 2022 to 2037.

After conversion to U.S. dollars, Photo Therapeutics Limited had approximately $12.8 million of net operating loss carryforwards in the U.K. A 100% valuation allowance has been applied against these loss carryforwards.


The following table summarizes the components of deferred income tax assets and (liabilities):

  December 31, 
  2017  2016 
       
Loss carryforwards $29,693  $30,770 
AMT credits  112   112 
Foreign tax credits  12,308   12,308 
Accrued employment expenses  11   2,652 
Amortization and write-offs  875   1,299 
Capitalized R&D costs  1,013   1,342 
Deferred revenues     6,263 
Depreciation  635   1,224 
Doubtful accounts     225 
Inventory reserves     459 
Tax on undistributed earnings  (517)  (517)
Other accruals and reserves (As Restated)  1,737   602 
Return allowances     456 
         
Gross deferred tax asset (As Restated)  45,867   57,195 
         
Less: valuation allowance (As Restated)  (45,867)  (57,195)
         
Net deferred tax asset $  $ 
         
Among other non-current liabilities      

Taxes, which may apply in the event of a disposal of investments in subsidiaries, have not been included in computing the deferred taxes, as the Company anticipates it would liquidate those subsidiaries that can be closed on a tax free basis

FC Global Realty Inc. (formerly PhotoMedex, Inc.) files corporate income tax returns in the United States, both in the Federal jurisdiction and in various State jurisdictions. The Company is subject to Federal income tax examination for calendar years 2014 through 2017 and is also generally subject to various State income tax examinations for calendar years 2014 through 2017. Photo Therapeutics Limited files in the United Kingdom. Radiancy (Israel) Limited files in Israel. The Israeli subsidiary is subject to tax examination for calendar years 2013 through 2017.

The Israeli subsidiary is entitled to reduced tax rates regarding income that is subject to tax pursuant to the “approved enterprise” until end of year 2012 and “preferred enterprise” from year 2013. Other income is subject to the regular corporate income tax rate. For the year 2015 and thereafter, all income in Israel was taxed at the regular corporate income tax rate.

Change in Israel rates. Effective for tax periods beginning 1 January 2014, the standard corporate income tax rate was increased from 25% to 26.5%. On January 4, 2016, the plenary Knesset passed the Law for Amendment of the Income Tax Ordinance No. 216 which provides, inter alia, for a reduction of the Companies Tax rate commencing from 2016 and thereafter by the rate of 1.5% such that the rate will be 25%.

Change in U.K. rates. In addition, effective for tax periods beginning on April 1, 2014, the United Kingdom tax rate was reduced from 23% to 21%. A further enacted decrease in the tax rate to 20% took effect on April 1, 2015. The rate further reduced to 19% effective April 1, 2017. These changes in rate will affect the tax provision with regard to the tax attributes of Photo Therapeutics Limited, the United Kingdom subsidiary.

Unrecognized Tax Benefits. The Company is subject to income taxation in the U.S., Israel, the U.K., and Colombia. Unrecognized tax benefits reflect the difference between positions taken or expected to be taken on income tax returns and the amounts recognized in the financial statements. Resolution of the related tax positions through negotiations with the relevant tax authorities or through litigation could take years to complete. It is difficult predict the timing of resolution for tax positions since such timing is not entirely within the control of the Company.

The Company and its subsidiaries file income tax returns in all of the countries listed above.


Management conducted an analysis of the facts and law surrounding the then existing income tax uncertainties, and found that such liability as may have arisen was of a much lesser magnitude and is able to be extinguished by loss carryforwards and carrybacks,

Reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

Balance at December 31, 2015 $1,921 
Additions / Settlements due 2016   
Balance at December 31, 2016 $1,921 
Additions / Settlements due 2017   
Balance at December 31, 2017 $1,921 

Note 16 

Significant Customer Concentration:

No single customer accounted for more than 10% of total company revenues of discontinued operations for the years ended December 31, 2017 and 2016.

Note 17

Subsequent Events:

Second Closing under Securities Purchase Agreement

On January 24, 2018, the Company and the Investor, as discussed in Note 13, completed a second closing under the Purchase Agreement, pursuant to which the Investor provided $2,225 to the Company in exchange for 2,225,000 shares of the Company’s Series B Preferred Stock. The issuance of these securities was made in reliance upon an exemption from the registration requirements of Section 5 of the Securities Act of 1933, as amended. The proceeds from this closing shall be used to perform due diligence and invest in Income Generating Properties (as defined in the Purchase Agreement) that have been approved by the Company’s Board of Directors.

Amended and Restated Separation Agreement

On February 12, 2018, the Company entered into an Amended and Restated Separation Agreement (the “Restated Agreement”), pursuant to which the Company has agreed to pay Mr. Stephen Johnson, its former Chief Financial officer, an amount of $123 in 11 installments as follows: the first 6 installments of $10 each, and the following five installments of $12.5 each. The first payment was made on February 15, 2018, and subsequent payments are to be made on or before the 15th day of each succeeding month, with the final installment to be paid on or before December 15, 2018. The Company will also provide a health (medical, dental and/or vision) insurance reimbursement payment for Mr. Johnson and his family, for a period of 11 months, in the agreed upon amount of $3 per month.

In addition, the Company has agreed to issue to Mr. Johnson 271,000 shares of the Company’s common stock, subject to appropriate adjustment for any stock splits, stock or business combinations, recapitalizations or similar events occurring after the date of the Restated Agreement. Those shares will be issued on any business day during the period commencing on the date that is six months after the date of the Restated Agreement and ending on the date that is three business days after such six-month anniversary.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On February 20, 2018, the Company received written notification (the “Notice”) from Nasdaq that the closing bid price of its common stock had been below the minimum $1.00 per share for the previous 30 consecutive business days, and that the Company is therefore not in compliance with the requirements for continued listing on Nasdaq under Nasdaq Marketplace Rule 5550(a)(2). The Notice provides the Company with an initial period of 180 calendar days, or until August 19, 2018, to regain compliance with the listing rules. The Company will regain compliance if the closing bid price of its common stock is $1.00 per share or higher for a minimum period of ten consecutive business days during this compliance period, as confirmed by written notification from Nasdaq. 

If the Company does not achieve compliance by August 19, 2018, the Company expects that Nasdaq would provide notice that its securities are subject to delisting from the Capital Market. 


Departure and Election of certain Directors 

Effective March 4, 2018, Suneet Singal, the Company’s former Chief Executive Officer, has resigned from the Company’s Board of Directors. In addition, effective March 5, 2018, Darrel Menthe has also resigned from the Company’s Board of Directors. Their resignations were not in connection with any known disagreement with the Company on any matter.

Under the provisions of the Stock Purchase Agreement dated December 22, 2017 (see also Note 14), Opportunity Fund I-SS, LLC has notified the Company that it may exercise its right to appoint two replacement directors to the Company’s Board of Directors. 

Letter Agreement with OFI

Under the Purchase Agreement, the proceeds from the first closing were to be used for working capital and general corporate purposes, the proceeds from the second closing were to be used to perform due diligence and invest in Income Generating Properties (as defined in the Purchase Agreement) that have been approved by the Board of Directors of the Company, and proceeds from subsequent closings were to be used to invest in Income Generating Properties (as defined in the Purchase Agreement) that have been approved by the Board of Directors of the Company or as otherwise agreed to between the Company and OFI in writing prior to such subsequent closings.

On March 16, 2018, the Company and OFI entered into a letter agreement, pursuant to which OFI agreed that the Company may use all proceeds for the purposes and uses described in a budget agreed to between the Company and OFI at the time the letter agreement was signed. In connection with such letter agreement, the Company agreed to provide OFI, on a quarterly basis, on or prior to 15 days after the end of each quarter, a report that describes, in reasonable detail, the actual expenses incurred, and payments made during such period compared to the expenses and payments specified in the budget for such period, certified by the Chief Financial Officer of the Company.


ANNEX B

REMEDIATION AGREEMENT

ThisRemediation Agreement (hereinafter the “Agreement”) is dated as of September 24, 2018, by and PhotoMedex Inc.betweenFC Global Realty Incorporated, a Nevada corporation (“Assignee Parent(the “Company”).,Opportunity Fund I-SS, LLC, a Delaware limited liability company (“OFI”), and the other parties signatory hereto.

 

RECITALS

WHEREAS, Assignor, Assignor Parent, Assignee and Assignee Parent have entered into an Interest Contribution Agreement dated March 31, 2017 (the “Contribution Agreement”), pursuant to which the Assignor has agreed to sell and transfer to Assignee all of its right, title and interest in and to (i) the properties set forth on Exhibit I hereto (the “Contributed Real Properties”) and (ii) the entities set forth on Exhibit II hereto (the “Contributed Entities”, and together with the Contributed Real Properties, the “Contributed Assets”);

WHEREAS, the Contributed Entities have rights or interests in and to the Contributed Properties (as such term is defined in the Contribution Agreement);

WHEREAS, Assignor or Assignor Parent has either (singly or together) guaranteed certain obligations of the Contributed Entities or undertaken or agreed to perform certain services on behalf of the Contributed Entities or the Contributed Properties, as set forth on Exhibit III hereto (such guarantees or other obligations, the “Guaranteed Obligations”); and

WHEREAS, Assignor or Assignor Parent has entered into agreements, commitments or obligations with respect to the Contributed Real Properties, as set forth on Exhibit IV hereto (the “Contributed Agreements”).

NOW, THEREFORE, in consideration of the premises and the agreements hereinafter set forth, the parties hereto hereby agree as follows:

1.Capitalized terms used but not otherwise defined in this Agreement have the meanings given said terms in the Contribution Agreement.

2.Assignor hereby irrevocably assigns to Assignee, and Assignee hereby irrevocably accepts from Assignor, all of Assignor’s rights, title and interests in and to the Contributed Assets and the Contributed Agreements. In order to reflect the assignment of Interests in the Contributed Entities, the Contributor Parties shall amend and restate the operating agreement or other constituent instruments of the Contributed Entities or otherwise amend the schedule of members or equity owners to reflect Acquiror as the owner of such Interests and shall deliver to the Acquiror Parties an Interest assignment instrument reflecting such assignment.

3.Assignee hereby irrevocably agrees to assume and perform all of the obligations of the Assignor and the Assignor Parent pursuant to the Contributed Agreements and the Guaranteed Obligations, in the same manner and to the same extent as if the Assignee were the original obligor or obligors thereunder.

4.To the fullest extent permitted by law, each party shall indemnify, defend and hold harmless the other parties, their respective officers, directors, shareholders, employees, agents, representatives, consultants, and contractors from and against any and all suits, judgments, actions, liabilities, costs, penalties, fines, damages, claims and expenses (including, without limitation, reasonable attorney’s fees) arising out of, resulting from, the breach or threatened breach by the other party of its obligations hereunder.

5.Assignee Parent does hereby unconditionally and irrevocably guarantee the payment and performance, when due, of each of the obligations of Assignee pursuant hereto.

6.Each of the parties hereto hereby represents and warrants to the other as follows:

1

(a) The execution, delivery and performance of this Agreement are within such party’s powers and have been duly authorized by all necessary limited liability company, corporate or other action.

(b) This Agreement constitutes the legal, valid and binding obligation of such party, enforceable against such party in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, moratorium, fraudulent transfer or similar laws affecting the enforcement of creditors’ rights generally or by equitable principles (whether considered in a proceeding at law or in equity) and an implied covenant of good faith and fair dealing.

(c) No authorization or approval or other action by, and no notice to or filing with, any Governmental Authority, regulatory body or any other third party is required for the due execution, delivery and performance by each party to this Agreement.

7.This Agreement will be binding upon and will inure to the benefit of parties hereto and their respective successors and assigns.

8.Each party shall, upon the request of the other, from time to time, execute and deliver promptly to such other party all instruments and documents of further assurances or otherwise and will do any and all such acts and things as may be reasonably required to carry out the obligations of such party hereunder and to consummate the transactions contemplated hereby.

9.This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original and all of which together will be deemed to be one and the same instrument.

10.THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF.

11.Any one or more of the provisions in this Agreement held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality and unenforceability without affecting the validity, legality and enforceability of the remaining provisions of this Agreement; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.

2

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first above written by their respective duly authorized officers.

ASSIGNOR:
FIRST CAPITAL REAL ESTATE OPERATING PARTNERSHIP, L.P.
By: First Capital Real Estate Trust Incorporated, its general partner
By:
Name:
Title:
ASSIGNOR PARENT:
FIRST CAPITAL REAL ESTATE TRUST INCORPORATED
By:
Name:
Title:
ASSIGNEE:
FC GLOBAL REALTY OPERATING PARTNERSHIP, LLC
By:
Name:
Title:
ASSIGNEE PARENT:
PHOTOMEDEX, INC
By:
Name:
Title:

Exhibit I to Assignment and Assumption Agreement

 Exhibit II to Assignment and Assumption Agreement

Exhibit III to Assignment and Assumption Agreement

Exhibit IV to Assignment and Assumption Agreement

Exhibit B

Certificate of Designation

EXHIBIT B

PHOTOMEDEX, INC.

CERTIFICATE OF DESIGNATION OF PREFERENCES,

RIGHTS AND LIMITATIONS

OF

SERIESACONVERTIBLE PREFERRED STOCK

PURSUANT TO SECTION 78.1955 OF THE

NEVADA REVISED STATUTES

The undersigned, __________ and ____________, do hereby certify that:

1.        They are the President and Secretary, respectively, of PhotoMedex, Inc., a Nevada corporation (the “Corporation”).

2.        The Corporation is authorized to issue five million (5,000,000) shares of preferred stock, $.01 par value per share, none of which have been issued.

3.        The following resolutions were duly adopted by the board of directors of the Corporation (the “Board of Directors”):

WHEREAS, the articles of incorporation of the Corporation provide for a class of its authorized stock known as preferred stock, consisting of five million (5,000,000) shares, $.01 par value per share, issuable from time to time in one or more series;

WHEREAS, the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms of redemption and liquidation preferences of any wholly unissued series of preferred stock and the number of shares constituting any series and the designation thereof, of any of them; and

WHEREAS, it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and other matters relating to a series of the preferred stock, which shall consist of, except as otherwise set forth in the Contribution Agreement, up to [__________] shares of the preferred stock which the Corporation has the authority to issue, as follows:

NOW, THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock for cash or exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters relating to such series of preferred stock as follows:

1

TERMS OF PREFERRED STOCK

Section 1.          Definitions. For the purposes hereof, the following terms shall have the following meanings:

Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.

Alternate Consideration” shall have the meaning set forth in Section 7(d).

Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

Closing” means the Closing pursuant to Section 8.1 of the Contribution Agreement.

Closing Date” means the Trading Day on which all of the Transaction Documents (as defined in the Contribution Agreement) have been executed and delivered by the applicable parties thereto and all conditions precedent to the Corporation’s obligations to deliver the Securities have been satisfied or waived.

Commission” means the United States Securities and Exchange Commission.

Common Stock” means the Corporation’s common stock, par value $.01 per share, and stock of any other class of securities into which such securities may hereafter be reclassified or changed.

Common Stock Equivalents” means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

Contribution Agreement” means the Interest Contribution Agreement, dated March 31, 2017, among the Corporation, First Capital Real Estate Operating Partnership, L.P., First Capital Real Estate Trust Incorporated, and FC Global Realty Operating Partnership, LLC, as amended, modified or supplemented from time to time in accordance with its terms.

Conversion Amount” means the sum of the Stated Value at issue.

Conversion Date” shall have the meaning set forth in Section 6(a).

Conversion Price” shall have the meaning set forth in Section 6(b).

Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance with the terms hereof.

2

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

Fundamental Transaction” shall have the meaning set forth in Section 7(d).

GAAP” means United States generally accepted accounting principles.

Holder” shall have the meaning given such term in Section 2.

Issuable Maximum” shall have the meaning set forth in Section 6(d).

Liquidation” shall have the meaning set forth in Section 5.

New York Courts” shall have the meaning set forth in Section 8(d).

Notice of Conversion” shall have the meaning set forth in Section 6(a).

Original Issue Date” means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred Stock.

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

Preferred Stock” shall have the meaning set forth in Section 2.

Securities” means the Preferred Stock, the Warrants, the Warrant Shares and the Underlying Shares.

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

Stated Value” shall have the meaning set forth in Section 2, as the same may be increased pursuant to Section 3.

Shareholder Approval” means such approval as may be required by the applicable rules and regulations of The Nasdaq Stock Market (or any successor entity) from the shareholders of the Corporation with respect to the transactions contemplated by the Transaction Documents (as defined in the Contribution Agreement), including the issuance of all of the Underlying Shares in excess of 19.99% of the issued and outstanding Common Stock on the Closing Date.

Subsidiary” means any subsidiary of the Corporation as set forth onSchedule 5.1 of the Contribution Agreement and shall, where applicable, also include any direct or indirect subsidiary of the Corporation formed or acquired after the date of the Contribution Agreement.

Successor Entity” shall have the meaning set forth in Section 7(d).

Trading Day” means a day on which the principal Trading Market is open for business.

3

Transfer Agent” means Broadridge Corporate Issuer Solutions the current transfer agent of the Corporation with a mailing address of 5 Dakota Drive, Suite 300, Lake Success, NY 11042 and any successor transfer agent of the Corporation.

Underlying Shares” means the shares of Common Stock issued and issuable upon conversion of the Preferred Stock and upon exercise of the Warrants.

Warrants” means, collectively, the Common Stock purchase warrants delivered to the Holder at the Optional Entity Interest Closing in accordance with Section 9.1(b) of the Contribution Agreement, which Warrants shall be exercisable according to the vesting schedule in the table set forth in Section 9.1(b)(ii) of the Contribution Agreement and have a term of exercise equal to five years, in the form ofExhibit K attached to the Contribution Agreement.

Warrant Shares” means the shares of Common Stock issuable upon exercise of the Warrants.

Section 2.        Designation, Amount and Par Value. The series of preferred stock shall be designated as its Series A Convertible Preferred Stock (the “Preferred Stock”) and the number of shares so designated shall be up to [_____________] (which shall not be subject to increase without the written consent of all of the holders of the Preferred Stock (each, a “Holder” and collectively, the “Holders”)). Each share of Preferred Stock shall have a par value of $0.01 per share and a stated value equal to $[______] (the “Stated Value”).

Section 3.        Dividends. Except for stock dividends or distributions for which adjustments are to be made pursuant to Section 7, Holders shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of Preferred Stock.

Section 4.        Voting Rights. Except as otherwise provided herein or as otherwise required by law, the Preferred Stock shall have no voting rights. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (c) increase the number of authorized shares of Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

Section 5.        Liquidation. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a “Liquidation”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation the same amount that a holder of Common Stock would receive if the Preferred Stock were fully converted (disregarding for such purposes any conversion limitations hereunder) to Common Stock which amounts shall be paidpari passu with all holders of Common Stock. The Corporation shall mail written notice of any such Liquidation, not less than 45 days prior to the payment date stated therein, to each Holder.

4

Section 6.               Conversion.

a)            Conversions at Option of Holder. Each share of Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to the limitations set forth in Section 6(d)) determined by dividing the Stated Value of such share of Preferred Stock by the Conversion Price. Holders shall effect conversions by providing the Corporation with the form of conversion notice attached hereto asAnnex A (a “Notice of Conversion”). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers by facsimile such Notice of Conversion to the Corporation (such date, the “Conversion Date”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued.

b)            Conversion Price. The conversion price for the Preferred Stock shall equal $[_____], subject to adjustment herein (the “Conversion Price”).

c)            Mechanics of Conversion.

i.            Delivery of Conversion Shares Upon Conversion. The Corporation shall, as soon as practicable after the Conversion Date (i) issue and deliver to such holder of Preferred Stock, or to his, her or its nominees, a certificate or certificates for the number of full shares of Common Stock issuable upon such conversion in accordance with the provisions hereof and a certificate for the number (if any) of the shares of Preferred Stock represented by the surrendered certificate that were not converted into Common Stock and (ii) pay in cash such amount as provided in Section 6(c)(iii) in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion.

5

ii.         Reservation of Shares Issuable Upon Conversion. The Corporation covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the Preferred Stock), not less than such aggregate number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Contribution Agreement) be issuable (taking into account the adjustments and restrictions of Section 7) upon the conversion of the then outstanding shares of Preferred Stock. The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.

iii.         Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion Price or round up to the next whole share.

iv.         Transfer Taxes and Expenses. The issuance of Conversion Shares on conversion of this Preferred Stock shall be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares.

6

d)            Issuance Limitations. Notwithstanding anything herein to the contrary, if the Corporation has not obtained Shareholder Approval, then the Corporation may not issue, upon conversion of the Preferred Stock, a number of shares of Common Stock which, when aggregated with any shares of Common Stock issued on or after the Original Issue Date and prior to such Conversion Date (i) to any party under the terms of the Contribution Agreement, (ii) in connection with any conversion of Preferred Stock issued pursuant to the Contribution Agreement, (iii) in connection with the exercise of any Warrants issued pursuant to the Contribution Agreement, (iv) in connection with the conversion of the Payout Notes (as defined in the Contribution Agreement), and (v) in connection with the exercise of any warrants issued to any registered broker-dealer as a fee in connection with the issuance of the Securities pursuant to the Contribution Agreement, would exceed [________]1 shares of Common Stock (subject to adjustment for forward and reverse stock splits, recapitalizations and the like) (such number of shares, the “Issuable Maximum”). Each Holder shall be entitled to a portion of the Issuable Maximum equal to the quotient obtained by dividing (x) the original Stated Value of such Holder’s Preferred Stock by (y) the aggregate Stated Value of all Preferred Stock issued on the Original Issue Date to all Holders. In addition, each Holder may allocate its pro-rata portion of the Issuable Maximum among Preferred Stock and Warrants held by it in its sole discretion. Such portion shall be adjusted upward ratably in the event a Holder no longer holds any Preferred Stock or Warrants and the amount of shares issued to such Holder pursuant to such Holder’s Preferred Stock and Warrants was less than such Holder’s pro-rata share of the Issuable Maximum. For avoidance of doubt, unless and until any required Shareholder Approval is obtained and effective, warrants issued to any registered broker-dealer as a fee in connection with the Securities issued pursuant to the Contribution Agreement as described in clause (iv) above shall provide that such warrants shall not be allocated any portion of the Issuable Maximum and shall be unexercisable unless and until such Shareholder Approval is obtained and effective.

Section 7.               Certain Adjustments.

a)            Stock Dividends and Stock Splits. If the Corporation, at any time while this Preferred Stock is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of, or payment of a dividend on, this Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 7(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

b)            Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 7(a) above, if at any time the Corporation grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder of will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder’s Preferred Stock (without regard to any limitations on exercise hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase.

1 19.99% of the number of shares of Common Stock outstanding on the Trading Day immediately preceding the date of the Contribution Agreement.

7

c)            Pro Rata Distributions. During such time as this Preferred Stock is outstanding, if the Corporation declares or makes any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Preferred Stock, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete Conversion of this Preferred Stock (without regard to any limitations on Conversion hereof) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution.

d)            Fundamental Transaction. If, at any time while this Preferred Stock is outstanding, (i) the Corporation, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii) the Corporation, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Corporation, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent conversion of this Preferred Stock, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section 6(d) on the conversion of this Preferred Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Corporation, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Preferred Stock is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 6(d) on the conversion of this Preferred Stock). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Corporation shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designation with the same terms and conditions and issue to the Holders new preferred stock consistent with the foregoing provisions and evidencing the Holders’ right to convert such preferred stock into Alternate Consideration. The Corporation shall cause any successor entity in a Fundamental Transaction in which the Corporation is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Corporation under this Certificate of Designation and the other Transaction Documents (as defined in the Contribution Agreement) in accordance with the provisions of this Section 7(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the holder of this Preferred Stock, deliver to the Holder in exchange for this Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Preferred Stock (without regard to any limitations on the conversion of this Preferred Stock) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation and the other Transaction Documents (as defined in the Contribution Agreement) referring to the “Corporation” shall refer instead to the Successor Entity), and may exercise every right and power of the Corporation and shall assume all of the obligations of the Corporation under this Certificate of Designation and the other Transaction Documents (as defined in the Contribution Agreement) with the same effect as if such Successor Entity had been named as the Corporation herein.

8

e)            Calculations. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.

f)             Notice to the Holders.

i.            Adjustment to Conversion Price. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

ii.         Notice to Allow Conversion by Holder. If (A) the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion of this Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Corporation, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Corporation or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Conversion Amount of this Preferred Stock (or any part hereof) during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

9

Section 8.               Miscellaneous.

a)            Notices. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service, addressed to the Corporation, at the address set forth above Attention: Secretary, facsimile number [________], e-mail address Mpupach@photomedex.com or such other facsimile number, e-mail address or address as the Corporation may specify for such purposes by notice to the Holders delivered in accordance with this Section 8(a). Any and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number or address of such Holder appearing on the books of the Corporation, or if no such facsimile number or address appears on the books of the Corporation, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.

b)            Absolute Obligation. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages and accrued dividends, as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.

c)            Lost or Mutilated Preferred Stock Certificate. If a Holder’s Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation.

10

d)              Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by any of the Transaction Documents (as defined in the Contribution Agreement) (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state and federal courts sitting in the City of New York, Borough of Manhattan (the “New York Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents (as defined in the Contribution Agreement)), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Certificate of Designation and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Certificate of Designation or the transactions contemplated hereby. If any party shall commence an action or proceeding to enforce any provisions of this Certificate of Designation, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

e)               Waiver. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designation or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designation on any other occasion. Any waiver by the Corporation or a Holder must be in writing.

f)               Severability. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law.

g)               Next Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

h)               Headings. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation and shall not be deemed to limit or affect any of the provisions hereof.

i)                Status of Converted or Redeemed Preferred Stock. Shares of Preferred Stock may only be issued pursuant to the Contribution Agreement. If any shares of Preferred Stock shall be converted, redeemed or reacquired by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series A Preferred Stock.

*********************

11

ANNEX A

NOTICE OF CONVERSION

(To be Executed by the Registered Holder in order to Convert Shares of Preferred Stock)

The undersigned hereby elects to convert the number of shares of Series A Convertible Preferred Stock indicated below into shares of common stock, par value $.01 per share (the “Common Stock”), of PhotoMedex, Inc. a Nevada corporation (the “Corporation”), according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto. No fee will be charged to the Holders for any conversion, except for any such transfer taxes.

Conversion calculations:

Date to Effect Conversion: ________________________________________________

Number of shares of Preferred Stock owned prior to Conversion: ___________________

Number of shares of Preferred Stock to be Converted: ___________________________

Stated Value of shares of Preferred Stock to be Converted: _______________________

Number of shares of Common Stock to be Issued: ______________________________

Applicable Conversion Price:______________________________________________

Number of shares of Preferred Stock subsequent to Conversion: ___________________

Address for Delivery: _______________________

or

DWAC Instructions:

Broker no: _________

Account no: ___________

[HOLDER]
By:
Name:
Title:

12

Exhibit C

Lock Up Agreement

LOCK-UP and resale restriction AGREEMENT

This lock-up and resale restriction agreement (the “Agreement”) is made and entered into the ____ day of ____________, 2017, by and among PhotoMedex, a Nevada corporation (the “Company”), First Capital Real Estate Trust Incorporated (“First Capital”) and the persons executing this Agreement (each a “Holder” and, collectively, the “Holders”).

RECITALS

 

A.       First Capital, First Capital Real Estate Operating Partnership, L.P.On October 12, 2017, the Company issued to Dolev Rafaeli, Dennis M. McGrath and Yoav Ben-Dror (each a “Note Holder” and, collectively the “Note Holders”) Secured Convertible Promissory Notes in the principal amounts of $3,133,934, $977,666 and $1,515,000, respectively (the “ContributorNotes”). Pursuant to the terms of the Notes, the principal was to convert to shares of the Company’s common stock, $0.01 par value per share (the “Common Stock”), at maturity at the lower of (i) the Per Share Price, which equated to a price of $2.5183 or (ii) the volume-weighted average price (“VWAP”) with respect to on-exchange transactions in the Company’s Common Stock executed on The Nasdaq Stock Market (“Nasdaq”) (or such other market on which the Company’s stock may then trade) during the thirty (30) trading days prior to the maturity date, as reported by Bloomberg L.P.; provided, however, that there was a conversion floor of $1.75 per share (the “Floor Price”).

B.       On December 22, 2017, the Company and the Note Holders entered into a stock grant agreement (the “Stock Grant Agreement”) to, among other things, cause the early conversion of the Notes into an aggregate of 5,628,291 shares of the Company’s Common Stock (the “Payout Shares”), resulting in a conversion price of $0.9997, which is less than the Floor Price. In addition, pursuant to the Stock Grant Agreement, the Company agreed to (i) issue an additional 1,857,336 shares of Common Stock to the Note Holders as consideration for the various agreements of the Note Holders contained in the Stock Grant Agreement (the “Additional Shares”), including the Note Holders’ agreement to give up their first priority security interest and convert the Notes to equity and (ii) provide the Note Holders with certain cash payments (the “Cash Payments”) in consideration for services to be provided by the Note Holders, in an amount equal to the amount of interest foregone by the Note Holders as a result of the conversion of the Notes.

C.        On December 22, 2017, the Company and OFI entered into a Securities Purchase Agreement (the “OFI Purchase Agreement”) pursuant to which OFI may invest up to $15,000,000 in the Company in a series of closings, in exchange for which OFI will receive shares of the Company’s Series B Preferred Stock at a purchase price of $1.00 per share. To date, the Company and OFI completed the three closing under the OFI Purchase Agreement, pursuant to which OFI provided, in the aggregate $3,825,000 to the Company in exchange for an aggregate of 3,825,000 shares of the Company’s Series B Preferred Stock.

D.       Pursuant to the terms of the Certificate of Designation for the Series B Preferred Stock (the “Series B Certificate of Designation”), the Series B Preferred Stock, which votes on an as-converted basis, was issued to OFI with a conversion price that constitutes a discount to the market price of the Common Stock at the date of issuance of the Series B Preferred Stock, resulting in the Series B Preferred Stock having a greater voting rights than the existing shares of Common Stock, which violates the Nasdaq Voting Rights rule. On April 20, 2018, the Company and FC Global Realty Operating Partnership, LLC (the “Acquiror”) haveOFI entered into a ContributionSupplemental Agreement dated March 31, 2017 (the “ContributionSupplemental Agreement”), pursuant to which the Contributor has(i) OFI agreed to contributelimit the voting power of the Series B Preferred Stock, to address this violation, and (ii) the parties thereto corrected a violation of the Listing Rules of The Nasdaq Stock Market that require approval from the Company’s stockholders prior to the Acquiror its interests in and to certain entities and real properties in exchange for certain securitiesissuance of Common Stock upon conversion of the Company. Capitalized terms used hereinSeries B Preferred Stock issued under the OFI Purchase Agreement that are in excess of 19.99% of the Company’s issued and not otherwise defined herein shall haveoutstanding Common Stock on the respective meanings set forthdate of initial issuance of the Series B Preferred Stock to OFI, which resulted from a provision in the Contribution Agreement.OFI Purchase Agreement that incorrectly stated that such percentage is to be calculated as of the applicable conversion date of the Series B Preferred Stock instead of the date of initial issuance thereof.


E.       The Company was notified by letter from Nasdaq dated April 10, 2018, that it is not in compliance with Nasdaq’s Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2.5 million in stockholders’ equity.

 

B.           Each Holder (i) is either an existing stockholder of the Company or, (ii) as a result of one or more of the Closings of the Transactions contemplated in the Contribution Agreement, has acquired securities of the Company.

C.           As a condition precedent to the Closing, each Holder is requiredF.       The parties hereto desire to enter into this Agreement and take all necessary steps contemplated by this Agreement in order to comply with Listing Rule 5550(b)(1) and address the Companyconcerns of the Staff of the Nasdaq regarding the shareholder approval violations described above.

G.       FC Global will hold a special meeting of its shareholders (the “Shareholders’ Meeting”) as soon as possible after the date hereof in order to obtain the approval of the FC Global shareholders (the “Shareholder Approval”) of this Agreement and First Capital.the transactions contemplated hereby, including, the conversion of the Series C Preferred Stock and the Series D Preferred Stock into Common Stock.

 

AGREEMENT

 

NOW, THEREFORE,, for good and valuable in consideration of the receipt and sufficiency of which is hereby acknowledged,mutual promises herein contained, the parties hereto, intending to be legally bound, hereby agree as follows:

 

1.        Restrictions on TransferUnwinding of Transactions with the Note Holders. No Holder shall, directly or indirectly, priorThe Company and the Note Holders hereby agree to the terminationfollowing:

(a)       Termination of this Agreement: the Stock Grant Agreement. Upon execution of the Agreement, the Stock Grant Agreement will automatically terminate and will be of no further force or effect and no party shall have any liability to any other party arising thereunder.

(b)       Cancellation of the Payout Shares.

(i)        transfer, assign, sell, lend, sell short, gift-over, pledge, encumber, hypothecate, exchangeEach of the Note Holders hereby agrees to surrender to the Company the Payout Shares issued to it under the Stock Grant Agreement free and clear of all claims, charges, liens, contracts, rights, options, security interests, mortgages, encumbrances and restrictions of every kind and nature, in each case, to the extent incurred by each of the Note Holders or otherwise dispose (whether by sale, liquidation, dissolution, dividend or distribution), or offer or solicit to do any of the foregoing, of any or allits assignees (collectively, “Claims”) for cancellation concurrently with, and against delivery of, the equity securities and/orissuance of Series C Preferred Stock pursuant to Section 1(c) hereof (it being acknowledged that any debt or similar securities that are convertible into equity securitiesrights of the Company held by him, herto or it, including any additional equity securities and/or any debt or similar securities that are convertible into equity securities of the Company which Holder may subsequently acquire, including all additional equity securities which may be issued to Holder upon the exercise of any options, warrants or other securities convertible into or exchangeable for securities of the Company (all such securities of such Holder, “Subject Securities”) or any right or interest therein, or consentwith respect to any of the foregoing (anyPayout Shares other than under this Agreement shall not be a Claim). After such action, a “Transfer”), (ii) entercancellation and receipt of the Series C Preferred Stock by each of the Note Holders or offer to enter into any derivative arrangementits assignees, each of the Note Holders acknowledges and agrees that all such Payout Shares shall no longer be outstanding, and each of the Note Holders shall have no further rights with respect to the Payout Shares or createthe equity ownership in the Company represented thereby.


(ii)       Each of the Note Holders hereby represents and warrants that such Note Holder owns the Payout Shares issued to it under the Stock Grant Agreement beneficially and of record, free and clear of all Claims other than Claims in favor of the Company or sufferany assignee of the Company under this Agreement or otherwise. Each Note Holder has never transferred or agreed to existtransfer its Payout Shares, other than pursuant to this Agreement. There is no restriction affecting the ability of each Note Holder to transfer the legal and beneficial title and ownership of its Payout Shares to the Company for cancellation other than restrictions, if any, liensin favor of the Company or encumbrancesany assignee of the Company. Neither the execution and delivery of this Agreement, the consummation of the transactions contemplated hereby, nor the performance of this Agreement in compliance with its terms and conditions by each Note Holder will conflict with or result in any violation of any agreement, judgment, decree, order, statute or regulation applicable to such Note Holder, or any breach of any agreement to which such Note Holder is a party, or constitute a default thereunder, or result in the creation of any Claim of any kind or nature on, or with respect to the such Note Holder or its assets.

(iii)       At the request of the Company and without further consideration, each Note Holder will execute and deliver such other instruments of sale, transfer, conveyance, assignment and confirmation as may be reasonably requested in order to effectively transfer, convey and assign to the Company for cancellation its Payout Shares.

(c)       Issuance of Series C Preferred Stock. Upon the execution of this Agreement, the Company shall issue to the Note Holders, in the aggregate, a total of 7,485,627 shares of newly-designated Series C Preferred Stock in such amounts as set forth inExhibit A hereto (the “Series C Shares”). The Series C Preferred Stock has the rights, preferences, and limitations specified in the Certificate of Designation of the Series C Preferred Stock in the form attached hereto asExhibit B. The Series C Preferred Stock will automatically convert into 7,485,627 shares of the Company’s Common Stock upon Shareholder Approval being obtained.

(d)       Resignations of Dr. Dolev Rafaeli and Mr. Dennis McGrath. Section 5 of the Stock Grant Agreement provided for the resignations of Dr. Dolev Rafaeli and Mr. Dennis McGrath effective upon certain events as described therein. Notwithstanding the termination of the Stock Grant Agreement as provided for in Section 1(a) above, Dr. Dolev Rafaeli and Mr. Dennis McGrath agree that such resignation will survive the termination of the Stock Grant Agreement, but become effective upon the last to occur of (i) receipt of all of the shares of Common Stock underlying the Series C Shares and (ii) the date that the shares of Common Stock underlying the Series C Shares are registered for re-sale in accordance with the Registration Rights Agreement (as defined below). Dr. Dolev Rafaeli and Dennis McGrath hereby represent and warrant to the Company that their resignation is not the result of any disagreement that either of them has with the Company or the Board of Directors regarding the Company’s financial or accounting policies or operations.

2.        Unwinding of Transactions with OFI. The Company and OFI hereby agree to the following:

(a)       Termination of the OFI Purchase Agreement and the Supplemental Agreement.

(i)        Subject to Section 2(a)(ii) below, upon execution of the Agreement, the OFI Purchase Agreement will automatically terminate and will be of no further force or effect, including, without limitation, OFI’s option under the OFI Purchase Agreement to purchase additional shares of Series B Preferred Stock and no party shall have any liability to any other party arising thereunder.

(ii)       Notwithstanding Section 2(a)(i) above, the representations and warranties (the “Reps and Warranties”) contained in Article 3 of the OFI Purchase Agreement and the indemnification provisions contained in Article 6 of the OFI Purchase Agreement, are hereby incorporated by reference into this Agreement as if set forth in full herein. The Reps and Warranties are being made as of the date hereof and subject to the exceptions to such Reps and Warranties set forth on a disclosure schedule to be provided by the Company.


(iii)      Upon execution of the Agreement, the Supplement Agreement will automatically terminate and will be of no further force or effect and no party shall have any liability to any other party arising thereunder.

(b)       Cancellation of the Series B Stock.

(i)        OFI hereby agrees to surrender to the Company the Series B Preferred Stock issued to OFI under the OFI Purchase Agreement free and clear of all Claims for cancellation concurrently with, and against delivery of, the issuance of Series D Preferred Stock pursuant to Section 2(c) hereof (it being acknowledged that any rights of the Company to or with respect to any or all of the Subject Securities or any right or interest therein, in either case that would reasonablySeries B Preferred Stock other than under this Agreement shall not be expected to prevent or delaya Claim). After such Holder’s compliance with his, hercancellation and receipt of the Series D Preferred Stock by OFI or its obligations hereunder; or (iii) enter of offer to enter into any contract, option or other agreement, arrangement or understanding with respect to any Transfer.

2.          Stop Transfer Orders.Each Holder herebyassignees, OFI acknowledges and agrees that all such Series B Preferred Stock shall no longer be outstanding, and OFI shall have no further rights with respect to the Series B Preferred Stock or the equity ownership in the Company represented thereby.

(ii)        OFI hereby represents and warrants that OFI owns the Series B Preferred Stock beneficially and of record, free and clear of all Claims other than Claims in favor of the Company or any assignee of the Company under this Agreement or otherwise. OFI has never transferred or agreed to transfer the Series B Preferred Stock, other than pursuant to this Agreement. There is no restriction affecting the ability of OFI to transfer the legal and beneficial title and ownership of the Series B Preferred Stock to the Company for cancellation other than restrictions, if any, in favor of the Company or any assignee of the Company. Neither the execution and delivery of this Agreement, the consummation of the transactions contemplated hereby, nor the performance of this Agreement in compliance with its terms and conditions by OFI will conflict with or result in any violation of any agreement, judgment, decree, order, statute or regulation applicable to OFI, or any breach of any agreement to which OFI is a party, or constitute a default thereunder, or result in the creation of any Claim of any kind or nature on, or with respect to OFI or its assets.

(iii)       At the request of the Company and without further consideration, OFI will execute and deliver such other instruments of sale, transfer, conveyance, assignment and confirmation as may be reasonably requested in order to effectively transfer, convey and assign to the Company for cancellation the Series B Preferred Stock.

(c)       Issuance of Series D Preferred Stock. On the date hereof, the Company shall be entitled, duringissue to OFI a total of 6,217,490 shares of newly-designated Series D Preferred Stock. The Series D Preferred Stock has the termrights, preferences, and limitations specified in the Certificate of this Agreement, to cause any transfer agent for the Subject Securities to decline to effect any Transfer and to note stop transfer restrictions on the stock register and other records relating to Subject Securities, and each Holder agrees to execute and deliver any further documents reasonably requested by the Company in furtheranceDesignation of the same.Series D Preferred Stock in the form attached hereto asExhibit C. The Series D Preferred Stock will automatically convert into shares of the Company’s Common Stock upon Shareholder Approval being obtained.

 

3.          (d)       Permitted Transfers. Notwithstanding the foregoing, the restrictions set forth herein shall not apply to the following Transfers of Subject Securities by a Holder:

a.           if such Holder is an individual (A) for nominal consideration or as a gift to any member of such Holder’s “immediate family” (defined for purposes of this Agreement as the spouse, parents, lineal descendants, the spouse of any lineal descendant,Purchase and brothers and sisters) or a trust for the benefit of such Holder or any member of such Holder’s immediate family, or (B) upon the death of such Holder pursuant to a will or other instrument taking effect upon the death of such Holder, or pursuant to the applicable laws of descent and distribution to such Holder’s estate, heirs or distributees; and

b.           if the Holder is a corporation, partnership, limited liability company or other entity, any Transfer to an AffiliateSale of the Holder if such Transfer is not for value;

provided, however, that in the case of any Transfer described in clauses (a) or (b) above, it shall be a conditionAdditional Series D Preferred Stock. Subject to the Transfer that (x) the transferee executes and delivers to the Company, not later than one business day prior to such Transfer, a written agreement that is reasonably satisfactory in form and substance to the Company to be bound by all of the terms of this Agreement and the Contribution Agreement (any references to immediate family in the agreement executed by such transferee shall expressly refer only to the immediate family of the Holder and not to the immediate family of the transferee) and (y) if the Holder is required to file a report under Section 16(a) of the Securities Exchange Act of 1934, as amended, reporting a reduction in beneficial ownership of the Subject Securities or any securities convertible into or exercisable or exchangeable for the Subject Securities, the Holder shall include a statement in such report to the effect that, in the case of any Transfer pursuant to (i) above, such Transfer is being made as a gift or by will or intestate succession or, in the case of any Transfer pursuant to (ii) above, such Transfer is being made to a shareholder, partner or member of, or owner of a similar equity interest in, the Holder and is not a Transfer for value.

c.           For purposes hereof, “Affiliate” shall mean, with respect to any entity, any other person or entity directly or indirectly controlling, controlled by or under common control with such entity. For purposes hereof, “control” (including the terms “controlled by” and “under common control with”), as used with respect to any entity or person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such entity or person, whether through the ownership of voting securities or otherwise.

4.          Transfers in Violation Void. Any attempted sale, transfer or other disposition in violation of this Agreement shall be null and void.

2

5.          Binding Effect; Waiver. This Agreement shall be binding upon the Holder, its agents, heirs, successors, assigns and beneficiaries. Any waiver by the Company of any of the terms and conditions of this Agreement, on the last day of each month, commencing on September 30, 2018, OFI shall purchase from the Company $100,000 of shares of Series D Preferred Stock for a purchase price of $0.65 per share. OFI shall continue to purchase $100,000 of shares, at a purchase price of $0.65 per share, each month until it has purchased an aggregate of $500,000 of shares of Series D Preferred Stock (not including the shares issued pursuant to Section 2(c) above) (collectively, the “Series D Shares”); provided that, upon closing of any material business combination involving the Company that is approved by OFI, OFI shall purchase an additional $1,500,000 of shares of Series D Preferred Stock at a purchase price of $0.65. Notwithstanding the foregoing, from and after the date that Shareholder Approval has been obtained, instead of purchasing Series D Shares for $0.65 per share pursuant to this Section 2(d), OFI shall be required to purchase shares of Common Stock at a price of $0.65 per share. Each purchase and sale of Series D Shares, or shares of Common Stock, as applicable, contemplated by this Section 2(d) (each, a “Closing”) shall be subject to the following conditions:


(i)        The representations and warranties of OFI contained in this Agreement shall be true and correct as of the date when made and as of the Closing as though made on and as of such date.

(ii)        OFI shall have performed, satisfied and complied with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by it at or prior to the Closing.

(iii)       The representations and warranties of the Company contained in this Agreement and the Reps and Warranties incorporated by reference herein pursuant to Section 2(a)(ii) shall be true and correct as of the date when made and as of the Closing as though made on and as of such date.

(iv)       The Company shall have performed, satisfied and complied with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by it at or prior to the Closing.

(v)       No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any instance mustcourt or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by this Agreement.

(vi)       Since the date of execution of this Agreement, no event or series of events shall have occurred that reasonably could have or result in a Material Adverse Effect (as defined in the OFI Purchase Agreement) or a material adverse change with respect to the Company or its subsidiaries.

(vii)      The Company shall have obtained any and all consents, permits, approvals, registrations and waivers necessary or appropriate for consummation of the purchase and sale of the Series D Shares or shares of Common Stock, as applicable, all of which shall be in full force and effect.

(viii)     At each Closing, the Company shall have delivered (A) a stock certificate for the requisite number of Series D Shares or shares of Common Stock, as applicable, to be delivered to OFI at such Closing and (B) a certificate executed on behalf of the Company by its Chief Executive Officer or its Chief Financial Officer, dated as of the applicable Closing, certifying to the fulfillment of the conditions specified in Sections 2(d)(iii) to 2(d)(vii).

(ix)       At each Closing, OFI shall have delivered payment for the requisite number of Series D Shares or shares of Common Stock, as applicable, in United States dollars and in immediately available funds, by wire transfer to the account designated in writing by the Company for such purpose.


3.        Termination of Additional Agreements.

(a)       Termination of Voting Agreement. Upon the execution of the Agreement, the Shareholder Voting Support and mustConfidentiality Agreement, dated as of December 22, 2017 (and any amendments thereto), by and among the Note Holders and the Securityholders (as defined therein) will automatically terminate and will be duly executedof no further force or effect and no party shall have any liability to any other party arising thereunder.

(b)       Termination of Voting Agreement. Upon execution of the Agreement, the Shareholder Voting Support and Confidentiality Agreement, dated as of December 22, 2017 (and any amendments thereto), by and among OFI and the Securityholders (as defined therein) will automatically terminate and will be of no further force or effect and no party shall have any liability to any other party arising thereunder.

(c)       Exchange and Cancellation Agreement. Upon execution of the Agreement, the Exchange and Cancellation Agreement, dated as of April 20, 2018 (and any amendments thereto), by and among the Company and OFI will automatically terminate and will be of no further force or effect and no party shall have any liability to any other party arising thereunder.

(d)       Registration Rights Agreements. Upon the execution of the Agreement, (i) the Registration Rights Agreement, dated as of December 22, 2017 (and any amendments thereto) by and between the Company and OFI and (ii) the Registration Rights Agreement, dated as of December 22, 2017 (and any amendments thereto) by and between the Company and the HolderNote Holders will each automatically terminate and will be of no further force and effect and no party shall not be deemed or construedhave any liability to be a waiver of such term or condition for the future, or of any subsequent breach thereof.other party arising thereunder.

 

6.          4.        TerminationServices Agreements. ThisConcurrent with the entry into this Agreement, and all rights and obligationsthe Company is entering into a services agreement with each of the parties hereunder, shall terminateNote Holders on the first anniversaryterms specified therein, pursuant to which the support services previously provided by each of the Approval Date or sooner uponNote Holders under the consentStock Grant Agreement will continue in exchange for cash compensation from the Company as specified in such agreements; provided, however, that such cash payments will be directly tied to the nature and amount of the Companyservices being provided by the Note Holders, and First Capital.provided further, that such services agreements will be approved by the non-interested members of the Company’s board of directors.

 

7.          5.        MiscellaneousRegistration Rights Agreement. FacsimileUpon execution and delivery of this Agreement, is legal, validthe Company will enter into a registration rights agreement with the Note Holders and binding execution and delivery for all purposes. This AgreementOFI in the form attached hereto asExhibit D.


6.        Shareholder Approval.

(a)       Proxy Statement.

(i)       The Company shall not confer any rights or remedies upon any person other than the parties and their respective successors and permitted assigns. This Agreement (including the documents referred to herein) constitutes the entire agreement among the Parties and supersedes any prior understandings, agreements, or representations by or among the Parties, written or oral, to the extent they relatedprepare in any way to the subject matter hereof. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together will constitute oneconsultation with OFI and the same instrument. The Section headings contained in this Agreement are inserted for convenience onlyNote Holders, and shall not affect in any way the meaning or interpretation of this Agreement. This Agreement shall be governed by and construed in accordancefile with the laws ofSecurities and Exchange Commission (the “SEC”) a preliminary proxy statement relating to (i) the State of New York without regard to principles of conflicts of laws. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. Each of the parties will bear his or its own costs and expenses (including legal fees and expenses) incurred in connection with this Agreement and the transactions contemplated hereby. Each arty acknowledgesthereby and agrees that the other party would be damaged irreparably in the event any(ii) conversion of the provisionsSeries C Preferred Stock and the Series D Preferred Stock (a “Proxy Statement”) promptly after the date of this Agreement are not performed(and in accordance with their specific terms or otherwise are breached. Accordingly, each party agrees thatno event later than thirty (30) days after the other party shall be entitled to an injunction or injunctions to prevent breaches of the provisions of this Agreementdate hereof) and to enforce specifically this Agreement and the terms and provisions hereof in any action instituted in any court of the United States or any state thereof having jurisdiction over the Parties and the matter, in addition to any other remedy to which they may be entitled, at law or in equity.use its reasonable best efforts to:

 

[Signature page follows]

3

IN WITNESS WHEREOF,(A)      obtain and furnish the undersigned have duly executed and delivered this Agreement as ofinformation required to be included by the day and year first above written.

Photomedex, Inc.
By:
Name:
Title:
First Capital Real Estate Trust Incorporated
By:
Name:
Title:

HOLDERS:
Lewis C. Pell
Yoav Ben-Dror
Dolev Rafaeli
Dennis M. McGrath
Katsumi Oneda
Stephen P. Connelly

First Capital Real Estate Investments LLC
By:
Name:
Title:
FC Borrower LLC
By:
Name:
Title:

Exhibit DSEC in the preliminary Proxy Statement;

 

Registration Rights Agreement

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is(B)       respond promptly to any comments made and entered into as of _____________, 2017, between PhotoMedex, Inc., a Nevada corporation (the “Company”), and each ofby the several parties signatory hereto that will become holders of the registration rights granted hereunder (each such holder, a “Holder” and, collectively, the “Holders”).

This Agreement is made pursuant to the Contribution Agreement, dated as of March 31, 2017, among the Company, First Capital Real Estate Trust Incorporated (“FCREIT”), First Capital Real Estate Operating Partnership, L.P., FC Global Realty Operating Partnership, LLC, and each Holder (the “Contribution Agreement”).

The Company and each Holder hereby agrees as follows:

1.            Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Contribution Agreement shall have the meanings given such terms in the Contribution Agreement. As used in this Agreement, the following terms shall have the following meanings:

Advice” shall have the meaning set forth in Section 6(d).

Effectiveness Date” means,SEC or its staff with respect to the Initial Registration Statement required to be filed hereunder, the 120th calendar day following the date hereof (or, in the event of a “full review” by the Commission, the 150th calendar day following the date hereof) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the 120th calendar day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of a “full review” by the Commission, the 150th calendar day following the date such additional Registration Statement is required to be filed hereunder);provided,however, that in the event the Company is notified by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day.

Effectiveness Period” shall have the meaning set forth in Section 2(a).

Event” shall have the meaning set forth in Section 2(d).

Event Date” shall have the meaning set forth in Section 2(d).

Filing Date” means, with respect to the Initial Registration Statement required hereunder, the 60th calendar day following the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable Securities.

Holder” or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

Indemnified Party” shall have the meaning set forth in Section 5(c).preliminary Proxy Statement;

 


Indemnifying Party” shall have the meaning set forth in Section 5(c).

Initial Registration(C)       cause a definitive Proxy Statement” means the initial Registration Statement filed pursuant to this Agreement.

Losses” shall have the meaning set forth in Section 5(a).

Plan of Distribution” shall have the meaning set forth in Section 2(a).

Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes (together with any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemedthereto) to be incorporated by reference in such Prospectus.

Registrable Securities” means, as of any date of determination, (a) all Transaction Shares, including, without limitation, any Transaction Shares that the Contributor Parties instruct the Acquiror Parentmailed to deliver to Maxim Group LLC instead of to the Contributor Parties, (b) all Warrant Shares, and (c) any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing;provided, however, that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders, as reasonably determined by the Company, upon the advice of counsel to the Company.

Registration Statement” means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in any such registration statement.

Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

Selling Stockholder Questionnaire” shall have the meaning set forth in Section 3(a).

2

SEC Guidance” means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission staff and (ii) the Securities Act.

Warrant Shares” means all shares of Acquiror Parent Common Stock issuable upon exercise of the Warrants (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein) held by the Holders.

2.            Shelf Registration.

(a)          On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all or such maximum portion of the Registrable Securities as permitted by SEC Guidance (provided that, the Company shall use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, the Manual of Publicly Available Telephone Interpretations D.29) that are not then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on S-3, as appropriate (except if the Company is not then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in accordance herewith, subject to the provisions of Section 2(d)) and shall contain (unless otherwise directed by at least 85% in interest of the Holders) substantially the “Plan of Distribution” attached hereto asAnnex A and substantially the “Selling Stockholder” section attached hereto asAnnex B. Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) (A) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and (B) (I) may be sold without the requirement for the Company to be in compliance with the current public information requirement under Rule 144 or (II) the Company is in compliance with the current public information requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the “Effectiveness Period”). The Company shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. Eastern Time on a Trading Day. The Company shall promptly notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 5:00 p.m. Eastern Time on the second Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).

(b)          Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary offering, subject to the provisions of Section 2(d)), with respect to filing on Form S-3 or other appropriate form;provided,however, that prior to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.

3

(c)          Notwithstanding any other provision of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater portion of Registrable Securities), the number of Registrable Securities and other shares of the Company’s Common Stock to be registered on such Registration Statement, including the shares issuable upon conversion of the Payout Notes (the “Other Shares”) will be reduced on a pro rata basis based upon the number of Registrable Securities or Other Shares held by the Holders or the holders of the Other Shares. In the event of a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder’s allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended.

(d)          If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3shareholders as soon as such form is available, provided thatreasonably practicable containing all information required under applicable law to be furnished to the Company shall maintain the effectiveness of the Registration Statement thenCompany’s shareholders in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.

3.            Registration Procedures. In connection with the Company’s registration obligations hereunder,matters to be approved by the Company shall: Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the filing of any related Prospectus or any amendmentshareholders;

(D)       promptly amend or supplement thereto (including any document that would be incorporated or deemed to be incorporated thereininformation provided by reference), the Company shall (i) furnish to FCREIT copies of all such documents proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of FCREIT, and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary,it for use in the reasonable opinion of respective counsel to FCREIT, to conduct a reasonable investigation within the meaning of the Securities Act. The Company shall not file a Registrationpreliminary or definitive Proxy Statement or any such Prospectus or(including any amendments or supplements thereto to which FCREIT shall reasonably object in good faith, provided that, the Company is notified of such objection in writing no later than five (5) Trading Days after FCREIT has been so furnished copies of a Registration Statement or one (1) Trading Day after FCREIT have been so furnished copies of any related Prospectus or amendments or supplements thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement asAnnex B (a “Selling Stockholder Questionnaire”) on a date that is not less than two (2) Trading Days prior to the Filing Date or by the end of the fourth (4th) Trading Day following the date on which such Holder receives draft materials in accordance with this Section.

4

(a)          (i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to FCREIT true and complete copies of all correspondence fromthereof) if and to the Commission relatingextent that it shall have become false or misleading in any material respect and take all steps necessary to a Registration Statement (provided that,cause the Company may excise any information contained therein which would constitute material non-public information as to FCREIT if it has not executed a confidentiality agreement with respect thereto with the Company or its Subsidiaries), and (iv) comply in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition by the Holders thereof set forth in such RegistrationProxy Statement as so amended or in such Prospectus as so supplemented.

(b)          If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable Securities.

(c)          Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposedsupplemented to be filed (B) whenwith the Commission notifiesSEC and to be disseminated to the Company whether there will be a “review”Company’s shareholders, in each case as and to the extent required by applicable United States federal securities laws; and

(E)       cause the preliminary and definitive Proxy Statements, on each relevant filing date, on the date of such Registration Statementmailing to the Company’s shareholders and wheneverat the Commission comments in writing on such Registration Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, (iii)time of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification with respectShareholders’ Meeting, not to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they wereare made, not misleading, and (vi)cause the Proxy Statement to comply as to form in all material respects with the provisions of the occurrence or existenceSecurities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules and regulations promulgated thereunder.

(b)       Meeting of Company Shareholders. The Company shall take all action reasonably necessary in accordance with Nevada law and the Company’s articles of incorporation and bylaws to establish a record date, duly call, give notice of, convene and hold the Shareholders’ Meeting reasonably promptly after the date of any pending corporate development with respectSEC comments on the Proxy Statement have been resolved and the final Proxy Statement is otherwise ready for dispatch and, in connection therewith, the Company shall mail the Proxy Statement to the Company’s shareholders in advance of such meeting. The Proxy Statement shall include the board recommendation of the Company that shareholders approve the proposals coming before them at the Shareholders’ Meeting, and the Company believes may be material and that, in the determination of the Company, makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus, provided that, any and all of such information shall remain confidential to each Holder until such information otherwise becomes public, unless disclosure by a Holder is required by law; provided, further, that notwithstanding each Holder’s agreement to keep such information confidential, each such Holder makes no acknowledgement that any such information constitutes material, non-public information.

5

(d)          Use itswill use reasonable best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness of a Registration Statement, or (ii) any suspensionsolicit from its shareholders proxies in favor of the qualification (or exemption from qualification)adoption of anyproposals coming before the Shareholders’ Meeting and to take all other actions necessary or advisable to pursue the vote or consent of its shareholders, including such actions as are required by the rules and regulations of the Registrable Securities for sale inNadaq or Nevada law or any jurisdiction, at the earliest practicable moment.

(e)          Furnishother applicable laws to each Holder, without charge, at least one conformed copy of eachobtain such Registration Statement and each amendment thereto, including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission; provided, that any such item which is available on the EDGAR system (or successor thereto) need not be furnished in physical form.

(f)          Subject to the terms ofapprovals. Unless this Agreement the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).

(g)          Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of such Registrable Securities for the resaleis terminated by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that,parties hereto, the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such jurisdiction.

(h)          If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by the Contribution Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holder may request.

(i)          Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use of such Prospectus. The Company will use itsreasonable best efforts to ensure that the use of the Prospectus may be resumed as promptly asany Shareholders’ Meeting (including any adjournment or postponement thereof) is practicable. The Company shall be entitled to exercise its right under this Section 3(j) to suspend the availability of a Registration Statementcalled, noticed, convened, held and Prospectus for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.

6

(j)          Otherwise use commercially reasonable efforts to comply withconducted, and that all applicable rules and regulations of the Commission under the Securities Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Holders are required to deliver a Prospectusproxies solicited by it in connection with the Shareholders’ Meeting (including any dispositionadjournment or postponement thereof) are solicited, in compliance with Nevada law, the Company’s articles of Registrable Securitiesincorporation and take such other actions as may be reasonably necessary to facilitatebylaws, the registrationrules of the Registrable Securities hereunder.

(k)          The Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration of the resale of Registrable Securities.

(l)          The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially owned by such HolderNasdaq and if required by the Commission, the natural persons thereof that have voting and dispositive control over the shares.all other applicable laws.

 

4.            7.        Registration ExpensesRepresentations and Warranties of the parties. All feesEach party to this Agreement represents and expenses incidentwarrants to the performance of or compliance with,other parties to this Agreement as follows:

(a)       If such party is an entity, it is validly existing and in good standing under the laws of its jurisdiction of incorporation or formation, as applicable, and has the requisite power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated by this Agreement.


(b)       The execution, delivery and performance by such party and the consummation by such party of the transactions contemplated hereby have been duly authorized by all necessary action on the part of such party and no other action is necessary on the part of such party to authorize this Agreement or to consummate the transactions contemplated hereby.

(c)       This Agreement has been duly executed and delivered by such party and, assuming the due authorization, execution and delivery by the Company shall be borneother parties, constitutes a legal, valid and binding obligation of such party, enforceable against such party in accordance with its terms, except as limited by (i) bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws relating to creditors’ rights generally and (ii) general principles of equity, whether such enforceability is considered in a proceeding in equity or at law.

(d)       Neither the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The feesexecution and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expensesdelivery of the Company’s counsel and independent registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection withthis Agreement, nor the consummation of the transactions contemplated hereby, will conflict with, result in a breach of, constitute a default under, result in the acceleration of, create in any party the right to accelerate, terminate, modify or cancel, or require any notice under any agreement, contract, lease, license, instrument or other arrangement to which the party making representations hereunder is a party or by this Agreement. In addition, the Company shall be responsible for allwhich it is bound or to which any of its internal expenses incurredassets is subject.

(e)       The execution and delivery of this Agreement by such party does not, and the performance of this Agreement by such party will not, require any consent, approval, authorization or permit of, or filing with or notification to, any governmental entity.

8.        Further Action. Subject to the terms and conditions of this Agreement, each of the parties will take all such reasonable and lawful action as may be necessary or appropriate in connection with the consummation oforder to effectuate the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchangeagreements attached hereto as required hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.exhibits as promptly as practicable.

 

7

5.            9.        IndemnificationGoverning Law; Miscellaneous.

 

(a)       Indemnification byGoverning Law; Dispute Resolution. In the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a resultevent of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) receipt of written notice from the Company in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(d). The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities bydispute between any of the Holdersparties arising under or relating in any way whatsoever to this Agreement, the disputing parties shall attempt to resolve it through good faith negotiation. If the dispute is not resolved through such negotiation, then the disputing parties shall attempt to resolve it through mediation in the State of New York, USA, with a neutral, third-party mediator mutually agreed upon by the disputing parties. Unless otherwise agreed by the disputing parties, the costs of mediation shall be shared equally. If the dispute is not resolved through mediation, then upon written demand by one of the disputing parties it shall be referred to a mutually agreeable arbitrator. The arbitration process shall be conducted in accordance with Section 6(h).the laws of the United States of America and the State of New York, except as modified herein. Venue for the arbitration hearing shall be the State of New York, USA. All remedies, legal and equitable, available in court shall also be available in arbitration. The arbitrator’s decision shall be final and binding, and judgment may be entered thereon in a court of competent jurisdiction. This Agreement shall be interpreted and enforced in accordance with the laws of the United States of America and the State of New York, without regard to conflict of law principles thereof.

 

(b)       Indemnification by HoldersCounterparts. Each HolderThis Agreement may be executed in two or more counterparts, each of which shall severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaningbe deemed an original, but all of Section 15 of the Securities Act and Section 20 of the Exchange Act),which together shall constitute one and the directors, officers, agentssame instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or employeesany electronic signature complying with the U.S. federal ESIGN Act of such controlling Persons,2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.


(c)       Headings; Interpretation. The headings of this Agreement are for convenience of reference and shall not form a part of, or affect the interpretation of, this Agreement. As used herein, unless the context clearly requires otherwise, the words “herein,” “hereunder” and “hereby” shall refer to the fullest extent permitted by applicable law, fromentire Agreement and against all Losses, as incurred, to the extent arising out of or based solely upon: (x) such Holder’s failure to comply with the prospectus delivery requirements of the Securities Act or (y) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (i) to the extent, but only to the extent, thatSection or paragraph in which such untrue statementword appears. If any date specified herein falls upon a Saturday, Sunday or omission is contained in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus, (ii) to the extent, but only to the extent, that such information relates to such Holder’s information providedlegal holiday in the Selling Stockholder Questionnairestate of Nevada, the date shall be construed to mean the next business day following such Saturday, Sunday or the proposed methodlegal holiday. For purposes of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use inthis Agreement, a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose), such Prospectus“business day” is any day other than a Saturday, Sunday or in any amendment or supplement thereto, or (iii)legal holiday in the casestate of an occurrenceNew York. Each Party intends that this Agreement be deemed and construed to have been jointly prepared by the parties. As a result, the parties agree that any uncertainty or ambiguity existing herein shall not be interpreted against any of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(d). In no event shall the liability of a selling Holder be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.them.

 

8

(c)(d)       Conduct of Indemnification ProceedingsSeverability. If any Proceedingprovision of this Agreement shall be broughtinvalid or asserted againstunenforceable in any Person entitledjurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other jurisdiction.

(e)       Entire Agreement; Amendments. This Agreement and the exhibits, schedules and other appendices hereto contain the entire understanding of the parties with respect to indemnitythe matters covered herein and supersede all prior agreements, negotiations and understandings, written or oral, with respect to such subject matter, including, without limitation, the agreements being terminated hereby. Except as specifically set forth herein, none of the parties makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement shall be waived or amended other than by an instrument in writing signed by each of the parties hereto. No delay or omission of any party hereto in exercising any right or remedy hereunder (an “Indemnified Party”),shall constitute a waiver of such Indemnified Partyright or remedy, and no waiver as to any obligation shall promptly notifyoperate as a continuing waiver or as a waiver of any subsequent breach.

(f)       Reliance. The parties acknowledge and represent that: (i) they have read the Person from whom indemnity is sought (the “Agreement; (ii) they clearly understand the Agreement and each of its terms; (iii) they fully and unconditionally consent to the terms of this Agreement; (iv) they have had the benefit and advice of counsel of their own selection; (v) they have executed this Agreement, freely, with knowledge, and without influence or duress; (vi) they have not relied upon any other representations, either written or oral, express or implied, made to them by any person; and (vii) the consideration received by them has been actual and adequate.

(g)       Indemnifying PartyNotices”). Any notices required or permitted to be given under the terms of this Agreement shall be in writing and sent by U. S. Mail or delivered personally or by overnight courier or via facsimile or e-mail (if via facsimile or e-mail, to be followed within one (1) business day by an original of the Indemnifying Partynotice document via overnight courier) and shall havebe effective (i) five (5) business days after being placed in the rightmail, if sent by registered mail, return receipt requested, (ii) upon receipt, if delivered personally, (iii) upon delivery by facsimile or e-mail (if received between 8:00 a.m. and 5:00 p.m. ET; otherwise delivery shall be considered effective the following business day) or (iv) one (1) business day after delivery to assume the defense thereof, including the employment of counsel reasonably satisfactorya courier service for overnight delivery, in each case properly addressed to the Indemnified Party andparty to receive the payment of all fees and expenses incurred in connection with defense thereof; provided, that,same. The addresses for such communications shall be as specified on the failuresignature page hereto. Each party shall provide written notice to the other parties of any Indemnified Party to give such noticechange in address.


(h)       Successors and Assigns. This Agreement shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only)be binding upon and inure to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially and adversely prejudiced the Indemnifying Party.

An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expensebenefit of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereofparties and the reasonable feestheir respective successors and expenses ofpermitted assigns;provided,however, that no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected withoutparty may assign its written consent, which consent shall not be unreasonably withheldrights hereunder or delayed. No Indemnifying Party shall,delegate its duties hereunder without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.other parties hereto.

 

Subject to(i)       No Third Party Beneficiaries. This Agreement is intended for the termsbenefit of the parties hereto and their respective successors and permitted assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other individual or entity.

(j)       Remedies. No provision of this Agreement all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expensesproviding for any specific remedy to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section)party shall be paidconstrued to the Indemnified Party, as incurred, within ten Trading Days of written notice thereoflimit such party to the Indemnifying Party; provided, that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such feesspecific remedy, and expenses applicable to such actions for which such Indemnified Party is determined by a court of competent jurisdiction not to be entitled to indemnification hereunder.

9

(d)          Contribution. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shallremedy that would otherwise be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party at law or in accordance with its terms.

equity shall also be available. The parties hereto agreealso intend that it wouldthe rights and remedies hereunder be cumulative, so that exercise of any one or more of such rights or remedies shall not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocationpreclude the later or byconcurrent exercise of any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph.rights or remedies. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.

The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.

6.            Miscellaneous.

(a)          Remedies. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights provided herein or granted by law, and under this Agreement, including recovery of damages, shalleach of the parties will be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder agreesThe parties agree that monetary damages wouldmay not providebe adequate compensation for any lossesloss incurred by reason of aany breach by it of any ofobligations described in the provisions of this Agreementforegoing sentence and hereby further agrees that,agree to waive in the event of any action for specific performance in respect of any such breach, it shall not assert or shall waiveobligation the defense that a remedy at law would be adequate.

 

(b)          No Piggyback on Registrations; Prohibition on Filing Other Registration Statements. Except for the Other Shares and those securities set forth onSchedule 6(b) attached hereto, neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) shall not prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement.

(c)          Compliance. Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it in connection with sales of Registrable Securities pursuant to a Registration Statement.

(d)          Discontinued Disposition. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject to the provisions of Section 2(d).

10

(e)          Piggy-Back Registrations. If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company’s stock option or other employee benefit plans, then the Company shall deliver to each Holder a written notice of such determination and, if within fifteen days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include in such registration statement all or any part of such Registrable Securities such Holder requests to be registered;provided,however, that the Company shall not be required to register any Registrable Securities pursuant to this Section 6(e) that are eligible for resale pursuant to Rule 144, without volume restrictions or current public information requirements, promulgated by the Commission pursuant to the Securities Act or that are the subject of a then effective Registration Statement that is available for resales or other dispositions by such Holder.

(f)          Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and the Holders of 51% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates;provided,however, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of the first sentence of this Section 6(f). No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.

(g)          Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth in the Contribution Agreement.

(h)          Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights hereunder in the manner and to the Persons as permitted under Section 12.8 of the Contribution Agreement.

11

(i)          No Inconsistent Agreements. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except as set forth onSchedule 6(i), neither the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.

(j)          Execution and Counterparts. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof.

(k)       Governing LawExpenses. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in accordance with the provisions of the Contribution Agreement.

(l)          Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.

(m)          Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

(n)          Headings. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or affect any of the provisions hereof.

(o)          Independent Nature of Holders’ Obligations and Rights. The obligations of each Holder hereunder are several and not joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.

(Signature Pages Follow)

12

IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.

PHOTOMEDEX, INC.
By:
Name:
Title:

[SIGNATURE PAGE OF HOLDERS FOLLOWS]

[SIGNATURE PAGE OF HOLDERS]

Name of Holder: 

Signature of Authorized Signatory of Holder

Name of Authorized Signatory: 

Title of Authorized Signatory: 

Annex A

Plan of Distribution

Each Selling Stockholder (the “Selling Stockholders”) of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:

·ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

·block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;

·purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

·an exchange distribution in accordance with the rules of the applicable exchange;

·privately negotiated transactions;

·settlement of short sales;

·in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;

·through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;

·a combination of any such methods of sale; or

·any other method permitted pursuant to applicable law.

The Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the “Securities Act”), if available, rather than under this prospectus.

Broker-dealers engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or markdown in compliance with FINRA IM-2440.

In connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

The Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.

The Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.

We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).

SELLING SHAREHOLDERS

The common stock being offered by the selling shareholders are those previously issued to the selling shareholders, and those issuable to the selling shareholders, upon exercise of the warrants. For additional information regarding the issuances of those shares of common stock and warrants, see "Contribution Transaction” above. We are registering the shares of common stock in order to permit the selling shareholders to offer the shares for resale from time to time. Except for [Describe relationships with affiliated selling stockholders] and the ownership of the shares of common stock and the warrants, the selling shareholders have not had any material relationship with us within the past three years.

The table below lists the selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders. The second column lists the number of shares of common stock beneficially owned by each selling shareholder, based on its ownership of the shares of common stock and warrants, as of ________, 2017, assuming exercise of the warrants held by the selling shareholders on that date, without regard to any limitations on exercises.

The third column lists the shares of common stock being offered by this prospectus by the selling shareholders.

In accordance with the terms of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale of the sum of (i) the number of shares of common stock issued to the selling shareholders in connection with the Contribution Transaction and (ii) the maximum number of shares of common stock issuable upon exercise of the warrants issued to the Selling Stockholders in connection with the Contribution Transaction, (iii) the maximum number of shares of common stock issuable upon the conversion of Series A Preferred Stock issued to the Selling Stockholders in connection with the Contribution Trasaction, (iv) the maximum number of shares of common stock issuable upon the conversion of certain promissory notes issued to affiliates of the company in connection with the Contribution Transaction, determined as if the outstanding warrants, Series A Preferred Stock and Payout Notes were exercised or converted, as the case may be, in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants. The fourth column assumes the sale of all of the shares offered by the selling shareholders pursuant to this prospectus.

Under the terms of the warrants and the Series A Preferred Stock, a selling shareholder may not exercise the warrants or convert the Series A Preferred Stock if such exercise or conversion would result in the issuance of more than 19.9% of the shares of our common stock outstanding immediately prior to the closing of the Contribution Transaction taken together with other issuances of common stock in connection with the Contribution Transaction unless the approval of a majority of the outstanding common stock of the Company not including for this purpose the shares of Common Stock underlying the warrants or the Series A Preferred Stock or the other shares of common stock issued in connection with the Contribution Transaction. The number of shares in the second column does not reflect this limitation. The selling shareholders may sell all, some or none of their shares in this offering. See "Plan of Distribution."

Name of Selling Shareholder

Number of shares of

Common Stock

Owned Prior to

Offering

Maximum Number

of shares of Common

Stock to be Sold

Pursuant to this

Prospectus

Number of shares

of Common Stock

Owned After

Offering

Annex C

PHOTOMEDEX, INC.

Selling Stockholder Notice and Questionnaire

The undersigned beneficial owner of common stock (the “Registrable Securities”) of PhotoMedex, Inc., a Nevada corporation (the “Company”), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the “Registration Rights Agreement”) to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.

Certain legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.

NOTICE

The undersigned beneficial owner (the “Selling Stockholder”) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration Statement. The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:

QUESTIONNAIRE

1.Name.

(a)Full Legal Name of Selling Securityholder

(b)Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities Listed in Item 3 below are held:

(c)Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by the questionnaire):

1

2.Address for Notices to Selling Securityholder:

Telephone:

Fax:

Contact Person:

3.Beneficial Ownership of Registrable Securities:

Type and Principal Amount of Registrable Securities beneficially owned:

4.Broker-Dealer Status:

(a)Are you a broker-dealer?

Yes   ¨          No   ¨

Note:If yes, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

(b)Are you an affiliate of a broker-dealer?

Yes   ¨          No   ¨

(c)If you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?

Yes   ¨          No   ¨

Note:If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

2

5.Beneficial Ownership of Other Securities of the Company Owned by the Selling Securityholder.

Except as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company other than the Registrable Securities listed above in Item 3.

Type and Amount of Other Securities beneficially owned by the Selling Securityholder:

6.Relationships with the Company:

Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.

State any exceptions here:

The undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.

By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus and any amendments or supplements thereto.

IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent.

Date:Beneficial Owner:

By:
Name:
Title:

3

PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:

4

Exhibit E

Amended and Restated Articles of Incorporation of Acquiror Parent

AMENDED AND RESTATED ARTICLES OF INCORPORATION

OF

PHOTOMEDEX, INC.

Pursuant to NRS Chapter 78

1.          The name of the corporation (the “Corporation”) is PhotoMedex, Inc.

2.          The address of the registered office of the Corporation in the State of Nevada shall be at [Jolley Urga Wirth Woodbury & Standish, 3800 Howard Hughes Parkway, Sixteenth Floor, Las Vegas, Nevada 89169. The name and address of the Corporation’s registered agent in the State of Nevada is Jolley Urga Wirth Woodbury & Standish.]

3.            (a)              The total number of shares of capital stock which the Corporation shall have authority to issue is five hundred fifty million (550,000,000) shares, of which (i) fifty million (50,000,000) shares are designated as preferred stock, with a par value of $0.01 per share (“Preferred Stock”) and (ii) five hundred million (500,000,000) shares are designated as common stock, with a par value of $0.01 per share (“Common Stock”).

(b)           The Preferred Stock of the Corporation may be issued by the Board of Directors of the Corporation in one or more series and each such series shall have such voting powers, full or limited, or no voting powers, and such designations, preferences, limitations or restrictions as the Board of Directors of the Corporation may determine, from time to time, including but not limited to:

(i)          the designation of such class or series;

(ii)         the dividend rate, if any, of such class or series, the conditions and dates upon which such dividends shall be payable, the preference or relation which such dividends shall bear to the dividends payable on any other class or classes or of any other series of capital stock, whether such dividends shall be cumulative or non-cumulative, and whether such dividends may be paid in shares of any class or series of capital stock or other securities of the Corporation;

(iii)        whether the shares of such class or series shall be subject to redemption by the Corporation, and, if made subject to such redemption, the times, prices and other terms and conditions of such redemption;

(iv)        the terms and amount of any sinking fund provided for the purchase or redemption of the shares of such class or series;

(v)         whether or not the shares of such class or series shall be convertible into or exchangeable for shares of any other class or classes or series of capital stock or other securities of the Corporation, and, if provision be made for conversion or exchange, the times, prices, rates, adjustment and other terms and conditions of such conversion or exchange; 

(vi)        the extent, if any, to which the holders of the shares of such class or series shall be entitled to vote, as a class or otherwise, with respect to the election of the directors or otherwise, and the number of votes to which the holder of each share of such class or series shall be entitled;

(vii)       the restrictions, if any, on the issue or reissue of any additional shares or any class or series of Preferred Stock; and

(viii)      the rights of the holders of the shares of such class or series upon the dissolution of, or upon the distribution of assets of, the Corporation.

(c)          Holders of shares of Common Stock shall be entitled to cast one vote for each share held at all stockholders’ meetings for all purposes, including the election of directors. The Common Stock does not have cumulative voting rights.

(d)          Subject to such rights as may be granted to the holders of any series of Preferred Stock, no holder of shares of stock of any class shall be entitled as a matter of right to subscribe for or purchase or receive any part of any new or additional issue of shares of stock of any class, or of securities convertible into shares of stock of any class, whether now hereafter authorized or whether issued for money, for consideration other than money, or by way of dividend.

4.          The purpose of the Corporation shall be to engage in any lawful act or activity for which corporations may be organized in Nevada.

5. Except as otherwise provided by law, a director or officer is not individually liable to the Corporation or its stockholders or creditors for any damages as a result of any act or failure to act in his or her capacity as a director or officer unless it is proven that (a) the director’s or officer’s act or failure to act constituted a breach of his or her fiduciary duties as a director or officer; and (b) the breach of those duties involved intentional misconduct, fraud or a knowing violation of law. Any repeal or modification of this paragraph 5 by the stockholders of the Corporation shall be prospective only, and shall not adversely affect any limitation of the personal liability of a director of officer of the Corporation for acts or omissions prior to such repeal or modification.

6.          The Corporation shall provide indemnification to its directors and officers to the maximum extent permitted by law. The Corporation shall pay advancements of expenses in advance of the final disposition of the action, suit, or proceedings upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately determined that he or she is not entitled to be indemnified by the corporation.

7.          The provisions of NRS Sections 78.378 to 78.3793, inclusive, shall be inapplicable to the Corporation.

8.          The provisions of NRS Sections 78.411 to 78.444, inclusive, shall be inapplicable to the Corporation.

9.          These Restated Articles of Incorporation were approved by the Board of Directors and the holders of a majority of the outstanding shares of common stock pursuant to NRS 78.390 and NRS 78.320, and this instrument correctly sets forth in full the articles of incorporation, as amended and restated.

IN WITNESS WHEREOF, the undersigned officer has signed these restated articles of incorporation this ___ day of _______, 2017.

_________________, Chief Executive Officer

Exhibit F

Amended and Restated Bylaws of Acquiror Parent

AMENDED AND RESTATED

BYLAWS OF

PHOTOMEDEX, INC.

(a Nevada Corporation)

(adopted effective as of ______, 2017)

These Amended and Restated Bylaws of PhotoMedex, Inc., a Nevada corporation (the “Corporation”) are adopted pursuant to Section 7.01 of the Corporation’s existing Amended and Restated Bylaws, as amended (the “Original Bylaws”), and are intended to amend, restate and replace, in their entirety, the Original Bylaws effective as of the date first written above.

ARTICLE 1

OFFICES

SECTION 1.1.   Principal Office. The principal offices of the Corporation shall be in such location as the Board of Directors of the Corporation (the “Board of Directors”) may determine.

SECTION 1.2.   Other Offices. The Corporation may also have offices at such other places both within and without the State of Nevada as the Board of Directors may from time to time determine or the business of the Corporation may require.

ARTICLE 2

MEETINGS OF STOCKHOLDERS

SECTION 2.1.   Place of Meeting; Chairman. All meetings of stockholders shall be held at such place, either within or without the State of Nevada, as shall be designated from time to time by the Board of Directors and stated in the notice of the meeting. The Chairman of the Board of the Corporation (or the Executive Chairman of the Corporation, if such office is designated and filled in accordance with these Bylaws) (the “Chairman of the Board”) or any other person specifically designated by the Board of Directors shall act as the Chairman for any meeting of stockholders of the Corporation. The Chairman of the Board (or his or her designee) shall have full authority to control the process of any stockholder or Board of Directors meeting, including, without limitation, determining whether any proposals or nominations were properly brought before such meeting, establishing an agenda or order of business for the meeting, rules and procedures for maintaining order at the meeting, limitations on participation in such meeting to stockholders of record of the Corporation and their duly authorized and constituted proxies and such other persons as the Chairman of the Board (or his or her designee) shall permit, restrictions on entry to the meeting after the time fixed for the commencement thereof, requiring ballots by written consent, limitations on the time allotted to questions or comments by participants and regulation of the opening and closing of the polls for balloting on matters which are to be voted on by ballot.

SECTION 2.2.   Annual Meetings. The annual meeting of stockholders of the Corporation shall be held at such date and time as shall be designated from time to time by the Board of Directors and stated in the notice of the meeting, subject to any postponement in the Board of Directors’ sole discretion, upon notice of such postponement given in any manner deeded reasonable by the Board of Directors.

1

SECTION 2.3.   Special Meetings. Special meetings of the stockholders of the Corporation, for any purpose or purposes, unless otherwise prescribed by the Nevada Revised Statutes (“NRS”) or by the Articles of Incorporation of the Corporation, as amended (the “Articles of Incorporation”), may be called exclusively by: (i) the Chairman of the Board or the Chief Executive Officer, President or other executive officer of the Corporation, (ii) the majority of the Board of Directors or (iii) the request in writing of stockholders of record, and only of record, owning not less than a majority of the entire capital stock of the Corporation issued and outstanding and entitled to vote (the “Requisite Percent”). Such request shall state the purpose or purposes of the proposed meeting. The officers or directors shall fix the date, time and any place, either within or without the State of Nevada, as the place for holding such meeting; provided, however, that the date of any such special meeting shall be not more than ninety (90) days after the date on which a special meeting request properly brought pursuant to Sections 2.3 and 2.5 are delivered to the Secretary of the Corporation.

SECTION 2.4.   Notice of Meeting. Written notice of the annual and each special meeting of stockholders of the Corporation, stating the time, place and purpose or purposes thereof, shall be given to each stockholder entitled to vote thereat, not less than ten (10) nor more than sixty (60) days before the meeting and shall be signed by the Chairman of the Board, the President or the Secretary of the Corporation (the “Secretary”). The Board of Directors may postpone a special meeting in its sole discretion in any manner it deems reasonable. In no event shall any adjournment or postponement of an annual meeting or special meeting or the announcement thereof commence a new time period for the giving of a stockholder’s notice as described below.

SECTION 2.5.   Business Conducted at Meetings.

Section 2.5.1   At any meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To be properly brought before a meeting, business must be: (a) specified in the notice of meeting (or any supplement thereto provided within the notice period specified in Section 2.4) given by or at the direction of the Chairman of the Board, the President or the Board of Directors, (b) otherwise properly brought before the meeting by or at the direction of the Board of Directors, or (c) otherwise properly brought before the meeting by a stockholder or stockholders of record, and only of record, holding the Requisite Percent in accordance with applicable law, these Bylaws or otherwise. In addition to any other applicable requirements set forth in these Bylaws, the U.S. federal securities laws or otherwise, for business to be properly brought before a meeting called by stockholders representing the Requisite Percent, such stockholder(s) must have given timely notice thereof in writing to the Secretary. Any special meeting of the Corporation proposed to be called by a stockholder or stockholders in such capacity shall not be required to be held: (i) with respect to any matter, within 12 months after any annual or special meeting of stockholders at which the same matter was included on the agenda, or if the same matter will be included on the agenda at an annual meeting to be held within 90 days after the receipt by the Corporation of such request (the election or removal of directors to be deemed the same matter with respect to all matters involving the election or removal of directors) or (ii) if the purpose of the special meeting is not a lawful purpose or if such request violates applicable law. A stockholder may revoke a request for a special meeting at any time by written revocation delivered to the Secretary, and if, following such revocation, there are un-revoked requests from stockholders holding in the aggregate less than the requisite number of shares entitling the stockholders to request the calling of a special meeting, the Board of Directors, in its discretion, may cancel the special meeting. If none of the stockholders who submitted the request for a special meeting appears or sends a qualified representative to present the nominations proposed to be presented or other business proposed to be conducted at the special meeting, the Corporation need not present such nominations or other business for a vote at such meeting.

Section 2.5.2   To be timely, a stockholder’s notice of a proposal to be included at an annual meeting must be delivered to or mailed and received at the principal executive offices of the Corporation not less than ninety (90) days nor more than one hundred twenty (120) days prior to the anniversary of the date on which the Corporation first mailed its proxy materials for the previous year’s annual meeting of stockholders (or the date on which the Corporation mails its proxy materials for the current year if during the prior year the Corporation did not hold an annual meeting or if the date of the annual meeting was changed more than thirty (30) days from the prior year).

2

Section 2.5.3   A record stockholders’ notice to the Secretary shall set forth in writing as to each matter the stockholder(s) propose to bring before the meeting: (a) a detailed description of the business desired to be brought before the meeting and the reasons for proposing such business, including the complete text of any resolutions, bylaws or Articles of Incorporation amendments proposed for consideration (b) the name and address, as they appear on the Corporation’s books, of the stockholders proposing such business, (c) the class and number of shares of the Corporation which are owned directly or indirectly of record and directly or indirectly beneficially owned by the stockholders and each of its affiliates (within the meaning of Rule 144 promulgated under the Securities Act of 1933, as amended, or any successor rule thereto (“Rule 144”)), including any shares of the Corporation owned or controlled via derivatives, synthetic securities, hedged positions and other economic and voting mechanisms, (d) any material interest of the stockholders in such proposed business and any agreements or understandings to which such stockholders are a party which relate in any way, directly or indirectly, to the proposed business to be conducted, including a description of all arrangements or understandings between such stockholder and any other person or persons (including their names), (e) a representation as to whether or not such stockholder intends to solicit proxies; (f) a representation as to whether or not such stockholder intends to appear in person or by proxy at the applicable meeting, and (g) such other information regarding the stockholder in his, her or its capacity as a proponent of a stockholder proposal that would be required to be disclosed in a proxy statement or other filing with the United States Securities and Exchange Commission (“SEC”) required to be made in connection with the contested solicitation of proxies pursuant to the SEC’s proxy rules.

Section 2.5.4   Notwithstanding anything in these Bylaws to the contrary, no business shall be conducted at a meeting except in accordance with the procedures set forth in this Section 2.5. The Chairman of the meeting shall, in his or her sole discretion, determine and declare to the meeting whether or not any business was properly brought before the meeting. Any such business not properly brought before the meeting shall not be transacted. Nothing in this Section 2.5 shall affect the right of a stockholder to request inclusion of a proposal in the Corporation’s proxy statement to the extent that such right is provided by an applicable rule of the SEC. Notwithstanding the foregoing, the advance notice provisions of these Bylaws shall apply toAgreement all stockholder proposals regardless of whether such proposal is sought to be included in the Corporation’s proxy statement or in a separate proxy statement.

SECTION 2.6.   Nomination of Directors. Nomination of candidates for election as directors of the Corporation at any meeting of stockholders called for the election of directors, in whole or in part (an “Election Meeting”), must be made by the Board of Directors or by any stockholder entitled to vote at such Election Meeting, in accordance with the following procedures.

Section 2.6.1.   Nominations made by the Board of Directors shall be made at a meeting of the Board of Directors or by written consent of the directors in lieu of a meeting prior to the date of the Election Meeting. At the request of the Corporation, each proposed individual nominated by the Board of Directors shall provide the Corporation with such information concerning himself or herself as is required, under the rules of the SEC and any applicable securities exchange, to be included in the Corporation’s proxy statement soliciting proxies for his or her election as a director.

3

Section 2.6.2.   The exclusive means by which a stockholder may nominate a director shall be: (i) in the case of the nomination of a director for election at an annual meeting, by delivery of a notice to the Secretary, not less than ninety (90) days nor more than one hundred twenty (120) days prior to the anniversary of the date on which the Corporation first mailed its proxy materials for the previous year’s annual meeting of stockholders (or the date on which the Corporation mails its proxy materials for the current year if during the prior year the Corporation did not hold an annual meeting or if the date of the annual meeting was changed more than thirty (30) days from the prior year); or (ii) in the case of the nomination of a director for election at a special meeting (other than pursuant to a special meeting request in accordance with the requirements set forth in Sections 2.3 and 2.5), not less than ninety (90) days nor more than one hundred twenty (120) days prior to such special meeting or, if later, the tenth (10th) day following the day on which public disclosure (of the date of such special meeting was first made, setting forth: (a) the name, age, business address and the primary legal residence address of each nominee proposed in such notice, (b) the principal occupation or employment of such nominee, (c) the number of shares of capital stock of the Corporation which are owned directly or indirectly of record and directly or indirectly beneficially owned by the nominee and each of its affiliates (within the meaning of Rule 144), including any shares of the Corporation owned or controlled via derivatives, hedged positions and other economic and voting mechanisms, (d) any material agreements, understandings or relationships, including financial transactions and compensation, between the nominating stockholder and the proposed nominees and (d) such other information concerning each such nominee as would be required, under the rules of the SEC, in a proxy statement soliciting proxies in a contested election of such nominees. Such notice shall include a signed consent of each such nominee to serve as a director of the Corporation, if elected. In addition, any stockholder nominee, to be validly nominated, shall submit to the Secretary the questionnaire required pursuant to Section 2.6.3 of these Bylaws. A stockholder intending to nominate one or more candidates for election as directors must comply with the advance notice bylaw provisions specifically applicable to the nomination of candidates for election as directors for such nomination to be properly brought before the meeting. For purposes of these Bylaws, “public disclosure” shall mean shall mean disclosure in a press release reported by a national news service or in a document publicly filed by the Corporation with the SEC pursuant to Sections 13, 14 or 15(d) of the Securities Exchange Act of 1934, as amended.

Section 2.6.3   To be eligible to be a director nominee nominated by a stockholder or stockholders for election or reelection as a director of the Corporation, such nominee must deliver (in accordance with the time periods prescribed for delivery of notice under Section 2.6.2 of these Bylaws) to the Secretary at the principal executive offices of the Corporation a written questionnaire (the “Questionnaire”) with respect to the background, qualification and experience of such person and the background of any other person or entity on whose behalf the nomination is being made (which questionnaire shall be in the form approved by the Corporation and provided by the Secretary or such Secretary’s designee) and a written representation and agreement that such person: (a) will abide by the requirements of these Bylaws and the Articles of Incorporation as in effect at the time of their nomination and as validly amended, (b) is not and will not become a party to (1) any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director of the Corporation, will act or vote on any issue or question (a “Voting Commitment”) that has not been disclosed to the Corporation or (2) any Voting Commitment that could limit or interfere with such person’s ability to comply, if elected as a director of the Corporation, with such person’s fiduciary duties under applicable law, (c) is not and will not become a party to any agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director that has not been disclosed therein, and (d) in such person’s individual capacity and on behalf of any person or entity on whose behalf the nomination is being made, would be in compliance, if elected as a director of the Corporation, and will comply with all applicable publicly disclosed corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Corporation. If, prior to the Election Meeting, there is a change in any information set forth on the Questionnaire, then such director candidate shall promptly notify the Secretary by submitting a revised Questionnaire.

Section 2.6.4.   In the event that a person is validly designated by the Board of Directors as a nominee in accordance with this Section 2.6 and shall thereafter become unable or willing to stand for election to the Board of Directors, the Board of Directors may designate a substitute nominee who meets all applicable standards under these Bylaws.

4

Section 2.6.5.   If the Chairman of the Election Meeting determines that a nomination was not made in accordance with the foregoing procedures, such nomination shall be void.

SECTION 2.7.   Quorum; Adjournment.

Section 2.7.1   The holders of a majority of the shares of capital stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy (provided the proxy has authority to vote on at least one matter at such meeting), shall constitute a quorum at any meeting of stockholders for the transaction of business, except when stockholders are required to vote by class, in which event a majority of the issued and outstanding shares of the appropriate class shall be present in person or by proxy (provided the proxy has authority to vote on at least one matter at such meeting) in order to constitute a quorum as to such class vote, and except as otherwise provided by the NRS or by the Articles of Incorporation. The stockholders present at a duly called or held meeting at which a quorum is present may continue to do business until adjournment, notwithstanding the withdrawal of enough stockholders to have less than a quorum if any action taken (other than adjournment) is approved by at least a majority of the shares required to constitute a quorum.

Section 2.7.2   Notwithstanding any other provision of the Articles of Incorporation or these Bylaws, at any annual or special meeting of stockholders of the Corporation, whether or not a quorum is present, the Chairman of the Board or the person presiding as Chairman of the meeting shall have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, whether or not a quorum shall be present or represented. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting in accordance with Section 2.4 of these Bylaws. At such adjourned meeting at which a quorum shall be present or represented, any business may be transacted which might have been transacted at the meeting as originally notified.

SECTION 2.8.   Voting; Proxies.

Section 2.8.1   Except as provided for below or by applicable law, rule or regulation, when a quorum is present at any meeting of the stockholders, any action by the stockholders on a matter except the election of directors shall be approved if approved by the majority of the votes cast. Each nominee for director shall be elected by the majority of the votes cast with respect to that nominee’s election at any meeting for the election of directors at which a quorum is present, provided, however, that, in the case of a director nominee in a Contested Election, the Board of Directors, in its sole discretion, may determine that directors shall be elected by a plurality of the votes cast in any Contested Election, such determination to be made no later than five (5) days prior to the date of the Election Meeting as initially announced. For purposes of these Bylaws, a “Contested Election” means an election of directors with respect to which the Board of Directors determines that the number of nominees exceeds the number of directors to be elected and the Board of Directors has not rescinded such determination by the date that is five (5) days prior to the date of the Election Meeting as initially announced. In determining the number of votes cast in a Contested Election, abstentions and broker non-votes, if any, will not be treated as votes cast. The provisions of this paragraph will govern with respect to all votes of stockholders except as otherwise provided for in the Articles of Incorporation or by a specific statutory provision superseding the provisions of these Bylaws.

5

Section 2.8.2   Every stockholder having the right to vote shall be entitled to vote in person, or by proxy: (a) appointed by an instrument in writing subscribed by such stockholder or by his or her duly authorized attorney or (b) authorized by the transmission of an electronic record by the stockholder to the person who will be the holder of the proxy or to a firm which solicits proxies or like agent who is authorized by the person who will be the holder of the proxy to receive the transmission subject to any procedures the Board of Directors may adopt from time to time to determine that the electronic record is authorized by the stockholder; provided, however, that no such proxy shall be valid after the expiration of six (6) months from the date of its execution, unless coupled with an interest, or unless the person executing it specifies therein the length of time for which it is to continue in force, which in no case shall exceed seven (7) years from the date of its execution. If such instrument or record shall designate two (2) or more persons to act as proxies, unless such instrument shall provide the contrary, a majority of such persons present at any meeting at which their powers thereunder are to be exercised shall have and may exercise all the powers of voting or giving consents thereby conferred, or if only one (1) be present, then such powers may be exercised by that one (1). Unless required by the NRS or determined by the Chairman of the meeting to be advisable, the vote on any matter need not be by written ballot. No stockholder shall have cumulative voting rights.

SECTION 2.9.   Consent of Stockholders. Whenever the vote of the stockholders at a meeting thereof is required or permitted to be taken for or in connection with any corporate action, the meeting and vote of stockholders may be dispensed with if stockholders, having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted, consent in writing to such corporate action being taken; provided, that in no case shall the written consent be by the holders of stock having less than the minimum percentage of the vote required by the NRS. Any action by consent of the stockholders pursuant to this Section 2.9 must follow the notice and timing procedures of Section 2.5 applicable to any business to be conducted at a stockholder meeting. Further, upon the request of a stockholder to conduct a consent solicitation, the Board of Directors shall adopt a resolution fixing a record date within ten (10) days of the date on which a request therefor is received, provided that such record date shall not be more than ten (10) days after the date of the adoption of such resolution.

SECTION 2.10.   Voting of Stock of Certain Holders. Shares standing in the name of another entity, domestic or foreign, may be voted by such officer, agent or proxy as the governing documents of such entity may prescribe, or in the absence of such provision, as the Board of Directors or governing body of such entity may determine. Shares standing in the name of a deceased person may be voted by the executor or administrator of such deceased person, either in person or by proxy. Shares standing in the name of a guardian, conservator or trustee may be voted by such fiduciary, either in person or by proxy, but no such fiduciary shall be entitled to vote shares held in such fiduciary capacity without a transfer of such shares into the name of such fiduciary. Shares outstanding in the name of a receiver may be voted by such receiver. A stockholder whose shares are pledged shall be entitled to vote such shares, unless in the transfer by the pledgor on the books of the Corporation, he or she has expressly empowered the pledgee to vote thereon, in which case only the pledgee, or his or her proxy, may represent the stock and vote thereon.

SECTION 2.11.   Treasury Stock. The Corporation shall not vote, directly or indirectly, shares of its own stock owned by it; and such shares shall not be counted in determining the total number of outstanding shares.

SECTION 2.12.   Fixing Record Date. The Board of Directors may fix in advance a date for any meeting of stockholders (which date shall not be more than sixty (60) nor less than ten (10) days preceding the date of any such meeting of stockholders), a date for payment of any dividend or distribution, a date for the allotment of rights, a date when any change or conversion or exchange of capital stock shall go into effect, or a date in connection with obtaining a consent of stockholders (which date shall not precede or be more than ten (10) days after the date the resolution setting such record date is adopted by the Board of Directors), in each case as a record date (the “Record Date”) for the determination of the stockholders entitled to notice of, and to vote at, any such meeting and any adjournment thereof, to receive payment of any such dividend or distribution, to receive any such allotment of rights, to exercise the rights in respect of any such change, conversion or exchange of capital stock, or to give such consent, as the case may be. In any such case such stockholders and only such stockholders as shall be stockholders of record on the Record Date shall be entitled to such notice of and to vote at any such meeting and any adjournment thereof, to receive payment of such dividend or distribution, to receive such allotment of rights, to exercise such rights, or to give such consent, as the case may be, notwithstanding any transfer of any stock on the books of the Corporation after any such Record Date.

6

ARTICLE 3

BOARD OF DIRECTORS

SECTION 3.1.   Powers. The business and affairs of the Corporation shall be managed by the Board of Directors, which may exercise all such powers of the Corporation and do all such lawful acts and things as are not by statute or by the Articles of Incorporation or by these Bylaws directed or required to be exercised or done by the stockholders. Subject to compliance with the provisions of the NRS, the powers of the Board of Directors shall include the power to make a liquidating distribution of the assets, and wind up the affairs of, the Corporation.

SECTION 3.2.   Number and Qualifications. The number of directors which shall constitute the whole Board of Directors shall be not less than one (1) and not more than nine (9). Within the limits above specified, the number of the directors of the Corporation shall be determined solely in the discretion of the Board of Directors from time to time. All directors shall be elected annually. Directors need not be residents of Nevada or stockholders of the Corporation.

SECTION 3.3.   Vacancies, Additional Directors; Removal From Office; Resignation.

SECTION 3.3.1   If any vacancy occurs in the Board of Directors caused by death, resignation, retirement, disqualification, removal from office or otherwise, or if any new directorship is created in accordance with Section 3.2 by an increase in the authorized number of directors, a majority of the directors then in office, though less than a quorum, or a sole remaining director, but not the stockholders of the Corporation, may choose a successor or fill the newly created directorship. Any director so chosen shall hold office for the unexpired term of his or her predecessor in his or her office and until his or her successor shall be elected and qualified, unless sooner displaced.

SECTION 3.3.2   No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director.

SECTION 3.3.3   The stockholders of the Corporation may remove a member of the Board of Directors by the affirmative vote of sixty-six and two-thirds percent (66 2/3%) of the issued and outstanding stock entitled to vote.

SECTION 3.3.4   Any director may resign or voluntarily retire upon giving written notice to the Chairman of the Board or the Board of Directors. Such retirement or resignation shall be effective upon the giving of the notice, unless the notice specifies a later time for its effectiveness. If such retirement or resignation is effective at a future time, the Board of Directors may elect a successor to take office when the retirement or resignation becomes effective.

SECTION 3.4.   Regular Meetings. A regular meeting of the Board of Directors shall be held each year, without notice other than this Bylaw provision, at the place of, and immediately prior to and/or following, the annual meeting of stockholders; and other regular meetings of the Board of Directors shall be held during each year, at such time and place as the Board of Directors may from time to time provide by resolution, either within or without the State of Nevada, without other notice than such resolution. The Board of Directors shall keep minutes of its regular meetings.

7

SECTION 3.5.   Special Meetings. Special meetings of the Board of Directors may be called by the Chairman of the Board or by the President and shall be called by the Secretary on the written request of any two (2) directors (should there be such number then in office). The Chairman of the Board or President so calling, or the directors so requesting, any such meeting shall fix the time and any place, either within or without the State of Nevada, as the place for holding such meeting. The Board of Directors shall keep minutes of its special meetings.

SECTION 3.6.   Notice of Special Meeting. Written notice (including via e-mail) of special meetings of the Board of Directors shall be given to each director at least twenty-four (24) hours prior to the time of a special meeting. Any director may waive notice of any meeting. The attendance of a director at any meeting shall constitute a waiver of notice of such meeting, except where a director attends a meeting solely for the purpose of objecting to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any special meeting of the Board of Directors need be specified in the notice or waiver of notice of such meeting, except that notice shall be given with respect to any matter when notice is required by the NRS.

SECTION 3.7.   Quorum. A majority of the Board of Directors then serving shall constitute a quorum for the transaction of business at any meeting of the Board of Directors, and the act of a majority of the directors present at any meeting at which there is quorum shall be the act of the Board of Directors, except as may be otherwise specifically provided by the NRS, by the Articles of Incorporation or by these Bylaws. If a quorum shall not be present at any meeting of the Board of Directors, the directors present thereat may adjourn the meeting, without notice other than announcement at the meeting, until a quorum shall be present. A meeting at which a quorum is initially present may continue to transact business notwithstanding the withdrawal of directors, if any action taken is approved of by at least a majority of the required quorum for that meeting.

SECTION 3.8.   Action Without Meeting. Unless otherwise restricted by the Articles of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board of Directors, or of any committee thereof as provided in Article 4 of these Bylaws, may be taken without a meeting, if a written consent thereto is signed by all of the members of the Board of Directors or of such committee, as the case may be. Evidence of any consent to action under this Section3.8 may be provided in writing, including electronically via email or facsimile.

SECTION 3.9.   Meeting by Telephone. Any action required or permitted to be taken by the Board of Directors or any committee thereof may be taken by means of a meeting by telephone conference or similar communications method so long as all persons participating in the meeting can hear each other. Any person participating in such meeting shall be deemed to be present in person at such meeting.

SECTION 3.10.   Compensation. Directors, as such, may receive reasonable compensation for their services, which shall be set by the Board of Directors, and expenses of attendance at each regular or special meeting of the Board of Directors; provided, however, that nothing herein contained shall be construed to preclude any director from serving the Corporation in any other capacity and receiving additional compensation therefor. Members of special or standing committees may be allowed like compensation for their services on committees.

SECTION 3.11.   Rights of Inspection.   Every director shall have the absolute right at any reasonable time to inspect and copy all books, records and documents of every kind and to inspect the physical properties of the Corporation and also of its subsidiary corporations, domestic or foreign. Such inspection by a director may be made in person or by agent or attorney and includes the right to copy and obtain extracts.

8

SECTION 3.12   Interested Directors. No contract or transaction between the Corporation and one or more of its directors or officers, or between the Corporation and any other corporation, partnership, association, or other organization in which one or more of its directors or officers are directors or officers, or have a financial interest, shall be void or voidable solely for this reason, or solely because the director or officer is present at or participates in the meeting of the Board of Directors or committee thereof which authorizes the contract or transaction, or solely because his or their votes are counted for such purpose if: (i) the material facts as to his or their relationship or interest and as to the contract or transaction are disclosed or are known to the Board of Directors or their committee, and the Board of Directors or committee in good faith authorizes the contract or transaction by the affirmative votes of a majority of the disinterested directors, even though the disinterested directors be less than a quorum; or (ii) the material facts as to his or their relationship or interest and as to the contract or transaction are disclosed or are known to the shareholders entitled to vote thereon, and the contract or transaction is specifically approved in good faith by vote of the shareholders; or (iii) the contract or transaction is fair as to the Corporation as of the time it is authorized, approved or ratified, by the Board of Directors, a committee thereof or the shareholders. Common or interested directors may be counted in determining the presence of a quorum at a meeting of the Board of Directors or of a committee which authorizes the contract or transaction.

ARTICLE 4

COMMITTEES OF DIRECTORS

SECTION 4.1.   Generally. The Board of Directors may, by resolution passed by a majority of the whole Board of Directors, designate one or more additional special or standing committees, each such additional committee to consist of one or more of the directors of the Corporation. Each such committee shall have and may exercise such of the powers of the Board of Directors in the management of the business and affairs of the Corporation as may be provided in such resolution, except as delegated by these Bylaws or by the Board of Directors to another standing or special committee or as may be prohibited by law.

SECTION 4.2.   Committee Operations. A majority of a committee shall constitute a quorum for the transaction of any committee business. Such committee or committees shall have such name or names and such limitations of authority as provided in these Bylaws or as may be determined from time to time by resolution adopted by the Board of Directors. The Corporation shall pay all expenses of committee operations. The Board of Directors may designate one or more appropriate directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of such committee. In the absence or disqualification of any members of such committee or committees, the member or members thereof present at any meeting and not disqualified from voting, whether or not he, she or they constitute a quorum, may unanimously appoint another appropriate member of the Board of Directors to act at the meeting in the place of any absent or disqualified member.

SECTION 4.3.   Minutes. Each committee of directors shall keep regular minutes of its proceedings and report the same to the Board of Directors when required. The Corporation’s Secretary, or any other person designated by the applicable committee shall (a) serve as the Secretary of the special or standing committees of the Board of Directors of the Corporation, (b) keep regular minutes of standing or special committee proceedings, (c) make available to the Board of Directors, as required, copies of all resolutions adopted or minutes or reports of other actions recommended or taken by any such standing or special committee and (d) otherwise as requested keep the members of the Board of Directors apprised of the actions taken by such standing or special committees.

9

ARTICLE 5

NOTICE

SECTION 5.1.   Methods of Giving Notice.

SECTION 5.1.1.Notice to Directors or Committee Members. Whenever under the provisions of the NRS, the Articles of Incorporation or these Bylaws, notice is required to be given to any director or member of any committee of the Board of Directors, personal notice is not required but such notice may be: (a) given in writing and mailed to such director or committee member, (b) sent by electronic transmission (including via e-mail) to such director or committee member, or (c) given orally or by telephone; provided, however, that any notice from a stockholder to any director or member of any committee of the Board of Directors must be given in writing and mailed to such director or member and shall be deemed to be given upon receipt by such director or member. If mailed, notice to a director or member of a committee of the Board of Directors shall be deemed to be given when deposited in the United States mail first class, or by overnight courier, in a sealed envelope, with postage thereon prepaid, addressed, to such person at his or her business address. If sent by electronic transmission, notice to a director or member of a committee of the Board of Directors shall be deemed to be given if by (i) facsimile transmission, when receipt of the fax is confirmed electronically, (ii) electronic mail, when delivered to an electronic mail address of the director or member, (iii) a posting on an electronic network together with a separate notice to the director or member of the specific posting, upon the later of (1) such posting and (2) the giving of the separate notice (which notice may be given in any of the manners provided above), or (iv) any other form of electronic transmission, when delivered to the director or member.

SECTION 5.1.2.Notices to Stockholders. Whenever under the provisions of the NRS, the Articles of Incorporation or these Bylaws, notice is required to be given to any stockholder, personal notice is not required but such notice may be given: (a) in writing and mailed to such stockholder, (b) by a form of electronic transmission consented to by the stockholder to whom the notice is given or (c) as otherwise permitted by the SEC. If mailed, notice to a stockholder shall be deemed to be given when deposited in the United States mail in a sealed envelope, with postage thereon prepaid, addressed to the stockholder at the stockholder’s address as it appears on the records of the Corporation. If sent by electronic transmission, notice to a stockholder shall be deemed to be given if by (i) facsimile transmission, when directed to a number at which the stockholder has consented to receive notice, (ii) electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice, (iii) a posting on an electronic network together with a separate notice to the stockholder of the specific posting, upon the later of (1) such posting and (2) the giving of the separate notice (which notice may be given in any of the manners provided above), or (iv) any other form of electronic transmission, when directed to the stockholder.

SECTION 5.2.   Written Waiver. Whenever any notice is required to be given by the NRS, the Articles of Incorporation or these Bylaws, a waiver thereof in a signed writing or sent by the transmission of an electronic record attributed to the person or persons entitled to said notice, whether before or after the time stated therein, shall be deemed equivalent thereto.

SECTION 5.3.   Consent. Whenever all parties entitled to vote at any meeting, whether of directors or stockholders, consent, either by a writing on the records of the meeting or filed with the Secretary, or by presence at such meeting and oral consent entered in the minutes of such meeting, or by taking part in the deliberations at such meeting without objection, the actions taken at such meeting shall be as valid as if had at a meeting regularly called and noticed. At such meeting any business may be transacted which is not excepted from the written consent or to the consideration of which no objection for lack of notice is made at the time, and if any meeting be irregular for lack of notice or such consent, provided a quorum was present at such meeting, the proceedings of such meeting may be ratified and approved and rendered valid and the irregularity or defect therein waived by a writing signed by all parties having the right to vote thereat. Such consent or approval, if given by stockholders, may be by proxy or power of attorney, but all such proxies and powers of attorney must be in writing.

10

ARTICLE 6

OFFICERS

SECTION 6.1.   Officers.

SECTION 6.1.1   The officers of the Corporation shall include the Chairman of the Board (or Executive Chairman, if the Board of Directors designates such office), the President, the Secretary and the Treasurer, each as approved and appointed by the Board of Directors.

SECTION 6.1.2   The officers of the Corporation may further include a Chief Executive Officer and a Chief Financial Officer, each as approved and appointed by the Board of Directors, and may further include, without limitation, such other executive or subordinate officers and agents, including, without limitation, one or more Vice Presidents (any one or more of which may be designated Senior Executive Vice President, Executive Vice President, Senior Vice President or such other title as may be determined b the Board of Directors), Assistant Vice Presidents, Assistant Secretaries and Assistant Treasurers, in each case as the Board of Directors deems necessary and approve and appoint.

SECTION 6.1.3   The Board of Directors may in its discretion delegate to the President the power and authority to appoint subordinate officers of the Corporation and to prescribe their respective duties and powers, but in any instance the Chairman of the Board, the President, the Secretary, the Treasuer and, if designated, the Chief Executive Officer, Chief Financial Officer or any other officer responsible for a principal business unit, division or function of the Corporation (such as sales, administration or finance), or any other officer who performs a policy making function (collectively, the “Principal Officers”), shall be subject to the approval of and appointment by the Board of Directors.

SECTION 6.1.4   All officers of the Corporation shall hold their offices for such terms and shall exercise such powers and perform such duties as prescribed by these Bylaws, the Board of Directors or President, as applicable. Any two or more offices may be held by the same person. The Chairman of the Board shall be elected from among the directors. With the foregoing exception, none of the other officers need be a director, and none of the officers need be a stockholder of the Corporation.

SECTION 6.2.   Election and Term of Office. The Principal Officers shall each be elected only by, and shall serve only at the pleasure of, the Board of Directors. All other officers of the Corporation may be appointed as the Board of Directors or the President deem necessary and elect or appoint. The officers of the Corporation shall be elected or ratified annually by the Board of Directors at its first regular meeting held concurrently with or after the annual meeting of stockholders or as soon thereafter as conveniently possible (or, in the case of those officers elected or appointed other than by the Board of Directors, ratified at the Board of Directors’ first regular meeting held following their election or appointment or as soon thereafter as conveniently possible). Subject to the terms and conditions of any applicable contract between an officer and the Corporation, each officer shall hold office until his or her successor shall have been chosen and shall have qualified or until his or her death or the effective date of his or her resignation or removal, or until he or she shall cease to be a director in the case of the Chairman of the Board.

11

SECTION 6.3.   Removal and Resignation. Any officer or agent may be removed, either with or without cause, by the affirmative vote of a majority of the Board of Directors and, other than the Principal Officers, may also be removed, either with or without cause, by action of the President whenever, in his, her judgment, the best interests of the Corporation shall be served thereby, but such right of removal and any purported removal shall be without prejudice to the contractual rights, if any, of the person so removed. Any Principal Officer or other officer or agent may resign at any time by giving written notice to the Corporation. Any such resignation shall take effect at the date of the receipt of such notice or at any later time specified therein, and unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.

SECTION 6.4.   Vacancies. Any vacancy occurring in any Principal Officer office by death, resignation, removal or otherwise, shall be filled by the Board of Directors for the unexpired portion of the term. Any vacancy in any other office may be filled as the Board of Directors or President deem necessary.

SECTION 6.5.   Compensation. The compensation of the Principal Officers shall be determined by the Board of Directors or a designated committee thereof. Compensation of all other officers and employees of the Corporation shall be determined by the President in consultation with the Board of Directors or a designated committee thereof and in accordance with any charter of any such committee as has been approved by the Board of Directors or any policies as have been approved by the Board of Directors. No officer who is also a director shall be prevented from receiving such compensation by reason of his or her also being a director.

SECTION 6.6.   Chairman of the Board. The Chairman of the Board (who may also be designated as Executive Chairman), shall preside at all meetings of the Board of Directors and of the stockholders of the Corporation. In the Chairman of the Board’s absence, such duties shall be attended to by any vice chairman of the Board of Directors, or if there is no vice chairman, or such vice chairman is absent, then by the President. The Chairman of the Board shall act as liaison between the Board of Directors and the executive officers of the Corporation and shall be responsible for general oversight of such executive officers. The Chairman of the Board may also hold the position of Chief Executive Officer or President, if so approved or appointed by the Board of Directors. The Chairman of the Board shall formulate and submit to the Board of Directors matters of general policy for the Corporation and shall perform such other duties as usually appertain to the office or as may be prescribed by the Board of Directors. He or she may sign with the President or any other officer of the Corporation thereunto authorized by the Board of Directors certificates for shares of the Corporation, the issuance of which shall have been authorized by resolution of the Board of Directors, and any deeds or bonds, which the Board of Directors has authorized to be executed, except in cases where the signing and execution thereof has been expressly delegated or reserved by these Bylaws or by the Board of Directors to some other officer or agent of the Corporation, or shall be required by law to be otherwise executed.

SECTION 6.7.   President. The President shall, subject to the oversight by and control of the Board of Directors, have general and active management of the business of the Corporation and shall see that all orders and resolutions of the Board of Directors are carried into effect. The President may also, but shall not be required to, hold the position of Chief Executive Officer of the Corporation, if so approved or appointed by the Board of Directors. The President shall keep the Board of Directors fully informed and shall consult them concerning the business of the Corporation. Subject to the supervisory powers of the Board of Directors, the President may sign with the Chairman of the Board or any other officer of the Corporation thereunto authorized by the Board of Directors, certificates for shares of capital stock of the Corporation, the issuance of which shall have been authorized by resolution of the Board of Directors, and any deeds, bonds, mortgages, contracts, checks, notes, drafts or other instruments which the Board of Directors has authorized to be executed, except in cases where the signing and execution thereof has been expressly delegated by these Bylaws or by the Board of Directors to some other officer or agent of the Corporation, or shall be required by law to be otherwise executed. In general, the President shall perform all other duties normally incident to the office of the President, except any duties expressly delegated to other persons by these Bylaws, the Board of Directors and such other duties as may be prescribed by the Board of Directors from time to time.

12

SECTION 6.8.   Chief Executive Officer. The Chief Executive Officer, if any, shall, in general, perform such duties as usually pertain to the position of chief executive officer and such duties as may be prescribed by the Board of Directors.

SECTION 6.9.   Chief Financial Officer. The Chief Financial Officer, if any, shall, in general, perform such duties as usually pertain to the position of chief financial officer and such duties as may be prescribed by the Board of Directors. The Chief Financial Officer (or the Treasurer, if the office of Chief Financial Officer is unoccupied) shall prepare annually (by the thirtieth (30th) day following the end of each fiscal year) a customary and appropriate financial and operational budget of income, expense and cash flows of the Company for the upcoming fiscal year, which budget shall be reviewed and approved by the Board of Directors. Such budget shall be updated quarterly (including a reconciliation of the Company’s actual performance versus the approved budget) and presented to the Board of Directors for review and revision as determined by the Board of Directors.

SECTION 6.10.Secretary. The Secretary shall: (a) keep the minutes of the meetings of the stockholders, the Board of Directors and committees of directors; (b) see that all notices are duly given in accordance with the provisions of these Bylaws and as required by law; (c) be custodian of the corporate records and of the seal of the Corporation, and see that the seal of the Corporation or a facsimile thereof is affixed to all certificates for shares prior to the issuance thereof and to all documents, the execution of which on behalf of the Corporation under its seal is duly authorized in accordance with the provisions of these Bylaws; (d) keep or cause to be kept a register of the post office address of each stockholder which shall be furnished by such stockholder; (e) have general charge of other stock transfer books of the Corporation; and (f) in general, perform all duties normally incident to the office of the Secretary and such other duties as from time to time may be assigned to him or her by the Chairman of the Board, the President or the Board of Directors.

SECTION 6.11.   Treasurer. The Treasurer shall: (a) have charge and custody of and be responsible for all funds and securities of the Corporation; receive and give receipts for monies due and payable to the Corporation from any source whatsoever and deposit all such moneys in the name of the Corporation in such banks, trust companies or other depositories as shall be selected in accordance with the provisions of Section 7.3 of these Bylaws; and (b) in general, perform all the duties incident to the office of Treasurer and such other duties as from time to time may be assigned to him or her by the Board of Directors or the President. If required by the Board of Directors, the Treasurer shall give a bond for the faithful discharge of his or her duties in such sum and with such surety or sureties as the Board of Directors shall determine.

SECTION 6.12.   Interim Officer Status. Any office of the Corporation may be designated by the Board of Directors as interim, and such interim status shall be on such terms and for such duration as may be designated by the Board of Directors.

ARTICLE 7

EXECUTION OF CORPORATE INSTRUMENTS AND
VOTING OF SECURITIES OWNED BY THE CORPORATION

SECTION 7.1.   Contracts. Subject to the provisions of Section 6.1, the Board of Directors may authorize any officer, officers, agent or agents to enter into any contract or execute and deliver an instrument in the name of and on behalf of the Corporation, and such authority may be general or confined to specific instances.

13

SECTION 7.2.   Checks, etc. All checks, demands, drafts or other orders for the payment of money, and notes or other evidences of indebtedness issued in the name of the Corporation shall be signed by such officer or officers or such agent or agents of the Corporation, and in such manner, as shall be determined by the Board of Directors.

SECTION 7.3.   Deposits. All funds of the Corporation not otherwise employed shall be deposited from time to time to the credit of the Corporation in such banks, trust companies or other depositories as the President, the Treasurer or the Chief Financial Officer may be empowered by the Board of Directors to select or as the Board of Directors may select.

SECTION 7.4.   Voting of Securities Owned by Corporation. All stock and other securities of any other corporation owned or held by the Corporation for itself, or for other parties in any capacity, and all proxies with respect thereto shall be executed by the person authorized to do so by resolution of the Board of Directors or, in the absence of such authorization, by any Principal Officer.

ARTICLE 8

SHARES OF STOCK

SECTION 8.1.   Issuance. Each stockholder of the Corporation shall be entitled to a certificate or certificates showing the number of shares of stock registered in his or her name on the books of the Corporation. The certificates shall be in such form as may be determined by the Board of Directors, shall be issued in numerical order and shall be entered in the books of the Corporation as they are issued. They shall exhibit the holder’s name and the number of shares and shall be signed by the Chairman of the Board and the President or such other officers as may from time to time be authorized by resolution of the Board of Directors. Any or all the signatures on the certificate may be a facsimile. In case any officer who has signed or whose facsimile signature has been placed upon any such certificate shall have ceased to be such officer before such certificate is issued, such certificate may nevertheless be issued by the Corporation with the same effect as if such officer had not ceased to be such officer at the date of its issue. If the Corporation shall be authorized to issue more than one class of stock or more than one series of any class, the designation, preferences and relative participating, option or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and rights shall be set forth in full or summarized on the face or back of the certificate which the Corporation shall issue to represent such class of stock; provided that except as otherwise provided by the NRS, in lieu of the foregoing requirements there may be set forth on the face or back of the certificate which the Corporation shall issue to represent such class or series of stock, a statement that the Corporation will furnish to each stockholder who so requests the designations, preferences and relative participating, option or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and rights. All certificates surrendered to the Corporation for transfer shall be canceled and no new certificate shall be issued until the former certificate for a like number of shares shall have been surrendered and canceled, except that in the case of a lost, stolen, destroyed or mutilated certificate a new certificate (or uncertificated shares in lieu of a new certificate) may be issued therefor upon such terms and with such indemnity, if any, to the Corporation as the Board of Directors may prescribe. In addition to the above, all certificates (or uncertificated shares in lieu of a new certificate) evidencing shares of the Corporation’s stock or other securities issued by the Corporation shall contain such legend or legends as may from time to time be required by the NRS.

14

SECTION 8.2.   Lost Certificates. The Board of Directors may direct that a new certificate or certificates (or uncertificated shares in lieu of a new certificate) be issued in place of any certificate or certificates theretofore issued by the Corporation alleged to have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen or destroyed. When authorizing such issue of a new certificate or certificates (or uncertificated shares in lieu of a new certificate), the Board of Directors may, in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen or destroyed certificate or certificates, or his or her legal representative, to advertise the same in such manner as it shall require or to give the Corporation a bond in such sum as it may direct as indemnity against any claim that may be made against the Corporation with respect to the certificate or certificates alleged to have been lost, stolen or destroyed, or both.

SECTION 8.3.   Transfers. In the case of shares of stock represented by a certificate, upon surrender to the Corporation or the transfer agent of the Corporation of a certificate for shares duly endorsed or accompanied by proper evidence of succession, assignment or authority to transfer, it shall be the duty of the Corporation to issue a new certificate to the person entitled thereto, cancel the old certificate and record the transaction upon its books. Transfers of shares shall be made only on the books of the Corporation by the registered holder thereof, or by his or her attorney thereunto authorized by power of attorney and filed with the Secretary and the Corporation’s transfer agent, if any.

SECTION 8.4.   Registered Stockholders. The Corporation shall be entitled to treat the holder of record of any share or shares of stock as the holder in fact thereof and, accordingly, shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of the State of Nevada.

SECTION 8.5.   Uncertificated Shares. The Board of Directors may approve the issuance of uncertificated shares of some or all of the shares of any or all of its classes or series of capital stock.

ARTICLE 9

DIVIDENDS

SECTION 9.1.   Declaration. Dividends upon the capital stock of the Corporation, subject to the provisions of the Articles of Incorporation, if any, may be declared by the Board of Directors at any regular or special meeting, pursuant to law. Dividends may be paid in cash, in property or in shares of capital stock, subject to the provisions of the Articles of Incorporation.

SECTION 9.2.   Reserve. Before payment of any dividend, there may be set aside out of any funds of the Corporation available for dividends such sum or sums as the Board of Directors from time to time, in its absolute discretion, think proper as a reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the Corporation, or for such other purpose as the Board of Directors shall think conducive to the interests of the Corporation, and the Board of Directors may modify or abolish any such reserve in the manner in which it was created.

ARTICLE 10

LIMITATION ON LIABIILTY AND INDEMNIFICATION1

SECTION 10.1   No director or officer shall be personally liable to the Corporation or its shareholders for monetary damages for any breach of fiduciary duty by such director as a director. Notwithstanding the foregoing sentence, a director shall be liable to the extent provided by applicable law: (i) for acts or omissions not in good faith or which involve intentional misconduct, fraud or a knowing violation of law, or (ii) for any transaction from which the director derived an improper personal benefit. If the NRS is hereafter is amended to authorize the further elimination or limitation of the liability of directors, then the liability of a director of the Corporation, in addition to the limitation on personal liability provided herein, shall be limited to the fullest extent permitted by applicable law. No amendment to or repeal of this Section shall apply to or have any effect on the liability or alleged liability of any director of the Corporation for or with respect to any acts or omissions of such director occurring prior to such amendment.

1   Subject to further review by litigation counsel and review of D&O insurance policy.

15

SECTION 10.2    The Corporation shall, to the maximum extent permitted under the applicable law and except as set forth below, indemnify, old harmless and, upon request, advance expenses to each person (and the heirs, executors or administrators of such person) who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she is or was, or has agreed to become, a director or officer of the Corporation, or is or was serving, or has agreed to serve, at the request of the Corporation, as a director, officer or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, including any employee benefit plan (any such person being referred to hereafter as an “Indemnitee”), or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her or on his or her behalf in connection with such action, suit or proceeding and any appeal therefrom, if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. Notwithstanding anything to the contrary in this Section, the Corporation shall not indemnify an Indemnitee seeking indemnification in connection with any action, suit, proceeding, claim or counterclaim, or part thereof: initiated by the Indemnitee unless the initiation thereof was approved by the Board of Directors.

SECTION 10.3   Advance of Expenses. Notwithstanding any other provisions of the Articles of Incorporation, these Bylaws, or any agreement, vote of stockholder or disinterested directors, or arrangement to the contrary, the Corporation shall advance payment of expenses incurred by an Indemnitee in advance of the final disposition of any matter only upon receipt of an undertaking by or on behalf of the Indemnitee to repay all amounts so advanced in the event that it shall ultimately be determined that the Indemnitee is not entitled to be indemnified by the Corporation as authorized in this Section. Such undertaking may be accepted without reference to the financial ability of the Indemnitee to make such repayment.

SECTION 10.4   Subsequent Amendment. No amendment, termination or repeal of this Article 10 or of the relevant provisions of the Chapter 78 of the NRS or any other applicable laws shall affect or diminish in any way the rights of any Indemnitee to indemnification under the provisions hereof with respect to any action, suit, proceeding or investigation arising out of or relating to any actions, transactions or facts occurring prior to the final adoption of such amendment, termination or repeal.

SECTION 10.5   Non-Exclusivity of Rights. The indemnification and advancement of expenses provided by, or granted pursuant to, this Article 10 shall not be deemed exclusive of any other rights to which an Indemnitee seeking indemnification or advancement of expenses may be entitled under any Bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office, and shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be an officer, director or agent of the Corporation and shall inure to the benefit of the heirs, executors and administrators of such a person. All rights to indemnification under this Article 10 shall be deemed to be provided by a contract between the Corporation and the Indemnitee who serves in such capacity at any time while these Bylaws and other relevant provisions of the NRS and other applicable law, if any, are in effect.

16

SECTION 10.6   Other Rights. The Corporation may, to the extent authorized from time to time by its Board of Directors, grant indemnification rights to other employees or agents of the Corporation or other persons serving the Corporation and such rights may be equivalent to, or greater or less than, those set forth in this Section.

SECTION 10.7   Reliance. Persons who after the date of the adoption of this provision become or remain directors or officers of the Corporation or who, while a director or officer of the Corporation, become or remain a director, officer, employee or agent of a subsidiary, shall be conclusively presumed to have relied on the rights to indemnity, advance of expenses and other rights contained in this Section in entering into or continuing such service. The rights to indemnification and to the advance of expenses conferred in this Section shall apply to claims made against an Indemnitee arising out of acts or omissions which occurred or occur both prior and subsequent to the adoption hereof.

SECTION 10.8   Merger or Consolidation. If the Corporation is merged into or consolidated with another corporation and the Corporation is not the surviving corporation, the surviving corporation shall assume the obligations of the Corporation under this Section with respect to any action, suit, proceeding or investigation arising out of or relating to any actions, transactions or facts occurring prior to the date of such merger or consolidation,

SECTION 10.9   Insurance. The Corporation shall have power to purchase and maintain insurance on behalf of any person who is or was, or has agreed to become, a director, officer, employee or agent of the Corporation, or is or was serving, or has agreed to serve, at the request of the Corporation as a director, officer, employee, agent or trustee of another corporation, partnership, joint venture, trust or other enterprise, including any employee benefit plan, against all expenses (including attorney's fees) judgments, fines or amounts paid in settlement incurred by such person in any such capacity or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify him or her against such expenses under the Chapter 78 of the NRS.

SECTION 10.10Savings Clause. If this Article 10 or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the Corporation shall nevertheless indemnify each Indemnitee as to any expenses, including attorneys' fees, judgments, fines and amounts paid in settlement in connection with any action, suit, proceeding or investigation, whether civil, criminal or administrative, including an action by or in the right of the Corporation, to the fullest extent permitted by any applicable portion of this Article 10 that shall not have been invalidated and to the fullest extent permitted by applicable law.

SECTION 10.11Contested Director Indemnification. Notwithstanding anything to the contrary contained in these Bylaws, a director who was elected in any Contested Election who is not a continuing director shall not be entitled to any indemnification or advancement of expenses unless and until a majority of the continuing directors vote that the indemnification provisions set forth in this Article 10 shall apply to such newly elected director.

ARTICLE 11

MISCELLANEOUS

SECTION 11.1.   Books. The books of the Corporation may be kept within or without the State of Nevada (subject to any provisions contained in the NRS) at such place or places as may be designated from time to time by the Board of Directors.

17

SECTION 11.2.   Fiscal Year. The fiscal year of the Corporation shall be such fiscal year as may be designated by the Board of Directors.

SECTION 11.3   Forum Selection. Unless the Corporation consents in writing to the selection of an alternative forum, a state or federal court located in the City and County of Denver, Colorado shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim for breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any actions asserting a claim arising pursuant to any provision of the NRS, the Articles of Incorporation or these Bylaws, in each case as amended, or (iv) any action asserting a claim governed by the internal affairs doctrine, in each such case subject to such court having personal jurisdiction over the indispensable parties named as defendants therein. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Section 11.3.

ARTICLE 12

AMENDMENTS

SECTION 12.1   Amendment By Stockholders. The stockholders of the Corporation may alter, amend, repeal or the remove these Bylaws or any portion thereof only by the affirmative vote of sixty-six and two-thirds percent (66 2/3%) of the stockholders entitled to vote at a meeting of the stockholders, duly called; provided, however, that no such change to any Bylaw shall alter, modify, waive, abrogate or diminish the Corporation’s obligation to provide the indemnity called for by Article 10 of these Bylaws, the Articles of Incorporation or applicable law.

SECTION 12.2   Amendment by the Board of Directors. Notwithstanding Section 12.1, the Board of Directors may, by majority vote of those present at any meeting at which a quorum is present, alter, amend or repeal these Bylaws or any portion thereof, or enact such other Bylaws as in their judgment may be advisable for the regulation of the conduct of the affairs of the Corporation.

18

Exhibit G

Voting Agreement

SHAREHOLDER VOTING SUPPORT AND CONFIDENTIALITY AGREEMENT

SHAREHOLDER VOTING SUPPORT AND CONFIDENTIALITY AGREEMENT (this “Agreement”), dated as of March 31, 2017, by and among First Capital Real Estate Trust Incorporated, a Maryland corporation (“First Capital”), and those holders of securities of PhotoMedex, Inc. a Nevada corporation (the “Company”), listed on Schedule I annexed hereto (each a “Stockholder” and collectively, the Stockholders”).

Whereas, First Capital, First Capital Real Estate Operating Partnership, L.P. (the “Contributor”), the Company, and FC Global Realty Operating Partnership, LLC (the “Acquiror”) have entered into a Contribution Agreement dated March 31, 2017 (the “Contribution Agreement”), pursuant to which the Contributor will contribute to the Acquiror its interests in and to certain entities and real properties in exchange for shares of common stock, par value $.01 per share, of the Company, shares of preferred stock, par value $.01 per share, of the Company and warrants to purchase shares of common stock, par value $0.01 per share, of the Company.

Whereas, in connection with the Contribution Agreement, the parties hereto desire to enter into this shareholder voting support and confidentiality agreement.

Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Contribution Agreement.

As of the date hereof, each Stockholder is the record owner of the number and type of securities of the Company set forth opposite the name of such Stockholder on Schedule I hereto.

As a condition to the willingness of First Capital to enter into the Contribution Agreement and as an inducement and in consideration therefor, First Capital and each Stockholder have agreed to enter into this Agreement.  

The parties, intending to be legally bound, agree as follows:

SECTION 1.  Stockholder Meetings; Voting.  Each Stockholder hereby agrees that from and after the date hereof and until this Agreement is terminated in accordance with Section 7, such Stockholder shall appear in person or by proxy at any meeting of the stockholders of the Company called for purposes, and any adjournment or postponement thereof, or in any other circumstances upon which a vote, consent or other approval with respect to the Contribution Agreement or the transactions contemplated by the Contribution Agreement is sought by the Company and approved by the board of directors of the Company and recommended to the stockholders of the Company by the board of directors that include any of the following (i) the adoption of the Contribution Agreement and the transactions contemplated by the Contribution Agreement, or (ii) the approval of the number of shares or voting power that can be issued or granted by the Company to First Capital or its stockholders or Affiliates; provided, however, that if a proposal presented to the stockholders of the Company involves the approval of the issuance of the Company’s securities in connection with the contribution of the Mandatory Entity Interests or the Optional Entity Interests, then the board shall have approved and recommended this proposal to the stockholders of the Company by a vote of at least six board members in favor of the proposal.  The Company shall notify the Stockholders of whether such requirement has been met.

Each Stockholder hereby agrees that from and after the date hereof and until this Agreement is terminated in accordance with Section 7, such Stockholder shall exercise all of his, her or its rights as a holder of securities of the Company to vote as follows to the extent that the following are approved by the board of directors of the Company and recommended to the stockholders of the Company: (i) in favor of the adoption of the Contribution Agreement and the approval of the transactions contemplated by the Contribution Agreement; (ii) in favor of any proposal seeking approval for the issuance to the Contributor or its designees of common stock of the Company (or securities convertible into or exercisable for common stock of the Company) equal to 20 percent or more of the common stock or 20 percent or more of the voting power outstanding before the issuance, in order that (A) any shares of Series A Preferred Stock of the Company previously issued by the Company to the Contributor or its designees can be immediately converted into Common Stock of the Company, (B) the Warrant (as defined in the Contribution Agreement) can be fully exercised for Common Stock of the Company in accordance with its terms, and (iii) all shares of Common Stock of the Company issuable to the Contributor or its designees pursuant to the Contribution Agreement can be issued to the Contributor as provided therein , (iii) against any proposal made in opposition to, or in competition with, the matters set forth in (i) or (ii) above; and (iv) against any other action that is intended, or would reasonably be expected to, impede, interfere with, delay, postpone, discourage or adversely affect the adoption of the Contribution Agreement and approval of the transactions contemplated by the Contribution Agreement; at any meeting of the stockholders of the Company.  Notwithstanding the foregoing, if a proposal presented to the stockholders of the Company involves the approval of the issuance of the Company’s securities in connection with the contribution of the Mandatory Entity Interests or the Optional Entity Interests, then the board shall have approved and recommended this proposal to the stockholders of the Company by a vote of at least six board members in favor of the proposal.  The Company shall notify the Stockholders of whether such requirement has been met.  It is the intention of this paragraph that each Stockholder shall be obligated to vote in accordance with the above regardless of the particular wording of any proposal put forth to the stockholders of the Company, in a manner consistent with the purpose of authorizing the Contribution Agreement and the issuance to the Contributor or its designees of shares of Common Stock of the Company having the maximum voting power as is contemplated by the Contribution Agreement.

SECTION 2.  Restriction on Transfer.  

(a)  Each Stockholder agrees that he, she or it will not directly or indirectly, prior to the termination of this Agreement: (i) transfer, assign, sell, lend, sell short, gift-over, pledge, encumber, hypothecate, exchange or otherwise dispose (whether by sale, liquidation, dissolution, dividend or distribution), or offer or solicit to do any of the foregoing, of any or all of the equity securities and/or any debt or similar securities that are convertible into equity securities of the Company held by him, her or it, including any additional equity securities and/or any debt or similar securities that are convertible into equity securities of the Company which Stockholder may subsequently acquire, including all additional equity securities which may be issued to Stockholder upon the exercise of any options, warrants or other securities convertible into or exchangeable for securities of the Company (all such securities of such Stockholder, “Subject Securities”) or any right or interest therein, or consent to any of the foregoing (any such action, a “Transfer”), (ii) enter or offer to enter into any derivative arrangement with respect to, or create or suffer to exist any liens or encumbrances with respect to, any or all of the Subject Securities or any right or interest therein, in either case that would reasonably be expected to prevent or delay such Stockholder’s compliance with his, her or its obligations hereunder; (iii) enter of offer to enter into any contract, option or other agreement, arrangement or understanding with respect to any Transfer; (iv) grant any proxy, power-of-attorney or other authorization or consent with respect to any Subject Securities with respect to any matter that is, or that could be exercised in a manner, inconsistent with the transactions contemplated by the Contribution Agreement and this Agreement or the provisions thereof and hereof; (v) deposit any Subject Securities into a voting trust, or enter into a voting agreement or arrangement with respect to any Subject Securities; or (vi) enter or offer to enter into any contract or agreement that would be breached by, or take any other action that would reasonably be expected to prevent or delay such Stockholder’s compliance with its obligations hereunder.

2

(b)  Each Stockholder hereby acknowledges and agrees that the Company shall be entitled, during the term of this Agreement, to cause any transfer agent for the Subject Securities to decline to effect any Transfer and to note stop transfer restrictions on the stock register and other records relating to Subject Securities, and each Stockholder agrees to execute and deliver any further documents reasonably requested by the Company in furtherance of the same.

(c)  Notwithstanding the foregoing, the restrictions set forth in this Section 2 shall not apply (A) to the exercise of any option, warrant or other securities convertible or exchangeable for securities of the Company or (B) to the following Transfers of Subject Securities by the Stockholder:

(i)  if such Stockholder is an individual (A) for nominal consideration or as a gift to any member of such Stockholder’s “immediate family” (defined for purposes of this Agreement as the spouse, parents, lineal descendants, the spouse of any lineal descendant, and brothers and sisters) or a trust for the benefit of such Stockholder or any member of such Stockholder’s immediate family, or (B) upon the death of such Stockholder pursuant to a will or other instrument taking effect upon the death of such Stockholder, or pursuant to the applicable laws of descent and distribution to such Stockholder’s estate, heirs or distributees; and

(ii)  if the Stockholder is a corporation, partnership, limited liability company or other entity, any Transfer to an Affiliate of the Stockholder if such Transfer is not for value;

provided, however, that in the case of any Transfer described in clauses (i) or (ii) of this Section 2(c), it shall be a condition to the Transfer that (x) the transferee executes and delivers to the Company and First Capital, not later than one business day prior to such Transfer, a written agreement that is reasonably satisfactory in form and substance to the Company and First Capital to be bound by all of the terms of this Agreement and the Contribution Agreement (any references to immediate family in the agreement executed by such transferee shall expressly refer only to the immediate family of the Stockholder and not to the immediate family of the transferee) and (y) if the Stockholder is required to file a report under Section 16(a) of the Securities Exchange Act of 1934, as amended, reporting a reduction in beneficial ownership of the Subject Securities or any securities convertible into or exercisable or exchangeable for the Subject Securities, the Stockholder shall include a statement in such report to the effect that, in the case of any Transfer pursuant to Section 2(c)(i) above, such Transfer is being made as a gift or by will or intestate succession or, in the case of any Transfer pursuant to Section 2(c)(ii) above, such Transfer is being made to a shareholder, partner or member of, or owner of a similar equity interest in, the Stockholder and is not a Transfer for value.

(iii)  For purposes hereof, “Affiliate” shall mean, with respect to any entity, any other person or entity directly or indirectly controlling, controlled by or under common control with such entity.  For purposes hereof, “control” (including the terms “controlled by” and “under common control with”), as used with respect to any entity or person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such entity or person, whether through the ownership of voting securities or otherwise.  

SECTION 3.  Representations and Warranties of Stockholders. Each Stockholder on its own behalf hereby represents and warrants to First Capital as follows:

(a)  Such Stockholder is the record owner of the equity securities and/or any debt or similar securities that are convertible into equity securities of the Company set forth opposite the name of such Stockholder on Schedule I to this Agreement.  As of the date of this Agreement, the equity securities and/or any debt or similar securities that are convertible into equity securities of the Company set forth opposite the name of such Stockholder on Schedule I to this Agreement represent all of the shares of equity securities and/or any debt or similar securities that are convertible into equity securities of the Company owned of record by such Stockholder.

3

(b)  If the Stockholder is a corporation, partnership, limited liability company or other entity, such Stockholder is an entity duly organized, validly existing and in good standing under the laws of its jurisdiction, and has all requisite organizational power and authority to execute and deliver this Agreement and to consummate the transactions contemplated hereby, and has taken all necessary organizational action to authorize the execution, delivery and performance of this Agreement.

(c)  If the Stockholder is an individual, such Stockholder has the valid capacity to execute and deliver this Agreement and has duly executed and delivered this Agreement.

(d)  If the Stockholder is a corporation, partnership, limited liability company or other entity, this Agreement has been duly authorized, executed and delivered by such Stockholder.

(e)  This Agreement, assuming it constitutes a valid and binding obligation of First Capital, constitutes a valid and binding obligation of the Stockholder, enforceable against such Stockholder in accordance with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and other laws of general application affecting enforcement of creditors’ rights generally.

(f)  The execution, delivery and performance by such Stockholder of this Agreement does not require any consent, approval, authorization or permit of, action by, filing with or notification to any governmental authority or other third party, other than any consent, approval, authorization, permit, action, filing or notification the failure of which to make or obtain would not, individually or in the aggregate, be reasonably expected to prevent or materially delay the consummation of the transactions contemplated by the Contribution Agreement or such Stockholder’s ability to observe and perform its material obligations hereunder (a “Stockholder Material Adverse Effect”).

(g)  The execution, delivery and performance by such Stockholder of this Agreement will not (i) result in a violation of, or default (with or without notice or lapse of time, or both) under, require consent under or give rise to a right of termination, cancellation or acceleration of any obligation or the loss of any benefit under any (A) contract, trust, commitment, agreement, understanding or arrangement of any kind (a “Contract”) or (B) permit, concession, franchise, right or license binding upon such Stockholder, (ii) result in the creation of any pledges, liens, claims, security interests, proxies, voting trusts or agreements, options, rights (other than community property interests), understandings or arrangements or any other encumbrance or restriction whatsoever on title transfer (collectively, “Encumbrances”), other than Encumbrances imposed by federal or state securities laws (collectively, “Permitted Encumbrances”), upon any of the properties or assets of such Stockholder, (iii) If the Stockholder is a corporation, partnership, limited liability company or other entity, conflict with or result in any violation of any provision of the organizational documents of such Stockholder, or (iv) conflict with or violate any applicable laws, other than, in the case of clauses (i), (ii) and (iv), as would not, individually or in the aggregate, be reasonably expected to have a Stockholder Material Adverse Effect. The consummation by such Stockholder of the transactions contemplated by this Agreement will not (i) violate any provision of any judgment, order or decree applicable to such Stockholder or (ii) require any consent, approval, or notice under any statute, law, rule or regulation applicable to such Stockholder.

(h)  Such Stockholder’s Subject Securities are now, and at all times during the term hereof will be, held by such Stockholder or by a nominee or custodian for the benefit of such Stockholder, free and clear of all Encumbrances, except for (i) any such Encumbrances arising hereunder, (ii) Permitted Encumbrances and (iii) any Encumbrance imposed by any margin account in with the Subject Securities may be held (provided, that the Stockholder retains voting and dispositional control of any such Subject Securities); provided, that such Stockholder may Transfer such Subject Securities in accordance with the provisions of a separate lock-up agreement being entered into between such Stockholder and the other parties thereto in accordance with the Contribution Agreement.

4

(i)  Such Stockholder understands and acknowledges that First Capital is entering into the Contribution Agreement in reliance upon Stockholder’s execution and delivery of this Agreement.

(j)  No broker, investment bank, financial advisor or other person is entitled to any broker’s, finder’s, financial adviser’s or similar fee or commission in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of such Stockholder.

SECTION 4.  Representations and Warranties of First Capital.  First Capital hereby represents and warrants to the Stockholders as follows:

(a)  First Capital is a corporation duly organized, validly existing and in good standing under the laws of the State of Maryland, and First Capital has all requisite organizational power and authority to execute and deliver this Agreement and to consummate the transactions contemplated hereby, and has taken all necessary corporate action to authorize the execution, delivery and performance of this Agreement.

(b)  This Agreement has been duly authorized, executed and delivered by First Capital, and, assuming this Agreement constitutes a valid and binding obligation of the other parties hereto, constitutes a valid and binding obligation of First Capital, enforceable against it in accordance with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium and other laws of general application affecting enforcement of creditors’ rights generally.

(c)  The execution, delivery and performance by First Capital of this Agreement does not require any consent, approval, authorization or permit of, action by, filing with or notification to any governmental authority or other third party, other than any consent, approval, authorization, permit, action, filing or notification the failure of which to make or obtain would not, individually or in the aggregate, be reasonably expected to prevent or materially delay the consummation of the transaction contemplated by the Contribution Agreement or First Capital’s ability to observe and perform its material obligations hereunder (a “First Capital Material Adverse Effect”).

(d)  The execution, delivery and performance by First Capital of this Agreement will not (i) result in a violation of, or default (with or without notice or lapse of time, or both) under, require consent under or give rise to a right of termination, cancellation or acceleration of any obligation or the loss of any benefit under any (A) Contract or (B) permit, concession, franchise, right or license binding upon First Capital, (ii) result in the creation of Encumbrances (other than Permitted Encumbrances) upon any of the properties or assets of First Capital, (iii) conflict with or result in any violation of any provision of the organizational documents of First Capital, or (iv) conflict with or violate any applicable laws, other than, in the case of clauses (i), (ii) and (iv), as would not, individually or in the aggregate, be reasonably expected to have a First Capital Material Adverse Effect. The consummation by First Capital of the transactions contemplated by this Agreement will not (i) violate any provision of any judgment, order or decree applicable to First Capital or (ii) require any consent, approval, or notice under any statute, law, rule or regulation applicable to First Capital.

5

SECTION 5.  Confidentiality.  

(a)  Confidentiality by the Stockholders.  Except as otherwise required by applicable law, each Stockholder agrees to treat and hold as confidential, any confidential or proprietary information of First Capital relating, except for any such information which is generally known to the public or becomes generally known to the public, other than as a result of a disclosure by such Stockholder and not due to the breach of this Agreement (“Confidential Information”), and to refrain from disclosing any Confidential Information, except in accordance with the provisions of this Section 5.  Unless otherwise public information, the existence of any business negotiations, discussions, consultations or agreements in progress between the parties hereto, or between First Capital and certain third parties, shall not be released to any form of public media without the prior written consent of First Capital.  Each Stockholder agrees that it shall treat all Confidential Information with at least the same degree of care as it accords to its own information of like nature, and each Stockholder represents that it exercises at least reasonable care to protect its own confidential information.  Each Stockholder may disclose Confidential Information only to those of its employees, officers, directors, shareholders, partners, members, or owners of a similar equity interest in the Stockholder, or any of Stockholder’s agents or representatives (all such persons or entities, collectively, “Stockholder Representatives”) who (i) need to know such information for the purposes of advising such Stockholder with respect to the Contribution Agreement and the consummation of the transactions contemplated by the Contribution Agreement and (ii) are informed by such Stockholder of the confidential nature of the Confidential Information and the obligations under this Agreement with respect to such Confidential Information.  Each Stockholder also agrees to be responsible for enforcing the terms of this letter agreement as to its Stockholder Representatives and maintaining the confidentiality of the Confidential Information and to take such action, legal or otherwise, to the extent necessary to cause them to comply with the terms and conditions of this letter agreement and thereby prevent any disclosure or prohibited use of Confidential Information by any of its Stockholder Representatives.

(b)  Disclosure Required by Law.  Notwithstanding the foregoing, the Stockholder or any of the Stockholder’s Representatives may disclose Confidential Information without First Capital’s consent to the extent required by law or legal process (provided that, unless prohibited by law, it first provides prompt notice to First Capital so that First Capital may seek a protective order or other appropriate remedy or consent to the disclosure).  In the event the Stockholder or any of the Stockholder’s Representatives are required to so disclose Confidential Information, the Stockholder or such Representative may furnish that portion (and only that portion) of the Confidential Information that such person or entity has been advised by legal counsel that it is legally compelled or otherwise required to disclose, and such person or entity shall use all reasonable efforts to obtain reliable assurance that confidential treatment will be accorded any Confidential Information so disclosed and, if requested by First Capital, shall use reasonable efforts to assist First Capital in obtaining an order or other assurance that confidential treatment will be accorded to such Confidential Information so disclosed.

(c)  Stockholder Acknowledgment.  Each Stockholder also acknowledges and agrees that he, she or it is aware of the restrictions imposed by the United States federal securities laws and other applicable foreign and domestic laws on a person or entity in possession of material non-public information about a public company and that such Stockholder will comply with such laws.

SECTION 6.  Fiduciary Responsibilities. No Stockholder executing this Agreement who is or becomes during the term hereof a director or officer of the Company makes (or shall be deemed to have made) any agreement or understanding herein in his or her capacity as such director or officer. Without limiting the generality of the foregoing, each Stockholder signs solely in his or her capacity as the record owner of such Stockholder’s Subject Securities and nothing herein shall limit or affect any actions taken by such Stockholder (or a designee of such Stockholder) in his or her capacity as an officer or director of the Company in exercising his or her or the Company’s or the Company’s Board of Directors’ rights in connection with the Contribution Agreement or otherwise and such actions shall not be deemed to be a breach of this Agreement.

6

SECTION 7.  Termination.

(a)  This Agreement, and all rights and obligations of the parties hereunder, shall terminate immediately upon the earliest to occur of the following:

(i)  that date of the termination of the Contribution Agreement in accordance with its terms;

(ii)  the later of (A) the date of the last closing of the transactions described in the Contribution Agreement or (B) the first Business Day following the date of the approval by the stockholders of the Company of the full issuance of Transaction Shares having voting rights in excess of 20% to First Capital or its stockholders or Affiliates;

(iii)  upon the earlier of (1) 14 days written notice by Stockholder to the Company and First Capital or (2) the day preceding the initial date of the meeting of the Stockholders called to vote on the adoption of the Contribution Agreement, following any modification, waiver or amendment of the Contribution Agreement that has a materially adverse effect on (x) the value of (A) the Subject Securities following the closing of the transactions described in the Contribution Agreement or (B) the consideration to be paid to such Stockholder pursuant to the Contribution Agreement, or (y) the date of the closing of the transactions described in the Contribution Agreement;

(iv)  the mutual written consent of First Capital and the Stockholders.

(b)  Except as set forth in Section 6(c), upon termination of this Agreement, except in the case of liability for any willful breach by any party to this Agreement prior to termination from which liability termination shall not relieve any such party, all obligations of the parties under this Agreement will terminate, without any liability or other obligation on the part of any party hereto to any person or entity in respect hereof or the transactions contemplated hereby, and no party shall have any claim against another (and no person shall have any rights against such party), whether under contract, tort or otherwise.

(c) Sections 4 of this Agreement shall survive the termination of this Agreement until the first anniversary of the date of this Agreement.  Section 7 of this Agreement shall survive the termination of this Agreement indefinitely.  

SECTION 8.  Expenses. All fees and expenses incurred in connection with this Agreement and the transactions contemplated hereby shallwill be paid by the party incurring such expenses. As used in this Agreement, “expenses” means the out-of-pocket fees orand expenses whether or notof the financial advisor, counsel and accountants incurred in connection with this Agreement and the transactions contemplated by the Contribution Agreement are consummated.  hereby and thereby.

 

SECTION 9.(l)       Miscellaneous.

(a)  Liabilities SeveralAttorney’s Fees. The agreements, obligations, representations and warranties of the Stockholders hereunder are made severally and not jointly.  

(b)  Effectiveness of Agreement.  The agreements, obligations, representations and warranties of the Stockholders set forth inIf any party to this Agreement shall not be effectivebring any action for relief against another arising out of or binding upon any Stockholder until after such time as the Contribution Agreement is executed and delivered by the parties thereto.  

(c)  Notices. All notices, consents, waivers and other communications required or permitted byin connection with this Agreement, in addition to all other remedies to which the prevailing party may be entitled, the losing party shall be in writing and shall be deemed givenrequired to a party when (a) deliveredpay to the appropriate address by handprevailing party a reasonable sum for attorney’s fees and costs incurred in bringing or by nationally recognized overnight courier service; defending such action and/or (b) transmitted by telecopy or e-mail (with confirmation of transmission) by the transmitting equipment confirmed with a copy delivered as provided in clause (a), in each case to the following addresses, facsimile numbers or e-mail addresses and marked to the attention of the person (by name or title) designated below (or to such other address, telecopy number, e-mail address or person as a party may designate by notice to the other parties).

7

If to a Stockholder, to:

the address set forth on the signature page hereof

and to:

PhotoMedex, Inc.
2300 Computer Drive, Building G

Willow Grove, PA 19090

Attention: Dr. Dolev Rafaeli

Email:dolev@radiancy.com

With a copy (which shall not constitute notice) to:

BEVILACQUA PLLC
1629 K Street, NW, Suite 300

Washington, DC  20006

Attention: Louis A. Bevilacqua, Esq.

Email: lou@bevilacquapllc.com

If to the Company or Acquiror, to:

First Capital Real Estate Trust Incorporated

60 Broad Street, 34th Floor

New York NY 10004

Attention: Suneet Singal

Email: s@firstcapitalre.com

with a copy (which shall not constitute notice) to:

Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas

New York, New York 10105
Attention:  Barry I. Grossman, Esq.
Facsimile: (212) 370-7889

(d)  Headings. The headings contained in this Agreement are for reference purposes only and shall not affect inenforcing any way the meaning or interpretation of this Agreement.

(e)  Counterparts. This Agreement may be executed in one or more counterparts, eachjudgment granted therein, all of which shall be deemed an originalto have accrued upon the commencement of such action and all of which taken together shall constitute one and the same instrument.  This Agreement or any counterpart may be executed and delivered by facsimile copies or delivered by electronic communications by portable document format (.pdf), each of which shall be deemed an originalpaid whether or not such action is prosecuted to judgment. Any judgment or order entered in such action shall contain a specific provision providing for the other parties.

(f)  Entire Agreement; No Third Party Beneficiaries. This Agreement (includingrecovery of attorney’s fees and costs incurred in enforcing such judgment. For the Exhibits and Schedules hereto) constitutes the entire agreement, and supersedes all prior agreements and understandings, both written and oral, among the partiespurposes of this Section, attorney’s fees shall include, without limitation, fees incurred with respect to the subject matter of this Agreement, including the Original Agreementfollowing: (i) post-judgment motions, (ii) contempt proceedings, (iii) garnishment, levy and (b) is not intended to confer, nor shall it confer, upondebtor and third party examinations, (iv) discovery, (v) bankruptcy litigation and (vi) any Person other than the parties hereto any legal or equitable rights or remedies or benefits of any nature whatsoever.

8

(g)  Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, regardless of the laws that might otherwise apply under applicable principles of conflicts of law thereof.appellate proceedings.

 

(h)(m)       Waiver of Jury Trial.  EACH OF THE PARTIES HERETO IRREVOCABLY WAIVESEACH WAIVE, TO THE EXTENT PERMITTED BY LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION PROCEEDING OR LITIGATION BETWEEN THE PARTIES HERETO ARISING OUT OF ORPROCEEDING RELATING TO THIS AGREEMENT.

 

(i)  Assignment; Binding Effect.  Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned (in whole or in part) by any of the parties hereto (whether by operation of law or otherwise) without the prior written consent of the other parties, and any such assignment without such consent shall be null and void.  No assignment by any party shall relieve such party of any of its obligations hereunder.  Subject to the preceding sentences, this Agreement shall be binding upon, and shall inure to the benefit of, and shall be enforceable by the parties hereto and their respective successors and assigns.

(j)  Severability of Provisions.  If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect, insofar as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable law in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the extent possible.

(k)  Specific Performance, Jurisdiction, Enforcement.

(i)  The parties agree that irreparable damage for which money damages, even if available, would not be an adequate remedy, if any provision of this Agreement is not performed in accordance with its specific terms or is otherwise breached. Accordingly, the parties agree that, prior to the valid termination of this Agreement in accordance with Section 7, each party shall be entitled to an injunction or injunctions, or any other appropriate form of specific performance or equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement exclusively in the federal and state courts located in New York County, New York, this being in addition to any other remedy to which they are entitled at law or in equity.  Each party further agrees that no other party shall be required to obtain, furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in this Section 9(k), and each party hereto hereby irrevocably waives any right he, she or it may have to require the obtaining, furnishing or posting of any such bond or similar instrument.

(ii)  Each of the parties irrevocably submits itself to the exclusive jurisdiction of the federal and state courts located in the New York County, New York for the purpose of any action, proceeding or litigation directly or indirectly based upon, relating to or arising out of this Agreement or any of the transactions contemplated by this Agreement or the negotiation, execution or performance hereof or thereof, or any other appropriate form of specific performance or equitable relief, (b) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court and (c) agrees that it will not bring any action, proceeding or ligitation relating to this Agreement or the transactions contemplated by this Agreement in any court other than any of the federal and state courts located in the State of Delaware. Each of the parties hereby irrevocably waives, and agrees not to assert, by way of motion, as a defense, counterclaim or otherwise, in any action, proceeding or litigation with respect to this Agreement, (i) any claim that it is not personally subject to the jurisdiction of the above-named courts for any reason other than the failure to serve in accordance with this Section 9(k), (ii) any claim that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (iii) to the fullest extent permitted by the applicable law, any claim that (A) the suit, action or proceeding in such court is brought in an inconvenient forum, (B) the venue of such suit, action or proceeding is improper or (C) this Agreement, or the subject matter of this Agreement, may not be enforced in or by such courts.

9

(iii)  Each of the parties hereby irrevocably consents to service being made through the notice procedures set forth in Section 9(c) and agrees that service of any process, summons, notice or document by personal delivery or by registered mail (return receipt requested and first-class postage prepaid) to the respective addresses set forth in Section 9(c) and on the signature pages hereto shall be effective service of process for any action, proceeding or litigation in connection with this Agreement or the transactions contemplated hereby.  Nothing in this Section 9(k) shall affect the right of any party to serve legal process in any other manner permitted by law.

(l)  Amendment. No amendment or modification of this Agreement shall be effective unless it shall be in writing and signed by each of the parties hereto, and no waiver or consent hereunder shall be effective against any party unless it shall be in writing and signed by such party.

[Signature Page Follows]

page follows]

10

IN WITNESS WHEREOF, each of the parties hereto hashave caused this Agreement to be duly executed and delivered as of the date and year first written above.

 

 

FIRST CAPITAL REAL ESTATE OPERATING

PARTNERSHIP, L.P.

FC GLOBAL:
  
 

By: First Capital Real Estate TrustFCGlobal Realty Incorporated its

general partner

  
 By: 
 Name: Suneet SingalMichael R. Stewart
 Title:Chief Executive Officer
  
 STOCKHOLDERS:Address:  2300 Computer Drive, Building G
Willow Grove, PA 19090
Fax:
Email: Michael@fcglobalrealty.com
OFI:
Opportunity FundI-SS, LLC
By: OP Fund I Manager, LLC
By:
Name: Kristen Pigman
Title: Director
Address:2481 Sunrise Boulevard, Suite 200
Gold River, CA 95670
Fax: 916.853.2805
Email: kris@thepigmancompanies.com
NOTE HOLDERS:
  
  
 Lewis C. Pell
Yoav Ben-Dror
Dr. Dolev Rafaeli
  
 Dennis M. McGrath
  
 
Katsumi Oneda
Stephen P. ConnellyYoav Ben-Dror

SCHEDULE I

 

Name and AddressType of SecurityNumber of Shares
Lewis C. Pell
2300 Computer Drive, Building G
Willow Grove, PA 19090
Common stock401,064
Yoav Ben-Dror
2300 Computer Drive, Building G
Willow Grove, PA 19090
Common stock299,185
Dolev Rafaeli
2300 Computer Drive, Building G
Willow Grove, PA 19090
Common stock149,775
Dennis M. McGrath
2300 Computer Drive, Building G
Willow Grove, PA 19090
Common stock51,278
Katsumi Oneda
2300 Computer Drive, Building G
Willow Grove, PA 19090
Common stock265,033
Stephen P. Connelly
2300 Computer Drive, Building G
Willow Grove, PA 19090
Common stock1,435

EXHIBIT A

  

 Payout SharesSeries C Preferred Stock

Dr. Dolev Rafaeli

 

3,134,8764,169,385

Dennis M. McGrath

 

977,9601,300,687

Yoav Ben-Dror

 

1,515,4552,015,555


Exhibit HEXHIBIT B

 

Form of Payout NotesCertificate of Designation of Series C Preferred Stock

 

(See Attached)


NEITHER THIS NOTE NOR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAW, AND SUCH SECURITIES MAY NOT BE SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR STATE LAW OR AN OPINION OF COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED.

$[                         ].00[               ], 201_

PHOTOMEDEX, INC.FC GLOBAL REALTY INCORPORATED

 

SECURED CONVERTIBLE PAYOUT NOTE DUE [                      ], 201_
CERTIFICATE OF DESIGNATION OF PREFERENCES,
RIGHTS AND LIMITATIONS
OF
SERIES C PREFERRED STOCK

 

PURSUANT TO SECTION 78.1955 OF THE
NEVADA REVISED STATUTES

FOR VALUE RECEIVED, PhotoMedex, Inc.,
FC Global Realty Incorporated, a Nevada corporation (the “CompanyCorporation”), does hereby promises to paycertify that, pursuant to the orderauthority contained in its Articles of [                               ]Incorporation, as amended, and in accordance with the provisions of Section 78.1955 of the Nevada Revised Statutes, the board of directors of the Corporation (the “Board of Directors”) has adopted the following resolution creating the following series of the Corporation’s Series C Preferred Stock and determined the voting powers, designations, powers, preferences and relative, participating, optional, or other special rights, and the qualifications, limitations, and restrictions thereof, of such series:

RESOLVED, that the Board of Directors does hereby provide for the issuance of the following series of preferred stock for cash or exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters relating to such series of preferred stock as follows:

Section 1.          Definitions. For the purposes hereof, the following terms shall have the following meanings:

Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act of 1933, as amended.

Common Stock” means the Corporation’s common stock, par value $0.01 per share, and stock of any other class of securities into which such securities may hereafter be reclassified or changed.

Common Stock Equivalents” means any securities of the Corporation or any of its subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

Conversion Date” means the date on which approval from the stockholders of the Corporation with respect to the Remediation Agreement and the transactions contemplated thereby, including the issuance of the Conversion Shares, has been obtained.

Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Series C Preferred Stock in accordance with the terms hereof.

Holder” means a holder of shares of Series C Preferred Stock.


Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

Remediation Agreement” means the Remediation Agreement, dated September 24, 2018, between the Corporation, Opportunity Fund I-SS, LLC, Dr. Dolev Rafaeli, Dennis M. McGrath and Yoav Ben-Dror.

Requisite Holders” means holders of a majority of the outstanding shares of Series C Preferred Stock.

Trading Day” means a day on which the principal Trading Market is open for business.

Trading Market” means any of the NYSE, the NYSE MKT, NASDAQ, the OTC Bulletin Board system, the OTCQX market operated by OTC Markets and the OTCQB market operated by OTC Markets Group or any other market on which the Common Stock may be listed or quoted for trading on the date in question.

Section 2.          Designation, Amount and Stated Value. The series of preferred stock shall be designated as Series C Preferred Stock, par value $0.01 per share (the “Series C Preferred Stock”), and the principal amountnumber of [                     ] ($[ ])shares so designated shall be Seven Million Four Hundred Eighty-Five Thousand Six Hundred Twenty-Seven (7,485,627) (which shall not be subject to increase without the written consent of the Requisite Holders). Each share of Series C Preferred Stock shall have a stated value of $1.00 per share (the “Principal Amount”), together with interest as hereinafter provided, on [                               ], 201_1 (the “Maturity DateStated Value”).

 

This Secured Convertible Payout Note (this “Note”) is being issuedSection 3.          Dividends. Except for stock dividends or distributions for which adjustments are to be made pursuant to Section 7, Holders shall be entitled to receive, and the Corporation shall pay, dividends on shares of Series C Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in connection with the closingsame form as dividends actually paid on shares of the transactions contemplated by that certain Interest Contribution Agreement, dated March 31, 2017 (the “Contribution Agreement”), byCommon Stock when, as and among First Capital Real Estate Operating Partnership, L.P., a Delaware limited partnership, First Capital Real Estate Trust Incorporated, a Maryland corporation, FC Global Realty Operating Partnership, LLC, a Delaware limited liability company, andif such dividends are paid on shares of the Company. All capitalized terms used but not otherwise defined in this NoteCommon Stock. No other dividends shall have the same meanings ascribed to them in the Contribution Agreement.be paid on shares of Series C Preferred Stock.

 

By his receipt hereof, the Holder acknowledges and agrees that: (i) the Principal Amount represents, asSection 4.          Liquidation. Upon any liquidation, dissolution or winding-up of the date hereof,Corporation, whether voluntary or involuntary (a “Liquidation”), the full and completeHolders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation the same amount that a holder of all compensation liabilities owed byCommon Stock would receive if the Company and its Subsidiaries and affiliatesSeries C Preferred Stock were fully converted to Common Stock immediately prior to such Liquidation, which amount shall be paid to the Holder (“Compensation Liabilities”); (ii)Holders of the Series C Preferred Stockpari passu with all such Compensation Liabilities are being memorializedholders of the Corporation’s outstanding Series D Preferred Stock and in this Note and no other oral or written agreement, document or instrument; and (iii) upon payment in full of all obligations hereunder, the Company shall have repaid all Compensation Liabilitiespreference to the holders of the Corporation’s Common Stock. The Corporation shall mail written notice of any such Liquidation, not less than 45 days prior to the payment date stated therein, to each Holder.

 

Any payments on account ofSection 5.          Voting Rights. Except as otherwise provided herein or as otherwise required by law, the NoteSeries C Preferred Stock shall be applied first to interest and then to principal.have no voting rights.

 

Interest on the outstanding Principal Amount shall be paid in: (i) cash or (ii) at the election of the Holder, in restricted shares of the Company’s common stock, par value $.01 per share (“Common Stock”) as provided in Article 1(a)Section 6.         Automatic Conversion. Interest shall be paid at the rate of ten percent (10%) per annum and shall be payable monthly in arrears commencing on [                     ], 2017 (each such payment, a “Monthly Interest Payment” and each date of such payment, an “Interest Payment Date”). Interest shall be computed on the basis of a 360-day year, and any partial periods (other than monthly) shall be computed using the number of days actually elapsed.

 

The Principal Amount(a)       Trigger Event. On the Conversion Date, each share of Series C Preferred Stock plus accrued, but unpaid, dividends thereon shall be mandatorily convertibleautomatically converted (without the payment of additional consideration by the Holder thereof), into such number of fully paid and non-assessable shares of Common Stock as is determined by dividing the Stated Value by the Conversion Price in effect on the Conversion Date. The “Conversion Price” shall initially be equal to $1.00. Such initial Conversion Price, and the rate at which shares of Series C Preferred Stock plus accrued, but unpaid dividends thereon, may be converted into shares of Common Stock, shall be subject to adjustment as provided in Article 1(b).

below. Except as aforesaid, the Series C Preferred Stock is not convertible into Common Stock or any other securities of the Corporation.


1     One year anniversary(b)       Mechanics of Approval Date.

The Company’s obligations under this Note are subject to a security interest in allConversion. All Holders of record shall be sent written notice of the Company’s assets, which security interestConversion Date and the place designated for conversion of all such shares of Series C Preferred Stock pursuant to this Section 6. Such notice need not be sent in advance of the occurrence of the Conversion Date. Upon receipt of such notice, each Holder shall surrender his, her or its certificate or certificates for all such shares (or, if such Holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation and its transfer agent to indemnify the Corporation and/or its transfer agent against any claim that may be made against the Corporation and/or its transfer agent on account of the alleged loss, theft or destruction of such certificate) to the Corporation at the place designated in such notice. If so required by the Corporation or its transfer agent, certificates surrendered for conversion shall be memorializedendorsed or accompanied by written instrument or instruments of transfer, in form satisfactory to the Corporation or its transfer agent, duly executed by the registered Holder or by his, her or its attorney duly authorized in writing. All rights with respect to the Series C Preferred Stock converted pursuant to Section 6(a), including the rights, if any, to receive notices and vote (other than as a Security Agreement entered into betweenholder of Common Stock), will terminate at the Conversion Date (notwithstanding the failure of the Holder or Holders to surrender the certificates at or prior to such time), except only for the rights of the Holders, upon surrender of their certificate or certificates (or lost certificate affidavit and agreement), to receive the items provided for in the next sentence of this Section 6(b). As soon as practicable after the Conversion Date and the Company assurrender of the date hereof (the “Security Agreement”), it being acknowledged thatcertificate or certificates (or lost certificate affidavit and agreement) for Series C Preferred Stock, the Holder’s security interest isCorporation shall issue and shall be subordinated as provided in Article 3(a) hereof.

Article 1.

CONVERSION

(a)          Interest. Shoulddeliver to such Holder, or to his, her or its nominees, a certificate or certificates for the Holder elect to have a Monthly Interest Payment paid innumber of full shares of Common Stock (suchissuable on such conversion in accordance with the provisions hereof. Such converted Series C Preferred Stock shall be retired and cancelled and may not be reissued as shares of such series, and the Interest Shares”),Corporation may thereafter take such appropriate action (without the Holder shall make such election by written notice deliveredneed for stockholder action) as may be necessary to reduce the Company not less than three (3) NASDAQ Trading Days prior to the applicable Interest Payment Date. Theauthorized number of Interest Shares to be issued to the Holder shall be determined by dividing: (i) the applicable interest payment owed by (ii) the VWAP with respect to on-exchange transactions in Common Stock executed on the NASDAQ during the thirty (30) NASDAQ Trading Days ending five (5) NASDAQ trading days prior to the applicable Interest Payment Date as reported by Bloomberg L.P. Any Interest Shares shall be delivered to the Holder with five (5) Business Days of the applicable Interest Payment Date.

(b)          Principal. The Principal Amount shall be mandatorily convertible on the Maturity Date into restricted shares of Common Stock (such shares, the “Principal Shares”) which shall be delivered within three (3) Business Days of the Maturity Date. The Number of Principal Shares to be issued to the Holder shall be determined by dividing: (i) the Principal Amount by (ii) a price (the “Note Conversion Price”) equal to the lower of (A) the Per Share Value or (B) the VWAP with respect to on-exchange transactions in Common Stock executed on the NASDAQ during the thirty (30) NASDAQ Trading Days prior to the Maturity Date as reported by Bloomberg L.P;provided, however, that the Note Conversion Price shall (except as adjusted pursuant to Article 1(f)) in no event be less than $1.75 per share (the “Floor Price”). In the event that the Note Conversion Price on the Maturity Date is lower than the Floor Price, then the Company may, in its discretion undertaken by a vote of a majority of the disinterested members of the Company’s board of directors, elect to either: (i) pay the Principal Amount in cash to the Holder or (ii) extend the Maturity Date for a period of sixty (60) days, at the conclusion of which the foregoing mechanism for determining the Note Conversion Price and repayment of the Principal Amount shall be determined with finality;provided, however, that at the conclusion of such sixty (60) day period, no Floor Price shall apply in the determining the Note Conversion Price and the Principal Shares shall be issued within three (3) Business Days of the extended Maturity Date.preferred stock accordingly.

 

(c)       Reservation of Shares Issuable Upon Conversion. The CompanyCorporation covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock solely for the sole purpose of issuance upon conversion of this Note,the Series C Preferred Stock as herein provided, free from preemptive rights or any other actual contingent purchase rights of personsPersons other than the Holder,Holders, not less than such aggregate number of shares of the Common Stock as shall be issuable (taking into account the adjustments and restrictions of Section 7) upon the conversion of this Note.the then outstanding shares of Series C Preferred Stock. The CompanyCorporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly andauthorized, validly authorized, issued, and fully paid non-assessable.and nonassessable.

 

(d)       Fractional Shares. Upon a conversion hereunder, the Company shall not be required to issue stock certificatesNo fractional shares or scrip representing fractions of shares of the Common Stock. All fractional shares shall be roundedissued upon the conversion of the Series C Preferred Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation shall round up to the nearestnext whole number of shares.share.

 


(e)       Transfer Taxes and Expenses. The issuance of certificates for shares of the Common StockConversion Shares on conversion of this Notethe Series C Preferred Stock shall be made without charge to theany Holder thereof for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificate,Conversion Shares, provided that the CompanyCorporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such certificateConversion Shares upon conversion in a name other than that of the Holder,Holders of such shares of Series C Preferred Stock and the CompanyCorporation shall not be required to issue or deliver such certificatesConversion Shares unless or until the personPerson or personsPersons requesting the issuance of such shares upon transferthereof shall have paid to the CompanyCorporation the amount of such tax or shall have established to the satisfaction of the CompanyCorporation that such tax has been paid. The Corporation shall pay all transfer agent fees required for same-day processing and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares.

 

2

Section 7.          Certain Adjustments.

 

(f)(a)       Adjustments for Stock Dividends Splits and Other Capital TransactionsStock Splits. If the Company,Corporation, at any time from and afterwhile the date of this Note and as long as this NoteSeries C Preferred Stock is outstanding: (i) shall paypays a stock dividend effect a stock split or otherwise makemakes a distribution or distributions on shares of its Common Stock payable in shares of Common Stock on shares of Common Stock or any classother Common Stock Equivalents (which, for avoidance of capital stock,doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of, or payment of a dividend on, the Series C Preferred Stock), (ii) subdividesubdivides outstanding shares of Common Stock into a larger number of shares, (iii) combinecombines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issue byissues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Company,Corporation, then the Note Conversion Price shall be computed onmultiplied by a fraction of which the applicable measuring date to reflectnumerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such occurrences.event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 3(f)7(a) shall become effective onimmediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

(g)(b)       Subsequent Rights Offerings. In addition to any adjustments pursuant to Article 1(f)Section 7(a) above, if at any time the CompanyCorporation grants, issues or sells any Common Stock Equivalents (as defined below) or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder ofthereof will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Notesuch Holder’s Series C Preferred Stock immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.purchase.


(h)          Pro Rata Distributions. During such time as this Note is outstanding, if the Company declares or makes any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Note, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete Conversion of this Note immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution.

3

(i)(c)       Fundamental Transaction. If, at any time while this Notethe Series C Preferred Stock is outstanding, (i) the Company,Corporation, directly or indirectly, in one or more related transactions effects any merger or consolidation of the CompanyCorporation with or into another person,Person, (ii) the Company,Corporation, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the CompanyCorporation or another person)Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company,Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company,Corporation, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other personPerson or other personsPersons making or party to, or associated or affiliatedAffiliated with the other personsPersons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent conversion of this Note,the Series C Preferred Stock, the Holder shall have the right to receive, for each PrincipalConversion Share or Interest Share, as the case may be, that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (disregarding for such purposes any conversion limitations hereunder), the number of shares of Common Stock of the successor or acquiring corporation or of the Company,Corporation, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Notethe Series C Preferred Stock is convertible immediately prior to such Fundamental Transaction.Transaction (disregarding for such purposes any conversion limitations hereunder). For purposes of any such conversion, the determination of the Note Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the CompanyCorporation shall apportion the Note Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Notethe Series C Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the CompanyCorporation or surviving entity in such Fundamental Transaction shall issue to the Holderfile a new NoteCertificate of Designation with the same terms and conditions as this Note that is otherwiseand issue to the Holders new preferred stock consistent with the foregoing provisions and evidencing the Holders’ right to convert this Notesuch preferred stock into Alternate Consideration. The CompanyCorporation shall cause any successor entity in a Fundamental Transaction in which the CompanyCorporation is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of Companythe Corporation under this Note and the other Transaction DocumentsCertificate of Designation in accordance with the provisions of this Article 1(d)Section 7(c) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)entered into prior to such Fundamental Transaction and shall at the option of the holder of this Note, deliver to the Holder in exchange for this Notethe Series C Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Notethe Series C Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Notethe Series C Preferred Stock prior to such Fundamental Transaction (disregarding for such purposes any conversion limitations hereunder), and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Notethe Series C Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Note and the other Transaction DocumentsCertificate of Designation referring to the “Company”“Corporation” shall refer instead to the Successor Entity), and may exercise every right and power of the CompanyCorporation and shall assume all of the obligations of the CompanyCorporation under this Note and the other Transaction DocumentsCertificate of Designation with the same effect as if such Successor Entity had been named as the CompanyCorporation herein.

 


(j)(d)       Calculations. All calculations under this Article 1Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Article 1,Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Company)Corporation) issued and outstanding.

 

4

(k)(e)       Notice to the Holders.

(i)          Adjustment to Note Conversion Price. Whenever the Note Conversion Price is adjusted pursuant to any provision of this Article 1,Section 7, the CompanyCorporation shall promptly deliver to each Holder a notice setting forth the Note Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

(ii)         Notice to Allow Conversion by Holder. If (A)(i) the CompanyCorporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B)(ii) the CompanyCorporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)(iii) the CompanyCorporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D)(iv) the approval of any stockholders of the CompanyCorporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the CompanyCorporation is a party, any sale or transfer of all or substantially all of the assets of the Company,Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (E)(v) the CompanyCorporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company,Corporation, then, in each case, the CompanyCorporation shall cause to be filed at each office or agency maintained for the purpose of conversion of this Note,the Series C Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Company,Corporation, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x)(A) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)(B) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-publicnonpublic information regarding the CompanyCorporation or any of its subsidiaries, the Subsidiaries, the CompanyCorporation shall simultaneously file such notice with the Securities and Exchange Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Principal Amount and accrued, but unpaid interest thereonits Series C Preferred Stock (or any part hereof) during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

Article 2.Section 8.          Redemption. The Series C Preferred Stock is not redeemable other than as otherwise expressly authorized herein.


Section 9.          EVENTS OF DEFAULTMiscellaneous.

 

(a)       Events of Default DefinedNotices. The entire unpaid Principal Amount of this Note, together with interest thereonAny and all notices or other communications or deliveries to be provided by the Holders hereunder shall on writtenbe in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service, addressed to the Corporation, at 40 Ramland Road South, Suite 200, Orangeburg, NY 10962, Attention: Secretary, facsimile number 215-657-5161, e-mail address Mpupach@photomedex.com or such other facsimile number, e-mail address or address as the Corporation may specify for such purposes by notice to the Company givenHolders delivered in accordance with this Section 9(a). Any and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number or address of such Holder appearing on the books of the Corporation, or if no such facsimile number or address appears on the books of the Corporation, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.

(b)       Absolute Obligation. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages and accrued dividends, as applicable, on the shares of Series C Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.

(c)       Lost or Mutilated Series C Preferred Stock Certificate. If a Holder’s Series C Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Series C Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation.

(d)       Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflict of laws thereof.


(e)       Amendments; Waiver. This Certificate of Designation may be amended or any provision of this Certificate of Designation may be waived by the Corporation with the affirmative vote at a duly held meeting or written consent of the Requisite Holders. Any waiver by the Corporation or a Holder of a breach of any provision of this Note, forthwith become andCertificate of Designation shall not operate as or be due and payable without presentment, demand, protestconstrued to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designation or a waiver by any other Holders, except that a waiver by the Requisite Holders will constitute a waiver of all Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designation on any other occasion. Any waiver by the Corporation or a Holder must be in writing. Any action nor obligationthat is required or permitted to be taken by the Requisite Holders may be taken at any meeting called by any Holder or Holders or by a written consent or action by such Holders in lieu of any such meeting. With respect to any meeting of Holders, unless otherwise specified in this Certificate of Designation, the procedures for calling and holding a meeting of the holder of Common Stock of the Corporation shall be applicable with respect to a meeting of the Holders,mutatis mutandis. The Corporation shall promptly provide to any Holder a list of the other Holders upon the request of any kind,Holder, and otherwise provide such cooperation and assistance to any Holder for the purposes of calling and holding a meeting of the Holders as from time to time reasonably requested by a Holder.

(f)       Severability. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of whichinterest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law.

(g)       Next Trading Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Trading Day, such payment shall be made on the next succeeding Trading Day.

(h)       Headings. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation and shall not be deemed to limit or affect any of the provisions hereof.


EXHIBIT C

Form of Certificate of Designation of Series D Preferred Stock

(See Attached)


FC GLOBAL REALTY INCORPORATED

CERTIFICATE OF DESIGNATION OF PREFERENCES,
RIGHTS AND LIMITATIONS
OF
SERIES D PREFERRED STOCK

PURSUANT TO SECTION 78.1955 OF THE
NEVADA REVISED STATUTES


FC Global Realty Incorporated, a Nevada corporation (the “Corporation”), does hereby expressly waived, ifcertify that, pursuant to the authority contained in its Articles of Incorporation, as amended, and in accordance with the provisions of Section 78.1955 of the Nevada Revised Statutes, the board of directors of the Corporation (the “Board of Directors”) has adopted the following resolution creating the following series of the Corporation’s Series D Preferred Stock and determined the voting powers, designations, powers, preferences and relative, participating, optional, or other special rights, and the qualifications, limitations, and restrictions thereof, of such series:

RESOLVED, that the Board of Directors does hereby provide for the issuance of the following series of preferred stock for cash or exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters relating to such series of preferred stock as follows:

Section 1.          Definitions. For the purposes hereof, the following terms shall have the following meanings:

Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 of the following events (“EventsSecurities Act of Default1933, as amended.

Change in Control Transaction” means the acquisition by any Person of beneficial ownership of more than 50% (on a fully diluted basis) of either (i) the then outstanding shares of Common Stock, taking into account as outstanding for this purpose such Common Stock issuable upon the exercise of options or warrants, the conversion of convertible stock or debt, and the exercise of any similar right to acquire such Common Stock or (ii) the combined voting power of the then outstanding voting securities of the Corporation entitled to vote generally in the election of directors.

Common Stock” means the Corporation’s common stock, par value $0.01 per share, and stock of any other class of securities into which such securities may hereafter be reclassified or changed.

Common Stock Equivalents” means any securities of the Corporation or any of its subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

Conversion Date” means the date on which approval from the stockholders of the Corporation with respect to the Remediation Agreement and the transactions contemplated thereby, including the issuance of the Conversion Shares, has been obtained.


Conversion Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Series D Preferred Stock in accordance with the terms hereof.

Holder” means a holder of shares of Series D Preferred Stock.

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

Remediation Agreement” means the Remediation Agreement, dated September 24, 2018, between the Corporation, Opportunity Fund I-SS, LLC, Dr. Dolev Rafaeli, Dennis M. McGrath and Yoav Ben-Dror.

Requisite Holders” means the holders of a majority of the outstanding shares of Series D Preferred Stock.

Trading Day” means a day on which the principal Trading Market is open for business.

Trading Market” means any of the NYSE, the NYSE MKT, NASDAQ, the OTC Bulletin Board system, the OTCQX market operated by OTC Markets and the OTCQB market operated by OTC Markets Group or any other market on which the Common Stock may be listed or quoted for trading on the date in question.

Section 2.        Designation, Amount and Stated Value. The series of preferred stock shall be designated as Series D Preferred Stock, par value $0.01 per share (the “Series D Preferred Stock”), and the number of shares so designated shall be Nine Million Two Hundred Ninety-Four Thousand Four Hundred Fourteen (9,294,414) (which shall not be subject to increase without the written consent of the Requisite Holders). Each share of Series D Preferred Stock shall have occurreda stated value of $1.00 per share, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series D Preferred Stock (the “Stated Value”).

Section 3.         Dividends. The Holders of shares of Series D Preferred Stock shall receive cumulative dividends,pro rata among such Holders, prior to and in preference to any dividend on outstanding Common Stock, at the per annum rate of 8% of the Stated Value. Dividends on each share of Series D Preferred Stock will accrue daily and be continuing; provided, however, that no noticecumulative from and including the date of issuance thereof and shall be payable upon the occurrence of a Liquidation (as defined below) or converted to common stock upon a conversion pursuant to Section 6. The amount of dividends payable will be computed on the basis of a 360-day year of twelve 30-day months, and for any period of less than a month, actual days elapsed over a 30-day month. Holders shall also be entitled to receive, and the Corporation shall pay, dividends on shares of Series D Preferred Stock equal (on an as-if-converted-to-Common-Stock basis regardless of whether the Series D Preferred Stock is then convertible) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock.

Section 4.         Liquidation. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a “Liquidation”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation the same amount that a holder of Common Stock would receive if the Series D Preferred Stock were fully converted to Common Stock immediately prior to such Liquidation, which amount shall be paid to the holders of the Series D Preferred Stockpari passu with all holders of the Corporation’s outstanding Series C Preferred Stock and in preference to the holders of the Corporation’s Common Stock. The Corporation shall mail written notice of any such Liquidation, not less than 45 days prior to the payment date stated therein, to each Holder.


Section 5.         Voting Rights; Veto Right.

(a)       Except as otherwise provided herein or as otherwise required and this Noteby law, the Series D Preferred Stock shall automatically become due and payable ifhave no voting rights.

(b)       As long as any shares of Series D Preferred Stock are outstanding, the holders of the Series D Preferred Stock shall have the right to prohibit or veto the Corporation from entering into any agreement or taking any action with respect to (i) a Change in Control Transaction or (ii) the issuance any equity securities or equity-linked securities at a price per share below $0.6505 subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to Corporation’s Common Stock. The Corporation must notify the holders of the Series D Preferred Stock at least twenty (20) days in advance of the events described in Article 2(a)(iii) through (vi) occurs. An Event5(b)(i) and (ii) above and the holder shall exercise its veto right by notifying the Corporation in writing within fifteen (15) days after the receipt of Default shall occur:such notice that it is exercising its veto right to prohibit such agreement from being entered into or action from being taken.

Section 6.         Automatic Conversion.

 

(a)       Trigger Event. On the Conversion Date, each share of Series D Preferred Stock plus accrued, but unpaid, dividends thereon (the “Aggregate Preference Amount”), shall be automatically converted (without the payment of additional consideration by the Holder thereof), into such number of fully paid and non-assessable shares of Common Stock as is determined by a formula (computed on the Conversion Date) (i) the numerator of which is equal to the Aggregate Preference Amount and (ii) the denominator of which is equal to the Conversion Price. The “Conversion Price” shall initially be equal to $1.00. Such initial Conversion Price, and the rate at which shares of Series D Preferred Stock plus accrued, but unpaid dividends thereon, may be converted into shares of Common Stock, shall be subject to adjustment as provided below. Except as aforesaid, the Series D Preferred Stock is not convertible into Common Stock or any other securities of the Corporation.

(b)       Mechanics of Conversion. All Holders of record shall be sent written notice of the Conversion Date and the place designated for conversion of all such shares of Series D Preferred Stock pursuant to this Section 6. Such notice need not be sent in advance of the occurrence of the Conversion Date. Upon receipt of such notice, each Holder shall surrender his, her or its certificate or certificates for all such shares (or, if such Holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation and its transfer agent to indemnify the Corporation and/or its transfer agent against any claim that may be made against the Corporation and/or its transfer agent on account of the alleged loss, theft or destruction of such certificate) to the Corporation at the place designated in such notice. If so required by the Corporation or its transfer agent, certificates surrendered for conversion shall be endorsed or accompanied by written instrument or instruments of transfer, in form satisfactory to the Corporation or its transfer agent, duly executed by the registered Holder or by his, her or its attorney duly authorized in writing. All rights with respect to the Series D Preferred Stock converted pursuant to Section 6(a), including the rights, if any, to receive notices and vote (other than as a holder of Common Stock), will terminate at the Conversion Date (notwithstanding the failure of the Holder or Holders to surrender the certificates at or prior to such time), except only for the rights of the Holders, upon surrender of their certificate or certificates (or lost certificate affidavit and agreement), to receive the items provided for in the next sentence of this Section 6(b). As soon as practicable after the Conversion Date and the surrender of the certificate or certificates (or lost certificate affidavit and agreement) for Series D Preferred Stock, the Corporation shall issue and deliver to such Holder, or to his, her or its nominees, a certificate or certificates for the number of full shares of Common Stock issuable on such conversion in accordance with the provisions hereof. Such converted Series D Preferred Stock shall be retired and cancelled and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the need for stockholder action) as may be necessary to reduce the authorized number of shares of its preferred stock accordingly.


(c)       Reservation of Shares Issuable Upon Conversion. The Corporation covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Series D Preferred Stock as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holders, not less than such aggregate number of shares of the Common Stock as shall be issuable (taking into account the adjustments and restrictions of Section 7) upon the conversion of the then outstanding shares of Series D Preferred Stock. The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.

(d)       Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Series D Preferred Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation shall round up to the next whole share.

(e)       Transfer Taxes and Expenses. The issuance of Conversion Shares on conversion of the Series D Preferred Stock shall be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Series D Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all transfer agent fees required for same-day processing and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares.

Section 7.         Certain Adjustments.

(a)       Stock Dividends and Stock Splits. If the Corporation, at any time while the Series D Preferred Stock is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of, or payment of a dividend on, the Principal AmountSeries D Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 7(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.


(b)       Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 7(a) above, if at any time the Corporation grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder thereof will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder’s Series D Preferred Stock immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such purchase.

(c)       Fundamental Transaction. If, at any time while the Series D Preferred Stock is outstanding, (i) the Corporation, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii) the Corporation, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any interestcompulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Corporation, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or Affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent conversion of the Series D Preferred Stock, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (disregarding for such purposes any conversion limitations hereunder), the number of shares of Common Stock of the successor or acquiring corporation or of the Corporation, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which the Series D Preferred Stock is convertible immediately prior to such Fundamental Transaction (disregarding for such purposes any conversion limitations hereunder). For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Corporation shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of the Series D Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designation with the same terms and conditions and issue to the Holders new preferred stock consistent with the foregoing provisions and evidencing the Holders’ right to convert such preferred stock into Alternate Consideration. The Corporation shall cause any successor entity in a Fundamental Transaction in which the Corporation is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Corporation under this Certificate of Designation in accordance with the provisions of this Section 7(c) pursuant to written agreements entered into prior to such Fundamental Transaction and shall deliver to the Holder in exchange for the Series D Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Series D Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Series D Preferred Stock prior to such Fundamental Transaction (disregarding for such purposes any conversion limitations hereunder), and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Series D Preferred Stock immediately prior to the consummation of such Fundamental Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation referring to the “Corporation” shall refer instead to the Successor Entity), and may exercise every right and power of the Corporation and shall assume all of the obligations of the Corporation under this Certificate of Designation with the same effect as if such Successor Entity had been named as the Corporation herein.


(d)       Calculations. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.

(e)       Notice to the Holders. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment. If (i) the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (ii) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (iii) the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (iv) the approval of any stockholders of the Corporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (v) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion of the Series D Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Corporation, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (A) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (B) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, nonpublic information regarding the Corporation or any of its subsidiaries, the Corporation shall simultaneously file such notice with the Securities and Exchange Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to convert its Series D Preferred Stock (or any part hereof) during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.


Section 8.          Redemption. The Series D Preferred Stock is not redeemable other than as otherwise expressly authorized herein.

Section 9.          Miscellaneous.

(i)       Notices. Any and all notices or other communications or deliveries to be provided by the Holders hereunder shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service, addressed to the Corporation, at 40 Ramland Road South, Suite 200, Orangeburg, NY 10962, Attention: Secretary, facsimile number 215-657-5161, e-mail address Mpupach@photomedex.com or such other facsimile number, e-mail address or address as the Corporation may specify for such purposes by notice to the Holders delivered in accordance with this Note when,Section 9(a). Any and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number or address of such Holder appearing on the books of the Corporation, or if no such facsimile number or address appears on the books of the Corporation, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.

(j)       Absolute Obligation. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages and accrued dividends, as applicable, on the shares of Series D Preferred Stock at the time, place, and rate, and in the manner (i.e., cashcoin or Common Stock) ascurrency, herein prescribed.


(k)       Lost or Mutilated Series D Preferred Stock Certificate. If a Holder’s Series D Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the sameCorporation shall become due pursuantexecute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Series D Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably satisfactory to the terms hereof; orCorporation.

 

5

(l)       Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflict of laws thereof.

 

(ii)         if(m)       Amendments; Waiver. This Certificate of Designation may be amended or any provision of this Certificate of Designation may be waived by the CompanyCorporation with the affirmative vote at a duly held meeting or written consent of the Requisite Holders. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall violatenot operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designation or a waiver by any other Holders, except that a waiver by the Requisite Holders will constitute a waiver of all Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designation on any other occasion. Any waiver by the Corporation or a Holder must be in writing. Any action that is required or permitted to be taken by the Requisite Holders may be taken at any meeting called by any Holder or Holders or by a written consent or action by such Holders in lieu of any such meeting. With respect to any meeting of Holders, unless otherwise specified in this Certificate of Designation, the procedures for calling and holding a meeting of the holder of Common Stock of the Corporation shall be applicable with respect to a material extentmeeting of the Holders,mutatis mutandis. The Corporation shall promptly provide to any Holder a list of the other Holders upon the request of any Holder, and otherwise provide such cooperation and assistance to any Holder for the purposes of calling and holding a meeting of the Holders as from time to time reasonably requested by a Holder.

(n)       Severability. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law.

(o)       Next Trading Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Trading Day, such payment shall be made on the next succeeding Trading Day.

(p)       Headings. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation and shall not be deemed to limit or affect any of the representations, warrantiesprovisions hereof.


EXHIBIT D

Form of Registration Rights Agreement

(See Attached)


REGISTRATION RIGHTS AGREEMENT

ThisREGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of September 24, 2018, by and among FC Global Realty Incorporated, a Nevada corporation (the “Company”), Opportunity Fund I-SS, LLC, a Delaware limited liability company (“OFI”), and Dolev Rafaeli, Dennis M. McGrath and Yoav Ben-Dror (each a “Note Holder” and, collectively the “Note Holders”).

RECITALS

A.          On the date hereof, the Company, OFI and the Note Holders entered into a remediation agreement (the “Remediation Agreement”), pursuant to which the Company has agreed, upon the terms and subject to the conditions set forth in the Remediation Agreement, to issue (i) to the to the Note Holders shares of the Company’s Series C Preferred Stock, $0.001 par value per share (the “Series C Preferred Stock”), which are convertible into shares of the Company’s Common Stock, $0.001 par value per share (the “Common Stock”), and (ii) to OFI shares of the Company’s Series D Preferred Stock, $0.001 par value per share (the “Series D Preferred Stock”), which are convertible into shares of Common Stock.

B.           In accordance with the terms of the Remediation Agreement, the Company has agreed to provide certain registration rights for shares of Common Stock underlying the Series C Preferred Stock and Series D Preferred Stock under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the “Securities Act”), and applicable state securities laws.

AGREEMENT

NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

1.            Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Remediation Agreement will have the respective meanings given such terms in the Remediation Agreement. As used in this NoteAgreement, the following terms have the respective meanings set forth in this Section 1 and other terms are defined throughout this Agreement:

Business Day” means any day except Saturday, Sunday and any day which is a federal legal holiday or a day on which banking institutions in the Security AgreementState of New York are authorized or required by law or other governmental action to close.

Business Combination” means the business combination referred to in clause (B) of the definition of Registrable Securities.

Commission” means the United States Securities and such violation or breach shall continue for thirty (30) days afterExchange Commission.

Commission Comments” means written notice of such breach shall beencomments pertaining solely to Rule 415 which are received by the Company from the Holder;Commission to a filed Registration Statement, which either (i) requires the Company to limit the number of Registrable Securities which may be included therein to a number which is less than the number sought to be included thereon as filed with the Commission or (ii) requires the Company to either exclude Registrable Securities held by specified Holders or deem such Holders to be underwriters with respect to Registrable Securities they seek to include in such Registration Statement.

 


(iii)        if the Company shall consentEffective Date” means, as to the appointment of a receiver, trustee or liquidator of itself or of a substantial part of its property, or shall admit in writing its inability to pay its debts generally as they become due, or shall make a general assignment for the benefit of creditors, or shall file a voluntary petition in bankruptcy, or an answer seeking reorganization in a proceeding under any bankruptcy law (as now or hereafter in effect) or an answer admitting the material allegations of a petition filed against the Company in any such proceeding, or shall by voluntary petition, answer or consent, seek relief under the provisions of any other now existing or future bankruptcy or other similar law providing for the reorganization or winding up of corporations, or an arrangement, composition, extension or adjustment with its or their creditors, or shall, in a petition in bankruptcy filed against it or them be adjudicated a bankrupt, or the Company or its board of directors or a majority of its stockholders shall vote to dissolve or liquidate the Company; or

(iv)        if an involuntary petition shall be filed against the Company seeking relief against the Company under any now existing or future bankruptcy, insolvency or other similar law providing for the reorganization or winding up of corporations, or an arrangement, composition, extension or adjustment with its or their creditors, and such petition shall not be vacated or set aside within ninety (90) days from the filing thereof; or

(v)         if a court of competent jurisdiction shall enter an order, judgment or decree (not subject to appeal) appointing, without consent of the Company, a receiver, trustee or liquidator of the Company, or of all or any substantial part of the property of the Company, or approving a petition filed against the Company seeking a reorganization or arrangement of the Company under the Federal bankruptcy laws or any other applicable law or statute of the United States of America or any State thereof, or any substantial part of the property of the Company shall be sequestered; and such order, judgment or decree shall not be vacated or set aside within ninety (90) days fromRegistration Statement, the date ofon which such Registration Statement is first declared effective by the entry thereof; or

(vi)        if, under the provisions of any law for the relief or aid of debtors, any court of competent jurisdiction shall assume custody or control of the Company or of all or any substantial part of the property of the Company and such custody or control shall not be terminated within ninety (90) days from the date of assumption of such custody or control.

Article 3.

SUBORDINATIONCommission.

 

Effectiveness Date” means (a) with respect to the initial Registration Statement required to be filed pursuant to Section 2(a), the earlier of: (i) the 150th day following the Filing Date and (ii) the fifth Trading Day following the date on which the Company is notified by the Commission that the initial Registration Statement will not be reviewed or is no longer subject to further review and comments; (b) with respect to any additional Registration Statements required to be filed pursuant to Section 2(a), the earlier of: (i) the 120th day following the applicable Filing Date for such additional Registration Statement(s) and (ii) the fifth Trading Day following the date on which the Company is notified by the Commission that such additional Registration Statement(s) will not be reviewed or is no longer subject to further review; (c) with respect to a Registration Statement required to be filed under Section 2(b), the earlier of: (i) the 120th day following the Filing Date, and (ii) the fifth Trading Day following the date on which the Company is notified by the Commission that the Registration Statement will not be reviewed or is no longer subject to further review and comments; and (d) with respect to any additional Registration Statements required to be filed solely due to SEC Restrictions, the earlier of: (i) the 120th day following the applicable Restriction Termination Date and (ii) the fifth Trading Day following the date on which the Company is notified by the Commission that such Registration Statement will not be reviewed or is no longer subject to further review and comments. Notwithstanding the foregoing, the Effectiveness Date shall be tolled (i.e., it shall be extended) during such time as the Company is actively pursuing a Business Combination.

Effectiveness Period” means, as to any Registration Statement required to be filed pursuant to this Agreement, the period commencing on the Effective Date of Subordination. Thesuch Registration Statement and ending on (a) the date that all of the Registrable Securities covered by such Registration Statement have been publicly sold by the Holders of the Registrable Securities included therein, or (b) such time as all of the Registrable Securities covered by such Registration Statement may be sold by the Holders without restriction pursuant to Rule 144 as determined by the counsel to the Company for itself, its successorspursuant to a written opinion letter to such effect, addressed and assigns, covenants and agrees,acceptable to the Company’s transfer agent and the Holder by his acceptanceaffected Holders.

Exchange Act” means the Securities Exchange Act of this Note likewise covenants and agrees, that the payment of the Principal Amount of and interest on this Note is hereby expressly subordinated1934, as amended.

Filing Date” means (a) with respect to the extent and ininitial Registration Statement required to be filed pursuant to Section 2(a), the manner hereinafter set forth,30th day following the date hereof; (b) with respect to any additional Registration Statements required to be filed pursuant to Section 2(a), the prior payment in full of all Senior Indebtedness, as hereinafter defined. The provisions of this Article 3(a) shall constitute a continuing offer to all persons who, in reliance upon such provision, become holders of, or continue to hold, Senior Indebtedness, and such provisions are made30th day following the Effective Date for the benefitlast Registration Statement filed pursuant to this Agreement under Section 2(a); (c) with respect to a Registration Statement required to be filed under Section 2(b), the 30th day following the date on which the Company becomes eligible to utilize Form S-3 to register the resale of Common Stock; and (d) with respect to any additional Registration Statements required to be filed due to SEC Restrictions, the holders of Senior Indebtedness, and30thday following the applicable Restriction Termination Date. Notwithstanding the foregoing, the Filing Date shall be tolled (i.e., it shall be extended) during such holders are hereby made obligees hereundertime as the same as if their names were written herein as such, and they and/or each of them may proceed to enforce such provisions. As used in this Article 3,Company is actively pursuing a Business Combination.

FINRA” means the term “Company” shall include all Subsidiaries who are, or whose assets are, encumbered by Senior Indebtedness.Financial Industry Regulatory Authority, Inc.

 

6


(b)          Company Not to Make Payments with Respect to Note in Certain Circumstances.

(i)          Upon the maturity of any Senior Indebtedness by lapse of time, accelerationHolder or otherwise, all principal thereof and premium, if any, and interest thereon shall first be paid in full, or such payment duly provided for in cash or in a manner satisfactory toHolders” means the holder or holders, as the case may be, from time to time of such Senior Indebtedness, before any payment is made byRegistrable Securities and, if other than OFI or the Company on account ofNote Holders, a Person to whom the Principal Amount of or interest on this Note; provided, however, that nothing in this Article 3 shall impair or otherwise affect the right and ability of the Company to issue Common Stock upon conversion of the Principal Amount of and interest on this Noterights hereunder have been properly assigned pursuant to Article 1 of this Note.Section 7 hereof.

 

(ii)         InPerson” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or threatened.

Prospectus” means the eventprospectus included in a Registration Statement (including, without limitation, a prospectus that notwithstandingincludes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the provision of this Article 3(b)Securities Act), the Company shall makeas amended or supplemented by any paymentprospectus supplement, with respect to the Holder on accountterms of the Principal Amountoffering of or interest on this Note after the happening of a default in paymentany portion of the principalRegistrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

Registrable Securities” means: (i) all of the shares of Common Stock then issued and issuable upon conversion in full of the Series C Preferred Stock issuable to the Note Holders under the Remediation Agreement (assuming on such date the shares of Series C Preferred Stock are converted in full without regard to any conversion limitations therein), (ii) all of the shares of Common Stock then issued and issuable to OFI under the Remediation Agreement, including upon conversion in full of the Series D Preferred Stock issuable to OFI under the Remediation Agreement (assuming on such date the shares of Series D Preferred Stock are converted in full without regard to any conversion limitations therein), all other shares of Common Stock held by OFI, and all shares of Common Stock issuable to OFI upon conversion in full of the Series A Convertible Preferred Stock held by OFI, and (iii) any securities issued or premium, ifissuable upon any stock split, dividend or interest on, Senior Indebtednessother distribution, recapitalization or after receipt by the Companysimilar event, or any price adjustment as a result of written notice of an event of defaultsuch stock splits, reverse stock splits or similar events with respect to any Senior Indebtednessof the securities referenced in (i) or (ii) above. Notwithstanding the foregoing, a security shall cease to be a Registrable Security for purposes of this Agreement from and after written noticesuch time as (A) the Holder of such default or event of default is givensecurity may resell such security without restriction under Rule 144, as determined by the Companycounsel to the Holder, then unlessCompany pursuant to a written opinion letter to such effect, addressed and untilacceptable to the Company’s transfer agent and the affected Holders, or (B) such default or event of default shall have been cured or waived or shall have ceased to exist, such payment shall be held by the Holder in trustsecurity is exchanged for the benefitsecurity of and shall be paid forthwith over and delivered to,another entity in connection with a business combination involving the holders of Senior Indebtedness (pro rata as toCompany that is approved by each of such holders on the basis of the respective amounts of Senior Indebtedness held by them) or their representative or the trustee under the indenture or other agreement (if any) pursuant to which any instruments evidencing any Senior Indebtedness may have been issued, as their respective interests may appear, for application to the payment of all Senior Indebtedness remaining unpaid to the extent necessary to pay all Senior Indebtedness in full in accordance with the terms of such Senior Indebtedness, after giving effect to any concurrent payment or distribution to or for the holders of Senior Indebtedness.

(c)          Note Subordinated to Prior Payment of all Senior Indebtedness on Dissolution, Liquidation, or Reorganization of Company. Upon any distribution of assets of the Company upon any dissolution, winding up, liquidation, or reorganization of the Company (whether in bankruptcy, insolvency or receivership proceedings or upon an assignment for the benefit of creditors or otherwise):

(i)          The holders of all Senior Indebtedness shall first be entitled to receive payment in full of the principal thereof, premium, if any, and interest due thereon before the Holder is entitled to receive any payment on account of the Principal Amount of or interest on this Note (other than payment of shares of stock of the Company as reorganized or readjusted, or securities of the Company or any other corporation provided for by a plan of reorganization or readjustment which stock and securities are subordinated to the payment of all Senior Indebtedness and securities received in lieu thereof which may at the time be outstanding); and

(ii)         Any payment or distribution of assets of the Company of any kind or character whether in cash, property or securities (other than equity of the Company as reorganized or readjusted, or securities of the Company or any other corporation provided for by a plan of reorganization or readjustment which stock and securities are subordinated to the payment of all Senior Indebtedness and securities received in lieu thereof which may at the time be outstanding), to which the Holder would be entitled except for the provisions of this Article 3, shall be paid by the liquidating trustee or agent or other person making such payment of distribution, whether a trustee in bankruptcy, a receiver or liquidating trustee or other trustee or agent, directly to the holders of Senior Indebtedness or their representative or representatives, or to the trustee or trustees under any indenture under which any instruments evidencing any of such Senior Indebtedness may have been issued, to the extent necessary to make payment in full of all Senior Indebtedness remaining unpaid, after giving effect to any concurrent payment or distribution or provision therefor to the holders of such Senior Indebtedness.

7

(iii)        In the event that notwithstanding the foregoing provision of this Article 3, any payment or distribution of assets of the Company of any kind or character, whether in cash, property or securities (other than equity of the Company as reorganized or readjusted, or securities of the Company or any other corporation provided for by a plan of reorganization or readjustment which stock and securities are subordinated to the payment of all Senior Indebtedness and securities received in lieu thereof which may at the time be outstanding), shall be received by the Holder on account of the Principal Amount of or interest on this Note before all Senior Indebtedness is paid in full, or effective provision made for its payment or distribution, such payment or distribution shall be received and held in trust for and shall be paid over to the holders of the Senior Indebtedness remaining unpaid or unprovided for or their representative or representatives, or to the trustee or trustees under any indenture under which any instruments evidencing any of such Senior Indebtedness may have been issued, for application to the payment of such Senior Indebtedness until all such Senior Indebtedness shall have been paid in full, after giving effect to any concurrent payment or distribution or provision therefor to the holders of such Senior Indebtedness.

(d)          Holder to be Subrogated to Right of Holders of Senior Indebtedness. Subject to the payment in full of all Senior Indebtedness, the Holder shall be subrogated to the rights of the holders of Senior Indebtedness to receive payments or distributions of assets of the Company applicable to the Senior Indebtedness until all amounts owing on this Note shall be paid in full, and, for the purpose of such subrogation, no payments or distributions to the holders of the Senior Indebtedness by or on behalf of the Company or by or on behalf of the Holder by virtue of this Article 3 which otherwise would have been made to the holders of this Note shall, as between the CompanyOFI and the Holder, be deemed to be paymentNote Holders and covered by the Company to oran effective registration statement on account of the Senior Indebtedness, it being understood that the provisions of this Article 3 are, and are intended solely, for the purpose of defining the relative rights of the Holder, on the one hand, and the holders of the Senior Indebtedness, on the other hand.Form S-4.

 

(e)          Definition of Senior Indebtedness. The term Senior Indebtedness” means the principal of and premium, if any, and interest on the following: (i) all indebtedness and obligations (other than under this Note) that are created, assumed or guaranteed by the Company existing after the Closing or that are Assumed Liabilities, that are (A) for money borrowed or (B) secured by purchase money mortgages or other similar security interests given by the Company or any subsidiary on real or personal property, (ii) all obligations of the Company existing on or after the Closing or that are Assumed Liabilities, as lessee under a lease of real or personal property, which in accordance with generally accepted accounting principles have been capitalized, unless, with respect to any indebtedness or obligations described in clause (i) or (ii) of this Article 3(e), the instrument creating or evidencing such indebtedness expressly provides that such indebtedness is not superior in right of payment of this Note, (iii) all indebtedness or obligations of a kind not described in said clause (i) or (ii) which were incurred or guaranteed by the Company after the Closing in connection with the acquisition of an existing business or assets, whether by means of a merger, consolidation, stock acquisition or acquisition of all or part of the assets of a corporation, partnership, limited lability company, business trust, sole proprietorship or other entity, or otherwise, and (iv) any deferrals, renewals, extensions or refundings of any of the foregoing, unless, in the case of any particular indebtedness or obligation or renewal, extension or refunding thereof, under the express provisions of the instrument creating or evidencing the same, or pursuant to which the same is outstanding, such indebtedness or other obligation or such renewal, extension or refunding thereof is not superior in right of payment to this Note. Senior Indebtedness shall not include indebtedness incurred in the ordinary course of business for goods, materials, or services, any obligations of the Company under, or in respect of, leases other than as hereinbefore described or any obligations of the Company that arose prior to the Closing unless such obligations constitute Assumed Liabilities. There are no restrictions on the right of the Company to incur Senior Indebtedness.

8

Article 4.
REGISTRATION RIGHTS

The Company hereby grants the following registration rights to the Holder.

(a)          Registration Statement. The Company shall file with the Securities and Exchange Commission (the “SEC”) not later than thirty (30) days after the date of this Note a registration statement on an appropriate form (the “Registration Statement) means the initial registration statement required to be filed in accordance with Section 2(a) and any additional registration statements required to be filed under this Agreement, including in each case the Prospectus, amendments and supplements to such registration statements or Prospectus, including pre- and post- effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference therein.

Required Holders” means the Holders of at least a majority of the Registrable Securities.


Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

Trading Day” means: (i) a day on which the Common Stock is traded on a Trading Market or (ii) if the Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over the counter market as reported by the Pink Sheets LLC (or any similar organization or agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i) and (ii) hereof, then Trading Day shall mean a Business Day.

Trading Market” means any of the New York Stock Exchange, the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market, the OTC Bulletin Board system, the OTCQX market operated by OTC Markets and the OTCQB market operated by OTC Markets Group, or any other market on which the Common Stock of the Company is listed or quoted for trading on the date in question.

2.             Registration.

(a)           On or prior to the applicable Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all Registrable Securities not already covered by an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each Registration Statement required to be filed under this Agreement shall be filed on Form S-1 (or on such other form appropriate for such purpose) and contain (except if otherwise required pursuant to written comments received from the Principal Shares andCommission upon a review of such Registration Statement, other than as to the Interest Shares (collectively,characterization of any Holder as an underwriter, which shall not occur unless such Holder consents in writing to such characterization) the Shares”) issuable upon conversion“Plan of Distribution” attached hereto asAnnex A. The Company shall cause each Registration Statement required to be filed under this NoteAgreement to be declared effective under the Securities Act as soon as possible but, in any event, no later than its Effectiveness Date, and shall use its commercially reasonable efforts to keep each such Registration Statement continuously effective during its entire Effectiveness Period. By 5:00 p.m. (Eastern time) on the Business Day immediately following the Effective Date of each Registration Statement, the Company shall file with the Commission in accordance with Rule 424 under the Securities Act the final prospectus to be used in connection with sales pursuant to such Registration Statement (whether or not such filing is technically required under such Rule). If for any reason other than due solely to SEC Restrictions (as defined below), a Registration Statement is effective but not all outstanding Registrable Securities are registered for resale pursuant thereto, then the Company shall prepare and file by the applicable Filing Date an additional Registration Statement to register the resale of all such unregistered Registrable Securities for an offering to be made on a continuous basis pursuant to Rule 415.


(b)           Promptly following any date on which the Company becomes eligible to use a registration statement on Form S-3 to register Registrable Securities for resale, the Company shall file a Registration Statement on Form S-3 covering all Registrable Securities (or a post-effective amendment on Form S-3 to the then effective Registration Statement) and shall cause thesuch Registration Statement to be filed by the Filing Date for such Registration Statement and declared effective within one hundred twenty (120) daysunder the Securities Act as soon as possible thereafter, but in any event by the Effectiveness Date therefor. Such Registration Statement shall contain (except if otherwise required pursuant to written comments received from the Commission upon a review of such Registration Statement, other than as to the characterization of any Holder as an underwriter, which shall not occur unless such Holder consents in writing to such characterization) the “Plan of Distribution” attached hereto asAnnex A. The Company shall use its commercially reasonable efforts to keep such Registration Statement continuously effective under the Securities Act during the entire Effectiveness Period. By 5:00 p.m. (Eastern time) on the Business Day immediately following the date hereof.Effective Date of such Registration Statement, the Company shall file with the Commission in accordance with Rule 424 under the Securities Act the final prospectus to be used in connection with sales pursuant to such Registration Statement (whether or not such filing is technically required under such Rule).

(c)           Notwithstanding anything to the contrary contained in this Section 2, if the Company receives Commission Comments, and following discussions with and responses to the Commission (it being understood that the Company will permit the Holders and counsel to the Holders to review and comment on such responses and any related amendments to the Registration Statement and incorporate any and all reasonable comments of the Holders and counsel to the Holders relating thereto) in which the Company uses its commercially reasonable efforts to cause as many Registrable Securities for as many Holders as possible to be included in the Registration Statement filed pursuant to Section 2(a) without characterizing any Holder as an underwriter unless such Holder consents in writing to such characterization (and in such regard uses its commercially reasonable efforts to cause the Commission to permit any Holder or its counsel to participate in Commission conversations on such issue together with the Company’s counsel, and timely conveys relevant information concerning such issue with the Holders or their counsel) (the day that such discussions and responses are concluded shall be referred to as the “Tolling Date”), the Company is unable to cause the inclusion of all Registrable Securities, then the Company may, following not less than three (3) Trading Days prior written notice to the Holders (i) remove from the Registration Statement such Registrable Securities (the “Cut Back Shares”) and/or (ii) agree to such restrictions and limitations on the registration and resale of the Registrable Securities, in each case as the Commission may require in order for the Commission to allow such Registration Statement to become effective;provided, that in no event may the Company characterize any Holder as an underwriter unless such Holder consents in writing to such characterization (collectively, the “SEC Restrictions”). Unless the SEC Restrictions otherwise require, any cut-back imposed pursuant to this Section 2(c) shall be allocated among the Registrable Securities of the Holders on a pro rata basis. The required Effectiveness Date for such Registration Statement will be tolled until such time as the Company is able to effect the registration of the Cut Back Shares in accordance with any SEC Restrictions if such Registrable Securities cannot at such time be resold by the Holders thereof without restrictions pursuant to Rule 144 (such date, the “Restriction Termination Date”). From and after the Restriction Termination Date, all provisions of this Section 2 shall again be applicable to the Cut Back Shares (which, for avoidance of doubt, retain their character as “Registrable Securities”) if such Registrable Securities cannot at such time be resold by the Holders thereof without volume limitations pursuant to Rule 144 so that the Company will be required to file with and cause to be declared effective by the Commission such additional Registration Statements in the time frames set forth herein as necessary to ultimately cause to be covered by effective Registration Statements all Registrable Securities. For the avoidance of doubt, the time period starting from the Tolling Date and ending with the Restriction Termination Date shall be excluded in calculating the applicable Effectiveness Date.


(d)           Each Holder agrees to furnish to the Company a completed Questionnaire in the form attached to this Agreement asAnnex B(a “Selling Holder Questionnaire”). The Company shall not be required to include the Registrable Securities of a Holder in a Registration Statement) to any Holder who fails to furnish to the Company a fully completed Selling Holder Questionnaire at least two Trading Days prior to the Filing Date (subject to the requirements set forth in Section 3(a)).

(e)           If: (i) a Registration Statement is not filed on or prior to its Filing Date covering the Registrable Securities required under this Agreement to be included therein, or (ii) a Registration Statement is not declared effective by the Commission on or prior to its required Effectiveness Date or if by the first Business Day immediately following the Effective Date in which the Commission accepts filings on its EDGAR database, the Company shall not have filed a “final” prospectus for the Registration Statement with the Commission under Rule 424(b) in accordance with the terms hereof (whether or not such a prospectus is technically required by such Rule), or (iii) after its Effective Date, without regard for the reason thereunder or efforts therefor, such Registration Statement ceases for any reason to be effective and available to the Holders as to all Registrable Securities to which it is required to cover at any time the Company may delay the disclosure of material, non-public information concerning the Company the disclosure of which at the time is not, in the good faith opinion of the Board of Directors of the Company, in the best interest of the Company and otherwise required (a “Grace Period”);provided, that the Company shall promptly: (i) notify the Holder in writing of the existence of material, non-public information giving rise to a Grace Period (provided that in each notice the Company will not disclose the content of such material, non-public informationprior to the Holder)expiration of its Effectiveness Period for more than an aggregate of 30 Trading Days during any 12-month period, which need not be consecutive (any such failure or breach being referred to as an “Event,” and for purposes of clauses (i) or (ii) the date on which such Event occurs, or for purposes of clause (iii) the Grace Period will begin,date on which such 30 Trading Day-period is exceeded, being referred to as “Event Date”), then in addition to any other rights the Holders may have hereunder or under applicable law: on the last day of each 30-day period after each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages and (ii) use commercially reasonable effortsnot as a penalty, equal to resolve any issue that makes disclosure1.0% of the material, non-public information notproduct obtained by multiplying (x) $1.00 by (y) the number of Registrable Securities held by such Holder (such product being the “Investment Amount”). The parties agree that in no event will the best interestsCompany be liable for liquidated damages under this Agreement in excess of 1.0% of the Company.Investment Amount in any single month and that the maximum aggregate liquidated damages payable to the Holders under this Agreement shall be ten percent (10%) of the Investment Amount. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro-rata basis for any portion of each 30-day period prior to the cure of an Event, and shall cease to accrue (unless earlier cured) upon the expiration of the Effectiveness Period.

 

(b)3.            Registration Procedures. In connection with the Registration Statement, the Company will:Company’s registration obligations hereunder:

 

(a)           The Company shall not file a Registration Statement, any Prospectus or any amendments or supplements thereto in which the “Selling Stockholder” section thereof differs from the disclosure received from a Holder in its Selling Holder Questionnaire (as amended or supplemented). The Company shall not file a Registration Statement, any Prospectus or any amendments or supplements thereto in which it (i) Preparecharacterizes any Holder as an underwriter, unless such Holder consents in writing to such characterization, (ii) excludes a particular Holder due to such Holder refusing to be named as an underwriter, or (iii) reduces the number of Registrable Securities being registered on behalf of a Holder except pursuant to, in the case of subsection (iii), the Commission Comments, without, in each case, such Holder’s express written authorization, unless such reduction is made pursuant to Section 2(c) hereof. The Company shall also ensure that each Registration Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances in which they were made) not misleading.


(b)           The Company shall (i) prepare and file with the SECCommission such amendments, and supplementsincluding post-effective amendments, to theeach Registration Statement and the prospectusProspectus used in connection therewith as may be necessary to keep such Registration Statement continuously effective as to the applicable Registrable Securities for its Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for resale under the Securities Act all of the Registrable Securities; (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement, and as so supplemented or amended to be filed pursuant to Rule 424; (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to each Registration Statement or any amendment thereto and, as promptly as reasonably possible provide the Holders true and complete copies of all correspondence from and to the Commission relating to such Registration Statement that would not result in the disclosure to the Holders of material and non-public information concerning the Company; and (iv) comply in all material respects with the provisions of the Securities Act and the Exchange Act with respect to the Holder untilRegistration Statement(s) and the disposition of all Registrable Securities covered by each Registration Statement.

(c)           The Company shall notify the Shares ownedHolders as promptly as reasonably possible (and, in the case of (i)(A) below, not less than three Trading Days prior to such filing and, in the case of (v) below, not less than three Trading Days prior to the financial statements in any Registration Statement becoming ineligible for inclusion therein) and (if requested by any such Person) confirm such notice in writing no later than one Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed; (B) when the Commission notifies the Company whether there will be a “review” of such Registration Statement and whenever the Commission comments in writing on such Registration Statement (the Company shall provide true and complete copies thereof and all written responses thereto that pertain to the Holders as a Selling Stockholder or to the Plan of Distribution, but not information which the Company believes would constitute material and non-public information); and (C) with respect to each Registration Statement or any post-effective amendment, when the same has become effective; (ii) of any request by the Commission or any other Federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information; (iii) of the issuance by the Commission of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose; (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in such Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to such Registration Statement, Prospectus or other documents so that, in the case of such Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.


(d)           The Company shall use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of a Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify the Holders of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.

(e)           The Company shall provide to the Holders and their counsel with drafts of each Registration Statement and each amendment thereto within a reasonable time in advance of the filing of the same with the Commission such that the Holders and their counsel may review and comment on each such Registration Statement and each amendment thereto and the Company shall incorporate all reasonable comments received from the Holders and their counsel with respect to such drafts prior to filing the same with the Commission. The Company shall furnish to the Holders, without charge and at the option of the Company in electronic format, at least one conformed copy of each Registration Statement and each amendment thereto and all exhibits to the extent requested by the Holders (including those previously furnished) promptly after the filing of such documents with the Commission.

(f)           The Company shall promptly deliver to the Holders, without charge, as many copies of each Prospectus or Prospectuses (including each form of prospectus) and each amendment or supplement thereto as the Holders may reasonably request. The Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Holder may be resold without restriction under the Securities Act;Prospectus and any amendment or supplement thereto.

 

(g)           Prior to any public offering of Registrable Securities, the Company shall register or qualify such Registrable Securities for offer and sale under the securities or Blue Sky laws of all jurisdictions within the United States as any Holder may request, to keep each such registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things necessary or advisable to enable the disposition in such jurisdictions of the Registrable Securities covered by the Registration Statements;provided,however, in connection with any such registration or qualification, the Company shall not be required to (i) qualify to do business in any jurisdiction where the Company would not otherwise be required to qualify, (ii) Immediatelysubject itself to general taxation in any such jurisdiction, (iii) file a general consent to service of process in any jurisdiction, or (iv) make any change to the Company’s articles of incorporation or bylaws.

(h)           The Company shall cooperate with the Holders to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to the Registration Statement(s), which certificates shall be free, to the extent permitted by the Remediation Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may request.

(i)            Upon the occurrence of any event contemplated by Section 3(c) (v), as promptly as reasonably possible, the Company shall prepare a supplement or amendment, including a post-effective amendment, to the affected Registration Statements or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.


(j)           The Company shall notify the Holders when the prospectus included in the Registration Statement is required to be delivered under the Securities Act of 1933, as amended (the “Securities Act”),writing of the happening of any event, as promptly as practicable after becoming aware of which the Company has knowledgesuch event, as a result of which the prospectus containedincluded in sucha Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein, not misleading in the light of the circumstances then existing.under which they were made, not misleading (provided that in no event shall such notice contain any material, nonpublic information), and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement or omission. The Company shall also promptly notify the Holders in writing when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when a Registration Statement or any post-effective amendment has become effective.

(k)           If any Holder is required under applicable securities laws to be described in the Registration Statement as an underwriter, at the reasonable request of such Holder, the Company notifiesshall furnish to such Holder, on the date of the effectiveness of the Registration Statement and thereafter from time to time on such dates as a Holder may reasonably request: (i) a letter, dated such date, from the Company’s independent certified public accountants in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the Holders, to suspendand (ii) an opinion, dated as of such date, of counsel representing the useCompany for purposes of any prospectus until the requisite changessuch Registration Statement, in form, scope and substance reasonably acceptable to such prospectus havecounsel and as is customarily given in an underwritten public offering, addressed to the Holders.

(l)           The Company shall hold in confidence and not make any disclosure of information concerning a Holder provided to the Company unless: (i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the release of such information is ordered pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made thengenerally available to the Holderspublic other than by disclosure in violation of this Agreement or any other agreement. The Company agrees that it shall, suspend useupon learning that disclosure of such prospectus. Ininformation concerning a Holder is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt written notice to such event,Holder and allow such Holder, at the Holder’s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.

(m)           The Company willshall use its commercially reasonable efforts to updatecause all of the Registrable Securities covered by a Registration Statement to be listed on each national securities exchange on which securities of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules of such exchange. The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3(m).

(n)           The Company shall cooperate with the Holders who hold Registrable Securities being offered and, to the extent applicable, facilitate the timely preparation and delivery of certificates (not bearing any restrictive legend to the extent permitted by the Remediation Agreement) representing the Registrable Securities to be offered pursuant to a Registration Statement and enable such certificates to be in such denominations or amounts, as the case may be, as the Holders may reasonably request and registered in such names as the Holders may request.


(o)           If requested by a Holder, the Company shall as soon as practicable: (i) incorporate in a prospectus supplement or post-effective amendment such information as a Holder reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus as promptly as is practicable.supplement or post-effective amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement if reasonably requested by a Holder holding any Registrable Securities.

4.            Registration Expenses.

 

(c)           Provision of Documents etc. In connection with the Registration Statement, the Holder will furnish(a)           All fees and expenses incident to the Company in writing such information and representation letters with respect to itself and the proposed distribution by it as reasonably shall be necessary in order to assureperformance of or compliance with federal and applicable state securities laws. The Company may require the Holder, upon five business days’ notice, to furnish to the Company a certified statement as to, among other things, the number of Shares and the number of other shares of the Company’s Common Stock beneficially owned by such Holder and the person that has voting and dispositive control over such shares. The Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act, if applicable, in connection with sales of Shares pursuant to the Registration Statement.

9

(d)          Expenses.All expenses incurredthis Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in complying with this article, including,the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses (A) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed or quoted for trading, (B) with respect to filings with FINRA by any underwriter’s counsel for compensation review pursuant to FINRA Rule 5110, and (C) in compliance with applicable state securities or Blue Sky laws), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities and of printing prospectuses if the printing of prospectuses is reasonably requested by a Holder), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel and independent public accountants for the Company, fees of transfer agents(v) Securities Act liability insurance, if the Company so desires such insurance, and registrars are called “Registration Expenses.” All underwriting discounts and selling commissions applicable to the sale of the Shares, including any(vi) fees and disbursementsexpenses of any counsel toall other Persons retained by the Holder, are called “Selling Expenses.” The Company will pay all Registration Expenses in connection with the Registration Statement. Selling Expensesconsummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the Registration Statementconsummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company be borneresponsible for any broker or similar commissions incurred by the applicableany Holder.

 

(e)5.            Indemnification and Contribution.

 

(i)(a)           Indemnification by the Company. The Company will, to the extent permitted by law,shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the Holder,officers, directors, agents, investment advisors, partners, members and as applicable,employees of each officer of Holder,them, each director of Holder, and each other person, if any,Person who controls any such Holder within(within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, agents and employees of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, or liabilities, joint or several, to which such Holder or such other person (acosts (including, without limitation, reasonable costs of preparation and reasonable attorneys’ fees) and expenses (collectively,controlling personLosses”) may become subject under the Securities Act or otherwise, insofar, as such losses, claims, damages or liabilities (or actions in respect thereof) (“Claims”) ariseincurred, arising out of or are based uponrelating to (i) any untrue statement or alleged untrue statement of anya material fact contained in theany Registration Statement, at the timeany Prospectus or any form of its effectiveness,prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or final prospectus contained therein,in any blue sky application or other document executed by the Company specifically for that purpose or based upon written information furnished by the Company filed in any amendmentstate or supplementother jurisdiction in order to qualify any or all of the Registrable Securities under the securities laws thereof (any such application, document or ariseinformation herein called a “Blue Sky Application”), or arising out of or are based upon therelating to any omission or alleged omission to state thereinof a material fact required to be stated therein or necessary to make the statements therein not misleading(in the case of any Prospectus or form of prospectus or supplement thereto, in light of the circumstances when made, and will, subjectunder which they were made) not misleading, except to the limitations herein,extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in the Registration Statement, such Prospectus or such form of Prospectus, or such Blue Sky Application or in any amendment or supplement thereto, (ii) any violation by the Company or its agents of any rule or regulation promulgated under the Securities Act applicable to the Company or its agents and relating to action or inaction required of the Company in connection with such registration; or (iii) any failure to register or qualify the Registrable Securities included in any such Registration Statement in any state where the Company or its agents has affirmatively undertaken or agreed in writing that the Company will undertake such registration or qualification on such Holder’s behalf and will reimburse such Holder, and each such controlling person for any legalofficer, director or other expenses reasonably incurred by them in connection with investigating or defending any such Claim; provided, however, that the Company shall not be liable to Holder to the extent that any Claim arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in conformity with information furnished by such Holder or any such controlling person in writing specifically for use in the Registration Statement or related prospectus, as amended or supplemented.

(ii)         The Holder will, to the extent permitted by law, indemnify and hold harmless the Company,member and each person, if any, who controls the Company within the meaning of the Securities Act, each underwriter, each officer of the Company who signs the Registration Statement and each director of the Company against all Claims to which the Company or such officer, director, underwriter or controlling person may become subject under the Securities Act or otherwise, insofar as such Claims arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the Registration Statement, any preliminary prospectus or final prospectus contained therein, or any amendment or supplement thereof, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Company and each such officer, director, underwriter and controlling person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action, provided, however, thataction. The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding of which the Company is aware in connection with the transactions contemplated by this Agreement.


(b)           Indemnification by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such Holder will be liable hereundercontrolling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, arising solely out of or based solely upon any untrue statement of a material fact contained in any such case if andRegistration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement thereto, or arising solely out of or based solely upon any omission of a material fact required to be stated therein or necessary to make the statements therein not misleading to the extent, but only to the extent that, any such Claim arises out ofuntrue statements or isomissions are based solely upon an untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with information pertaining toregarding such Holder as such, furnished in writing to the Company by such Holder specificallyexpressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in the Registration Statement, such Prospectus or related prospectus, as amendedsuch form of Prospectus or supplemented.in any amendment or supplement thereto. In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

 

10

(iii)        Promptly after receipt by an indemnified party(c)           Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall assume the defense thereof, including the employment of noticecounsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof;provided, that the commencementfailure of any action,Indemnified Party to give such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party hereunder, notify the indemnifying party in writing thereof, but the omission so to notify the indemnifying partynotice shall not relieve it from any liability which it may havethe Indemnifying Party of its obligations or liabilities pursuant to such indemnified party other than under this section and shall only relieve it from any liability which it may have to such indemnified party under this sectionAgreement, except and only if and(and only) to the extent the indemnifying party is materially prejudiced by such omission. In case any such actionthat it shall be brought against any indemnified party and it shall notify the indemnifying partyfinally determined by a court of the commencement thereof, the indemnifying party shall be entitledcompetent jurisdiction (which determination is not subject to participate in and, to the extent it shall wish, to assume and undertake the defense thereof with counsel satisfactory toappeal or further review) that such indemnified party, and, after notice from the indemnifying party to such indemnified party of its election so to assume and undertake the defense thereof, the indemnifying party shall not be liable to such indemnified party under this section for any legal expenses subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of investigation and of liaison with counsel so selected; provided, however, that, if the defendants in any such action include both the indemnified party and the indemnifying party and the indemnified partyfailure shall have reasonably concluded that there may be reasonable defenses available to it which are different from or additional to those available toproximately and materially adversely prejudiced the indemnifying party or if the interests of the indemnified party reasonably may be deemed to conflict with the interests of the indemnifying party, the indemnified parties, as a group,Indemnifying Party.


An Indemnified Party shall have the right to select oneemploy separate counsel and to assumein any such legal defensesProceeding and otherwise to participate in the defense thereof, but the fees and expenses of such action, withcounsel shall be at the reasonable expenses and feesexpense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and such Indemnified Party shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and other expenses related to such participation tocounsel shall be reimbursedat the expense of the Indemnifying Party);provided, that, the Indemnifying Party shall pay for no more than two separate sets of counsel for all Indemnified Parties and such legal counsel shall be selected by the indemnifying party as incurred.Required Holders. The indemnifying partyIndemnifying Party shall not be liable for any settlement of any such proceeding affectedProceeding effected without its written consent, which consent shall not be unreasonably withheld. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.

 

(iv)        In order to provide for justAll fees and equitable contribution in the event of joint liability under the Securities Act in any case in which either (i) the Holder, or any controlling personexpenses of the Holder, makesIndemnified Party (including reasonable fees and expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party (regardless of whether it is ultimately determined that an Indemnified Party is not entitled to indemnification hereunder;provided, that the Indemnifying Party may require such Indemnified Party to undertake to reimburse all such fees and expenses to the extent it is finally judicially determined that such Indemnified Party is not entitled to indemnification hereunder).

(d)           Contribution. If a claim for indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party (by reason of public policy or otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in Section 5(c), any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.


The parties hereto agree that it would not be just and equitable if contribution pursuant to this section but it is judiciallySection 5(d) were determined (byby pro rata allocation or by any other method of allocation that does not take into account the entry of a final judgment or decree by a court of competent jurisdiction andequitable considerations referred to in the expiration of time to appeal orimmediately preceding paragraph. Notwithstanding the denial of the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this section provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of the Holder or controlling person of the Holder in circumstances for which indemnification is not provided under this section, then, and in each such case, the Company and the Holder will contribute to the aggregate losses, claims, damages or liabilities to which they may be subject (after contribution from others) in a manner that reflects, as near as practicable, the economic effect of the foregoing provisions of this section. NotwithstandingSection 5(d), (i) no Person involved in the foregoing, no person or entitysale of Registrable Securities which Person is guilty of fraudulent misrepresentation (within the meaning of Section 10(f)11(f) of the Securities Act) willin connection with such sale shall be entitled to contribution from any person or entityPerson involved in such sale of Registrable Securities who was not guilty of fraudulent misrepresentation; and (ii) no Holder shall be required to contribute, in the aggregate, any amount in excess of the amount by which the proceeds actually received by such fraudulent misrepresentation.Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.

The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.

 

(f)6.            DeliveryReports Under the Exchange Act. With a view to making available to the Holders the benefits of Unlegended Shares.Rule 144 or any other similar rule or regulation of the Commission that may at any time permit the Holders to sell Registrable Securities of the Company to the public without registration, the Company agrees, for so long as Registrable Securities are outstanding and held by the Holders, to:

 

(i)          Within three business days (such business day, the “Unlegended Shares Delivery Date”) after the business day on which the Company has received (i) a notice that Shares have been sold either pursuant to,(a)           make and keep public information available, as those terms are understood, defined and required in complianceRule 144;

(b)           file with the Registration Statement or Rule 144Commission in a timely manner all reports and other documents required of the Company under the Securities Act (“Rule 144”) and (ii) in the caseExchange Act so long as the Company remains subject to such requirements and the filing of sales under Rule 144, customary representation letters ofsuch reports and other documents is required for the Holder and Holder’s broker regarding compliance with the requirementsapplicable provisions of Rule 144, the Company at its expense, (A) shall deliver the Shares so sold without any restrictive legends relating to the Securities Act (the “Unlegended Shares”);144; and (B) shall cause the transmission of the certificates representing the Unlegended Shares together with a legended certificate representing the balance of the unsold Shares, if any, to the Holder at the address specified in the notice of sale, via express courier, by electronic transfer or otherwise on or before the Unlegended Shares Delivery Date. Transfer fees shall be the responsibility of the Holder.

 

11

(ii)         In lieu of delivering physical certificates representing the Unlegended Shares, if the Company’s transfer agent is participating in the Depository Trust Company (“DTC”) Fast Automated Securities Transfer program, upon request of(c)           furnish to each Holder so long as such Holder owns Registrable Securities, promptly upon request, such information as may be reasonably and customarily requested to permit the certificates therefor do not bear a legend and the Holder is not obligatedHolders to returnsell such certificate for the placement of a legend thereon, the Company shall use its best efforts to cause its transfer agent to electronically transmit the Unlegended Shares by crediting the account of Holder’s broker with DTC through its Deposit/Withdrawal at Custodian system. Such delivery must be made on or before the Unlegended Shares Delivery Date but is subject to the cooperation of the Holder’s broker (the so-called DTC participant).

(iii)        The Holder agrees that the removal of the restrictive legend from certificates representing the Shares as set forth in this section is predicated upon the Company’s reliance that the Holder will sell any Shares pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom.

(g)          Rule 144. The Company agrees that until all the Shares have been sold under a Registration Statement orsecurities pursuant to Rule 144 without registration.

7.            Assignment of Registration Rights. The rights under this Agreement shall be automatically assignable by the Note Holders and OFI to any permitted transferee of all or other available exemption fromany portion of their Registrable Securities Act registration requirements, it shall use its reasonable commercial efforts to keep currentif: (i) the transferor agrees in filing all reports, statements and other materials required to be filedwriting with the SECtransferee or assignee to permit the Investors to sell the Shares under Rule 144. The Company shall use commercially reasonable efforts to facilitate salesassign such rights, and a copy of the Shares under Rule 144, including the delivery of customary transfer agent instructionssuch agreement is furnished to the Company’sCompany within five (5) Business Days after such assignment; (ii) the Company is, within five (5) Business Days after such transfer agentor assignment, furnished with written notice of (a) the name and causing its counseladdress of such transferee or assignee, and (b) the securities with respect to deliver any required opinion towhich such registration rights are being transferred or assigned; (iii) immediately following such transfer or assignment the Company’s transfer agent if resales under Rule 144 are permissiblefurther disposition of such securities by the transferee or assignee is restricted under the Securities Act.Act or applicable state securities laws; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this sentence the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein; and (v) such transfer shall have been made in accordance with the applicable requirements of the Remediation Agreement.

 


Article 5.
MISCELLANEOUS8.            Miscellaneous.

 

(a)           SecurityRemedies. The obligationsIn the event of a breach by the Company or by a Holder, of any of their obligations under this Note are secured by a lien on all of the assets ofAgreement, each Holder or the Company, as more fully describedthe case may be, in the Securityaddition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this Agreement.

(b)          Taxes, Charges, and Expenses. The Company at its own cost, shall report interest income, if any, to the IRS and/or other applicable tax authorities and to theeach Holder on a Form 1099-INT or other appropriate form in accordance with applicable law. The Company shall bear sole responsibilityagree that monetary damages would not provide adequate compensation for any costs or fees in connection with the paymentlosses incurred by reason of Interest with respect to this Note, including, but not limited to, wire transfer fees, bank check fees and escrow agent fees.

(c)          Transferability. The Company may not assign this Note. This Note will be binding upon the Company and its successors and will inure to the benefita breach by it of any of the Holderprovisions of this Agreement and its successors and assigns and may be assigned by the Holder to anyone of its choosing without the Company’s approval, but subject to transfer restrictions under applicable law.

(d)          Prepayment. This Note may not be prepaid by the Company without the written consent of the Holder.

(e)          WAIVER OF TRIAL BY JURY.COMPANY AND HOLDER hereby knowingly and voluntarily with the benefit of counsel waive trial by jury in any actions, proceedings, claims or counter-claims, whether in contract or tort or otherwise, at law or in equity, arising out of or in any way relating to this NOTE.

(f)          Mutilated, Destroyed, Lost or Stolen Notes. If this Note shall become mutilated or defaced, or be destroyed, lost or stolen, the Company shall execute and deliver a new note of like principal amount in exchange and substitution for the mutilated or defaced Note, or in lieu of and in substitution for the destroyed, lost or stolen Note certificate. In the case of a mutilated or defaced Note certificate, the Holder shall surrender such Note certificate to the Company. In the case of any destroyed, lost or stolen Note certificate, the Holder shall furnish to the Company: (i) evidence to its satisfaction of the destruction, loss or theft of such Note certificate and (ii) such security or indemnity (which shall not include the posting of any bond) as may be reasonably required by the Company to hold the Company harmless.

12

(g)          Waiver of Demand, Presentment, etc. The Company hereby expressly waives demand and presentment for payment, notice of nonpayment, protest, notice of protest, notice of dishonor, notice of acceleration or intent to accelerate, bringing of suit and diligence in taking any action to collect amounts called for hereunder and shall be directly and primarily liable for the payment of all sums owing and to be owing hereunder, regardless of and without any notice, diligence, act or omission as or with respect to the collection of any amount called for hereunder. The Companyfurther agrees that, in the event of an Eventany action for specific performance in respect of Default,such breach, it shall waive the defense that a remedy at law would be adequate.

(b)           No Piggyback on Registrations. Neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in a Registration Statement other than the Registrable Securities, and the Company shall not during the Effectiveness Period enter into any agreement providing any such right to reimburseany of its security holders.

(c)           Compliance. Each Holder covenants and agrees that it will comply with the Holder for all reasonable costs and expenses (including reasonable legal feesprospectus delivery requirements of one counsel) incurredthe Securities Act as applicable to it in connection with sales of Registrable Securities pursuant to the enforcement and collection of this Note.Registration Statement.

 

(h)(d)           PaymentDiscontinued Disposition. All payments with respect to this Note shall be made in lawful moneyEach Holder agrees by its acquisition of such Registrable Securities that, upon receipt of a notice from the Company of the United Statesoccurrence of America, at the addressany event of the kind described in Section 3(c), such Holder aswill forthwith discontinue disposition of such Registrable Securities under the Registration Statement until such Holder’s receipt of the date hereof copies of the supplemented Prospectus and/or as designatedamended Registration Statement or until it is advised in writing by the Holder from time to time. The receipt byCompany that the Holder of immediately available funds shall constitute a payment of principal and interest hereunder and shall satisfy and discharge the liability for principal and interest on this Note to the extentuse of the sum representedapplicable Prospectus may be resumed, and, in either case, has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such payment. Payment shall be credited firstProspectus or Registration Statement. The Company may provide appropriate stop orders to enforce the accrued interest then due and payable and the remainder applied to principal.provisions of this paragraph.

 

(i)(e)           Waiver and AmendmentPiggy-Back Registrations. Any provisionIf at any time during the Effectiveness Period there is not an effective Registration Statement covering all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection with stock option or other employee benefit plans, then the Company shall send to each Holder written notice of such determination and, if within fifteen calendar days after receipt of such notice, any such Holder shall so request in writing, the Company shall include in such registration statement all or any part of such Registrable Securities such holder requests to be registered, subject to customary underwriter cutbacks applicable to all holders of registration rights.

(f)           Amendments and Waivers. Provisions of this Note, including, without limitation, the due date hereof,Agreement may be amended and the observance of any term hereof,thereof may be amended, waived or modified (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Holder.

(j)          Severability. If oneRequired Holders. Any amendment or more provisions of this Note are held to be unenforceable under applicable law, such provisions shall be excluded from this Note, and the balance of this Note shall be interpreted as if such provisions were so excluded and shall be enforceablewaiver effected in accordance with its terms.

(k)          Notices. All noticesthis Section 8(f) shall be binding upon the Holders and the Company. No such amendment shall be effective to the extent that are requiredit applies to less than all of the Holders. No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of certain Holders and that does not directly or indirectly affect the rights of other Holders may be given pursuantby Holders of at least a majority of the Registrable Securities to which such waiver or consent relates.


(g)           Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement shallmust be sufficient in all respects if given in writing in English and by personal delivery (if signed for receipt), by certified or registered United States mail (postage prepaid, return receipt requested), by a nationally recognized overnight delivery service for next day delivery, or transmitted via electronic mail (following appropriate confirmation of receipt by return email, including an automated confirmation of receipt) and shallwill be deemed to have been made anddelivered if delivered in accordance with Section 9(g) of the receiving Party charged with notice, when received except that if received after 5:00 p.m. (in the recipient’s time zone) on a Business Day or if received on a day that is not a Business Day, such notice, request or communication will not be effective until the next succeeding Business Day. All notices shall be addressed as follows:Remediation Agreement.

 

If to the Company:

PhotoMedex, Inc.

2300 Computer Drive, Building G

Willow Grove, PA 19090

Attention: Dr. Dolev Rafaeli

Email: dolev@radiancy.com

If to the Holder:

[Holder]

[address]

Email: [          ]

13

(l)(h)           Governing Law; VenueSuccessors and Assigns. This Agreement shall be governed and construed in accordance with the laws of the State of New York applicable to agreements executed and to be performed wholly within such State, without regard to any principles of conflicts of law. Each of the parties hereby (i) irrevocably consents and agrees that any legal or equitable action or proceeding arising under or in connection with this Agreement may be brought in the federal or state courts located in the County of New York in the State of New York, (ii) by execution and delivery, or receipt, of this Note , irrevocably submits to and accepts the jurisdiction of said courts, (iii) waives any defense that such court is not a convenient forum, and (iv) consent that any service of process may be made (x) in the manner set forth in Article 4(e) of this Note, or (y) by any other method of service permitted by law.

[remainder of page intentionally left blank]

14

IN WITNESS WHEREOF, the Company has executed this Note as of the date and year first aforesaid.

PHOTOMEDEX, INC.

By:
Name:
Title:

Exhibit I

Payout Notes Security Agreement

Security Agreement

ThisSECURITY AGREEMENT (“Agreement”) is made as of __________, 2017, by and between PhotoMedex, Inc., a Nevada corporation (to be renamed ____________) (the “Debtor”), and Dolev Rafaeli (“Rafaeli”), Dennis M. McGrath (“McGrath”)and Yoav Ben-Dror (“Ben-Dror”) (each, a “Secured Party” and together, the “Secured Parties”).

WHEREAS, each Secured Party is the holder of a Secured Payout Note Due ___________, 2018 made by the Debtor in favor of such Secured Party as of the date hereof in the principal amount of $________ with respect to Rafaeli, $__________ with respect to McGrath, and $__________ with respect to Ben-Dror, (each, a “Note” and together, the “Notes”); and

WHEREAS, in connection with the Notes, Secured Parties desire to obtain from Debtor, and Debtor desires to grant to Secured Parties, a security interest in the collateral more particularly described below.

NOW, THEREFORE, in consideration of the foregoing premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

1.            Grant of Security Interest.  Debtor hereby grants to Secured Parties a security interest in all of the properties, assets and personal property of Debtor, whether now owned or hereafter acquired (collectively, the “Collateral”) including, without limitation, the following:

(a)          presently existing and hereafter arising accounts, contract rights, and all other forms of obligations owing to Debtor arising out of the sale or lease of goods or the rendition of services by Debtor, whether or not earned by performance, and any and all credit insurance, guaranties, and other security therefor, as well as all merchandise returned to or reclaimed by Debtor and Debtor's Books relating to any of the foregoing (collectively, “Accounts”);

(b)          present and future general intangibles and other personal property (including payment intangibles, choses or things in action, goodwill, intellectual property, patents, trade names, trademarks, servicemarks, copyrights, blueprints, drawings, purchase orders, customer lists, monies due or recoverable from pension funds, route lists, monies due under any royalty or licensing agreements, infringement claims, software, computer programs, computer discs, computer tapes, literature, reports, catalogs deposit accounts, insurance premium rebates, tax refunds, and tax refund claims) (collectively, “General Intangibles”);

(c)          present and future letters of credit, letter-of-credit rights (whether or not evidenced by a writing) and other supporting obligations, notes, drafts, instruments (including promissory notes), certificated and uncertificated securities, documents, leases, and chattel paper (whether tangible or electronic), and Debtor's Books relating to any of the foregoing (collectively, “Negotiable Collateral”);

(d)          present and future inventory in which Debtor has any interest, including goods held for sale or lease or to be furnished under a contract of service and all of Debtor's present and future raw materials, work in process, finished goods, and packing and shipping materials, wherever located, and any documents of title representing any of the above, and Debtor's Books relating to any of the foregoing (collectively, “Inventory”);

(e)          present and hereafter acquired machinery, machine tools, motors, equipment, furniture, furnishings, fixtures, vehicles (including motor vehicles and trailers), tools, parts, dies, jigs, goods (other than consumer goods or farm products), and any interest in any of the foregoing, and all attachments, accessories, accessions, replacements, substitutions, additions, and improvements to any of the foregoing, wherever located (collectively, “Equipment”);

(f)          present and hereafter acquired books and records including: ledgers; records indicating, summarizing, or evidencing Debtor's assets or liabilities, or the collateral; all information relating to Debtor's business operations or financial condition; and all computer programs, disc or tape files, printouts, funds or other computer prepared information, and the equipment containing such information (collectively, “Debtor's Books”);

(g)          “Investment Property,” as that term is defined in Section 9 of the UCC (defined below).

(h)          substitutions, replacements, additions, accessions, proceeds, products to or of any of the foregoing, including, but not limited to, proceeds of insurance covering any of the foregoing, or any portion thereof, and any and all Accounts, General Intangibles, Inventory, Equipment, Investment Property, money, deposits, accounts, or other tangible or intangible property resulting from the sale or other disposition of the Accounts, General Intangibles, Inventory, Equipment, Investment Property or any portion thereof or interest therein and the proceeds thereof.

The security interests granted hereby shall secure the prompt payment of the principal and all accrued interest due under and pursuant to the terms of the Notes (the “Obligations”).  

Notwithstanding any term or provision of this Agreement to the contrary, the security interest granted hereby is and shall be expressly subordinated and subrogated (in accordance with the terms of Article 3 of each Note) to any security interest, claims or liens of the holders of any Senior Indebtedness (as defined in the Notes).

2.            Perfection by Filing.  Debtor hereby specifically authorizes Secured Parties at any time and from time to time to file financing statements, continuation statements and amendments thereto that describe the Collateral and contain any other information required by Article 9 of the Uniform Commercial Code, as enacted in New York (the “UCC”) for the sufficiency or filing office acceptance of any financing statement, continuation statement or amendment, including whether Debtor is an organization, the type of organization and any organization identification number issued to Debtor.  Debtor agrees to furnish any such information to the Secured Parties promptly upon request.  Any such financing statements, continuation statements or amendments may be signed by an agent of Secured Parties on behalf of Debtor and may be filed at any time in any jurisdiction. Debtor hereby irrevocably constitutes and appoints Secured Parties and any officer or agent thereof, with full power of substitution, as its true and lawful attorney-in-fact with full irrevocable power and authority in the place and stead of Debtor and in the name of Debtor or in its own name, from time to time in such Secured Parties’ discretion, for the limited purpose of carrying out the terms of this subsection regarding perfection by filing.  Debtor hereby ratifies all that said attorneys shall lawfully do or cause to be done by virtue hereof.  All powers, authorizations and agencies contained in this subsection are coupled with an interest and are irrevocable until all of the Obligations (as defined in the Loan Documents) have been paid and satisfied in full.

3.            Perfection Other Than by Filing, etc.  At any time and from time to time, Debtor shall take such steps as Secured Parties may reasonably request for Debtor (a) to obtain an acknowledgment, in form and substance reasonably satisfactory to Secured Parties, of any bailee having possession of any of the Collateral, that such bailee holds such Collateral for the Secured Parties, (b) to obtain control of any investment property, deposit accounts, letter-of-credit rights or electronic chattel paper (as such terms are defined in Article 9 of the UCC) as set forth in Article 9 of the UCC, and, where control is established by written agreement, such agreement shall be in form and substance reasonably satisfactory to Secured Parties, and (c) otherwise to insure the continued perfection and priority of Secured Parties’ security interest in any of the Collateral and of the preservation of its rights therein.

2

4.            Agreements With Respect to the Collateral.  Debtor covenants and agrees with Secured Parties as follows:

(a)          Debtor shall notify Secured Parties in writing of any change in the location of Debtor's principal place of business or the location of any material tangible Collateral or the place(s) where the records concerning all intangible Collateral are kept or maintained.

(b)          Debtor will keep the Collateral in good condition and repair, ordinary wear and tear excepted, and will pay and discharge all taxes, levies and other impositions levied thereon as well as the cost of repairs to or maintenance of same, and will not permit anything to be done that may materially impair the value of any of the Collateral.  If Debtor fails to pay such sums, Secured Parties may do so for Debtor's account and add the amount thereof to the Obligations.

(c)          Until the occurrence of an Event of Default (as defined in the Note), Debtor shall be entitled to exercise the remedies set forth herein.

(d)          So long as an Event of Default has not occurred, Debtor shall have the right to process and sell the Collateral in the regular course of business.  Secured Parties’ security interest hereunder shall attach to all proceeds of all sales of the Collateral.  If at any time any such proceeds shall be represented by any instruments, chattel paper or documents of title, then such instruments, chattel paper or documents of title shall be subject to the security interest granted hereby.

5.          Remedies Upon Default.  Upon the occurrence of an Event of Default under and as defined in the Notes, including without limitation, a payment default under the Notes, Secured Parties may (subject in all instances to Article 3 of the Notes) pursue any or all of the following remedies:

(a)          Secured Parties shall give written notice of default to Debtor, following which Debtor shall not dispose of, conceal, transfer, sell or encumber any of the Collateral (including, but not limited to, cash proceeds) without Secured Parties prior written consent, except in the ordinary course of business.  

(b)          Secured Parties may dispose of the Collateral at private or public sale in accordance with the applicable provisions of the UCC.  Any required notice of sale shall be deemed commercially reasonable if given at least twenty (20) days prior to sale.    

(c)          Secured Parties may exercise their lien upon and right of setoff against any monies, items, credits, deposits or instruments that Secured Parties may have in their possession and that belong to Debtor or to any other person or entity liable for the payment of any or all of the Obligations.

(d)          Secured Parties may exercise any right that they may have under any other document evidencing or securing the Obligations or otherwise available to Secured Party at law or equity.

(e)          Notwithstanding anything herein to the contrary, Secured Parties shall not be entitled to exercise any rights with respect to the Collateral to the extent that the reasonable value of the Collateral exceeds the amount then due and owing to the Secured Parties.

3

(f)          The Secured Party acknowledges and agrees that Collateral is subject to security interests granted to other secured parties by the Debtor. In exercising any of Secured Parties’ rights hereunder, the Secured Parties shall undertake to (i) coordinate its efforts with such other secured parties to minimize any inconvenience to the Secured Parties or disruption to its business activities, and (ii) effect the exercise of their rights hereunder so as to not adversely affect in any manner the value of the Collateral or to impose costs or obligations on Secured Parties in excess of what Secured Parties would reasonably be expected to bear were the Debtor the sole party with rights to the Collateral.

6.          Termination Statement.  Upon receipt of proper written demand following the payment in full of the Obligations, Secured Parties shall promptly file a termination statement with respect to any financing statement filed to perfect Secured Party's security interests in any of the Collateral to Debtor or cause such termination statement to be filed with the appropriate filing officer(s).  If the Secured Parties shall fail to file any such termination statement within ten (10) days of the payment in full of all Obligations, Debtor shall have the right to file such termination statements.

7.          Binding Effect. This Agreement shall inure to the benefit of Secured Parties’and be binding upon the successors and permitted assigns of each of the parties and shall bind Debtor's successorsinure to the benefit of each Holder. The Company may not assign its rights or obligations hereunder without the prior written consent of each Holder. Each Holder may assign their respective rights hereunder in the manner and assigns.  

8.          Severability.  If any provision of this Agreement is held invalid, such invalidity shall not affectto the validity or enforceability ofPersons as permitted hereunder and under the remaining provisions of thisRemediation Agreement.

 

9.(i)           Governing LawExecution and Amendments.  This Agreement shall be construed and enforced under the laws of the State of New York applicable to contracts to be wholly performed in such State.  No amendment or modification hereof shall be effective except in a writing executed by each of the parties hereto.

10.         Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original instrument, butand, all such counterpartsof which taken together shall constitute but one agreement. Signatures to this Agreement transmitted byand the same Agreement. Counterparts may be delivered via facsimile, transmission, by electronic mail in “portable document format” (.pdf) form,(including pdf or by any electronic signature complying with the U.S. federal ESIGN Act of 2000,e.g., www.docusign.com) or other electronic means intendedtransmission method and any counterpart so delivered shall be deemed to preserve the original graphichave been duly and pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing the original signature.validly delivered and be valid and effective for all purposes.

 

11.(j)           Construction and InterpretationMediation; Arbitration; Governing Law.  Should In the event of a dispute between any provision of this Agreement require judicial interpretation, the parties hereto agree that the court interpreting or construing the same shall not apply a presumption that the terms hereof shall be more strictly construed against one party by reason of the rule of construction that a document is to be more strictly construed against the party that itself or through its agent prepared the same, it being agreed that Debtor, Secured Parties and their respective agents have participated in the preparation hereof.

12.         Exclusive Venue.  Each of the parties hereby (i) irrevocably consents and agrees that any legal or equitable action or proceeding arising under or relating in connection withany way whatsoever to this Agreement, may be brought in the federal or state courts located indisputing parties shall attempt to resolve it through good faith negotiation. If the County of New Yorkdispute is not resolved through such negotiation, then the disputing parties shall attempt to resolve it through mediation in the State of New York, (ii)USA, with a neutral, third-party mediator mutually agreed upon by execution and delivery, or receipt,the disputing parties. Unless otherwise agreed by the disputing parties, the costs of this Note , irrevocably submits to and acceptsmediation shall be shared equally. If the jurisdiction of said courts, (iii) waives any defense that such courtdispute is not resolved through mediation, then upon written demand by one of the disputing parties it shall be referred to a convenient forum,mutually agreeable arbitrator. The arbitration process shall be conducted in accordance with the laws of the United States of America and (iv) consent that any servicethe State of processNew York, except as modified herein. Venue for the arbitration hearing shall be the State of New York, USA. All remedies, legal and equitable, available in court shall also be available in arbitration. The arbitrator’s decision shall be final and binding, and judgment may be made (x)entered thereon in a court of competent jurisdiction. This Agreement shall be interpreted and enforced in accordance with the manner set forthlaws of the United States of America and the State of New York, without regard to conflict of law principles thereof. In any dispute arising out of or relating in Article 4(e)way whatsoever to this Agreement, including arbitration, the substantially prevailing party shall be entitled to recover its costs and attorney fees from the other disputing parties.

(k)           Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of this Note, or (y) by any other method of service permittedremedies provided by law.

 

13.(l)           WaiverEntire Agreement. This Agreement, the Remediation Agreement and the instruments referenced herein and therein constitute the entire agreement among the parties hereto with respect to the subject matter hereof and thereof. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein. This Agreement, the Remediation Agreement and the instruments referenced herein and therein supersede all prior agreements and understandings among the parties hereto with respect to the subject matter hereof and thereof.


(m)           Severability. If any term, provision, covenant or restriction of Trialthis Agreement is held by Jurya court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

(n)           Headings.Secured PartIES The headings in this Agreement are for convenience of reference only and Debtor hereby knowinglyshall not limit or otherwise affect the meaning hereof.

(o)           Independent Nature of Holders’ Obligations and voluntarilyRights. The obligations of each Holder under this Agreement are several and not joint with the benefitobligations of counsel waive trial by jury in any actions, proceedings, claims or counter-claims, whether in contract or tort or otherwise, at law or in equity, arising out of oreach other Holder, and no Holder shall be responsible in any way relatingfor the performance of the obligations of any other Holder under this Agreement. Nothing contained herein or in the Remediation Agreement, and no action taken by any Holder pursuant thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Holders are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or the Loan Documents.Remediation Agreement. Each Holder acknowledges that no other Holder will be acting as agent of such Holder in enforcing its rights under this Agreement. Each Holder shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any Proceeding for such purpose. The Company acknowledges that each of the Holders has been provided with the same Registration Rights Agreement for the purpose of closing a transaction with multiple Holders and not because it was required or requested to do so by any Holder.

 

[Signature Page Follows]


14.         Notice.  Any notice under this Agreement shall be made in accordance with the terms of the Notes.

4

IN WITNESS WHEREOF Debtor and Secured Party, the parties have executed this Registration Rights Agreement or have caused this Agreement to be executed as of the date first above written.written above.

 

 Debtor:COMPANY:
  
 PHOTOMEDEX, INC.FC GLOBAL REALTY INCORPORATED
  
 By: 
 Name: Michael R. Stewart
 Title: Chief Executive Officer
  
 Secured Party:OFI:
  
 
Dr. Dolev RafaeliOPPORTUNITY FUND I-SS, LLC
  
BY:OP FUND I MANAGER, LLC
By:
Name: Kristen Pigman
Title: Director
NOTE HOLDERS:
Dolev Rafaeli
  
 Dennis M. McGrath
  
 Yoav Ben-Dror

Annex A

Plan of Distribution

The Selling Stockholders and any of their pledgees, donees, transferees, assignees and successors-in-interest may, from time to time, sell any or all of their shares of common stock on any stock exchange, market or trading facility on which the shares are traded or quoted or in private transactions. These sales may be at fixed or negotiated prices. The Selling Stockholders may use any one or more of the following methods when selling shares:

ordinary brokerage transactions and transactions in which the broker-dealer solicits Investors;

block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;

purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

an exchange distribution in accordance with the rules of the applicable exchange;

privately negotiated transactions;

through the writing of options on the shares;

to cover short sales made after the date that this Registration Statement is declared effective by the Commission;

broker-dealers may agree with the Selling Stockholders to sell a specified number of such shares at a stipulated price per share;

a combination of any such methods of sale; and

any other method permitted by applicable law.

The selling stockholders may also sell shares under Rule 144 of the Securities Act of 1933, as amended (the “Securities Act”), if available, rather than under this prospectus. The selling stockholders shall have the sole and absolute discretion not to accept any purchase offer or make any sale of shares if it deems the purchase price to be unsatisfactory at any particular time.

The selling stockholders, alternatively, may sell all or any part of the shares offered in this prospectus through an underwriter.  The selling stockholders have not entered into any agreement with a prospective underwriter and there is no assurance that any such agreement will be entered into.

The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.


The selling stockholders or their respective pledgees, donees, transferees or other successors in interest, may also sell the shares directly to market makers acting as principals and/or broker-dealers acting as agents for themselves or their customers. Such broker-dealers may receive compensation in the form of discounts, concessions or commissions from the selling stockholders and/or the purchasers of shares for whom such broker-dealers may act as agents or to whom they sell as principal or both in amounts to be negotiated. Market makers and block purchasers purchasing the shares will do so for their own account and at their own risk. It is possible that a selling stockholder will attempt to sell shares of common stock in block transactions to market makers or other purchasers at a price per share which may be below the then existing market price. We cannot assure that all or any of the shares offered in this prospectus will be issued to, or sold by, the selling stockholders. The selling stockholders and any brokers, dealers or agents, upon effecting the sale of any of the shares offered in this prospectus, may be deemed to be “underwriters” as that term is defined under the Securities Act, the Exchange Act and the rules and regulations of such acts. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.

In connection with the sale of our common stock, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

The selling stockholders and any other persons participating in the sale or distribution of the shares will be subject to applicable provisions of the Exchange Act, and the rules and regulations under such act, including, without limitation, Regulation M. These provisions may restrict certain activities of, and limit the timing of purchases and sales of any of the shares by, the selling stockholders or any other such person. In the event that any of the selling stockholders are deemed an affiliated purchaser or distribution participant within the meaning of Regulation M, then the selling stockholders will not be permitted to engage in short sales of common stock. Furthermore, under Regulation M, persons engaged in a distribution of securities are prohibited from simultaneously engaging in market making and certain other activities with respect to such securities for a specified period of time prior to the commencement of such distributions, subject to specified exceptions or exemptions. In addition, if a short sale is deemed to be a stabilizing activity, then the selling stockholders will not be permitted to engage in a short sale of our common stock. All of these limitations may affect the marketability of the shares.

If a selling stockholder notifies us that it has a material arrangement with a broker-dealer for the resale of the common stock, then we would be required to amend the registration statement of which this prospectus is a part, and file a prospectus supplement to describe the agreements between the selling stockholder and the broker-dealer.


The aggregate proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common stock less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. We will not receive any of the proceeds from this offering.

We are required to pay all fees and expenses incident to the registration of the shares, including fees and disbursements of counsel to the selling stockholders, but excluding brokerage commissions or underwriter discounts.

We have agreed to indemnify the selling stockholders against liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares offered by this prospectus. 

In order to comply with the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered or qualified for sale or an exemption from registration or qualification requirements is available and is complied with.


ANNEX C 

 Yoav Ben-Dror

BARBARA K. CEGAVSKE

Secretary of State

202 North Carson Street

Carson City, Nevada 89701-4201 (775) 684-5708

Website: www.nvsos.gov

 

 

Exhibit J

Employment Agreement with Suneet Singal

[PhotoMedex, Inc. Letterhead]

[Date]

Mr. Suneet Singal

[Address]

[Address]

Re: Employment Terms

Dear Suneet:

PhotoMedex, Inc, (the “Company”) is pleased to offer you the position of Chief Executive Officer of the Company on the following terms.

You will be responsible for overseeing the corporate strategy of the Company and the implementation of the Company’s business plan as its most senior executive officer and will report to the board of directors of the Company. The Company acknowledges and agrees that you have and will continue to have executive and management responsibilities to First Capital Real Estate Trust Incorporated and its subsidiaries and affiliates (collectively, “First Capital”) and that nothing in this Agreement shall be construed to restrict or otherwise affect your obligations to First Capital. Further, notwithstanding anything to the contrary contained in this offer letter, you (i) may serve on the board(s) of additional companies or organizations and receive compensation for such services rendered (ii) may engage in charitable, civic, fraternal, professional, trade association or other activities on behalf of private companies and receive compensation for such services rendered, provided that in each such case the activities engaged in by you do not materially interfere with his obligations to the Company, and do not compete with the Company.

Your salary will be $__________ per year, less payroll deductions and withholdings, paid on the Company’s normal payroll schedule.

During your employment, you will be eligible to participate in the standard benefits plans offered to similarly situated employees by the Company from time to time, subject to plan terms and generally applicable Company policies. A full description of these benefits is available upon request. The Company may change compensation and benefits from time to time in its discretion.

Page 2

As a Company employee, you will be expected to abide by Company rules and policies. As a condition of employment, you agree that you will keep confidential during your employment and for a period of five (5) years following your employment, and will not disclose to any Person, any Confidential Information of the Company. “Confidential Information” means any non-public information about the Company, other than information which (i) is or becomes generally available to the public other than as a result of a disclosure by you, or any person acting on your behalf, or (ii) is disclosed by you pursuant to requirement of applicable law. If you are requested or required (by deposition, interrogatories, requests for information or documents in legal proceedings, subpoenas, civil investigative demand or similar process), in connection with any proceeding, to disclose any Confidential Information, you will give the Company prompt written notice of such request or requirement so that the Company may seek an appropriate protective order or other remedy or waive compliance with the provisions of this paragraph and you will reasonably cooperate with the Company to obtain such protective order upon the Company’s request and at the Company’s expense. If, in the absence of a protective order or the receipt of a waiver hereunder, you are nonetheless compelled to disclose Confidential Information to or at the direction of any governmental authority or else stand liable for contempt or suffer other censure, penalty or adverse consequences, you may disclose such specifically requested Confidential Information to or at the direction of such governmental authority only after first notifying the Company.

In your work for the Company, you will be expected not to use or disclose any confidential information, including trade secrets, of any former employer or other person to whom you have an obligation of confidentiality. Rather, you will be expected to use only that information which is generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company. You agree that you will not bring onto Company premises any unpublished documents or property belonging to any former employer or other person to whom you have an obligation of confidentiality. You hereby represent that you have disclosed to the Company any contract you have signed that may restrict your activities on behalf of the Company.

You may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company. Likewise, the Company may terminate your employment at any time, with or without cause or advance notice. Your employment at-will status can only be modified in a written agreement signed by you and by an officer of the Company.

This letter, forms the complete and exclusive statement of your employment agreement with the Company. It supersedes any other agreements or promises made to you by anyone, whether oral or written. Changes in your employment terms, other than those changes expressly reserved to the Company’s discretion in this letter, require a written modification signed by an officer of the Company.

Please sign and date this letter and return them to me by _________________, if you wish to accept employment at the Company under the terms described above. If you accept our offer, we would like you to start on _________________.

Page 3

We look forward to your favorable reply and to a productive and enjoyable work relationship.

Sincerely,

 

Certificate of Amendment

(PURSUANT TO NRS 78.385 AND 78.390)

 

[name, title]USE BLACK INK ONLY - DO NOT HIGHLIGHT
Understood and Accepted:
[Employee Name]DateABOVE SPACE IS FOR OFFICE USE ONLY

 

Exhibit K

Warrant

Certificate of Amendment to Articles of Incorporation

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE COMPANY TO SUCH EFFECT.For Nevada Profit Corporations

(Pursuant to NRS 78.385 and 78.390 - After Issuance of Stock)

 

______________, 20171.Name of corporation:
FC Global Realty Incorporated

2.The articles have been amended as follows: (provide article numbers, if available)

Article 3 of the Amended and Restated Articles of Incorporation is hereby amended to add the following subsection:

(e) Upon the filing of this Certificate of Amendment, each [ ] ([ ]) shares of the issued and outstanding Common Stock of the Corporation shall be combined into one (1) share of Common Stock. No fractional shares shall be issued in connection with this reverse stock split. Any fractional share that would otherwise be issued as a result of the reverse split will be rounded up to the nearest whole share.

 

PHOTOMEDEX, INC.3.   The vote by which the stockholders holding shares in the corporation entitling them to exercise at least a majority of the voting power, or such greater proportion of the voting power as may be required in the case of a vote by classes or series, or as may be required by the provisions of the articles of incorporation* have voted in favor of the amendment is:

Common Stock Purchase Warrant

4.Effective date and time of filing: (optional)                   Date:                                         Time:

5.Signature: (required)

(must not be later than 90 days after the certificate is filed)

 

THIS CERTIFIES THAT, for value received, First Capital Real Estate Operating Partnership, L.P.,X

Signature of Officer

*If any proposed amendment would alter or change any preference or any relative or other right given to any class or series of outstanding shares, then the amendment must be approved by the vote, in addition to the affirmative vote otherwise required, of the holders of shares representing a Delaware limited partnershipmajority of the voting power of each class or series affected by the amendment regardless to limitations or restrictions on the voting power thereof.


ANNEX D 

FC GLOBAL REALTY INCORPORATED

2018 EQUITY INCENTIVE PLAN

1.             Purpose; Eligibility.

1.1.          General Purpose. The name of this plan is the FC Global Realty Incorporated 2018 Equity Incentive Plan (the “HolderPlan”), is entitled. The purposes of the Plan are to subscribe for and purchase, at the Exercise Price (as defined below), from PhotoMedex, Inc,(a) enable FC Global Realty Incorporated, a Nevada corporation (the “Company”), sharesand any Affiliate to attract and retain the types of Employees, Consultants and Directors who will contribute to the Company’s long-term success; (b) provide incentives that align the interests of Employees, Consultants and Directors with those of the stockholders of the Company; and (c) promote the success of the Company’s common stock, par value $.01 (the “Commonbusiness.

1.2.          Eligible Award Recipients. The persons eligible to receive Awards are the Employees, Consultants and Directors of the Company and its Affiliates and such other individuals designated by the Committee who are reasonably expected to become Employees, Consultants and Directors after the receipt of Awards.

1.3.          Available Awards. Awards that may be granted under the Plan include: (a) Incentive Stock”), at any time prior to 5:00 p.m., New York time, on the _________________, 2022 (the “Warrant Exercise Term”) Options, (b) Non-qualified Stock Options, (c) Stock Appreciation Rights, (d) Restricted Awards, (e) Performance Share Awards, and (f) Performance Compensation Awards.

2.             Definitions.

 

This WarrantAffiliate” means a corporation or other entity that, directly or through one or more intermediaries, controls, is issuedcontrolled by or is under common control with, the Company.

Applicable Laws” means the requirements related to or implicated by the administration of the Plan under applicable state corporate law, United States federal and state securities laws, the Code, any stock exchange or quotation system on which the shares of Common Stock are listed or quoted, and the applicable laws of any foreign country or jurisdiction where Awards are granted under the Plan.

Award” means any right granted under the Plan, including an Incentive Stock Option, a Non-qualified Stock Option, a Stock Appreciation Right, a Restricted Award, a Performance Share Award or a Performance Compensation Award.

Award Agreement” means a written agreement, contract, certificate or other instrument or document evidencing the terms and conditions of an individual Award granted under the Plan which may, in accordance with, andthe discretion of the Company, be transmitted electronically to any Participant. Each Award Agreement shall be subject to the terms and conditions described inof the Interest Contribution Agreement, dated March 31, 2017, among the initial Holder, First Capital Real Estate Trust Incorporated, the Company and FC Global Realty Operating Partnership, LLP (the “Contribution Agreement”). All capitalized terms used but not defined herein shall have the meanings ascribed to them in the Contribution Agreement.

This Warrant is subject to the following terms and conditions:

1.          Shares. The Holder has, subject to the terms set forth herein, the right to purchase up to an aggregate ofTwenty-Five Million (25,000,000)shares of Common Stock (the “Warrant Shares”) at a per share exercise price of $3.00, subject to adjustment as provided for herein (the “Exercise Price”).Plan.

 

2.          ExerciseBeneficial Owner” has the meaning assigned to such term in Rule 13d-3 and Rule 13d-5 under the Exchange Act, except that in calculating the beneficial ownership of Warrant.any particular “person” (as that term is used in Section 13(d)(3) of the Exchange Act), such “person” shall be deemed to have beneficial ownership of all securities that such “person” has the right to acquire by conversion or exercise of other securities, whether such right is currently exercisable or is exercisable only after the passage of time. The terms “Beneficially Owns” and “Beneficially Owned” have a corresponding meaning.

 

(a)          Exercise; Vesting.

(i)          Exercise. This Warrant may be exercised by the Holder to the extent vested in accordance with Section 2(a)(ii) below at any time prior to the Warrant Exercise Term, in whole or in part and on more than one occasion, by delivering the notice of exercise attached asExhibit A hereto (the Notice of Exercise”), duly executed by the Holder to the Company at its principal office, or at such other office as the Company may designate, accompanied by payment, by wire transfer of immediately available funds to the order of the Company to an account designated by the Company, of the amount obtained by multiplying the number of Warrant Shares designated in the Notice of Exercise by the Exercise Price (the “Purchase Price”). For purposes hereof, “Exercise DateBoard” shall mean the date on which all deliveries required to be made to the Company upon exercise of this Warrant pursuant to this Section 2(a)(i) shall have been made. The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. No originals of the Notice of Exercise shall be required to be delivered, nor shall any medallion guarantee (or any other type of guarantee or notarization) of any Notice of Exercise shall be required.

(ii)         Vesting. This warrant may only be exercised to the extent that it has vested in accordance with this Section 2(a)(ii). This warrant shall vest (become exercisable) with respect to the number of Warrant Shares specified in the table below upon the achievement of the milestone specified opposite such number of Warrant Shares in the table below. The number of Warrant Shares that vest below will be equitably adjusted in the event of a stock split, stock combination, recapitalization or similar transaction.

Milestone to be AchievedNumber of Warrant
Shares to Vest
First revenues of at least $500,000 from either asset sales or real estate income – Punta Brava8,333,334
Upon Ground-Breaking with respect to the golf course (Shovels in the ground) - Punta Brava8,333,333
First revenues of at least $500,000 from either asset sales or real estate income – Melrose4,666,667
Upon Ground-Breaking with respect to residential home lots (Shovels in the ground)- Melrose4,666,666
Total25,000,000

(b)          Cashless Exercise. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, exercise this Warrant and, in lieu of making the cash payment otherwise required to be made to the Company upon such exercise in payment of the Aggregate Exercise Price for the applicable Warrant Shares, elect instead to receive upon such exercise the "Net Number" of shares of Common Stock determined according to the following formula (a "Cashless Exercise"):

X       =       Y (A - B)

            A

with:X =the number of Warrant Shares to be issued to the Holder
Y =the number of Warrant Shares with respect to which the Warrant is being exercised
A =the fair value per share of Common Stock on the date of exercise of this Warrant
B =the then-current Exercise Price of the Warrant

Solely for the purposes of this paragraph, “fair value” per share of Common Stock shall mean (A) the average of the closing sales prices on the Trading Market for the twenty (20) trading days immediately preceding the date on which the Notice of Exercise is deemed to have been sent to the Company, or (B) if the Common Stock is not publicly traded as set forth above, as reasonably and in good faith determined bymeans the Board of Directors of the Company, as of the date which the Notice of Exercise is deemed to have been sent to the Company.

2

For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a Cashless Exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for such shares shall be deemed to have commenced, on the date this Warrant was originally issued.

(c)          Issuance of Certificates. As soon as practicable after the exercise of this Warrant, in whole or in part, in accordance with Section 2(a)(i) or 2(b) hereof (and in no event later than two (2) Trading Days following the delivery of the Notice of Exercise), the Company,constituted at its expense, shall cause to be issued in the name of and delivered to the Holder: (i) a certificate or certificates for (or, if applicable, by delivery through the facilities of the Depository Trust Company in electronic form of) the number of fully paid and non-assessable Warrant Shares to which the Holder shall be entitled upon such exercise and, if applicable, (ii) a new warrant of like tenor to purchase all of the Warrant Shares that may be purchased pursuant to the portion, if any of this Warrant not exercised by the Holder. The Holder shall for all purposes hereof be deemed to have become the Holder of record of such Warrant Shares on the date on which the Notice of Exercise and payment of the Purchase Price in accordance with Section 2(a)(i) hereof were delivered and made, respectively, irrespective of the date of delivery of such certificate or certificates, except that if the date of such delivery, notice and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of record of such Warrant Shares at the close of business on the next succeeding date on which the stock transfer books are open.time.

 

3.          AdjustmentCause” means:


 With respect to any Employee or Consultant: (a) if the Employee or Consultant is a party to an employment or service agreement with the Company or its Affiliates and such agreement provides for a definition of Exercise Price.Cause, the definition contained therein; or (b) if no such agreement exists, or if such agreement does not define Cause: (i) the commission of, or plea of guilty or no contest to, a felony or a crime involving moral turpitude or the commission of any other act involving willful malfeasance or material fiduciary breach with respect to the Company or an Affiliate; (ii) conduct that results in or is reasonably likely to result in harm to the reputation or business of the Company or any of its Affiliates; (iii) gross negligence or willful misconduct with respect to the Company or an Affiliate; or (iv) material violation of state or federal securities laws.

With respect to any Director, a determination by a majority of the disinterested Board members that the Director has engaged in any of the following: (a) malfeasance in office; (b) gross misconduct or neglect; (c) false or fraudulent misrepresentation inducing the director’s appointment; (d) willful conversion of corporate funds; or (e) repeated failure to participate in Board meetings on a regular basis despite having received proper notice of the meetings in advance.

The Committee, in its absolute discretion, shall determine the effect of all matters and questions relating to whether a Participant has been discharged for Cause.

 

Change in Control” means (a) Adjustment for Reclassification, Consolidationthe direct or Merger. If while this Warrant,indirect sale, transfer, conveyance or any portion hereof, remains outstanding and unexpired there shall be (i) a reorganization or recapitalizationother disposition (other than a combination, reclassification, exchange or subdivisionby way of shares otherwise provided for herein), (ii) a merger or consolidation of the Company with or into another corporation or other entityconsolidation), in which the Company shall not be the surviving entity, or a reverse merger in which the Company shall be the surviving entity but the shares of the Company’s capital stock outstanding immediately prior to the merger are converted by virtue of the merger into other property, whether in the form of securities, cash or otherwise, or (iii) a sale or transfer of the Company’s properties and assets as, or substantially as, an entirety to any other corporation or other entity in one transaction or a series of related transactions, then,of all or substantially all of the properties or assets of the Company and its subsidiaries, taken as a partwhole, to any Person that is not a subsidiary of the Company; (b) the Incumbent Directors cease for any reason to constitute at least a majority of the Board; (c) the date which is 10 business days prior to the consummation of a complete liquidation or dissolution of the Company; (d) the acquisition by any Person of Beneficial Ownership of more than 50% (on a fully diluted basis) of either (i) the then outstanding shares of Common Stock of the Company, taking into account as outstanding for this purpose such Common Stock issuable upon the exercise of options or warrants, the conversion of convertible stock or debt, and the exercise of any similar right to acquire such Common Stock (the “Outstanding Company Common Stock”) or (ii) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided, however, that for purposes of this Plan, the following acquisitions shall not constitute a Change in Control: (A) any acquisition by the Company or any Affiliate, (B) any acquisition by any employee benefit plan sponsored or maintained by the Company or any subsidiary, (C) any acquisition which complies with clauses, (i), (ii) and (iii) of subsection (e) of this definition or (D) in respect of an Award held by a particular Participant, any acquisition by the Participant or any group of persons including the Participant (or any entity controlled by the Participant or any group of persons including the Participant); or (e) the consummation of a reorganization, recapitalization, merger, consolidation, salestatutory share exchange or transfer,similar form of corporate transaction involving the Company that requires the approval of the Company’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), unless otherwise directedimmediately following such Business Combination: (i) more than 50% of the total voting power of (A) the entity resulting from such Business Combination (the “Surviving Company”), or (B) if applicable, the ultimate parent entity that directly or indirectly has beneficial ownership of sufficient voting securities eligible to elect a majority of the members of the board of directors (or the analogous governing body) of the Surviving Company (the “Parent Company”), is represented by the Holder, all necessary or appropriate lawful provisions shall be made soOutstanding Company Voting Securities that the Holder shall thereafter be entitled to receive upon exercise of this Warrant, during the period specified herein and upon payment of the Exercise Price then in effect, the greatest number of shares of capital stock or other securities or property that a holder of the Warrant Shares deliverable upon exercise of this Warrant would have been entitled to receive in such reorganization, recapitalization, merger, consolidation, sale or transfer if this Warrant had been exercisedwere outstanding immediately prior to such reorganization, recapitalization, merger, consolidation, saleBusiness Combination (or, if applicable, is represented by shares into which the Outstanding Company Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the voting power of the Outstanding Company Voting Securities among the holders thereof immediately prior to the Business Combination; (ii) no Person (other than any employee benefit plan sponsored or transfer, allmaintained by the Surviving Company or the Parent Company) is or becomes the Beneficial Owner, directly or indirectly, of 50% or more of the total voting power of the outstanding voting securities eligible to elect members of the board of directors of the Parent Company (or the analogous governing body) (or, if there is no Parent Company, the Surviving Company); and (iii) at least a majority of the members of the board of directors (or the analogous governing body) of the Parent Company (or, if there is no Parent Company, the Surviving Company) following the consummation of the Business Combination were Board members at the time of the Board’s approval of the execution of the initial agreement providing for such Business Combination. The foregoing notwithstanding, in no event shall a Change in Control be deemed to have occurred unless such change shall satisfy the definition of a change in control under Section 409A of the Code.


Code” means the Internal Revenue Code of 1986, as it may be amended from time to time. Any reference to a section of the Code shall be deemed to include a reference to any regulations promulgated thereunder.

Committee” means a committee of one or more members of the Board appointed by the Board to administer the Plan in accordance withSection3.3 andSection3.4.

Common Stock” means the common stock, $0.01 par value per share, of the Company, or such other securities of the Company as may be designated by the Committee from time to time in substitution thereof.

Consultant” means any individual who is engaged by the Company or any Affiliate to render consulting or advisory services.

Continuous Service” means that the Participant’s service with the Company or an Affiliate, whether as an Employee, Consultant or Director, is not interrupted or terminated. The Participant’s Continuous Service shall not be deemed to have terminated merely because of a change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service,provided that there is no interruption or termination of the Participant’s Continuous Service;provided further that if any Award is subject to further adjustment as provided inSection 409A of the Code, this Section 3. If the per share consideration payablesentence shall only be given effect to the Holderextent consistent with Section 409A of the Code. For example, a change in status from an Employee of the Company to a Director of an Affiliate will not constitute an interruption of Continuous Service. The Committee or its delegate, in its sole discretion, may determine whether Continuous Service shall be considered interrupted in the case of any leave of absence approved by that party, including sick leave, military leave or any other personal or family leave of absence.

Covered Employee” has the same meaning as set forth in Section 162(m)(3) of the Code, as interpreted by IRS Notice 2007-49.

Director” means a member of the Board.

Disability” means that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment;provided, however, for Warrant Sharespurposes of determining the term of an Incentive Stock Option pursuant toSection6.10 hereof, the term Disability shall have the meaning ascribed to it under Section 22(e)(3) of the Code. The determination of whether an individual has a Disability shall be determined under procedures established by the Committee. Except in connection withsituations where the Committee is determining Disability for purposes of the term of an Incentive Stock Option pursuant toSection6.10 hereof within the meaning of Section 22(e)(3) of the Code, the Committee may rely on any determination that a Participant is disabled for purposes of benefits under any long-term disability plan maintained by the Company or any Affiliate in which a Participant participates. The foregoing notwithstanding, in no event shall a Disability be deemed to have occurred unless such transactiondisability satisfies the requirements of Section 409A of the Code.

Effective Date” shall mean the date as of which this Plan is inadopted by the Board.

Employee” means any person, including an Officer or Director, employed by the Company or an Affiliate;provided, that, for purposes of determining eligibility to receive Incentive Stock Options, an Employee shall mean an employee of the Company or a form other than cashparent or marketable securities, thensubsidiary corporation within the meaning of Section 424 of the Code. Mere service as a Director or payment of a director’s fee by the Company or an Affiliate shall not be sufficient to constitute “employment” by the Company or an Affiliate.

Exchange Act” means the Securities Exchange Act of 1934, as amended.


Fair Market Value” means, as of any date, the value of the Common Stock as determined below. If the Common Stock is listed on any established stock exchange or a national market system, including without limitation, the New York Stock Exchange or the Nasdaq Stock Market, the Fair Market Value shall be the closing price of a share of Common Stock (or if no sales were reported the closing price on the date immediately preceding such considerationdate) as quoted on such exchange or system on the day of determination, as reported in theWall Street Journal or similar publication. In the absence of an established market for the Common Stock, the Fair Market Value shall be determined in good faith by the Company’sCommittee and such determination shall be conclusive and binding on all persons.

Grant Date” means the date on which the Committee adopts a resolution, or takes other appropriate action, expressly granting an Award to a Participant that specifies the key terms and conditions of the Award or, if a later date is set forth in such resolution, then such date as is set forth in such resolution.

Incentive Stock Option” means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code.

Incumbent Directors” means individuals who, on the Effective Date, constitute the Board, of Directors. The foregoing provisions of this paragraph shall similarly apply to successive reorganizations, recapitalizations, mergers, consolidations, sales and transfers andprovided that any individual becoming a Director subsequent to the capital stockEffective Date whose election or securitiesnomination for election to the Board was approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for Director without objection to such nomination) shall be an Incumbent Director. No individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to Directors or as a result of any other corporationactual or threatened solicitation of proxies by or on behalf of any person other than the Board shall be an Incumbent Director.

Negative Discretion” means the discretion authorized by the Plan to be applied by the Committee to eliminate or reduce the size of a Performance Compensation Award in accordance withSection7.4(d)(iv) of the Plan. “Non-Employee Director” means a Director who is a “non-employee director” within the meaning of Rule 16b-3.

Non-qualified Stock Option” means an Option that areby its terms does not qualify or is not intended to qualify as an Incentive Stock Option.

Officer” means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder.

Option” means an Incentive Stock Option or a Non-qualified Stock Option granted pursuant to the Plan.

Optionholder” means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.

Option Exercise Price” means the price at the time receivablewhich a share of Common Stock may be purchased upon the exercise of this Warrant. In all events, appropriate adjustmentan Option.

Outside Director” means a Director who is not a current employee of the Company, is not a former employee of the Company who receives compensation for prior services (other than benefits under a tax-qualified retirement plan) during the year, has not been an officer of the Company and does not receive remuneration from the Company, directly or indirectly, in any capacity other than as a director.

Participant” means an eligible person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Award.


Performance Compensation Award” means any Award designated by the Committee as a Performance Compensation Award pursuant toSection7.4 of the Plan.

Performance Criteria” means the criterion or criteria that the Committee shall select for purposes of establishing the Performance Goal(s) for a Performance Period with respect to any Performance Compensation Award under the Plan. The Performance Criteria that will be used to establish the Performance Goal(s) shall be madebased on the attainment of specific levels of performance of the Company (or Affiliate, division, business unit or operational unit of the Company) and may include the following: (a) net earnings or net income (before or after taxes); (b) basic or diluted earnings per share (before or after taxes); (c) net revenue or net revenue growth; (d) gross revenue; (e) gross profit or gross profit growth; (f) net operating profit (before or after taxes); (g) return on assets, capital, invested capital, equity, or sales; (h) cash flow (including, but not limited to, operating cash flow, free cash flow, and cash flow return on capital); (i) earnings before or after taxes, interest, depreciation and/or amortization; (j) gross or operating margins; (k) improvements in capital structure; (l) budget and expense management; (m) productivity ratios; (n) economic value added or other value added measurements; (o) share price (including, but not limited to, growth measures and total stockholder return); (p) expense targets; (q) margins; (r) operating efficiency; (s) working capital targets; (t) enterprise value; (u) safety record; (v) completion of acquisitions or business expansion; (w) achieving research and development goals and milestones; (x) achieving product commercialization goals; and (y) other criteria as may be set by the Committee from time to time.

Any one or more of the Performance Criteria may be used on an absolute or relative basis to measure the performance of the Company and/or an Affiliate as a whole or any division, business unit or operational unit of the Company and/or an Affiliate or any combination thereof, as the Committee may deem appropriate, or as compared to the performance of a group of comparable companies, or published or special index that the Committee, in its sole discretion, deems appropriate, or the Committee may select Performance Criterion (o) above as compared to various stock market indices. The Committee also has the authority to provide for accelerated vesting of any Award based on the achievement of Performance Goals pursuant to the Performance Criteria specified in this paragraph, provided such accelerated vesting does not violate the rules of Code Section 409A. The Committee shall, within the first 90 days of a Performance Period (or, such longer or shorter time period as the Committee shall determine) define in an objective fashion the manner of calculating the Performance Criteria it selects to use for such Performance Period. In the event that applicable tax and/or securities laws change to permit the Committee discretion to alter the governing Performance Criteria without obtaining stockholder approval of such changes, the Committee shall have sole discretion to make such changes without obtaining stockholder approval.

Performance Formula” means, for a Performance Period, the one or more objective formulas applied against the relevant Performance Goal to determine, with regard to the Performance Compensation Award of a particular Participant, whether all, some portion but less than all, or none of the Performance Compensation Award has been earned for the Performance Period.

Performance Goals” means, for a Performance Period, the one or more goals established by the Committee for the Performance Period based upon the Performance Criteria. The Committee is authorized at any time during the first 90 days of a Performance Period (or such longer or shorter time period as the Committee shall determine) or at any time thereafter, in its sole and absolute discretion, to adjust or modify the calculation of a Performance Goal for such Performance Period to the extent permitted under Section 409A of the Code in order to prevent the dilution or enlargement of the rights of Participants based on the following events: (a) asset write-downs; (b) litigation or claim judgments or settlements; (c) the effect of changes in tax laws, accounting principles, or other laws or regulatory rules affecting reported results; (d) any reorganization and restructuring programs; (e) extraordinary nonrecurring items as described in Accounting Principles Board Opinion No. 30 (or any successor or pronouncement thereto) and/or in management’s discussion and analysis of financial condition and results of operations appearing in the applicationCompany’s annual report to stockholders for the applicable year; (f) acquisitions or divestitures; (g) any other specific unusual or nonrecurring events, or objectively determinable category thereof; (h) foreign exchange gains and losses; and (i) a change in the Company’s fiscal year.


Performance Period” means the one or more periods of time not less than one fiscal quarter in duration, as the Committee may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant’s right to and the payment of a Performance Compensation Award.

Performance Share” means the grant of a right to receive a number of actual shares of Common Stock or share units based upon the performance of the Company during a Performance Period, as determined by the Committee.

Permitted Transferee” means: (a) a member of the Optionholder’s immediate family (child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships), any person sharing the Optionholder’s household (other than a tenant or employee), a trust in which these persons have more than 50% of the beneficial interest, a foundation in which these persons (or the Optionholder) control the management of assets, and any other entity in which these persons (or the Optionholder) own more than 50% of the voting interests; (b) third parties designated by the Committee in connection with a program established and approved by the Committee pursuant to which Participants may receive a cash payment or other consideration in consideration for the transfer of a Non-qualified Stock Option; and (c) such other transferees as may be permitted by the Committee in its sole discretion.

Restricted Award” means any Award granted pursuant toSection7.2(a).

Rule 16b-3” means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.

Securities Act” means the Securities Act of 1933, as amended.

Stock Appreciation Right” means the right pursuant to an Award granted underSection7.1 to receive, upon exercise, an amount payable in cash or shares equal to the number of shares subject to the Stock Appreciation Right that is being exercised multiplied by the excess of (a) the Fair Market Value of a share of Common Stock on the date the Award is exercised, over (b) the exercise price specified in the Stock Appreciation Right Award Agreement.

Ten Percent Stockholder” means a person who owns (or is deemed to own pursuant to Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or of any of its Affiliates.

3.             Administration.

3.1.          Authority of Committee. The Plan shall be administered by the Committee or, in the Board’s sole discretion, by the Board. Subject to the terms of the Plan and the provisions of this WarrantSection 409A of the Code, the Committee’s charter and Applicable Laws, and in addition to other express powers and authorization conferred by the Plan, the Committee shall have the authority:

(a)          to construe and interpret the Plan and apply its provisions;

(b)          to promulgate, amend, and rescind rules and regulations relating to the administration of the Plan;

(c)          to authorize any person to execute, on behalf of the Company, any instrument required to carry out the purposes of the Plan;


(d)          to delegate its authority to one or more Officers of the Company with respect to Awards that do not involve Covered Employees or “insiders” within the meaning of Section 16 of the Exchange Act;

(e)          to determine when Awards are to be granted under the Plan and the applicable Grant Date;

(f)           from time to time to select, subject to the limitations set forth in this Plan, those Participants to whom Awards shall be granted;

(g)          to determine the number of shares of Common Stock to be made subject to each Award;

(h)          to determine whether each Option is to be an Incentive Stock Option or a Non-qualified Stock Option;

(i)           to prescribe the terms and conditions of each Award, including, without limitation, the exercise price and medium of payment and vesting provisions, and to specify the provisions of the Award Agreement relating to such grant;

(j)           to determine the target number of Performance Shares to be granted pursuant to a Performance Share Award, the performance measures that will be used to establish the performance goals, the performance period(s) and the number of Performance Shares earned by a Participant;

(k)          to designate an Award (including a cash bonus) as a Performance Compensation Award and to select the Performance Criteria that will be used to establish the Performance Goals;

(l)           to amend any outstanding Awards, including for the purpose of modifying the time or manner of vesting, or the term of any outstanding Award;provided, however, that if any such amendment impairs a Participant’s rights or increases a Participant’s obligations under his or her Award or creates or increases a Participant’s federal income tax liability with respect to an Award, such amendment shall also be subject to the Participant’s consent;

(m)         to determine the duration and purpose of leaves of absences which may be granted to a Participant without constituting termination of their employment for purposes of the Plan, which periods shall be no shorter than the periods generally applicable to Employees under the Company’s employment policies;

(n)          to make decisions with respect to outstanding Awards that may become necessary upon a change in corporate control or an event that triggers anti-dilution adjustments;

(o)          to interpret, administer, reconcile any inconsistency in, correct any defect in and/or supply any omission in the Plan and any instrument or agreement relating to, or Award granted under, the Plan; and

(p)          to exercise discretion to make any and all other determinations which it determines to be necessary or advisable for the administration of the Plan.

The Committee also may modify the purchase price or the exercise price of any outstanding Award,provided that if the modification effects a repricing, stockholder approval shall be required before the repricing is effective.

3.2.          Committee Decisions Final. All decisions made by the Committee pursuant to the provisions of the Plan shall be final and binding on the Company and the Participants, unless such decisions are determined by a court having jurisdiction to be arbitrary and capricious.


3.3.          Delegation. The Committee, or if no Committee has been appointed, the Board, may delegate administration of the Plan to a committee or committees of one or more members of the Board, and the term “Committee” shall apply to any person or persons to whom such authority has been delegated. The Committee shall have the power to delegate to a subcommittee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board or the Committee shall thereafter be to the committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Board may abolish the Committee at any time and re-vest in the Board the administration of the Plan. The members of the Committee shall be appointed by and serve at the pleasure of the Board. From time to time, the Board may increase or decrease the size of the Committee, add additional members to, remove members (with or without cause) from, appoint new members in substitution therefor, and fill vacancies, however caused, in the Committee. The Committee shall act pursuant to a vote of the majority of its members or, in the case of a Committee comprised of only two members, the unanimous consent of its members, whether present or not, or by the written consent of the majority of its members and minutes shall be kept of all of its meetings and copies thereof shall be provided to the Board. Subject to the limitations prescribed by the Plan and the Board, the Committee may establish and follow such rules and regulations for the conduct of its business as it may determine to be advisable.

3.4.          Committee Composition. Except as otherwise determined by the Board, the Committee shall consist solely of two or more Non-Employee Directors who are also Outside Directors. The Board shall have discretion to determine whether or not it intends to comply with the exemption requirements of Rule 16b-3. However, if the Board intends to satisfy such exemption requirements, with respect to Awards to any Covered Employee and with respect to any insider subject to Section 16 of the Exchange Act, the Committee shall be a compensation committee of the Board that at all times consists solely of two or more Non-Employee Directors who are also Outside Directors. Within the scope of such authority, the Board or the Committee may (a) delegate to a committee of one or more members of the Board who are not Outside Directors the authority to grant Awards to eligible persons who are not then Covered Employees and are not expected to be Covered Employees at the time of recognition of income resulting from such Award or (b) delegate to a committee of one or more members of the Board who are not Non-Employee Directors the authority to grant Awards to eligible persons who are not then subject to Section 16 of the Exchange Act. Nothing herein shall create an inference that an Award is not validly granted under the Plan in the event Awards are granted under the Plan by a compensation committee of the Board that does not at all times consist solely of two or more Non-Employee Directors who are also Outside Directors.

3.5.          Indemnification. In addition to such other rights of indemnification as they may have as Directors or members of the Committee, and to the extent allowed by Applicable Laws, the Committee shall be indemnified by the Company against the reasonable expenses, including attorney’s fees, actually incurred in connection with any action, suit or proceeding or in connection with any appeal therein, to which the Committee may be party by reason of any action taken or failure to act under or in connection with the Plan or any Award granted under the Plan, and against all amounts paid by the Committee in settlement thereof (provided, however, that the settlement has been approved by the Company, which approval shall not be unreasonably withheld) or paid by the Committee in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such Committee did not act in good faith and in a manner which such person reasonably believed to be in the best interests of the HolderCompany, or in the case of a criminal proceeding, had no reason to believe that the conduct complained of was unlawful;provided, however, that within 60 days after institution of any such action, suit or proceeding, such Committee shall, in writing, offer the transaction,Company the opportunity at its own expense to handle and defend such action, suit or proceeding.

4.          Shares Subject to the end that the provisionsPlan.

4.1.          Subject to adjustment in accordance withSection11, a total of this Warrant5,000,000 shares of Common Stock shall be applicable after that event,available for the grant of Awards under the Plan. Any shares of Common Stock granted in connection with Options and Stock Appreciation Rights shall be counted against this limit as nearone (1) share for every one (1) Option or Stock Appreciation Right awarded. Any shares of Common Stock granted in connection with Awards other than Options and Stock Appreciation Rights shall be counted against this limit as reasonably may be,two (2) shares of Common Stock for every one (1) share of Common Stock granted in relationconnection with such Award. During the terms of the Awards, the Company shall keep available at all times the number of shares of Common Stock required to any shares or other property deliverable or issuable aftersatisfy such reorganization, recapitalization, merger, consolidation, sale or transfer upon exercise of this Warrant.Awards.

 

3

4.2.          Shares of Common Stock available for distribution under the Plan may consist, in whole or in part, of authorized and unissued shares, treasury shares or shares reacquired by the Company in any manner.

 

(b)          Adjustments for Split, Subdivision or Combination of Shares. If while this Warrant, or any portion hereof, remains outstanding and unexpired the Company shall subdivide (by any stock split, stock dividend, recapitalization, reorganization, reclassification or otherwise) the4.3.          Any shares of Common Stock subject to acquisition hereunder, then,an Award that is canceled, forfeited or expires prior to exercise or realization, either in full or in part, shall again become available for issuance under the Plan. Any shares of Common Stock that again become available for future grants pursuant to thisSection4.3 shall be added back as one (1) share if such shares were subject to Options or Stock Appreciation Rights and as two (2) shares if such shares were subject to other Awards. Notwithstanding anything to the contrary contained herein: shares subject to an Award under the Plan shall not again be made available for issuance or delivery under the Plan if such shares are (a) shares tendered in payment of an Option, (b) shares delivered or withheld by the Company to satisfy any tax withholding obligation, or (c) shares covered by a stock-settled Stock Appreciation Right or other Awards that were not issued upon the effectivesettlement of the Award.

5.             Eligibility.

5.1.          Eligibility for Specific Awards. Incentive Stock Options may be granted only to Employees. Awards other than Incentive Stock Options may be granted to Employees, Consultants and Directors and those individuals whom the Committee determines are reasonably expected to become Employees, Consultants and Directors following the Grant Date.

5.2.          Ten Percent Stockholders. A Ten Percent Stockholder shall not be granted an Incentive Stock Option unless the Option Exercise Price is at least 110% of the Fair Market Value of the Common Stock at the Grant Date and the Option is not exercisable after the expiration of five years from the Grant Date.

6.          Option Provisions. Each Option granted under the Plan shall be evidenced by an Award Agreement. Each Option so granted shall be subject to the conditions set forth in thisSection6, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. All Options shall be separately designated Incentive Stock Options or Non-qualified Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. Notwithstanding the foregoing, the Company shall have no liability to any Participant or any other person if an Option designated as an Incentive Stock Option fails to qualify as such at any time or if an Option is determined to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code and the terms of such Option do not satisfy the requirements of Section 409A of the Code. The provisions of separate Options need not be identical, but each Option shall include (through incorporation of provisions hereof by reference in the Option or otherwise) the substance of each of the following provisions:

6.1.          Term. Subject to the provisions ofSection5.2 regarding Ten Percent Stockholders, no Incentive Stock Option shall be exercisable after the expiration of 10 years from the Grant Date. The term of a Non-qualified Stock Option granted under the Plan shall be determined by the Committee;provided, however, no Non-qualified Stock Option shall be exercisable after the expiration of 10 years from the Grant Date.

6.2.          Exercise Price of An Incentive Stock Option. Subject to the provisions ofSection5.2 regarding Ten Percent Stockholders, the Option Exercise Price of each Incentive Stock Option shall be not less than 100% of the Fair Market Value of the Common Stock subject to the Option on the Grant Date. Notwithstanding the foregoing, an Incentive Stock Option may be granted with an Option Exercise Price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 424(a) of the Code.


6.3.          Exercise Price of a Non-qualified Stock Option. The Option Exercise Price of each Non-qualified Stock Option shall be not less than 100% of the Fair Market Value of the Common Stock subject to the Option on the Grant Date. Notwithstanding the foregoing, a Non-qualified Stock Option may be granted with an Option Exercise Price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 409A of the Code.

6.4.          Consideration. The Option Exercise Price of Common Stock acquired pursuant to an Option shall be paid, to the extent permitted by applicable statutes and regulations, either (a) in cash or by certified or bank check at the time the Option is exercised or (b) in the discretion of the Committee, upon such terms as the Committee shall approve, the Option Exercise Price may be paid: (i) by delivery to the Company of other Common Stock, duly endorsed for transfer to the Company, with a Fair Market Value on the date of such subdivision,delivery equal to the Option Exercise Price (or portion thereof) due for the number of shares being acquired, or by means of attestation whereby the Participant identifies for delivery specific shares of Common Stock that have an aggregate Fair Market Value on the date of attestation equal to the Option Exercise Price (or portion thereof) and receives a number of shares of Common Stock equal to the difference between the number of shares thereby purchased and the number of identified attestation shares of Common Stock (a “Stock for Stock Exchange”); (ii) a “cashless” exercise program established with a broker; (iii) by reduction in effect immediately priorthe number of shares of Common Stock otherwise deliverable upon exercise of such Option with a Fair Market Value equal to the aggregate Option Exercise Price at the time of exercise; (iv) any combination of the foregoing methods; or (v) in any other form of legal consideration that may be acceptable to the Committee. Unless otherwise specifically provided in the Option, the exercise price of Common Stock acquired pursuant to an Option that is paid by delivery (or attestation) to the Company of other Common Stock acquired, directly or indirectly from the Company, shall be paid only by shares of the Common Stock of the Company that have been held for more than six months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes). Notwithstanding the foregoing, during any period for which the Common Stock is publicly traded (i.e., the Common Stock is listed on any established stock exchange or a national market system) an exercise by a Director or Officer that involves or may involve a direct or indirect extension of credit or arrangement of an extension of credit by the Company, directly or indirectly, in violation of Section 402(a) of the Sarbanes-Oxley Act of 2002 shall be prohibited with respect to any Award under this Plan.

6.5.          Transferability of An Incentive Stock Option. An Incentive Stock Option shall not be transferable except by will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the foregoing, the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option.

6.6.          Transferability of a Non-qualified Stock Option. A Non-qualified Stock Option may, in the sole discretion of the Committee, be transferable to a Permitted Transferee, upon written approval by the Committee to the extent provided in the Award Agreement. If the Non-qualified Stock Option does not provide for transferability, then the Non-qualified Stock Option shall not be transferable except by will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the foregoing, the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option.

6.7.          Vesting of Options. Each Option may, but need not, vest and therefore become exercisable in periodic installments that may, but need not, be equal. The Option may be subject to such subdivision willother terms and conditions on the time or times when it may be proportionately reducedexercised (which may be based on performance or other criteria) as the Committee may deem appropriate. The vesting provisions of individual Options may vary. No Option may be exercised for a fraction of a share of Common Stock. The Committee may, but shall not be required to, provide for an acceleration of vesting and exercisability in the terms of any Award Agreement upon the occurrence of a specified event, provided such acceleration of vesting and exercisability complies with the provisions of Section 409A of the Code.


6.8.          Termination of Continuous Service. Unless otherwise provided in an Award Agreement or in an employment agreement the terms of which have been approved by the Committee, in the event an Optionholder’s Continuous Service terminates (other than upon the Optionholder’s death or Disability), the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination) but only within such period of time ending on the earlier of (a) the date three months following the termination of the Optionholder’s Continuous Service or (b) the expiration of the term of the Option as set forth in the Award Agreement;provided that, if the termination of Continuous Service is by the Company for Cause, all outstanding Options (whether or not vested) shall immediately terminate and cease to be exercisable. If, after termination, the Optionholder does not exercise his or her Option within the time specified in the Award Agreement, the Option shall terminate.

6.9.          Extension of Termination Date. An Optionholder’s Award Agreement may also provide that if the exercise of the Option following the termination of the Optionholder’s Continuous Service for any reason would be prohibited at any time because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act or any other state or federal securities law or the rules of any securities exchange or interdealer quotation system, then the Option shall terminate on the earlier of (a) the expiration of the term of the Option in accordance withSection6.1 or (b) the expiration of a period after termination of the Participant’s Continuous Service that is three months after the end of the period during which the exercise of the Option would be in violation of such registration or other securities law requirements.

6.10.          Disability of Optionholder. Unless otherwise provided in an Award Agreement, in the event that an Optionholder’s Continuous Service terminates as a result of the Optionholder’s Disability, the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination), but only within such period of time ending on the earlier of (a) the date 12 months following such termination or (b) the expiration of the term of the Option as set forth in the Award Agreement. If, after termination, the Optionholder does not exercise his or her Option within the time specified herein or in the Award Agreement, the Option shall terminate.

6.11.          Death of Optionholder. Unless otherwise provided in an Award Agreement, in the event an Optionholder’s Continuous Service terminates as a result of the Optionholder’s death, then the Option may be exercised (to the extent the Optionholder was entitled to exercise such Option as of the date of death) by the Optionholder’s estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a person designated to exercise the Option upon the Optionholder’s death, but only within the period ending on the earlier of (a) the date 12 months following the date of death or (b) the expiration of the term of such Option as set forth in the Award Agreement. If, after the Optionholder’s death, the Option is not exercised within the time specified herein or in the Award Agreement, the Option shall terminate.

6.12.          Incentive Stock Option $100,000 Limitation. To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and its Affiliates) exceeds $100,000, the Options or portions thereof which exceed such limit (according to the order in which they were granted) shall be treated as Non-qualified Stock Options.

7.             Provisions of Awards Other Than Options.

7.1.          Stock Appreciation Rights.  

(a)          General. Each Stock Appreciation Right granted under the Plan shall be evidenced by an Award Agreement. Each Stock Appreciation Right so granted shall be subject to the conditions set forth in thisSection7.1, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. Stock Appreciation Rights may be granted alone (“Free Standing Rights”) or in tandem with an Option granted under the Plan (“Related Rights”). All such grants shall comply with the provisions of Section 409A of the Code.


(b)          Grant Requirements. Any Related Right that relates to a Non-qualified Stock Option may be granted at the same time the Option is granted or at any time thereafter but before the exercise or expiration of the Option. Any Related Right that relates to an Incentive Stock Option must be granted at the same time the Incentive Stock Option is granted.

(c)          Term of Stock Appreciation Rights. The term of a Stock Appreciation Right granted under the Plan shall be determined by the Committee;provided, however, no Stock Appreciation Right shall be exercisable later than the tenth anniversary of the Grant Date.

(d)          Vesting of Stock Appreciation Rights. Each Stock Appreciation Right may, but need not, vest and therefore become exercisable in periodic installments that may, but need not, be equal. The Stock Appreciation Right may be subject to such other terms and conditions on the time or times when it may be exercised as the Committee may deem appropriate. The vesting provisions of individual Stock Appreciation Rights may vary. No Stock Appreciation Right may be exercised for a fraction of a share of Common Stock. The Committee may, but shall not be required to, provide for an acceleration of vesting and exercisability in the terms of any Stock Appreciation Right upon the occurrence of a specified event, provided such acceleration of vesting and exercisability complies with the provisions of Section 409A of the Code.

(e)          Exercise and Payment. Upon exercise of a Stock Appreciation Right, the holder shall be entitled to receive from the Company an amount equal to the number of shares of Common Stock subject to acquisitionthe Stock Appreciation Right that is being exercised multiplied by the excess of (i) the Fair Market Value of a share of Common Stock on the date the Award is exercised, over (ii) the exercise price specified in the Stock Appreciation Right or related Option. Payment with respect to the exercise of a Stock Appreciation Right shall be made on the date of exercise. Payment shall be made in the form of shares of Common Stock (with or without restrictions as to substantial risk of forfeiture and transferability, as determined by the Committee in its sole discretion), cash or a combination thereof, as determined by the Committee.

(f)          Exercise Price. The exercise price of a Free Standing Stock Appreciation Right shall be determined by the Committee, but shall not be less than 100% of the Fair Market Value of one share of Common Stock on the Grant Date of such Stock Appreciation Right. A Related Right granted simultaneously with or subsequent to the grant of an Option and in conjunction therewith or in the alternative thereto shall have the same exercise price as the related Option, shall be transferable only upon the same terms and conditions as the related Option, and shall be exercisable only to the same extent as the related Option;provided, however, that a Stock Appreciation Right, by its terms, shall be exercisable only when the Fair Market Value per share of Common Stock subject to the Stock Appreciation Right and related Option exceeds the exercise price per share thereof and no Stock Appreciation Rights may be granted in tandem with an Option unless the Committee determines that the requirements ofSection7.1(b) are satisfied.

(g)          Reduction in the Underlying Option Shares. Upon any exercise of a Related Right, the number of shares of Common Stock for which any related Option shall be exercisable shall be reduced by the number of shares for which the Stock Appreciation Right has been exercised. The number of shares of Common Stock for which a Related Right shall be exercisable shall be reduced upon any exercise of any related Option by the number of shares of Common Stock for which such Option has been exercised.

7.2.          Restricted Awards.  

(a)          General. A Restricted Award is an Award of actual shares of Common Stock (“Restricted Stock”) or hypothetical Common Stock units (“Restricted Stock Units”) having a value equal to the Fair Market Value of an identical number of shares of Common Stock, which may, but need not, provide that such Restricted Award may not be sold, assigned, transferred or otherwise disposed of, pledged or hypothecated as collateral for a loan or as security for the performance of any obligation or for any other purpose for such period (the “Restricted Period”) as the Committee shall determine. Each Restricted Award granted under the Plan shall be evidenced by an Award Agreement. Each Restricted Award so granted shall be subject to the conditions set forth in thisSection7.2, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement.


(b)          Restricted Stock and Restricted Stock Units.

(i)          Each Participant granted Restricted Stock shall execute and deliver to the Company an Award Agreement with respect to the Restricted Stock setting forth the restrictions and other terms and conditions applicable to such Restricted Stock. If the Committee determines that the Restricted Stock shall be held by the Company or in escrow rather than delivered to the Participant pending the release of the applicable restrictions, the Committee may require the Participant to additionally execute and deliver to the Company (A) an escrow agreement satisfactory to the Committee, if applicable and (B) the appropriate blank stock power with respect to the Restricted Stock covered by such agreement. If a Participant fails to execute an agreement evidencing an Award of Restricted Stock and, if applicable, an escrow agreement and stock power, the Award shall be null and void. Subject to the restrictions set forth in the Award, the Participant generally shall have the rights and privileges of a stockholder as to such Restricted Stock, including the right to vote such Restricted Stock and the right to receive dividends;provided that, any cash dividends and stock dividends with respect to the Restricted Stock shall be withheld by the Company for the Participant’s account, and interest may be credited on the amount of the cash dividends withheld at a rate and subject to such terms as determined by the Committee. The cash dividends or stock dividends so withheld by the Committee and attributable to any particular share of Restricted Stock (and earnings thereon, if applicable) shall be distributed to the Participant in cash or, at the discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to the amount of such dividends, if applicable, upon the release of restrictions on such share and, if such share is forfeited, the Participant shall have no right to such dividends.

(ii)         The terms and conditions of a grant of Restricted Stock Units shall be reflected in an Award Agreement. No shares of Common Stock shall be issued at the time a Restricted Stock Unit is granted, and the Company will not be required to set aside a fund for the payment of any such Award. A Participant shall have no voting rights with respect to any Restricted Stock Units granted hereunder. The Committee may also grant Restricted Stock Units with a deferral feature, whereby settlement is deferred beyond the vesting date until the occurrence of a future payment date or event set forth in an Award Agreement (“Deferred Stock Units”). At the discretion of the Committee, each Restricted Stock Unit or Deferred Stock Unit (representing one share of Common Stock) may be credited with cash and stock dividends paid by the Company in respect of one share of Common Stock (“Dividend Equivalents”). Dividend Equivalents shall be withheld by the Company and credited to the Participant’s account, and interest may be credited on the amount of cash Dividend Equivalents credited to the Participant’s account at a rate and subject to such terms as determined by the Committee. Dividend Equivalents credited to a Participant’s account and attributable to any particular Restricted Stock Unit or Deferred Stock Unit (and earnings thereon, if applicable) shall be distributed in cash or, at the discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to the amount of such Dividend Equivalents and earnings, if applicable, to the Participant upon settlement of such Restricted Stock Unit or Deferred Stock Unit and, if such Restricted Stock Unit or Deferred Stock Unit is forfeited, the Participant shall have no right to such Dividend Equivalents.

(c)          Restrictions.

(i)          Restricted Stock awarded to a Participant shall be subject to the following restrictions until the expiration of the Restricted Period, and to such other terms and conditions as may be set forth in the applicable Award Agreement: (A) if an escrow arrangement is used, the Participant shall not be entitled to delivery of the stock certificate; (B) the shares shall be subject to the restrictions on transferability set forth in the Award Agreement; (C) the shares shall be subject to forfeiture to the extent provided in the applicable Award Agreement; and (D) to the extent such shares are forfeited, the stock certificates shall be returned to the Company, and all rights of the Participant to such shares and as a stockholder with respect to such shares shall terminate without further obligation on the part of the Company.


(ii)         Restricted Stock Units and Deferred Stock Units awarded to any Participant shall be subject to (A) forfeiture until the expiration of the Restricted Period, and satisfaction of any applicable Performance Goals during such period, to the extent provided in the applicable Award Agreement, and to the extent such Restricted Stock Units or Deferred Stock Units are forfeited, all rights of the Participant to such Restricted Stock Units or Deferred Stock Units shall terminate without further obligation on the part of the Company and (B) such other terms and conditions as may be set forth in the applicable Award Agreement.

(iii)        The Committee shall have the authority to remove any or all of the restrictions on the Restricted Stock, Restricted Stock Units and Deferred Stock Units whenever it may determine that, by reason of changes in Applicable Laws or other changes in circumstances arising after the date the Restricted Stock or Restricted Stock Units or Deferred Stock Units are granted, such action is appropriate.

(d)          Restricted Period. With respect to Restricted Awards, the Restricted Period shall commence on the Grant Date and end at the time or times set forth on a schedule established by the Committee in the applicable Award Agreement. No Restricted Award may be granted or settled for a fraction of a share of Common Stock. The Committee may, but shall not be required to, provide for an acceleration of vesting in the terms of any Award Agreement upon the occurrence of a specified event, provided such acceleration is consistent with the provisions of Section 409A of the Code.

(e)          Delivery of Restricted Stock and Settlement of Restricted Stock Units. Upon the expiration of the Restricted Period with respect to any shares of Restricted Stock, the restrictions set forth inSection7.2(c) and the applicable Award Agreement shall be of no further force or effect with respect to such shares, except as set forth in the applicable Award Agreement. If an escrow arrangement is used, upon such expiration, the Company shall deliver to the Participant, or his or her beneficiary, without charge, the stock certificate evidencing the shares of Restricted Stock which have not then been forfeited and with respect to which the Restricted Period has expired (to the nearest full share) and any cash dividends or stock dividends credited to the Participant’s account with respect to such Restricted Stock and the interest thereon, if any. Upon the expiration of the Restricted Period with respect to any outstanding Restricted Stock Units, or at the expiration of the deferral period with respect to any outstanding Deferred Stock Units, the Company shall deliver to the Participant, or his or her beneficiary, without charge, one share of Common Stock for each such outstanding vested Restricted Stock Unit or Deferred Stock Unit (“Vested Unit”) and cash equal to any Dividend Equivalents credited with respect to each such Vested Unit in accordance withSection7.2(b)(ii)hereof and the interest thereon or, at the discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to such Dividend Equivalents and the interest thereon, if any;provided, however, that, if explicitly provided in the applicable Award Agreement, the Committee may, in its sole discretion, elect to pay cash or part cash and part Common Stock in lieu of delivering only shares of Common Stock for Vested Units. If a cash payment is made in lieu of delivering shares of Common Stock, the amount of such payment shall be equal to the Fair Market Value of the Common Stock as of the date on which the Restricted Period lapsed in the case of Restricted Stock Units, or the delivery date in the case of Deferred Stock Units, with respect to each Vested Unit.

(f)           Stock Restrictions. Each certificate representing Restricted Stock awarded under the Plan shall bear a legend in such form as the Company deems appropriate.


7.3.          Performance Share Awards.  

(a)          Grant of Performance Share Awards. Each Performance Share Award granted under the Plan shall be evidenced by an Award Agreement. Each Performance Share Award so granted shall be subject to the conditions set forth in thisSection7.3, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. The Committee shall have the discretion to determine: (i) the number of shares of Common Stock or stock-denominated units subject to a Performance Share Award granted to any Participant; (ii) the performance period applicable to any Award; (iii) the conditions that must be satisfied for a Participant to earn an Award; and (iv) the other terms, conditions and restrictions of the Award.

(b)          Earning Performance Share Awards. The number of Performance Shares earned by a Participant will depend on the extent to which the performance goals established by the Committee are attained within the applicable Performance Period, as determined by the Committee. No payout shall be made with respect to any Performance Share Award except upon written certification by the Committee that the minimum threshold performance goal(s) have been achieved.

7.4.          Performance Compensation Awards.  

(a)          General. The Committee shall have the authority, at the time of grant of any Award described in this Plan (other than Options and Stock Appreciation Rights granted with an exercise price equal to or greater than the Fair Market Value per share of Common Stock on the Grant Date), to designate such Award as a Performance Compensation Award. In addition, the Committee shall have the authority to make an Award of a cash bonus to any Participant and designate such Award as a Performance Compensation Award.

(b)          Eligibility. The Committee will, in its sole discretion, designate within the first 90 days of a Performance Period (or such shorter or longer time period as the Committee shall determine) which Participants will be eligible to receive Performance Compensation Awards in respect of such Performance Period. However, designation of a Participant eligible to receive an Award hereunder for a Performance Period shall not in any manner entitle the Participant to receive payment in respect of any Performance Compensation Award for such Performance Period. The determination as to whether or not such Participant becomes entitled to payment in respect of any Performance Compensation Award shall be decided solely in accordance with the provisions of thisSection7.4. Moreover, designation of a Participant eligible to receive an Award hereunder for a particular Performance Period shall not require designation of such Participant eligible to receive an Award hereunder in any subsequent Performance Period and designation of one person as a Participant eligible to receive an Award hereunder shall not require designation of any other person as a Participant eligible to receive an Award hereunder in such period or in any other period.

(c)          Discretion of Committee with Respect to Performance Compensation Awards. With regard to a particular Performance Period, the Committee shall have full discretion to select the length of such Performance Period (provided any such Performance Period shall be not less than one fiscal quarter in duration), the type(s) of Performance Compensation Awards to be issued, the Performance Criteria that will be used to establish the Performance Goal(s), the kind(s) and/or level(s) of the Performance Goal(s) that is (are) to apply to the Company and the Performance Formula. Within the first 90 days of a Performance Period (or such shorter or longer time period as the Committee shall determine), the Committee shall, with regard to the Performance Compensation Awards to be issued for such Performance Period, exercise its discretion with respect to each of the matters enumerated in the immediately preceding sentence of thisSection7.4(c) and record the same in writing.

(d)          Payment of Performance Compensation Awards.

(i)          Condition to Receipt of Payment. Unless otherwise provided in the applicable Award Agreement, a Participant must be employed by the Company on the last day of a Performance Period to be eligible for payment in respect of a Performance Compensation Award for such Performance Period.


(ii)         Limitation. A Participant shall be eligible to receive payment in respect of a Performance Compensation Award only to the extent that: (A) the Performance Goals for such period are achieved; and (B) the Performance Formula as applied against such Performance Goals determines that all or some portion of such Participant’s Performance Compensation Award has been earned for the Performance Period.

(iii)        Certification. Following the completion of a Performance Period, the Committee shall review and certify in writing whether, and to what extent, the Performance Goals for the Performance Period have been achieved and, if so, calculate and certify in writing the amount of the Performance Compensation Awards earned for the period based upon the Performance Formula. The Committee shall then determine the actual size of each Participant’s Performance Compensation Award for the Performance Period and, in so doing, may apply Negative Discretion in accordance withSection7.4(d)(iv) hereof, if and when it deems appropriate.

(iv)        Use of Discretion. In determining the actual size of an individual Performance Compensation Award for a Performance Period, the Committee may reduce or eliminate the amount of the Performance Compensation Award earned under the Performance Formula in the Performance Period through the use of Negative Discretion if, in its sole judgment, such reduction or elimination is appropriate. The Committee shall not have the discretion to grant or provide payment in respect of Performance Compensation Awards for a Performance Period if the Performance Goals for such Performance Period have not been attained.

(v)        Timing of Award Payments. Performance Compensation Awards granted for a Performance Period shall be paid to Participants as soon as administratively practicable following completion of the certifications required by thisSection7.4 but in no event later than 2 1/2 months following the end of the fiscal year during which the Performance Period is completed.

8.             Securities Law Compliance. Each Award Agreement shall provide that no shares of Common Stock shall be purchased or sold thereunder unless and until (a) any then applicable requirements of state or federal laws and regulatory agencies have been fully complied with to the satisfaction of the Company and its counsel and (b) if required to do so by the Company, the Participant has executed and delivered to the Company a letter of investment intent in such form and containing such provisions as the Committee may require. The Company shall use reasonable efforts to seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Awards and to issue and sell shares of Common Stock upon exercise of the Warrant will be proportionately increased. IfAwards;provided, however, that this undertaking shall not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or issuable pursuant to any such Award. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Awards unless and until such authority is obtained.

9.             Use of Proceeds from Stock. Proceeds from the sale of Common Stock pursuant to Awards, or upon exercise thereof, shall constitute general funds of the Company.

10.           Miscellaneous.

10.1.        Acceleration of Exercisability and Vesting. The Committee shall have the power to accelerate the time at which an Award may first be exercised or the time during which an Award or any part thereof will vest in accordance with the Plan, notwithstanding the provisions in the Award stating the time combines (by reverse stock split, recapitalization, reorganization, reclassificationat which it may first be exercised or otherwise) the time during which it will vest, provided any such acceleration or exercisability or vesting is in compliance with the provisions of Section 409A of the Code.


10.2.        Stockholder Rights. Except as provided in the Plan or an Award Agreement, no Participant shall be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to such Award unless and until such Participant has satisfied all requirements for exercise of the Award pursuant to its terms and no adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property) or distributions of other rights for which the record date is prior to the date such Common Stock certificate is issued, except as provided inSection11 hereof.

10.3.        No Employment or Other Service Rights. Nothing in the Plan or any instrument executed or Award granted pursuant thereto shall confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or shall affect the right of the Company or an Affiliate to terminate (a) the employment of an Employee with or without notice and with or without Cause or (b) the service of a Director pursuant to the By-laws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be.

10.4.        Transfer; Approved Leave of Absence. For purposes of the Plan, no termination of employment by an Employee shall be deemed to result from either (a) a transfer of employment to the Company from an Affiliate or from the Company to an Affiliate, or from one Affiliate to another, or (b) an approved leave of absence for military service or sickness, or for any other purpose approved by the Company, if the Employee’s right to reemployment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Committee otherwise so provides in writing, in either case, except to the extent inconsistent with Section 409A of the Code if the applicable Award is subject thereto.

10.5.        Withholding Obligations. To the extent provided by the terms of an Award Agreement and subject to the discretion of the Committee, the Participant may satisfy any federal, state or local tax withholding obligation relating to the exercise or acquisition hereunder, then, uponof Common Stock under an Award by any of the effective datefollowing means (in addition to the Company’s right to withhold from any compensation paid to the Participant by the Company) or by a combination of such means: (a) tendering a cash payment; (b) authorizing the Company to withhold shares of Common Stock from the shares of Common Stock otherwise issuable to the Participant as a result of the exercise or acquisition of Common Stock under the Award,provided, however, that no shares of Common Stock are withheld with a value exceeding the minimum amount of tax required to be withheld by law; or (c) delivering to the Company previously owned and unencumbered shares of Common Stock of the Company.

11.           Adjustments Upon Changes in Stock. In the event of changes in the outstanding Common Stock or in the capital structure of the Company by reason of any stock or extraordinary cash dividend, stock split, reverse stock split, an extraordinary corporate transaction such as any recapitalization, reorganization, merger, consolidation, combination, exchange, or other relevant change in capitalization occurring after the Exercise Price in effect immediately prior to such combination will be proportionately increasedGrant Date of any Award, Awards granted under the Plan and any Award Agreements, the exercise price of Options and Stock Appreciation Rights, the maximum number of shares of Common Stock subject to acquisition upon exercise ofall Awards stated inSection4and the Warrant will be proportionately decreased.

(c)          Notice of Adjustments. Upon any adjustment of the Exercise Price and any increase or decrease in themaximum number of Warrant Shares purchasable upon the exercise of this Warrant, then, and in each such case, the Company, within 15 days thereafter, shall give written notice thereof to the Holder at the address of such Holder as shown on the books of the Company, which notice shall state the Exercise Price as adjusted and, if applicable, the increased or decreased number of Warrant Shares purchasable upon the exercise of this Warrant, setting forth in reasonable detail the method of calculation of each.

4.          Participation Rights.

(a)          Rights upon Distribution of Assets. Except with respect to such events in which an adjustment to the Exercise Price has been made pursuant to Section 3 above, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock by waywith respect to which any one person may be granted Awards during any period stated inSection4 will be equitably adjusted or substituted, as to the number, price or kind of returna share of capital or otherwise (including, without limitation, any distribution of cash, stockCommon Stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a "Distribution"), at any time after the issuance of this Warrant, then, in eachconsideration subject to such case, the Company shall provide at least thirty (30) days advance written notice to the Holder of its intention to make the Distribution and,Awards to the extent this Warrant has vested in accordance with Section 2(a)(ii),necessary to preserve the Holder may exercise this Warrant duringeconomic intent of such thirty (30) day period and will be entitled to receiveAward. In the property that is the subjectcase of the Distribution with respect to the number of Warrant Shares received upon such exercise.

(b)          Purchase Rights. In addition to any adjustments made pursuant to thisSection 3 above, if at any time11, unless the Company grants, issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property,Committee specifically determines that such adjustment is in each case pro rata to the record holders of any class of Common Stock (the "Purchase Rights"), then in each such case, the Company shall provide at least thirty (30) days advance written notice to the Holder of its intention to grant, issue or sell such Purchase Rights and, to the extent this Warrant has vested in accordance with Section 2(a)(ii), the Holder may exercise this Warrant during such thirty (30) day period and will be entitled to receive Purchase Rights with respect to the number of Warrant Shares received upon such exercise.

5.          Notices. Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be delivered in accordance with Section 11.3 of the Contribution Agreement.

4

6.          Legends. Unless the Warrant Shares are registered for resale with the Commission, each certificate evidencing the Warrant Shares issued upon exercise of this Warrant shall be stamped or imprinted with an appropriate restrictive legend.

7.          Removal of Legend. Upon request of a holder of a certificate with the legends required by Section 6 hereof, the Company shall issue to such holder a new certificate therefor free of any transfer legend, if, with such request, the Company shall have received an opinion of counsel satisfactory to the Company in form and substance to the effect that any transfer by such holder of the Warrant Shares evidenced by such certificate will not violate the Securities Act or any applicable state securities laws.

8.          Fractional Shares. No fractional Warrant Shares will be issued in connection with any exercise hereunder. Instead, the Company shall round up, as nearly as practicable to the nearest whole Share, the number of Warrant Shares to be issued.

9.          Rights of Stockholders. Except as expressly provided herein, the Holder, as such, shall not be entitled to vote or be deemed the holder of the Warrant Shares or any other securities of the Company that may at any time be issuable on the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of a stockholderbest interests of the Company or its Affiliates, the Committee shall, in the case of Incentive Stock Options, ensure that any right to vote for the election of directorsadjustments under thisSection11 will not constitute a modification, extension or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive notice of meetings, or otherwise until this Warrant shall have been exercised and the Warrant Shares purchasable upon the exercise hereof shall have been issued, as provided herein.

10.         No Transfer. This Warrant shall be assignable and transferable, provided that no such assignment and transfer shall be valid unless the same shall be valid under and undertaken in accordance with applicable law, rule or regulation.

11.         Miscellaneous.

(a)          This Warrant and disputes arising hereunder shall be governed by and construed and enforced in accordance with the lawsrenewal of the StateIncentive Stock Options within the meaning of Delaware applicable to agreements made and to be performed wholly within such State, without regard to its conflict of law rules.

(b)          The headings in this Warrant are for purposes of reference only, and shall not limit or otherwise affect anySection 424(h)(3) of the terms hereof.

(c)          The covenants of the respective parties contained herein shall survive the execution and delivery of this Warrant.

(d)          The terms of this Warrant shall be binding upon and shall inure to the benefit of any successors or permitted assigns of the Company and of the Holder and of the Warrant Shares issued or issuable upon the exercise hereof.

(e)          This Warrant and the other documents delivered pursuant hereto constitute the full and entire understanding and agreement between the parties with regard to the subject hereof.

(f)          The Company shall not, by amendment of its Certificate of Incorporation or Bylaws, or through any other means, directly or indirectly, avoid or seek to avoid the observance or performance of any of the terms of this Warrant and shall at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder contained herein against impairment.

5

(g)          Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this WarrantCode and in the case of Non-qualified Stock Options, ensure that any adjustments under thisSection11 will not constitute a modification of such loss, theft or destruction, upon deliveryNon-qualified Stock Options within the meaning of Section 409A of the Code. Any adjustments made under thisSection11 shall be made in a manner which does not adversely affect the exemption provided pursuant to Rule 16b-3 under the Exchange Act. The Company shall give each Participant notice of an indemnity agreement reasonably satisfactoryadjustment hereunder and, upon notice, such adjustment shall be conclusive and binding for all purposes.


12.           Effect of Change in formControl.

12.1.        In the discretion of the Board and amountthe Committee, any Award Agreement may provide, or the Board or the Committee may provide by amendment of any Award Agreement or otherwise, notwithstanding any provision of the Plan to the Company, or, in the case of any such mutilation, upon surrender and cancellation of such Warrant, the Company, at its expense, will execute and deliver to the Holder, in lieu thereof, a new Warrant of like date and tenor.

(h)          This Warrant and any provision hereof may be amended, waived or terminated only by an instrument in writing signed by the Company and the Holder.

(i)          The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agreescontrary, that in the event of a Change in Control, Options and/or Stock Appreciation Rights shall become immediately exercisable with respect to all or a specified portion of the shares subject to such Options or Stock Appreciation Rights, and/or the Restricted Period shall expire immediately with respect to all or a specified portion of the shares of Restricted Stock or Restricted Stock Units.

12.2.        In addition, in the event of a Change in Control, the Committee may in its discretion and upon at least 10 days’ advance notice to the affected persons, cancel any outstanding Awards and pay to the holders thereof, in cash or stock, or any combination thereof, the value of such breachAwards based upon the price per share of Common Stock received or threatened breach,to be received by other stockholders of the holderCompany in the event. In the case of this Warrantany Option or Stock Appreciation Right with an exercise price that equals or exceeds the price paid for a share of Common Stock in connection with the Change in Control, the Committee may cancel the Option or Stock Appreciation Right without the payment of consideration therefor.

12.3.        The obligations of the Company under the Plan shall be entitled,binding upon any successor corporation or organization resulting from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to all or substantially all of the assets and business of the Company and its Subsidiaries, taken as a whole.

13.           Amendment of the Plan and Awards.

13.1.        Amendment of Plan. The Board at any time, and from time to time, may amend or terminate the Plan. However, except as provided inSection11 relating to adjustments upon changes in Common Stock andSection13.3, no amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder approval is necessary to satisfy any Applicable Laws. At the time of such amendment, the Board shall determine, upon advice from counsel, whether such amendment will be contingent on stockholder approval.

13.2.        Stockholder Approval. The Board may, in its sole discretion, submit any other amendment to the Plan for stockholder approval.

13.3.        Contemplated Amendments. It is expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide eligible Employees, Consultants and Directors with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated thereunder relating to Incentive Stock Options or to the nonqualified deferred compensation provisions of Section 409A of the Code and/or to bring the Plan and/or Awards granted under it into compliance therewith.

13.4.        No Impairment of Rights. Rights under any Award granted before amendment of the Plan shall not be impaired by any amendment of the Plan unless (a) the Company requests the consent of the Participant and (b) the Participant consents in writing.

13.5.        Amendment of Awards. The Committee at any time, and from time to time, may amend the terms of any one or more Awards;provided, however, that the Committee may not affect any amendment which would otherwise constitute an impairment of the rights under any Award unless (a) the Company requests the consent of the Participant and (b) the Participant consents in writing.


14.           General Provisions.

14.1.        Forfeiture Events. The Committee may specify in an Award Agreement that the Participant’s rights, payments and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain events, in addition to all other available remedies, toapplicable vesting conditions of an injunction restraining anyAward. Such events may include, without limitation, breach without the necessity of showing economic loss and without any bondnon-competition, non-solicitation, confidentiality, or other security being required.restrictive covenants that are contained in the Award Agreement or otherwise applicable to the Participant, a termination of the Participant’s Continuous Service for Cause, or other conduct by the Participant that is detrimental to the business or reputation of the Company and/or its Affiliates.

 

(j)14.2.        Clawback. Notwithstanding anything hereinany other provisions in this Plan, any Award which is subject to recovery under any law, government regulation or stock exchange listing requirement, will be subject to such deductions and clawback as may be required to be made pursuant to such law, government regulation or stock exchange listing requirement (or any policy adopted by the Company pursuant to any such law, government regulation or stock exchange listing requirement).

14.3.        Other Compensation Arrangements. Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation arrangements, subject to stockholder approval if such approval is required; and such arrangements may be either generally applicable or applicable only in specific cases.

14.4.        Sub-plans. The Committee may from time to time establish sub-plans under the Plan for purposes of satisfying blue sky, securities, tax or other laws of various jurisdictions in which the Company intends to grant Awards. Any sub-plans shall contain such limitations and other terms and conditions as the Committee determines are necessary or desirable. All sub-plans shall be deemed a part of the Plan, but each sub-plan shall apply only to the contrary,Participants in nothe jurisdiction for which the sub-plan was designed.

14.5.        Deferral of Awards. The Committee may establish one or more programs under the Plan to permit selected Participants the opportunity to elect to defer receipt of consideration upon exercise of an Award, satisfaction of performance criteria, or other event willthat absent the Holder hereof be entitledelection would entitle the Participant to receive a net-cash settlement as liquidated damages in lieupayment or receipt of physical settlement in shares of Common Stock regardlessor other consideration under an Award. The Committee may establish the election procedures, the timing of whethersuch elections, the Common Stock underlying this Warrant is registered pursuant to an effective registration statement; provided, however,mechanisms for payments of, and accrual of interest or other earnings, if any, on amounts, shares or other consideration so deferred, and such other terms, conditions, rules and procedures that the foregoing will not precludeCommittee deems advisable for the Holder from seeking other remedies at law or equity for breaches byadministration of any such deferral program. All of such programs and procedures shall be consistent with the Companyrules of its registration obligations toSection 409A of the Holder.Code.

 

12.14.6.        Certain Defined TermsUnfunded Plan. The Plan shall be unfunded. Neither the Company, the Board nor the Committee shall be required to establish any special or separate fund or to segregate any assets to assure the performance of its obligations under the Plan.

14.7.        Recapitalizations. Each Award Agreement shall contain provisions required to reflect the provisions ofSection11.

 

(a)          "Closing Sale Price" means,14.8.        Delivery. Upon exercise of a right granted under this Plan, the Company shall issue Common Stock or pay any amounts due within a reasonable period of time thereafter. Subject to any statutory or regulatory obligations the Company may otherwise have, for any security aspurposes of any date, the last closing trade price for such security on an Eligible Market that is the principal market for such security, as reported by Bloomberg, or, if the Eligible Market that is the principal market for such security begins to operate on an extended hours basis and does not designate the closing trade price, then the last trade price of such security prior to 4:00:00 p.m., New York Time, as reported by Bloomberg, or, if the Eligible Market for such security is not the principal securities exchange or trading market for such security, the last trade price, respectively, of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no last trade price is reported for such security by Bloomberg, the average of the ask prices of any market makers for such security as reported in the OTC Link or "pink sheets" by OTC Markets Group Inc. (formerly Pink OTC Markets Inc.). If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such datethis Plan, thirty (30) days shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market valueconsidered a reasonable period of such security, then such dispute shall be resolved pursuant to Section 1(c). All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or other similar transaction during the applicable calculation period.

6

(b)          "Eligible Market" means the OTC Bulletin Board, OTCQX Market and/or OTCQB Market operated by OTC Markets Group, Inc., the NYSE MKT LLC, The NASDAQ Global Market, The NASDAQ Global Select Market, The NASDAQ Capital Market or The New York Stock Exchange, Inc.time.

 

(c)          "Trading Day" means any day on which the Common Stock is traded on an Eligible Market that is the principal market for such security;14.9.        providedNo Fractional Shares that "Trading Day" shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time).

[Signature Page Follows]

7

IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly authorized officer.

PHOTOMEDEX, INC.
By:
Name:
Title:

Exhibit A

NOTICE OF EXERCISE

TO:        PhotoMedex, Inc., attention: President

The undersigned hereby elects to purchase the below referenced shares (the “Warrant Shares”) of Common Stock of PhotoMedex, Inc. (the “Company”) pursuant to the terms of this Warrant, and tenders herewith payment of the purchase price of such Warrant Shares in full. Payment of the purchase price is being made by (check one):

____________   a cash exercise with respect to _________________ Warrant Shares; or

____________   a "cashless exercise" with respect to _______________ Warrant Shares

(as permitted pursuant to Section 2(b) of the Warrant).

Please issue a certificate or certificates representing said shares in the name of the undersigned or in such other name as is specified below:

1.          Name: __________________________________________________

2.          Address: ________________________________________________

3.          DWAC Instructions (if applicable): ___________________________________________

The undersigned hereby represents and warrants the following:

(a)          It (i) has such knowledge and experience in financial and business affairs that he/she/it is capable of evaluating the merits and risks involved in purchasing the Warrant Shares, (ii) is able to bear the economic risks involved in purchasing the Warrant Shares, and (iii) is an “accredited investor,” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended;

(b)          In making the decision to purchase the Warrant Shares, it has relied solely on independent investigations made by it and has had the opportunity to ask questions of, and receive answers from, the Company concerning the Warrant Shares, the financial condition, prospective business and operations of the Company and has otherwise had an opportunity to obtain any additional information, to the extent that the Company possess such information or could acquire it without unreasonable effort or expense;

(c)          Its overall commitment to investments that are not readily marketable is not disproportionate to its net worth and income, and the purchase of the Warrant Shares will not cause such overall commitment to become disproportionate; it can afford to bear the loss of the purchase price of the Warrant Shares;

(d)          It has no present need for liquidity in its investment in the Warrant Shares; and

(e)          It acknowledges that the transaction contemplated in connection with the purchase of the Warrant Shares has not been reviewed or approved by the Securities and Exchange Commission or by any administrative agency charged with the administration of the securities laws of any state, and that no such agency has passed on or made any recommendation or endorsement of any of the securities contemplated hereby.

(Signature)

ANNEX C

First Amendment to the Interest Contribution Agreement

 (GRAPHICS)

August 3, 2017

Mr. Suneet Singal

Authorized Representative

First Capital Real Estate Operating Partnership, L.P.

First Capital Real Estate Trust Incorporated

60 Broad Street

34th Floor

New York, NY 10004

Re:Amendment No. 1 to Interest Contribution Agreement, dated March 31, 2017, among First Capital Real Estate Operating Partnership, L.P., First Capital Real Estate Trust Incorporated, FC Global Realty Operating Partnership, LLC and PhotoMedex, Inc., as modified by the Agreement to Waive Closing Deliverables, dated May 17, 2017, and the Agreement to Waive Closing Deliverables, dated July 3, 2017 (collectively, the “Contribution Agreement”). Capitalized terms used, but not otherwise defined, herein have the meanings ascribed to them in the Contribution Agreement.

Dear Suneet,

As you know, since entering into the Contribution Agreement, the Acquiror Parent received notice from The NASDAQ Stock Market LLC (“NASDAQ”) indicating that, based upon the the Acquiror Parent’s non-compliance with NASDAQ Listing Rule 5110, which requires an issuer to file an initial listing application and satisfy the initial listing criteria upon completion of a change of control transaction, the NASDAQ Hearings Panel had determined to delist the Acquiror Parent’s common stock from NASDAQ and that trading of the Acquiror Parent’s common stock was suspended on NASDAQ effective with the open of trading on July 7, 2017. The Acquiror has appealed that decision, has already filed an initial listing application with NASDAQ, and is working to evidence full compliance with the applicable NASDAQ Listing Rules as soon as possible.

While awaiting that appeal, the Acquiror Parent’s stock remains listed, but suspended from trading, on NASDAQ. The stock has commenced trading on the OTCQB. The Securities and Exchange Commission (the “SEC”) considers the OTCQB marketplace to be an “established public market” for the purpose of determining the public market price of a company’s stock when registering securities for resale with the SEC, and the majority of broker-dealers trade stocks on the OTCQB marketplace.

Because of the cessation of trading on NASDAQ, the Parties agree to amend the Contribution Agreement as follows:

1.Waiver. The Contributor Parties hereby irrevocably waive any conditions to the Closing, including those contained in Section 7 of the Contribution Agreement, that require the Acquiror Parent to maintain its listing and active trading of its securities on any of the NASDAQ markets.

First Capital Real Estate Operating Partnership, L.P.

First Capital Real Estate Trust Incorporated

July 31, 2017

Page 2

2.Reaffirmation of Obligation to Contribute Mandatory Entity Interests. The Contributor Parties hereby reaffirm their obligation to use their best efforts to satisfy the Mandatory Contribution Conditions and contribute the Mandatory Entity Interests on or before December 31, 2017.

3.Confirmation Regarding Mandatory Contribution of Mandatory Entity Interests. The Acquiror Parties confirm the Contributor Parties’ understanding that the failure of the Contributor Parties to satisfy the Mandatory Contribution Conditions after using commercially reasonable efforts to do so does not give rise to a unilateral right of the Acquiror Parties to terminate the Contribution Agreement pursuant to Article 10 of the Contribution Agreement.

4.References to NASDAQ in the Contribution Agreement and Exhibits. The Parties agree that all references in the Contribution Agreement and each of the exhibits to the Contribution Agreement to NASDAQ shall, to the extent necessary, be deemed to be references to NASDAQ or such other trading market as the Company’s securities may be trading on, including, without limitation, the OTCQB. For the avoidance of doubt, for purposes of calculating the number of Acquiror Parent Shares into which principal under the Payout Notes will be converted for purposes of Section 6.17 and the Payout Notes, if the Acquiror Parent Shares are not traded on NASDAQ on the Approval Date, VWAP shall be calculated with respect to transaction in Acquiror Parent Shares executed on the OTCQB or such other market as the Acquiror Parent Shares may then be traded on instead of NASDAQ.

Except as aforesaid, the Interest Contribution Agreement remain unmodified and in full force and effect.

Very truly yours,
PhotoMedex, Inc.FC Global Realty Operating Partnership, LLC
By: /s/ Stephen JohnsonBy: /s/ Stephen Johnson
Stephen Johnson, CFOStephen Johnson, CFO
ACCEPTED AND AGREED TO:

First Capital Real Estate Operating Partnership, L.P.First Capital Real Estate Trust Incorporated
By:/s/ Suneet SingalBy:/s/ Suneet Singal
Suneet Singal, CEOSuneet Singal, CEO

ANNEX D

Form of Amendment to Amended and Restated Articles of Incorporation

To Effect a Reverse Stock Split

The Amended and Restated Articles of Incorporation of PhotoMedex, Inc. are hereby amended as follows:

Article 3 of the Amended and Restated Articles of Incorporation is hereby amended to add the following subsection:

(e) Upon the filing and effectiveness (the "Effective Time") pursuant to the Nevada General Corporation Law of this Certificate of Amendment to the Articles of Incorporation of PhotoMedex, Inc. (the “Corporation”), each [two, three, four, five, six or seven] (2 3, 4, 5, 6, 7) shares of Common Stock issued and outstanding immediately prior to the Effective Time shall, automatically and without any action on the part of the respective holders thereof, be combined and converted into one (1) share of Common Stock (the "Reverse Stock Split"). No fractional shares shall be issued in connection with the Reverse Stock Split. Stockholders who otherwise would be entitled to receive fractional shares of Common Stock shall be entitled to receive shares rounded upissued or delivered pursuant to the nearest whole share.Plan. The Committee shall determine whether cash, additional Awards or other securities or property shall be issued or paid in lieu of fractional shares of Common Stock or whether any fractional shares should be rounded, forfeited or otherwise eliminated.

 


14.10.      Other Provisions. The Award Agreements authorized under the Plan may contain such other provisions not inconsistent with this Plan, including, without limitation, restrictions upon the exercise of the Awards, as the Committee may deem advisable.

 

PROXY CARD14.11.      Section 409A. The Plan is intended to comply with Section 409A of the Code to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance therewith. Any payments described in the Plan that are due within the “short-term deferral period” as defined in Section 409A of the Code shall not be treated as deferred compensation unless Applicable Laws require otherwise. Notwithstanding anything to the contrary in the Plan, to the extent required to avoid accelerated taxation and tax penalties under Section 409A of the Code, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six (6) month period immediately following the Participant’s termination of Continuous Service shall instead be paid on the first payroll date after the six-month anniversary of the Participant’s separation from service (or the Participant’s death, if earlier). Notwithstanding the foregoing, neither the Company nor the Committee shall have any obligation to take any action to prevent the assessment of any excise tax or penalty on any Participant under Section 409A of the Code and neither the Company nor the Committee will have any liability to any Participant for such tax or penalty.

 

14.12.      Disqualifying Dispositions. Any Participant who shall make a “disposition” (as defined in Section 424 of the Code) of all or any portion of shares of Common Stock acquired upon exercise of an Incentive Stock Option within two years from the Grant Date of such Incentive Stock Option or within one year after the issuance of the shares of Common Stock acquired upon exercise of such Incentive Stock Option (a “Disqualifying Disposition”) shall be required to immediately advise the Company in writing as to the occurrence of the sale and the price realized upon the sale of such shares of Common Stock.

14.13.      Section 16. It is the intent of the Company that the Plan satisfy, and be interpreted in a manner that satisfies, the applicable requirements of Rule 16b-3 as promulgated under Section 16 of the Exchange Act so that Participants will be entitled to the benefit of Rule 16b-3, or any other rule promulgated under Section 16 of the Exchange Act, and will not be subject to short-swing liability under Section 16 of the Exchange Act. Accordingly, if the operation of any provision of the Plan would conflict with the intent expressed in thisSection14.13, such provision to the extent possible shall be interpreted and/or deemed amended so as to avoid such conflict.

14.14.      Beneficiary Designation. Each Participant under the Plan may from time to time name any beneficiary or beneficiaries by whom any right under the Plan is to be exercised in case of such Participant’s death. Each designation will revoke all prior designations by the same Participant, shall be in a form reasonably prescribed by the Committee and shall be effective only when filed by the Participant in writing with the Company during the Participant’s lifetime.

14.15.      Expenses. The costs of administering the Plan shall be paid by the Company.

14.16.      Severability. If any of the provisions of the Plan or any Award Agreement is held to be invalid, illegal or unenforceable, whether in whole or in part, such provision shall be deemed modified to the extent, but only to the extent, of such invalidity, illegality or unenforceability and the remaining provisions shall not be affected thereby.

14.17.      Plan Headings. The headings in the Plan are for purposes of convenience only and are not intended to define or limit the construction of the provisions hereof.

14.18.      Non-Uniform Treatment. The Committee’s determinations under the Plan need not be uniform and may be made by it selectively among persons who are eligible to receive, or actually receive, Awards. Without limiting the generality of the foregoing, the Committee shall be entitled to make non-uniform and selective determinations, amendments and adjustments, and to enter into non-uniform and selective Award Agreements.


15.           Effective Date of Plan. The Plan shall become effective as of the Effective Date, but no Award shall be exercised (or, in the case of a stock Award, shall be granted) unless and until the Plan has been approved by the stockholders of the Company, which approval shall be within twelve (12) months before or after the date the Plan is adopted by the Board.

16.           Termination or Suspension of the Plan. The Plan shall terminate automatically on April 18, 2028. No Award shall be granted pursuant to the Plan after such date, but Awards theretofore granted may extend beyond that date. The Board may suspend or terminate the Plan at any earlier date pursuant toSection13.1 hereof, provided any such suspension or termination is consistent with the provisions of Section 409A of the Code. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated.

17.           Choice of Law. Except to the extent governed by Federal law, the law of the State of Nevada shall govern all questions concerning the construction, validity and interpretation of this Plan, without regard to such state’s conflict of law rules.

As adopted by the Board of Directors of the Company on April 18, 2018.

As approved by the stockholders of the Company on __________, 2018.




PHOTOMEDEX, INC.FC GLOBAL REALTY INCORPORATED C/O
BROADRIDGE
1717 ARCH STREET, SUITE 1300
PHILADELPHIA, PA 19103



VOTE BY INTERNET -www.proxyvote.com

Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M.p.m. Eastern Time September 13, 2017.on November 28, 2018. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.

C/O BROADRIDGE

1717 ARCH STREET, SUITE 1300

PHILADELPHIA, PA 19103

ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS

If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.

Voting:

P.O. Box 1342

Brentwood, NY  11717

VOTE BY PHONE - 1-800-690-6903

Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M.p.m. Eastern Time on September 13, 2017.November 28, 2018. Have your proxy card in hand when you call and then follow the instructions.

VOTE BY MAIL

Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, P.O. Box 1342, Brentwood,51 Mercedes Way, Edgewood, NY 11717.

 

TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
E52507-P14927KEEP THIS PORTION FOR YOUR RECORDS
DETACH AND RETURN THIS PORTION ONLY

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.

 

           
 FC GLOBAL REALTY INCORPORATED  ForWithholdFor All
  The Board of Directors recommends that you vote FOR ALL the following:AllAllExcept
           

DETACH AND RETURN THIS PORTION ONLY

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.

PHOTOMEDEX, INC.

The Board of Directors recommends you vote FOR the following proposals:

1.To approve an amendment and restatement of the Amended and Restated Articles of Incorporation of the Company to, among other things, change the name of the Company to “FC Global Realty Incorporated,” increase the number of authorized shares of common stock, $.01 par value per share, of the Company from fifty million (50,000,00) shares to five hundred million (500,000,000) shares, and increase the number of authorized shares of preferred stock, $.01 par value per share, of the Company from five million (5,000,000) shares to fifty million (50,000,000) shares. 

For

¨

4.
Election of Directors 

Against

¨

 

Abstain

¨

2.To approve the issuance of securities of the Company pursuant to that certain Interest Contribution Agreement, dated March 31, 2017, by and among First Capital Real Estate Operating Partnership, L.P., a Delaware limited partnership (the “Contributor”), First Capital Real Estate Trust Incorporated, a Maryland corporation (the “Contributor Parent”), FC Global Realty Operating Partnership, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company (the “Acquiror”), and the Company (the “Contribution Agreement”), under which the Contributor has agreed to contribute certain real estate assets to the Acquiror, and in exchange, the Company has agreed to issue to the Contributor or its designees shares of the Company’s common stock and Series A Convertible Preferred Stock and, if certain additional real estate assets are contributed to the Acquiror, a warrant for the purchase of shares of common stock (the “Contribution Transaction”).  Also under the Contribution Agreement, all outstanding compensation liabilities owed by the Company toNominees:
01) Richard Leider              04) Dr. Dolev Rafaeli
02) Dennis M. McGrath      and Yoav Ben-Dror will be converted into secured convertible promissory notes. The Company’s common stock is listed on the NASDAQ Capital Market and, as a result, the Company is subject to NASDAQ’s Listing Rules. The potential consummation of the Contribution Transaction implicates certain of NASDAQ’s Listing Rules requiring prior stockholder approval in order to maintain the Company’s listing on the NASDAQ Capital Market, including (i) NASDAQ Listing Rule 5635(a), which requires stockholder approval prior to the issuance of securities in connection with the acquisition of the stock or assets of another company if the common stock has or will have upon issuance voting power equal to or in excess of 20% of the voting power outstanding before the issuance of stock or securities convertible into or exercisable for common stock, or if the number of shares of common stock to be issued is or will be equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the stock or securities, and (ii) NASDAQ Listing Rule 5635(b), which requires stockholder approval when any issuance or potential issuance will result in a “change of control” of the issuer.  In order to comply with these NASDAQ Listing Rules, the Company would need to obtain the approval of its stockholders prior to the issuance of all securities as contemplated by the Contribution Transaction, including the secured convertible promissory notes.  Accordingly, prior to stockholder approval at the annual meeting, the Contributor has received a number of shares of common stock equal to up to 19.9% of the issued and outstanding common stock of the Company immediately prior to the initial closing of the Contribution Transaction and the balance of the shares shall be paid in the Company’s Series A Convertible Preferred Stock.  At the annual meeting, stockholders will be asked to approve the issuance of shares of common stock upon conversion of the Series A Convertible Preferred Stock, the issuance of the warrant, the issuance of shares of common stock upon exercise of the warrant, the issuance of the secured convertible promissory notes, and the issuance of shares of common stock upon conversion of the secured convertible promissory notes, all as more particularly described in the accompanying proxy statement.05) Michael R. Stewart 

For

¨

 

Against

¨

03) Kristen E. Pigman 

Abstain

¨

        
3.
The Board of Directors recommends you vote FOR the following proposals:ForAgainstAbstain
1.To approve athe transactions contemplated by that certain remediation agreement, dated September 24, 2018, among the Company, Opportunity Fund I-SS, LLC, Dr. Dolev Rafaeli, Dennis M. McGrath and Yoav Ben-Dror, including the issuance of shares of the Company’s common stock upon the conversion of shares of preferred stock that have been issued thereunder.
2.To authorize the Company’s Board of Directors, in its discretion, to implement one or more reverse stock splitsplits of the shares of the Company’s common stock at an exchange ratio of not less than 1-for-2 and not more than 1-for-7 and to authorize the Company’s Board of Directors, in its discretion, to implement such reverse stock split at an exchange ratio within this range and to do so1-for-15 at any time prior to the Company’s 20182019 annual meeting of stockholders by filing an amendment to the Company’s Amended and Restated Articles of Incorporation. 
3.To adopt the FC Global Realty Incorporated 2018 Equity Incentive Plan to provide for long-term incentives in the form of grants of stock, stock options and other forms of incentive compensation to officers, employees, directors and consultants.
Please sign exactly as your name appears hereon. When signing as attorney, executor, administrator, or other fiduciary, please give your full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.

For

¨

 

Against

¨

 

Abstain

¨

The Board of Directors recommends that you vote FOR ALL the following: 

For

All

 

Withhold

All

Signature [PLEASE SIGN WITHIN BOX]
 

For All

Except

Date
 
To withhold authority to vote for any individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below.
   
       
4.Election of Directors ¨ ¨¨  
Nominees:       

 01Dr. Robert Froehlich02Richard Leider03Dennis McGrath04Darrel Menthe 
 05Dr. Dolev Rafaeli  06 Suneet Singal 07 Michael R. Stewart    

The Board of Directors recommends you vote FOR the following proposals:

For AgainstAbstain
5.To ratify the appointment of Fahn Kanne & Co. Grant Thornton Israel to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2017.2018. 

For

¨

Against

¨

Abstain

¨

       
6.To approve the adjournment of the annual meeting for any purpose, including to solicit additional proxies if there are insufficient votes at the time of the annual meeting to approve the proposals described above.

For

¨

 

Against

¨

 

Abstain

¨

NOTE: To transact such other business as may come before the Meeting and any adjournments thereto.

Please sign exactly as your name appears hereon. When signing as attorney, executor, administrator, or other fiduciary, please give your full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, authorized officer.   

NOTE: To transact such other business as may come before the Meeting and any adjournments thereto.
       
 

Signature (PLEASE SIGN WITHIN BOX)(Joint Owners)Date Signature (Joint Owner)Date


Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The Combined Document is available at www.proxyvote.com.

E52508-P14927

FC GLOBAL REALTY INCORPORATED
Annual Meeting of Stockholders
November 29, 2018 9:30 AM
This proxy is solicited by the Board of Directors
The stockholder(s) hereby appoint(s) Michael R. Stewart and Michele Pupach, or either of them, as proxies, each with the power to appoint his/her substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Common stock of FC GLOBAL REALTY INCORPORATED that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 9:30 AM, EST on November 29, 2018, at the 2300 Computer Drive, Building G, Willow Grove, Pennsylvania 19090, and any adjournment or postponement thereof.
This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors’ recommendations.
Continued and to be signed on reverse side